Citrus Sinensis ID: 002533
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 911 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FID8 | 873 | Putative receptor-like pr | yes | no | 0.933 | 0.973 | 0.501 | 0.0 | |
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.951 | 0.985 | 0.492 | 0.0 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.925 | 0.941 | 0.485 | 0.0 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.914 | 0.970 | 0.429 | 0.0 | |
| Q9SR05 | 850 | Receptor-like protein kin | no | no | 0.879 | 0.942 | 0.435 | 0.0 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.851 | 0.914 | 0.390 | 1e-152 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.903 | 0.962 | 0.376 | 1e-150 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.827 | 0.858 | 0.388 | 1e-145 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.882 | 0.968 | 0.377 | 1e-145 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.844 | 0.913 | 0.397 | 1e-144 |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 837 bits (2161), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/897 (50%), Positives = 573/897 (63%), Gaps = 47/897 (5%)
Query: 21 AAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQEN 80
E + Y PTD L CG++SN GRNW + + K SSN SFT++AS+QE+
Sbjct: 18 VGEGATSTYEPTDVFLFNCGDTSNNVDVSGRNWTAE-NQKILSSNLVNASFTAQASYQES 76
Query: 81 SVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFT 140
V Q+PYMTAR+F EFTY+FPV+PG FLRL+FYP Y G Q + SFF+
Sbjct: 77 GVSQIPYMTARIFRSEFTYSFPVTPGSNFLRLYFYPTRY--GSQFNAVK-------SFFS 127
Query: 141 VSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSSSSSYAFINGI 200
V N +TLL NFSA LTV A P + KEFII V Q LNLTF+PS S AF+NGI
Sbjct: 128 VKVNGFTLLNNFSADLTVKASKPQTEFIIKEFIIPVY--QTLNLTFTPSLDS-LAFVNGI 184
Query: 201 EVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHVSAKDDTGMFR 260
E+VS+P+ Y + D I + S+ F + A ET YRLNVGG V D+GMFR
Sbjct: 185 EIVSIPNRFY-SKGGFDDVITNVGSSVDFHIENSTAFETVYRLNVGGKTVG---DSGMFR 240
Query: 261 EWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMGK--DPNINKKYN 318
W+ D I +SG++P +P +I YT TP+Y+AP VY TSR+MG P N +N
Sbjct: 241 RWVSDDEIILSESSGISPIVPDIKINYTEKTPSYVAPDDVYATSRSMGNADHPEQNLNFN 300
Query: 319 LTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAENDADVIHWSGGSGIPV 378
LTW F+VD GF+YLVRLHFCET E+ +E QRVFSIFI NQTA + DV SGGS IP+
Sbjct: 301 LTWLFTVDAGFSYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWIPM 360
Query: 379 FKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAILNGLEIFKLNNSDGNLAGP 438
+ DY V I + D L LHP + ++P KY DAILNG+EI K+N+ DGNLAGP
Sbjct: 361 YLDYTV---IAGSGSGRRHDLRLDLHPLVSINP--KYYDAILNGVEILKMNDPDGNLAGP 415
Query: 439 NPASKPPPEPKPGKQQ-NVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRVNVN 497
NP P+ P + ++ NK ++ I + AV+GS+ L + + +
Sbjct: 416 NPDPLVSPDLIPNRATPRIRKNKSHILPITL--AVVGSLVVLAMFVVGVLV-------IM 466
Query: 498 ESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQATCDFADHCIIGS 557
+ + K ++ SW P + +TNT A SLP+DLCRRFS+ EIK AT DF D IIG
Sbjct: 467 KKKKKSKPSTNSSWCPLPHGTDSTNTKPAKSLPADLCRRFSIFEIKSATNDFEDKLIIGV 526
Query: 558 GGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG 617
GGFG V+KG ID G+ VAVKRL +S QGA+EF TE+EM+S+LRH+H+VSL+G+CDE
Sbjct: 527 GGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDN 586
Query: 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAK 677
EM+LVYE+MP G L+DHL+ +++ + PL+WKRRLEI IGAARGL YLH GAK
Sbjct: 587 EMVLVYEYMPHGTLKDHLFR-------RDKTSDPPLSWKRRLEICIGAARGLQYLHTGAK 639
Query: 678 HTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ 737
+TIIHRD+K+TNILLDEN+ K+SDFGLSR+GP+ SQ+HVSTVVKG+FGY+DPEY RRQ
Sbjct: 640 YTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQ 699
Query: 738 QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRG 797
LTEKSDVYSFGVVLLEVLC RP + +V E+ L+ W + + RGTVDQI+D L
Sbjct: 700 VLTEKSDVYSFGVVLLEVLCCRPIRMQ-SVPPEQADLIRWVKSNYRRGTVDQIIDSDLSA 758
Query: 798 KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSD---QGRPFVPR 854
I L KF EIA C + G RP M DV W LEFALQL E A+K + + +P
Sbjct: 759 DITSTSLEKFCEIAVRCVQDRGMERPPMNDVVWALEFALQLHETAKKKNDNVESLDLMPS 818
Query: 855 GEVITSSTTTDSDEPFSRSSGQVSESRSNTTSSGADGERIRVRSENVFTEIMDPKGR 911
GEV +TT D+ FSR++G V +S + S G+ S VF+EI +PK R
Sbjct: 819 GEV--GTTTDGEDDLFSRTTGHVGKSTTTDDSVLVVGDERSGSSWGVFSEINEPKAR 873
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/911 (49%), Positives = 582/911 (63%), Gaps = 44/911 (4%)
Query: 10 IIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNSATK 69
++ F ++ SA + T+ Y PTD LI CG++SN GRNW + + KF SSN+
Sbjct: 5 VLVIFTILVSAVVDATAS-YEPTDVFLINCGDTSNNMDYSGRNWTTE-NPKFMSSNAVDD 62
Query: 70 -SFTSRASFQENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLGQQQGGL 128
SFTS AS+QE+ +PQVPY+ AR+F +FTY+FPVSPG KFLRL+FYP Y G
Sbjct: 63 ASFTSSASYQESGIPQVPYLKARIFRYDFTYSFPVSPGWKFLRLYFYPTRY-------GS 115
Query: 129 DNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSP 188
D + SFF+V+ N++TLL NFS V A IP + KEFI+ V+ Q L+LTF+P
Sbjct: 116 DFDAV--KSFFSVNVNRFTLLHNFS----VKASIPESSSLIKEFIVPVN--QTLDLTFTP 167
Query: 189 SSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGA 248
S +S AF+NGIE++SMPD Y + D + + + F D A ET YR+NVGG
Sbjct: 168 SPNS-LAFVNGIEIISMPDRFY-SKGGFDDVVRNVGRDVDFEIDNSTAFETVYRVNVGGK 225
Query: 249 HVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMG 308
V D+GMFR WL D ++ G SG P++ G +I YT TPAY+AP VYTT R MG
Sbjct: 226 VVGDVGDSGMFRRWLSDEGFLLGINSGAIPNITGVKINYTDKTPAYVAPEDVYTTCRLMG 285
Query: 309 -KD-PNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAENDAD 366
KD P +N +NLTW F VD GF Y+VRLHFCETQ E+ + RVFSIF Q A + D
Sbjct: 286 NKDSPELNLNFNLTWLFEVDAGFAYIVRLHFCETQPEVNKTGDRVFSIFFGYQLAMREMD 345
Query: 367 VIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAILNGLEIF 426
V SGG +P++ D+ V V D + + + L P+ + P Y DAIL+G+EI
Sbjct: 346 VFRLSGGFRLPMYLDFKVLVDADGTSQ--RPSLRVDLTPYKE--DYPTYYDAILSGVEIL 401
Query: 427 KLNNSDGNLAGPNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFF 486
KL+NSDGNLAG NP + P P+ K V+ III AV+GS AL +
Sbjct: 402 KLSNSDGNLAGLNPIPQLSPPPQSITPLKGKGKSSHVLPIII--AVVGSAVALAFFVLVV 459
Query: 487 F---LRKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIK 543
+++KK+ N + + K ++ SW P + +TNT +ASSLPSDLCRRFS+ EIK
Sbjct: 460 VLVVMKRKKKSNESSVDTTNKPSTNSSWGPLLHGTGSTNTKSASSLPSDLCRRFSIYEIK 519
Query: 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRH 603
AT DF + IIG GGFG V+KG ID G+ VAVKRL +S QGA+EF TE+EM+S+LRH
Sbjct: 520 SATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKLRH 579
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
+H+VSL+G+CD+ EM+LVYE+MP G L+DHL+ K + + PL+WKRRLEI I
Sbjct: 580 VHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKAS-------DPPLSWKRRLEICI 632
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
GAARGL YLH GAK+TIIHRD+K+TNILLDEN+ AK+SDFGLSR+GP+ SQ+HVSTVVK
Sbjct: 633 GAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRVGPTSASQTHVSTVVK 692
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783
G+FGY+DPEY RRQ LTEKSDVYSFGVVLLEVLC RP + +V E+ L+ W + +
Sbjct: 693 GTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQ-SVPPEQADLIRWVKSNFN 751
Query: 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAE 843
+ TVDQI+D L I + KF EIA C + G RP M DV W LEFALQL E A+
Sbjct: 752 KRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALEFALQLHETAK 811
Query: 844 KSD---QGRPFVPRGEVITSSTTTDSDEPFSRSSGQVSESRSNTTSSGADGERIRVRSEN 900
K + + +P GEV +TT D+ FSR++G V +S + S G+ S
Sbjct: 812 KKNDNVESLDLMPSGEV--GTTTDGEDDLFSRTTGHVGKSTTTDDSVLVVGDERSGSSWG 869
Query: 901 VFTEIMDPKGR 911
VF+EI +PK R
Sbjct: 870 VFSEINEPKAR 880
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 800 bits (2065), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/926 (48%), Positives = 577/926 (62%), Gaps = 83/926 (8%)
Query: 19 SAAAEQTSPPYIPTDYILIICGE-SSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASF 77
SAA ++ Y PT+ IL+ CG +SN T +D R W D SKF SS+S + A
Sbjct: 20 SAATLISAADYSPTEKILLNCGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSP-ALT 78
Query: 78 QENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTS 137
Q+ SVP+VPYMTARVF FTYTFPV+ G KF+RL+FYP Y GL+ + S
Sbjct: 79 QDPSVPEVPYMTARVFRSPFTYTFPVASGRKFVRLYFYPNSY------DGLN----ATNS 128
Query: 138 FFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSS--SSSYA 195
F+VS YTLL+NFSA T A+ A+ KEF+++V LN+TF+P S S++YA
Sbjct: 129 LFSVSFGPYTLLKNFSASQTAEALT--YAFIIKEFVVNVEGGT-LNMTFTPESAPSNAYA 185
Query: 196 FINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHVSAKDD 255
F+NGIEV SMPD S D ++ + S+ + D ALE YRLNVGG +S D
Sbjct: 186 FVNGIEVTSMPD----MYSSTDGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSAD 241
Query: 256 TGMFREWLDDTNYIYGAASGVTPHL-PGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNIN 314
TG++R W DD YI+GA G+ P IKY + TP Y+APV VY+T+R+MG IN
Sbjct: 242 TGLYRSWYDDQPYIFGAGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQIN 301
Query: 315 KKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAENDADVIHWSGGS 374
YNLTW FS+D GF YLVRLHFCE IT+ NQRVF+I++NNQTAE +ADVI W+ +
Sbjct: 302 LNYNLTWIFSIDSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSN 361
Query: 375 GIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPL--PKYADAILNGLEIFKLNNSD 432
G+P KDYVV P E +QD WLALHP +P+ P+Y D++LNG+EIFK+N SD
Sbjct: 362 GVPFHKDYVVNPP----EGNGQQDLWLALHP----NPVNKPEYYDSLLNGVEIFKMNTSD 413
Query: 433 GNLAGPNPASKPPPEPKPGK-----QQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFFF 487
GNLAG NP P P K + K+N + A VL I + F
Sbjct: 414 GNLAGTNPIPGPQVTADPSKVLRPTTRKSKSNTAIIAGAASGAVVLALI---IGFCVFGA 470
Query: 488 LRKKKRVNVNESASEVKTKSSQSWVPFSY---------ALTATNTNTASSLPSDLCRRFS 538
R++KR + ++ ++ W+P S A T T + ASSLPS+LCR FS
Sbjct: 471 YRRRKRGDYQPASD-----ATSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFS 525
Query: 539 LTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMI 598
EIK AT +F + ++G GGFG V++G ID G+ VA+KR N S QG EF+TEIEM+
Sbjct: 526 FAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEML 585
Query: 599 SELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRR 658
S+LRH H+VSL+G+C+E+ EMILVY++M G +R+HLY + QN L WK+R
Sbjct: 586 SKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLY----------KTQNPSLPWKQR 635
Query: 659 LEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV 718
LEI IGAARGLHYLH GAKHTIIHRDVK+TNILLDE W AK+SDFGLS+ GP+ + +HV
Sbjct: 636 LEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHV 694
Query: 719 STVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778
STVVKGSFGY+DPEY RRQQLTEKSDVYSFGVVL E LC R P +N + KE+VSL WA
Sbjct: 695 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCAR-PALNPTLAKEQVSLAEWA 753
Query: 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838
+G +DQIVDP L+GKI P C KF E A C ++G RP+MGDV W LEFALQL
Sbjct: 754 PYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLEFALQL 813
Query: 839 QEAAEKSDQGRPFVPRGEVITSSTTTD-------SDEPFSRSSGQVSESRSNTTSSGADG 891
QE+AE++ +G G++ D +D+ G V++SRS+ G
Sbjct: 814 QESAEENGKGVC----GDMDMDEIKYDDGNCKGKNDKSSDVYEGNVTDSRSSGIDMSIGG 869
Query: 892 ERIRVRSEN------VFTEIMDPKGR 911
+ + VF++IM+PKGR
Sbjct: 870 RSLASEDSDGLTPSAVFSQIMNPKGR 895
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/926 (42%), Positives = 540/926 (58%), Gaps = 93/926 (10%)
Query: 7 LYFIIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNS 66
L + F C + SP I + CG S D + W+ D +KF + +
Sbjct: 5 LRILFSFLCFFYVLLV---SPSQSNGQDISLSCGASEPAVDQDKKKWEPD--TKFLKTPN 59
Query: 67 ATKSFTSRASFQENSV-PQVPYMTARVFPEEFTYTFPVSPGPK-FLRLHFYPAPYLLGQQ 124
+ A++Q+ S+ VPYMT+R+F TY PV + LRLHFYP+ Y
Sbjct: 60 TVHA---PATYQDPSLLSTVPYMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYT---- 112
Query: 125 QGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNL 184
GL+ I S+F+V+AN TLL NFSA +T A+ AY +E+ ++ S +L++
Sbjct: 113 --GLN----ILDSYFSVAANDLTLLSNFSAAITCQALTQ--AYLVREYSLAPSEKDVLSI 164
Query: 185 TFSPSSS--SSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYR 242
F+PS ++AFINGIEV+ MP+ D + F + S K L+T +R
Sbjct: 165 IFTPSDKHPKAFAFINGIEVIPMPELF-----DTASLVGFSDQT---SDTKTANLQTMFR 216
Query: 243 LNVGGAHV-SAKDDTGMFREWLDDTNYIYGAASGVTPHLPGA-RIKYTSDTPAYIAPVIV 300
LNVGG + ++D G+ R W +D YI+ A GVT RI Y P AP V
Sbjct: 217 LNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFRIDY-QKMPVSTAPADV 275
Query: 301 YTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQT 360
Y T+R+ G + +IN K NLTW F VD F Y++RLHFCE QL + NQ+VF+IFINN+T
Sbjct: 276 YKTARSQGPNGDINMKSNLTWMFQVDTNFTYIMRLHFCEFQL--AKINQKVFNIFINNRT 333
Query: 361 AEND---ADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYAD 417
A+ D AD++ W+GG GIP +KDY ++V DA ++ L + P P+Y D
Sbjct: 334 AQGDTNPADILGWTGGKGIPTYKDYAIYV--DANTGGGGEEISLQMTP--STFGQPEYYD 389
Query: 418 AILNGLEIFKLNNSDGNLAGPNPASKPPPEPKPGKQQNVKNNKG-RVILIIIIAAVLGSI 476
+ LNGLEIFK++ NLAGPNP P P + K+ +G + I +I + G
Sbjct: 390 SQLNGLEIFKIDTMK-NLAGPNPK----PSPMQANEDVKKDFQGDKRITAFVIGSAGGVA 444
Query: 477 FALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPF-----------SYALTATNTNT 525
L L F ++K++ + ++S + SW+P + + + N +
Sbjct: 445 AVLFCALCFTMYQRKRKFSGSDS-------HTSSWLPIYGNSHTSATKSTISGKSNNGSH 497
Query: 526 ASSLPSDLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM 585
S+L + LCRRFSL+EIK T +F + +IG GGFG V+KG ID G+ VA+K+ N +S
Sbjct: 498 LSNLAAGLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGT-KVAIKKSNPNSE 556
Query: 586 QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQ 645
QG EF TEIE++S LRH H+VSL+G+CDE GEM L+Y++M G LR+HLYN+++
Sbjct: 557 QGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQ--- 613
Query: 646 NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705
LTWKRRLEI+IGAARGLHYLH GAK+TIIHRDVK+TNILLDENW AK+SDFGL
Sbjct: 614 -------LTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGL 666
Query: 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMING 765
S+ GP+ M+ HV+TVVKGSFGY+DPEY RRQQLTEKSDVYSFGVVL EVLC RP + N
Sbjct: 667 SKTGPN-MNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPAL-NP 724
Query: 766 AVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM 825
++ KE+VSL WA + +GT++ I+DP L+GKI P CL KF + A C + G RPTM
Sbjct: 725 SLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTM 784
Query: 826 GDVTWGLEFALQLQEAAEKSDQGRPFVPRGEVITSSTTTDSDEPFSRSSGQVSESRSNTT 885
GDV W LEFALQLQE A+ S P G V S + + S+
Sbjct: 785 GDVLWNLEFALQLQETADGSRHRTPSNGGGSVDLGGGGGGVTVNISAGESDLGDDLSSEE 844
Query: 886 SSGADGERIRVRSENVFTEIMDPKGR 911
+SG +F++I++PKGR
Sbjct: 845 NSG------------IFSQIVNPKGR 858
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/898 (43%), Positives = 533/898 (59%), Gaps = 97/898 (10%)
Query: 35 ILIICGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQENSV-PQVPYMTARVF 93
+ + CG S + D + W+ D +KF + + S + A++Q+ S+ VPYMTAR+F
Sbjct: 29 LALSCGTSEASADQDKKKWEPD--TKFLKTGN---SIHATATYQDPSLLSTVPYMTARIF 83
Query: 94 PEEFTYTFPVSPGPK-FLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLRNF 152
TY P+ + LRL+FYP+ Y GL+ IS S+FTV AN TLL NF
Sbjct: 84 TAPATYEIPIKGDKRHLLRLYFYPSTYT------GLN----ISNSYFTVEANDVTLLSNF 133
Query: 153 SAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSSS--SSYAFINGIEVVSMPDNLY 210
SA +T A+ AY KE+ ++ + +L++ F+PS ++AFINGIEV+ MP+
Sbjct: 134 SAAITCQALTQ--AYLVKEYSLAPTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPELF- 190
Query: 211 LQQSDGDRSIPFINSNTIFSFDKPVA-LETAYRLNVGGAHV-SAKDDTGMFREWLDDTNY 268
D + F + + D A L++ +RLNVGG + ++D G+ R W +D Y
Sbjct: 191 ----DTAALVGFTDQ----TMDAKTANLQSMFRLNVGGQDIPGSQDSGGLTRTWYNDAPY 242
Query: 269 IYGAASGVTPHLPGA-RIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLTWNFSVDP 327
I+ A GVT RI Y + P IAP +Y T+R+ G + +IN K NLTW F +D
Sbjct: 243 IFSAGLGVTLQASNNFRINY-QNMPVSIAPADIYKTARSQGPNGDINLKSNLTWMFQIDK 301
Query: 328 GFNYLVRLHFCETQLEITRENQRVFSIFINNQTAEND---ADVIHWSGGSGIPVFKDYVV 384
F Y++RLHFCE QL ++ NQ+VF+I+INN+TA+ D AD+I W+G GIP++KDY +
Sbjct: 302 NFTYILRLHFCEFQL--SKINQKVFNIYINNRTAQADTTPADIIGWTGEKGIPMYKDYAI 359
Query: 385 WVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAILNGLEIFKLNNSDGNLAGPNPASKP 444
+V DA ++ L + P P+Y D+ LNGLEIFK++ NLAGPNP
Sbjct: 360 YV--DA--NNGGEEITLQMTP--STFGQPEYYDSSLNGLEIFKMDTMK-NLAGPNPE--- 409
Query: 445 PPEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRVNVNESASEVK 504
P P +++ K K II + G + L+ L F +KK+ +S
Sbjct: 410 -PSPMQAEEEVKKEFKNEKRHAFIIGSAGGVLAVLIGALCFTAYKKKQGYQGGDS----- 463
Query: 505 TKSSQSWVPFSYALTATNTNTA-----------SSLPSDLCRRFSLTEIKQATCDFADHC 553
+ SW+P T + T + S+L + LCRRFSL EIK T +F D
Sbjct: 464 --HTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSN 521
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+IG GGFG V+KG ID G+ VAVK+ N +S QG EF TEIE++S LRH H+VSL+G+C
Sbjct: 522 VIGVGGFGKVYKGVID-GTTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYC 580
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
DE GEM LVY++M G LR+HLYN++K LTWKRRLEI+IGAARGLHYLH
Sbjct: 581 DEGGEMCLVYDYMAFGTLREHLYNTKKPQ----------LTWKRRLEIAIGAARGLHYLH 630
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
GAK+TIIHRDVK+TNIL+DENW AK+SDFGLS+ GP+ M+ HV+TVVKGSFGY+DPEY
Sbjct: 631 TGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPN-MNGGHVTTVVKGSFGYLDPEY 689
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDP 793
RRQQLTEKSDVYSFGVVL E+LC RP + N ++ KE+VSL WA + +G ++ I+DP
Sbjct: 690 FRRQQLTEKSDVYSFGVVLFEILCARPAL-NPSLPKEQVSLGDWAMNCKRKGNLEDIIDP 748
Query: 794 RLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSDQGRPFVP 853
L+GKI CL KF + A C ++ G RPTMGDV W LEFALQLQE A+ + P
Sbjct: 749 NLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQLQETADGTRHRTP--- 805
Query: 854 RGEVITSSTTTDSDEPFSRSSGQVSESRSNTTSSGADGERIRVRSENVFTEIMDPKGR 911
S E R V+ + + S + + +F++I++PKGR
Sbjct: 806 --------NNGGSSEDLGRGGMAVNVAGRDDVSDLSSEDNTE-----IFSQIVNPKGR 850
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 540 bits (1391), Expect = e-152, Method: Compositional matrix adjust.
Identities = 337/863 (39%), Positives = 474/863 (54%), Gaps = 87/863 (10%)
Query: 7 LYFIIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNS 66
L ++ FF V Q+ L+ CG S+ TT DGR W GD S +
Sbjct: 12 LLCVLIFFTYVIGYGEAQSKS-------FLVDCG-SNATTEVDGRTWVGDLSPNKSVTLQ 63
Query: 67 ATKSFTSRASFQENSVPQVPYMTARVFPEEFTYTFP-VSPGPKFLRLHFYPAPYLLGQQQ 125
+ T+ S + +SV Y TARVF YTF ++ G F+RLHF P
Sbjct: 64 GFDAITASTS-KGSSVYAEIYKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAI------ 116
Query: 126 GGLDNNDTISTSFFTVSANKYTLLR--NFSAHLTVSAII-------PPVAYFFKEFIISV 176
N ++ S F+V A+ L+ N + + +I + KEF++
Sbjct: 117 ----ENHNVNESSFSVFADGLRLMLDINIAGEIAHKNLILESTGHNATASSLVKEFLLPT 172
Query: 177 SSSQMLNLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVA 236
+++ L+F P S + F+N IE+VS+ D L+ + S+ + + +
Sbjct: 173 GPGKLV-LSFIPEKGS-FGFVNAIEIVSVDDKLFKE------SVTKVGGSEVELGLGGRG 224
Query: 237 LETAYRLNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIA 296
+ET YRLNVGG + D ++R W D +Y+ +GV + I Y + +A
Sbjct: 225 IETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENAGVEVK-NSSNITYALADDSPVA 283
Query: 297 PVIVYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFI 356
P++VY T+R M + K++N++W F VDP F+YLVRLHFCE L + ++NQR+F I+I
Sbjct: 284 PLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCE--LLVDKQNQRIFRIYI 341
Query: 357 NNQTAENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQD-FWLALHPFLDLDPLPKY 415
NNQTA + D+ +GG +++DY +D + SK D W+ L P +
Sbjct: 342 NNQTAAGNFDIFAHAGGKNKGIYQDY-----LDPVS--SKNDVLWIQLGPD---SSVGAS 391
Query: 416 ADAILNGLEIFKLNNSDGNLAGPNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLGS 475
DA+L+GLEIFKL+ +GNLA +V ++K R+I I + A +
Sbjct: 392 GDALLSGLEIFKLSK-NGNLAHLIRFDSTG--------HSVSDSKMRIIWISVGAGIAII 442
Query: 476 IFALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPFSYAL---TATNTNTASSL--- 529
IF + + L KK+R +ES + + W P + TA T SL
Sbjct: 443 IFFVFLGILVVCLCKKRRSKSDESKN-----NPPGWRPLFLHVNNSTANAKATGGSLRLN 497
Query: 530 ---PSDLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ 586
S + R+F+L EI+ AT +F D IG GGFG V++G ++DG++ +A+KR S Q
Sbjct: 498 TLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTL-IAIKRATPHSQQ 556
Query: 587 GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQN 646
G EF TEI M+S LRH H+VSL+GFCDEH EMILVYE+M G LR HL+ S
Sbjct: 557 GLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNL------ 610
Query: 647 QNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706
PL+WK+RLE IG+ARGLHYLH G++ IIHRDVK+TNILLDEN+ AK+SDFGLS
Sbjct: 611 ----PPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLS 666
Query: 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGA 766
+ GPS M +HVST VKGSFGY+DPEY RRQQLTEKSDVYSFGVVL E +C R +IN
Sbjct: 667 KAGPS-MDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCAR-AVINPT 724
Query: 767 VRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG 826
+ K++++L WA + + ++ I+D LRG +P L K+ EIA C +EG RP MG
Sbjct: 725 LPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMG 784
Query: 827 DVTWGLEFALQLQEAAEKSDQGR 849
+V W LE+ LQ+ EA + G
Sbjct: 785 EVLWSLEYVLQIHEAWLRKQNGE 807
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1372), Expect = e-150, Method: Compositional matrix adjust.
Identities = 353/938 (37%), Positives = 508/938 (54%), Gaps = 115/938 (12%)
Query: 4 FTTLYFIIPFF--CLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHS-- 59
FT ++ +F C + ++ +PP D LI CG S N T + HS
Sbjct: 3 FTKSLLVLLWFLSCYTTTTSSALFNPP----DNYLISCGSSQNITFQNRIFVPDSLHSSL 58
Query: 60 --KFSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEEFTYTFPV-SPGPKFLRLHFYP 116
K +S+ AT + ++ ++ Y TARVF +Y F + S G ++RLHF P
Sbjct: 59 VLKIGNSSVATSTTSNNST-------NSIYQTARVFSSLASYRFKITSLGRHWIRLHFSP 111
Query: 117 APYLLGQQQGGLDNNDT--ISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFII 174
NN T ++++ TV + LL NFS + + Y FKE+ +
Sbjct: 112 I------------NNSTWNLTSASITVVTEDFVLLNNFSFNNFNGS------YIFKEYTV 153
Query: 175 SVSSSQMLNLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKP 234
+V+S + L L+F PS++S F+N IEVVS+PDNL Q+ +N +T FS
Sbjct: 154 NVTS-EFLTLSFIPSNNS-VVFVNAIEVVSVPDNLIPDQALA------LNPSTPFSGLSL 205
Query: 235 VALETAYRLNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAY 294
+A ET YRLN+GG +++++DT + R+W +D Y++ +S + + IKY+
Sbjct: 206 LAFETVYRLNMGGPLLTSQNDT-LGRQWDNDAEYLHVNSSVLVVTANPSSIKYSPSVTQE 264
Query: 295 IAPVIVYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSI 354
AP +VY T+ TMG + +N+TW VDP F Y VR+HFC+ + N VF++
Sbjct: 265 TAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVSQAL--NTLVFNL 322
Query: 355 FINNQTAENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPK 414
++N+ A D+ + G +P FKD+ I ES +++ P D
Sbjct: 323 YVNDDLALGSLDLSTLTNGLKVPYFKDF-----ISNGSVESSGVLTVSVGP----DSQAD 373
Query: 415 YADAILNGLEIFKLNNSDGNLAGPNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLG 474
+A +NGLE+ K++N +L+G + P K + +II +++G
Sbjct: 374 ITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKA---------VIIGSLVG 424
Query: 475 SI--FALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPFS-YALTATNTNTASSLPS 531
++ L+++ + L ++ S S + + W+P Y L+ T T + +S S
Sbjct: 425 AVTLILLIAVCCYCCLVASRK---QRSTSPQEGGNGHPWLPLPLYGLSQTLTKSTASHKS 481
Query: 532 -----------DLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRL 580
L R F EI AT F + ++G GGFG V+KG ++DG+ VAVKR
Sbjct: 482 ATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGT-KVAVKRG 540
Query: 581 NTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQK 640
N S QG EFRTEIEM+S+LRH H+VSL+G+CDE EMILVYE+M G LR HLY +
Sbjct: 541 NPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADL 600
Query: 641 QNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700
PL+WK+RLEI IGAARGLHYLH GA +IIHRDVK+TNILLDEN AK+
Sbjct: 601 P----------PLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKV 650
Query: 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+DFGLS+ GPS + Q+HVST VKGSFGY+DPEY RRQQLTEKSDVYSFGVVL+EVLC RP
Sbjct: 651 ADFGLSKTGPS-LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRP 709
Query: 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGF 820
+ N + +E+V++ WA + +G +DQI+D L GK+ P L KF E A C E G
Sbjct: 710 AL-NPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGV 768
Query: 821 RRPTMGDVTWGLEFALQLQEAA-------EKSDQGRPFVPRGEVITSSTTTDSDEPFSRS 873
RP+MGDV W LE+ALQL+E + + S P +P + EPF S
Sbjct: 769 DRPSMGDVLWNLEYALQLEETSSALMEPDDNSTNHIPGIPMAPM----------EPFDNS 818
Query: 874 SGQVSESRSNTTSSGADGERIRVRSENVFTEIMDPKGR 911
+ N + +G D + + VF++++ P+GR
Sbjct: 819 MSIIDRGGVN-SGTGTDDDAEDATTSAVFSQLVHPRGR 855
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 515 bits (1327), Expect = e-145, Method: Compositional matrix adjust.
Identities = 336/864 (38%), Positives = 465/864 (53%), Gaps = 110/864 (12%)
Query: 29 YIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQENSVPQVP-- 86
+ P D ILI CG S++ + DGR F S + ++ Q ++ P
Sbjct: 52 FKPADDILIDCGSKSSSKTPDGR--------VFKSDQETIQYIEAKEDIQVSAPPSDKVA 103
Query: 87 ---YMTARVFPEEFTYTFPVS-PGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVS 142
Y+TAR+F EE TY F ++ PG ++RLHF P ++ + + F+V
Sbjct: 104 SPIYLTARIFREEATYKFHLTRPGWHWVRLHFLAFP----------NDKFDLQQATFSVL 153
Query: 143 ANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSSSSSYAFINGIEV 202
KY LL NF + V KE++++++ +Q L F P SS+ AFIN IEV
Sbjct: 154 TEKYVLLHNFKISNNNNDSQAAVQ---KEYLVNMTDAQ-FALRFRPMKSSA-AFINAIEV 208
Query: 203 VSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHVSAKDDTGMFREW 262
VS PD L G P I FS A ++ YR+NVGG + ++DT + R W
Sbjct: 209 VSAPDELI--SDSGTALFPVIG----FSGLSDYAYQSVYRVNVGGPLIMPQNDT-LGRTW 261
Query: 263 LDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLTWN 322
+ D ++ + IKY + IAP VY T+ M I+ +N++WN
Sbjct: 262 IPDKEFLKDENLAKDVKTTPSAIKYPPEVTPLIAPQTVYATAVEMANSLTIDPNFNVSWN 321
Query: 323 FSVDPGFNYLVRLHFCETQLEITRE-NQRVFSIFINNQTAENDADVIHWSGGSGIPVFKD 381
F +P FNYL+RLHFC+ +++ N F+++IN +TA + D+ +G P +KD
Sbjct: 322 FPSNPSFNYLIRLHFCDI---VSKSLNDLYFNVYINGKTAISGLDLSTVAGNLAAPYYKD 378
Query: 382 YVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYAD-----AILNGLEIFKLNNSDGNLA 436
VV + + P L + P D AILNG+E+ K++NS +L
Sbjct: 379 IVVNATL--------------MGPELQVQIGPMGEDTGTKNAILNGVEVLKMSNSVNSLD 424
Query: 437 GPNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRVNV 496
G G+ + K ++ + G+ L +++Y + KKR
Sbjct: 425 GEFGVD--------GRTTGM--GKHGMVATAGFVMMFGAFIGLGAMVY----KWKKR--- 467
Query: 497 NESASEVKTKSSQSWV-PFSYALTATNTNTASSLPSD-------LCRRFSLTEIKQATCD 548
K S SW+ P + T+ S S+ L R FSL+E+++AT +
Sbjct: 468 --PQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKN 525
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVS 608
F IIG GGFG+V+ G +DDG+ VAVKR N S QG EF+TEI+M+S+LRH H+VS
Sbjct: 526 FEASQIIGVGGFGNVYIGTLDDGT-KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVS 584
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L+G+CDE+ EMILVYEFM G RDHLY +PLTWK+RLEI IG+ARG
Sbjct: 585 LIGYCDENSEMILVYEFMSNGPFRDHLYGKNL----------APLTWKQRLEICIGSARG 634
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
LHYLH G IIHRDVKSTNILLDE AK++DFGLS+ Q+HVST VKGSFGY
Sbjct: 635 LHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK--DVAFGQNHVSTAVKGSFGY 692
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788
+DPEY RRQQLT+KSDVYSFGVVLLE LC R P IN + +E+V+L WA + +G ++
Sbjct: 693 LDPEYFRRQQLTDKSDVYSFGVVLLEALCAR-PAINPQLPREQVNLAEWAMQWKRKGLLE 751
Query: 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEA-----AE 843
+I+DP L G I P + KF E A C ++ G RPTMGDV W LE+ALQLQEA AE
Sbjct: 752 KIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAE 811
Query: 844 KSDQGRPFVPRGEVITSSTTTDSD 867
+++ +P +V+T + SD
Sbjct: 812 ETENAKP-----DVVTPGSVPVSD 830
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1325), Expect = e-145, Method: Compositional matrix adjust.
Identities = 350/928 (37%), Positives = 500/928 (53%), Gaps = 124/928 (13%)
Query: 3 TFTTLYFIIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFS 62
TF + I C+ H + P D LI CG +N T GR + D S
Sbjct: 8 TFILISTISILLCICHG---------FTPVDNYLINCGSPTNGTLM-GRIFLSDKLS--- 54
Query: 63 SSNSATKSFTSRASFQENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLG 122
S T S AS NS + Y TARVF E +Y F V+ G ++RL+F P Y
Sbjct: 55 -SKLLTSSKEILASVGGNSGSDI-YHTARVFTEVSSYKFSVTRGRHWVRLYFNPFDY--- 109
Query: 123 QQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQML 182
N + ++ F VS+ + LL +F+ +T S ++ KE+ ++V+++ ++
Sbjct: 110 -------QNFKMGSAKFAVSSQSHVLLSDFT--VTSSKVV-------KEYSLNVTTNDLV 153
Query: 183 NLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYR 242
LTF+PSS S +AF+N IEV+S+PD L S F+ + F LET +R
Sbjct: 154 -LTFTPSSGS-FAFVNAIEVISIPDTLITG------SPRFVGNPAQFPDMSMQGLETIHR 205
Query: 243 LNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSD--TPAYI----A 296
+N+GG V++ +DT + R W+ D+ ++ + +L + K+++ P Y A
Sbjct: 206 VNMGGPLVASNNDT-LTRTWVPDSEFL------LEKNLAKSMSKFSTVNFVPGYATEDSA 258
Query: 297 PVIVYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCE-TQLEITRENQRVFSIF 355
P VY + M N N +N+TW F VDPGF Y R HFC+ L + NQ F+++
Sbjct: 259 PRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSL---NQLYFNLY 315
Query: 356 INNQTAENDADVIHWSGGSGIPVFK-DYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPK 414
+++ A D D+ + + D+V P + +++ P
Sbjct: 316 VDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTP------KGSNKVRVSIGP---STVHTD 366
Query: 415 YADAILNGLEIFKLNNSDGNLAGPNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLG 474
Y +AI+NGLEI K+NNS G L+ PG + K+N G +I+ + +G
Sbjct: 367 YPNAIVNGLEIMKMNNSKGQLSTGTFV--------PGSSSSSKSNLG-----LIVGSAIG 413
Query: 475 SIFALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPFSYALTA-----TNTNTASSL 529
S+ A+V L F L KK++ + S++W+PFS T+ +N T +S+
Sbjct: 414 SLLAVVFLGSCFVLYKKRK--------RGQDGHSKTWMPFSINGTSMGSKYSNGTTLTSI 465
Query: 530 PSDLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR 589
++ R +K AT +F + IG GGFG V+KG ++DG+ VAVKR N S QG
Sbjct: 466 TTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGT-KVAVKRGNPKSQQGLA 524
Query: 590 EFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQ 649
EFRTEIEM+S+ RH H+VSL+G+CDE+ EMIL+YE+M G ++ HLY S +
Sbjct: 525 EFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPS------- 577
Query: 650 NSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709
LTWK+RLEI IGAARGLHYLH G +IHRDVKS NILLDEN+ AK++DFGLS+ G
Sbjct: 578 ---LTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTG 634
Query: 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK 769
P + Q+HVST VKGSFGY+DPEY RRQQLT+KSDVYSFGVVL EVLC R P+I+ + +
Sbjct: 635 PE-LDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR-PVIDPTLPR 692
Query: 770 EEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVT 829
E V+L WA + +G +DQI+D LRG I P L KF E C + G RP+MGDV
Sbjct: 693 EMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVL 752
Query: 830 WGLEFALQLQEA---AEKSDQGRPFVPRGEV---ITSSTTTDSDEPFSRSSGQVSESRSN 883
W LE+ALQLQEA E D + GE+ I + + D+ ++G+ ES +
Sbjct: 753 WNLEYALQLQEAVIDGEPEDNSTNMI--GELPPQINNFSQGDTSVNVPGTAGRFEESSID 810
Query: 884 TTSSGADGERIRVRSENVFTEIMDPKGR 911
S V VF++++ +GR
Sbjct: 811 DLSG--------VSMSKVFSQLVKSEGR 830
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1323), Expect = e-144, Method: Compositional matrix adjust.
Identities = 336/846 (39%), Positives = 465/846 (54%), Gaps = 77/846 (9%)
Query: 24 QTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHS-KFSSSNSATKSFTSRASFQENSV 82
++S + P D LI CG S T SDGRN+ D S F ++ K+ +++
Sbjct: 23 KSSSSFTPADNYLIDCGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNA 82
Query: 83 PQVP-YMTARVFPEEFTYTFPVS-PGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFT 140
+P Y+TAR+F + TY+F +S PG ++RLHFYP + L ++ S F+
Sbjct: 83 STLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYN----------LTNSVFS 132
Query: 141 VSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSSSSSYAFINGI 200
V+ + LL +FSA T S + FKE++I +++ L+L F P S+ AFIN +
Sbjct: 133 VTTDTTVLLHDFSAGDTSSIV-------FKEYLIY--AAEKLSLYFKPHKGST-AFINAV 182
Query: 201 EVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHVSAKDDTGMFR 260
E+VS+PD L + P + FS LE +R+N+GG +S K D + R
Sbjct: 183 EIVSVPDELVPDSASSVPQAPDFKGLSSFS------LEILHRINIGGDLISPKIDP-LSR 235
Query: 261 EWLDDTNYIYGAASGVTPHLPGARIKY-TSDTPAYIAPVIVYTTSRTMGKDPNINKKYNL 319
WL D Y + + I Y A IAP VY T+ M +NL
Sbjct: 236 TWLSDKPYNTFPEGSRNVTVDPSTITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNL 295
Query: 320 TWNFSVDPGFNYLVRLHFCETQLEITRE-NQRVFSIFINNQTAENDADVIHWSGGSGIPV 378
+W SVD G +Y +RLHFC+ +++ N +F++FIN +A + D+ + G
Sbjct: 296 SWRMSVDFGHDYFIRLHFCDI---VSKSLNDLIFNVFINKLSAISALDLSSLTSALGTAY 352
Query: 379 FKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYA----DAILNGLEIFKLNNSDGN 434
+ D+V+ I S + + P P +AILNGLEI KLNN+ G+
Sbjct: 353 YADFVLNA--STITNGSI---------LVQVGPTPNLQSGKPNAILNGLEIMKLNNAAGS 401
Query: 435 LAGPNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRV 494
L G P G ++K I I L + +V LL + R K
Sbjct: 402 LDGLFGVDGKYKGPIGGM-----SSKKLAIAGIGFVMALTAFLGVVVLLVRWQRRPKDWQ 456
Query: 495 NVNE-----------SASEVKTKSSQSWVPFS-YALTATNTNTASSLPSD--LCRRFSLT 540
N +S + +K + S + + +N SS S+ L R F T
Sbjct: 457 KQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIFGSKKSKSNGFSSFFSNQGLGRYFPFT 516
Query: 541 EIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISE 600
E++ AT +F ++ + G GGFG V+ G ID G+ VA+KR + SS QG EF+TEI+M+S+
Sbjct: 517 ELQTATQNFDENAVCGVGGFGKVYIGEIDGGT-QVAIKRGSQSSEQGINEFQTEIQMLSK 575
Query: 601 LRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660
LRH H+VSL+GFCDE+ EMILVYE+M G LRDHLY S++ + N L+WK+RLE
Sbjct: 576 LRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDPNPIPT----LSWKQRLE 631
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
I IG+ARGLHYLH GA IIHRDVK+TNILLDEN AK+SDFGLS+ P M + HVST
Sbjct: 632 ICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSKDAP--MDEGHVST 689
Query: 721 VVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780
VKGSFGY+DPEY RRQQLT+KSDVYSFGVVL EVLC R P+IN + +E+V+L +A
Sbjct: 690 AVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCAR-PVINPQLPREQVNLAEYAMN 748
Query: 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQE 840
+G +++I+DP++ G I+ L KFVE A C E G RP MGDV W LE+ALQLQE
Sbjct: 749 LHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLWNLEYALQLQE 808
Query: 841 AAEKSD 846
A+ + D
Sbjct: 809 ASAQVD 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 911 | ||||||
| 224113037 | 825 | predicted protein [Populus trichocarpa] | 0.888 | 0.980 | 0.585 | 0.0 | |
| 224120632 | 819 | predicted protein [Populus trichocarpa] | 0.883 | 0.982 | 0.581 | 0.0 | |
| 224120622 | 879 | predicted protein [Populus trichocarpa] | 0.956 | 0.990 | 0.554 | 0.0 | |
| 224111058 | 852 | predicted protein [Populus trichocarpa] | 0.927 | 0.991 | 0.545 | 0.0 | |
| 296082187 | 974 | unnamed protein product [Vitis vinifera] | 0.882 | 0.825 | 0.559 | 0.0 | |
| 359488506 | 869 | PREDICTED: receptor-like protein kinase | 0.862 | 0.904 | 0.568 | 0.0 | |
| 255580334 | 888 | kinase, putative [Ricinus communis] gi|2 | 0.925 | 0.949 | 0.531 | 0.0 | |
| 147807268 | 853 | hypothetical protein VITISV_025026 [Viti | 0.847 | 0.905 | 0.540 | 0.0 | |
| 15241606 | 873 | putative receptor-like protein kinase [A | 0.933 | 0.973 | 0.501 | 0.0 | |
| 155242084 | 895 | FERONIA receptor-like kinase [Brassica o | 0.915 | 0.931 | 0.501 | 0.0 |
| >gi|224113037|ref|XP_002332659.1| predicted protein [Populus trichocarpa] gi|222833139|gb|EEE71616.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/849 (58%), Positives = 616/849 (72%), Gaps = 40/849 (4%)
Query: 1 MATFTTLYFIIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSK 60
M+ F LY + P ++ A PY PTD IL+ CG SSN +S DGR+WDGD+ SK
Sbjct: 1 MSIFIALYLLPPLHLFLYVTATTDYLLPYSPTDLILLNCGASSNLSSPDGRSWDGDSQSK 60
Query: 61 FSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYL 120
F++SN S AS Q+ SV QVPYMTAR+F +FTYTFPV PGPKF+RL+FYPA Y
Sbjct: 61 FAASNPPETSSVFAASNQDPSVNQVPYMTARIFHSKFTYTFPVLPGPKFVRLYFYPASY- 119
Query: 121 LGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQ 180
+N ISTS+F++SAN Y LL NFSA LTVSAIIPPV F KEFII+V +Q
Sbjct: 120 ---------SNLDISTSYFSLSANDYELLNNFSASLTVSAIIPPVDSFTKEFIITVWDNQ 170
Query: 181 MLNLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETA 240
L LTF PS +S +AFINGIE+VSMPD+ Y + +D + ++ ++ F D LET
Sbjct: 171 KLELTFIPSPAS-FAFINGIEIVSMPDSFYARGND--NPLTYVGTDLFFYLDNTTVLETV 227
Query: 241 YRLNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIV 300
YRLNVGG + + DTGM+R W D+ Y+ G +G TP+LPG +IKYT+ TP Y APV+V
Sbjct: 228 YRLNVGGKDIGSTGDTGMYRTWHQDSEYLPGGQTGNTPYLPGVKIKYTTKTPNYSAPVMV 287
Query: 301 YTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQT 360
Y+T R+MG +P++N YNLTW F VD GF+YL+RLHFCET++EI ENQ+VF IFINNQT
Sbjct: 288 YSTMRSMGPEPHLNLNYNLTWIFPVDAGFHYLLRLHFCETRMEIKNENQQVFLIFINNQT 347
Query: 361 AENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAIL 420
AE+DADVIH SGG+GIPV+KDY+V VP + +SKQD WL LHP ++L P YADAIL
Sbjct: 348 AEHDADVIHMSGGNGIPVYKDYIVQVPQGS---QSKQDLWLELHPNMELK--PTYADAIL 402
Query: 421 NGLEIFKLNNSDGNLAG--PNPASKPPP-EPKPGKQQNVKNNKGRVILII-IIAAVLGSI 476
NGLEIFKLN +DGNLAG P P PPP E P ++ + ++ +I I+ +G++
Sbjct: 403 NGLEIFKLNRTDGNLAGFNPEPTVAPPPAEQHPSLKERRTGKRSSILTVIGIVGGSIGAV 462
Query: 477 FALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRR 536
FA SL+ +FF K+KRV + S SE K+ SW S +T T + SLP+DLCRR
Sbjct: 463 FAF-SLILYFFAFKQKRVK-DPSKSEEKS----SWTIISQTSRST-TTISPSLPTDLCRR 515
Query: 537 FSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE 596
F+ EI +AT +F D IIGSGGFG V+KGYI+ G I VA+KRL++SS QG REF+TEIE
Sbjct: 516 FTFFEINEATGNFDDQNIIGSGGFGTVYKGYIEYGFIAVAIKRLDSSSKQGTREFQTEIE 575
Query: 597 MISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWK 656
M+S LRHLH+VSL+G+CD+HGEMILVY++M RG LR+HLY + ++SPL WK
Sbjct: 576 MLSNLRHLHLVSLIGYCDDHGEMILVYDYMSRGTLREHLY----------KTKSSPLPWK 625
Query: 657 RRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS 716
+RLEI IGAA+GLHYLH+GAKHTIIHRDVKSTNILLDENW AK+SDFGLSR+GP+ SQ+
Sbjct: 626 QRLEICIGAAKGLHYLHSGAKHTIIHRDVKSTNILLDENWVAKVSDFGLSRLGPTSTSQT 685
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
HVSTVV+GS GYVDPEY RRQ LTEKSDVYSFGVVL EVLC RPP+I + K++ SL
Sbjct: 686 HVSTVVRGSIGYVDPEYYRRQHLTEKSDVYSFGVVLFEVLCARPPVIPSS-PKDQASLAE 744
Query: 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836
WAR RGT+D+IVDP L+G++APV LNKF EIA SC +G RP MGDV WGLEFAL
Sbjct: 745 WARKCYLRGTLDEIVDPHLKGEVAPVSLNKFAEIANSCLHGQGIERPKMGDVVWGLEFAL 804
Query: 837 QLQEAAEKS 845
QLQ+ AEK+
Sbjct: 805 QLQQTAEKN 813
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120632|ref|XP_002330913.1| predicted protein [Populus trichocarpa] gi|222873107|gb|EEF10238.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 958 bits (2477), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/849 (58%), Positives = 618/849 (72%), Gaps = 44/849 (5%)
Query: 1 MATFTTLYFIIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSK 60
M+ F LY + P ++ A + S PY PTD IL+ CG SSN +S DGR+WDGD+ SK
Sbjct: 1 MSIFIALYLLPPLHLFLYVTATKDYSLPYSPTDLILLNCGASSNLSSPDGRSWDGDSQSK 60
Query: 61 FSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYL 120
F++S S AS + SV QVPYMTAR+F +FTYTFPV PGPKF+RL+FYPA Y
Sbjct: 61 FAASKPPEASSVFEASNHDPSVNQVPYMTARIFHSKFTYTFPVLPGPKFVRLYFYPASY- 119
Query: 121 LGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQ 180
+N ISTS+F++SAN Y LL NFSA LTVSAIIPPV YF KEFII+V +Q
Sbjct: 120 ---------SNLDISTSYFSISANNYQLLNNFSASLTVSAIIPPVDYFTKEFIITVRDNQ 170
Query: 181 MLNLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETA 240
L LTF PS +S ++FINGIE+VSMPD+ Y + D + ++ + D ALET
Sbjct: 171 KLELTFIPSPAS-FSFINGIEIVSMPDSFYARGHD--NPLTYVGPDVHTFLDNTTALETV 227
Query: 241 YRLNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIV 300
YRLNVGG + + DTGM+R W D+ Y++G A G TP+LPG +IKYT+ TPAY APV+V
Sbjct: 228 YRLNVGGQDIGSTGDTGMYRTWHQDSEYLFGQA-GNTPYLPGVKIKYTTKTPAYSAPVMV 286
Query: 301 YTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQT 360
Y+T R+MG++P +N YNLTW F VD F YL+RLHFCET++EI ENQ+VF IFINNQT
Sbjct: 287 YSTMRSMGREPRLNMNYNLTWIFPVDADFLYLLRLHFCETRMEIKNENQQVFLIFINNQT 346
Query: 361 AENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAIL 420
AE+DADVIH SGG+GIPV+KDY+V VP + +SKQ+ WL LHP ++L P YADAIL
Sbjct: 347 AEHDADVIHMSGGNGIPVYKDYIVLVPPGS---QSKQELWLELHPNMELKP--TYADAIL 401
Query: 421 NGLEIFKLNNSDGNLAG--PNPASKPPPEPKPGKQQNVKNNKGRVILII-IIAAVLGSIF 477
NGLEIFKLN +DGNLAG P+P PPP + +++ K + +I++I I+ +G++F
Sbjct: 402 NGLEIFKLNTTDGNLAGFNPDPTVAPPPAEQHPERRTGK--RSSIIMVIGIVGGSIGTVF 459
Query: 478 ALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRF 537
A SL+ +FF K+KRV + S SE K+ SW S +T T ++S ++LCRRF
Sbjct: 460 A-CSLILYFFAFKQKRVK-DPSKSEEKS----SWTIISQTSKSTTTISSSLP-TNLCRRF 512
Query: 538 SLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEM 597
+ EIK+AT +F D IIGSGGFG V+KGYI+ G+ VA+KRL++SS QG REF+TEIEM
Sbjct: 513 TFVEIKEATRNFDDQNIIGSGGFGTVYKGYIEYGA--VAIKRLDSSSKQGTREFQTEIEM 570
Query: 598 ISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
+S LRHLH+VSL+G+CD+HGEMILVY+++ RG LR+HLY + +NSPL WK+
Sbjct: 571 LSNLRHLHLVSLIGYCDDHGEMILVYDYISRGTLREHLY----------KTKNSPLPWKQ 620
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
RLEI IGAA+GLHYLH+ AKHTIIHRDVKSTNILLDENW AK+SDFGLSR+GP+ SQ+H
Sbjct: 621 RLEICIGAAKGLHYLHSEAKHTIIHRDVKSTNILLDENWVAKVSDFGLSRLGPTSTSQTH 680
Query: 718 VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777
VSTVV+GS GYVDPEY RRQ LTEKSDVYSFGVVL EVLC RPP+I + K++ SL W
Sbjct: 681 VSTVVRGSIGYVDPEYYRRQHLTEKSDVYSFGVVLFEVLCARPPVIPSS-PKDQASLAEW 739
Query: 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837
AR RGT+DQIVDP L+G++APV LNKF EIA SC +G RP MGDV WGLEFALQ
Sbjct: 740 ARKCYQRGTLDQIVDPHLKGEVAPVSLNKFAEIANSCLHGQGIERPKMGDVVWGLEFALQ 799
Query: 838 LQEAAEKSD 846
LQ+ AEK+D
Sbjct: 800 LQQTAEKND 808
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120622|ref|XP_002330911.1| predicted protein [Populus trichocarpa] gi|222873105|gb|EEF10236.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2474), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 510/919 (55%), Positives = 641/919 (69%), Gaps = 48/919 (5%)
Query: 1 MATFTTLYFIIPFFCLVHSAAAEQTSPPYIP-TDYILIICGESSNTTSSDGRNWDGDAHS 59
M+ F LY + P ++ A Y P TD IL+ CG SSN +S DGR WDGD+ S
Sbjct: 1 MSIFIALYLLPPLHLFLYVTATTDYLQRYSPSTDLILLNCGASSNLSSPDGRGWDGDSQS 60
Query: 60 KFSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPY 119
KF++SN S AS Q+ SV QVPYMTAR+F +FTYTFPV PGPKF+RL+FYPA Y
Sbjct: 61 KFAASNPPEASSVFAASNQDPSVNQVPYMTARIFHSKFTYTFPVLPGPKFVRLYFYPASY 120
Query: 120 LLGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSS 179
+N ISTS+F++ AN Y LL NFSA LTVSAIIPPV YF KEFII+V +
Sbjct: 121 ----------SNLDISTSYFSIRANNYQLLNNFSASLTVSAIIPPVDYFTKEFIITVRDN 170
Query: 180 QMLNLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIP-FINSNTIFSFDKPVALE 238
Q L LTF PS +S ++FINGIE+VSMPD+ Y + GD + P ++ ++ S ALE
Sbjct: 171 QKLELTFIPSPAS-FSFINGIEIVSMPDSFYAR---GDDNPPTYVGTDNPCSLYNTTALE 226
Query: 239 TAYRLNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPV 298
T YRLNVGG + + DTGM+R W D+ Y++G A G TP+LPG +IKYT+ TPAY APV
Sbjct: 227 TVYRLNVGGQDIGSTGDTGMYRTWHQDSEYLFGQA-GNTPYLPGVKIKYTTKTPAYSAPV 285
Query: 299 IVYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINN 358
+VY+T R+MG +P +N YNLTW F VD GF YL+RLHFCET++E ENQ+VF IFINN
Sbjct: 286 MVYSTMRSMGPEPRLNMNYNLTWIFPVDAGFLYLLRLHFCETRMEFKNENQQVFLIFINN 345
Query: 359 QTAENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADA 418
QTAE+DADVIH SGG+GIPV+KDY+V VP + +SKQ+ WL LHP ++L P YADA
Sbjct: 346 QTAEHDADVIHMSGGNGIPVYKDYIVLVPPGS---QSKQELWLELHPNMELKP--TYADA 400
Query: 419 ILNGLEIFKLNNSDGNLAG--PNPASKPPPEPKPGKQQNVKNNKGRVILII-IIAAVLGS 475
ILNGLEIFKLN +DGNLAG P+P PPP + +++ K + +I++I I+ +G+
Sbjct: 401 ILNGLEIFKLNTTDGNLAGFNPDPTVAPPPAEQHPERRTGK--RSSIIMVIGIVGGSIGT 458
Query: 476 IFALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCR 535
+FA SL+ +FF K+KRV + S SE K+ SW S +T T ++S +DLCR
Sbjct: 459 VFA-CSLILYFFAFKQKRVK-DPSKSEEKS----SWTIISQTSKSTTTISSSLP-TDLCR 511
Query: 536 RFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEI 595
RF+ EIK+AT +F D IIGSGGFG V+K YI+ G I VA+KRL++SS QG REF+TEI
Sbjct: 512 RFTFFEIKEATGNFDDQNIIGSGGFGTVYKAYIEYGFIAVAIKRLDSSSKQGTREFQTEI 571
Query: 596 EMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
EM+S LRHLH+VSL+G+CD+HGEMILVY++M RG LR+HLY + ++SPL W
Sbjct: 572 EMLSNLRHLHLVSLIGYCDDHGEMILVYDYMSRGTLREHLY----------KTKSSPLPW 621
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ 715
K+RLEI IGAA+GLHYLH+GAKHTIIHRDVKSTNILLDENW AK+SDFGLSR+GP+ SQ
Sbjct: 622 KQRLEICIGAAKGLHYLHSGAKHTIIHRDVKSTNILLDENWVAKVSDFGLSRLGPTSTSQ 681
Query: 716 SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775
+HVSTVV+GS GYVDPEY RRQ +TEKSDVYSFGVVL EVLC RPP+I + K++ SL
Sbjct: 682 THVSTVVRGSIGYVDPEYYRRQHVTEKSDVYSFGVVLFEVLCARPPVIPSS-PKDQASLA 740
Query: 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835
WAR RGT+D+IVDP L+G++APV LNKF EIA SC +G RP MGDV WGLEFA
Sbjct: 741 EWARRCYQRGTLDEIVDPHLKGEVAPVSLNKFAEIANSCLHVQGIERPKMGDVVWGLEFA 800
Query: 836 LQLQEAAEKSDQGRPFV--PRGEVITSSTTTDSDEPFSRSSGQVSESRSN-TTSSGADGE 892
LQLQ+ AEK+ + ++ + + SG S SRS +T
Sbjct: 801 LQLQQTAEKNGNSVDGINMENKSSLSPHRDVMTTDDDDMFSGAESHSRSTVSTHESVTQS 860
Query: 893 RIRVRSENVFTEIMDPKGR 911
R+ VF+EI+DPK R
Sbjct: 861 DPDQRARGVFSEIIDPKAR 879
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111058|ref|XP_002332993.1| predicted protein [Populus trichocarpa] gi|222834355|gb|EEE72832.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 933 bits (2411), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/918 (54%), Positives = 617/918 (67%), Gaps = 73/918 (7%)
Query: 1 MATFTTLYFIIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSK 60
M+ F LY + P ++ A + PY PTD IL+ CG SSN S DGR WDGD+ SK
Sbjct: 1 MSIFIALYLLPPLHLFLYVTATDDYLLPYSPTDLILLNCGASSNLLSPDGRGWDGDSQSK 60
Query: 61 FSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYL 120
F++SN S AS Q+ SV QVPYMTAR+F +FTYTFPV PGPKF+RL+FYPA Y
Sbjct: 61 FAASNPPEASSVFEASNQDPSVNQVPYMTARIFHSKFTYTFPVLPGPKFVRLYFYPASY- 119
Query: 121 LGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQ 180
+N ISTS+F++SAN Y LL NFSA LTVSAI PPV YF KEFII+V SQ
Sbjct: 120 ---------SNLDISTSYFSLSANNYELLNNFSASLTVSAIRPPVDYFTKEFIITVWDSQ 170
Query: 181 MLNLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETA 240
L L F PS +S +AFINGIE+VSMPD+ Y + D + ++ ++ +FS ALE
Sbjct: 171 KLELNFIPSPAS-FAFINGIEIVSMPDSFYARGDD--NPLTYVGTDNLFSLYNTTALERV 227
Query: 241 YRLNVGGAHVSAK-DDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVI 299
YRLNVGG +S+ D TGM+R W D Y+ G A G P+LPG +IKYT+ TPAY APV
Sbjct: 228 YRLNVGGQDISSTGDHTGMYRTWHQDIEYLIGQA-GNAPYLPGVKIKYTTKTPAYSAPVE 286
Query: 300 VYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQ 359
VY+T R+MG++P N YNLTW F VD GF YL+RLHFCET+ E+ NQ+VF IFINNQ
Sbjct: 287 VYSTMRSMGREPRHNMNYNLTWIFPVDAGFLYLLRLHFCETRKEVINVNQQVFLIFINNQ 346
Query: 360 TAENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAI 419
TAE DADVIH SGG GIPV+KDY+V VP + SKQD WL LHP ++L P YADAI
Sbjct: 347 TAEYDADVIHMSGGHGIPVYKDYIVQVPPGS---PSKQDLWLELHPNMELK--PTYADAI 401
Query: 420 LNGLEIFKLNNSDGNLAG--PNPASKPPPEPKPGKQQNVKNNKGRVILII-IIAAVLGSI 476
LNGLEIFKLN +DGNLAG P+P PPP + +++ K + +I++I I+ +G++
Sbjct: 402 LNGLEIFKLNKTDGNLAGFNPDPTVAPPPAEQHPERRTGK--RSSIIMVIGIVGGSIGTV 459
Query: 477 FALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRR 536
FA SL+ +FF K+KRV + S SE K+ SW
Sbjct: 460 FA-CSLILYFFAFKQKRVK-DPSKSEEKS----SW------------------------- 488
Query: 537 FSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE 596
T I Q + +F D IIGSGGFG V+KGYI+ G VA+KRL++SS QG REF+TEIE
Sbjct: 489 ---TLISQTSRNFDDQNIIGSGGFGTVYKGYIEYGFTAVAIKRLDSSSKQGTREFQTEIE 545
Query: 597 MISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWK 656
M+S LRHLH+VSL+G+CD+HGEMILVY++M RG LR+HLY + ++SPL WK
Sbjct: 546 MLSNLRHLHLVSLIGYCDDHGEMILVYDYMSRGTLREHLY----------KTKSSPLPWK 595
Query: 657 RRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS 716
+RLEI IGAA+GLHYLH+GAKHTIIHRDVKSTNILLDENW AK+SDFGLSR+GP+ SQ+
Sbjct: 596 QRLEICIGAAKGLHYLHSGAKHTIIHRDVKSTNILLDENWVAKVSDFGLSRLGPTSTSQT 655
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
HVSTVV+GSFGYVDPEY RRQ LTEKSDVYSFGVVL EVLC RPP+I + K++ SL
Sbjct: 656 HVSTVVRGSFGYVDPEYYRRQHLTEKSDVYSFGVVLFEVLCARPPVIPSS-PKDQASLAD 714
Query: 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836
WAR RGT+DQIVDP L+G++APV LNKF EIA SC +G RP MGDV WGLEFAL
Sbjct: 715 WARKCYLRGTLDQIVDPHLKGEVAPVSLNKFAEIANSCLHGQGIERPKMGDVVWGLEFAL 774
Query: 837 QLQEAAEKSDQGRPFV--PRGEVITSSTTTDSDEPFSRSSGQVSESRSN-TTSSGADGER 893
QLQ+ AEK+ + ++ + + SG S SRS +T
Sbjct: 775 QLQQTAEKNANSVEGINMENKSSLSPHRDVMTTDDDDMFSGAESHSRSTVSTHESVTQSD 834
Query: 894 IRVRSENVFTEIMDPKGR 911
R+ VF+EI+DPK R
Sbjct: 835 PDQRAMGVFSEIIDPKAR 852
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082187|emb|CBI21192.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/847 (55%), Positives = 584/847 (68%), Gaps = 43/847 (5%)
Query: 4 FTTLYFIIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSS 63
T ++ FF + A SPPY PTD IL+ CG S NT S DGR W GD SKFS
Sbjct: 92 LTLAVYLSSFFLQFLISMAGDESPPYRPTDNILLDCGSSINTKSPDGRTWQGDQGSKFSG 151
Query: 64 SNSATKSFTSRASF-QENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLG 122
++ S +S +F Q+ SV QVPYMTAR+F FTY+FPVS GPKF+R +FYP Y
Sbjct: 152 TSDVQNSSSSSKAFRQDPSVDQVPYMTARIFNSSFTYSFPVSAGPKFVRFYFYPTAY--- 208
Query: 123 QQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQML 182
+ S FF+V++ YTLL NFSA LTV+ + V+ KEF I+V +Q+L
Sbjct: 209 -------SGHNESEFFFSVTSGVYTLLSNFSASLTVAPMGSGVSSLVKEFSINVWDNQIL 261
Query: 183 NLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYR 242
N+TFSPS +S +AF+NGIEVVSMP++LY G + +++ F D ALET YR
Sbjct: 262 NITFSPSPNS-WAFVNGIEVVSMPNHLY-----GQIDLKLVSAVQQFEMDNYTALETVYR 315
Query: 243 LNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYT 302
LNVGG H+ A+ D+GMFR W D +YIYG G+TP+L RI+YT TP YIAP VYT
Sbjct: 316 LNVGGNHIPAEADSGMFRSWSQDDSYIYGGNLGLTPNL-DIRIQYTQTTPPYIAPRTVYT 374
Query: 303 TSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAE 362
TSRTM K INK+ NLTW F VD GF YLVRLHFCE QLE+TR +RVFSIF+NNQTAE
Sbjct: 375 TSRTMTKQEEINKRTNLTWLFHVDSGFYYLVRLHFCELQLEVTRPGERVFSIFLNNQTAE 434
Query: 363 NDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAILNG 422
+ DVI SGG+G P+++DYVV++ D + KQ+ WL LHP D KYA+ ILNG
Sbjct: 435 EEMDVIVRSGGTGYPIYQDYVVYLLSDGSRR--KQELWLDLHPNAD----SKYANVILNG 488
Query: 423 LEIFKLNNSDGNLAG--PNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALV 480
LE+FKLNNS+G+LAG P+P PPP + NN+ ++LI +I A +G + AL
Sbjct: 489 LEMFKLNNSNGSLAGLNPDPVLNPPPSEQHPNSPVKPNNRAPLVLITVIVAAVGGVVAL- 547
Query: 481 SLLYFFFLRKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLT 540
SLL+F LR + RV S K+ SWVPFSY +T+TN SSLP+D+CR FSL
Sbjct: 548 SLLWFLVLRPRMRVKHVGGISRAKS----SWVPFSYTTRSTSTN-GSSLPADICRHFSLA 602
Query: 541 EIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISE 600
+IK ATC+F + IIG GGFG+V+KG+I GS TVAVKRLN SS QGAREF TEI M+S+
Sbjct: 603 QIKDATCNFNKNFIIGEGGFGNVYKGFIKGGSTTVAVKRLNPSSKQGAREFETEIRMLSK 662
Query: 601 LRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660
LRH+H+VS++G+CDE GEMILVY++M RG LRDHLY + +N PL WK+RL+
Sbjct: 663 LRHIHLVSMIGYCDEEGEMILVYDYMARGTLRDHLY----------KTKNPPLPWKQRLQ 712
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
+ IGAARGLHYLH GAKHTIIHRDVKSTNILLDE W AK+SDFGLSR+GP+ M+Q+HVST
Sbjct: 713 VCIGAARGLHYLHTGAKHTIIHRDVKSTNILLDEKWVAKVSDFGLSRVGPTSMTQTHVST 772
Query: 721 VVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780
VKGSFGYVDPEY R +QLTEKSDVYSFGVVL EVLC RP +I A K +V L W R
Sbjct: 773 AVKGSFGYVDPEYFRLRQLTEKSDVYSFGVVLFEVLCARPAVIPDAPEK-QVCLAEWGRR 831
Query: 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQE 840
S +G + +I+D LR ++AP CL KF EIA SC ++G RP M DV W LEFALQLQE
Sbjct: 832 SYRKGALVRIMDQNLRDEVAPECLKKFGEIADSCVRDKGIERPPMSDVVWALEFALQLQE 891
Query: 841 AAEKSDQ 847
AE++ Q
Sbjct: 892 TAERNSQ 898
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488506|ref|XP_002277584.2| PREDICTED: receptor-like protein kinase FERONIA-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2299), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/829 (56%), Positives = 578/829 (69%), Gaps = 43/829 (5%)
Query: 22 AEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASF-QEN 80
A SPPY PTD IL+ CG S NT S DGR W GD SKFS ++ S +S +F Q+
Sbjct: 2 AGDESPPYRPTDNILLDCGSSINTKSPDGRTWQGDQGSKFSGTSDVQNSSSSSKAFRQDP 61
Query: 81 SVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFT 140
SV QVPYMTAR+F FTY+FPVS GPKF+R +FYP Y + S FF+
Sbjct: 62 SVDQVPYMTARIFNSSFTYSFPVSAGPKFVRFYFYPTAY----------SGHNESEFFFS 111
Query: 141 VSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSSSSSYAFINGI 200
V++ YTLL NFSA LTV+ + V+ KEF I+V +Q+LN+TFSPS +S +AF+NGI
Sbjct: 112 VTSGVYTLLSNFSASLTVAPMGSGVSSLVKEFSINVWDNQILNITFSPSPNS-WAFVNGI 170
Query: 201 EVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHVSAKDDTGMFR 260
EVVSMP++LY G + +++ F D ALET YRLNVGG H+ A+ D+GMFR
Sbjct: 171 EVVSMPNHLY-----GQIDLKLVSAVQQFEMDNYTALETVYRLNVGGNHIPAEADSGMFR 225
Query: 261 EWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLT 320
W D +YIYG G+TP+L RI+YT TP YIAP VYTTSRTM K INK+ NLT
Sbjct: 226 SWSQDDSYIYGGNLGLTPNL-DIRIQYTQTTPPYIAPRTVYTTSRTMTKQEEINKRTNLT 284
Query: 321 WNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAENDADVIHWSGGSGIPVFK 380
W F VD GF YLVRLHFCE QLE+TR +RVFSIF+NNQTAE + DVI SGG+G P+++
Sbjct: 285 WLFHVDSGFYYLVRLHFCELQLEVTRPGERVFSIFLNNQTAEEEMDVIVRSGGTGYPIYQ 344
Query: 381 DYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAILNGLEIFKLNNSDGNLAG--P 438
DYVV++ D + KQ+ WL LHP D KYA+ ILNGLE+FKLNNS+G+LAG P
Sbjct: 345 DYVVYLLSDGSRR--KQELWLDLHPNAD----SKYANVILNGLEMFKLNNSNGSLAGLNP 398
Query: 439 NPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRVNVNE 498
+P PPP + NN+ ++LI +I A +G + AL SLL+F LR + RV
Sbjct: 399 DPVLNPPPSEQHPNSPVKPNNRAPLVLITVIVAAVGGVVAL-SLLWFLVLRPRMRVKHVG 457
Query: 499 SASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQATCDFADHCIIGSG 558
S K+ SWVPFSY +T+TN SSLP+D+CR FSL +IK ATC+F + IIG G
Sbjct: 458 GISRAKS----SWVPFSYTTRSTSTN-GSSLPADICRHFSLAQIKDATCNFNKNFIIGEG 512
Query: 559 GFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGE 618
GFG+V+KG+I GS TVAVKRLN SS QGAREF TEI M+S+LRH+H+VS++G+CDE GE
Sbjct: 513 GFGNVYKGFIKGGSTTVAVKRLNPSSKQGAREFETEIRMLSKLRHIHLVSMIGYCDEEGE 572
Query: 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKH 678
MILVY++M RG LRDHLY + +N PL WK+RL++ IGAARGLHYLH GAKH
Sbjct: 573 MILVYDYMARGTLRDHLY----------KTKNPPLPWKQRLQVCIGAARGLHYLHTGAKH 622
Query: 679 TIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ 738
TIIHRDVKSTNILLDE W AK+SDFGLSR+GP+ M+Q+HVST VKGSFGYVDPEY R +Q
Sbjct: 623 TIIHRDVKSTNILLDEKWVAKVSDFGLSRVGPTSMTQTHVSTAVKGSFGYVDPEYFRLRQ 682
Query: 739 LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGK 798
LTEKSDVYSFGVVL EVLC RP +I A K +V L W R S +G + +I+D LR +
Sbjct: 683 LTEKSDVYSFGVVLFEVLCARPAVIPDAPEK-QVCLAEWGRRSYRKGALVRIMDQNLRDE 741
Query: 799 IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSDQ 847
+AP CL KF EIA SC ++G RP M DV W LEFALQLQE AE++ Q
Sbjct: 742 VAPECLKKFGEIADSCVRDKGIERPPMSDVVWALEFALQLQETAERNSQ 790
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255580334|ref|XP_002530995.1| kinase, putative [Ricinus communis] gi|223529422|gb|EEF31383.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/902 (53%), Positives = 612/902 (67%), Gaps = 59/902 (6%)
Query: 31 PTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQENSVPQVPYMTA 90
P D IL+ CG SS+ TS DGR WDGDA SKF +SNS T S+ AS ++ S +VPYM A
Sbjct: 25 PADLILLNCGTSSSATSLDGRGWDGDAQSKFLASNSETASYGCSASQRDPSATEVPYMDA 84
Query: 91 RVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLR 150
RV +FTY FPVSPG KF+RL+FYP Y ++ IS SFF+V+AN YTLLR
Sbjct: 85 RVSQSKFTYLFPVSPGSKFVRLYFYPTKY----------SDLEISKSFFSVTANDYTLLR 134
Query: 151 NFSAHLTVSAIIPPVAYFFKEFIISV-SSSQMLNLTFSPSSSSSYAFINGIEVVSMPDNL 209
NFSA+L VSA+ P V F KE++I+V ++Q L+LTFS +S S+AFINGIE+VS+PDNL
Sbjct: 135 NFSAYLAVSAMKPDVYSFVKEYVITVWDNNQKLDLTFS-ASRGSFAFINGIEIVSIPDNL 193
Query: 210 YLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHVSAKDDTGMFREWLDDTNYI 269
Y S + + ++ N F D ALET +RLNVGG +S DTGM+R WL D++YI
Sbjct: 194 Y--ASSINNPLTYVGINNPFYLDNTTALETFHRLNVGGKDISGSGDTGMYRTWLQDSDYI 251
Query: 270 YGAASGVTPHLP-GARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLTWNFSVDPG 328
+G A G+ LP IKY TP Y AP++VY+ R MG DPN + YNLTW FSVD G
Sbjct: 252 FGGAFGLLTILPKNVTIKYKMATPDYTAPLLVYSILRFMGHDPNRSMNYNLTWLFSVDAG 311
Query: 329 FNYLVRLHFCETQLEITRE-NQRVFSIFINNQTAENDADVIHWSGGSGIPVFKDYVVWVP 387
FNYLVRLHFCE ++EI NQ VF +FINNQTA++ DVI+ SGG +P +KDYVVWVP
Sbjct: 312 FNYLVRLHFCEFRVEIAESWNQLVFFVFINNQTADDQVDVIYLSGGKSVPAYKDYVVWVP 371
Query: 388 IDAIEKESKQDFWLALHPFLDLDPLPKYADAILNGLEIFKLNNSDGNLAGPNP--ASKPP 445
+ SKQD WLALHP + P + DAILNGLEIFKLN SDG+LAG NP PP
Sbjct: 372 EGS---HSKQDLWLALHP--NTKSKPAFHDAILNGLEIFKLNKSDGSLAGSNPELVVAPP 426
Query: 446 PEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRVNVNESASEVKT 505
P + ++ K +I+ +I A G++ ++S++ F+ K+++ N + +++
Sbjct: 427 SPEHPSLSKEKRSRKSSMIMAVIGAVCGGAL--MLSVVICSFVYKQRKAN---DSGKIEA 481
Query: 506 KSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFK 565
KS + V FS+ ++ TN AS D RRFS+ EI+ AT F D IIGSGGFG+V+K
Sbjct: 482 KSFRVPVRFSFVSRSSTTN-ASLRSLDRFRRFSIFEIEMATFKFDDEFIIGSGGFGNVYK 540
Query: 566 GYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625
GYIDDG+ VA+KRL++SS QGAREF+TEI+++++L++ ++V+L+G+CD+ GEMILVYE+
Sbjct: 541 GYIDDGATPVAIKRLHSSSRQGAREFKTEIKLLAKLQNPNLVALIGYCDDPGEMILVYEY 600
Query: 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDV 685
M RG LRDHLY + +N PL WK+RLEI IGAARGLHYLH G K IIHRDV
Sbjct: 601 MHRGTLRDHLY----------KTRNPPLPWKQRLEICIGAARGLHYLHTGMKPPIIHRDV 650
Query: 686 KSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDV 745
KSTNIL+DENW AK+SDFGLSR GP+ SQ+HVSTVV+GSFGYVDPEY RRQ LTEKSDV
Sbjct: 651 KSTNILIDENWVAKVSDFGLSRTGPTSDSQTHVSTVVRGSFGYVDPEYYRRQHLTEKSDV 710
Query: 746 YSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLN 805
YSFGVVLLEVLC RPP+I G + KE+V+L WAR+ RG ++QI+DP L G +AP CL
Sbjct: 711 YSFGVVLLEVLCARPPVIPG-LPKEQVNLADWARICYRRGALNQIIDPNLMGDVAPACLV 769
Query: 806 KFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKS-------------DQGRPFV 852
KF EIA SC ++G RP M DV +GL+ LQLQE+ E S P +
Sbjct: 770 KFGEIAESCLRDQGILRPAMSDVVFGLQLVLQLQESNEVSIASGGGDGDGVSEQHESPLL 829
Query: 853 PRGEVITSSTTTDSDEPFSRSSGQVSESRSNTTSSG---ADGERIRVRSENVFTEIMDPK 909
EV+ TT D D FS S GQ E++S+ +S G A + R++S VF+EI+ PK
Sbjct: 830 VHREVV---TTEDDDNLFSGSGGQEEETKSSISSWGRSVAQSDPDRLKSGAVFSEIISPK 886
Query: 910 GR 911
GR
Sbjct: 887 GR 888
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147807268|emb|CAN77538.1| hypothetical protein VITISV_025026 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2182), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/845 (54%), Positives = 562/845 (66%), Gaps = 73/845 (8%)
Query: 4 FTTLYFIIPFFCLVHSAAAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSS 63
T ++ FF + A SPPY PTD IL+ CG S NT S DGR W GD SKFS
Sbjct: 2 LTLAVYLSSFFLQFLISMAGDESPPYRPTDNILLDCGSSINTKSPDGRTWQGDQGSKFSG 61
Query: 64 SNSATKSFTSRASF-QENSVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLG 122
++ S +S +F Q+ SV QVPYMTAR+F FTY+FPVS GPKF+R +FYP Y
Sbjct: 62 TSDVQNSSSSSKAFRQDPSVDQVPYMTARIFNSSFTYSFPVSAGPKFVRFYFYPTAY--- 118
Query: 123 QQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQML 182
+ S FF+V++ YTLL NFSA LTV+ + V+ KEF I+V +Q+L
Sbjct: 119 -------SGHNESEFFFSVTSGVYTLLSNFSASLTVAPMGSGVSSLVKEFSINVWDNQIL 171
Query: 183 NLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYR 242
N+TFSPS +S +AF+NGIEVVSMP++LY G + +++ F D ALET YR
Sbjct: 172 NITFSPSPNS-WAFVNGIEVVSMPNHLY-----GQIDLKLVSAVQQFEMDNYTALETVYR 225
Query: 243 LNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYT 302
LNVGG H+ A+ D+GMFR W D +YIYG G+TP+L RI+YT TP YIAP VYT
Sbjct: 226 LNVGGNHIPAEADSGMFRSWSQDDSYIYGGNLGLTPNL-DIRIQYTQTTPPYIAPRTVYT 284
Query: 303 TSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAE 362
TSRTM K INK+ NLTW F VD GF YLVRLHFCE QLE+TR +RVFSIF+NNQTAE
Sbjct: 285 TSRTMTKQEEINKRTNLTWLFHVDSGFYYLVRLHFCELQLEVTRPGERVFSIFLNNQTAE 344
Query: 363 NDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAILNG 422
+ DVI SGG+G P+++DYVV++ D + KQ+ WL LHP D KYA+
Sbjct: 345 EEMDVIVRSGGTGYPIYQDYVVYLLSDGSRR--KQELWLDLHPNAD----SKYANH---- 394
Query: 423 LEIFKLNNSDGNLAGPNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALVSL 482
PN KP NN+ ++LI +I A +G + AL SL
Sbjct: 395 ---------------PNSPVKP-------------NNRAPLVLITVIVAAVGGVVAL-SL 425
Query: 483 LYFFFLRKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEI 542
L+F LR + RV S K+ SWVPFSY +T+TN SSLP+D+CR FSL +I
Sbjct: 426 LWFLVLRPRMRVKHVGGISRAKS----SWVPFSYTTRSTSTN-GSSLPADICRHFSLAQI 480
Query: 543 KQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR 602
K ATC+F + IIG GGFG+V+KG+I GS TVAVKRLN SS QGAREF TEI M+S+LR
Sbjct: 481 KDATCNFNKNFIIGEGGFGNVYKGFIKGGSTTVAVKRLNPSSKQGAREFETEIRMLSKLR 540
Query: 603 HLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
H+H+VS++G+CDE GEMILVY++M RG LRDHLY + +N PL WK+RL++
Sbjct: 541 HIHLVSMIGYCDEEGEMILVYDYMARGTLRDHLY----------KTKNPPLPWKQRLQVC 590
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
IGAARGLHYLH GAKHTIIHRDVKSTNILLDE W AK+SDFGLSR+GP+ M+Q+HVST V
Sbjct: 591 IGAARGLHYLHTGAKHTIIHRDVKSTNILLDEKWVAKVSDFGLSRVGPTSMTQTHVSTAV 650
Query: 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782
KGSFGYVDPEY R +QLTEKSDVYSFGVVL EVLC RP +I A K +V L W R S
Sbjct: 651 KGSFGYVDPEYFRLRQLTEKSDVYSFGVVLFEVLCARPAVIPDAPEK-QVCLAEWGRRSY 709
Query: 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAA 842
+G + +I+D LR ++AP CL KF EIA SC ++G RP M DV W LEFALQLQE A
Sbjct: 710 RKGALVRIMDQNLRDEVAPECLKKFGEIADSCVRDKGIERPPMSDVVWALEFALQLQETA 769
Query: 843 EKSDQ 847
E++ Q
Sbjct: 770 ERNSQ 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15241606|ref|NP_198716.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|75333906|sp|Q9FID8.1|Y5900_ARATH RecName: Full=Putative receptor-like protein kinase At5g39000; Flags: Precursor gi|10177545|dbj|BAB10824.1| receptor-like protein kinase [Arabidopsis thaliana] gi|332007002|gb|AED94385.1| putative receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2161), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/897 (50%), Positives = 573/897 (63%), Gaps = 47/897 (5%)
Query: 21 AAEQTSPPYIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQEN 80
E + Y PTD L CG++SN GRNW + + K SSN SFT++AS+QE+
Sbjct: 18 VGEGATSTYEPTDVFLFNCGDTSNNVDVSGRNWTAE-NQKILSSNLVNASFTAQASYQES 76
Query: 81 SVPQVPYMTARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFT 140
V Q+PYMTAR+F EFTY+FPV+PG FLRL+FYP Y G Q + SFF+
Sbjct: 77 GVSQIPYMTARIFRSEFTYSFPVTPGSNFLRLYFYPTRY--GSQFNAVK-------SFFS 127
Query: 141 VSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSSSSSYAFINGI 200
V N +TLL NFSA LTV A P + KEFII V Q LNLTF+PS S AF+NGI
Sbjct: 128 VKVNGFTLLNNFSADLTVKASKPQTEFIIKEFIIPVY--QTLNLTFTPSLDS-LAFVNGI 184
Query: 201 EVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHVSAKDDTGMFR 260
E+VS+P+ Y + D I + S+ F + A ET YRLNVGG V D+GMFR
Sbjct: 185 EIVSIPNRFY-SKGGFDDVITNVGSSVDFHIENSTAFETVYRLNVGGKTVG---DSGMFR 240
Query: 261 EWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMGK--DPNINKKYN 318
W+ D I +SG++P +P +I YT TP+Y+AP VY TSR+MG P N +N
Sbjct: 241 RWVSDDEIILSESSGISPIVPDIKINYTEKTPSYVAPDDVYATSRSMGNADHPEQNLNFN 300
Query: 319 LTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAENDADVIHWSGGSGIPV 378
LTW F+VD GF+YLVRLHFCET E+ +E QRVFSIFI NQTA + DV SGGS IP+
Sbjct: 301 LTWLFTVDAGFSYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWIPM 360
Query: 379 FKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAILNGLEIFKLNNSDGNLAGP 438
+ DY V I + D L LHP + ++P KY DAILNG+EI K+N+ DGNLAGP
Sbjct: 361 YLDYTV---IAGSGSGRRHDLRLDLHPLVSINP--KYYDAILNGVEILKMNDPDGNLAGP 415
Query: 439 NPASKPPPEPKPGKQQ-NVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRVNVN 497
NP P+ P + ++ NK ++ I + AV+GS+ L + + +
Sbjct: 416 NPDPLVSPDLIPNRATPRIRKNKSHILPITL--AVVGSLVVLAMFVVGVLV-------IM 466
Query: 498 ESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQATCDFADHCIIGS 557
+ + K ++ SW P + +TNT A SLP+DLCRRFS+ EIK AT DF D IIG
Sbjct: 467 KKKKKSKPSTNSSWCPLPHGTDSTNTKPAKSLPADLCRRFSIFEIKSATNDFEDKLIIGV 526
Query: 558 GGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG 617
GGFG V+KG ID G+ VAVKRL +S QGA+EF TE+EM+S+LRH+H+VSL+G+CDE
Sbjct: 527 GGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDN 586
Query: 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAK 677
EM+LVYE+MP G L+DHL+ +++ + PL+WKRRLEI IGAARGL YLH GAK
Sbjct: 587 EMVLVYEYMPHGTLKDHLFR-------RDKTSDPPLSWKRRLEICIGAARGLQYLHTGAK 639
Query: 678 HTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ 737
+TIIHRD+K+TNILLDEN+ K+SDFGLSR+GP+ SQ+HVSTVVKG+FGY+DPEY RRQ
Sbjct: 640 YTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQ 699
Query: 738 QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRG 797
LTEKSDVYSFGVVLLEVLC RP + +V E+ L+ W + + RGTVDQI+D L
Sbjct: 700 VLTEKSDVYSFGVVLLEVLCCRPIRMQ-SVPPEQADLIRWVKSNYRRGTVDQIIDSDLSA 758
Query: 798 KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSD---QGRPFVPR 854
I L KF EIA C + G RP M DV W LEFALQL E A+K + + +P
Sbjct: 759 DITSTSLEKFCEIAVRCVQDRGMERPPMNDVVWALEFALQLHETAKKKNDNVESLDLMPS 818
Query: 855 GEVITSSTTTDSDEPFSRSSGQVSESRSNTTSSGADGERIRVRSENVFTEIMDPKGR 911
GEV +TT D+ FSR++G V +S + S G+ S VF+EI +PK R
Sbjct: 819 GEV--GTTTDGEDDLFSRTTGHVGKSTTTDDSVLVVGDERSGSSWGVFSEINEPKAR 873
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|155242084|gb|ABT18094.1| FERONIA receptor-like kinase [Brassica oleracea] | Back alignment and taxonomy information |
|---|
Score = 830 bits (2145), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/915 (50%), Positives = 588/915 (64%), Gaps = 81/915 (8%)
Query: 29 YIPTDYILIICGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQENSVPQVPYM 88
Y PTD + CG SS+ +D R W D SKF SS++ +K TS A+ Q+ SVP VPYM
Sbjct: 30 YSPTDNFFLNCGGSSDLPDTDNRTWIPDVKSKFLSSSADSK--TSPAATQDPSVPDVPYM 87
Query: 89 TARVFPEEFTYTFPVSPGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTL 148
TAR+F FTY+FPV+ G KF+RLHFYP Y GL+ + S F+VS YTL
Sbjct: 88 TARIFRSPFTYSFPVAAGRKFVRLHFYPNSY------DGLN----ATNSLFSVSLGSYTL 137
Query: 149 LRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSS--SSSYAFINGIEVVSMP 206
L+NFSA T A+ ++ KEFI++V LN+TF+P S S++YA++NGIEV SMP
Sbjct: 138 LKNFSAAQTAQALT--FSFIVKEFIVNVEGG-ALNVTFTPESAPSNAYAYVNGIEVTSMP 194
Query: 207 DNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHVSAKDDTGMFREWLDDT 266
D LY S D S+ + S+ + D ALE YRLNVGG +S DDTG++R W DD
Sbjct: 195 D-LY---SSTDGSLTVVGSSGGVTIDNSTALENVYRLNVGGNDISPSDDTGLYRSWYDDQ 250
Query: 267 NYIYGAASGVTPHL-PGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLTWNFSV 325
YI+GA G+T P I+Y S TP Y+APV VY+T+R+MG P IN YNLTW FS+
Sbjct: 251 PYIFGAGLGITETADPNMTIEYPSGTPTYVAPVDVYSTARSMGPTPQINLNYNLTWIFSI 310
Query: 326 DPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAENDADVIHWSGGSGIPVFKDYVVW 385
D GF+YLVRLHFCE +T+ NQRVF++++NNQTAE +ADV W+GG GIP+ KDYVV
Sbjct: 311 DSGFSYLVRLHFCEVAPNMTKINQRVFTVYLNNQTAEPEADVAGWTGGHGIPLHKDYVVN 370
Query: 386 VPIDAIEKESKQDFWLALHPFLDLDPLPKYADAILNGLEIFKLNNSDGNLAGPNPASKPP 445
P + + +QD WLALHP + P+Y DAILNG+EIFK+NNSDGNLAGPNP P
Sbjct: 371 PP----DGKGQQDLWLALHP--NTKNNPEYYDAILNGVEIFKMNNSDGNLAGPNPIPGPQ 424
Query: 446 PEPKPGK-----QQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRVNVNESA 500
P K KN+ V A VLG I L +++ + R++ R N+ A
Sbjct: 425 VTADPSKVLRPRTSQSKNHTAVVAGAASGAVVLGLIVGLCAMIAY---RRRNR-GENQPA 480
Query: 501 SEVKTKSSQSWVPF-----SYALTATNTNT----ASSLPSDLCRRFSLTEIKQATCDFAD 551
S+ ++ W+P S++ + TNT ASSLPS+LCR FS EIK AT +F +
Sbjct: 481 SD----ATSGWLPLSLYGNSHSGGSGKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDE 536
Query: 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLG 611
++G GGFG V++G ID G+ VA+KR N S QG EF+TEIEM+S+LRH H+VSL+G
Sbjct: 537 SRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+C+E+ EMILVY++M G +R+HLY + QNSPL WK+RLEI IGAARGLHY
Sbjct: 597 YCEENCEMILVYDYMAHGTMREHLY----------KTQNSPLPWKQRLEICIGAARGLHY 646
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH GAKHTIIHRDVK+TNILLDE W AK+SDFGLS+ GP+ + +HVSTVVKGSFGY+DP
Sbjct: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPA-LDHTHVSTVVKGSFGYLDP 705
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791
EY RRQQLT+KSDVYSFGVVL E LC R P +N + KE+VSL WA +G +DQIV
Sbjct: 706 EYFRRQQLTDKSDVYSFGVVLFEALCAR-PALNPTLAKEQVSLAEWAPYCYKKGMLDQIV 764
Query: 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSDQGRPF 851
DP L+GKI P C KF E A C ++G RP+MGDV W LEFALQLQE+AE+S +G
Sbjct: 765 DPHLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEESGKGI-- 822
Query: 852 VPRGEVITSSTTTDSDEPFSRSS---------GQVSESRSNTTSSGADGERIRVRSEN-- 900
E+ D D +++ G V++SRS+ G + +
Sbjct: 823 --CSEMDMDEIKYDDDNCKGKNNSEKGCDVYEGNVTDSRSSGIDMSIGGRSLASEDSDGL 880
Query: 901 ----VFTEIMDPKGR 911
VF++IM+PKGR
Sbjct: 881 TPSGVFSQIMNPKGR 895
|
Source: Brassica oleracea Species: Brassica oleracea Genus: Brassica Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FID8 | Y5900_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5016 | 0.9330 | 0.9736 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.277.2.1 | hypothetical protein (807 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 911 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 6e-60 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-28 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-27 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-27 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-26 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-25 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-24 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-22 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-15 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-14 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-13 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 3e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 6e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| pfam14283 | 213 | pfam14283, DUF4366, Domain of unknown function (DU | 7e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 6e-60
Identities = 98/402 (24%), Positives = 148/402 (36%), Gaps = 81/402 (20%)
Query: 39 CGESSNTTSSD---GRNWDGDAHSKFSSSNSATKSFTSRASFQENSVPQVPYMTARVFPE 95
CG SN + +D G W DA + + + + +S PY T R FP+
Sbjct: 3 CGLPSNESYTDPSTGITWVSDAGFIDTGKS------GNISKENSSSFLSKPYKTLRSFPD 56
Query: 96 --EFTYTFPVSPGPK---FLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLR 150
YT PV+PG +R F Y D +++S+ + L
Sbjct: 57 GKRNCYTLPVTPGKGTKYLIRATFLYGNY---------DGLNSVSSP------PSFDLYL 101
Query: 151 NFSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNLTFSPSSSSSYAFINGIEVVSMPDNLY 210
+ TV+ KE+II V+ S L++ + + + FI+ +E+ +PD+LY
Sbjct: 102 GVNLWTTVNLSNDSGDSVVKEYIIHVTKSDTLSVCLVNTGTGT-PFISALELRPLPDSLY 160
Query: 211 LQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVG--GAHVSAKDDTGMFREWLDDTNY 268
AL+ RLN G + DD R W +
Sbjct: 161 PSSGGS------------------QALKLVARLNFGGSEGTIRYPDDV-YDRIWEPFFSS 201
Query: 269 IYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLTWNFSVDPG 328
+ + + +S+ YI P V T+ T N + N TW+ VDP
Sbjct: 202 PGWSQISTSLS-----VDISSNNAPYIPPSAVLQTAVTPT---NASAPLNFTWDL-VDPN 252
Query: 329 FNYLVRLHFCETQLEITRENQRVFSIFINNQTAENDADVIHWSGGSGIPVFKDYVVWVPI 388
F Y V LHF EI R F I+IN +T D + G ++ D+ V V
Sbjct: 253 FEYYVYLHFA----EIQSLETREFDIYINGKTVYGDVS-PKYLGTDTGALYLDFPVNVS- 306
Query: 389 DAIEKESKQDFWLALHP--FLDLDPLPKYADAILNGLEIFKL 428
++L P L P +LN LEIFK+
Sbjct: 307 ------GGGLLNISLVPTSGSTLPP-------LLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 3e-53
Identities = 72/216 (33%), Positives = 109/216 (50%), Gaps = 18/216 (8%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
+G G FG V+KG D + VAVK L + + R +F E ++ +L H ++V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
LG C E + LV E+M G+L D+L +K + S L+ K L +I A+G+
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYL---RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTV--VKGSF 726
YL +HRD+ + N L+ E+ KISDFGLSR + + ++
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR--- 172
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
++ PE ++ T KSDV+SFGV+L E+ G P
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 555 IGSGGFGHVFKGYI----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
+G G FG V+KG + + VAVK L + + R EF E ++ +L H +IV L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
LG C + + +V E+MP G+L D L + LT K L++++ A+G+
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFL-----------RKHGEKLTLKDLLQMALQIAKGM 115
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YL + +HRD+ + N L+ EN KISDFGLSR K ++
Sbjct: 116 EYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE-DDYYRKRGGGKLPIKWM 171
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
PE ++ + T KSDV+SFGV+L E+ G P
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 71/241 (29%), Positives = 114/241 (47%), Gaps = 31/241 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGFC 613
+G GGFG V+ VA+K + E EIE++ +L H +IV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
++ + LV E+ G+L+D L + L+ L I + GL YLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL-----------KENEGKLSEDEILRILLQILEGLEYLH 109
Query: 674 AGAKHTIIHRDVKSTNILLDENWA-AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
+ IIHRD+K NILLD + K++DFGLS++ S S + G+ Y+ PE
Sbjct: 110 ---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK---TIVGTPAYMAPE 163
Query: 733 YIRRQQ-LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791
+ + +EKSD++S GV+L E+ P + + +RK + + R + +I+
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL----PELKD-LIRK------MLQKDPEKRPSAKEIL 212
Query: 792 D 792
+
Sbjct: 213 E 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 4e-50
Identities = 70/215 (32%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
+G G FG V+KG + VAVK L + + EF E ++ +L H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG C E + +V E+M G+L +L ++N+ + L+ L ++ ARG
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPK-------LSLSDLLSFALQIARG 114
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL IHRD+ + N L+ EN KISDFGLSR + K +
Sbjct: 115 MEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIRW 169
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRPP 761
+ PE ++ + T KSDV+SFGV+L E+ L +P
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY 204
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 75/215 (34%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
+G G FG V+KG D + VAVK L + + EF E ++ +L H +IV
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG C E +++V E+MP G+L D+L +K N+ L+ L ++ ARG
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL---RK-------NRPKELSLSDLLSFALQIARG 115
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL IHRD+ + N L+ EN KISDFGLSR + K +
Sbjct: 116 MEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYKVKGGKLPIRW 170
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRPP 761
+ PE ++ + T KSDV+SFGV+L E+ L P
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY 205
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 549 FADHCIIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHI 606
+ +G G FG V+ G + VA+K + ++ RE EI+++ +L+H +I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKL-VAIKVIKKKKIKKDRERILREIKILKKLKHPNI 59
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V L ++ ++ LV E+ G+L D L + L+
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLL------------KKRGRLSEDEARFYLRQIL 107
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
L YLH I+HRD+K NILLDE+ K++DFGL+R + T G+
Sbjct: 108 SALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQ----LDPGEKLTTFVGTP 160
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE + + + D++S GV+L E+L G+PP
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 76/211 (36%), Positives = 111/211 (52%), Gaps = 21/211 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLG 611
+GSG FG V+K VAVK L S + + R EI ++ L H +IV L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
++ + LV E+ G+L D+L ++ PL+ +I++ RGL Y
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL------------SRGGPLSEDEAKKIALQILRGLEY 113
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH+ + IIHRD+K NILLDEN KI+DFGL++ S S ++T V G+ Y+ P
Sbjct: 114 LHS---NGIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFV-GTPWYMAP 167
Query: 732 EYIRRQQL-TEKSDVYSFGVVLLEVLCGRPP 761
E + K DV+S GV+L E+L G+PP
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 553 CIIGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIVSLL 610
++G G FG V+ D +AVK L+ S + EI ++S L+H +IV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 611 GFC-DEHGEMILVY-EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
G DE + ++ E++ G+L L K + P+ R+ I G
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--------PVI--RKYTRQI--LEG 113
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L YLH+ + I+HRD+K NIL+D + K++DFG ++ + V+G+ +
Sbjct: 114 LAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE-TGEGTGSVRGTPYW 169
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE IR ++ +D++S G ++E+ G+PP
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG GGFG V+K VA+K + S + + EI+++ + +H +IV G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ E+ +V EF G+L+D L ++ N LT + + +GL YLH
Sbjct: 68 KKDELWIVMEFCSGGSLKDLL-----------KSTNQTLTESQIAYVCKELLKGLEYLH- 115
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ IIHRD+K+ NILL + K+ DFGLS ++ + + V G+ ++ PE
Sbjct: 116 --SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-----GTPYWMAPEV 168
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762
I + K+D++S G+ +E+ G+PP
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 75/214 (35%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 555 IGSGGFGHVFKGYID---DGS-ITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSL 609
+G G FG V D D + VAVK LN S Q +F EIE++ L H +IV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 610 LGFCDEHGEMI--LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
G C++ G L+ E++P G+LRD+L Q+ N KR L S +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINL--------KRLLLFSSQICK 120
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS-- 725
G+ YL G++ IHRD+ + NIL++ KISDFGL+++ P + VK
Sbjct: 121 GMDYL--GSQR-YIHRDLAARNILVESEDLVKISDFGLAKVLP----EDKDYYYVKEPGE 173
Query: 726 ---FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
F Y PE +R + + SDV+SFGV L E+
Sbjct: 174 SPIFWYA-PECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREF-RTEIEMISELRHLHIVSLLGF 612
IG G FG V+ +K ++ S+M + RE E++++ +L H +I+
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+E G++ +V E+ G+L + +K+ + P ++ L+ + L YL
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGK--------PFPEEQILDWFVQLCLALKYL 119
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H I+HRD+K NI L N K+ DFG+S++ S + TVV G+ Y+ PE
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVV-GTPYYLSPE 173
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + KSD++S G VL E+ + P
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 71/224 (31%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVS 608
+G G FG VF G ++ VAVK L ++ AR+ F E E+++ +H +IV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHL--YNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
G C E I+V+E+M G+L L + + LT + L+I++ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV----V 722
G+ YL A +HRD+ + N L+ + KI DFG+SR V T V
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---------DVYTTDYYRV 180
Query: 723 KGS----FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
G ++ PE I ++ T +SDV+SFGVVL E+ G+ P
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+GSG FG V++G + + VA+K L + + ++F+ E++ + LRH H++SL C
Sbjct: 14 LGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ ++ E M +G+L L + + Q + L ++++ A G+ YL
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVL-----PVASL-----IDMACQVAEGMAYLEE 122
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
IHRD+ + NIL+ E+ K++DFGL+R+ + S K + + PE
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK---KIPYKWTAPEAA 176
Query: 735 RRQQLTEKSDVYSFGVVLLEVL----CGRPPMINGAV 767
+ KSDV+SFG++L E+ P M N V
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 41/283 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G+G FG V++G + + + VAVK L +M ++F E +++ +LRH ++ L C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ +V E M G+L ++L + L + ++++ A G+ YL A
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRA----------LKLPQLIDMAAQVASGMAYLEA 121
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
IHRD+ + N+L+ EN K++DFGL+R+ + ++ K + PE
Sbjct: 122 ---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA--KFPIKWTAPEAA 176
Query: 735 RRQQLTEKSDVYSFGVVLLEVLC-GRPP---MINGAVRKEEVSLVLWARVSRARGTVDQI 790
+ + KSDV+SFG++L E++ GR P M N V Q
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL--------------------QQ 216
Query: 791 VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
VD R P C + +I C E+ RPT + W LE
Sbjct: 217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 71/216 (32%), Positives = 114/216 (52%), Gaps = 24/216 (11%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVS 608
+G G FG V+KG + + +VA+K L + + +EFR E E++S+L+H +IV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLY----NSQKQNQNQNQNQNSPLTWKRRLEISIG 664
LLG C + +++E++ G+L + L +S ++ ++ S L L I+I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG-----MSQSHVS 719
A G+ YL + H +HRD+ + N L+ E KISDFGLSR S S+S +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV 755
++ PE I + T +SD++SFGVVL E+
Sbjct: 190 V------RWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 552 HCIIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVS 608
+IG G FG V+KG ++ G VA+K+++ ++ + EI+++ L+H +IV
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGD-FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA-- 666
+G + + ++ E+ G+LR + ++ +++
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPES---------------LVAVYVYQV 108
Query: 667 -RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVKG 724
+GL YLH + +IHRD+K+ NIL ++ K++DFG++ ++ S V G
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN----DVSKDDASVVG 161
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ ++ PE I + SD++S G ++E+L G PP
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 22/214 (10%)
Query: 554 IIGSGGFGHVFKGY-IDDGS---ITVAVKRLNTSSMQGA-REFRTEIEMISELRHLHIVS 608
++GSG FG V+KG I +G I VA+K L + A +E E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG C ++ L+ + MP G L D++ + +++ N L W ++ A+G
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYV----RNHKD-NIGSQYLLNWCVQI------AKG 121
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL + ++HRD+ + N+L+ KI+DFGL+++ + H K +
Sbjct: 122 MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG-GKVPIKW 177
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
+ E I + T KSDV+S+GV + E++ G P
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 23/208 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G FG V G D VAVK L S A+ F E +++ LRH ++V LLG
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + +V E+M +G+L D+L + + +T ++L ++ G+ YL
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAV----------ITLAQQLGFALDVCEGMEYLEE 120
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+HRD+ + N+L+ E+ AK+SDFGL++ SQ K + PE +
Sbjct: 121 ---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQ--DSGKLPVKWTAPEAL 171
Query: 735 RRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
R ++ + KSDV+SFG++L E+ GR P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 69/300 (23%), Positives = 131/300 (43%), Gaps = 41/300 (13%)
Query: 536 RFSLTEIKQATCDFADHCIIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR- 589
R +L EI +G G FG VF + G V VK L + + +
Sbjct: 4 RSNLQEITT----------LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS 53
Query: 590 EFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQ 649
EFR E++M +L H ++V LLG C E ++ E+ G+L+ L ++ ++ + +
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD---EKLK 110
Query: 650 NSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709
PL+ K+++ + A G+ +L + +HRD+ + N L+ K+S LS+
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV 167
Query: 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVR 768
+ + ++ ++ PE ++ + KSDV+SFGV++ EV G P +
Sbjct: 168 YNSEYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF--YGLS 223
Query: 769 KEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
EEV ++++ +L + C ++ ++ C RP+ ++
Sbjct: 224 DEEV--------------LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 27/222 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGFC 613
IG G FG V+KG + + VAVK ++ + F E E++ + H +IV L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNT-EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ + +V E +P G+L L ++ +N+ LT K+ L++S+ AA G+ YL
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL----RKKKNR-------LTVKKLLQMSLDAAAGMEYLE 110
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGM--SQSHVSTV-VKGSFGYVD 730
+ IHRD+ + N L+ EN KISDFG+SR G+ + + +K +
Sbjct: 111 S---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK----WTA 163
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVL----CGRPPMINGAVR 768
PE + + T +SDV+S+G++L E P M N R
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR 205
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 41/283 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G+G FG V+ G + G+ VAVK L +M F E +++ +LRH +V L C
Sbjct: 14 LGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E + +V E+M +G+L D L + + + Q ++++ A G+ YL
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ----------LVDMAAQIAEGMAYLE- 120
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
IHRD+ + NIL+ EN KI+DFGL+R+ + K + PE
Sbjct: 121 --SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA--KFPIKWTAPEAA 176
Query: 735 RRQQLTEKSDVYSFGVVLLEVLC-GRPP---MINGAVRKEEVSLVLWARVSRARGTVDQI 790
+ T KSDV+SFG++L E++ GR P M N R ++Q
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------------------REVLEQ- 216
Query: 791 VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
V+ R P C + ++ C D++ RPT + LE
Sbjct: 217 VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 71/226 (31%), Positives = 115/226 (50%), Gaps = 27/226 (11%)
Query: 553 CIIGSGGFGHVFKG-YID----DGSITVAVKRLNTSSM-QGAREFRTEIEMISEL-RHLH 605
+G G FG V K + + + TVAVK L + + + +E+EM+ + +H +
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSP----LTWKRRLEI 661
I++LLG C + G + +V E+ GNLRD L + + + + P LT K +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ ARG+ +L A IHRD+ + N+L+ E+ KI+DFGL+R H+
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR------DIHHIDYY 188
Query: 722 VKGSFG-----YVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
K + G ++ PE + + T +SDV+SFGV+L E+ L G P
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 71/212 (33%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 555 IGSGGFGHVFKGYI---DDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLL 610
+G G FG V KG + VAVK L + G +EF E ++++L H IV L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
G C ++LV E P G L +L K+ + S L E++ A G+
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYL----KKRREI---PVSDL-----KELAHQVAMGMA 109
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YL + KH +HRD+ + N+LL AKISDFG+SR +G +T + +
Sbjct: 110 YLES--KH-FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
PE I + + KSDV+S+GV L E G P
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 75/222 (33%), Positives = 116/222 (52%), Gaps = 27/222 (12%)
Query: 554 IIGSGGFGHVFKGYI--DDGSITVAVKRLNT-SSMQGAREFRTEIEMISEL-RHLHIVSL 609
+IG G FG V + I D + A+K L +S R+F E+E++ +L H +I++L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQN----QNQNQNSPLTWKRRLEISIGA 665
LG C+ G + + E+ P GNL D L S+ + + S LT ++ L+ +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
A G+ YL ++ IHRD+ + N+L+ EN A+KI+DFGLSR VK +
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---------GEEVYVKKT 176
Query: 726 FGYVDPEYIRRQQL-----TEKSDVYSFGVVLLEV--LCGRP 760
G + ++ + L T KSDV+SFGV+L E+ L G P
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHL-HIVSLL 610
+G G FG V+ VA+K L S + F EI++++ L H +IV L
Sbjct: 8 LGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
F + G + LV E++ G+L D L + PL+ L I L
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIG---------RKGPLSESEALFILAQILSALE 115
Query: 671 YLHAGAKHTIIHRDVKSTNILLDEN-WAAKISDFGLSRMGPSGMSQSHV---STVVKGSF 726
YLH IIHRD+K NILLD + K+ DFGL+++ P S S + + G+
Sbjct: 116 YLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 727 GYVDPEYIRRQQL---TEKSDVYSFGVVLLEVLCGRPP 761
GY+ PE + L + SD++S G+ L E+L G PP
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHIVS 608
+G G FG V++G + VA+K +N +SM+ EF E ++ E H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG ++V E M +G+L+ +L ++ + +N P T ++ ++++ A G
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-------MGPSGMSQSHVSTV 721
+ YL AK +HRD+ + N ++ E+ KI DFG++R G V
Sbjct: 132 MAYLA--AKK-FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
++ PE ++ T KSDV+SFGVVL E+
Sbjct: 187 ------WMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 75/217 (34%), Positives = 115/217 (52%), Gaps = 17/217 (7%)
Query: 554 IIGSGGFGHVFKGYI--DDGSITVAVKRL-NTSSMQGAREFRTEIEMISEL-RHLHIVSL 609
+IG G FG V K I D + A+KR+ +S R+F E+E++ +L H +I++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQN----QNQNSPLTWKRRLEISIGA 665
LG C+ G + L E+ P GNL D L S+ + + S L+ ++ L +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
ARG+ YL ++ IHRD+ + NIL+ EN+ AKI+DFGLSR G T+ +
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 186
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
++ E + T SDV+S+GV+L E+ L G P
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 555 IGSGGFGHVFKGYIDDGS---ITVAVKRLNTSSMQGA-REFRTEIEMISELRHLHIVSLL 610
+G G FG V +G I VAVK L + + +F E ++ L H +++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
G H +++V E P G+L D L ++ + ++ A G+
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRL----------RKDALGHFLISTLCDYAVQIANGMR 111
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YL + K IHRD+ + NILL + KI DFGL R P + +K F +
Sbjct: 112 YLES--KR-FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMI 763
PE +R + + SDV+ FGV L E+ G P
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IGSG FG V+ GY + VA+K + +M +F E +++ +L H +V L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E + LV+EFM G L D+L + Q + + L + + G+ YL
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL-----------RAQRGKFSQETLLGMCLDVCEGMAYLE- 117
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+IHRD+ + N L+ EN K+SDFG++R Q ST K + PE
Sbjct: 118 --SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD--DQYTSSTGTKFPVKWSSPEVF 173
Query: 735 RRQQLTEKSDVYSFGVVLLEVLC-GRPPMIN 764
+ + KSDV+SFGV++ EV G+ P N
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G +G V++G S+TVAVK L +M+ EF E ++ E++H ++V LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
++ EFM GNL D+L +Q + L ++ + + YL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQE----------VNAVVLLYMATQISSAMEYLE- 121
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
K IHRD+ + N L+ EN K++DFGLSR+ +H K + PE +
Sbjct: 122 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA--KFPIKWTAPESL 177
Query: 735 RRQQLTEKSDVYSFGVVLLEV 755
+ + KSDV++FGV+L E+
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLH 605
DF IG G FG VFK A+K+++ S M E E ++++L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
I+ + G++ +V E+ G+L L + + ++Q W+ ++I +G
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ------VWRFFIQILLG- 113
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVKG 724
L +LH I+HRD+KS N+ LD KI D G+++ + ++ + + G
Sbjct: 114 ---LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD----NTNFANTIVG 163
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ Y+ PE + EKSDV++ GVVL E G+ P
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLH 605
D ++G G G V+K + G I A+K+++ + ++ E++ + +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKI-YALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 606 IVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL-EISI 663
+V G F E GE+ +V E+M G+L D L K + L I+
Sbjct: 61 VVKCYGAFYKE-GEISIVLEYMDGGSLADLLKKVGKIPEPV-------------LAYIAR 106
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ--SHVSTV 721
+GL YLH K IIHRD+K +N+L++ KI+DFG+S++ + + Q + V TV
Sbjct: 107 QILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTV 164
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE I+ + + +D++S G+ LLE G+ P
Sbjct: 165 T-----YMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 42/222 (18%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR--TEIEMISELRHLHIVSLLGF 612
IG G G V+K VA+K++ ++ + EI ++ + +H +IV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 613 CDEHGEMI-LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA----- 666
G+ + +V E+M G+L D + + + E I
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQN-----------FVRMN-----EPQIAYVCREVL 126
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG----LSRMGPSGMSQSHVSTVV 722
+GL YLH+ ++ +IHRD+KS NILL ++ + K++DFG L++ +S ++VV
Sbjct: 127 QGLEYLHS--QN-VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK------EKSKRNSVV 177
Query: 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
G+ ++ PE I+R+ K D++S G++ +E+ G PP +
Sbjct: 178 -GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-25
Identities = 76/222 (34%), Positives = 116/222 (52%), Gaps = 27/222 (12%)
Query: 554 IIGSGGFGHVFKGYI--DDGSITVAVKRLNT-SSMQGAREFRTEIEMISEL-RHLHIVSL 609
+IG G FG V K I D + A+KR+ +S R+F E+E++ +L H +I++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQN----QNQNQNSPLTWKRRLEISIGA 665
LG C+ G + L E+ P GNL D L S+ + + S L+ ++ L +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
ARG+ YL ++ IHRD+ + NIL+ EN+ AKI+DFGLSR VK +
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKT 169
Query: 726 FGYVDPEYIRRQQL-----TEKSDVYSFGVVLLEV--LCGRP 760
G + ++ + L T SDV+S+GV+L E+ L G P
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 72/210 (34%), Positives = 112/210 (53%), Gaps = 27/210 (12%)
Query: 554 IIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612
IIG G FG V +G Y VAVK + A+ F E ++++L H ++V LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQ---KVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+G + +V E M +GNL + L + + Q L+ S+ A G+ YL
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQ----------LLQFSLDVAEGMEYL 116
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
+ ++HRD+ + NIL+ E+ AK+SDFGL+R+G G+ S + VK + PE
Sbjct: 117 ES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP--VK----WTAPE 167
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
++ ++ + KSDV+S+GV+L EV GR P
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 555 IGSGGFGHVFK----GYIDDGSIT-VAVKRL-NTSSMQGAREFRTEIEMISELRHLHIVS 608
IG G FG VF+ G + T VAVK L +S +F+ E +++E H +IV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNS----------PLTWKRR 658
LLG C M L++E+M G+L + L + + Q + S PL+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 659 LEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV 718
L I+ A G+ YL ++ +HRD+ + N L+ EN KI+DFGLSR +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-------NIYS 182
Query: 719 STVVKGS------FGYVDPEYIRRQQLTEKSDVYSFGVVLLEV 755
+ K S ++ PE I + T +SDV+++GVVL E+
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 71/215 (33%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 554 IIGSGGFGHVFKG-YID-DG-SITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHIVSL 609
+IG G FG V+ G ID DG I AVK LN + ++ +F E ++ + H +++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 610 LGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LG C G ++V +M G+LR+ + + ++P T K + + A+G
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSET----------HNP-TVKDLIGFGLQVAKG 110
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVKGSFG 727
+ YL A +HRD+ + N +LDE++ K++DFGL+R + H T K
Sbjct: 111 MEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
++ E ++ Q+ T KSDV+SFGV+L E++ G PP
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNT--SSMQGARE---FRTEIEMISELRHLHIVS 608
++G G FG V+ Y D +AVK++ S + +E EI+++ L+H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
G + + + E+MP G+++D L K + +T K +I G
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTET----VTRKYTRQI----LEG 116
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVKGSFG 727
+ YLH + I+HRD+K NIL D K+ DFG S R+ S + + +V G+
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPY 172
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
++ PE I + K+DV+S G ++E+L +PP
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+GSG FG V G G I VA+K + +M +F E +++ +L H ++V L G C
Sbjct: 12 LGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + +V E+M G L ++L + + + L++ + YL
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTE-----------WLLDMCSDVCEAMEYLE- 117
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ IHRD+ + N L+ E+ K+SDFGL+R Q S K + PE
Sbjct: 118 --SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQGTKFPVKWAPPEVF 173
Query: 735 RRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+ + KSDV+SFGV++ EV G+ P
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 70/213 (32%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSL- 609
+IG G FG V D A+K +N R E ++ EL H +V+L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS-IGAARG 668
F DE M LV + + G+LR HL SQK ++ Q + I I A
Sbjct: 67 YSFQDEE-NMYLVVDLLLGGDLRYHL--SQKVKFSEEQV---------KFWICEIVLA-- 112
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L YLH+ IIHRD+K NILLDE I+DF ++ ++T G+ GY
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD----TLTTSTSGTPGY 165
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE + RQ + D +S GV E L G+ P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 15/217 (6%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG VF + + VAVK L +S ++F+ E E+++ L+H HIV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 610 LGFCDEHGEMILVYEFMPRGN----LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
G C E +++V+E+M G+ LR H +++ ++ LT + L I+
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV-APGQLTLGQMLAIASQI 131
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
A G+ YL A +HRD+ + N L+ + KI DFG+SR S V
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTMLP 187
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
++ PE I ++ T +SD++SFGVVL E+ G+ P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 73/215 (33%), Positives = 105/215 (48%), Gaps = 13/215 (6%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG VF + I VAVK L +S ++F E E+++ L+H HIV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSP--LTWKRRLEISIGAAR 667
G C E +I+V+E+M G+L L + + N P LT + L I+ A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFL-RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YL A +HRD+ + N L+ EN KI DFG+SR S V
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-TDYYRVGGHTMLPIR 187
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
++ PE I ++ T +SDV+S GVVL E+ G+ P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGS---ITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
+IG G FG V +G + I VA+K L S R +F TE ++ + H +I+ L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G + ++++ E+M G+L L + + T + + + G A G+
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-----------FTVGQLVGMLRGIASGM 119
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG---SF 726
YL ++ +HRD+ + NIL++ N K+SDFGLSR S++ +T KG
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTT--KGGKIPI 172
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ PE I ++ T SDV+SFG+V+ EV+
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 25/210 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLG-F 612
IG G FG V G D VAVK + + A+ F E ++++LRH ++V LLG
Sbjct: 13 TIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+E G + +V E+M +G+L D+L + + S L L+ S+ + YL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYL 118
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
A + +HRD+ + N+L+ E+ AK+SDFGL++ S +Q VK + PE
Sbjct: 119 EA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVK----WTAPE 169
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
+R ++ + KSDV+SFG++L E+ GR P
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 29/213 (13%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGARE-FRTEIEMISEL-RHLHI 606
+G+G FG V + D + VAVK L ++ RE +E++++S L H +I
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V+LLG C G ++++ E+ G+L + L + + S LT + L S A
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLR----------RKRESFLTLEDLLSFSYQVA 151
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS- 725
+G+ +L A IHRD+ + N+LL KI DFGL+R M+ S+ VVKG+
Sbjct: 152 KGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNY--VVKGNA 203
Query: 726 ---FGYVDPEYIRRQQLTEKSDVYSFGVVLLEV 755
++ PE I T +SDV+S+G++L E+
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612
+G G +G V+K + VA+K + +E EI ++ + +IV G
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI---GAARGL 669
++ ++ +V E+ G++ D + + N LT + EI+ +GL
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIM-----------KITNKTLTEE---EIAAILYQTLKGL 112
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YLH + IHRD+K+ NILL+E AK++DFG+S M++ +TV+ G+ ++
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR--NTVI-GTPFWM 166
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
PE I+ K+D++S G+ +E+ G+PP +
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREF---RTEIEMISELRHLHIVSLL- 610
+G G FG V D A+K L + +E TE ++S + H IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR--- 667
F E ++ LV E+ P G L HL + S AR
Sbjct: 61 AFQTEE-KLYLVLEYAPGGELFSHLS--------------------KEGRFSEERARFYA 99
Query: 668 -----GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
L YLH II+RD+K NILLD + K++DFGL++ S S+ +T
Sbjct: 100 AEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFC 154
Query: 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE + + + D +S GV+L E+L G+PP
Sbjct: 155 -GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 555 IGSGGFGHVFKGYIDDGSIT-----VAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG VF + S T VAVK L ++ ++F+ E E+++ L+H HIV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 610 LGFCDEHGEMILVYEFMPRGN----LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
G C + +I+V+E+M G+ LR H ++ Q + L + L I+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
A G+ YL A +HRD+ + N L+ N KI DFG+SR S V
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST-DYYRVGGHTMLP 188
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
++ PE I ++ T +SDV+SFGV+L E+ G+ P
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 22/222 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLGF 612
++G G FG VFKG + D + VAVK Q + +F +E ++ + H +IV L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKT-PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
C + + +V E +P G+ L + + L K+ ++ ++ AA G+ YL
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFL-----------RKKKDELKTKQLVKFALDAAAGMAYL 109
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
+ IHRD+ + N L+ EN KISDFG+SR G+ S S + + + PE
Sbjct: 110 ES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--SGLKQIPIKWTAPE 164
Query: 733 YIRRQQLTEKSDVYSFGVVLLEV----LCGRPPMINGAVRKE 770
+ + + +SDV+S+G++L E +C P M N R++
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 554 IIGSGGFGHVFK-GYIDDGSITVAVKRLNTSSMQGAREFRTEIEMI-------SELRHLH 605
IG G FG V K DG I + K ++ +M E + + EL+H +
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKI-LVWKEIDYGNMT-----EKEKQQLVSEVNILRELKHPN 60
Query: 606 IVSLLG-FCDEHGEMI-LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
IV D + + +V E+ G+L + +K+ + + W+ ++ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF----IWRILTQLLL 116
Query: 664 GAARGLHYLHAG--AKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG--MSQSHVS 719
L+ H +T++HRD+K NI LD N K+ DFGL+++ ++++V
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
T Y+ PE + EKSD++S G ++ E+ PP
Sbjct: 173 TPY-----YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 30/230 (13%)
Query: 554 IIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSSMQGA-REFRTEIEMISELRHLHIV 607
+G G FG V K G TVAVK L ++ R+ +E ++ ++ H H++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQK---------QNQNQNQNQN---SPLTW 655
L G C + G ++L+ E+ G+LR L S+K N+N + N LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---MGPSG 712
+ + +RG+ YL A+ ++HRD+ + N+L+ E KISDFGLSR S
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
+ +S VK ++ E + T +SDV+SFGV+L E+ L G P
Sbjct: 184 VKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 38/236 (16%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISEL-RH 603
DF IIG G F V + + A+K L+ + + + E E+++ L H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 604 LHIVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
I+ L F DE + V E+ P G L ++ ++ + + EI
Sbjct: 62 PGIIKLYYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA--------EIL 112
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQS----- 716
+ L YLH+ IIHRD+K NILLD++ KI+DFG ++ + P+ +S
Sbjct: 113 LA----LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 717 -------HVSTVVKGSF-G---YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ SF G YV PE + + + SD+++ G ++ ++L G+PP
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 555 IGSGGFGHV----FKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLL 610
+G G FG V + D+ VAVK+L S+ + R+F EIE++ L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 611 GFCDEHG--EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
G C G + LV E++P G+LRD+L Q L ++ L + +G
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL-----------QKHRERLDHRKLLLYASQICKG 120
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL G+K +HRD+ + NIL++ KI DFGL+++ P V + +
Sbjct: 121 MEYL--GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEV 755
PE + + + SDV+SFGVVL E+
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 80/280 (28%), Positives = 125/280 (44%), Gaps = 31/280 (11%)
Query: 555 IGSGGFGHV----FKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSL 609
+G G FG V + D VAVK L Q ++ EI ++ L H +IV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 610 LGFCDEHGEMI--LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
G C E G L+ E++P G+LRD+L K N Q L + +++
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQ----LLLFAQQI------CE 118
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YLH+ +H IHRD+ + N+LLD + KI DFGL++ P G V
Sbjct: 119 GMAYLHS--QH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787
+ E ++ + + SDV+SFGV L E+L + + EE+ + + TV
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-----IGPKQGQMTV 230
Query: 788 DQIVDPRLRGKIAPV---CLNKFVEIAGSCTDEEGFRRPT 824
++++ RG P C + + +C + E RPT
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPT 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 31/216 (14%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRL-----NTSSMQGAREFRTEIEMISELRHLHIVS 608
+GSG FG V++G +DDG AVK + + + ++ EI ++S+L+H +IV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDF-FAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHL--YNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
LG E + + E +P G+L L Y S + + + R++
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--------YTRQI------L 112
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
GL YLH +HRD+K NIL+D N K++DFG+++ + S + KGS
Sbjct: 113 LGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKS-FKGSP 165
Query: 727 GYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPP 761
++ PE I +Q +D++S G +LE+ G+PP
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT--EIEMISELRHLH 605
DF +G G +G V+K + A+K ++ SM EI +++ + H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 606 IVSLL-GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
I+S F D + ++ +V E+ P G+L + +K+ + Q W+ I I
Sbjct: 61 IISYKEAFLDGN-KLCIVMEYAPFGDLSKAISKRKKK-RKLIPEQ---EIWR----IFIQ 111
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
RGL LH I+HRD+KS NILL N KI D G+S++ M+++ + T
Sbjct: 112 LLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH-- 166
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762
Y+ PE + + + KSD++S G +L E+ PP
Sbjct: 167 ---YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 65/212 (30%), Positives = 112/212 (52%), Gaps = 22/212 (10%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVS 608
+G G FG V++G D+ VA+K +N + SM+ EF E ++ E H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG + +++ E M RG+L+ +L + + + +N N Q +P + K+ ++++ A G
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN-NPVQ-APPSLKKMIQMAGEIADG 131
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG- 727
+ YL+A + +HRD+ + N ++ E++ KI DFG++R KG G
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRKGGKGL 182
Query: 728 ----YVDPEYIRRQQLTEKSDVYSFGVVLLEV 755
++ PE ++ T SDV+SFGVVL E+
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGAREFRT--EIEMISELRHLHIVSLLG 611
IG G +G V+K G I VA+K++ EI+++ EL H +I+ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEI-VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 612 FCDEHGEMILVYEFMPRGNLRDH-LYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
G++ LV+EFM D LY K Q L +GL
Sbjct: 66 VFRHKGDLYLVFEFM------DTDLYKLIKDRQ-------RGLPESLIKSYLYQLLQGLA 112
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM--GPSGMSQSHVSTVVKGSFGY 728
+ H H I+HRD+K N+L++ K++DFGL+R P +V T Y
Sbjct: 113 FCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WY 164
Query: 729 VDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
PE + + + D++S G + E+L RP
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 555 IGSGGFGHVF---KGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVS 608
I G +G VF K D A+K + + M + TE +++S+ + ++V
Sbjct: 1 ISKGAYGRVFLAKKKSTGD---IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 609 LL-GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNS-PLTWKRRLEISIGAA 666
L F + + LV E++P G+L L +N S R I A
Sbjct: 58 LYYSFQGKK-NLYLVMEYLPGGDLASLL-----------ENVGSLDEDVARIYIAEIVLA 105
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK--- 723
L YLH + IIHRD+K NIL+D N K++DFGLS++G + +
Sbjct: 106 --LEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 724 --GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE I Q ++ D +S G +L E L G PP
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA-REFRTEIEMISELRHLHIVSLLG 611
+IG G V+ + VA+KR++ Q + E R E++ +S+ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA----- 666
E+ LV ++ G+L D + +S + E I
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD--------------EAIIATVLKEVL 112
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGM-SQSHVSTVVKGS 725
+GL YLH + IHRD+K+ NILL E+ + KI+DFG+S G V G+
Sbjct: 113 KGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 726 FGYVDPEYIRRQQ-LTEKSDVYSFGVVLLEVLCGRPP 761
++ PE + + K+D++SFG+ +E+ G P
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 7e-22
Identities = 67/221 (30%), Positives = 121/221 (54%), Gaps = 19/221 (8%)
Query: 555 IGSGGFGHVFKGY---IDDG----SITVAVKRL-NTSSMQGAREFRTEIEMISEL-RHLH 605
+G G FG V ID ++TVAVK L + ++ + + +E+EM+ + +H +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQ----KQNQNQNQNQNSPLTWKRRLEI 661
I++LLG C + G + ++ E+ +GNLR++L + + + + + + +T+K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ ARG+ YL A IHRD+ + N+L+ EN KI+DFGL+R + + +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYKKTTN 198
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
+ ++ PE + + T +SDV+SFGV++ E+ L G P
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IG G FG V+K + VA+K ++ + + + EI+ +S+ R +I G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG-----AARG 668
+ ++ ++ E+ G+ D L + L E I G
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL-------------KPGKLD-----ETYIAFILREVLLG 110
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L YLH K IHRD+K+ NILL E K++DFG+S G + S +T V F +
Sbjct: 111 LEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPF-W 164
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762
+ PE I++ EK+D++S G+ +E+ G PP+
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 554 IIGSGGFGHVFKGYID---DGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
+IG+G FG VF+G + + VA+K L + R +F +E ++ + H +I+ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G + +++ E+M G L +L + + S L G A G+
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYL--------RDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YL + +HRD+ + NIL++ N K+SDFGLSR+ ++ ++ K +
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVL 756
PE I ++ T SDV+SFG+V+ EV+
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 554 IIGSGGFGHVFKGYI--DDGSI-TVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIVS 608
I+G G FG V +G + DDGS VAVK +L+ + EF +E + + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 609 LLGFCDEHGEM------ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
L+G C E + +++ FM G+L L S+ + L + L+
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK------LPLQTLLKFM 119
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG--MSQSHVST 720
+ A G+ YL + IHRD+ + N +L E+ ++DFGLS+ SG Q ++
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 721 V-VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ VK ++ E + + T KSDV++FGV + E+
Sbjct: 177 MPVK----WIAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 554 IIGSGGFGHVFKG-YID--DGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSL 609
IG G FG V++G Y+ + I VAVK + RE F E ++ + H HIV L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+G E+ + +V E P G LR +L + N+ L + S + L
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYL----QVNKYS-------LDLASLILYSYQLSTAL 120
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV--STVVKGSFG 727
YL + +HRD+ + N+L+ K+ DFGLSR + ++ K
Sbjct: 121 AYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY----LEDESYYKASKGKLPIK 173
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
++ PE I ++ T SDV+ FGV + E+L
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 554 IIGSGGFGHVFKGYIDD------GSITVAVKRLNT-SSMQGAREFRTEIEMISELRHLHI 606
+GSG FG V++G D G I VAVK L ++ Q +EF E ++S H +I
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V LLG C + ++ E M G+L +L +++ + + LT K L+I + A
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVE-----RFGPPLLTLKELLDICLDVA 116
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAA-----KISDFGLSR-MGPSGMSQSHVST 720
+G YL + IHRD+ + N L+ E KI DFGL+R + S +
Sbjct: 117 KGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 721 VVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
++ ++ PE + + T +SDV+SFGV++ E+L
Sbjct: 174 LL--PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 62/221 (28%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKR--LNTSSMQGA-REFRT---EIEMISELRHLHIV 607
++G G +G V+ G + G + +AVK+ L+TS++ A +E+ E++++ L+H++IV
Sbjct: 7 VLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
LG C + + + EF+P G++ L N+ PL + +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQILD 113
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR----MGPSGMSQSHVSTVVK 723
G+ YLH + ++HRD+K N++L N K+ DFG +R +G G + S++ +
Sbjct: 114 GVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG-THSNMLKSMH 169
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
G+ ++ PE I KSD++S G + E+ G+PP+ +
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLLG 611
IG G F V+K VA+K++ M A+ + EI+++ +L H +++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
E+ E+ +V E G+L + + +KQ + + WK +++ L +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE----RTIWKYFVQL----CSALEH 121
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
+H+ I+HRD+K N+ + K+ D GL R S + +H S V G+ Y+ P
Sbjct: 122 MHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLV--GTPYYMSP 175
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E I KSD++S G +L E+ + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-21
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 554 IIGSGGFGHVFKGYID---DGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSL 609
+IG+G FG V +G + I VA+K L + + + R+F +E ++ + H +I+ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G + ++++ EFM G L L QN Q + + L G A G+
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL--------RQNDGQFTVIQLVGMLR---GIAAGM 119
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG-- 727
YL ++ +HRD+ + NIL++ N K+SDFGLSR S ++ + G
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ PE I ++ T SDV+S+G+V+ EV+
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 8e-21
Identities = 82/292 (28%), Positives = 136/292 (46%), Gaps = 43/292 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+I G G +KG + VK +N + + +EI + +L+H +IV L+G C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLC 752
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
L++E++ NL + L N L+W+RR +I+IG A+ L +LH
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN---------------LSWERRRKIAIGIAKALRFLH 797
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
++ ++ I++D D R+ G+ + + S YV PE
Sbjct: 798 CRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFI--SSAYVAPET 849
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPPM-----INGAVRKEEVSLVLWARVSRARGTVD 788
+ +TEKSD+Y FG++L+E+L G+ P ++G S+V WAR + +D
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-------SIVEWARYCYSDCHLD 902
Query: 789 QIVDPRLRGKIAPVCLNKFVEI---AGSCTDEEGFRRPTMGDVTWGLEFALQ 837
+DP +RG ++ V N+ VE+ A CT + RP DV LE A +
Sbjct: 903 MWIDPSIRGDVS-VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 70/244 (28%), Positives = 121/244 (49%), Gaps = 31/244 (12%)
Query: 535 RRFSLTEIKQATCDFADHCIIGSGGFGHVFKG-YIDDG---SITVAVKRL-NTSSMQGAR 589
R TE+++ ++GSG FG V KG +I +G I VA+K + + S Q +
Sbjct: 2 RILKETELRKLK-------LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 590 EFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQ 649
E + + L H +IV LLG C + LV + P G+L DH+ Q+++
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHV--------RQHRDS 105
Query: 650 NSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709
P +R L + A+G++YL +H ++HR++ + NILL + +I+DFG++ +
Sbjct: 106 LDP---QRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159
Query: 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVR 768
+ + + K ++ E I + T +SDV+S+GV + E++ G P +R
Sbjct: 160 YPD-DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY--AGMR 216
Query: 769 KEEV 772
EV
Sbjct: 217 PHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLH------IVS 608
+G+G G V K +AVK + + + +I + EL LH IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQI--LRELDILHKCNSPYIVG 63
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
G +G++ + E+M G+L D + + + L +I++ +G
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPE-----RILG-----KIAVAVLKG 112
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L YLH KH IIHRDVK +NIL++ K+ DFG+S + ++++ V G+ Y
Sbjct: 113 LTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSY 165
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE I+ + KSD++S G+ L+E+ GR P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 555 IGSGGFGHV-------FKGYID---------DGSITVAVKRLNTSSMQGAR-EFRTEIEM 597
+G G FG V + + + D + VAVK L + AR +F E+++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 598 ISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
+S L +I LLG C + ++ E+M G+L L + N S L++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS-LSFST 131
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
L ++ A G+ YL +HRD+ + N L+ +N+ KI+DFG+SR S
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS----- 183
Query: 718 VSTVVKGSFGYVDP------EYIRRQQLTEKSDVYSFGVVLLEV--LCGRPP 761
V+G P E + + T KSDV++FGV L E+ LC P
Sbjct: 184 DYYRVQGR--APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 62/213 (29%), Positives = 114/213 (53%), Gaps = 16/213 (7%)
Query: 555 IGSGGFGHVFKGYI----DDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G FG ++KG++ D + VA+K L + ++ Q EF+ E +++EL H +IV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHL-----YNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
LG + + +++E++ +G+L + L ++ + +++ S L L I+I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVK 723
A G+ YL + H +H+D+ + NIL+ E KISD GLSR + + + +++
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL- 188
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
++ PE I + + SD++SFGVVL E+
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE--FRTEIEMISELRHLHIVSLLG 611
+G G G V K + + + A+K + T ++ R E+E+ + +IV G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYYG 66
Query: 612 -FCDEHGEMI-LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
F DE I + E+ G+L D +Y K+ + + K +I+ +GL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGR-------IGEKVLGKIAESVLKGL 118
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YLH IIHRD+K +NILL K+ DFG+S G S + T SF Y+
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVNSLA--GTFTGTSF-YM 170
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMI 763
PE I+ + + SDV+S G+ LLEV R P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIVSLLG 611
IG G FG V+ +D G + +AVK R+ + + +E E++++ L+H ++V G
Sbjct: 8 IGGGTFGKVYTAVNLDTGEL-MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
++ + E+ G L + L + + R + + GL Y
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGR----------ILDEHVIRVYTLQL--LEGLAY 114
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM--GPSGMSQSHVSTVVKGSFGYV 729
LH H I+HRD+K NI LD N K+ DFG + + V ++ G+ Y+
Sbjct: 115 LH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYM 170
Query: 730 DPEYIRRQQLTEK---SDVYSFGVVLLEVLCGRPP 761
PE I + +D++S G V+LE+ G+ P
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT---------EIEMISELRHL 604
+IGSG FG V+ G +AVK++ S+ + + R EI ++ EL+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+IV LG + + + E++P G++ L N T R I
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL----------NNYGAFEETLVRNFVRQI- 115
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---MGPSGMSQSHVSTV 721
+GL+YLH IIHRD+K NIL+D KISDFG+S+ +
Sbjct: 116 -LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
++GS ++ PE +++ T K+D++S G +++E+L G+ P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 3e-20
Identities = 67/226 (29%), Positives = 118/226 (52%), Gaps = 29/226 (12%)
Query: 555 IGSGGFGHVFK--GY-ID----DGSITVAVKRL-NTSSMQGAREFRTEIEMISEL-RHLH 605
+G G FG V + Y ID D ++TVAVK L + ++ + + +E+E++ + +H +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQN----QNQNSPLTWKRRLEI 661
I++LLG C + G + ++ E+ +GNLR+ L + + + L++K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ ARG+ YL IHRD+ + N+L+ E+ KI+DFGL+R +
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR------GVHDIDYY 190
Query: 722 VKGSFG-----YVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
K S G ++ PE + + T +SDV+SFG+++ E+ L G P
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 34/223 (15%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRL---------NTSSMQGARE-FRTEIEMISELR 602
+IG G +G V+ + G + +AVK++ + S + + R+EIE + +L
Sbjct: 8 LIGKGTYGRVYLALNVTTGEM-MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 603 HLHIVSLLGFCDEHGEMIL--VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660
HL+IV LGF E E L E++P G++ L + + L R
Sbjct: 67 HLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--------QLV--RFFT 114
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
+ GL YLH I+HRD+K+ N+L+D + KISDFG+S+ +
Sbjct: 115 EQV--LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-NM 168
Query: 721 VVKGSFGYVDPEYI--RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
++GS ++ PE I Q + K D++S G V+LE+ GR P
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-20
Identities = 63/199 (31%), Positives = 108/199 (54%), Gaps = 22/199 (11%)
Query: 575 VAVKRLNT-SSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632
VAVK L + ++ + + +E+EM+ + +H +I++LLG C + G + ++ E+ +GNLR
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 633 DHLYNSQ----KQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKST 688
++L + + N Q L++K + + ARG+ YL A IHRD+ +
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169
Query: 689 NILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG-----YVDPEYIRRQQLTEKS 743
N+L+ E+ KI+DFGL+R H+ K + G ++ PE + + T +S
Sbjct: 170 NVLVTEDNVMKIADFGLAR------DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223
Query: 744 DVYSFGVVLLEV--LCGRP 760
DV+SFGV+L E+ L G P
Sbjct: 224 DVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 41/274 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G+G FG V+ GY ++ S VAVK L +M + F E ++ L+H +V L
Sbjct: 14 LGAGQFGEVWMGYYNN-STKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + ++ E+M +G+L D L ++ + + ++ S A G+ Y+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFL----------KSDEGGKVLLPKLIDFSAQIAEGMAYIE- 120
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ IHRD+++ N+L+ E+ KI+DFGL+R+ ++ K + PE I
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI 176
Query: 735 RRQQLTEKSDVYSFGVVLLEVLC-GR---PPMINGAVRKEEVSLVLWARVSRARGTVDQI 790
T KSDV+SFG++L E++ G+ P M N V + R R
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV------MSALQRGYRM------- 223
Query: 791 VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT 824
PR+ C ++ +I +C E+ RPT
Sbjct: 224 --PRMEN-----CPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT----EIEMISELRHLHIVS 608
++G G +G V K VA+K+ S + + + E++++ +LRH +IV+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L G + LV+E++ R L + L + P + +
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELL--------EASPGGLPPDAVRS---YIWQLLQA 112
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ Y H H IIHRD+K NIL+ E+ K+ DFG +R + + Y
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD--------Y 161
Query: 729 VDPEYIRRQQLTEKS-------DVYSFGVVLLEVLCGRP 760
V + R +L DV++ G ++ E+L G P
Sbjct: 162 VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG--AREFRTEIEMISELRHLHIVSLLGF 612
IG G G VFK + TVA+K++ ++G + EI+ + +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+LV E+MP L + L + ++ PL + +G+ Y+
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEER-----------PLPEAQVKSYMRMLLKGVAYM 115
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
HA I+HRD+K N+L+ + KI+DFGL+R+ + + V + Y PE
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV--ATRWYRAPE 170
Query: 733 YIR-RQQLTEKSDVYSFGVVLLEVLCGRP 760
+ ++ D+++ G + E+L G P
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G+G FG V+ GY + G VA+K L SM F E ++ +L+H +V L
Sbjct: 14 LGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + ++ E+M G+L D L + LT + ++++ A G+ ++
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPE----------GIKLTINKLIDMAAQIAEGMAFIE- 119
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ IHRD+++ NIL+ E KI+DFGL+R+ ++ K + PE I
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI 175
Query: 735 RRQQLTEKSDVYSFGVVLLEVLC-GR---PPMINGAV 767
T KSDV+SFG++L E++ GR P M N V
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 569 DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627
D + VAVK L + AR +F EI+++S L++ +I+ LLG C + ++ E+M
Sbjct: 41 DGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100
Query: 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKS 687
G+L L + ++ + N ++ L +++ A G+ YL A +HRD+ +
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157
Query: 688 TNILLDENWAAKISDFGLSRMGPSG---MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSD 744
N L+ ++ KI+DFG+SR SG Q ++ ++ E I + T SD
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMAWESILLGKFTTASD 213
Query: 745 VYSFGVVLLEV--LCGRPP 761
V++FGV L E+ LC P
Sbjct: 214 VWAFGVTLWEMFTLCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 551 DHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLL 610
+ ++G G +G V+ + +A+K + + + EI + S L+H +IV L
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
G E+G + E +P G+L L S+ N+ T K+ LE GL
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYT-KQILE-------GLK 122
Query: 671 YLHAGAKHTIIHRDVKSTNILLDE-NWAAKISDFG----LSRMGPSGMSQSHVSTVVKGS 725
YLH + I+HRD+K N+L++ + KISDFG L+ + P + G+
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-------CTETFTGT 172
Query: 726 FGYVDPEYIRRQQ--LTEKSDVYSFGVVLLEVLCGRPPMI 763
Y+ PE I + +D++S G ++E+ G+PP I
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 554 IIGSGGFGHVFKGYIDDGS---ITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
+IG+G FG V G + I VA+K L + R +F +E ++ + H +I+ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G + +++V E+M G+L L +++ Q T + + + G A G+
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQ-------FTVIQLVGMLRGIASGM 119
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YL + +HRD+ + NIL++ N K+SDFGLSR+ ++ + K +
Sbjct: 120 KYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVL 756
PE I ++ T SDV+S+G+V+ EV+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRL----NTSSMQGA--REFRTEIEMISELRHLHI 606
+G+G F ++ + G++ +AVK++ NTSS Q R EI +++ L H HI
Sbjct: 7 QLGTGAFSSCYQARDVKTGTL-MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
+ +LG E L E+M G++ L + + ++
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA--------VIINYTEQL----L 113
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWA-AKISDFGLS-RMGPSGMSQSHVSTVVKG 724
RGL YLH ++ IIHRDVK N+L+D +I+DFG + R+ G + G
Sbjct: 114 RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ ++ PE +R +Q DV+S G V++E+ +PP
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-19
Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 23/214 (10%)
Query: 554 IIGSGGFGHVFKG-YIDDGS---ITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHIVS 608
++GSG FG V+KG ++ +G I VA+K LN T+ + EF E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG C + LV + MP G L D+++ + N L W + A+G
Sbjct: 74 LLGVC-LSPTIQLVTQLMPHGCLLDYVHEHK-----DNIGSQLLLNW------CVQIAKG 121
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL + ++HRD+ + N+L+ KI+DFGL+R+ G + + + K +
Sbjct: 122 MMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPIKW 177
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLC--GRP 760
+ E I ++ T +SDV+S+GV + E++ G+P
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 28/218 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRL--NTSSMQGARE---FRTEIEMISELRHLHIVS 608
++G G FG V+ Y D +A K++ + S + ++E EI+++ L+H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 609 LLGFCDEHGE--MILVYEFMPRGNLRDHL--YNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
G + E + + E+MP G+++D L Y + ++ +T K +I
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES----------VTRKYTRQI--- 115
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVK 723
G+ YLH+ + I+HRD+K NIL D K+ DFG S R+ MS + + +V
Sbjct: 116 -LEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT- 170
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ ++ PE I + K+DV+S G ++E+L +PP
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G+G FG V G G VA+K + SM EF E +++ +L H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + +V E+M G L ++L K+ Q + LE+ G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPS-----------QLLEMCKDVCEGMAYLES 118
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV-VKGSFGYVDPEY 733
IHRD+ + N L+D+ K+SDFGLSR + + S+V K + PE
Sbjct: 119 ---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRY---VLDDEYTSSVGSKFPVRWSPPEV 172
Query: 734 IRRQQLTEKSDVYSFGVVLLEV 755
+ + + KSDV++FGV++ EV
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-19
Identities = 86/333 (25%), Positives = 151/333 (45%), Gaps = 36/333 (10%)
Query: 555 IGSGGFGHVFKGY---ID----DGSITVAVKRL-NTSSMQGAREFRTEIEMISEL-RHLH 605
+G G FG V ID + +TVAVK L + ++ + + +E+EM+ + +H +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQ----NSPLTWKRRLEI 661
I++LLG C + G + ++ E+ +GNLR++L + + + + LT+K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ ARG+ YL A IHRD+ + N+L+ E+ KI+DFGL+R + +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYKKTTN 195
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781
+ ++ PE + + T +SDV+SFGV+L E+ G +E L+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL------ 249
Query: 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEA 841
+ +D+ + C ++ I C +RPT + L+ L +
Sbjct: 250 KEGHRMDKPAN----------CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 842 AEKSDQGRPF---VPRGEVITSSTTTDSDEPFS 871
E D PF P SS ++ D F+
Sbjct: 300 DEYLDLSVPFEQYSPGCPDSPSSCSSGDDSVFA 332
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 555 IGSGGFGHVFKGY--IDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLL 610
+GSG FG V KG + TVAVK L + A E E ++ +L + +IV ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
G C+ M LV E G L L +N +T K E+ + G+
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFL------------QKNKHVTEKNITELVHQVSMGMK 109
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YL + +HRD+ + N+LL AKISDFGLS+ + + T K +
Sbjct: 110 YLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLE 754
PE + + + KSDV+SFGV++ E
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IG G FG VF G + + VAVK T +F E ++ + H +IV L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ + +V E + G+ L + + L K +++ AA G+ YL
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL-----------RTEGPRLKVKELIQMVENAAAGMEYLE 111
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ KH I HRD+ + N L+ E KISDFG+SR G+ S + + + PE
Sbjct: 112 S--KHCI-HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TGGMKQIPVKWTAPEA 167
Query: 734 IRRQQLTEKSDVYSFGVVLLE 754
+ + + +SDV+SFG++L E
Sbjct: 168 LNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 64/218 (29%), Positives = 111/218 (50%), Gaps = 28/218 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRL--NTSSMQGARE---FRTEIEMISELRHLHIVS 608
++G G FG V+ Y D +AVK++ + S + ++E EI+++ LRH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 609 LLGFCDEHGE--MILVYEFMPRGNLRDHL--YNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
G + E + + E+MP G+++D L Y + +N + + R++
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR--------YTRQI----- 115
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVK 723
+G+ YLH+ + I+HRD+K NIL D K+ DFG S R+ MS + + +V
Sbjct: 116 -LQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT- 170
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ ++ PE I + K+DV+S ++E+L +PP
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 555 IGSGGFGHVFKGYIDD-----GSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVS 608
+G G FG V++G D VAVK +N S S++ EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPL-TWKRRLEISIGAAR 667
LLG + ++V E M G+L+ +L + + + +N N P T + ++++ A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN---NPGRPPPTLQEMIQMAAEIAD 130
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YL+A +HRD+ + N ++ ++ KI DFG++R KG G
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETDYYRKGGKG 181
Query: 728 -----YVDPEYIRRQQLTEKSDVYSFGVVLLEV 755
++ PE ++ T SD++SFGVVL E+
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHLHIVS 608
+G G FG V++G D + VAVK L + S Q +F E ++S+ H +IV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L+G E ++ E M G+L+ L ++N+ + S LT K L + A+G
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL----RENRP-RPERPSSLTMKDLLFCARDVAKG 128
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWA---AKISDFGLS---------RMGPSGMSQS 716
YL H IHRD+ + N LL AKI+DFG++ R G M
Sbjct: 129 CKYLEE--NH-FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM--- 182
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV 755
+K ++ PE T K+DV+SFGV+L E+
Sbjct: 183 ---LPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-18
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLL 610
IGSG +G V VA+K+++ + R R EI+++ LRH +I+ LL
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLL 65
Query: 611 GF-----CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
++ ++ +V E M D L+ K Q PLT
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQ--------PLTDDHIQYFLYQI 112
Query: 666 ARGLHYLH-AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVK 723
RGL YLH A +IHRD+K +NIL++ N KI DFGL+R + P + ++
Sbjct: 113 LRGLKYLHSAN----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT---- 164
Query: 724 GSFGYV------DPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
YV PE + + T+ D++S G + E+L +P
Sbjct: 165 ---EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 64/236 (27%)
Query: 553 CIIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE-F-RT---EIEMISELRHLHI 606
IG G +G V+K G + VA+K++ M+ +E F T EI+++ +LRH +I
Sbjct: 5 AQIGEGTYGQVYKARNKKTGEL-VALKKIR---MENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 607 VSLLGFCDEH--GEMILVYEFMP---RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661
V L G + +V+E+M G L +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-----------------------KF 97
Query: 662 SIGAAR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGM 713
+ + GL YLH + I+HRD+K +NIL++ + K++DFGL+R
Sbjct: 98 TESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154
Query: 714 SQSHVSTVVKGSFGYVDPE-------YIRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762
S + + V+ + Y PE Y + D++S G +L E+ G+P
Sbjct: 155 SADYTNRVI--TLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRL--NTSSMQGARE---FRTEIEMISELRHLHIVS 608
++G G FG V+ Y D +AVK++ + S + ++E EI+++ L H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 609 LLGFCDEHGEMIL--VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
G + E L E MP G+++D L + +N +T K +I
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN--------VTRKYTRQI----L 116
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVKGS 725
G+ YLH+ + I+HRD+K NIL D K+ DFG S R+ +S + + +V G+
Sbjct: 117 EGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GT 172
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
++ PE I + K+D++S G ++E+L +PP
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IGSG +G V+K VA+K + + EI M+ E RH +IV+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
++ +V E+ G+L+D +Y Q PL+ + + +GL YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IY----------QVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS--QSHVSTVVKGSFGYVDPE 732
K IHRD+K NILL E+ K++DFG+S + ++ +S + T ++ PE
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY-----WMAPE 171
Query: 733 YI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
R+ K D+++ G+ +E+ +PPM +
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 70/260 (26%), Positives = 113/260 (43%), Gaps = 42/260 (16%)
Query: 575 VAVKRLNTSSMQGARE---FRTEIEMISELRHLHIVSLL--GFCDEHGEMILVYEFMPRG 629
VA+K L T + + + FR E + + L H +IV+LL G G + V+E++P
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGR 64
Query: 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTN 689
LR+ L R + + L L I+HRD+K N
Sbjct: 65 TLREVL---------AADGALPAGETGRLM------LQVLDALACAHNQGIVHRDLKPQN 109
Query: 690 ILL---DENWAAKISDFGLSRMGPSGMSQSHVSTV-----VKGSFGYVDPEYIRRQQLTE 741
I++ AK+ DFG+ + P G+ + V+T+ V G+ Y PE +R + +T
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLP-GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 742 KSDVYSFGVVLLEVLCGRPPMINGAVRK--------EEVSLVLWARVSRARGTVDQIV-- 791
SD+Y++G++ LE L G+ + +V + +VSL W G V +
Sbjct: 169 NSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPL-GQVLRKALN 227
Query: 792 -DPRLRGKIAPVCLNKFVEI 810
DPR R AP +F +
Sbjct: 228 KDPRQRAASAPALAERFRAL 247
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 25/211 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G+G FG V+ G + G+ VAVK L +M F E +++ +LRH +V L
Sbjct: 14 LGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E + +V E+M +G+L D L + + + L ++++ A G+ Y+
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRA----------LKLPNLVDMAAQVAAGMAYIE- 119
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS---FGYVDP 731
+ IHRD++S NIL+ + KI+DFGL+R + + + T +G+ + P
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLAR-----LIEDNEYTARQGAKFPIKWTAP 172
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
E + T KSDV+SFG++L E++ GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 48/277 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG V+ G + G+ VA+K L +M F E +++ +LRH +V L
Sbjct: 14 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E + +V E+M +G+L D L L + ++++ A G+ Y+
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFL----------KGEMGKYLRLPQLVDMAAQIASGMAYVE- 119
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS---FGYVDP 731
+ +HRD+++ NIL+ EN K++DFGL+R + + + T +G+ + P
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYTARQGAKFPIKWTAP 172
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLC-GR---PPMINGAVRKEEVSLVLWARVSRARGTV 787
E + T KSDV+SFG++L E+ GR P M+N R +
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------------REVL 213
Query: 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT 824
DQ V+ R P C ++ C +E RPT
Sbjct: 214 DQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 67/223 (30%), Positives = 113/223 (50%), Gaps = 28/223 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG V+ G + G+ VA+K L +M F E +++ +LRH +V L
Sbjct: 14 LGQGCFGEVWMGTWN-GTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E + +V EFM +G+L D L + L + ++++ A G+ Y+
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFL----------KEGDGKYLKLPQLVDMAAQIADGMAYIE- 119
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS---FGYVDP 731
+ IHRD+++ NIL+ +N KI+DFGL+R + + + T +G+ + P
Sbjct: 120 --RMNYIHRDLRAANILVGDNLVCKIADFGLAR-----LIEDNEYTARQGAKFPIKWTAP 172
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLC-GR---PPMINGAVRKE 770
E + T KSDV+SFG++L E++ GR P M+N V ++
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 80/279 (28%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+GSG FG V G I VA+K +N +M +F E +++ +L H +V L G C
Sbjct: 12 LGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + +V EFM G L ++L Q Q + S L + G+ YL
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--------RQRQGKLSK---DMLLSMCQDVCEGMEYLE- 117
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSR--MGPSGMSQSHVSTVVKGSFGYVDPE 732
+++ IHRD+ + N L+ K+SDFG++R + S S VK S PE
Sbjct: 118 --RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS----PPE 171
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791
+ + KSDV+SFGV++ EV G+ P +++ + + +SR
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF------EKKSNYEVVEMISRGF------- 218
Query: 792 DPRL-RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVT 829
RL R K+A E+ SC E+ RPT ++
Sbjct: 219 --RLYRPKLAS---MTVYEVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLLG 611
+GSG +G V + VA+K+L+ S++ R +R E+ ++ + H +++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 612 -FC-DEHGE----MILVYEFMPRGNLRDHLYN---SQKQNQNQNQNQNSPLTWKRRLEIS 662
F E + LV M L N QK + + Q L
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGA-----DLNNIVKCQKLSDDHIQ----------FLVYQ 126
Query: 663 IGAARGLHYLH-AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
I RGL Y+H AG IIHRD+K +NI ++E+ KI DFGL+R M+ +V+T
Sbjct: 127 I--LRGLKYIHSAG----IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG-YVATR 179
Query: 722 VKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
Y PE + + D++S G ++ E+L G+
Sbjct: 180 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 38/274 (13%)
Query: 572 SITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGN 630
+ VAVK L + + AR +F E++++S L+ +I+ LLG C + + ++ E+M G+
Sbjct: 46 PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 631 LRDHLYNSQKQNQNQNQNQNSP-------LTWKRRLEISIGAARGLHYLHAGAKHTIIHR 683
L L + ++ +N N P +++ L +++ A G+ YL + +HR
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR 162
Query: 684 DVKSTNILLDENWAAKISDFGLSR---MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLT 740
D+ + N L+ EN KI+DFG+SR G Q ++ ++ E I + T
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFT 218
Query: 741 EKSDVYSFGVVLLEVL--CGRPPMINGAVRKEEVSLVLWARVSRA----RGTVDQIVDPR 794
SDV++FGV L E+L C P G + E+V + A R Q+ R
Sbjct: 219 TASDVWAFGVTLWEILMLCKEQPY--GELTDEQV-------IENAGEFFRDQGRQVYLFR 269
Query: 795 LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
P C E+ C + RP+ D+
Sbjct: 270 -----PPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 555 IGSGGFGHVFKGY--IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLG 611
+GSG FG V KG + I VA+K L + + R E E E++ +L + +IV ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
C+ M LV E G L L S K+++ +T +E+ + G+ Y
Sbjct: 63 VCEAEALM-LVMEMASGGPLNKFL--SGKKDE---------ITVSNVVELMHQVSMGMKY 110
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
L +HRD+ + N+LL AKISDFGLS+ + S + K + P
Sbjct: 111 LE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
E I ++ + +SDV+S+G+ + E G+ P
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-18
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G G V+ VA+K++N EI ++ E +H +IV+ L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA-----RGL 669
E+ +V E++ G+L D + + E I A + L
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMD------------------EGQIAAVCRECLQAL 128
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL-SRMGPSGMSQSHVSTVVKGSFGY 728
+LH+ + +IHRD+KS NILL + + K++DFG +++ P QS ST+V G+ +
Sbjct: 129 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMV-GTPYW 181
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
+ PE + R+ K D++S G++ +E++ G PP +N
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 555 IGSGGFGHVFK-GYIDDGSITVAVKRLNTSSM---QGAREFRTEIE-MISE-------LR 602
+GSG FG V+K ++G +A+K +N + + RE I ++SE LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 603 HLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
H +IV E+ + +V + + L +H +NS K+ + Q W +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH-FNSLKE---KKQRFTEERIWNIFVQMV 123
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM-GPSGMSQSHVSTV 721
+ L YLH + I+HRD+ NI+L E+ I+DFGL++ P S V T+
Sbjct: 124 LA----LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ Y PE ++ + EK+DV++FG +L ++ +PP
Sbjct: 178 L-----YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLH 605
F D IG G FG V+ + VA+K+++ S Q +++ E+ + +LRH +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 606 IVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI- 663
+ G + EH LV E+ G+ D L +K PL + +EI+
Sbjct: 77 TIEYKGCYLREHTAW-LVMEYC-LGSASDILEVHKK-----------PL---QEVEIAAI 120
Query: 664 --GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG-LSRMGPSGMSQSHVST 720
GA +GL YLH+ H IHRD+K+ NILL E K++DFG S + P + S V T
Sbjct: 121 CHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGT 174
Query: 721 VVKGSFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
++ PE I Q K DV+S G+ +E+ +PP+ N
Sbjct: 175 PY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 2e-17
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 31/163 (19%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKR---------LNTSSMQGAREFRTEIEMISELRHL 604
+G G +G V+K VA+K+ + ++++ R EI ++ EL+H
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL------R-EISLLKELKHP 58
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+IV LL ++ LV+E+ +L+ +L + PL+ I
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-----------DKRPGPLSPNLIKSIMYQ 106
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
RGL Y H+ H I+HRD+K NIL++ + K++DFGL+R
Sbjct: 107 LLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 50/168 (29%), Positives = 86/168 (51%), Gaps = 19/168 (11%)
Query: 594 EIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPL 653
E++++ E R +IVS G + + EFM G+L D +Y + P+
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYK-----------KGGPI 100
Query: 654 TWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGM 713
+ +I++ GL YL+ H I+HRD+K +NIL++ K+ DFG+S + +
Sbjct: 101 PVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158
Query: 714 SQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + V T Y+ PE I+ + T KSDV+S G+ ++E+ G+ P
Sbjct: 159 ADTFVGTST-----YMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 64/209 (30%), Positives = 113/209 (54%), Gaps = 23/209 (11%)
Query: 554 IIGSGGFGHVFKG-YIDDGS---ITVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIV 607
++GSG FG V+KG +I DG I VA+K R NTS + +E E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-KANKEILDEAYVMAGVGSPYVC 72
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
LLG C + LV + MP G L D++ ++N+++ +Q+ L W + A+
Sbjct: 73 RLLGICLT-STVQLVTQLMPYGCLLDYV----RENKDRIGSQDL-LNW------CVQIAK 120
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YL + ++HRD+ + N+L+ KI+DFGL+R+ ++ H K
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG-GKVPIK 176
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
++ E I ++ T +SDV+S+GV + E++
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREF--RTEIEMISELRHLHIVSLLG 611
++G G FG V V +K++ M + E +++ L H +I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
E +++V E+ P G L +++ + NS L L + LH+
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI----------QKRCNSLLDEDTILHFFVQILLALHH 116
Query: 672 LHAGAKHTIIHRDVKSTNILLDEN-WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
+H I+HRD+K+ NILLD++ KI DFG+S++ S+S TVV G+ Y+
Sbjct: 117 VHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVV-GTPCYIS 169
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVL 756
PE + +KSD+++ G VL E+
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 554 IIGSGGFGH-VFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLL 610
++G G FG +D S+ V K +N + + + R+ EI ++S L+H +I++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+ +++ E+ G L D + + Q + + W I +A +
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM-----VLW---YLFQIVSA--VS 115
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
Y+H K I+HRD+K+ NI L + K+ DFG+S++ G S TVV G+ Y+
Sbjct: 116 YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVV-GTPYYMS 169
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLC 757
PE + + KSD+++ G VL E+L
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG V+K + + A K + S + +F EI+++SE +H +IV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
++ ++ EF G L + ++ LT + + L++LH+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER-----------GLTEPQIRYVCRQMLEALNFLHS 121
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
H +IHRD+K+ NILL + K++DFG+S S + + T + G+ ++ PE +
Sbjct: 122 ---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFI-GTPYWMAPEVV 175
Query: 735 -----RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ K+D++S G+ L+E+ PP
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-17
Identities = 59/208 (28%), Positives = 111/208 (53%), Gaps = 21/208 (10%)
Query: 554 IIGSGGFGHVFKG-YIDDGS---ITVAVKRL-NTSSMQGAREFRTEIEMISELRHLHIVS 608
++GSG FG V+KG +I +G I VA+K L +S + +E E +++ + + H+
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG C + L+ + MP G L D++ +++++ +Q L W + A+G
Sbjct: 74 LLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYL-LNW------CVQIAKG 121
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
++YL + ++HRD+ + N+L+ KI+DFGL+++ + + H K +
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-GKVPIKW 177
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ E I + T +SDV+S+GV + E++
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 555 IGSGGFGHV-FKGYIDDGSIT---VAVKRLNTSSMQG-AREFRTEIEMISELRHLHIVSL 609
+G G FG V Y +G T VAVK L S + + EIE++ L H +IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 610 LGFCDEHGE--MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
G C E G + L+ EF+P G+L+++L +N+N+ + K++L+ ++ +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNK-------INLKQQLKYAVQICK 120
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YL G++ +HRD+ + N+L++ KI DFGL++ + V +
Sbjct: 121 GMDYL--GSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF 177
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ PE + + + SDV+SFGV L E+L
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLL- 610
+G GG+G VF D VA+KR+ S + E R TE ++++ + +V LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS--IGAARG 668
F D+ + L E++P G+ R L N +++ R ++ A
Sbjct: 69 AFQDDE-YLYLAMEYVPGGDFRTLLNNLGVLSEDHA-----------RFYMAEMFEAVDA 116
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
LH L IHRD+K N L+D + K++DFGLS+ ++ ++ S V GS Y
Sbjct: 117 LHEL------GYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYAN-SVV--GSPDY 164
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE +R + D +S G +L E LCG PP
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 69/234 (29%), Positives = 100/234 (42%), Gaps = 56/234 (23%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-----EFRTEI--EMISE 600
DF +G+G G V K S + AR E + I ++I E
Sbjct: 2 DFEKLGELGAGNGGVVTK------------VLHRPSGLIMARKLIHLEIKPAIRNQIIRE 49
Query: 601 LRHLH------IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLT 654
L+ LH IV G GE+ + E M G+L + L
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL------------------DQVLK 91
Query: 655 WKRRL------EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708
R+ +ISI RGL YL KH I+HRDVK +NIL++ K+ DFG+S
Sbjct: 92 KAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149
Query: 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762
M+ S V G+ Y+ PE ++ T +SD++S G+ L+E+ GR P+
Sbjct: 150 LIDSMANSFV-----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 68/233 (29%), Positives = 116/233 (49%), Gaps = 24/233 (10%)
Query: 554 IIGSGGFGHVF---KGYIDDGSITVAVKRLNTSSMQGAREFRTEIE--MISELRHLHIVS 608
++G G FG VF K D A+K L ++++ RT++E +++E+ H IV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L G++ L+ +F+ G+L L + + + L A
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL------------ALA 110
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L +LH+ II+RD+K NILLDE K++DFGLS+ +++ G+ Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEY 164
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781
+ PE + R+ T+ +D +SFGV++ E+L G P G RKE ++++L A++
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKDRKETMTMILKAKLG 216
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 573 ITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631
+ VAVK L + + AR +F EI+++S L+ +I+ LL C + ++ E+M G+L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNIL 691
L + Q + + + +++ + ++ A G+ YL + +HRD+ + N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVT-ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162
Query: 692 LDENWAAKISDFGLSRMGPSG---MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSF 748
+ +N+ KI+DFG+SR SG Q ++ ++ E I + T SDV++F
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMSWESILLGKFTTASDVWAF 218
Query: 749 GVVLLEVL--CGRPP 761
GV L E+L C P
Sbjct: 219 GVTLWEILTLCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLLG 611
+G GGFG V + A K+LN ++ + + E +++++ IVSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
++ LV M G+LR H+YN ++N R + GL +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--------FPEPRACFYTAQIISGLEH 112
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH + II+RD+K N+LLD + +ISD GL+ G S++ G+ G++ P
Sbjct: 113 LH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---GTPGFMAP 166
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E ++ ++ D ++ GV L E++ R P
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 555 IGSGGFGHVFKGYIDDG--SITVAVKRL-NTSSMQGAREFRTEIEMISELRHLHIVSLLG 611
IG+G FG V G G V VK L +++ F E++ EL H +++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
C E +LV EF P G+L+++L + N+ +R ++ A GL +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL----RSNRGMVAQMAQKDVLQR---MACEVASGLLW 115
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG--YV 729
LH + IH D+ N L + + KI D+GL + + T + ++
Sbjct: 116 LH---QADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRWL 169
Query: 730 DPEY--IRRQQL-----TEKSDVYSFGVVLLEV 755
PE IR Q L T+KS+++S GV + E+
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 59/278 (21%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 563 VFKGYIDDGSITV-AVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF----CDEHG 617
++KG ++ + + K+ + EI+ + + +I+ + GF D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAK 677
+ L+ E+ RG LR+ L + L++K +L+++I +GL+ L+
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD------------LSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 678 HTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR- 736
++++ S + L+ EN+ KI GL ++ S ++ V+ +V Y + +
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-VNFMV-----YFSYKMLNDI 195
Query: 737 -QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRL 795
+ T K D+YS GVVL E+ G+ P KE L+ +++ +L
Sbjct: 196 FSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLI-----------INKNNSLKL 243
Query: 796 RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
P+ + VE +CT + +RP + ++ + L
Sbjct: 244 PLD-CPLEIKCIVE---ACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGFC 613
IG G FG VFKG + VA+K ++ + E + EI ++S+ ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ ++ ++ E++ G+ D L + PL + I +GL YLH
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-------------EPGPLDETQIATILREILKGLDYLH 118
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ K IHRD+K+ N+LL E+ K++DFG++ G +Q +T V F ++ PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
I++ K+D++S G+ +E+ G PP
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 541 EIKQATCDFADHCIIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGARE-FRTE 594
EI +T F + +G FG V+KG++ + + VA+K L + RE F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 595 IEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLY----NSQKQNQNQNQNQN 650
M S L+H +IV LLG + + +++ + +L + L +S + + ++
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 651 SPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR--- 707
S L + I A G+ +L + H ++H+D+ + N+L+ + KISD GL R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 708 -------MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
MG S + ++ PE I + + SD++S+GVVL EV
Sbjct: 176 AADYYKLMGNSLL-----------PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 52/155 (33%), Positives = 77/155 (49%), Gaps = 13/155 (8%)
Query: 555 IGSGGFGHVFKGYIDDG--SITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLG 611
IG+G FG V G ++ G V VK L S S+Q +F E + L+H +++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
C E +LV EF P G+L+ +L ++ + + T +R+ I A GL +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYL-----RSCRKAELMTPDPTTLQRMACEI--ALGLLH 115
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706
LH K+ IH D+ N LL + KI D+GLS
Sbjct: 116 LH---KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLG 611
+G GGFG V + A K+L+ + +G + E +++ ++ IVSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+ ++ LV M G+L+ H+YN + R + + GL +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG----------FPEARAIFYAAQIICGLEH 110
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH + I++RD+K N+LLD++ +ISD GL+ G + G+ GY+ P
Sbjct: 111 LH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA---GTPGYMAP 163
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVS 773
E ++ + D ++ G L E++ GR P RKE+V
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSPF---RQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG V+K + A K + T S + ++ EIE+++ H +IV LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
G++ ++ EF P G + D + + + Q Q + ++ LE L YLH+
Sbjct: 80 WDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQ---VICRQMLE-------ALQYLHS 128
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
IIHRD+K+ N+LL + K++DFG+S + Q S + G+ ++ PE +
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFI--GTPYWMAPEVV 182
Query: 735 RRQQLTE-----KSDVYSFGVVLLEVLCGRPP 761
+ + + K+D++S G+ L+E+ PP
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ---GAREFRTEIEMISELRHLHIVSLLG 611
+G GGFG V + + A K+L+ ++ G + E E++ ++ IV+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+ + LV M G+L+ H+YN ++ L +R + S G+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG----------LEMERVIHYSAQITCGILH 110
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH+ I++RD+K N+LLD+ ++SD GL+ G + T G+ GY+ P
Sbjct: 111 LHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----ITQRAGTNGYMAP 163
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN--GAVRKEEV 772
E ++ + + D ++ G + E++ GR P + V KEE+
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G+G FG V+ + + VAVK + SM F E ++ L+H +V L
Sbjct: 14 LGAGQFGEVWMATYNKHT-KVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + ++ EFM +G+L D L S + ++ + ++ S A G+ ++
Sbjct: 72 KE-PIYIITEFMAKGSLLDFL-KSDEGSKQP---------LPKLIDFSAQIAEGMAFIE- 119
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ IHRD+++ NIL+ + KI+DFGL+R+ ++ K + PE I
Sbjct: 120 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI 175
Query: 735 RRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
T KSDV+SFG++L+E++ GR P
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G G VF VA+K++N EI ++ EL++ +IV+ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA-----RGL 669
E+ +V E++ G+L D + + E I A + L
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMD------------------EAQIAAVCRECLQAL 128
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL-SRMGPSGMSQSHVSTVVKGSFGY 728
+LHA + +IHRD+KS N+LL + + K++DFG +++ P QS ST+V G+ +
Sbjct: 129 EFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE---QSKRSTMV-GTPYW 181
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
+ PE + R+ K D++S G++ +E++ G PP +N
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 70/266 (26%), Positives = 114/266 (42%), Gaps = 77/266 (28%)
Query: 555 IGSGGFGHVFKGY---IDDGSI--TVAVKRLNTSSMQGAREFRTEIEMISELR------- 602
+G G FG V + I+ + TVAVK L + A E++ +++EL+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKA---LMTELKILIHIGH 69
Query: 603 HLHIVSLLGFCDE-HGEMILVYEFMPRGNLRDHL------YNSQKQNQNQNQNQNSPLTW 655
HL++V+LLG C + G ++++ E+ GNL ++L ++ + + +
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129
Query: 656 KRRLE-------------------------------------------ISIGAARGLHYL 672
K+RL+ S ARG+ +L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---MGPSGMSQSHVSTVVKGSFGYV 729
A IHRD+ + NILL EN KI DFGL+R P + + +K ++
Sbjct: 190 ---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WM 242
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEV 755
PE I + T +SDV+SFGV+L E+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 67/244 (27%), Positives = 97/244 (39%), Gaps = 58/244 (23%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSM----QGAREFRTEIEMISELRHLHIVS 608
+IG G FG V+ D G + A+K L S M Q A R E +++++ IV
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQV-YAMKVLRKSDMIKRNQIA-HVRAERDILADADSPWIVK 65
Query: 609 LL-GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
L F DE + LV E+MP G+L + L P R + A
Sbjct: 66 LYYSFQDEE-HLYLVMEYMPGGDLMNLLIRKDV----------FPEETARFYIAELVLA- 113
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK---- 723
L +H K IHRD+K NIL+D + K++DFGL M+++
Sbjct: 114 -LDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLC----KKMNKAKDREYYLNDSH 165
Query: 724 --------------------------GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC 757
G+ Y+ PE +R + D +S GV+L E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 758 GRPP 761
G PP
Sbjct: 226 GFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLGF 612
IG G FG + +K +N S M E R E+ ++S ++H +IV
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+E+G + +V ++ G+L + N + + L+ + L ++
Sbjct: 68 FEENGNLYIVMDYCEGGDLY----------KKINAQRGVLFPEDQILDWFVQICLALKHV 117
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H I+HRD+KS NI L ++ K+ DFG++R+ S + ++ G+ Y+ PE
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---ELARTCIGTPYYLSPE 171
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVL 756
+ KSD+++ G VL E+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 555 IGSGGFGHVFKG----YIDDGSI---TVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV 607
+G G F +FKG D G + V +K L+ S + F M+S+L H H+V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
G C E I+V E++ G+L +L K+N+N ++WK LE++ A
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNL-----INISWK--LEVAKQLAW 111
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST-VVKGSF 726
LH+L + H +V + N+LL K + ++ G+S + + ++
Sbjct: 112 ALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI 168
Query: 727 GYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCG 758
+V PE I Q L+ +D +SFG L E+ G
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 69/256 (26%), Positives = 112/256 (43%), Gaps = 22/256 (8%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHI 606
DF +G+G G V K + +A K ++ R + E++++ E +I
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V G GE+ + E M G+L D + K+ + + +SI
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK-----------VSIAVL 113
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
RGL YL KH I+HRDVK +NIL++ K+ DFG+S M+ S V G+
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 166
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786
Y+ PE ++ + +SD++S G+ L+E+ GR P+ + E+ + V
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEG 224
Query: 787 VDQIVDPRLRGKIAPV 802
+ PR R PV
Sbjct: 225 EPHSISPRPRPPGRPV 240
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 553 CIIGSGGFGHVFK-GYIDDGSITVAVKRLNTS---------SMQGAREFRTEIEMISELR 602
IG G +G VFK + G I VA+K+ S +++ EI M+ +L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQI-VAIKKFVESEDDPVIKKIALR-------EIRMLKQLK 58
Query: 603 HLHIVSLLGFCDEHGEMILVYEFMPRGNLRDH-LYNSQKQNQNQ-NQNQNSPLTWKRRLE 660
H ++V+L+ ++ LV+E+ DH + N ++N ++ + W+
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQ---- 108
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM--GPSGMSQSHV 718
+ +++ H KH IHRDVK NIL+ + K+ DFG +R+ GP +V
Sbjct: 109 ----TLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 719 STVVKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
+T Y PE + Q DV++ G V E+L G+P
Sbjct: 162 ATR-----WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 78/269 (28%), Positives = 114/269 (42%), Gaps = 78/269 (28%)
Query: 554 IIGSGGFGHVFKGY---IDDGSI--TVAVKRLNTSSMQGAREFRTEIEMISELR------ 602
++G G FG V + ID S TVAVK L + A E + ++SEL+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKA---LMSELKILIHIG 68
Query: 603 -HLHIVSLLGFCDE-HGEMILVYEFMPRGNLRDHL------------------------- 635
HL++V+LLG C + +G ++++ EF GNL + L
Sbjct: 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMV 128
Query: 636 -----------------------YNSQKQNQNQNQNQ--NSPLTWKRRLEISIGAARGLH 670
S N Q + SPLT + + S ARG+
Sbjct: 129 EQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME 188
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---MGPSGMSQSHVSTVVKGSFG 727
+L A IHRD+ + NILL EN KI DFGL+R P + + +K
Sbjct: 189 FL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK---- 241
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
++ PE I + T +SDV+SFGV+L E+
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 67/252 (26%), Positives = 113/252 (44%), Gaps = 22/252 (8%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHI 606
DF +G+G G VFK + +A K ++ R + E++++ E +I
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V G GE+ + E M G+L L + + + + ++SI
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------------IPEQILGKVSIAVI 113
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
+GL YL KH I+HRDVK +NIL++ K+ DFG+S M+ S V G+
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 166
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786
Y+ PE ++ + +SD++S G+ L+E+ GR P+ + E+ L+ V
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCPVEGDPAE 224
Query: 787 VDQIVDPRLRGK 798
+ PR G+
Sbjct: 225 SETSPRPRPPGR 236
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 71/224 (31%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLH 605
F+D IG G FG V+ S VA+K+++ S Q +++ E+ + +LRH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 606 IVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+ G + EH LV E+ G+ D L +K PL ++ G
Sbjct: 77 TIQYRGCYLREHTAW-LVMEYC-LGSASDLLEVHKK-----------PLQEVEIAAVTHG 123
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG-LSRMGPSGMSQSHVSTVVK 723
A +GL YLH+ H +IHRDVK+ NILL E K+ DFG S M P + V T
Sbjct: 124 ALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGTPY- 176
Query: 724 GSFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
++ PE I Q K DV+S G+ +E+ +PP+ N
Sbjct: 177 ----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ---GAREFRTEIEMISELRHLH 605
F + ++G GGFG V + A KRL ++ G E +++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+V+L + + LV M G+L+ H+YN N +R L +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG----------NPGFEEERALFYAAEI 111
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS-QSHVSTVVKG 724
GL LH + ++RD+K NILLD+ +ISD GL+ P G S + V TV
Sbjct: 112 LCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTV--- 165
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEV 772
GY+ PE + Q+ T D + G ++ E++ G+ P RKE+V
Sbjct: 166 --GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 555 IGSGGFGHVFKGYI--DDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLL 610
+G G FG V +G + DD + VAVK + + + +F +E + E H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 611 GFCDEHGEM------ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
G C + E +++ FM G+L L S+ + Q L + ++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY------LPTQMLVKFMTD 120
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG--MSQSHVSTVV 722
A G+ YL + + IHRD+ + N +L+EN ++DFGLS+ +G Q ++
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--- 174
Query: 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV 755
K ++ E + + T KSDV+SFGV + E+
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGFC 613
IG G FG V+KG + VA+K ++ + E + EI ++S+ +I G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ ++ ++ E++ G+ D L + PL I +GL YLH
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-------------KPGPLEETYIATILREILKGLDYLH 118
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ K IHRD+K+ N+LL E K++DFG++ G +Q +T V F ++ PE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
I++ K+D++S G+ +E+ G PP
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 554 IIGSGGFGHVF--KGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLG 611
IG G FG ++ K D + L ++ + E+ ++++++H +IV+
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQ---NQNSPLTWKRRLEISIGAARG 668
E+G + +V E+ G+L K+ Q +++ L+W ++IS+G
Sbjct: 67 SFQENGRLFIVMEYCDGGDL-------MKRINRQRGVLFSEDQILSW--FVQISLG---- 113
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
L ++H I+HRD+KS NI L +N AK+ DFG++R M ++ G+
Sbjct: 114 LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV---GTPY 167
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLC 757
Y+ PE + + K+D++S G VL E LC
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYE-LC 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 23/221 (10%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHL-H 605
D D IG G FG V K +AVKR+ T + + +++++ +
Sbjct: 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPY 64
Query: 606 IVSLLGFCDEHGEMILVYEFMPRG--NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
IV G G+ + E M ++Y K + + K I++
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEE------ILGK----IAV 114
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
+ L+YL + IIHRDVK +NILLD N K+ DFG+S + S T
Sbjct: 115 ATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDA 168
Query: 724 GSFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G Y+ PE I R +SDV+S G+ L EV G+ P
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGFC 613
IG G FG VFKG + VA+K ++ + E + EI ++S+ ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ ++ ++ E++ G+ D L + P + + +GL YLH
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-------------RAGPFDEFQIATMLKEILKGLDYLH 118
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ K IHRD+K+ N+LL E K++DFG++ G +Q +T V F ++ PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
I++ K+D++S G+ +E+ G PP
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 554 IIGSGGFGHVFKG-YIDDGSITVAVKRLN-TSSMQGAREFRTEIEMISEL-RHLHIVSLL 610
+IG G +G V+K + G + VA+K ++ + E + E ++ + H +I +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQL-VAIKIMDIIEDEE--EEIKEEYNILRKYSNHPNIATFY 69
Query: 611 GF------CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
G ++ LV E G++ D + +K+ + + + I
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--------YILRE 121
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
RGL YLH ++ +IHRD+K NILL +N K+ DFG+S S + + + G
Sbjct: 122 TLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---G 175
Query: 725 SFGYVDPEYI-----RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ ++ PE I +SDV+S G+ +E+ G+PP
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ---GAREFRTEIEMISELRHLH 605
F + ++G GGFG V + A K+L ++ G E +++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+VSL + + LV M G+L+ H+Y+ + + R + +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE----------GRAVFYAAEI 111
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS-QSHVSTVVKG 724
GL LH + I++RD+K NILLD++ +ISD GL+ P G + + V TV
Sbjct: 112 CCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV--- 165
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN--GAVRKEEV 772
GY+ PE ++ ++ T D ++ G +L E++ G+ P +++EEV
Sbjct: 166 --GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 38/224 (16%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT--EIEMISELRHLHIVSL-- 609
IG G +G V+K D VA+K++ + + EI+++ +L H +IV+L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 610 --------LGFCDEHGEMILVYEFMPRGNLRDH----LYNSQKQNQNQNQNQNSPLTWKR 657
L F + G LV+E+M DH L S + +++ ++ K+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSEDHIKS---FMKQ 124
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
LE GL+Y H K +HRD+K +NILL+ K++DFGL+R+ S S+ +
Sbjct: 125 LLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 718 VSTVVKGSFGYVDPEYIR-RQQLTEKSDVYSFGVVLLEVLCGRP 760
+ V+ + Y PE + ++ DV+S G +L E+ +P
Sbjct: 175 TNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 81/295 (27%), Positives = 123/295 (41%), Gaps = 45/295 (15%)
Query: 554 IIGSGGFGHVFKGYI--DDGSIT-VAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVS 608
++G G FG V + + +DGS VAVK L S EF E + E H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 609 LLGFC---DEHGEM---ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
L+G G + +++ FM G+L L S+ + L + +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT------LPLQTLVRFM 119
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG--MSQSHVST 720
I A G+ YL + IHRD+ + N +L+EN ++DFGLS+ SG Q S
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 721 V-VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWA 778
+ VK ++ E + T SDV++FGV + E++ G+ P V E+ L
Sbjct: 177 LPVK----WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY--AGVENSEIYNYL-- 228
Query: 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
I RL K P CL E+ C E RP+ + LE
Sbjct: 229 -----------IKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 46/175 (26%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIVS 608
+G G + V+K + VA+K++ + A++ R EI+++ EL+H +I+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 609 LLG-FCDEHGEMI-LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
LL F H I LV+EFM +L K + I + A
Sbjct: 67 LLDVFG--HKSNINLVFEFME-TDLE--------------------KVIKDK-SIVLTPA 102
Query: 667 ----------RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711
RGL YLH + I+HRD+K N+L+ + K++DFGL+R S
Sbjct: 103 DIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLH 605
F D IG G FG V+ + VA+K+++ S Q +++ E++ + ++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 606 IVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+ G + EH LV E+ G+ D L +K PL I+ G
Sbjct: 87 SIEYKGCYLREHTAW-LVMEYC-LGSASDLLEVHKK-----------PLQEVEIAAITHG 133
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
A +GL YLH+ H +IHRD+K+ NILL E K++DFG + + S G
Sbjct: 134 ALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-------FVG 183
Query: 725 SFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
+ ++ PE I Q K DV+S G+ +E+ +PP+ N
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLGF 612
IGSG G V+K A+K + + R + EIE++ ++ H ++V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
D +GE+ ++ EFM G+L ++ L R +S G+ YL
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQF-----------LADVARQILS-----GIAYL 184
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H + I+HRD+K +N+L++ KI+DFG+SR+ M + S G+ Y+ PE
Sbjct: 185 H---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPE 238
Query: 733 YIRRQQLTE------KSDVYSFGVVLLEVLCGRPP 761
I L D++S GV +LE GR P
Sbjct: 239 RI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 65/291 (22%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE------MISELRHLH--- 605
+G G +G V+K +T+A+K E R E++ +I EL LH
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMK-----------EIRLELDESKFNQIIMELDILHKAV 57
Query: 606 ---IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
IV G G + + E+M G+L D LY + ++ RR I+
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDV------LRR--IT 108
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
+GL +L +H IIHRDVK TN+L++ N K+ DFG+S + ++++++
Sbjct: 109 YAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---- 162
Query: 723 KGSFGYVDPEYIR------RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
G Y+ PE I+ T +SDV+S G+ +LE+ GR P E +
Sbjct: 163 -GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY------PPETYANI 215
Query: 777 WARVSRARGTVDQIVD---PRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT 824
+A++S IVD P L + FV C ++ RRPT
Sbjct: 216 FAQLS-------AIVDGDPPTLPSGYSDDA-QDFVA---KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGS---ITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSL 609
I+G+G FG + +G + S + VA+ L S + R F E + + H +IV L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G M++V E+M G L L + Q L + + + G A G+
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-----------LVAGQLMGMLPGLASGM 120
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG-Y 728
YL ++ +H+ + + +L++ + KIS F R S++ +T+ S +
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLW 174
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
PE I+ + SDV+SFG+V+ EV+
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 555 IGSGGFGHVF----KGYIDDGSITV----AVKRLNTSSMQGAREFRTEIEMISELRHLHI 606
+G G FG V+ K + + + V V LN + A + E +++S+L H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHPAI 64
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V E ++ E+ +L L + + ++NQ W +L +
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ--VCEWFIQLLL----- 117
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
G+HY+H + I+HRD+K+ NI L N KI DFG+SR+ M ++T G+
Sbjct: 118 -GVHYMH---QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL---MGSCDLATTFTGTP 169
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC 757
Y+ PE ++ Q KSD++S G +L E+ C
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-14
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 554 IIGSGGFGHVF--KGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL-- 609
++GSG G V K D V V + S + E+ + IV
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 610 -LGFCDEHGE-----MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
D + LV ++ G+LR + + K N+ +++ L I
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF--------I 150
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
+H++H+ KH +IHRD+KS NILL N K+ DFG S+M + +S V
Sbjct: 151 QVLLAVHHVHS--KH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD-VGRTFC 206
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ YV PE RR+ ++K+D++S GV+L E+L + P
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 37/106 (34%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
+I++ + L YLH+ K ++IHRDVK +N+L++ N K+ DFG+S + S
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAK 160
Query: 720 TVVKGSFGYVDPEYI----RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
T+ G Y+ PE I ++ KSDV+S G+ ++E+ GR P
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 53/223 (23%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLLG 611
+G G FG V VA+K++ ++ + R +R E++++ LRH +I+SL
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 612 -FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE------ISIG 664
F ++ V E + R L R LE
Sbjct: 77 IFISPLEDIYFVTELLGTDLHR--------------------LLTSRPLEKQFIQYFLYQ 116
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
RGL Y+H+ ++HRD+K +NIL++EN KI DFGL+R+ M+
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMT---------- 163
Query: 725 SFGYVDPEYIRR-------QQLTEKSDVYSFGVVLLEVLCGRP 760
GYV Y R Q+ + D++S G + E+L G+P
Sbjct: 164 --GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 73/268 (27%)
Query: 555 IGSGGFGHVFKGY---IDDGSI--TVAVKRLNTSSMQGA-REFRTEIEMISEL-RHLHIV 607
+G G FG V + ID + TVAVK L + R +E++++ + HL++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 608 SLLGFCDEH-GEMILVYEFMPRGNLRDHL---------YNSQ--KQNQNQNQNQNSPLTW 655
+LLG C + G ++++ EF GNL ++L Y ++ + Q ++ +
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 656 KRRLE--------------------------------------------ISIGAARGLHY 671
KRRL+ S A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---MGPSGMSQSHVSTVVKGSFGY 728
L A IHRD+ + NILL EN KI DFGL+R P + + +K +
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----W 247
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ PE I + T +SDV+SFGV+L E+
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLLG 611
IG G FG V+ + VAVK+++ S Q +++ E++ + +L+H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 612 -FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+ EH LV E+ G+ D L +K PL I+ GA +GL
Sbjct: 89 CYLKEHTAW-LVMEYC-LGSASDLLEVHKK-----------PLQEVEIAAITHGALQGLA 135
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YLH+ H +IHRD+K+ NILL E K++DFG S S ++ V G+ ++
Sbjct: 136 YLHS---HNMIHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFV-GTPYWMA 185
Query: 731 PEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
PE I Q K DV+S G+ +E+ +PP+ N
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV 607
+ IG G G V VAVK+++ Q E+ ++ + +H +IV
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+ E+ +V EF+ G L D + ++ N+ Q + + + +
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIA--------TVCLAVLK 126
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
L +LHA +IHRD+KS +ILL + K+SDFG + + S V G+
Sbjct: 127 ALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK-SLV--GTPY 180
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
++ PE I R + D++S G++++E++ G PP N
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLL 610
++G G +G V K + VA+K+ S M R EI M+ +LRH ++V+L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 611 GFCDEHGEMILVYEFMPRGNLRDH-LYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+ LV+EF+ DH + + ++ N L R + RG+
Sbjct: 67 EVFRRKKRLYLVFEFV------DHTVLDDLEKYPNG-------LDESRVRKYLFQILRGI 113
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM--GPSGMSQSHVST------- 720
+ H+ H IIHRD+K NIL+ ++ K+ DFG +R P + +V+T
Sbjct: 114 EFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170
Query: 721 -VVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+V D +Y R D+++ G ++ E+L G P
Sbjct: 171 LLVG------DTKYGR------AVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 555 IGSGGFGHVFKG-YIDDGSITVAVKRLNT--SSMQGAREFRTEIEMISEL-RHLHIVSLL 610
+G G FG V+ + G + VA+K++ S + R E++ + +L H +IV L
Sbjct: 7 LGDGTFGSVYLARNKETGEL-VAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLK 64
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
E+ E+ V+E+M GNL Y K + + P + I +GL
Sbjct: 65 EVFRENDELYFVFEYM-EGNL----YQLMKDRKGK------PFSESVIRSIIYQILQGLA 113
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
++H KH HRD+K N+L+ KI+DFGL+R
Sbjct: 114 HIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 65/288 (22%), Positives = 123/288 (42%), Gaps = 34/288 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLLG 611
IG G F V++ VA+K++ M A+ + EI+++ +L H +++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
E E+ +V E G+L + +KQ + + WK +++ + +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT----VWKYFVQL----CSAVEH 121
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
+H+ ++HRD+K N+ + K+ D GL R S + +H S V G+ Y+ P
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLV--GTPYYMSP 175
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791
E I KSD++S G +L E+ + P ++++L + ++Q
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLFSLCQ------KIEQCD 224
Query: 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839
P L + K E+ C + +RP D+ + + A Q+
Sbjct: 225 YPPLPTEHYS---EKLRELVSMCIYPDPDQRP---DIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 30/168 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSIT--VAVKRLNTS-------SMQGAREFRTEIEMISELRHLH 605
IG G +G V+K +G A+K+ S RE I ++ EL+H +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHEN 63
Query: 606 IVSLLGFCDEHGEMI--LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
+VSL+ EH + L++++ + ++ Q + + + L W+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ------- 116
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSR 707
G+HYLH+ + ++HRD+K NIL+ E KI D GL+R
Sbjct: 117 -ILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 2e-13
Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G G V+ VA+K++N EI ++ E ++ +IV+ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E+ +V E++ G+L D + + ++ Q + + + + L +LH+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRE--------CLQALDFLHS 133
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGL-SRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ +IHRD+KS NILL + + K++DFG +++ P QS ST+V G+ ++ PE
Sbjct: 134 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMV-GTPYWMAPEV 186
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
+ R+ K D++S G++ +E++ G PP +N
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 10/105 (9%)
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
+++ + LHYL KH +IHRDVK +NILLD + K+ DFG+S + S T
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKT 172
Query: 721 VVKGSFGYVDPEYIRRQQLTEK----SDVYSFGVVLLEVLCGRPP 761
G Y+ PE I K +DV+S G+ L+E+ G+ P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 36/117 (30%), Positives = 53/117 (45%), Gaps = 16/117 (13%)
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ LH + IIHRD+K N+L+D+ K++DFGLSR G + G+
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-------LENKKFVGTPD 158
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784
Y+ PE I + SD +S G V+ E L G PP ++ + R
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRR 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 549 FADHCI-IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV 607
+ D+ I IG G G V + VAVK+++ Q E+ ++ + +H ++V
Sbjct: 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 80
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+ E+ +V EF+ G L D + +++ N+ Q + + + +
Sbjct: 81 EMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIA--------AVCLAVLK 127
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
L LHA +IHRD+KS +ILL + K+SDFG S S V G+
Sbjct: 128 ALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ-VSKEVPRRKSLV--GTPY 181
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
++ PE I R + D++S G++++E++ G PP N
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 28/226 (12%)
Query: 542 IKQATCDFADHCIIGSGGFGHVFKG-YID---DGSITVAVKRL--NTSSMQGAREFRTEI 595
I + ++ G FG +F G ID V VK + + S +Q E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQES 59
Query: 596 EMISELRHLHIVSLLGFCDEHGEMILV-YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLT 654
++ L H +I+ +L C E GE V Y +M GNL+ L + N Q L+
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA----LS 115
Query: 655 WKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPS-- 711
++ + ++I A G+ YLH K +IH+D+ + N ++DE KI+D LSR + P
Sbjct: 116 TQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY 172
Query: 712 ---GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLE 754
G +++ VK ++ E + ++ + SDV+SFGV+L E
Sbjct: 173 HCLGDNENR---PVK----WMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 68/227 (29%), Positives = 111/227 (48%), Gaps = 27/227 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLGF 612
+G G + VFKG VA+K + +GA R E+ ++ L+H +IV+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDI 71
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ LV+E++ +L+ +L N N N + + L RGL Y
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCG----NLMSMHNVKIFMFQLL-------RGLSYC 119
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H K I+HRD+K N+L++E K++DFGL+R S ++++ + VV + Y P+
Sbjct: 120 H---KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV--TLWYRPPD 173
Query: 733 YIRRQQLTEKS---DVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
+ TE S D++ G +L E+ GR PM G+ KEE+ L+
Sbjct: 174 VLLGS--TEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIF 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
EI +G L +LH + II+RD+K N+LLD KI+DFG+ + G+ +
Sbjct: 104 EIVLG----LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTT 153
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G+ Y+ PE + Q D ++ GV+L E+L G+ P
Sbjct: 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRH 603
+F IG G F V++ + DG VA+K++ + A+ EI+++ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVP-VALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
+++ E E+ +V E G+L + + +KQ + + WK +++
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT----VWKYFVQL-- 115
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
L ++H+ ++HRD+K N+ + K+ D GL R S + +H +
Sbjct: 116 --CSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLV 167
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE I KSD++S G +L E+ + P
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLL-GFC 613
+G G FG V+K + + A K ++T S + ++ EI++++ H +IV LL F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
E+ IL+ EF G + + ++ PLT + + L+YLH
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELER-----------PLTEPQIRVVCKQTLEALNYLH 120
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
++ IIHRD+K+ NIL + K++DFG+S + Q S + G+ ++ PE
Sbjct: 121 ---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFI--GTPYWMAPEV 174
Query: 734 I-----RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + + K+DV+S G+ L+E+ PP
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 65/241 (26%), Positives = 109/241 (45%), Gaps = 35/241 (14%)
Query: 555 IGSGGFGHVFKG--YIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLG 611
IG+G FG V Y D G V VK L + S + EF + + L+H +I+ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
C E +LV+E+ G+L+ +L +Q Q +NS L +R+ I A G+ +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAA--GVTH 114
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG--YV 729
+H KH +H D+ N L + K+ D+G+ GPS + ++ T ++
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVPLRWL 168
Query: 730 DPEYIRRQQ-------LTEKSDVYSFGVVLLEVL-CGRPP--------MINGAVRKEEVS 773
PE + T+ S+V++ GV L E+ P ++N ++ ++V
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228
Query: 774 L 774
L
Sbjct: 229 L 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 33/144 (22%), Positives = 54/144 (37%), Gaps = 20/144 (13%)
Query: 241 YRLNVGGAHVSAKDDTGMFREWLDDTNYIYGAAS-GVTPHLPGARIKYTSDTPAYIAPVI 299
+N GG D G + DT + G+A V+ + I T+D
Sbjct: 3 LAINCGG--PEHTDSDG--ITYEADTYFTGGSADYYVSDTNGSSSIAGTTD-------PE 51
Query: 300 VYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQ 359
+Y T R + ++ NY V LHF E +RVF +++ +
Sbjct: 52 LYQTER-YSPS-------SFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGK 103
Query: 360 TAENDADVIHWSGGSGIPVFKDYV 383
D D++ +GG G K+Y+
Sbjct: 104 LVLKDFDIVAEAGGKGKTAHKEYI 127
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 38/224 (16%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHL 604
DF +G+G FG V A+K L+ + ++ E ++ +RH
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 605 HIVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
+V+L G F D+ + LV E++P G L HL S + + +
Sbjct: 62 FLVNLYGSFQDD-SNLYLVMEYVPGGELFSHLRKSGRFPEPVAR---------------F 105
Query: 664 GAAR---GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
AA+ L YLH+ I++RD+K N+LLD + KI+DFG ++ V
Sbjct: 106 YAAQVVLALEYLHS--LD-IVYRDLKPENLLLDSDGYIKITDFGFAK---------RVKG 153
Query: 721 VVK---GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE I + + D ++ G+++ E+L G PP
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 28/238 (11%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ---GAREFRTEIEMISELRHLH 605
F + ++G GGFG V + A K+L ++ G E ++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+VSL + + LV M G+L+ H+YN N +R + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG----------NPGFDEQRAIFYAAEL 111
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS-QSHVSTVVKG 724
GL L + I++RD+K NILLD+ +ISD GL+ P G + + V TV
Sbjct: 112 CCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTV--- 165
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782
GY+ PE I ++ T D + G ++ E++ G+ P RKE V V R
Sbjct: 166 --GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK---RKERVK---REEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHL 604
D +G+G FG V A+K + ++ + E ++ E+ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 605 HIVSLLGFCDEHGEMIL--VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
I+ L F EH + L + E++P G L +L NS + + + S EI
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS--------EI- 110
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST-V 721
+ A L YLH+ I++RD+K NILLD+ K++DFG ++ + T
Sbjct: 111 VCA---LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-------KLRDRTWT 157
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G+ Y+ PE I+ + + D ++ G+++ E+L G PP
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 47/283 (16%)
Query: 554 IIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLG 611
++G+G +G V+KG ++ G + A+K ++ + + E + EI M+ + H +I + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLA-AIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 70
Query: 612 -FCDEH-----GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
F ++ ++ LV EF G++ D + N++ + W + I
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE--------WIAYICREI-- 120
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
RGL +LH +H +IHRD+K N+LL EN K+ DFG+S + + + G+
Sbjct: 121 LRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GT 174
Query: 726 FGYVDPEYIRRQQLTE-----KSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780
++ PE I + + KSD++S G+ +E+ G PP+ +
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-------------MHP 221
Query: 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP 823
RA + + PRL+ K F+E SC + +RP
Sbjct: 222 MRALFLIPRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRP 261
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 554 IIGSGGFGHV-FKGYIDDGSITVAVKRLN--TSSMQGAREFRTEIEMISELRHLHIVSLL 610
++G G +G V + DG V +K+LN +S + + E +++S+L+H +IV+
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 611 -GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+ E G + +V F G+L Y+ K+ + + +N + W + A L
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDL----YHKLKEQKGKLLPENQVVEW------FVQIAMAL 115
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YLH KH I+HRD+K+ N+ L K+ D G++R+ +Q +++ + G+ Y+
Sbjct: 116 QYLHE--KH-ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE---NQCDMASTLIGTPYYM 169
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEV 755
PE + KSDV++ G + E+
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHLHIVSLL- 610
+G GGFG V + + T A+K + + + +E E++ E H IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 611 GFCDE-HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
F D+ + M++ E+ G L L + + + R I+
Sbjct: 61 TFKDKKYIYMLM--EYCLGGELWTILRDRGLFD-----------EYTARFYIA-CVVLAF 106
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YLH II+RD+K N+LLD N K+ DFG ++ SG T G+ YV
Sbjct: 107 EYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFC-GTPEYV 159
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE I + D +S G++L E+L GRPP
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 9e-13
Identities = 57/211 (27%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G G V+ VA++++N EI ++ E ++ +IV+ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E+ +V E++ G+L D + + ++ Q + + + + L +LH+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRE--------CLQALEFLHS 134
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGL-SRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ +IHRD+KS NILL + + K++DFG +++ P QS ST+V G+ ++ PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMV-GTPYWMAPEV 187
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
+ R+ K D++S G++ +E++ G PP +N
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 37/237 (15%)
Query: 538 SLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEM 597
+T+++ DF +IG G FG V A+K L+ M R++
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK----RSDSAF 89
Query: 598 ISELRHLH-------IVSL-LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQ 649
E R + IV L F D+ + +V E+MP G+L N N
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDK-YLYMVMEYMPGGDL-----------VNLMSNY 137
Query: 650 NSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RM 708
+ P W R + A L +H IHRDVK N+LLD++ K++DFG +M
Sbjct: 138 DIPEKWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQ----QLTEKSDVYSFGVVLLEVLCGRPP 761
+GM T V G+ Y+ PE ++ Q + D +S GV L E+L G P
Sbjct: 193 DANGM--VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 50/233 (21%)
Query: 555 IGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
+G G FG V+K I G + VA+K++ M ++ R EI+++ +L+H ++V
Sbjct: 16 LGEGTFGEVYKARQIKTGRV-VALKKI---LMHNEKDGFPITALR-EIKILKKLKHPNVV 70
Query: 608 SLL--------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNS-PLTWKRR 658
L+ + G + +V +M DH + +N + ++ +
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 659 LEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---------MG 709
LE G++YLH H I+HRD+K+ NIL+D KI+DFGL+R G
Sbjct: 125 LE-------GINYLHE--NH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 710 PSGMS-QSHVSTVVKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
G + + + VV + Y PE + ++ T D++ G V E+ RP
Sbjct: 175 GGGGGTRKYTNLVV--TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/222 (27%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 554 IIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLG 611
++G+G +G V+KG ++ G + A+K ++ + + E + EI M+ + H +I + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLA-AIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYG 80
Query: 612 -FCDEH-----GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
F + ++ LV EF G++ D + N++ ++ W + I
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED--------WIAYICREI-- 130
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
RGL +LHA H +IHRD+K N+LL EN K+ DFG+S + + + G+
Sbjct: 131 LRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GT 184
Query: 726 FGYVDPEYIRRQQLTE-----KSDVYSFGVVLLEVLCGRPPM 762
++ PE I + + +SD++S G+ +E+ G PP+
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 38/273 (13%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G G V VAVK+++ Q E+ ++ + H ++V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E+ +V EF+ G L D + + N+ Q + + R L YLH
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAT------------VCLSVLRALSYLH- 135
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFG----LSRMGPSGMSQSHVSTVVKGSFGYVD 730
+IHRD+KS +ILL + K+SDFG +S+ P S + G+ ++
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-------LVGTPYWMA 186
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN----GAVRKEEVSLV-----LWARVS 781
PE I R + D++S G++++E++ G PP N A+R+ +L S
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSS 246
Query: 782 RARGTVDQIV--DPRLRGKIAPVCLNKFVEIAG 812
RG +D ++ +P R + + F+++AG
Sbjct: 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIVSLLG 611
++G G FG + A+K RL SS + R E ++++++H +IV+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+ G + +V E+ G+L + K + + +++ L W ++ + G+ +
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKI----KLQRGKLFPEDTILQWFVQMCL------GVQH 115
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
+H + ++HRD+KS NI L +N K+ DFG +R+ S ++ T V G+ YV P
Sbjct: 116 IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYV-GTPYYVPP 169
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E KSD++S G +L E+ + P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLL 610
I+G G G V+K Y +AVK + T +Q ++ +E+E++ + +I+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIGFY 65
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
G + + EFM G+L +Y + + + I++ +GL
Sbjct: 66 GAFFVENRISICTEFMDGGSL--DVYRKIPE----------HVLGR----IAVAVVKGLT 109
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YL + I+HRDVK +N+L++ K+ DFG+S + +++++V G+ Y+
Sbjct: 110 YLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMA 161
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE I +Q SDV+S G+ +E+ GR P
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 28/238 (11%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ---GAREFRTEIEMISELRHLH 605
F + ++G GGFG V + A K+L ++ G E +++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+VSL + + LV M G+L+ H+YN N +R + +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG----------NPGFDEERAVFYAAEI 111
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS-QSHVSTVVKG 724
GL LH + I++RD+K NILLD+ +ISD GL+ P G + + V TV
Sbjct: 112 TCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTV--- 165
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782
GY+ PE ++ ++ T D + G ++ E++ G+ P RKE+V V R
Sbjct: 166 --GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF---RQRKEKVK---REEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IGSG +G V+K + A+K + + + EI M+ + +H +IV+ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
++ + EF G+L+D +Y+ PL+ + +S +GL+YLH+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHV-----------TGPLSESQIAYVSRETLQGLYYLHS 124
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF----GYVD 730
K +HRD+K NILL +N K++DFG+S +Q + + SF ++
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMA 174
Query: 731 PEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
PE R+ + D+++ G+ +E+ +PPM +
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLLG 611
+GSG +G V VA+K+L S + R +R E+ ++ ++H +++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 612 F------CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
D + LV FM G L +K ++++ Q L ++
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF----LVYQ--------M 127
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+GL Y+HA IIHRD+K N+ ++E+ KI DFGL+R S M+ V+
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----- 179
Query: 726 FGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRP 760
Y PE I T+ D++S G ++ E+L G+P
Sbjct: 180 -WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 36/217 (16%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLGF 612
+G G + V+KG VA+K ++ + +G R EI ++ EL+H +IV L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+++LV+E+M +L+ ++ ++ + N T++ +G+ +
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYM-DTHGVRGALDPNTVKSFTYQ--------LLKGIAFC 116
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MG-PSGMSQSHVST-------VVK 723
H ++ ++HRD+K N+L+++ K++DFGL+R G P + V T V+
Sbjct: 117 H---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
GS Y + D++S G ++ E++ GRP
Sbjct: 174 GSRTY-----------STSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 68/277 (24%), Positives = 116/277 (41%), Gaps = 46/277 (16%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG-AREFRTEIEMISELRHL---HIVSL 609
+IG G +G V++G VA+K +N + + + E+ ++S+LR +I
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G + + ++ E+ G++R + + P+ K I L
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM-------------KAGPIAEKYISVIIREVLVAL 114
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
Y+H K +IHRD+K+ NIL+ K+ DFG++ + S+ ST V G+ ++
Sbjct: 115 KYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STFV-GTPYWM 168
Query: 730 DPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788
PE I + K+D++S G+ + E+ G PP + V R +
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPY---------------SDVDAFR-AMM 212
Query: 789 QIVD---PRLRGKIAPVCLNKFVEIAGSCTDEEGFRR 822
I PRL L +FV +C DEE R
Sbjct: 213 LIPKSKPPRLEDNGYSKLLREFV---AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 48/226 (21%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLN--TSSMQGAREFRTEIEMISELRHLHIVSLL- 610
IG G +G V + VA+K+++ R R EI+++ +H +I+ +L
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGILD 70
Query: 611 ----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQN------QNSPLTWKRRLE 660
+ ++ +V E M LY K N + Q
Sbjct: 71 IIRPPSFESFNDVYIVQELME-----TDLYKLIKTQHLSNDHIQYFLYQ----------- 114
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM-----GPSGMSQ 715
RGL Y+H+ ++HRD+K +N+LL+ N KI DFGL+R+ +G
Sbjct: 115 ----ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 716 SHVSTVVKGSFGYVDPEYIRRQQLTEKS-DVYSFGVVLLEVLCGRP 760
+V+T Y PE + + K+ D++S G +L E+L RP
Sbjct: 168 EYVATR-----WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 66/236 (27%), Positives = 110/236 (46%), Gaps = 42/236 (17%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
IG G +G V++ VA+K++ M R+ R EI ++ LRH +IV
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLR-EITLLLNLRHPNIV 69
Query: 608 SLLGFC-DEHGEMI-LVYEFMPR--GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
L +H + I LV E+ + +L D N +P + + + +
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLD--------------NMPTPFSESQVKCLML 115
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS-TVV 722
RGL YLH ++ IIHRD+K +N+LL + KI+DFGL+R G+ ++ VV
Sbjct: 116 QLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART--YGLPAKPMTPKVV 170
Query: 723 KGSFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775
+ Y PE + T D+++ G +L E+L + P++ G E++ L+
Sbjct: 171 --TLWYRAPELLLGCTTY--TTAIDMWAVGCILAELLAHK-PLLPGKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE----MISELRHLHIVSL 609
+IG G FG V AVK L + +E + + ++ ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
++ V +F+ G L HL Q++ ++ P R I +A G
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL---QRE-------RSFPEPRARFYAAEIASALG- 110
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YLH+ I++RD+K NILLD ++DFGL + G++QS +T G+ Y+
Sbjct: 111 -YLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYL 163
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE IR+Q D + G VL E+L G PP
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 36/239 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV------- 607
+G G G VF D VAVK++ + Q + EI++I L H +IV
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 608 -------SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660
+G E + +V E+M +L + L Q +++ L + L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL------EQGPLSEEHARLFMYQLL- 124
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSR-MGPSGMSQSHV 718
RGL Y+H+ ++HRD+K N+ ++ E+ KI DFGL+R + P + ++
Sbjct: 125 ------RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 719 STVVKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
S + + Y P + T+ D+++ G + E+L G+ P+ GA E++ L+L
Sbjct: 176 SEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLIL 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612
IG G +G V+K VA+K RL+T + EI ++ EL H +IV LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
++ LV+EF+ + +L+ + S ++ + +L +GL +
Sbjct: 68 IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKS----YLFQL------LQGLAFC 116
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
H+ H ++HRD+K N+L++ A K++DFGL+R
Sbjct: 117 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 26/235 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSIT---VAVKRLNTSSM----QGAREFRTEIEMISELRHLHI 606
++G GG+G VF+ G+ T A+K L +++ + + E ++ ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V L+ G++ L+ E++ G L HL +++ L+ EIS+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLS-----EISLA-- 112
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
L +LH + II+RD+K NILLD K++DFGL + + +H G+
Sbjct: 113 --LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTI 164
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781
Y+ PE + R + D +S G ++ ++L G PP RK+ + +L +++
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAENRKKTIDKILKGKLN 218
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLLG 611
+GSG +G V + + VAVK+L+ S + R +R E+ ++ ++H +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 612 F------CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+E ++ LV M G +++ QK + Q L ++
Sbjct: 84 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQF----LIYQ--------I 129
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
RGL Y+H+ IIHRD+K +N+ ++E+ KI DFGL+R M+
Sbjct: 130 LRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------- 175
Query: 726 FGYVDPEYIRRQQL-------TEKSDVYSFGVVLLEVLCGR 759
GYV + R ++ + D++S G ++ E+L GR
Sbjct: 176 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 40/172 (23%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRLNTS-SMQGA-----REFRTEIEMISELRHL-- 604
IG G +G V+K ++ G VA+K++ S +G RE I+ L+ L
Sbjct: 6 EIGEGAYGTVYKARDLNTGRF-VALKKVRVPLSEEGIPLSTLRE-------IALLKQLES 57
Query: 605 ----HIVSLLGFC---DEHGEMI--LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
+IV LL C E+ LV+E + + +L +L K ++
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD----- 111
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
+ RG+ +LH+ H I+HRD+K NIL+ + KI+DFGL+R
Sbjct: 112 -----LMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/225 (25%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLGF 612
+G G + V+KG VA+K + +GA R E+ ++ +L+H +IV+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ LV+E++ + +L+ +L + N N L + L RGL+Y
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCG----NSINMHNVKLFLFQLL-------RGLNYC 120
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H + ++HRD+K N+L++E K++DFGL+R S ++++ + VV + Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV--TLWYRPPD 174
Query: 733 -YIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
+ + + D++ G + E+ GR P+ G+ +E++ +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLL 610
++G G FG V A+K L + E TE ++ RH + SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+ V E++ G L HL + ++++ + + + L
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV------------SALD 109
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YLH+G I++RD+K N++LD++ KI+DFGL + G++ + G+ Y+
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLA 163
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
PE + D + GVV+ E++CGR P N
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 6/94 (6%)
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
GL +LH K II+RD+K N+LLD++ KI+DFG M M+ ++ G+
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFG---MCKENMNGEGKASTFCGTPD 161
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE ++ Q+ E D +SFGV+L E+L G+ P
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE----MISELRHLHIVSL 609
+IG G FG V AVK L ++ +E + + ++ ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL---EISIGAA 666
++ V +++ G L HL Q + S + R EI A
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL-----------QRERSFPEPRARFYAAEI----A 106
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
L YLH+ II+RD+K NILLD ++DFGL + G+ S ++ G+
Sbjct: 107 SALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTP 160
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE +R+Q D + G VL E+L G PP
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 57/225 (25%), Positives = 112/225 (49%), Gaps = 23/225 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLGF 612
+G G + VFKG VA+K + +GA R E+ ++ +L+H +IV+L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ LV+E++ + +L+ ++ + N N + + L RGL Y
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCG----NIMSMHNVKIFLYQIL-------RGLAYC 120
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H + ++HRD+K N+L++E K++DFGL+R S ++++ + VV + Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV--TLWYRPPD 174
Query: 733 YIR-RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
+ + + + D++ G + E+ GR P+ G+ ++E+ L+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 553 CIIGSGGFGHVFKGYIDDGS--ITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVS 608
C +G G +GHV+K DG A+K++ + SM R EI ++ EL+H +++S
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR----EIALLRELKHPNVIS 62
Query: 609 LLGFCDEHGE--MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI--G 664
L H + + L++++ L++ K ++ N+ P+ R + S+
Sbjct: 63 LQKVFLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQ 116
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSRMGPSGMSQSHVST 720
G+HYLHA + ++HRD+K NIL+ E KI+D G +R+ S +
Sbjct: 117 ILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 721 VVKGSFGYVDPEYIR-RQQLTEKSDVYSFGVVLLEVLCGRP 760
V +F Y PE + + T+ D+++ G + E+L P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHL------HIV 607
IG G +G VFK + +G VA+KR+ + + T I ++ LRHL ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 67
Query: 608 SLLGFC-----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
L C D ++ LV+E + + +L +L + T K ++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-------PTETIK---DMM 116
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
RGL +LH+ H ++HRD+K NIL+ + K++DFGL+R+ S T V
Sbjct: 117 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQMALTSV 169
Query: 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+ Y PE + + D++S G + E+ +P
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 553 CIIGSGGFGHVFKGYIDDG--SITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVS 608
C +G G +GHV+K DG A+K++ + SM R EI ++ EL+H ++++
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIA 62
Query: 609 LLGFCDEHGE--MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
L H + + L++++ H+ + ++ + P + + L I
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQI--L 118
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
G+HYLHA + ++HRD+K NIL+ E KI+D G +R+ S + V
Sbjct: 119 DGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 723 KGSFGYVDPEYIR-RQQLTEKSDVYSFGVVLLEVLCGRP 760
+F Y PE + + T+ D+++ G + E+L P
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 46/227 (20%)
Query: 555 IGSGGFGHVFKG-YIDDGS---------ITVAVKRLNTSSMQGAREFRTEIEMISELRHL 604
+G G F +++KG ++V +K L S + + F ++S+L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 605 HIVSLLGFC--DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
H+V L G C DE+ I+V E++ G L L + N L WK L+++
Sbjct: 62 HLVKLYGVCVRDEN---IMVEEYVKFGPLDVFL---------HREKNNVSLHWK--LDVA 107
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILL---DENWA----AKISDFGLSRMGPSGMSQ 715
A LHYL ++H +V NIL+ N K+SD G+ +
Sbjct: 108 KQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSRE 162
Query: 716 SHVSTVVKGSFGYVDPEYIRRQQ--LTEKSDVYSFGVVLLEVLCGRP 760
V + ++ PE IR Q LT +D +SFG LLE+
Sbjct: 163 ERVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L +LH +H +I+RD+K NILLD K++DFG M G+ +T G+ Y
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTFCGTPDY 162
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE ++ + D ++ GV++ E++ G+PP
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 44/220 (20%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNT--SSMQGAREFRTEIEMISELRHLHIVSLLGF 612
+GSG +G V Y VAVK+L+ S+ AR E+ ++ ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 613 ------CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
+ E+ LV M G +++ QK + Q L
Sbjct: 83 FTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLL------------ 128
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
RGL Y+H+ IIHRD+K +N+ ++E+ +I DFGL+R M+
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT------------ 173
Query: 727 GYVDPEYIRRQQL-------TEKSDVYSFGVVLLEVLCGR 759
GYV + R ++ + D++S G ++ E+L G+
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 10/102 (9%)
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
EI+IG L +LH II+RD+K N++LD KI+DFG+ + + +
Sbjct: 109 EIAIG----LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTT 158
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE I Q + D ++FGV+L E+L G+PP
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 44/150 (29%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 230 SFDKPVALETAYRLNVG------GAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGA 283
S+ + V L TA RL+ G S D G R W + G+ ++
Sbjct: 183 SWGQGVILRTAKRLSCGAGKSKFDEDYSG-DHWGGDRFWNRMQTFGSGSDQAISTE---N 238
Query: 284 RIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLE 343
IK S+ P + + + + P+ L++ VDP NY V LHF E
Sbjct: 239 VIKKASNAPNFYPESLYQSALVSTDTQPD------LSYTMDVDPNRNYSVWLHFAEIDNS 292
Query: 344 ITRENQRVFSIFINNQTAENDADVIHWSGG 373
IT E +RVF + IN TA D D++ SG
Sbjct: 293 ITAEGKRVFDVLINGDTAFKDVDIVKMSGE 322
|
Length = 623 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLL 610
++G G FG V + + AVK L + + TE ++S R+ ++ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 611 GFCDEHGE-MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
C + + + V EF+ G+L H+ S++ ++ + + + +T L
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT------------SAL 109
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
+LH II+RD+K N+LLD K++DFG M G+ ++ G+ Y+
Sbjct: 110 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIFNGKTTSTFCGTPDYI 163
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE ++ D ++ GV+L E+LCG P
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 548 DFADHCIIGSGGFGHVF----KGYIDDGSITVAVKRLNTSSM----QGAREFRTEIEMIS 599
+F ++G+G +G VF G D G + A+K L +++ + A RTE +++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKL-YAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 600 ELRHL-HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRR 658
+R +V+L ++ L+ +++ G L HLY + ++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-------------E 106
Query: 659 LEISIGA-ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
+ + I L +LH + II+RD+K NILLD ++DFGLS+ + +
Sbjct: 107 VRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 718 VSTVVKGSFGYVDPEYIRRQQLTEKS--DVYSFGVVLLEVLCGRPP 761
S G+ Y+ PE IR D +S GV+ E+L G P
Sbjct: 164 YSFC--GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-10
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 26/236 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR---EFRTEIEMISELRHLHIVSLL 610
+IG GG G V+ Y S VA+K++ + F E ++ ++L H IV +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 611 GFCDEHGEMILVYEFMP--RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
C + G+ VY MP G L S Q ++ ++ + L I
Sbjct: 69 SICSD-GD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDE-------NWAAKIS-----DFGLSRMGPSGMSQS 716
+ Y+H+ ++HRD+K NILL +W A I + L
Sbjct: 126 IEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 717 HVSTV---VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK 769
T+ + G+ Y+ PE + +E +D+Y+ GV+L ++L P RK
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238
|
Length = 932 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 33/173 (19%)
Query: 596 EMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
E + RH +V+L + V E+ G+L H++ +
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV-------------FSE 100
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR--MGPSGM 713
R + + GL YLH ++ I++RD+K N+LLD KI+DFGL + MG
Sbjct: 101 PRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157
Query: 714 SQSHVSTVVKGSFGYVDPEYIRRQQLTEKS-----DVYSFGVVLLEVLCGRPP 761
+ + T PE++ + LTE S D + GV++ E+L G P
Sbjct: 158 TSTFCGT----------PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 61/260 (23%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG---AREFRTEIEMISELRHLHIVSLLG 611
+G G G VF + A+K L+ M + TE E+++ L H + +L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR---- 667
+ LV ++ P G L L Q+Q + L + AR
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLL---QRQP-------------GKCLSEEV--ARFYAA 110
Query: 668 ----GLHYLHA-GAKHTIIHRDVKSTNILLDENWAAKISDFGLS--------------RM 708
L YLH G I++RD+K NILL E+ +SDF LS R
Sbjct: 111 EVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 709 GPSGMSQSHVSTVVK------------GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
G S + + + G+ Y+ PE I D ++ G++L E+L
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
Query: 757 CGRPPMINGAVRKEEVSLVL 776
G P G+ R E S +L
Sbjct: 227 YGTTPF-KGSNRDETFSNIL 245
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 53/234 (22%)
Query: 554 IIGSGGFGHVFKGYIDDGS-ITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLL 610
IGSG +G V ID S VA+K++ + A+ E++++ +H +I+++
Sbjct: 12 NIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLY---NSQKQNQNQNQNQNSPLTWKRRLEISIGA-- 665
++ P G +Y + + + + + + PLT E I
Sbjct: 71 -------DI-----LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT-----EEHIRYFL 113
Query: 666 ---ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS------ 716
RGL Y+H+ +IHRD+K +N+L++E+ +I DFG++R G+S S
Sbjct: 114 YQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR----GLSSSPTEHKY 166
Query: 717 ----HVSTVVKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRPPMING 765
+V+T Y PE + + T D++S G + E+L GR + G
Sbjct: 167 FMTEYVATR-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G G V VAVK ++ Q E+ ++ + +H ++V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E+ ++ EF+ G L D + + + N+ Q + + L YLH+
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIAT------------VCESVLQALCYLHS 135
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFG----LSRMGPSGMSQSHVSTVVKGSFGYVD 730
+IHRD+KS +ILL + K+SDFG +S+ P S + G+ ++
Sbjct: 136 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-------LVGTPYWMA 185
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE I R + D++S G++++E++ G PP
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT----EIEMISELRHLHIVSL 609
++G G +G V K + VA+K+ S + E + E++M+ L+ +IV L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G++ LV+E++ + N+ + L + N K R I + +
Sbjct: 66 KEAFRRRGKLYLVFEYVEK-NMLELL----------EEMPNGVPPEKVRSYI-YQLIKAI 113
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
H+ H K+ I+HRD+K N+L+ N K+ DFG +R G + ++ V + Y
Sbjct: 114 HWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV--ATRWYR 168
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
PE + + D++S G +L E+ G+P
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE----MISELRHLHIVSL 609
+IG G FG V AVK L ++ +E + ++ L+H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
++ V +++ G L HL Q + L + R + A +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL-----------QRERCFLEPRARF-YAAEVASAI 109
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YLH+ II+RD+K NILLD ++DFGL + G+ ++ G+ Y+
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYL 163
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE +R++ D + G VL E+L G PP
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 6/94 (6%)
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
GL +LH+ II+RD+K N++LD + KI+DFG+ + G +++ + G+
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPD 161
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE ++ + T D +SFGV+L E+L G+ P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 6e-10
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 63/233 (27%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRL-----NTSSMQGAREFRTEIEMISELR-HLHIVS 608
+G G +G V+K VA+K++ N + Q R FR EI + EL H +IV
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQELGDHPNIVK 71
Query: 609 LLGF--CDEHGEMILVYEFMP-------RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
LL + ++ LV+E+M R N+ L + K+
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETDLHAVIRANI---LEDVHKRY----------------- 111
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
I + L Y+H+G +IHRD+K +NILL+ + K++DFGL+R +S
Sbjct: 112 -IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS---------LS 158
Query: 720 TVVKGSFGYVDPEYI-----RRQQLTEKSDVYSFGV-------VLLEVLCGRP 760
+ + V +Y+ R ++ S Y+ GV +L E+L G+P
Sbjct: 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
EIS+G L +LH + II+RD+K N++LD KI+DFG+ + M +
Sbjct: 109 EISVG----LFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTT 158
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE I Q + D +++GV+L E+L G+PP
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 17/172 (9%)
Query: 593 TEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSP 652
TE ++ RH + +L H + V E+ G L HL + ++++ + +
Sbjct: 44 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103
Query: 653 LTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712
+ L YLH+ + +++RD+K N++LD++ KI+DFGL + G
Sbjct: 104 IV------------SALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EG 146
Query: 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
+ G+ Y+ PE + D + GVV+ E++CGR P N
Sbjct: 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 555 IGSGGFGHVFK-GYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGF 612
IG G +G V+K DGS+ AVK L+ S E E ++ L H ++V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLA-AVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 613 ---CDEH--GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
D+ G++ LV E G++ + + Q ++ S + + GA
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY--------GALL 139
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
GL +LH + IIHRDVK NILL K+ DFG+S S + + S G+
Sbjct: 140 GLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPF 193
Query: 728 YVDPEYIRRQQLTEKS-----DVYSFGVVLLEVLCGRPPMIN 764
++ PE I +Q + S DV+S G+ +E+ G PP+ +
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+GSG +G V+K + G + AVK + + EI M+ E +H +IV+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELA-AVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
++ + E+ G+L+D +Y+ PL+ + + +GL YLH
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IYHV-----------TGPLSELQIAYVCRETLQGLAYLH 123
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ K +HRD+K NILL +N K++DFG++ + +++ G+ ++ PE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI---GTPYWMAPEV 177
Query: 734 IRRQQ---LTEKSDVYSFGVVLLEVLCGRPPMIN 764
++ + D+++ G+ +E+ +PPM +
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 68/264 (25%), Positives = 106/264 (40%), Gaps = 77/264 (29%)
Query: 548 DFADHCIIGSGGFGHV-FKGYIDDGSITVAVKRLNTSSM----QGAREFRTEIEMISELR 602
DF +IG G FG V D G I A+K+L S M Q A R E ++++E
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHI-YAMKKLRKSEMLEKEQVA-HVRAERDILAEAD 59
Query: 603 HLHIVSLL-GFCDEHGEMILVYEFMPRGNLRDHL--YNSQKQNQNQNQNQNSPLTWKRRL 659
+ +V L F DE+ + L+ E++P G++ L ++ + + +
Sbjct: 60 NPWVVKLYYSFQDEN-YLYLIMEYLPGGDMMTLLMKKDTFTEEETR-------------- 104
Query: 660 EISIG-AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV 718
I + +H K IHRD+K N+LLD K+SDFGL +G+ +SH
Sbjct: 105 -FYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLC----TGLKKSHR 156
Query: 719 -----------------------------------------STVVKGSFGYVDPEYIRRQ 737
STV G+ Y+ PE +
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQT 214
Query: 738 QLTEKSDVYSFGVVLLEVLCGRPP 761
++ D +S GV++ E+L G PP
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 35/169 (20%)
Query: 554 IIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHI 606
IG G FG VFK + I VA+K++ M+ +E R EI+++ L+H ++
Sbjct: 19 KIGQGTFGEVFKARHKKTKQI-VALKKV---LMENEKEGFPITALR-EIKILQLLKHENV 73
Query: 607 VSLLGFCDE--------HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRR 658
V+L+ C G LV+EF +H N+N + + K+
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKNV---KFTLSEIKKV 124
Query: 659 LEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
+++ + GL+Y+H ++ I+HRD+K+ NIL+ ++ K++DFGL+R
Sbjct: 125 MKMLLN---GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREF------RTEIEMISELRHLHIVS 608
IG G FG V++ D A+K L+ + +E R + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA-AR 667
L ++ LV ++M G L HL QK+ + R + I
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFSED----------RAKFYIAELVL 107
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
L +LH K+ I++RD+K NILLD + DFGLS+ + ++ + + G+
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTE 161
Query: 728 YVDPEYIRRQQ-LTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE + ++ T+ D +S GV++ E+ CG P
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QG---AREFRTEIEMISELRHLHIV 607
IIG GGFG V+ D A+K L+ + QG A R + ++S IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+ ++ + + M G+L HL +Q+ + K +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL------------SQHGVFSEKEMRFYATEIIL 108
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL----SRMGPSGMSQSHVSTVVK 723
GL ++H +++RD+K NILLDE+ +ISD GL S+ P H S
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HASV--- 156
Query: 724 GSFGYVDPEYIRRQQLTEKS-DVYSFGVVLLEVLCGRPP 761
G+ GY+ PE +++ + S D +S G +L ++L G P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 18/143 (12%)
Query: 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKH 678
+ V EF+ G+L H+ +K + + ++ EIS+ L++LH
Sbjct: 71 LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA--------EISLA----LNFLHERG-- 116
Query: 679 TIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ 738
II+RD+K N+LLD K++D+G M G+ ++ G+ Y+ PE +R +
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYG---MCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 739 LTEKSDVYSFGVVLLEVLCGRPP 761
D ++ GV++ E++ GR P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 27/216 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLL 610
+IG G FG V A+K L+ M + F E ++++ +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+ + +V E+MP G+L N N + P W + + A L
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDL-----------VNLMSNYDVPEKWAKFYTAEVVLA--LD 156
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVKGSFGYV 729
+H+ +IHRDVK N+LLD++ K++DFG +M +GM T V G+ Y+
Sbjct: 157 AIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM--VRCDTAV-GTPDYI 210
Query: 730 DPEYIRRQ----QLTEKSDVYSFGVVLLEVLCGRPP 761
PE ++ Q + D +S GV L E+L G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLN-TSSMQG--AREFRTEIEMISELRHLHIVSLL 610
IG G +G VFK + I VA+KR+ +G + R EI ++ EL+H +IV L
Sbjct: 8 IGEGTYGTVFKAKNRETHEI-VALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLY 65
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
++ LV+E+ + +L+ + + N + + ++ +L +GL
Sbjct: 66 DVLHSDKKLTLVFEYCDQ-DLKKYF-----DSCNGDIDPEIVKSFMFQL------LKGLA 113
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS-QSHVSTVVKGSFGYV 729
+ H+ H ++HRD+K N+L+++N K++DFGL+R G+ + + + VV + Y
Sbjct: 114 FCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVV--TLWYR 166
Query: 730 DPEYIRRQQLTEKS-DVYSFGVVLLEVLCGRPPMINGA 766
P+ + +L S D++S G + E+ P+ G
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQG--AREFRTEIEMISELRHLHIVSLL 610
IG G +G V+K VA+K RL T +G + R EI ++ EL H +IV LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIR-EISLLKELNHPNIVRLL 64
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
++ LV+EF+ +L+ ++ +S P K L + +G+
Sbjct: 65 DVVHSENKLYLVFEFLDL-DLKKYMDSSPLT-------GLDPPLIKSYLYQLL---QGIA 113
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
Y H+ H ++HRD+K N+L+D A K++DFGL+R
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 637 NSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696
S ++ + PL L S A+G+ +L A IHRDV + N+LL +
Sbjct: 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGR 249
Query: 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGS----FGYVDPEYIRRQQLTEKSDVYSFGVVL 752
AKI DFGL+R M+ S+ VVKG+ ++ PE I T +SDV+S+G++L
Sbjct: 250 VAKICDFGLAR---DIMNDSNY--VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304
Query: 753 LEVLC-GRPPMINGAVRKEEVSLV 775
E+ G+ P V + +V
Sbjct: 305 WEIFSLGKSPYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLL 610
++G G FG V A+K L + E TE ++ RH + +L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
H + V E+ G L HL + + + + + + L
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV------------SALE 109
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YLH+ +++RD+K N++LD++ KI+DFGL + G+S G+ Y+
Sbjct: 110 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLA 163
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
PE + D + GVV+ E++CGR P N
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 15/105 (14%)
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS------------QS 716
L YLH + I+HRD+K N+L+ K++DFGLS++G ++ +
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ V G+ Y+ PE I RQ + D ++ G++L E L G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLL- 610
+G+G FG V A+K L M+ + E ++ EL H IV+++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
F DE+ + + EF+ G L HL + + + + ++ L
Sbjct: 86 SFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL------------AFE 132
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YLH+ II+RD+K N+LLD K++DFG ++ P + + G+ Y+
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------TFTLCGTPEYLA 183
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE I+ + + D ++ GV+L E + G PP
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 10/102 (9%)
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
EI+IG L +LH+ II+RD+K N++LD KI+DFG+ + M +
Sbjct: 109 EIAIG----LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTT 158
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE I Q + D ++FGV+L E+L G+ P
Sbjct: 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
GL +LH+ I++RD+K NILLD + KI+DFG+ + G ++ + G+
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPD 161
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE + Q+ D +SFGV+L E+L G+ P
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG---AREFRTEIEMISELRHLHIVSLLG 611
IG G +G V+KG VA+K++ S + + R EI ++ EL+H +IV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQD 66
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+ + L++EF+ +L+ +L + K Q ++ L +I +G+ +
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPK-----GQYMDAELVKSYLYQI----LQGILF 116
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
H+ ++HRD+K N+L+D K++DFGL+R
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLLG 611
IGSG G V Y VA+K+L+ + R +R E+ ++ + H +I+ LL
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82
Query: 612 -FC-----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
F +E ++ LV E M D N Q L +R +
Sbjct: 83 VFTPQKSLEEFQDVYLVMELM------DA---------NLCQVIQMDLDHERMSYLLYQM 127
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM-GPSGMSQSHVSTVVKG 724
G+ +LH+ IIHRD+K +NI++ + KI DFGL+R G S M +V T
Sbjct: 128 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 182
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGR 759
Y PE I E D++S G ++ E++ G
Sbjct: 183 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 603 HLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
H +V L + V E++ G+L H+ +K + + ++ EIS
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------EIS 106
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
+ L+YLH + II+RD+K N+LLD K++D+G+ + G+ ++
Sbjct: 107 LA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTF 156
Query: 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762
G+ Y+ PE +R + D ++ GV++ E++ GR P
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 39/218 (17%)
Query: 555 IGSGGFGHVFKG-YIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELR-HLHIVSL 609
IG G F V K G A+K + S Q R EI+ + L H +I+ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKY-YAIKCMKKHFKSLEQ-VNNLR-EIQALRRLSPHPNILRL 63
Query: 610 LG--FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+ F + G + LV+E M NL + + + + PL KR +
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYELI-----------KGRKRPLPEKRVKSYMYQLLK 111
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
L ++H + I HRD+K NIL+ ++ K++DFG R G+ T +
Sbjct: 112 SLDHMHR---NGIFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTRW 163
Query: 728 YVDPEYIRRQQLTE-----KSDVYSFGVVLLEVLCGRP 760
Y PE + LT+ K D+++ G V E+L P
Sbjct: 164 YRAPECL----LTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L YLH+ +++RD+K N++LD++ KI+DFGL + G+S G+ Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
+ PE + D + GVV+ E++CGR P N
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 58/253 (22%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHL 604
DF +IG G FG V D A+K L + M + R E +++ E L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+V + + + L+ EF+P G++ L + + Q + ++
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY---------IAETVL 112
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK- 723
A +H L IHRD+K N+LLD K+SDFGL +G+ ++H + +
Sbjct: 113 AIDSIHQL------GFIHRDIKPDNLLLDSKGHVKLSDFGLC----TGLKKAHRTEFYRN 162
Query: 724 -----------------------------------GSFGYVDPEYIRRQQLTEKSDVYSF 748
G+ Y+ PE + + D +S
Sbjct: 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222
Query: 749 GVVLLEVLCGRPP 761
GV++ E+L G PP
Sbjct: 223 GVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612
IG G +G V+K + T+A+K RL EI ++ E++H +IV L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ LV+E++ +L+ H+ +S + +N ++ RG+ Y
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHMDSSP--DFAKNPRLIKTYLYQ--------ILRGIAYC 118
Query: 673 HAGAKHTIIHRDVKSTNILLDE-NWAAKISDFGLSR-MGPSGMSQSHVSTVVKGSFGYVD 730
H+ H ++HRD+K N+L+D A K++DFGL+R G + +H VV + Y
Sbjct: 119 HS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLWYRA 171
Query: 731 PE-YIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
PE + + + D++S G + E++ +P
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT--EIEMISELRHL---HIVSL 609
IG G +G V+K VA+K + + + T E+ ++ L +IV L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 610 LGFC-----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+ C D ++ LV+E + + +LR +L ++ P + L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL--------DKVPPPGLPAETIKDLMRQF- 117
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
RGL +LHA + I+HRD+K NIL+ K++DFGL+R+ M+ + V VV
Sbjct: 118 -LRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPV--VV-- 169
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+ Y PE + + D++S G + E+ +P
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QG---AREFRTEIEMISELRHLHIV 607
IIG GGFG V+ D A+K L+ + QG A R + ++S IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+ ++ + + M G+L HL +Q+ + E+ AA
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL------------SQHGVFSEA---EMRFYAAE 105
Query: 668 ---GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL----SRMGPSGMSQSHVST 720
GL ++H +++RD+K NILLDE+ +ISD GL S+ P H S
Sbjct: 106 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HASV 156
Query: 721 VVKGSFGYVDPEYIRRQQLTEKS-DVYSFGVVLLEVLCGRPP 761
G+ GY+ PE +++ + S D +S G +L ++L G P
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 59/249 (23%), Positives = 96/249 (38%), Gaps = 50/249 (20%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHL 604
DF +IG G FG V D A+K L + M + R E +++ E
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+V + + + L+ EF+P G++ L ++ Q + ++
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAE---------TVL 112
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG----------------LSRM 708
A +H L IHRD+K N+LLD K+SDFG L+
Sbjct: 113 AIDAIHQL------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 709 GPSGMSQSHVSTVVK----------------GSFGYVDPEYIRRQQLTEKSDVYSFGVVL 752
PS S ++++ K G+ Y+ PE + + D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 753 LEVLCGRPP 761
E+L G PP
Sbjct: 227 YEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 8e-09
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 11/95 (11%)
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
L+ LH KH IIH D+K N+L D + D+GL ++ G + T+
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSCYDGTLD---- 171
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y PE I+ D ++ GV+ E+L G+ P
Sbjct: 172 -YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 38/143 (26%), Positives = 73/143 (51%), Gaps = 18/143 (12%)
Query: 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKH 678
+ LV E++ G+L H+ +K + + + EI I L++LH +
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA--------EICIA----LNFLH---ER 115
Query: 679 TIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ 738
II+RD+K N+LLD + K++D+G+ + G+ ++ G+ Y+ PE +R ++
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 739 LTEKSDVYSFGVVLLEVLCGRPP 761
D ++ GV++ E++ GR P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 46/228 (20%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLG 611
IG G +G V + + VA+K++ + + R R EI+++ L H +++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 612 FC-----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
+ ++ +VYE M L+ + +Q L+
Sbjct: 72 IMPPPHREAFNDVYIVYELMD-----TDLHQIIRSSQ--------TLSDDHCQYFLYQLL 118
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
RGL Y+H+ ++HRD+K +N+LL+ N KI DFGL+R +T KG F
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR-----------TTSEKGDF 164
Query: 727 --GYVDPEYIRRQQL-------TEKSDVYSFGVVLLEVLCGRPPMING 765
YV + R +L T DV+S G + E+L GR P+ G
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLLG 611
IGSG G V Y VA+K+L+ + R +R E+ ++ + H +I+ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 612 F------CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+E ++ +V E M + N Q L +R +
Sbjct: 91 VFTPQKSLEEFQDVYIVMELM---------------DANLCQVIQMELDHERMSYLLYQM 135
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM-GPSGMSQSHVSTVVKG 724
G+ +LH+ IIHRD+K +NI++ + KI DFGL+R G S M +V T
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 190
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGR 759
Y PE I E D++S G ++ E++ G
Sbjct: 191 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 21/210 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLLG 611
IG G FG V + D A+K + + + E E +++++ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
++ LV F+ G L HL + + ++ + + L L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC------------ALEN 108
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH K +I+RD+K NILLD + DFGL ++ M + G+ Y+ P
Sbjct: 109 LH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLAP 162
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E + T+ D ++ GV+L E+L G PP
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 13/112 (11%)
Query: 648 NQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
++ PL + L I GL YLHA IIHRDVK+ NI +++ I D G ++
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
Query: 708 ---MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ P+ + + G+ PE + R + K+D++S G+VL E+L
Sbjct: 206 FPVVAPAFLG-------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLL 610
+IG G FG V A+K L+ M + F E ++++ +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA-RGL 669
+ + +V E+MP G+L N N + P W R + A +
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDL-----------VNLMSNYDVPEKWARFYTAEVVLALDAI 158
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVKGSFGY 728
H + IHRDVK N+LLD++ K++DFG +M GM + + G+ Y
Sbjct: 159 HSM------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---GTPDY 209
Query: 729 VDPEYIRRQ----QLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE ++ Q + D +S GV L E+L G P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISE-------LRHLHI 606
+IG G FG V AVK L ++ +E E ++SE ++H +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE---EKHIMSERNVLLKNVKHPFL 58
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V L ++ V +++ G L HL Q + L + R + A
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHL-----------QRERCFLEPRARF-YAAEIA 106
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
L YLH+ I++RD+K NILLD ++DFGL + + + ++ G+
Sbjct: 107 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTP 160
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE + +Q D + G VL E+L G PP
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 46/223 (20%)
Query: 555 IGSGGFGHVFKGYIDDGSIT-------VAVKRL-----NTSSMQGAREFRTEIEMISELR 602
IG G FG V+ S+T VA+K++ N S + R FR E++M+ +
Sbjct: 8 IGYGAFGVVW-------SVTDPRDGKRVALKKMPNVFQNLVSCK--RVFR-ELKMLCFFK 57
Query: 603 HLHIVSLL-----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
H +++S L D E+ +V E M + L+ Q PL+
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELM-----QSDLHKIIVSPQ--------PLSSDH 104
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
RGL YLH A I+HRD+K N+L++ N KI DFGL+R+ S+
Sbjct: 105 VKVFLYQILRGLKYLH-SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM 161
Query: 718 VSTVVKGSFGYVDPEYIR-RQQLTEKSDVYSFGVVLLEVLCGR 759
VV Y PE + + T D++S G + E+L R
Sbjct: 162 TQEVVTQY--YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 554 IIGSGGFGHVF---KGYIDDGSITVAVKRLNTSSM----QGAREFRTEIEMISELRHLHI 606
++G+G +G VF K D A+K L +++ + RTE ++ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 607 VSLLGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+ L + ++ L+ +++ G + HLY Q+ N ++++ + G
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDE-----------VRFYSGE 113
Query: 666 A-RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
L +LH K I++RD+K NILLD ++DFGLS+ S + S G
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC--G 168
Query: 725 SFGYVDPEYIRRQQLTEKS-DVYSFGVVLLEVLCGRPP 761
+ Y+ PE IR + K+ D +S G+++ E+L G P
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 554 IIGSGGFGHVF---KGYIDDGSITVAVKRLNTSSM----QGAREFRTEIEMISELRHLHI 606
++G+G +G VF K D A+K L +++ + RTE +++ +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 607 VSLLGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+ L + ++ L+ +++ G L HL SQ++ + + ++I G
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHL--SQRERFKEQE-----------VQIYSGE 113
Query: 666 -ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
L +LH K II+RD+K NILLD N ++DFGLS+ + S G
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCG 168
Query: 725 SFGYVDPEYIRRQQLTEKS--DVYSFGVVLLEVLCGRPP 761
+ Y+ P+ +R D +S GV++ E+L G P
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 26/224 (11%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHL 604
DF +IG G FG V + + A+K LN M E FR E +++ +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
I +L + + LV ++ G+L L + + ++ + + I+I
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-----LPEDMARFYLAEMVIAID 116
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVK 723
+ LHY +HRD+K NIL+D N +++DFG ++ G QS V+
Sbjct: 117 SVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--- 164
Query: 724 GSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPM 762
G+ Y+ PE ++ + + + D +S GV + E+L G P
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 34/214 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLLG 611
IGSG G V + I VAVK+L+ + R +R E+ ++ + H +I+SLL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 612 F------CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+E ++ LV E M + N Q + L +R +
Sbjct: 88 VFTPQKSLEEFQDVYLVMELM---------------DANLCQVIHMELDHERMSYLLYQM 132
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG-MSQSHVSTVVKG 724
G+ +LH+ IIHRD+K +NI++ + KI DFGL+R + M +V T
Sbjct: 133 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-- 187
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCG 758
Y PE I E D++S G ++ E++ G
Sbjct: 188 ---YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 13/210 (6%)
Query: 570 DGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629
D V K + + + A R+E+ ++ H IV +++L+ E+ G
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150
Query: 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTN 689
+L + K++ + + L ++ L L +H+ ++HRD+KS N
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVL--------ALDEVHS---RKMMHRDLKSAN 199
Query: 690 ILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFG 749
I L K+ DFG S+ +S V++ G+ Y+ PE R++ ++K+D++S G
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 750 VVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779
V+L E+L P G ++E + VL+ +
Sbjct: 259 VILYELLTLHRPF-KGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 43/225 (19%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLH 605
+ +GSG +G V VA+K+L+ S + R +R E+ ++ ++H +
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHEN 75
Query: 606 IVSLL----------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
++ LL F D + +++ Y + H + K Q
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFY--LVMPYMQTDLQKIMGHPLSEDKVQYLVYQ-------- 125
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ 715
GL Y+H+ IIHRD+K N+ ++E+ KI DFGL+R + M+
Sbjct: 126 ---------MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 173
Query: 716 SHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGR 759
V+ Y PE I + D++S G ++ E+L G+
Sbjct: 174 YVVTR------WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLLG 611
IGSG G V Y VA+K+L+ + R +R E+ ++ + H +I+SLL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 612 F------CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+E ++ LV E M + N Q L +R +
Sbjct: 84 VFTPQKSLEEFQDVYLVMELM---------------DANLCQVIQMELDHERMSYLLYQM 128
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM-GPSGMSQSHVSTVVKG 724
G+ +LH+ IIHRD+K +NI++ + KI DFGL+R G S M +V T
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 183
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
Y PE I E D++S G ++ E++
Sbjct: 184 ---YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNT--SSMQGAREFRTEIEMISELRHLHIVSL 609
+IG G +G V VA+K++N + A EI+++ LRH IV +
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 610 LGFC-----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
E ++ +V+E M + + +Q N LT +
Sbjct: 65 KHIMLPPSRREFKDIYVVFELM-------------ESDLHQVIKANDDLTPEHHQFFLYQ 111
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
R L Y+H + HRD+K NIL + + KI DFGL+R+ + + T
Sbjct: 112 LLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT---- 164
Query: 725 SFGYVDPEYIRRQQL--------TEKSDVYSFGVVLLEVLCGRP 760
YV + R +L T D++S G + EVL G+P
Sbjct: 165 --DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 68/268 (25%), Positives = 99/268 (36%), Gaps = 76/268 (28%)
Query: 548 DFADHCIIGSGGFGHV-FKGYIDDGSITVAVKRLNTSSM----QGAREFRTEIEMISELR 602
DF +IG G FG V D G I A+K L S M Q A + E ++++E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKI-YAMKTLLKSEMFKKDQLA-HVKAERDVLAESD 59
Query: 603 HLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
+VSL + + L+ EF+P G+L L +++ R ++
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT-----------RFYMA 108
Query: 663 --IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG----------- 709
+ A +H K IHRD+K NIL+D K+SDFGLS G
Sbjct: 109 ECVLAIEAVH------KLGFIHRDIKPDNILIDRGGHIKLSDFGLS-TGFHKQHDSAYYQ 161
Query: 710 ----------PSGMSQSHV--------------------------STVVKGSFGYVDPEY 733
S STV G+ Y+ PE
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV--GTPDYIAPEI 219
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+Q ++ D +S G ++ E L G PP
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 56/254 (22%), Positives = 96/254 (37%), Gaps = 60/254 (23%)
Query: 677 KHTIIHRDVKSTNILLDENWAAKISDFGL---------------------SRMGPSGM-- 713
K IHRD+K NIL+D + K++DFGL M PS +
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 714 ---------------------SQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVL 752
Q ++ + G+ Y+ PE + R+ T+ D +S GV+L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 753 LEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAG 812
E+L G+PP + + ++ ++ W V + P I +C
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVK--LSPEAVDLITKLC--------- 287
Query: 813 SCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSDQGRPFVPRGEVITSSTTTDSDEPFSR 872
C+ EE R D+ F ++ +++ Q P+VP+ I+ T + +P
Sbjct: 288 -CSAEERLGRNGADDIK-AHPFFSEVDFSSDIRTQPAPYVPK---ISHPMDTSNFDPVEE 342
Query: 873 SSGQVSESRSNTTS 886
S S +T +
Sbjct: 343 ESPWNDASGDSTRT 356
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 64/243 (26%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE------------FRT--EIEMIS 599
+G G +G V K Y G I VA+K++ + F T E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 600 ELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
E++H +I+ L+ E + LV + M +L+ + ++ LT +
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV------------DRKIRLTESQVK 122
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
I + GL+ LH K +HRD+ NI ++ KI+DFGL+R +
Sbjct: 123 CILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR--------RYGY 171
Query: 720 TVVKGSFGYVDPEYI-RRQQLTEK---------------------SDVYSFGVVLLEVLC 757
+ E + RR+++T K D++S G + E+L
Sbjct: 172 PPYSDT--LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
Query: 758 GRP 760
G+P
Sbjct: 230 GKP 232
|
Length = 335 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 36/107 (33%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
GL Y+H+ ++HRD+K N+L++ + KI DFGL+R G S++ G
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR----GFSENPG--ENAGFM 166
Query: 727 -GYVDPEYIRR-------QQLTEKSDVYSFGVVLLEVLCGRPPMING 765
YV + R Q T+ DV+S G +L E+L GR P+ G
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 12/102 (11%)
Query: 659 LEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV 718
L S A+G+ +L A IHRD+ + NILL KI DFGL+R ++
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDS 268
Query: 719 STVVKGS----FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ VVKG+ ++ PE I T +SDV+S+G++L E+
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 40/119 (33%), Positives = 61/119 (51%), Gaps = 14/119 (11%)
Query: 648 NQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
N++ L++ + S A G+ +L A +HRD+ + N+L+ E KI DFGL+R
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 708 MGPSGMSQSHVSTVVKGS----FGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
M S+ + KGS ++ PE I T SDV+SFG++L E+ L G P
Sbjct: 288 ---DIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 33/164 (20%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
I G +G V++ G I VA+K+L M+ +E R EI ++ +L+H +IV
Sbjct: 13 IEEGTYGVVYRARDKKTGEI-VALKKLK---MEKEKEGFPITSLR-EINILLKLQHPNIV 67
Query: 608 SL----LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
++ +G ++ +V E++ +L+ + + P + +
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEH-DLKSLM-----------ETMKQPFLQSEVKCLML 113
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
G+ +LH + I+HRD+K++N+LL+ KI DFGL+R
Sbjct: 114 QLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF- 612
IIG+G FG V++ D S VA+K++ +Q + E+ ++ L H++I+ L +
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 613 ---CDEHGE----MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
C + E + +V EF+P+ + + ++ N PL + +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR-------NNHALPLFLVKLYSYQL-- 179
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
R L Y+H+ I HRD+K N+L+D N K+ DFG ++ +G Q VS +
Sbjct: 180 CRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG--QRSVSYIC-- 232
Query: 725 SFGYVDPE-YIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
S Y PE + T D++S G ++ E++ G P
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLL 610
+G G + V+KG VA+K + +GA R E ++ +L+H +IV+L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+ LV+E++ +L+ ++ N L + L RGL
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYM----DDCGGGLSMHNVRLFLFQLL-------RGLA 117
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG--PSGMSQSHVST-------V 721
Y H + ++HRD+K N+L+ E K++DFGL+R PS + V T V
Sbjct: 118 YCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+ GS Y + D++ G + E+ GRP
Sbjct: 175 LLGSTEY-----------STSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGF- 612
IG G +G VFK AVK L+ E E ++ L H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 613 ----CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
++ LV E G++ D + K+ + + P+ I A G
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE----PII----AYILHEALMG 136
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L +LH + IHRDVK NILL K+ DFG+S S + + S G+ +
Sbjct: 137 LQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPFW 190
Query: 729 VDPEYIR-RQQL----TEKSDVYSFGVVLLEVLCGRPPM 762
+ PE I QQL + DV+S G+ +E+ G PP+
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVVK 723
A +H L +HRD+K N+LLD+N +++DFG R+ G QS+V+
Sbjct: 114 AIDSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--- 164
Query: 724 GSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE ++ + + + D +S GV + E+L G P
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT--EIEMISELRHLHIVSLLGF 612
+G G + V+KG VA+K ++ + +G F E ++ L+H +IV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ V+E+M L Q+ N L + L RGL Y+
Sbjct: 72 IHTKETLTFVFEYM-----HTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYI 119
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H I+HRD+K N+L+ K++DFGL+R S SQ++ S VV + Y P+
Sbjct: 120 H---GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV--TLWYRPPD 173
Query: 733 YIR-RQQLTEKSDVYSFGVVLLEVLCGRP 760
+ + D++ G + +E+L G+P
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQP 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHL 604
DF +IG G FG V + A+K LN M E FR E ++
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 605 HIVSL-LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
I +L F DE+ + LV ++ G+L L + + ++ + + ++I
Sbjct: 62 WITTLHYAFQDEN-YLYLVMDYYVGGDLLTLLSKFEDR-----LPEDMARFYIAEMVLAI 115
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVSTVV 722
+ LHY +HRD+K N+LLD N +++DFG +M G QS V+
Sbjct: 116 HSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-- 164
Query: 723 KGSFGYVDPEYIRRQQ-----LTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE ++ + + D +S GV + E+L G P
Sbjct: 165 -GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSIT-VAVKRLNTSSMQGAREFR---TEIEMISELRHLHIVSLL 610
+G+G FG V + VA+KR S + ++ +E ++++ + H V+L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG---AAR 667
G + + LV EF+ G L ++N +R +G AA+
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFL----RRN--------------KRFPNDVGCFYAAQ 139
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
+ I++RD+K N+LLD++ K++DFG ++ + + T+ G+
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-----VVDTRTYTLC-GTPE 193
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE + + +D ++ G+ + E+L G PP
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 17/138 (12%)
Query: 628 RGNLRDHLYNSQKQNQNQ-----NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIH 682
+ + D + + N ++ + + + LT L + ARG+ +L A +H
Sbjct: 204 QRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVH 260
Query: 683 RDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS----FGYVDPEYIRRQQ 738
RD+ + N+LL + KI DFGL+R M S+ V KGS ++ PE I
Sbjct: 261 RDLAARNVLLAQGKIVKICDFGLAR---DIMHDSNY--VSKGSTFLPVKWMAPESIFDNL 315
Query: 739 LTEKSDVYSFGVVLLEVL 756
T SDV+S+G++L E+
Sbjct: 316 YTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-06
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 22/159 (13%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLG 611
I G FG V+ G + S AVK + + M + + E + ++ + IV L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 612 FCDEHGEMILVYEFMPRGNLRD--HLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+ LV E++ G+++ H+Y + + K E A L
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE----------EMAVKYISE----VALAL 117
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708
YLH +H IIHRD+K N+L+ K++DFGLS++
Sbjct: 118 DYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 62/253 (24%), Positives = 101/253 (39%), Gaps = 47/253 (18%)
Query: 556 GSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR--EFRTEIEMISELRHLHIVSLLGFC 613
H+ K + ++ VAVK++N S + EI +L+H +I+ +
Sbjct: 11 EDLMIVHLAK-HKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI-----GAARG 668
E+ +V M G+ D L + E++I
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---------------ELAIAFILKDVLNA 113
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVKGS-- 725
L Y+H IHR VK+++ILL + +S S M G Q V K S
Sbjct: 114 LDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 726 -FGYVDPEYIRRQQL---TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEV--SLVLWAR 779
++ PE + +Q L EKSD+YS G+ E + NG V +++ + +L +
Sbjct: 171 NLPWLSPE-VLQQNLQGYNEKSDIYSVGITACE-------LANGHVPFKDMPATQMLLEK 222
Query: 780 VSRARGTVDQIVD 792
V RGTV ++D
Sbjct: 223 V---RGTVPCLLD 232
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 28/92 (30%), Positives = 54/92 (58%), Gaps = 7/92 (7%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGARE-FRTEIEMISEL-RHLHIV 607
+GSG FG V + ++ VAVK L +++ ++ +E++++S L HL+IV
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQ 639
+LLG C + G + ++ E+ G+L D+L+ ++
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 30/168 (17%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ------GAREFRTEIEMISELRHLHIV 607
IG G +G V+K + VA+K+ + RE + ++M+SE ++IV
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI-SLLQMLSE--SIYIV 64
Query: 608 SLLGFCDEHGE-------MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660
LL EH E + LV+E++ +L+ + ++ + PL K
Sbjct: 65 RLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGR-------PLPAKTIKS 114
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSR 707
+G+ + H KH ++HRD+K N+L+D + KI+D GL R
Sbjct: 115 FMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 35/236 (14%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITV-AVKRLNTSSMQGARE----FRTEIEMISELR 602
DF ++G G FG V + + + + A+K + S + A+E F E +++S
Sbjct: 2 DFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISN 59
Query: 603 HLHIVSLL-GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQ-NQNQNQNQNSPLTWKRRLE 660
I L F D+ + LV E+ P G+L L + Q +++ Q + L
Sbjct: 60 SPWIPQLQYAFQDKD-NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV------ 112
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVS 719
+H +H + +HRD+K N+L+D K++DFG + R+ + M S
Sbjct: 113 ------LAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV---NS 160
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKS------DVYSFGVVLLEVLCGRPPMINGAVRK 769
+ G+ Y+ PE + K D +S GV+ E++ GR P G K
Sbjct: 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 29/230 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT--EIEMISELRHLHIVSLLGF 612
+G G + V+KG VA+K + +G F E ++ L+H +IV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ LV+E+ ++ Q +++ P K L RGL Y+
Sbjct: 72 IHTKETLTLVFEY---------VHTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYI 119
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H + I+HRD+K N+L+ + K++DFGL+R S S ++ + VV + Y P+
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV--TLWYRPPD 173
Query: 733 YIRRQQLTEKS---DVYSFGVVLLEVLCGR---PPMINGAVRKEEVSLVL 776
+ TE S D++ G + +E++ G P M + + E + LVL
Sbjct: 174 VLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 35/145 (24%), Positives = 59/145 (40%), Gaps = 44/145 (30%)
Query: 677 KHTIIHRDVKSTNILLDENWAAKISDFGL------------------------------- 705
K IHRD+K NIL+D + K++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 706 --------SRMGP-----SGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVL 752
R+ P + Q ++ + G+ Y+ PE + R T+ D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 753 LEVLCGRPPMINGAVRKEEVSLVLW 777
E+L G+PP + + ++ ++ W
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 35/121 (28%), Positives = 50/121 (41%), Gaps = 40/121 (33%)
Query: 681 IHRDVKSTNILLDENWAAKISDFGL---------SR------------MGPSGMSQSHVS 719
IHRD+K NIL+D + K++DFGL S+ M PS
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 720 TVVK-------------------GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+K G+ Y+ PE + R T+ D +S GV+L E+L G+P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 761 P 761
P
Sbjct: 243 P 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 33/118 (27%), Positives = 49/118 (41%), Gaps = 16/118 (13%)
Query: 651 SPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710
PL ++ + I L YLH IIHRDVK+ NI LDE A + DFG +
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA---- 232
Query: 711 SGMSQSHVSTVVKGSFGYV------DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762
+ +G+ PE + K+D++S G+VL E+ +
Sbjct: 233 ---CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 21/196 (10%)
Query: 573 ITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632
+TV + L + + + + E+ + RH +I++ + ++ FM G+
Sbjct: 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 633 DHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL 692
L + ++ N I GA RGL+YLH ++ IHR++K+++IL+
Sbjct: 88 SLLKTYFPEGMSEALIGN----------ILFGALRGLNYLH---QNGYIHRNIKASHILI 134
Query: 693 DENWAAKISD----FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL---TEKSDV 745
+ +S + L R G ++ PE +R Q L KSD+
Sbjct: 135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR-QDLYGYNVKSDI 193
Query: 746 YSFGVVLLEVLCGRPP 761
YS G+ E+ GR P
Sbjct: 194 YSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 39/203 (19%)
Query: 566 GYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625
GY + I V +K L+ S + F M+ ++ H HIV L G C E I+V EF
Sbjct: 26 GYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEF 85
Query: 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDV 685
+ G L ++ ++ LT + +++ A L YL ++H +V
Sbjct: 86 VEFGPLDLFMH-----------RKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNV 131
Query: 686 KSTNILL-----DENWAA--KISDFG-----LSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ NILL D K+SD G LSR Q V + ++ PE
Sbjct: 132 CTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECVERI-----PWIAPEC 179
Query: 734 IR-RQQLTEKSDVYSFGVVLLEV 755
+ + L+ +D +SFG L E+
Sbjct: 180 VEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 30/120 (25%), Positives = 43/120 (35%), Gaps = 19/120 (15%)
Query: 37 IICGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEE 96
I CG T SDG ++ D + S S T+ +S + Y T R P
Sbjct: 5 INCG-GPEHTDSDGITYEADTYFT-GGSADYYVSDTNGSSSIAGTTDPELYQTERYSPSS 62
Query: 97 FTYTFPVSP-GPKFLRLHF---YPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLRNF 152
F+Y P G + LHF Y LG++ F V +L++F
Sbjct: 63 FSYYIPCLENGNYTVILHFAEIYFGEDGLGRRV-------------FDVYVQGKLVLKDF 109
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 18/167 (10%)
Query: 593 TEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSP 652
TE ++ + H I+ L G + L+ +PR + Y + K+N
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN---------- 178
Query: 653 LTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712
+ L I R + YLH ++ IIHRD+K+ NI ++ + DFG + P
Sbjct: 179 IAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVD 234
Query: 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGR 759
++ + G+ PE + R D++S G+VL E+
Sbjct: 235 INANKYYGWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-05
Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 7/89 (7%)
Query: 554 IIGSGGFGHVFKG-----YIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISEL-RHLHI 606
+G+G FG V + + D ++TVAVK L S+ RE +E++++S L H++I
Sbjct: 42 TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI 101
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHL 635
V+LLG C G +++ E+ G+L + L
Sbjct: 102 VNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGARE-FRTEIEMISEL-RHLHI 606
+G+G FG V + +D + VAVK L S+ RE +E++++S L +H +I
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHL 635
V+LLG C G ++++ E+ G+L + L
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 33/115 (28%), Positives = 64/115 (55%), Gaps = 12/115 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGS-----ITVAVKRLNTSSMQGARE-FRTEIEMISEL-RHLHI 606
I+GSG FG V +G S + VAVK L ++ ++ +E+++++ L HL+I
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661
V+LLG C + G + ++ E+ G+L ++L+ ++ +++ P K+ L+I
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRH-----PEKPKKDLDI 153
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 29/189 (15%)
Query: 575 VAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDH 634
V +K L+ S A F ++S++ H+H+ + G C E I+V EF+ G L D
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DV 105
Query: 635 LYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE 694
+K P+ WK + ++ A L YL ++H +V + NILL
Sbjct: 106 CLRKEK--------GRVPVAWK--ITVAQQLASALSYLE---DKNLVHGNVCAKNILLAR 152
Query: 695 NWAA-------KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVY 746
A K+SD G+S S + V + ++ PE + L+ +D +
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTALS--REERVERI-----PWIAPECVPGGNSLSTAADKW 205
Query: 747 SFGVVLLEV 755
SFG LLE+
Sbjct: 206 SFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 5e-04
Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 53/241 (21%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN------TSSMQGARE-----FRTEIEMISELRH 603
IG+G FG VF V KR S +G +E E+ ++ EL+H
Sbjct: 21 IGNGRFGEVF---------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 604 LHIVSLLG-FCDEHGE-MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661
+IV + F ++ + + ++ EF G+L ++ K ++ +T R+L
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT--RQL-- 127
Query: 662 SIGAARGLHYLHAGAK-HTIIHRDVKSTNILLDENW-----------------AAKISDF 703
+ A H L G ++HRD+K NI L AKI DF
Sbjct: 128 -LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 704 GLSR-MGPSGMSQSHVSTVVKGSFGYVDPEYI--RRQQLTEKSDVYSFGVVLLEVLCGRP 760
GLS+ +G M+ S V T Y PE + + +KSD+++ G ++ E+ G+
Sbjct: 187 GLSKNIGIESMAHSCVGTPY-----YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 761 P 761
P
Sbjct: 242 P 242
|
Length = 1021 |
| >gnl|CDD|222648 pfam14283, DUF4366, Domain of unknown function (DUF4366) | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 17/59 (28%), Positives = 30/59 (50%), Gaps = 9/59 (15%)
Query: 436 AGPNPASKPPPEPKPGKQQNVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRV 494
GP P +P PE +P K K+ G ++L++ +A + G + YF F + K++
Sbjct: 138 TGPEPEPEPEPEEEPEK----KSGMGPLLLVLAVALIGGGAYY-----YFKFYKPKQQE 187
|
This family of proteins is found in bacteria and eukaryotes. Proteins in this family are typically between 227 and 387 amino acids in length. Length = 213 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 32/126 (25%), Positives = 51/126 (40%), Gaps = 12/126 (9%)
Query: 647 QNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706
++ PL + R I + Y+H +IHRD+K NI L+ + + DFG +
Sbjct: 259 DWKDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 707 RMGPS---GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMI 763
V TV S PE + E +D++S G++LL++L I
Sbjct: 315 MPFEKEREAFDYGWVGTVATNS-----PEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369
Query: 764 NGAVRK 769
K
Sbjct: 370 GDGGGK 375
|
Length = 501 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 24/165 (14%)
Query: 554 IIGSGGFGHVFK-----GYIDDGSITVAVKRLNTSSMQGAREFRT---EIEMISELRHLH 605
+IG GGFG V++ + + ++ L ++ +I+ I+ +++H
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 606 IVSLLGF-----CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660
+ LG C + Y F+ L + L + K+ + + +N L
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLI----KN 130
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705
I L Y+H +H I H D+K NI++D N I D+G+
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 911 | |||
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.28 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.11 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.09 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.05 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.25 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.13 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.1 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.88 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.8 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.61 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.57 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.43 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.38 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.28 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.17 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.01 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.11 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.88 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.77 | |
| PLN02236 | 344 | choline kinase | 95.72 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.65 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.54 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.43 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.94 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.48 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.37 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.27 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.55 |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-59 Score=517.62 Aligned_cols=329 Identities=39% Similarity=0.587 Sum_probs=259.3
Q ss_pred EecCCCC----CccCCCCCeecCCCCC-cccCCCCCcccccccccccCCCCCCCCccceeeeccC--cceEeeeC--CCC
Q 002533 37 IICGESS----NTTSSDGRNWDGDAHS-KFSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEE--FTYTFPVS--PGP 107 (911)
Q Consensus 37 i~cG~~~----~~~~~~~~~~~~D~~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~--~~Y~~~~~--~g~ 107 (911)
||||++. +.++.+||+|++|..| ++|.++.++... .........+|+|||+||+| +||+||+. +|.
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~-----~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~ 75 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQP-----DSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGG 75 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCcccccccc-----CCcCCccccccceEEEcCCCCccEEEeeccCCCCc
Confidence 8999853 4455789999999999 888877773111 11234556779999999966 99999996 566
Q ss_pred eEE-EEeecCCccccccccCCCCCcc-----ccccceEEEEeCceEEeeccCccccccccCCCccceEEEEEEecCCCCe
Q 002533 108 KFL-RLHFYPAPYLLGQQQGGLDNND-----TISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQM 181 (911)
Q Consensus 108 ~~l-R~~f~~~~~~~~~~~g~~d~~~-----~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~i~~~~~~~ 181 (911)
||| ||||+ |||||+++ .++.||+++++|.|.+|+..+ .. .+++++||+|+++++++
T Consensus 76 ~yliRl~F~---------~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~-~~--------~~~~~~E~ii~v~~~~~ 137 (347)
T PF12819_consen 76 KYLIRLHFY---------YGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSN-SP--------SSPVVKEFIINVTWSDT 137 (347)
T ss_pred eEEEEEEec---------cccccccccccccCCcceEEEECCceeEEEEecC-CC--------cceEEEEEEEEEcCCCc
Confidence 888 99999 99999873 257799999999999998765 21 25789999999998899
Q ss_pred EEEEEecCCCCcceeeeeeEeEecCCceeeecCCCCCCccccCCCcccccCccceEEEEEEeecCCCc-ccCCCCCcccc
Q 002533 182 LNLTFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAH-VSAKDDTGMFR 260 (911)
Q Consensus 182 ~~v~~~~~~~~~~~fi~~iE~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~al~~~~R~n~Gg~~-~~~~~dd~~~R 260 (911)
+.|||+|+..+.+||||||||||||+++|+... .....||++++|+||||.. ..||+||.+||
T Consensus 138 l~vclv~~~~g~~pFIsaiEl~~lp~~ly~~~~----------------~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR 201 (347)
T PF12819_consen 138 LSVCLVPTGSGTFPFISAIELRPLPDSLYPDTD----------------ANSSQALETVYRLNVGGSSSFIRYPDDTYDR 201 (347)
T ss_pred EEEEEEeCCCCCCCceeEEEEEECCccceeccc----------------cCCCceeEEEEeecCCCcccccCCCCCccee
Confidence 999999776555699999999999999996431 1345679999999999886 56999999999
Q ss_pred ccccCC-CceeccCCCCccCCCCCceeecCCCCCccChhHHHHhhhccCCCCCCccceeeeEEeecCCCCceEEEEeeee
Q 002533 261 EWLDDT-NYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCE 339 (911)
Q Consensus 261 ~W~~d~-~~~~~~~s~~~~~~~~~~i~~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~~lt~~~~~~~~~~y~v~lhFae 339 (911)
+|.+.. ...|...++.. +++.....+.|.||..||+||++|.... .++||+|.+ +++++.|+|+|||||
T Consensus 202 ~W~~~~~~~~~~~ist~~------~i~~~~~~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaE 271 (347)
T PF12819_consen 202 IWQPYSSSPGWSNISTTS------NININSSNNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAE 271 (347)
T ss_pred eccccccCccccccccce------eeecccCCccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEee
Confidence 999753 44455444433 4442333556899999999999987663 238899999 999999999999999
Q ss_pred eeeeccccCcEEEEEEEcCeeccccccchh-ccCCCCccEEEEEEEEeecccccccccceEEEEeccCCCCCCCCcchhc
Q 002533 340 TQLEITRENQRVFSIFINNQTAENDADVIH-WSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADA 418 (911)
Q Consensus 340 ~~~~~~~~~~R~F~i~ing~~~~~~~~i~~-~~~~~~~p~~~~~~v~~~~~~~~~~~~~~l~~~~~p~~~~~~~~~~~~a 418 (911)
|+......++|+|||||||+.+.. ++.. ..+....|++++|.+.++.. ..++++|+|... . ..++
T Consensus 272 i~~~~~~~~~R~F~IyiN~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~-------~~~~isL~~t~~----S-~lpp 337 (347)
T PF12819_consen 272 IQSLSPNNNQREFDIYINGQTAYS--DVSPPYLGADTVPYYSDYVVNVPDS-------GFLNISLGPTPD----S-TLPP 337 (347)
T ss_pred cccccCCCCeEEEEEEECCeEccC--ccCcccccCcceEeecceEEEecCC-------CEEEEEEEeCCC----C-CcCc
Confidence 997434566899999999999996 6655 34556789999999977655 366888888554 2 3489
Q ss_pred ccccceeeEe
Q 002533 419 ILNGLEIFKL 428 (911)
Q Consensus 419 ~ln~~el~~l 428 (911)
+|||+|+|++
T Consensus 338 iLNalEIy~v 347 (347)
T PF12819_consen 338 ILNALEIYKV 347 (347)
T ss_pred eeEeeeeEeC
Confidence 9999999975
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=522.79 Aligned_cols=330 Identities=25% Similarity=0.329 Sum_probs=260.4
Q ss_pred CceEEEecCCCCCc-cCCCCCeecCCCCCcccCCCCCcccccccccccCCCCCCCCccceeeecc----CcceEeeeCCC
Q 002533 32 TDYILIICGESSNT-TSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQENSVPQVPYMTARVFPE----EFTYTFPVSPG 106 (911)
Q Consensus 32 ~~~~~i~cG~~~~~-~~~~~~~~~~D~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~----~~~Y~~~~~~g 106 (911)
.++|+||||++.+. +|.+||+|++|..|..|...... .+.....+|+|||+||. .|||+||+.++
T Consensus 23 ~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~~~~~~~~----------~~~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~ 92 (623)
T PLN03150 23 PFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANAT----------RPSFIAPPLKTLRYFPLSDGPENCYNINRVPK 92 (623)
T ss_pred CccEEEeCCCCCCcccCCCCCEEcCCcccccCcccccc----------CcccccchhhccccCCcccccccceEeeecCC
Confidence 48999999997554 56789999999877544333222 12344566999999996 39999999665
Q ss_pred CeEE-EEeecCCccccccccCCCCCccccccceEEEEeCceEEeec-cCccccccccCCCccceEEEEEEecCCCCeEEE
Q 002533 107 PKFL-RLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLRN-FSAHLTVSAIIPPVAYFFKEFIISVSSSQMLNL 184 (911)
Q Consensus 107 ~~~l-R~~f~~~~~~~~~~~g~~d~~~~~~~~~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~~v 184 (911)
.+|| |+||+ |||||+.++.+.||+++++|.|.+|.. |+. +.+++|+|+++.+.. +.++|
T Consensus 93 g~ylVRl~F~---------~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~---------~~~~v~~E~i~~~~~-~~l~v 153 (623)
T PLN03150 93 GHYSVRVFFG---------LVAEPNFDSEPLFDVSVEGTQISSLKSGWSS---------HDEQVFAEALVFLTD-GSASI 153 (623)
T ss_pred CcEEEEEEee---------cCCcCCCCCCCceEEEECcEEEEEEecCccc---------CCCcEEEEEEEEecC-CcEEE
Confidence 5666 99999 999999988999999999999999974 332 135689999988865 78999
Q ss_pred EEecCCCCcceeeeeeEeEecCCceeeecCCCCCCccccCCCcccccCccceEEEEEEeecCCCcc---cCCCCCcc--c
Q 002533 185 TFSPSSSSSYAFINGIEVVSMPDNLYLQQSDGDRSIPFINSNTIFSFDKPVALETAYRLNVGGAHV---SAKDDTGM--F 259 (911)
Q Consensus 185 ~~~~~~~~~~~fi~~iE~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~al~~~~R~n~Gg~~~---~~~~dd~~--~ 259 (911)
||+|+ ++++||||+||||+||+.+|..... .....+|++++|+||||.++ .+|+||++ |
T Consensus 154 cf~~~-~~~~pFIs~iEv~~l~~~~y~~~~~---------------~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~d 217 (623)
T PLN03150 154 CFHST-GHGDPAILSIEILQVDDKAYNFGPS---------------WGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGD 217 (623)
T ss_pred EEecC-CCCCCceeEEEEEEcCccccccccc---------------ccCceEEEEEEEEEecCcccccccCCCCCcccCc
Confidence 99964 5789999999999999999964310 01245699999999999865 49999999 9
Q ss_pred cccccCCCceeccCCCCccCCCCCceeecCCCCCccChhHHHHhhhccCCCCCCccceeeeEEeecCCCCceEEEEeeee
Q 002533 260 REWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCE 339 (911)
Q Consensus 260 R~W~~d~~~~~~~~s~~~~~~~~~~i~~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~~lt~~~~~~~~~~y~v~lhFae 339 (911)
|+|.+|+.|.-+ ......+...|++.++ +.+.+|+.||||||++... ..+++|.|+++++..|+|+|||||
T Consensus 218 R~W~~d~~~~~~---~~~~~st~~~I~~~~~-~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaE 288 (623)
T PLN03150 218 RFWNRMQTFGSG---SDQAISTENVIKKASN-APNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAE 288 (623)
T ss_pred cccCcCcccCCC---cccccccccccccccC-CCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEe
Confidence 999999886521 1122223336776643 4578899999999986542 247999999999889999999999
Q ss_pred eeeeccccCcEEEEEEEcCeeccccccchhccCCCCccEEEEEEEEeecccccccccceEEEEeccCCCCCCCCcchhcc
Q 002533 340 TQLEITRENQRVFSIFINNQTAENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLDPLPKYADAI 419 (911)
Q Consensus 340 ~~~~~~~~~~R~F~i~ing~~~~~~~~i~~~~~~~~~p~~~~~~v~~~~~~~~~~~~~~l~~~~~p~~~~~~~~~~~~a~ 419 (911)
++......++|+|||||||+.+..++||.+.+++...|++.+|.+.+. .+.|+++++|... .+|+
T Consensus 289 i~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~--------~g~l~isl~p~~~-------s~pi 353 (623)
T PLN03150 289 IDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVS--------GRTLTIVLQPKKG-------THAI 353 (623)
T ss_pred ccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeec--------CCeEEEEEeeCCC-------Ccce
Confidence 985345678999999999999999999999888888899999988543 2468889888432 2489
Q ss_pred cccceeeEeeC
Q 002533 420 LNGLEIFKLNN 430 (911)
Q Consensus 420 ln~~el~~l~~ 430 (911)
+||+|+|++..
T Consensus 354 lNaiEI~~~~~ 364 (623)
T PLN03150 354 INAIEVFEIIT 364 (623)
T ss_pred eeeeeeeeccc
Confidence 99999999874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-55 Score=486.50 Aligned_cols=291 Identities=51% Similarity=0.873 Sum_probs=255.4
Q ss_pred ccCcCCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecce
Q 002533 533 LCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612 (911)
Q Consensus 533 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~ 612 (911)
..+.|++.||+.||++|+..++||+|+||.||+|.+.++ ..||||++.....+..++|.+|+++|.+++|||||+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 467899999999999999999999999999999999987 6899999877654314569999999999999999999999
Q ss_pred eccCC-ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCee
Q 002533 613 CDEHG-EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNIL 691 (911)
Q Consensus 613 ~~~~~-~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 691 (911)
|.+.+ +.+||||||++|+|.++|+.... . +|+|.+|++||.++|+||+|||+.+.++|||||||++|||
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~---------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKG---------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCC---------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 99988 59999999999999999976421 1 7999999999999999999999988889999999999999
Q ss_pred ecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhh
Q 002533 692 LDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771 (911)
Q Consensus 692 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~ 771 (911)
||+++++||+|||||+..+.. ..+..+...||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+... ...+
T Consensus 210 LD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~ 286 (361)
T KOG1187|consen 210 LDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGE 286 (361)
T ss_pred ECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-Cccc
Confidence 999999999999999875541 1121111179999999999999999999999999999999999998886544 3455
Q ss_pred hhHhhHHhhhcccCCcccccCcccc-CCCCh-HHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 772 VSLVLWARVSRARGTVDQIVDPRLR-GKIAP-VCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
..++.|++....++.+.+++|+++. +..+. .+..++.+++.+|++.+|.+||+|.||+++|+.+..
T Consensus 287 ~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred ccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 5699999998888899999999997 56554 688899999999999999999999999999965443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=415.54 Aligned_cols=254 Identities=37% Similarity=0.583 Sum_probs=214.4
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccCC-ceEEEEeecCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEHG-EMILVYEFMPR 628 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~~ 628 (911)
.+.||+|+||+||+|.+.+.. .||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 446999999999999998873 499999976432 22568999999999999999999999999887 79999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCc-EEEecccCCCeeecCCC-ceEEeecCCc
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHT-IIHRDVKSTNILLDENW-AAKISDFGLS 706 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DFGla 706 (911)
|+|.++|+.. ....++|..++++|.|||+||+||| +.+ |||||||++||||+.++ ++||+|||++
T Consensus 125 GsL~~~l~~~----------~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 125 GSLSVLLHKK----------RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CcHHHHHhhc----------ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 9999999753 2456999999999999999999999 566 99999999999999997 9999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhc--ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIR--RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+...... ...+...||..|||||++. ...|+.|+|||||||+||||+||+.||..... . ..
T Consensus 192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~---~~---------- 254 (362)
T KOG0192|consen 192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V---QV---------- 254 (362)
T ss_pred eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H---HH----------
Confidence 8643221 2334468999999999999 66999999999999999999999999965442 1 11
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhh
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 838 (911)
...++....|..++..|+..+..++.+||+.||.+||++.+++..|+.+...
T Consensus 255 --~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 255 --ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred --HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1123334456666777899999999999999999999999999999987653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=411.94 Aligned_cols=261 Identities=32% Similarity=0.493 Sum_probs=222.6
Q ss_pred cCCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceecc
Q 002533 536 RFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDE 615 (911)
Q Consensus 536 ~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~ 615 (911)
.+..++|+. .+.||+|.||.||+|.+++. ..||+|.++... ...++|.+|+++|++|+|+|||+++|+|..
T Consensus 202 ei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 202 EIPREELKL-------IRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred eecHHHHHH-------HHHhcCCccceEEEEEEcCC-CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 445555554 45799999999999999887 479999998764 345789999999999999999999999999
Q ss_pred CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 616 HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 616 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
++.++||||||+.|+|.++|... ....+...+.+.++.|||+||+||+ ++++|||||.++||||+++
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~----------~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTR----------EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDED 339 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhc----------CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccC
Confidence 88999999999999999999652 3456888999999999999999999 7999999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhH
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSL 774 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l 774 (911)
..+||+||||||...+ .....+....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......
T Consensus 340 ~~vKIsDFGLAr~~~d--~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ 411 (468)
T KOG0197|consen 340 LVVKISDFGLARLIGD--DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------ 411 (468)
T ss_pred ceEEEcccccccccCC--CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------
Confidence 9999999999995332 22333344456778999999999999999999999999999999 88887554311
Q ss_pred hhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 775 VLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 775 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.+.+.++...|...|..|+..+.+||..||+.+|++|||+..+.+.|+.+..
T Consensus 412 -----------ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 412 -----------EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -----------HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1335567788888999999999999999999999999999999988876543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=413.57 Aligned_cols=262 Identities=26% Similarity=0.446 Sum_probs=225.0
Q ss_pred CccceeecccCcEEEEEEEeecC---CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~---~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
..++++||.|.||.|++|+++-. ...||||.|+... ....++|+.|..+|.++.||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 34678999999999999999633 3689999999764 4556789999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
||+||+|+.||+.. ...++|.+++.+..+||.||.||- ++++|||||.++|||++.+..+|++|||
T Consensus 711 yMENGsLDsFLR~~-----------DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN-----------DGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred hhhCCcHHHHHhhc-----------CCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEecccc
Confidence 99999999999654 345999999999999999999998 8999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+|.+.++......+..-+-..+|.|||.+...++|.+||||||||+|||+++ |.+||.+... ++
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-Qd------------- 842 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QD------------- 842 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HH-------------
Confidence 99987655433322233344578999999999999999999999999999998 9999976541 11
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhhHh
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEA 841 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~~ 841 (911)
+-.-++..+|.+-|.+|+..|.+||++||+.|-.+||.+.||+..|.+.++-+..
T Consensus 843 ---VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 843 ---VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred ---HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 1223456677788899999999999999999999999999999999998775443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=425.82 Aligned_cols=265 Identities=32% Similarity=0.497 Sum_probs=217.8
Q ss_pred ceeecccCcEEEEEEEeec-----CCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 552 HCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
.+.||+|+||+||+|+..+ ..+.||||.++..... ...+|++|+++|..|+|||||+|+|+|.+++.++||+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 5579999999999998743 3468999999877555 778999999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccc--cCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 626 MPRGNLRDHLYNSQKQNQNQN--QNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~--~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
|.+|+|.+||........... .....+|+..+.+.||.|||.||+||- ++.+|||||..+|+||.++..|||+||
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEeccc
Confidence 999999999976543322110 011456999999999999999999998 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
||+|......- ......-.-.++|||||.+..++||.+||||||||+|||+++ |+.|+.+.. ..+..
T Consensus 648 GLsRdiYssDY-Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-n~EVI---------- 715 (774)
T KOG1026|consen 648 GLSRDIYSSDY-YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-NQEVI---------- 715 (774)
T ss_pred ccchhhhhhhh-hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-hHHHH----------
Confidence 99986432211 111122234679999999999999999999999999999999 999986544 22222
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
..+-+..+ ...+..|+..+++||..||+.+|++||+++||...|+...+
T Consensus 716 -----e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 -----ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -----HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 12222333 56788999999999999999999999999999999986544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=376.06 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=215.9
Q ss_pred cCcCCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccC-CChhhHHHHHHHHHHHHhcccccEeeecce
Q 002533 534 CRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNT-SSMQGAREFRTEIEMISELRHLHIVSLLGF 612 (911)
Q Consensus 534 ~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~-~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~ 612 (911)
...+++.||+. .+.||+|..|+|||+.++.+++.+|+|++.. ......+++.+|++++++.+||+||.++|.
T Consensus 73 ~~~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~yga 145 (364)
T KOG0581|consen 73 DNGISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGA 145 (364)
T ss_pred ccccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEE
Confidence 34577778776 5689999999999999999999999999853 355667889999999999999999999999
Q ss_pred eccCC-ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCee
Q 002533 613 CDEHG-EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNIL 691 (911)
Q Consensus 613 ~~~~~-~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 691 (911)
|...+ +..|+||||.+|+|++++... +.+++...-+|+.++++||.|||+ +++||||||||+|||
T Consensus 146 F~~~~~~isI~mEYMDgGSLd~~~k~~------------g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlL 211 (364)
T KOG0581|consen 146 FYSNGEEISICMEYMDGGSLDDILKRV------------GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLL 211 (364)
T ss_pred EEeCCceEEeehhhcCCCCHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHee
Confidence 99888 599999999999999999532 458899999999999999999995 489999999999999
Q ss_pred ecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-chh
Q 002533 692 LDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAV-RKE 770 (911)
Q Consensus 692 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~-~~~ 770 (911)
++.+|++||||||.++..... ......||..|||||.+.+..|+.++||||||++++|+.+|+.|+..... ...
T Consensus 212 vNskGeVKicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~ 286 (364)
T KOG0581|consen 212 VNSKGEVKICDFGVSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD 286 (364)
T ss_pred eccCCCEEeccccccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC
Confidence 999999999999999865433 44566799999999999999999999999999999999999999865311 011
Q ss_pred hhhHhhHHhhhcccCCcccccCccccCCCCh-HHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 771 EVSLVLWARVSRARGTVDQIVDPRLRGKIAP-VCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
...+ +..+++..- ...+. .+..++..++..||+.||.+||++.|++++
T Consensus 287 ~~~L------------l~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 287 IFEL------------LCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHH------------HHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 122333111 22233 478889999999999999999999999876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.00 Aligned_cols=200 Identities=33% Similarity=0.511 Sum_probs=179.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.+|...+.||+|.||+||+|+++..+..||||.+... .....+.+..|+.+|++|+|||||+|++++..++.++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 3566666799999999999999988899999999776 55666778999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC------Cce
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN------WAA 698 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~------~~~ 698 (911)
||.+|+|.+||+.. +.+++.....++.|||.||++|| +++||||||||.||||+.. -.+
T Consensus 90 yC~gGDLs~yi~~~------------~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR------------GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred eCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceE
Confidence 99999999999644 35899999999999999999999 7999999999999999764 568
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
||+|||+||.+..+ ......+|++.|||||++..++|+.|+|+||.|++|||+++|+.||...
T Consensus 155 KIADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 155 KIADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred EecccchhhhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999999986533 3445678999999999999999999999999999999999999999643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=409.01 Aligned_cols=265 Identities=29% Similarity=0.455 Sum_probs=216.0
Q ss_pred CccceeecccCcEEEEEEEeecC-----CeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDG-----SITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~-----~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
....+.||+|.||.||+|...+- ...||||.+++. +.+...+|++|..+|++++|||||+++|+|.+....+|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 34466899999999999998643 346999999765 567788999999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
+|||++|+|..+|++.+... .+...|+..+++.+|.|||+|++||+ ++++|||||.++||||++...+||+|
T Consensus 774 leyM~gGDL~sflr~~r~~~-----~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAP-----FQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred ehhcccCcHHHHHHhccccc-----CCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence 99999999999997664322 13557999999999999999999999 79999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
|||||....... ........-..+|||||.++.+.++.|+|||||||+|||++| |..||.+.. .. .+..
T Consensus 846 FGlArDiy~~~y-yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-n~---~v~~----- 915 (1025)
T KOG1095|consen 846 FGLARDIYDKDY-YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-NF---EVLL----- 915 (1025)
T ss_pred cchhHhhhhchh-eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-hH---HHHH-----
Confidence 999994322111 111111234568999999999999999999999999999999 888885433 11 1111
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhh
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 839 (911)
.++... |.+.+..|++.+.+||.+||+.+|++||++..|++.++.+.+..
T Consensus 916 -------~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 916 -------DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred -------HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 011112 45567889999999999999999999999999999888776543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=352.17 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=208.8
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecc-eeccCCc-eEEEEe
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLG-FCDEHGE-MILVYE 624 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g-~~~~~~~-~~lV~E 624 (911)
|.+.++||+|.||+|||+....++..||.|.+.-. +.+..++...|+.+|++|+|||||++++ -+.++.+ ++||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 44567899999999999999888889999988633 4456677999999999999999999998 4555555 899999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCc--EEEecccCCCeeecCCCceEEee
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHT--IIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kl~D 702 (911)
||..|+|...+...+. ..+.+++..+|++..|+++||.++|+.. +. |+||||||.||+|+.+|.+||+|
T Consensus 101 ~c~~GDLsqmIk~~K~--------qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKK--------QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred hhcccCHHHHHHHHHh--------ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeecc
Confidence 9999999999977654 4566899999999999999999999522 34 89999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
|||++..... ........||+.||+||.+....|+.||||||+||++|||+.-++||.+.... ....+...
T Consensus 172 fGL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~------~L~~KI~q 242 (375)
T KOG0591|consen 172 FGLGRFLSSK---TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL------SLCKKIEQ 242 (375)
T ss_pred chhHhHhcch---hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH------HHHHHHHc
Confidence 9999986543 33445678999999999999999999999999999999999999999754211 11111111
Q ss_pred ccCCcccccCccccCCCC-hHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIA-PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
. .. ..++ ......+.+|+..|+..||+.||+...+++.+..
T Consensus 243 g----------d~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 G----------DY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred C----------CC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 11 1223 4567889999999999999999996666655543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=376.28 Aligned_cols=258 Identities=29% Similarity=0.471 Sum_probs=223.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+....++||.|.||.||.|.|+.....||||.|+...+ ..++|+.|..+|+.++|||+|+|+|+|..+...|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345557799999999999999999889999999987654 4789999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
.+|+|.++|+.+. +..++-..++.+|.||+.||+||. ++++|||||.++|+|+.++..+||+||||+
T Consensus 346 ~yGNLLdYLRecn----------r~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 346 CYGNLLDYLRECN----------RSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred cCccHHHHHHHhc----------hhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999997653 334666778999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
|++.......+ ....-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+.+..
T Consensus 413 RlMtgDTYTAH--AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----------------- 473 (1157)
T KOG4278|consen 413 RLMTGDTYTAH--AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------- 473 (1157)
T ss_pred hhhcCCceecc--cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----------------
Confidence 98654332222 22345678999999999999999999999999999999 88888654321
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.+-.+++...|.+.++.|+..+++||+.||+.+|.+||++.|+.+.+|...+
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1234566778888899999999999999999999999999999999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=361.41 Aligned_cols=262 Identities=28% Similarity=0.387 Sum_probs=209.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.....+.||+|-||.|.++...+. ..||||+++..... ..++|.+|+++|.+|+||||++|+|+|..++.+++|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~-lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGP-LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEecCc-eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 344567899999999999999874 68999999977544 4588999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|..+|..... +.+.-...++||.|||.||+||. +.++|||||.++|||+|.++++||+|||++
T Consensus 618 EnGDLnqFl~ahea----------pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 618 ENGDLNQFLSAHEL----------PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred hcCcHHHHHHhccC----------cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccc
Confidence 99999999965422 22455667889999999999999 799999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh--CCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC--GRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt--G~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
|-+..+.. .++.....-.++|||+|.+..++++.++|||+||++|||+++ ...||..... + ..+.-.......
T Consensus 685 R~lysg~y-y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e--~vven~~~~~~~ 759 (807)
T KOG1094|consen 685 RNLYSGDY-YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--E--QVVENAGEFFRD 759 (807)
T ss_pred cccccCCc-eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--H--HHHHhhhhhcCC
Confidence 96544332 223333446789999999999999999999999999999875 6788754321 1 111111111111
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
+.. ......|..|+..+++++.+||..|-++||++++|...|+.
T Consensus 760 ~~~------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 760 QGR------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCc------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 111 11234567789999999999999999999999999988864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=375.06 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=209.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
..|...++||+|||..||+++..+.++.||+|++... .....+...+||++.+.|+|||||++++++++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4577889999999999999999788889999998764 2344567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
|+|++|+|.+++. .++++++.++..+..||+.||.||| +++|+|||||-.|+||++++++||+||
T Consensus 98 ELC~~~sL~el~K------------rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 98 ELCHRGSLMELLK------------RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred EecCCccHHHHHH------------hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEeccc
Confidence 9999999999884 4567999999999999999999999 799999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|||...... .......+||+.|+|||++.....+..+||||+||+||-|+.|++||.......... +....
T Consensus 163 GLAt~le~~---~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~------~Ik~~ 233 (592)
T KOG0575|consen 163 GLATQLEYD---GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN------KIKLN 233 (592)
T ss_pred ceeeeecCc---ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH------HHHhc
Confidence 999875432 233456789999999999999999999999999999999999999996543221111 11111
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+ -.+|........+||.++|+.||.+|||+++|+..
T Consensus 234 ~------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 E------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred C------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 11222334556799999999999999999999876
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.62 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=201.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh-------hhHHHHHHHHHHHHhcccccEeeecceeccCCceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-------QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 620 (911)
.|-..+.||+|+||.|-+|....++..||||+++.... .......+|+++|++|+|||||+++++++.++..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 35557799999999999999999999999999865311 12233579999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC---Cc
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN---WA 697 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~ 697 (911)
|||||++||+|.+++-.. +.+.+.....++.|++.|+.||| +.||+||||||+|||+..+ ..
T Consensus 253 mVlE~v~GGeLfd~vv~n------------k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVAN------------KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred EEEEEecCccHHHHHHhc------------cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceE
Confidence 999999999999999533 44677777889999999999999 8999999999999999765 78
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCC---CchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhH
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL---TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l 774 (911)
+||+|||+|+... ....+...+||+.|.|||++..+.+ ..|.|+||+||+||-++||.+||........ +
T Consensus 318 lKItDFGlAK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l 390 (475)
T KOG0615|consen 318 LKITDFGLAKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---L 390 (475)
T ss_pred EEecccchhhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---H
Confidence 9999999999743 3455677899999999999987643 3488999999999999999999965442221 1
Q ss_pred hhHHhhhcccCCcccccCcccc--CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 775 VLWARVSRARGTVDQIVDPRLR--GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 775 ~~~~~~~~~~~~~~~i~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. +++...++. ........++..+||.++|..||++|||+.|++++
T Consensus 391 ~------------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 391 K------------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred H------------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1 011111110 11123446778899999999999999999999876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=352.73 Aligned_cols=265 Identities=30% Similarity=0.439 Sum_probs=201.7
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHh--cccccEeeecceeccCC----ceEEEEeec
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISE--LRHLHIVSLLGFCDEHG----EMILVYEFM 626 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~--l~HpnIv~l~g~~~~~~----~~~lV~E~~ 626 (911)
++||+|+||.||||.+.+ +.||||++. .+..+.|.+|-++.+. ++|+||++++++-.... +++||+||.
T Consensus 216 eli~~Grfg~V~KaqL~~--~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLDN--RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHhhcCccceeehhhccC--ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 379999999999999987 489999985 4556778888888665 58999999999875544 899999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhC------CCCcEEEecccCCCeeecCCCceEE
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAG------AKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~------~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+.|+|.++|. ...++|....+|+..+|+||+|||++ .+++|+|||||++||||.+|+++.|
T Consensus 291 ~kGsL~dyL~-------------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 291 PKGSLCDYLK-------------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cCCcHHHHHH-------------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 9999999994 34699999999999999999999974 3678999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccC-CC-----chhHHHHHHHHHHHHHhCCCCCCCCccchhhhhH
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ-LT-----EKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-----~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l 774 (911)
+|||||..+..+...... ....||.+|||||++.+.. +. .+.||||+|.|||||+++..-++.+..+.-+...
T Consensus 358 aDFGLAl~~~p~~~~~d~-~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDT-HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eccceeEEecCCCCCcch-hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 999999887655444333 3367999999999998642 22 3789999999999999977655322221111111
Q ss_pred hhHHhhhcccCCccc----ccCccccCCCCh-----HHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhh
Q 002533 775 VLWARVSRARGTVDQ----IVDPRLRGKIAP-----VCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 775 ~~~~~~~~~~~~~~~----i~d~~l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 839 (911)
.........+++ ++..+.|..++. ..+..+.+.+..||+.||+.|-|+.=|-+++.++....
T Consensus 437 ---e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 437 ---EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred ---hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111111111111 122223333222 34678899999999999999999999988887665543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=370.76 Aligned_cols=266 Identities=29% Similarity=0.480 Sum_probs=210.9
Q ss_pred HHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCC
Q 002533 540 TEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG 617 (911)
Q Consensus 540 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 617 (911)
++.+.-.+++.....||+|.||+||+|++.++ ||||+++.. ..+..+.|++|+.++++-+|.||+-++|||..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 33333334455577899999999999999875 999998754 5567789999999999999999999999999887
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
. .||+.+|++-+|+.+||..+ ..++..+.+.||.|||+||.||| .++|||||||..||+|.++++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-----------tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-----------TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred e-eeeehhccCchhhhhccchh-----------hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCc
Confidence 7 99999999999999998653 34888999999999999999999 799999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcc---cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhH
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR---QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l 774 (911)
|||+||||+..-..... ......-.|...|||||+++. .+|++.+||||||+|+|||+||..||.... .+ .
T Consensus 527 VkIgDFGLatvk~~w~g-~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~d---q 600 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSG-EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RD---Q 600 (678)
T ss_pred EEEecccceeeeeeecc-ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hh---h
Confidence 99999999875322111 111123347788999999975 479999999999999999999999996322 11 1
Q ss_pred hhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 775 VLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 775 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
+.|.. ..|- +.+++ ......|+..+.+|+..||..++++||.+.+|+.+|+.++.
T Consensus 601 IifmV---GrG~----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 601 IIFMV---GRGY----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred eEEEe---cccc----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11211 1110 01111 12345788899999999999999999999999999987665
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=374.98 Aligned_cols=255 Identities=30% Similarity=0.449 Sum_probs=212.2
Q ss_pred ceeecccCcEEEEEEEeecCC----eEEEEEEccC---CChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 552 HCIIGSGGFGHVFKGYIDDGS----ITVAVKRLNT---SSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~----~~vAvK~l~~---~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.++||+|+||.||+|++...+ ..||||..+. .......+|.+|.++|++++|||||+++|++.....+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 468999999999999986542 2389999885 346778899999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
+|.||+|.++|... ...+++.++++++.++|+||+||| +++++||||.++|||++.++.+||+|||
T Consensus 242 l~~gGsL~~~L~k~-----------~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKN-----------KKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred ecCCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999543 225999999999999999999999 7999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|++.... .........-..+|+|||.+..+.++.++|||||||++||+++ |..||.+..... +.
T Consensus 308 Ls~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~----v~-------- 372 (474)
T KOG0194|consen 308 LSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE----VK-------- 372 (474)
T ss_pred cccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH----HH--------
Confidence 9986431 1111112246679999999999999999999999999999999 788886543211 11
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhh
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 839 (911)
..+.-...+...+...+..+..++.+||..+|++||+|.++.+.|+.+....
T Consensus 373 ----~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 373 ----AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ----HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 1222334455566677888999999999999999999999999998776543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=363.96 Aligned_cols=248 Identities=32% Similarity=0.546 Sum_probs=210.0
Q ss_pred cCCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceecc
Q 002533 536 RFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDE 615 (911)
Q Consensus 536 ~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~ 615 (911)
.+.+++|.. .+-||.|+-|.||+|++++. .||||+++.- -..+|+-|++|+|+||+.+.|+|..
T Consensus 120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~ne--tVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 120 EIPFEEISE-------LEWLGSGAQGAVFLGRLHNE--TVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred cCCHHHhhh-------hhhhccCcccceeeeeccCc--eehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecC
Confidence 455566554 45799999999999999875 7999987532 2357888999999999999999999
Q ss_pred CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 616 HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 616 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
...+|||||||..|.|...|+ ...+++-...+.+..+||.||.||| .+.|||||||+-||||..+
T Consensus 184 sPcyCIiMEfCa~GqL~~VLk------------a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~ 248 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLK------------AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYD 248 (904)
T ss_pred CceeEEeeeccccccHHHHHh------------ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeecc
Confidence 999999999999999999995 3446888889999999999999999 7999999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
..+||+|||-++..... ..+-...||..|||||++++.+.++|.||||||||||||+||..||.+.+. ..+
T Consensus 249 d~VKIsDFGTS~e~~~~----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-----sAI 319 (904)
T KOG4721|consen 249 DVVKISDFGTSKELSDK----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-----SAI 319 (904)
T ss_pred ceEEeccccchHhhhhh----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-----hee
Confidence 99999999999864332 223456899999999999999999999999999999999999999954331 111
Q ss_pred hHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
.| -+-...|...++..|+..|.-|+++||+..|..||++++++.+|+.
T Consensus 320 Iw-----------GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 320 IW-----------GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred EE-----------eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 22 2233445667888999999999999999999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=408.43 Aligned_cols=270 Identities=28% Similarity=0.477 Sum_probs=221.3
Q ss_pred cCCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceecc
Q 002533 536 RFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDE 615 (911)
Q Consensus 536 ~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~ 615 (911)
.+++.++.. .+...++||+|+||.||+|+....+..||||+++..... ...|++++++++||||++++|+|.+
T Consensus 682 ~~~~~~~~~---~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 682 SITINDILS---SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhhHHHHHh---hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 455555544 466788999999999999999777789999998654321 2346889999999999999999999
Q ss_pred CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 616 HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 616 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
++..++||||+++|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.+
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~---------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~ 819 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR---------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh---------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC
Confidence 999999999999999999993 27899999999999999999997777899999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
+.+++. ||....... .....++..|||||++.+..++.|+|||||||++|||+||+.||.... .....+.
T Consensus 820 ~~~~~~-~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~ 889 (968)
T PLN00113 820 DEPHLR-LSLPGLLCT-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIV 889 (968)
T ss_pred CceEEE-ecccccccc-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc--CCCCcHH
Confidence 988876 666543211 112357889999999999999999999999999999999999985432 2334567
Q ss_pred hHHhhhcccCCcccccCccccCC--CChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 776 LWARVSRARGTVDQIVDPRLRGK--IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.|++..........++|+.+... .+..+...+.+++.+||+.||++||+|.||++.|+.+.+
T Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 78776665556666777776543 345667788999999999999999999999999987654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=346.07 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=201.5
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
..+|...++||+|+||+||.++.+++++.+|+|++++.. ....+....|..+|.+++||.||+++-.+++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 356888999999999999999999999999999997653 23456788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
+||+.||.|..+|.+ ...+++....-++..|+.||.||| +++||||||||+|||||++|+++|+|
T Consensus 104 ld~~~GGeLf~hL~~------------eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR------------EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred EeccCCccHHHHHHh------------cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEec
Confidence 999999999999953 345788877778889999999999 89999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
|||++..-.. ...+...+||+.|||||++.+..|+..+|.||+|++||||++|.+||....... +.....
T Consensus 169 FgL~k~~~~~---~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~ 238 (357)
T KOG0598|consen 169 FGLCKEDLKD---GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKIL 238 (357)
T ss_pred cccchhcccC---CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHh
Confidence 9999963322 233345789999999999999999999999999999999999999997644221 111111
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP 823 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 823 (911)
.. ++ ...+.-......+++.+.+..||++|-
T Consensus 239 ~~---------k~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 239 KG---------KL-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cC---------cC-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11 11 112222456677999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=334.23 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=204.3
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
.|....++|+|+||.|||++.+++++.||||++.... +...+-.++||++|++|+|+|+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 3455668999999999999999999999999997653 33345578999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
|+. ++.+-|.. ....++.....+++.|+++|+.|+| +++||||||||+||||+.++.+||||||+
T Consensus 83 ~dh-TvL~eLe~-----------~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 83 CDH-TVLHELER-----------YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred cch-HHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchh
Confidence 977 44444422 2234778888999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH-------
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW------- 777 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~------- 777 (911)
||.... .....+....|..|.|||.+.+ .+|+...||||+||++.||++|.+.|.+.. +-++..++.-
T Consensus 148 AR~L~~---pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-DiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 148 ARTLSA---PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-DIDQLYLIRKTLGNLIP 223 (396)
T ss_pred hHhhcC---CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-hHHHHHHHHHHHcccCH
Confidence 997653 2334456678999999999987 789999999999999999999998875433 3333332221
Q ss_pred --HhhhcccCCcccccCcccc-----CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 778 --ARVSRARGTVDQIVDPRLR-----GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 --~~~~~~~~~~~~i~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.......+.+.-+.-|... ...-+....-+++++..|++.||++|++-+|++.+
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111222222111111 11112334578899999999999999999999764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=361.33 Aligned_cols=271 Identities=29% Similarity=0.422 Sum_probs=206.3
Q ss_pred cCCccceeecccCcEEEEEEEee-----cCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhc-ccccEeeecceeccC-Cc
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID-----DGSITVAVKRLNTSS-MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEH-GE 618 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~-~~ 618 (911)
.+|...++||+|+||.||+|.+. ..+..||||+++... ....+.+.+|++++.++ +||||++++++|... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 46777889999999999999852 223579999987543 33456799999999999 899999999988654 46
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccc--------------------------------------------------cccC
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQN--------------------------------------------------QNQN 648 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~--------------------------------------------------~~~~ 648 (911)
.++||||+++|+|.++|......... ....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 89999999999999999653211000 0000
Q ss_pred CCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccc
Q 002533 649 QNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728 (911)
Q Consensus 649 ~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y 728 (911)
....+++.+++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++....... ........++..|
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y 242 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPLKW 242 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCccc
Confidence 1245888999999999999999999 78999999999999999999999999999986432211 1112233466789
Q ss_pred cChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHH
Q 002533 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKF 807 (911)
Q Consensus 729 ~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 807 (911)
+|||++.+..++.++|||||||+||||++ |+.||........ + ...... + .....+..++..+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~---~~~~~~-~---------~~~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---F---CQRLKD-G---------TRMRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---H---HHHHhc-C---------CCCCCCCCCCHHH
Confidence 99999999999999999999999999997 9999865332111 0 011110 0 0111233456678
Q ss_pred HHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 808 VEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 808 ~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.+++.+||+.||++||++.||++.|+.+++
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.62 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=203.2
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCC--ceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG--EMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~lV~E~~ 626 (911)
+...+.||+|.||.||++...+.+...|||..........+.+.+|+++|++|+|||||+.+|...... .++++|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 444678999999999999998877889999887654444677899999999999999999999854444 699999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-CCceEEeecCC
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NWAAKISDFGL 705 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGl 705 (911)
++|+|.+++.+. .. .|++..+.+++.||++||+||| +++||||||||+||||+. ++.+||+|||+
T Consensus 99 ~~GsL~~~~~~~----------g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 99 PGGSLSDLIKRY----------GG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred CCCcHHHHHHHc----------CC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcc
Confidence 999999999643 22 5999999999999999999999 899999999999999999 79999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccC-CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ-LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++................||+.|||||++..+. ...++|||||||++.||+||+.||... .+... +.-.
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~---~~~~---- 234 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAE---ALLL---- 234 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHH---HHHH----
Confidence 986543122223344578999999999999643 335999999999999999999998642 01010 0000
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
+........++...+....+++.+|++.+|++|||+.+++.+.
T Consensus 235 -----ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 235 -----IGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----HhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 0001111244555667788999999999999999999998875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.13 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=210.8
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
.|..-..||+|+.|.||.+.....+..||||++........+-+.+|+.+|+.++|+|||++++.+...+++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 35555679999999999999988888999999987766666778999999999999999999999988899999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.+.+. ...+++.++..||.+++.||+||| ..+|+|||||.+||||+.++.+||+|||++.
T Consensus 354 ggsLTDvVt-------------~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 354 GGSLTDVVT-------------KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred CCchhhhhh-------------cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeee
Confidence 999999983 334899999999999999999999 8999999999999999999999999999998
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
....... ......||+.|||||+.....|++|.||||||++++||+-|++||.....-+ ..|.-.
T Consensus 418 qi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-----AlyLIa------- 482 (550)
T KOG0578|consen 418 QISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIA------- 482 (550)
T ss_pred ccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-----HHHHHh-------
Confidence 6544322 3456679999999999999999999999999999999999999997643221 111110
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.---++ ...+......|.+++.+||+.|+++||++.|++++
T Consensus 483 -~ng~P~--lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 483 -TNGTPK--LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -hcCCCC--cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 011111 22344456788999999999999999999999886
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=353.32 Aligned_cols=258 Identities=29% Similarity=0.432 Sum_probs=218.1
Q ss_pred cCCccceeecccCcEEEEEEEee----cCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID----DGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
......++||+|-||.||+|.+. +....||||.-+.. .....+.|++|..+|+.++||||++|+|+|.+ ...+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34445668999999999999873 34567999988763 55667889999999999999999999999976 47899
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
|||.++.|.|+.+|... ...|+......+|.||+.+|+||| +..+|||||.++|||+...-.+||+
T Consensus 468 vmEL~~~GELr~yLq~n-----------k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN-----------KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred EEecccchhHHHHHHhc-----------cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeec
Confidence 99999999999999543 345888899999999999999999 7999999999999999999999999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhh
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
||||+|...+..-.. .....-...|||||.+.-.+++.+||||.|||++||++. |..||.+-...
T Consensus 534 DFGLSR~~ed~~yYk--aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------------ 599 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYK--ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------------ 599 (974)
T ss_pred ccchhhhccccchhh--ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc------------
Confidence 999999865443221 224456778999999999999999999999999999998 99999653311
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhh
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 838 (911)
++--.++..-|.++++.|+..|.-|+.+||..+|.+||.+.++...|+.+++.
T Consensus 600 -----DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 600 -----DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred -----ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 11223445557788999999999999999999999999999999999988773
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.87 Aligned_cols=260 Identities=22% Similarity=0.367 Sum_probs=205.1
Q ss_pred CcCCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhh---HHHHHHHHHHHHhcccccEeeecc
Q 002533 535 RRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG---AREFRTEIEMISELRHLHIVSLLG 611 (911)
Q Consensus 535 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g 611 (911)
+.++.++++. .....||+|++|.||+|.+. +..||||+++...... .+.|.+|+++|++++||||++++|
T Consensus 13 ~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 13 KCIESDDIDK-----YTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred eecCHHHcCC-----CCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 4456666633 33458999999999999984 3589999987643322 467889999999999999999999
Q ss_pred eecc----CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccC
Q 002533 612 FCDE----HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKS 687 (911)
Q Consensus 612 ~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp 687 (911)
++.+ ....++||||+++|+|.+++.. ...++|...++++.+++.||.|||. ..+++||||||
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------------~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp 151 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDK------------EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTS 151 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhh------------CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCCh
Confidence 9866 3578999999999999999953 2358899999999999999999994 34788999999
Q ss_pred CCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc--cCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 688 TNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR--QQLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 688 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
+|||+++++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 152 ~nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 152 VSFLVTENYKLKIICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred hhEEECCCCcEEEcccchHhhhcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999988543211 12347889999999976 68999999999999999999999999654
Q ss_pred ccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 766 AVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 766 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
... + +.. . +.....+...+..++..+.+++.+||+.||++|||+.||++.|+...+
T Consensus 226 ~~~-~---~~~---~---------i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 226 TTK-E---IYD---L---------IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CHH-H---HHH---H---------HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 311 1 110 0 001111122334567789999999999999999999999999986543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=355.96 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=214.9
Q ss_pred ceeecccCcEEEEEEEeec---CCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 552 HCIIGSGGFGHVFKGYIDD---GSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~---~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
.++||+|.||.|++|.|.. ....||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ..+.||+|+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 4579999999999999953 3468999999876544 66789999999999999999999999876 78899999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
.|+|.+.|+.. ....+....+..+|.|||.||.||. .+++|||||.++|+||-..-.+||+||||.|
T Consensus 194 lGSLldrLrka----------~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 194 LGSLLDRLRKA----------KKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred cchHHHHHhhc----------cccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeeccccee
Confidence 99999999763 3456888889999999999999999 7999999999999999999999999999999
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
.+....+...+.....-.+.|+|||.++...++.++|||+|||+||||+| |+.||.+.... .
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------------q 323 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------------Q 323 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------H
Confidence 87665554444445566788999999999999999999999999999999 78888654311 1
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
+.+.+|.+-+...++.|++++++++..||..+|++||++..|++.+
T Consensus 324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3345666667778899999999999999999999999999998654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.23 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=211.9
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
++|...+.||+|.||.||||+.+.+.+.||+|.+.+. ...+.+.+.+|++++++|+||||+.++++++...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4577777899999999999999999899999998654 34556779999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+.+ +|..+|. ....|++..+..|+.+++.||.||| +.+|+|||+||.||||+.++.+|+||||
T Consensus 82 ~a~g-~L~~il~------------~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 82 YAVG-DLFTILE------------QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred hhhh-hHHHHHH------------hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhh
Confidence 9966 9999994 4456999999999999999999999 8999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+||.+.. ...+.+.+.||+.|||||..++++|+..+|+||+||+|||+++|++||..... ....+....+
T Consensus 146 ~Ar~m~~---~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-------~~Lv~~I~~d 215 (808)
T KOG0597|consen 146 LARAMST---NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-------TQLVKSILKD 215 (808)
T ss_pred hhhhccc---CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-------HHHHHHHhcC
Confidence 9997543 35566788999999999999999999999999999999999999999964321 1111211111
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+ ...+......+..++...+..||.+|.+-.+++.+
T Consensus 216 --------~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 --------P---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --------C---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1 11233566788899999999999999999999876
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.63 Aligned_cols=250 Identities=36% Similarity=0.579 Sum_probs=196.1
Q ss_pred ceeecccCcEEEEEEEee----cCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 552 HCIIGSGGFGHVFKGYID----DGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~----~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+.||.|.||.||+|.+. ..+..|+||.++.. ..+..++|.+|++.+++++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999998 34578999999654 4445788999999999999999999999999888899999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.++|... ....+++..+++|+.|||+||+||| +.+++|+||+++|||+++++.+||+|||++
T Consensus 84 ~~g~L~~~L~~~----------~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 84 PGGSLDDYLKSK----------NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp TTEBHHHHHHHT----------CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred cccccccccccc----------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 999999999654 2346899999999999999999999 678999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+...... .............|+|||.+....++.++||||||+++|||++ |+.|+..... .+ +. ..
T Consensus 151 ~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~---~~---~~----- 217 (259)
T PF07714_consen 151 RPISEKS-KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EE---II---EK----- 217 (259)
T ss_dssp EETTTSS-SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HH---HH---HH-----
T ss_pred ccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccc-cc---cc---cc-----
Confidence 8652211 1122233456778999999999999999999999999999999 6788754321 11 11 11
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
+ ....+...+..++..+.+++..||+.+|++||+|.+|++.|
T Consensus 218 ----~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 ----L-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----H-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----c-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 11112223445677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.13 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=211.9
Q ss_pred HHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCce
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 619 (911)
...+||..++.||+|.|++|++|+....+..+|||++.+. .....+-...|-+.|.+| .||.|++|+-.+.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3446788889999999999999999999999999998654 223334567889999999 899999999999999999
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
|+|+||+++|+|.++|++. +.+++.....++.+|+.||+||| +.|||||||||+|||||+|+++|
T Consensus 150 YFvLe~A~nGdll~~i~K~------------Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY------------GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred EEEEEecCCCcHHHHHHHh------------CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEE
Confidence 9999999999999999654 45888888999999999999999 89999999999999999999999
Q ss_pred EeecCCccCCCCCCCC--------ccc--cccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccch
Q 002533 700 ISDFGLSRMGPSGMSQ--------SHV--STVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK 769 (911)
Q Consensus 700 l~DFGla~~~~~~~~~--------~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~ 769 (911)
|+|||-|+.+...... ... .....||..|.+||++..+..+..+|+|+|||+||+|+.|++||....
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--- 291 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--- 291 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---
Confidence 9999999976432211 111 245789999999999999999999999999999999999999996533
Q ss_pred hhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 770 EEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 770 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
+ ...+.+.+. +.-.+++..++...+|+.+.|..||.+|+|..+|-++.
T Consensus 292 e---yliFqkI~~------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 292 E---YLIFQKIQA------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred H---HHHHHHHHH------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1 112222221 12234455567788999999999999999999997764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=335.34 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=207.2
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
.+|...++||.|..++||+|+....++.||||++.-.. ....+.+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 45677789999999999999998888999999997542 23367899999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
|.+|++.+.+...- ...+++..+..|.+++.+||.||| .+|.||||||+.||||+.+|.+||+|||.
T Consensus 106 Ma~GS~ldIik~~~----------~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY----------PDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred hcCCcHHHHHHHHc----------cccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999996542 234888899999999999999999 79999999999999999999999999998
Q ss_pred ccCCCCCCCCcccc-ccccCcccccChhhhcc--cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 706 SRMGPSGMSQSHVS-TVVKGSFGYVDPEYIRR--QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 706 a~~~~~~~~~~~~~-~~~~gt~~y~APE~~~~--~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
+-.+.......... ....||+.|||||++.. ..|+.|+||||||++.+||.+|..||.....- .+- .....
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvL----l~tLq 246 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVL----LLTLQ 246 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHH----HHHhc
Confidence 76443322222222 55689999999999654 46999999999999999999999999654311 110 11111
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
....... -..+..+........+.+++..||+.||.+|||++++++.
T Consensus 247 n~pp~~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 247 NDPPTLL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCCCcc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111000 0111111222334578899999999999999999998654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=340.90 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=201.7
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
|...+.||+|+||.||+|....++..||||.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 566789999999999999998888899999986442 22334678999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++|+|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~~g~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 82 MNGGDLKFHIYNM----------GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred cCCCcHHHHHHhh----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999888532 2235889999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...........+ ....
T Consensus 149 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~---- 217 (285)
T cd05631 149 AVQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRV---- 217 (285)
T ss_pred cEEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHh----
Confidence 97643221 112346899999999999999999999999999999999999999653321110000 0000
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-----HHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 831 (911)
. ......+......+.+|+.+||+.||.+||+ +.+++++
T Consensus 218 -----~--~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 218 -----K--EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -----h--cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 0011223334567889999999999999997 7888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=357.29 Aligned_cols=268 Identities=27% Similarity=0.412 Sum_probs=205.0
Q ss_pred CCccceeecccCcEEEEEEEe-----ecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSS-MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~-----~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 620 (911)
+|...++||+|+||.||+|++ .+....||||+++... ....+.+.+|+++|..+ +||||++++++|...+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 466678999999999999974 2345689999997543 33456788999999999 8999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhcccc--------------------------------------------------------
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQN-------------------------------------------------------- 644 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~-------------------------------------------------------- 644 (911)
+||||+++|+|.+++.........
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 999999999999999653210000
Q ss_pred -------cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCcc
Q 002533 645 -------QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717 (911)
Q Consensus 645 -------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 717 (911)
........++|..+++++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 271 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-YV 271 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc-cc
Confidence 00011235889999999999999999999 78999999999999999999999999999986433221 11
Q ss_pred ccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCcccccCcccc
Q 002533 718 VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLR 796 (911)
Q Consensus 718 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 796 (911)
......++..|+|||++.+..++.++|||||||++|||++ |..||........ +..+. ....+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---~~~~~-------------~~~~~ 335 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---FYKMI-------------KEGYR 335 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---HHHHH-------------HhCcc
Confidence 1222345678999999999999999999999999999998 8888854332111 11110 11111
Q ss_pred CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 797 GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 797 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
...+...+..+.+|+.+||+.||++||++.||++.|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 112223356788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=356.41 Aligned_cols=269 Identities=27% Similarity=0.414 Sum_probs=206.5
Q ss_pred CCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCC-hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSS-MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 620 (911)
+|...+.||+|+||.||+|.... ....||||+++... ......+.+|+++++.+ +|+||++++++|...+..+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 56678899999999999998632 23579999997543 33456788999999999 8999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhcccc--------------------------------------------------------
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQN-------------------------------------------------------- 644 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~-------------------------------------------------------- 644 (911)
+||||+++|+|.++++........
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 999999999999999654221000
Q ss_pred --cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCccccccc
Q 002533 645 --QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722 (911)
Q Consensus 645 --~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 722 (911)
........+++.++++++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++....... .......
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~~~~ 274 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGNA 274 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeeccCC
Confidence 00011235888999999999999999999 78999999999999999999999999999976433211 1112223
Q ss_pred cCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCCh
Q 002533 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAP 801 (911)
Q Consensus 723 ~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 801 (911)
.++..|||||++.+..++.++|||||||++|||++ |+.||............ .....+...+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~----------------~~~~~~~~~~~ 338 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM----------------VKRGYQMSRPD 338 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH----------------HHcccCccCCC
Confidence 45678999999999999999999999999999997 99998653321110000 00111111222
Q ss_pred HHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 802 VCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 802 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
..+..+.+++.+||+.||++||++.+|++.|++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.62 Aligned_cols=273 Identities=24% Similarity=0.374 Sum_probs=205.1
Q ss_pred cCCccceeecccCcEEEEEEEeec----------------CCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDD----------------GSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSL 609 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~----------------~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l 609 (911)
.+|...+.||+|+||.||+|.+.+ ++..||||.+... ......+|.+|+++|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 356677899999999999998643 2347999998764 33445679999999999999999999
Q ss_pred cceeccCCceEEEEeecCCCchhhHhhhhhhccccc-------ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEE
Q 002533 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQ-------NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIH 682 (911)
Q Consensus 610 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~-------~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivH 682 (911)
++++...+..++||||+++|+|.+++.......... .......++|..+++++.||+.||+||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999985532211100 0112346889999999999999999999 789999
Q ss_pred ecccCCCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh--CCC
Q 002533 683 RDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC--GRP 760 (911)
Q Consensus 683 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt--G~~ 760 (911)
|||||+|||++.++.+||+|||+++....... ........++..|+|||++..+.++.++|||||||++|||++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999975432211 112223345788999999999999999999999999999997 456
Q ss_pred CCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 761 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
||...... ....+........ ........++.++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~~----~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE----QVIENAGEFFRDQ------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH----HHHHHHHHHhhhc------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66432211 1111111110000 000111123456778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=337.44 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=204.7
Q ss_pred cCCccceeecccCcEEEEEEEee---cCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID---DGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~---~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
++|...++||+|+||.||+|.+. .....||+|+++... ....+.|.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45777889999999999999875 335689999987653 34456799999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++|+|.+++... ...++|..++.++.|++.||+||| +.+++||||||+|||++.++.+|++|
T Consensus 85 ~e~~~~~~L~~~l~~~-----------~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 85 TEYMSNGALDSFLRKH-----------EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred EEeCCCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECC
Confidence 9999999999998532 235899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||++........ .......++..|+|||.+.+..++.++|||||||++||+++ |+.||....... +.. ..
T Consensus 151 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~----~~~---~~ 221 (266)
T cd05064 151 FRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----VIK---AV 221 (266)
T ss_pred Ccccccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHH---HH
Confidence 998765321111 11112335678999999999999999999999999999875 999986433111 111 00
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
. ...+...+..++..+.+++.+||+.+|.+||++.+|.+.|+..
T Consensus 222 ~----------~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 E----------DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred H----------CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 0111223445677899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.13 Aligned_cols=264 Identities=21% Similarity=0.277 Sum_probs=204.1
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhh-HHHHHHHHHHHHhcc-cccEeeecceeccCC-ceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG-AREFRTEIEMISELR-HLHIVSLLGFCDEHG-EMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~-~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~-~~~lV~E 624 (911)
+|...+.||.|.||.||+|+-...+..||||+++..-... .-.=++|++.|++|+ ||||++|.+++.+.+ .+++|||
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE 90 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE 90 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence 4555668999999999999998888899999997653221 122468999999998 999999999998877 9999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|| ..+|.+++.. ++..+++..+..|+.||++||+|+| ++|+.|||+||+|||+..+..+||+|||
T Consensus 91 ~M-d~NLYqLmK~-----------R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 91 FM-DCNLYQLMKD-----------RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred hh-hhhHHHHHhh-----------cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccc
Confidence 99 5599999853 3567999999999999999999999 8999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhc-ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR-RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|||....... .+....|.-|+|||++. .+-|+.+.||||+||+++|+.+-++.|.+... -++...+..+-....
T Consensus 156 LARev~SkpP----YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 156 LAREVRSKPP----YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPD 230 (538)
T ss_pred cccccccCCC----cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCc
Confidence 9997543322 24456788999999875 56899999999999999999999988865432 222211111100000
Q ss_pred cC--------------CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 784 RG--------------TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 784 ~~--------------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.. .+.+..--.+...++. +..+..+|+.+|+..||.+|||+.|.+++-
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00 0111111112222233 678899999999999999999999998874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=336.40 Aligned_cols=266 Identities=30% Similarity=0.476 Sum_probs=208.6
Q ss_pred CCccceeecccCcEEEEEEEeecCC-----eEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGS-----ITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
+|...+.||+|+||.||+|...... ..||+|.++... .....+|.+|++++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4566778999999999999986544 679999987543 3445679999999999999999999999999899999
Q ss_pred EEeecCCCchhhHhhhhhhcccccc----cCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQN----QNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~----~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
+|||+++|+|.+++........... ......+++..++.++.|++.||+||| +.+++||||||+|||+++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCc
Confidence 9999999999999965422111100 111256889999999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~ 776 (911)
+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||...... + +..
T Consensus 163 ~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~---~~~ 237 (283)
T cd05048 163 VKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-E---VIE 237 (283)
T ss_pred EEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-H---HHH
Confidence 99999999975432211 111223346788999999999999999999999999999998 99998653311 1 111
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
. +........+..++..+.+|+.+||+.||.+||++.||+++|+.
T Consensus 238 ~-------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 M-------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11111122345667889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=327.88 Aligned_cols=258 Identities=27% Similarity=0.388 Sum_probs=196.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHh--cccccEeeecceeccC----CceEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISE--LRHLHIVSLLGFCDEH----GEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~--l~HpnIv~l~g~~~~~----~~~~l 621 (911)
+....+.||+|.||+||+|.+.+. .||||++.... .+.+.+|-++.+. |+|+||+.+++.-..+ .+++|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe--~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGE--DVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred eeEEEEEecCccccceeeccccCC--ceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 455567899999999999999886 69999986443 3456667777665 6999999999875433 27899
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhh-----CCCCcEEEecccCCCeeecCCC
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA-----GAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-----~~~~~ivHrDlkp~NILl~~~~ 696 (911)
|.+|.++|||.|||. +..++....++++..+|.||+|||. +.++.|.|||||++|||+..++
T Consensus 287 vTdYHe~GSL~DyL~-------------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLN-------------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred eeecccCCcHHHHHh-------------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 999999999999993 3569999999999999999999994 3578899999999999999999
Q ss_pred ceEEeecCCccCCCCCCCCcc-ccccccCcccccChhhhcccC----C--CchhHHHHHHHHHHHHHhC----------C
Q 002533 697 AAKISDFGLSRMGPSGMSQSH-VSTVVKGSFGYVDPEYIRRQQ----L--TEKSDVYSFGVVLLEVLCG----------R 759 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~----~--t~ksDVwSfGvvL~ElltG----------~ 759 (911)
.+.|+|+|||.........-. ......||.+|||||++...- + -..+||||||+||||+..+ +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 999999999976544432222 234567999999999996532 2 2368999999999999863 2
Q ss_pred CCCCCCc---cchhhhhHhhHHhhhcccCCcccccCccccCCC-----ChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 760 PPMINGA---VRKEEVSLVLWARVSRARGTVDQIVDPRLRGKI-----APVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 760 ~p~~~~~---~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.||.+.- ...+++.. -+-..++|..+ ...+...+.+||+.||..+|..|-|+=-|-+.
T Consensus 434 ~Pyyd~Vp~DPs~eeMrk--------------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRK--------------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred CCcccCCCCCCCHHHHhc--------------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 4553321 11111111 11223333333 34678899999999999999999999888877
Q ss_pred HHHHHh
Q 002533 832 LEFALQ 837 (911)
Q Consensus 832 L~~~~~ 837 (911)
|.++.+
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 776554
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=331.69 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=207.1
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||+|+||.||+|.....+..||+|.+... ....+++.+|++++++++|+||++++++|..++..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 466778999999999999999887789999998754 3345679999999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++... ....+++..++.++.|++.||+||| ..+++||||||+|||+++++.+||+|||+++
T Consensus 86 ~~~L~~~~~~~----------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 86 YGNLLDYLREC----------NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CCcHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 99999998532 2345899999999999999999999 7899999999999999999999999999998
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
....... .......++..|+|||.+.+..++.++|||||||++|||++ |..|+....... .+...
T Consensus 153 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~------ 218 (263)
T cd05052 153 LMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELL------ 218 (263)
T ss_pred cccccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH------
Confidence 6433211 11112234568999999999999999999999999999998 888885432111 01111
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
....+...+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 219 -----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 -----EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112223344567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.10 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=203.8
Q ss_pred cCCccceeecccCcEEEEEEEeecCCe----EEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSI----TVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~----~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
.+|...+.||+|+||.||+|++..++. .||||+++.. .....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 457888899999999999999754433 4899998754 344567899999999999999999999999764 5789
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
|+||+++|+|.+++... ...+++..+++++.||+.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 86 v~e~~~~g~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~ 151 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-----------KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKIT 151 (316)
T ss_pred eeecCCCCCHHHHHHhc-----------cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEc
Confidence 99999999999998542 234788999999999999999999 7899999999999999999999999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhh
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... + + ...
T Consensus 152 DfG~a~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~--~---~~~ 223 (316)
T cd05108 152 DFGLAKLLGADEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E--I---SSI 223 (316)
T ss_pred cccccccccCCCcc-eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H--H---HHH
Confidence 99999865432211 11112234678999999999999999999999999999998 99998543211 1 1 111
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.. ...+...+..+...+.+++.+||+.+|.+||++.+|+..|..+.+
T Consensus 224 ~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 224 LE----------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred Hh----------CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11 111112233456678899999999999999999999999876644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=342.57 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=205.0
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
++|...+.||+|+||.||+++....+..+|+|.+... .....+.+.+|+++|++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 5788888999999999999999888889999998754 334456799999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 85 MDGGSLDQVLKEA------------KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred CCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 9999999998432 347888999999999999999994 35799999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh-hc-c
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV-SR-A 783 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~-~~-~ 783 (911)
++..... ......|+..|+|||++.+..++.++|||||||+||||++|+.||....... +...... .. .
T Consensus 151 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~ 221 (331)
T cd06649 151 SGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDG 221 (331)
T ss_pred ccccccc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhccccccc
Confidence 8754322 1223468999999999999999999999999999999999999996433111 1000000 00 0
Q ss_pred cC-C-------------------------------cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RG-T-------------------------------VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~-~-------------------------------~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. . ...+................+.+++.+||+.||++|||+.||+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0 000000000000011245678999999999999999999999876
Q ss_pred H
Q 002533 832 L 832 (911)
Q Consensus 832 L 832 (911)
.
T Consensus 302 ~ 302 (331)
T cd06649 302 T 302 (331)
T ss_pred h
Confidence 4
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=338.13 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=201.2
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccC--CceEEEEe
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEMILVYE 624 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~E 624 (911)
|...+.||+|.||.||||+...++..||+|+++... ..-..-..+||.+|++|.||||++|.+...+. +.+|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 444557999999999999999998999999986543 33344567999999999999999999998766 78999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
||++ +|.-++.. ..-.++..++..++.|++.||+|+| ..+|+|||||.+|||||.+|.+||+|||
T Consensus 199 YMdh-DL~GLl~~-----------p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 199 YMDH-DLSGLLSS-----------PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred cccc-hhhhhhcC-----------CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEecccc
Confidence 9976 88887743 2346899999999999999999999 8999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh-------
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL------- 776 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~------- 776 (911)
||++...... ...+...-|.-|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+.. +-++...+-
T Consensus 264 LAr~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t-EveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 264 LARFYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT-EVEQLHKIFKLCGSPT 340 (560)
T ss_pred ceeeccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc-HHHHHHHHHHHhCCCC
Confidence 9997544322 224556679999999999874 79999999999999999999998886543 333322221
Q ss_pred ---HHhhhcccC---CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 ---WARVSRARG---TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ---~~~~~~~~~---~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|.......- ...+-....++.. -...+...++|+..+|..||.+|.|+.++++.
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 220000000 0000011111111 12234567789999999999999999988754
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=349.88 Aligned_cols=271 Identities=26% Similarity=0.378 Sum_probs=208.5
Q ss_pred ccCCccceeecccCcEEEEEEEeecC-----CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcc-cccEeeecceeccCCc
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDG-----SITVAVKRLNTSS-MQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGE 618 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 618 (911)
..+|...++||+|+||.||+|++... ...||||+++... ....+.|.+|+++|+++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 44677788999999999999987432 2469999997543 334567999999999996 9999999999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhccccc-----------------------------------------------------
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQ----------------------------------------------------- 645 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~----------------------------------------------------- 645 (911)
.+||||||++|+|.++|+.........
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999997643210000
Q ss_pred -------------------------------ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC
Q 002533 646 -------------------------------NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE 694 (911)
Q Consensus 646 -------------------------------~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 694 (911)
.......+++..+++++.|+++||+||| ..+|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 0011235889999999999999999999 789999999999999999
Q ss_pred CCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhh
Q 002533 695 NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVS 773 (911)
Q Consensus 695 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~ 773 (911)
++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||+||||++ |..||.........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-- 349 (400)
T ss_pred CCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence 99999999999976432211 111223346778999999999999999999999999999997 88888643211110
Q ss_pred HhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 774 LVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 774 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
+.. . ....+...+..++..+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 350 ---~~~-~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 ---YNK-I----------KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHH-H----------hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 000 0 001111223445678899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=351.25 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=216.4
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc-cccEeeecce-ecc------C
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGF-CDE------H 616 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~-~~~------~ 616 (911)
...+..++++|.+|||+.||.|.+.+++..+|+|++-..+....+...+||++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3445677889999999999999998887899999998888889999999999999997 9999999993 221 2
Q ss_pred CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC
Q 002533 617 GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 617 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 696 (911)
-+.+|+||||++|+|-++|..... ..|++.++++|+.|+++|+++||. ++.+|||||||-+||||+.++
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq----------~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ----------TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh----------ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC
Confidence 378999999999999999965432 239999999999999999999995 477899999999999999999
Q ss_pred ceEEeecCCccCCCCCCCCcc-cc-----ccccCcccccChhhh---cccCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Q 002533 697 AAKISDFGLSRMGPSGMSQSH-VS-----TVVKGSFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAV 767 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~-~~-----~~~~gt~~y~APE~~---~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~ 767 (911)
..||||||.|........... +. -...-|+.|+|||++ .+..+++|+|||+|||+||-|+....||....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg- 262 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG- 262 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-
Confidence 999999999875322221111 00 012368899999987 47789999999999999999999999996432
Q ss_pred chhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhh
Q 002533 768 RKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 768 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 839 (911)
-..|++....-.-.+.....|.+||+.||+.||.+||++-+|++.+-++...+
T Consensus 263 -------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 -------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12345555554444678899999999999999999999999999988776543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=352.59 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=212.1
Q ss_pred ceeecccCcEEEEEEEeecC----CeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 552 HCIIGSGGFGHVFKGYIDDG----SITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~----~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.++||.|+||+||||.+-.. +.+||||++... ..+...++++|+-+|.+|.||||++|+|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 56999999999999998432 368999988654 5566788999999999999999999999997665 88999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
+.|+|.++++.. +..+--...+.|+.|||+||.||| +++++||||.++||||..-..+||.|||++
T Consensus 780 P~G~LlDyvr~h-----------r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 780 PLGCLLDYVREH-----------RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred ccchHHHHHHHh-----------hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchh
Confidence 999999999754 335778889999999999999999 799999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+........-. .....-.+.|||-|.+....++.++|||||||++||++| |..|+++....+
T Consensus 846 ~ll~~d~~ey~-~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------- 908 (1177)
T KOG1025|consen 846 KLLAPDEKEYS-APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------- 908 (1177)
T ss_pred hccCccccccc-ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------
Confidence 98655433222 223345678999999999999999999999999999999 999987654221
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
+.+++....|...++.|..++..++.+||..|+..||+++++...+.+..
T Consensus 909 -I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 909 -IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 23344445556678899999999999999999999999999988876543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=345.25 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=200.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
.+|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 35777889999999999999998888899999986432 234467889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 98 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 98 EFVVGGELFTHLRKA------------GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred cCCCCChHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeec
Confidence 999999999998532 34778888899999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .+....
T Consensus 163 g~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~-- 228 (329)
T PTZ00263 163 GFAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEKIL-- 228 (329)
T ss_pred cCceEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHHHh--
Confidence 999864321 123468999999999999999999999999999999999999996433111 111111
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-----HHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 831 (911)
... ...+......+.+++.+||+.||.+||+ +.+++.+
T Consensus 229 --------~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 229 --------AGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --------cCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 1122224456789999999999999997 6777655
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=337.58 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=200.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||+|+||.||+|....++..||||++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5777889999999999999998878899999986432 2345568899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++|+|.+++... ..+++.....++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 82 YVPGGELFSYLRNS------------GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred CCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecC
Confidence 99999999998432 34888899999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+++..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||....... + +......
T Consensus 147 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~--~~~i~~~- 213 (291)
T cd05612 147 FAKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----I--YEKILAG- 213 (291)
T ss_pred cchhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H--HHHHHhC-
Confidence 98864321 123458999999999999999999999999999999999999996533111 0 0010000
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-----HHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 831 (911)
. ...+......+.+++.+||+.||.+||+ +.+++++
T Consensus 214 ---------~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 ---------K--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---------C--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 1122233556789999999999999995 7777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.32 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=204.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||+|+||.||+|++...+..||||+++... ....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5778889999999999999998877899999986542 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~g~~L~~~l~~------------~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 82 YVPGGDFRTLLNN------------LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred CCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCc
Confidence 9999999999943 234788999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+++.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+..|.....
T Consensus 147 ~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-- 218 (333)
T cd05600 147 LSKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ-- 218 (333)
T ss_pred CCccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--
Confidence 9975432 22345689999999999999999999999999999999999999965432221111222211100
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+.. ......+...+.+++.+||..+|.+||++.+++++
T Consensus 219 -------~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 -------RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -------CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 00012345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.47 Aligned_cols=272 Identities=21% Similarity=0.336 Sum_probs=219.3
Q ss_pred HHHHHHHccCCccceeecccCcEEEEEEEeecC-----CeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecce
Q 002533 539 LTEIKQATCDFADHCIIGSGGFGHVFKGYIDDG-----SITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGF 612 (911)
Q Consensus 539 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~-----~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~ 612 (911)
..||....+++....++-+|.||.||+|.+.+. .+.|.||.++.. +.-....++.|-.++..+.|||++++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 446666777888888999999999999977543 245778877654 44456678999999999999999999999
Q ss_pred ecc-CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCee
Q 002533 613 CDE-HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNIL 691 (911)
Q Consensus 613 ~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 691 (911)
+.+ ....+++|.++.-|+|..+|...+... ......++..+.+.++.|++.||+||| ++++||.||.++|++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~----~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDD----PSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCV 428 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCC----CccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcce
Confidence 855 457799999999999999997665321 124456888999999999999999999 899999999999999
Q ss_pred ecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchh
Q 002533 692 LDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKE 770 (911)
Q Consensus 692 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~ 770 (911)
||+..++||+|-.|+|..-.. +..........+..||+||.+.+..|+..+|||||||+||||+| |+.|+...+..+
T Consensus 429 Idd~LqVkltDsaLSRDLFP~-DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPG-DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred ehhheeEEeccchhccccCcc-cccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 999999999999999865432 22333344456788999999999999999999999999999999 889985443211
Q ss_pred hhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 771 EVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
+ ...+....|..-|-.|+.+|..+|..||...|++||+++|++.-|.+.
T Consensus 507 -m---------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 -M---------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -H---------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1 111222334445667999999999999999999999999999998754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.10 Aligned_cols=269 Identities=20% Similarity=0.272 Sum_probs=215.1
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccC-----Cce
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEH-----GEM 619 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~ 619 (911)
..++|.+.+.||+|||+-||.++.-.++..+|+|++...+.++.+..++|++..++++|||++++++++..+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 345788889999999999999998777789999999998888889999999999999999999999998443 358
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
||+++|...|+|.+.+..... ....+++.+.+.|+.++++||++||+. ..+++||||||.|||+.+.+.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~--------kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKI--------KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred EEEeehhccccHHHHHHHHhh--------cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceE
Confidence 999999999999999976543 344699999999999999999999953 34599999999999999999999
Q ss_pred EeecCCccCCCCCCCCcc------ccccccCcccccChhhhc---ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh
Q 002533 700 ISDFGLSRMGPSGMSQSH------VSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE 770 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~------~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~ 770 (911)
|.|||.++..+-.....+ .......|..|.|||.+. +...++++|||||||+||+|+.|..||.......+
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 999999875432111111 112235788999999885 45689999999999999999999999954332111
Q ss_pred hhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 771 EVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
.. ...+..+.+.-+.....++.+.+++.+|++.||.+||+..+++..++.++
T Consensus 250 Sl--------------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SL--------------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eE--------------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 11222333322223336889999999999999999999999999887653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=343.03 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=197.8
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
++||+|+||.||++....++..||||+++.. .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999999888889999998753 2234456889999999999999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR------------ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99998843 235889999999999999999999 789999999999999999999999999998753
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 789 (911)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .....
T Consensus 146 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~--~~~~~------ 210 (323)
T cd05571 146 ISD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFE--LILME------ 210 (323)
T ss_pred ccC---CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----HHH--HHHcC------
Confidence 211 112234569999999999999999999999999999999999999996533111 110 00000
Q ss_pred ccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 790 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
+ ..++......+.+++.+||+.||++|| ++.+++++
T Consensus 211 --~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 211 --E----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --C----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0 112233456788999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=341.87 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=204.8
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC----Ch-hhHHHHHHHHHHHHhcc-cccEeeecceeccCCc
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS----SM-QGAREFRTEIEMISELR-HLHIVSLLGFCDEHGE 618 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~----~~-~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 618 (911)
....|...+.||+|.||+|++|.....+..||||+++.. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345677788999999999999999888889999977653 11 23445668999999998 9999999999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC-Cc
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WA 697 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~ 697 (911)
.++||||+.+|+|.+++.. ...+.+....+++.|++.|++||| .++|+||||||+|||++.+ +.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~------------~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN------------KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred EEEEEEecCCccHHHHHHH------------cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCC
Confidence 9999999999999999954 345888999999999999999999 7999999999999999999 99
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccC-CC-chhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ-LT-EKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
+||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||.+..... +
T Consensus 160 ~Kl~DFG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l- 231 (370)
T KOG0583|consen 160 LKLSDFGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----L- 231 (370)
T ss_pred EEEeccccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----H-
Confidence 9999999998753 2233445678999999999999877 75 78999999999999999999997632111 1
Q ss_pred hHHhhhcccCCcccccCccccCCCChHH-HHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 776 LWARVSRARGTVDQIVDPRLRGKIAPVC-LNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~-~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
... +.... -.++... ...+..|+.+|++.||.+|+++.+|++
T Consensus 232 -~~k----------i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 232 -YRK----------IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -HHH----------HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111 11111 1122233 567789999999999999999999983
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.09 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=210.5
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
...+|...++||+|+||.||+|...+ +..+++|.+.........++..|++++++++|+||+++++++......++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567778899999999999999988 57899999987766667789999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++|+|.+++... ....+++.++++++.|++.||+||| +.+++|+||||+|||+++++.+||+|||
T Consensus 83 ~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 83 LMEKGSLLAFLRSP----------EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred ecccCCHHHHHhcC----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEcccc
Confidence 99999999999542 2345899999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+ .....
T Consensus 150 ~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~---~~~~~----- 217 (261)
T cd05148 150 LARLIKEDVY---LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHE---VYDQI----- 217 (261)
T ss_pred chhhcCCccc---cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHH---HHHHH-----
Confidence 9976433211 1123345678999999998899999999999999999998 888885432 111 11110
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
....+...+..++..+.+++.+||+.+|.+|||++++++.|+.
T Consensus 218 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 218 --------TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --------HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0111223344566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=307.02 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=205.0
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh-h-HHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-G-AREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...++||+|.||.||+|++..+++.||||+++..... + .....+||+.|+.++|+||+.|++++...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 345567899999999999999999999999999765332 1 34578999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
|+. +|...++. ....++-.++..++.++.+||+||| .+.|+||||||.|+|++.++.+||+|||+
T Consensus 83 m~t-dLe~vIkd-----------~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 83 MPT-DLEVVIKD-----------KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred ccc-cHHHHhcc-----------cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccc
Confidence 965 89888843 3456888899999999999999999 79999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
|+....... ..+...-|.-|.|||.+.+ +.|+...||||.||++.||+-|.+-|. +..+-++...+--+-....+
T Consensus 148 Ar~f~~p~~---~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~sDidQL~~If~~LGTP~~ 223 (318)
T KOG0659|consen 148 ARFFGSPNR---IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDSDIDQLSKIFRALGTPTP 223 (318)
T ss_pred hhccCCCCc---ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCchHHHHHHHHHHcCCCCc
Confidence 998654322 2233367888999999886 579999999999999999998876553 33344444333211111111
Q ss_pred C---CcccccC--------ccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 G---TVDQIVD--------PRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~---~~~~i~d--------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. .+.++-| .......-+.+.+...+|+..++..||.+|++++|++++
T Consensus 224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 224 DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 0111111 111111334556777999999999999999999999876
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.90 Aligned_cols=267 Identities=27% Similarity=0.436 Sum_probs=205.2
Q ss_pred cCCccceeecccCcEEEEEEEee----cCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceecc--CCceE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID----DGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDE--HGEMI 620 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~ 620 (911)
.+|...+.||+|+||.||++... ..+..||||++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 45677789999999999999853 3456899999987777777889999999999999999999998743 45689
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||+++|+|.+++... ...++|..++.++.|++.||+||| +.+++||||||+|||+++++.+||
T Consensus 84 lv~e~~~~~~L~~~l~~~-----------~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l 149 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-----------RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKI 149 (284)
T ss_pred EEEEecCCCCHHHHHHhc-----------CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEE
Confidence 999999999999998532 235899999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
+|||+++................++..|+|||++.+..++.++|||||||++|||++|..++...... +...
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~ 221 (284)
T cd05081 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRM 221 (284)
T ss_pred CCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhh
Confidence 99999986543322111112223445699999999889999999999999999999988765322100 0000
Q ss_pred hcccC-------CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 781 SRARG-------TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 781 ~~~~~-------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
..... .+.+.+....+...+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 222 MGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000 01111111122223345567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=334.85 Aligned_cols=267 Identities=19% Similarity=0.261 Sum_probs=202.0
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
++|...+.||+|+||.||+|++..++..+|||++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36788889999999999999998888899999986542 2334668899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|++++.|..+.. ....+++..+..++.|++.||+||| ..+|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 81 YVEKNMLELLEE------------MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred cCCCCHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 999877654431 1235888999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH-------
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW------- 777 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~------- 777 (911)
+++....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+...
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07848 146 FARNLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223 (287)
T ss_pred Cccccccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHH
Confidence 9986433221 1122346889999999999989999999999999999999999999654321111111100
Q ss_pred -HhhhcccCCcccccCcccc------CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 778 -ARVSRARGTVDQIVDPRLR------GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 778 -~~~~~~~~~~~~i~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
...............+... ..........+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 224 QMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000001001100 0111224567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=336.25 Aligned_cols=285 Identities=22% Similarity=0.301 Sum_probs=221.9
Q ss_pred HHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh---hHHHHHHHHHHHHhcccccEeeecceeccCCceE
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ---GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 620 (911)
....+|...++||+|+||.||+++-++++..+|+|+|++.... ..+..+.|-.+|....+|+||+|+-.+.+...+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3557899999999999999999999999999999999887543 4456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
|||||++||++..+|.. ...|+.....-++.+++.|++-|| +.|+|||||||+|+|||..|++||
T Consensus 218 LiMEylPGGD~mTLL~~------------~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKL 282 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR------------KDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKL 282 (550)
T ss_pred EEEEecCCccHHHHHHh------------cCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEee
Confidence 99999999999999953 345888888888889999999999 899999999999999999999999
Q ss_pred eecCCccCCCC-----------------------CCCC----cc-----------------ccccccCcccccChhhhcc
Q 002533 701 SDFGLSRMGPS-----------------------GMSQ----SH-----------------VSTVVKGSFGYVDPEYIRR 736 (911)
Q Consensus 701 ~DFGla~~~~~-----------------------~~~~----~~-----------------~~~~~~gt~~y~APE~~~~ 736 (911)
+||||+.-... .... .. ......||+-|||||++.+
T Consensus 283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~ 362 (550)
T KOG0605|consen 283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG 362 (550)
T ss_pred ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence 99999842110 0000 00 0112469999999999999
Q ss_pred cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhccc
Q 002533 737 QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTD 816 (911)
Q Consensus 737 ~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~ 816 (911)
..|+..+|.||+|||+|||+.|.+||...........++.|......... ..+..+..+||.+|+.
T Consensus 363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 363 KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC 428 (550)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc
Confidence 99999999999999999999999999888766667777777654433221 1123566799999998
Q ss_pred ccCCCCCC---HHHHHHHHHHHHhhhHhhhccCCCCCCCCCCccccC
Q 002533 817 EEGFRRPT---MGDVTWGLEFALQLQEAAEKSDQGRPFVPRGEVITS 860 (911)
Q Consensus 817 ~dP~~RPs---~~eVl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~s 860 (911)
||++|-- +.||-++-=. +--+...-.+..+|++|.-.....
T Consensus 429 -d~~~RLG~~G~~EIK~HPfF--~~v~W~~l~~~~apfvP~v~~~~D 472 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKKHPFF--KGVDWDHLREMPAPFVPQVNSELD 472 (550)
T ss_pred -CHHHhcCcccHHHHhcCCcc--ccCCcchhhcCCCCCCCCCCCccc
Confidence 9999975 4444332100 001222233445677776554433
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=346.74 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=198.6
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.|...+.||+|+||+||+|+....+..||||++.... ....+.+.+|++++++++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4777889999999999999998888899999986532 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++|+|.+++... ..+++.....++.||+.||+||| ..+|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 82 YIPGGDMMSLLIRM------------EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred cCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCc
Confidence 99999999998532 34788888899999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCC--------------------------------------------CccccccccCcccccChhhhcccCCC
Q 002533 705 LSRMGPSGMS--------------------------------------------QSHVSTVVKGSFGYVDPEYIRRQQLT 740 (911)
Q Consensus 705 la~~~~~~~~--------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~t 740 (911)
+++....... .........||..|+|||++.+..++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 9753211000 00011234699999999999999999
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHh--ccccc
Q 002533 741 EKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGS--CTDEE 818 (911)
Q Consensus 741 ~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~--Cl~~d 818 (911)
.++|||||||++|||++|+.||...........+..|... +...........+.+++.+ |+..+
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------~~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT--------------LHIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc--------------cCCCCCCCCCHHHHHHHHHHccCccc
Confidence 9999999999999999999999654322221212111110 0000111233456677766 66777
Q ss_pred CCCCCCHHHHHHH
Q 002533 819 GFRRPTMGDVTWG 831 (911)
Q Consensus 819 P~~RPs~~eVl~~ 831 (911)
+..||++.+|+.+
T Consensus 293 ~~~R~~~~~~l~h 305 (381)
T cd05626 293 RLGRNGADDIKAH 305 (381)
T ss_pred ccCCCCHHHHhcC
Confidence 7789999999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.04 Aligned_cols=269 Identities=28% Similarity=0.439 Sum_probs=208.3
Q ss_pred CCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
+|...+.||+|+||.||+|.... +...+++|.+.... ....+++.+|+++++.++||||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 35667799999999999998743 23579999886543 3445679999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccc------------cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCC
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQN------------QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTN 689 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~------------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~N 689 (911)
++||+.+|+|.+++......... ........+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 99999999999998654321110 01112346899999999999999999999 7899999999999
Q ss_pred eeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccc
Q 002533 690 ILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVR 768 (911)
Q Consensus 690 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~ 768 (911)
||+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999754322111 11122345678999999998899999999999999999999 9988854321
Q ss_pred hhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 769 KEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 769 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
. .+..+ .....+...+..+...+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 236 ~---~~~~~-------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 E---RLFNL-------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H---HHHHH-------------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111 11111222233456788999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=333.65 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=206.2
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
|....+||+|.||.||||.+...++.||+|++.-. .....++..+|+.+|..++|+||.+++|.+..+..++++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 44456899999999999999999999999998754 34556788999999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|++.+.|. ....+++....-|+.++..||.||| ..+.+|||||+.|||+..++.+||+|||.+-
T Consensus 95 gGsv~~lL~------------~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 95 GGSVLDLLK------------SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred Ccchhhhhc------------cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceee
Confidence 999999994 2334578888889999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
....... ......||+.|||||+++...|+.|+||||||++.+||.+|.+|+.....- ++
T Consensus 160 ql~~~~~---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rv 219 (467)
T KOG0201|consen 160 QLTNTVK---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RV 219 (467)
T ss_pred eeechhh---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eE
Confidence 6433221 224567999999999999889999999999999999999999998654421 11
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.-++-+.-...+...+...+.+++..||+.||+.||++.+++++
T Consensus 220 lflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 220 LFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred EEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11122222222333566778999999999999999999999764
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.51 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=206.0
Q ss_pred cCCccceeecccCcEEEEEEEeecC---CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~---~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
++|...+.||+|+||.||+|.+... ...||||.++... .....+|.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 4677888999999999999998533 4689999987543 34456799999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++++|.+++... ...+++.++++++.|++.||+||| +.+|+|+||||+|||+++++.++|+|
T Consensus 84 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 84 TEYMENGSLDKFLREN-----------DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred EEcCCCCCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECc
Confidence 9999999999998532 235899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||....... +....
T Consensus 150 fg~~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~--- 221 (266)
T cd05033 150 FGLSRRLEDSEA-TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----VIKAV--- 221 (266)
T ss_pred cchhhccccccc-ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----HHHHH---
Confidence 999987531111 111222345678999999999999999999999999999998 999985432111 11110
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
.. ..+...+..++..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 222 ~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 ED----------GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred Hc----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 001112234567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.46 Aligned_cols=258 Identities=26% Similarity=0.452 Sum_probs=205.1
Q ss_pred cCCccceeecccCcEEEEEEEeecCC---eEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGS---ITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~---~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
++|+..+.||+|+||.||+|.+...+ ..+|+|.++.. .....+++.+|++++++++|+||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777889999999999999986433 37999998755 344456799999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++++|.+++... ...+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 85 TEYMENGALDKYLRDH-----------DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred EEcCCCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECC
Confidence 9999999999998532 235899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||++..................+..|+|||++....++.++|||||||++|||++ |+.||...... . +....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----~---~~~~i 223 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----E---VMKAI 223 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----H---HHHHH
Confidence 9998764332221111112223457999999998899999999999999999998 99998543211 1 11111
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
.. ..+......++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 ~~----------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 ND----------GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred hc----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 011122234567789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.46 Aligned_cols=268 Identities=27% Similarity=0.389 Sum_probs=204.9
Q ss_pred ccceeecccCcEEEEEEEe----ecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccC--CceEEE
Q 002533 550 ADHCIIGSGGFGHVFKGYI----DDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEMILV 622 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vykg~~----~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV 622 (911)
...+.||+|+||+||++.. ...+..||+|.++... ......|.+|+++|++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5667899999999988754 2345689999987543 34456788999999999999999999988653 468999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++|+|.+++.. ..++|.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|
T Consensus 87 ~e~~~~~~l~~~~~~-------------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~d 150 (283)
T cd05080 87 MEYVPLGSLRDYLPK-------------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGD 150 (283)
T ss_pred ecCCCCCCHHHHHHH-------------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEee
Confidence 999999999999842 24899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
||+++................++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .+..+.....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~ 228 (283)
T cd05080 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQGQM 228 (283)
T ss_pred cccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhccccccc
Confidence 99998654332211122223456679999999988999999999999999999999999754321111 1111111011
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
....+.+..+.......+..++..+.+++.+||+.+|++||++++|++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11112222333333334555678899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=339.29 Aligned_cols=238 Identities=24% Similarity=0.338 Sum_probs=193.4
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
||+|+||.||+|....++..||+|+++.. .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999888889999998643 234456788999999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 81 FHHLQR------------EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred HHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 999843 234888999999999999999999 78999999999999999999999999999985322
Q ss_pred CCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+......
T Consensus 146 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~-------- 208 (312)
T cd05585 146 D---DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQE-------- 208 (312)
T ss_pred C---CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcC--------
Confidence 1 112234568999999999999999999999999999999999999996432111 01111110
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eV 828 (911)
....+......+.+++.+||+.||++||++..+
T Consensus 209 ----~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 209 ----PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 011223345678899999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.64 Aligned_cols=262 Identities=27% Similarity=0.378 Sum_probs=205.2
Q ss_pred ccCCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCce
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 619 (911)
+++|...+.||+|+||.||+|.+.. ....|++|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4567888899999999999999976 56789999886543 34456799999999999999999999999988899
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC---
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW--- 696 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~--- 696 (911)
++||||+++++|.+++....... .....++|..+++++.||+.||+||| +.+++||||||+|||++.++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRP-----ERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCc
Confidence 99999999999999996553211 12235899999999999999999999 78999999999999998654
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHh
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~ 775 (911)
.+||+|||+++....... .........+..|+|||++.+..++.++|||||||++|||++ |+.||...... + +.
T Consensus 157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~---~~ 231 (277)
T cd05036 157 VAKIADFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-E---VM 231 (277)
T ss_pred ceEeccCccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-H---HH
Confidence 699999999986422111 111112223567999999999999999999999999999997 98988643311 1 11
Q ss_pred hHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.... ...+...+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 232 ---~~~~----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 ---EFVT----------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---HHHH----------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1000 11112223445677899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.79 Aligned_cols=269 Identities=28% Similarity=0.456 Sum_probs=211.0
Q ss_pred CCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
+|...+.||+|+||.||+|...+ ....+++|.+........+.+.+|++++++++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 46667799999999999998643 3356999999877777777899999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhccc----ccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQ----NQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
|||+++++|.+++........ .........++|..++.++.||+.||+||| +++|+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 999999999999965432110 001112345899999999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~ 777 (911)
+|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+| |+.||....... ...
T Consensus 163 ~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~- 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----VIE- 236 (291)
T ss_pred EECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH-
Confidence 9999999975432211 112233446788999999999999999999999999999999 999985433111 111
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
. . ..+.. ...+..++..+.+++.+||+.+|.+||++.+|+++|+.+..
T Consensus 237 -~-~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 -C-I-TQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -H-H-hCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0 0 01111 11122346678899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.15 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=197.8
Q ss_pred eecccCcEEEEEEEee--cCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCc
Q 002533 554 IIGSGGFGHVFKGYID--DGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~--~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 630 (911)
.||+|+||.||+|.+. +.+..||+|++.... ....++|.+|++++++++|+||++++++|.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999875 444579999987653 3345679999999999999999999998864 57899999999999
Q ss_pred hhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCC
Q 002533 631 LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710 (911)
Q Consensus 631 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 710 (911)
|.+++... ...+++..+++++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++...
T Consensus 81 L~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 81 LNKFLSGK-----------KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred HHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCcccccc
Confidence 99998532 235899999999999999999999 7899999999999999999999999999997543
Q ss_pred CCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCccc
Q 002533 711 SGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789 (911)
Q Consensus 711 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 789 (911)
.............++..|+|||++....++.++|||||||++||+++ |+.||....... .. ...
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~---~~~-------- 211 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----VM---SFI-------- 211 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----HH---HHH--------
Confidence 32221111122234578999999998899999999999999999996 999986543111 11 111
Q ss_pred ccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 790 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
....+...+..++..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 212 --~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 212 --EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11112233445678889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.99 Aligned_cols=269 Identities=30% Similarity=0.516 Sum_probs=208.2
Q ss_pred cCCccceeecccCcEEEEEEEeecCC--eEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGS--ITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~--~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 622 (911)
++|...++||+|+||.||+|.+..++ ..+++|.++.. .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46777889999999999999986654 35788888753 344556799999999999 799999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhccccc----ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQ----NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
+||+++|+|.+++.......... .......+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999996543211100 0112245899999999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~ 777 (911)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||....... + +
T Consensus 159 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----~--~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYV----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----L--Y 228 (297)
T ss_pred EECCcCCCcccccee----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----H--H
Confidence 999999986422110 1111223457999999999999999999999999999998 999986433111 0 0
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhh
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 839 (911)
.. .........+..++..+.+++.+||+.+|.+||++.++++.|+.+++..
T Consensus 229 ~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EK-----------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HH-----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 1111122233345677889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=339.00 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=192.1
Q ss_pred cceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 551 DHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 551 ~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
..+.||+|+||.||+|++...+..||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 3568999999999999998777899999986543 334567899999999999999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|.+.. .+.+..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++..
T Consensus 158 ~L~~~~----------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 158 SLEGTH----------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred cccccc----------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 986532 2456677889999999999999 789999999999999999999999999999864
Q ss_pred CCCCCCccccccccCcccccChhhhcc-----cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRR-----QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
..... ......||..|+|||++.. ...+.++|||||||+||||++|+.||...... .|.......
T Consensus 219 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-------~~~~~~~~~ 288 (353)
T PLN00034 219 AQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-------DWASLMCAI 288 (353)
T ss_pred ccccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-------cHHHHHHHH
Confidence 32211 1223468999999998753 23456899999999999999999999632211 111110000
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
........+..+...+.+++.+||+.||++||++.||+++
T Consensus 289 -------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 -------CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111233456678999999999999999999999875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.37 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=196.9
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
++||+|+||.||++....++..||+|+++.. .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999999888889999998653 2234456788999999999999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|..++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR------------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99988843 235889999999999999999999 789999999999999999999999999998753
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 789 (911)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... + +.....
T Consensus 146 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~--~~~~~~------- 209 (323)
T cd05595 146 ISD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----L--FELILM------- 209 (323)
T ss_pred cCC---CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----H--HHHHhc-------
Confidence 211 111223568999999999999999999999999999999999999996433111 0 000000
Q ss_pred ccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 790 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
.. ...+..+...+.+++.+||+.||++|| ++.+++++
T Consensus 210 ---~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 210 ---EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---CC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 00 012233456778999999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.78 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=200.6
Q ss_pred CCccceeecccCcEEEEEEEeecCCe----EEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSI----TVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~----~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
+|...+.||+|+||.||+|.+...+. .+++|.+.... .....++..|+.+++++.||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 45567789999999999999865443 47888876443 2344678889999999999999999998864 467889
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
+||+++|+|.+++... ...++|..++.++.||+.||+||| +.+++||||||+|||+++++.+||+|
T Consensus 87 ~e~~~~gsL~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 87 TQLSPLGSLLDHVRQH-----------RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred EEeCCCCcHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcC
Confidence 9999999999999532 235899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||+++....... ........++..|+|||.+.++.++.++|||||||++|||++ |+.||...... + +..+.
T Consensus 153 fg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~---~~~~~--- 224 (279)
T cd05111 153 FGVADLLYPDDK-KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-E---VPDLL--- 224 (279)
T ss_pred CccceeccCCCc-ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-H---HHHHH---
Confidence 999986433221 112234457788999999999999999999999999999998 99998543211 1 11110
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
....+...+..+...+.+++.+||..+|++||++.|+++.|+.+.+
T Consensus 225 ----------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 225 ----------EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ----------HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0111111122345677899999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=354.31 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=205.0
Q ss_pred CccceeecccCcEEEEEEEeecC-CeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDG-SITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~-~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
|...++||+|+||.||+|....+ +..||+|.+..........+.+|+++|+.++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 67788999999999999987665 67899998766665666678899999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.++|..... ...++++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 149 gg~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 149 GGDLNKQIKQRLK--------EHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred CCCHHHHHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 9999999864321 2346888999999999999999999 7899999999999999999999999999998
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .
T Consensus 218 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~--~-------- 282 (478)
T PTZ00267 218 QYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQ--Q-------- 282 (478)
T ss_pred ecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH--H--------
Confidence 6433211 12233456999999999999999999999999999999999999998543211 0100 0
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+..... ...+..+...+.+++.+||+.+|++||++.+++..
T Consensus 283 --~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 283 --VLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --HHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 000000 11223345678899999999999999999998753
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.34 Aligned_cols=270 Identities=29% Similarity=0.442 Sum_probs=210.4
Q ss_pred cCCccceeecccCcEEEEEEEee-----cCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID-----DGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
.+|...+.||+|+||.||++... .....+|+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46777889999999999999852 3346799999987766667789999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccc-cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQN-QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~-~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
||||+++++|.+++......... ........+++.+++.++.|++.||+||| ..+++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 99999999999999644321111 11112345999999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||....... ... .
T Consensus 162 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~~~--~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIE--C 234 (288)
T ss_pred ccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH--H
Confidence 99999975432211 111223345678999999999999999999999999999999 888885433111 100 0
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
. . .+.. ...+..++..+.+++.+||+.+|.+||++.+|.+.|+.+.+
T Consensus 235 i-~-~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 I-T-QGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred H-H-cCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 0 0 0000 01122345678999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.17 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=208.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
.+|...+.||+|+||.||+|+...++..||||.+... .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4677888999999999999999877789999987542 3344567899999999999999999999999889999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+|||++.++.++|+||
T Consensus 82 e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 82 ELADAGDLSQMIKYFKK--------QKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred EecCCCcHHHHHHHhhh--------ccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 99999999998854321 2345788899999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|++....... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ..+......
T Consensus 151 g~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~~ 222 (267)
T cd08228 151 GLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FSLCQKIEQ 222 (267)
T ss_pred ccceeccchh---HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HHHHHHHhc
Confidence 9987643221 11123457889999999998889999999999999999999999985433211 111111111
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
. .............+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 223 ~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 223 C---------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0 011111223457789999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=341.15 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=196.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC-----CceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH-----GEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~ 620 (911)
+|...++||+|+||.||+|....++..||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 366778999999999999999888889999998643 223445788999999999999999999987432 2479
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||+. ++|.+++.. ...+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||
T Consensus 81 lv~e~~~-~~L~~~l~~------------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 81 VVFELME-SDLHQVIKA------------NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred EEEecCC-CCHHHHHHh------------cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEE
Confidence 9999995 689888842 234889999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcc--cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh-H
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR--QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL-W 777 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~-~ 777 (911)
+|||+++................|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... .
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~ 223 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDL 223 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHH
Confidence 999999854322211122234568999999999876 678999999999999999999999996533211 100000 0
Q ss_pred --------HhhhcccCCcccc---cCccccCC---CChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 778 --------ARVSRARGTVDQI---VDPRLRGK---IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 --------~~~~~~~~~~~~i---~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..... .....+. +.+..... ..+.....+.+++.+||+.||++||++.|++++
T Consensus 224 ~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 224 LGTPSPETISRVR-NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hCCCCHHHHHHhh-hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0000000 00000000 001234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.53 Aligned_cols=236 Identities=24% Similarity=0.401 Sum_probs=199.1
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||.|+||.|.+++.+.++..+|+|+++... ....+...+|..+|+.+.||.++++++.|.+.+.++||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 4556789999999999999999888999999997653 3445567899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|++||-|..+|+.. ..++.....=+|.+|+.||+||| +.+|++|||||+|||||.+|.+||.|||
T Consensus 125 yv~GGElFS~Lrk~------------~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 125 YVPGGELFSYLRKS------------GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred ccCCccHHHHHHhc------------CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEecc
Confidence 99999999999654 34888888899999999999999 7999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+|+.... .....+||+.|+|||.+..+.++..+|.|||||++|||+.|.+||..... +..+.....
T Consensus 190 FAK~v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~-- 255 (355)
T KOG0616|consen 190 FAKRVSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILE-- 255 (355)
T ss_pred ceEEecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHh--
Confidence 9986432 24567899999999999999999999999999999999999999976442 222222222
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCC
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRR 822 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 822 (911)
..+ .+|.-....+.+|+...++.|-.+|
T Consensus 256 --------~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 --------GKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 222 2344445567788888888888888
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.64 Aligned_cols=248 Identities=29% Similarity=0.401 Sum_probs=196.6
Q ss_pred eecccCcEEEEEEEee--cCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 554 IIGSGGFGHVFKGYID--DGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~--~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
.||+|+||.||+|.+. .++..+|+|+++... ....+++.+|+.+++++.|+||+++++++.. ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 445789999986442 3445679999999999999999999998864 5678999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|.+++.. ...+++..+++++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~------------~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 81 PLNKFLQK------------NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred cHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 99999842 234889999999999999999999 789999999999999999999999999999864
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
..............++..|+|||.+....++.++|||||||++|||++ |+.||..... . .+.. ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~---~~~~---~i------- 211 (257)
T cd05116 146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-N---EVTQ---MI------- 211 (257)
T ss_pred CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-H---HHHH---HH-------
Confidence 333221111122234578999999988889999999999999999998 9999854321 1 1111 11
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
....+...+..++..+.+++.+||+.||++||++.+|.+.|+.
T Consensus 212 ---~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 212 ---ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---HCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1111222334566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=337.96 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=197.8
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
++||+|+||.||++.....+..||||++... .......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999999888889999998753 2334567889999999999999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSR------------ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99988842 235889999999999999999999 789999999999999999999999999998753
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 789 (911)
... ........||+.|+|||++.+..++.++|||||||+||||++|+.||....... ... .....
T Consensus 146 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-~~~-----~~~~~------ 210 (328)
T cd05593 146 ITD---AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFE-----LILME------ 210 (328)
T ss_pred CCc---ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-HHH-----HhccC------
Confidence 211 111234568999999999999999999999999999999999999996533111 000 00000
Q ss_pred ccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 790 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
+ ..++......+.+++.+||+.||.+|| ++.+++++
T Consensus 211 --~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 --D----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --C----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 112233456788999999999999997 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.88 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=199.6
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
++|...+.||+|+||.||++.+..+ ..+|+|.+.... ...++|.+|++++++++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccC-ceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 3466778899999999999998765 579999886443 23467889999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.++++.. ...++|..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++
T Consensus 82 ~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 82 ENGCLLNYLRQR-----------QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred CCCcHHHHHHhC-----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCc
Confidence 999999988532 124889999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....... ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----~~~~~i~---~~- 217 (256)
T cd05114 148 RYVLDDEY--TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----EVVEMIS---RG- 217 (256)
T ss_pred cccCCCce--eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH---CC-
Confidence 75432211 11122235668999999998899999999999999999999 88898543311 1111110 00
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
. +...+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 218 ~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 F---------RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C---------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 0111222345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.08 Aligned_cols=266 Identities=27% Similarity=0.427 Sum_probs=207.4
Q ss_pred cCCccceeecccCcEEEEEEEeecC-----CeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG-----SITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~-----~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 620 (911)
.+|...+.||+|+||.||+|...+. ...||||.++..... ..+.|.+|+++|++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 3466677899999999999987433 468999998765443 5578999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhccccc--ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQ--NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~--~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
+||||+++|+|.+++.......... .......+++.++..++.|++.||+||| ..+++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999996543211110 1123456899999999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~ 777 (911)
||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 162 kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----VIEC 236 (280)
T ss_pred EECCcccceecccCcc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHH
Confidence 9999999875322111 111223345678999999999999999999999999999999 999986433111 1111
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.. .+. ....+..++..+.+++.+||+.||++||++.||++.|+
T Consensus 237 ~~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 IT----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 110 11112335677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=338.87 Aligned_cols=270 Identities=29% Similarity=0.412 Sum_probs=205.3
Q ss_pred CCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCC-hhhHHHHHHHHHHHHhc-ccccEeeecceecc-CCce
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSS-MQGAREFRTEIEMISEL-RHLHIVSLLGFCDE-HGEM 619 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~-~~~~ 619 (911)
+|...++||+|+||.||+|...+ .+..||+|+++... ....+.+.+|++++.++ +|+||++++++|.. +...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 56778899999999999997543 23679999987543 33446688999999999 89999999998854 4678
Q ss_pred EEEEeecCCCchhhHhhhhhhcccc-------------------------------------------------cccCCC
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQN-------------------------------------------------QNQNQN 650 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~-------------------------------------------------~~~~~~ 650 (911)
+++|||+++|+|.++|......... ......
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999998643211000 000012
Q ss_pred CCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccccC
Q 002533 651 SPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730 (911)
Q Consensus 651 ~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~A 730 (911)
..++|..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++........ .......++..|+|
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y~a 243 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMA 243 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccccC
Confidence 36899999999999999999999 789999999999999999999999999999864332211 11223446678999
Q ss_pred hhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHH
Q 002533 731 PEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVE 809 (911)
Q Consensus 731 PE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 809 (911)
||++.+..++.++|||||||+||||++ |+.||....... . + ..... ...+...+..+...+.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~--~---~~~~~----------~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E--F---CRRLK----------EGTRMRAPEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H--H---HHHHh----------ccCCCCCCccCCHHHHH
Confidence 999999999999999999999999998 999985432111 0 0 01100 01111122334567899
Q ss_pred HHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 810 IAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 810 li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
++.+||+.+|++||++.||+++|+.+++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.44 Aligned_cols=255 Identities=28% Similarity=0.494 Sum_probs=204.1
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
..+|...+.||+|+||.||+|.+..+ ..||||.++... ...+++.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCC-eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 34577788999999999999997665 579999987543 3356789999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++... ....++|..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 83 MKYGSLLEYLQGG----------AGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred ccCCcHHHHHhcc----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcce
Confidence 9999999998532 1245899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++......... ......+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+. ...
T Consensus 150 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~--~~~---- 217 (261)
T cd05068 150 ARVIKEDIYEA--REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVL--QQV---- 217 (261)
T ss_pred EEEccCCcccc--cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHH--HHH----
Confidence 98653221111 111223457999999999999999999999999999999 88888543211 010 000
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
+.......+..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 218 -------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 218 -------DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -------HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011112233456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=324.32 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=203.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||+|...++ ..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCC-ceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4577788999999999999997655 579999986543 34568999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.+++... ....+++.+++.++.|++.||+||| ..+++||||||+||+++.++.++|+|||++
T Consensus 84 ~~~~L~~~l~~~----------~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 84 AKGSLLDFLKSD----------EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred CCCcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccc
Confidence 999999998543 2345788899999999999999999 789999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+....... .......++..|+|||++....++.++|||||||++|||++ |+.||...... ....+.. . .
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~---~-~ 220 (261)
T cd05072 151 RVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSALQ---R-G 220 (261)
T ss_pred eecCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHHH---c-C
Confidence 86433211 11122345678999999998899999999999999999998 89998543211 1111110 0 0
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
.+......++..+.+++.+||..+|++||++.++.+.|+.
T Consensus 221 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 221 ---------YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111122345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.94 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=205.1
Q ss_pred HccCCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCc
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGE 618 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 618 (911)
++++|...+.||+|+||.||+|.+.+ .+..||||++... ......+|.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678888999999999999998643 2457999998643 33445678999999999999999999999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
.++||||+++|+|.+++......... ......++|..++.++.|++.||+||| +.+++||||||+|||+++++.+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMEN--NPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccc--cccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence 99999999999999999653221110 011245788999999999999999999 6899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~ 777 (911)
+|+|||+++........ .......++..|+|||++.++.++.++|||||||++|||++ |..||..... .+ ...+
T Consensus 159 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~---~~~~ 233 (277)
T cd05062 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQ---VLRF 233 (277)
T ss_pred EECCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HH---HHHH
Confidence 99999998754322111 11112345678999999999999999999999999999999 6788754321 11 1110
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.... .. ...+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 234 ---~~~~---------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 ---VMEG---------GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---HHcC---------Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000 00 1122345667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.43 Aligned_cols=271 Identities=28% Similarity=0.434 Sum_probs=210.4
Q ss_pred HccCCccceeecccCcEEEEEEEeecC-----CeEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCC
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDG-----SITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHG 617 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~-----~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 617 (911)
...+|...+.||+|+||.||++...+. ...+|+|.+... ..+...++.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 345677788999999999999987643 368999998754 334456789999999999 8999999999999999
Q ss_pred ceEEEEeecCCCchhhHhhhhhhccccc----ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeec
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQ----NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD 693 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 693 (911)
..+++|||+++|+|.+++.......... .......+++..+++++.|++.||+||| +.+|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 9999999999999999996542211110 1123457899999999999999999999 78999999999999999
Q ss_pred CCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhh
Q 002533 694 ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEV 772 (911)
Q Consensus 694 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~ 772 (911)
+++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-F 244 (293)
T ss_pred CCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-H
Confidence 999999999999986433211 111122335678999999999999999999999999999998 8888854331110 0
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
. .+........+..+...+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 245 ------~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 ------K----------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------H----------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 00011111233345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=334.46 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=202.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
++|...+.||+|+||.||++.+..++..+|+|.+... .......+.+|++++++++|+||++++++|..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 5788888999999999999999888889999988754 334456799999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++|+|.+++.. ...+++.....++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~L~~~l~~------------~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 85 MDGGSLDQVLKK------------AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred CCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 999999999843 2347888899999999999999994 35799999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh-----hHHhh
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV-----LWARV 780 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~-----~~~~~ 780 (911)
++..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+. .+...
T Consensus 151 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 151 SGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred chhhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 8753221 1123468899999999999899999999999999999999999986433111100000 00000
Q ss_pred hc--ccC-----------------CcccccCcccc---CCCC-hHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 781 SR--ARG-----------------TVDQIVDPRLR---GKIA-PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 781 ~~--~~~-----------------~~~~i~d~~l~---~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. ... ....+.+.... ...+ ......+.+++.+||+.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 000 00000000000 0000 1124568899999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=324.60 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=200.2
Q ss_pred ccceeecccCcEEEEEEEeecCCe--EEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC------Cce
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGSI--TVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH------GEM 619 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vykg~~~~~~~--~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~ 619 (911)
...++||+|+||.||+|.+...+. .+|+|.++.. .....+.+.+|++++++++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999876543 6899988653 345567899999999999999999999987432 256
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
+++|||+++|+|.+++...... .....+++...+.++.|++.||+||| +++|+||||||+|||+++++.+|
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLG------DCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhccc------CCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEE
Confidence 8999999999999988543211 12345899999999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHH
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||..... . .+ +.
T Consensus 153 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~---~~--~~ 225 (272)
T cd05075 153 VADFGLSKKIYNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-S---EI--YD 225 (272)
T ss_pred ECCCCcccccCcccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-H---HH--HH
Confidence 999999986432211 111122345678999999999999999999999999999999 7888854221 1 11 11
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
... . +. ....+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 226 ~~~-~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 YLR-Q-GN---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHH-c-CC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 1 00 0112234566789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=353.83 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=207.2
Q ss_pred HHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCC--
Q 002533 542 IKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG-- 617 (911)
Q Consensus 542 l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~-- 617 (911)
++....+|...++||+|+||+||+|+...++..||||++... .......+.+|+.++..++|+||+++...+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344456888999999999999999999877789999998643 3455667889999999999999999987764322
Q ss_pred ------ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCee
Q 002533 618 ------EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNIL 691 (911)
Q Consensus 618 ------~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 691 (911)
.+++||||+++|+|.++|..... ....+++..+..++.|++.||+||| +.+|+||||||+|||
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~--------~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NIL 175 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAK--------TNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANIL 175 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEE
Confidence 36899999999999999964321 2346889999999999999999999 789999999999999
Q ss_pred ecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhh
Q 002533 692 LDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771 (911)
Q Consensus 692 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~ 771 (911)
++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 176 l~~~~~vkL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-- 252 (496)
T PTZ00283 176 LCSNGLVKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-- 252 (496)
T ss_pred EeCCCCEEEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--
Confidence 99999999999999986432211 122234569999999999999999999999999999999999999996432110
Q ss_pred hhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 772 VSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..... ... .....+..++..+.+++.+||+.||.+||++.+++.+
T Consensus 253 -----~~~~~---------~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 -----VMHKT---------LAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----HHHHH---------hcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 01100 000 0112334456778999999999999999999999864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.30 Aligned_cols=248 Identities=27% Similarity=0.468 Sum_probs=198.4
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchh
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 632 (911)
.||+|+||.||+|.+...+..+|+|..... .......+.+|++++++++||||++++++|......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 699999999999999877789999987644 3345567999999999999999999999999999999999999999999
Q ss_pred hHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCC
Q 002533 633 DHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 633 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 712 (911)
+++... ...+++.+++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 82 TFLRTE-----------GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred HHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence 998432 234889999999999999999999 789999999999999999999999999998754322
Q ss_pred CCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 713 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
.. .........+..|+|||.+.++.++.++|||||||++|||++ |..||...... ... . ..
T Consensus 148 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-~~~------~----------~~ 209 (252)
T cd05084 148 VY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-QTR------E----------AI 209 (252)
T ss_pred cc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-HHH------H----------HH
Confidence 11 111111223457999999999999999999999999999998 88887532211 100 0 00
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
....+...+..++..+.+++.+||+.+|++||++.+|.++|+
T Consensus 210 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111122233445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=342.36 Aligned_cols=269 Identities=26% Similarity=0.397 Sum_probs=207.1
Q ss_pred CCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSS-MQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 620 (911)
++...+.||+|+||.||+|++.+ ....||||+++... ....+.+.+|+++|.++. ||||++++++|...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 45567799999999999999643 34579999997653 233457889999999997 999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhcccc--------------------------------------------------------
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQN-------------------------------------------------------- 644 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~-------------------------------------------------------- 644 (911)
+||||+++|+|.++|+........
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 999999999999999764321000
Q ss_pred ------------------------------cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC
Q 002533 645 ------------------------------QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE 694 (911)
Q Consensus 645 ------------------------------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 694 (911)
........++|..+++++.|++.||+||| ..+++||||||+|||+++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeC
Confidence 00012245788899999999999999999 789999999999999999
Q ss_pred CCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhh
Q 002533 695 NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVS 773 (911)
Q Consensus 695 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~ 773 (911)
++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.........
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~-- 351 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-- 351 (401)
T ss_pred CCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--
Confidence 999999999999754322111 11122346788999999999899999999999999999998 88888543211110
Q ss_pred HhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 774 LVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 774 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
+ +.+....+...+..+...+.+++.+||+.+|.+||++++|++.|+.++
T Consensus 352 ---~-----------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 ---Y-----------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---H-----------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 001111122233445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=327.30 Aligned_cols=265 Identities=29% Similarity=0.436 Sum_probs=204.2
Q ss_pred CCccceeecccCcEEEEEEEee----cCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYID----DGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~----~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
+|+..+.||+|+||.||+|... .....|++|.+... ..+...++.+|++++++++||||+++++++..+...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 4666789999999999999852 33468999998753 344556799999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccc-----cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQN-----QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~-----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
|||+++|+|.+++......... ........+++.+.+.++.|++.||+||| +.+++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCc
Confidence 9999999999998643211100 00011345889999999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~ 776 (911)
+||+|||+++....... ........++..|+|||++.+..++.++|||||||+||||++ |..||..... . .+..
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~---~~~~ 237 (283)
T cd05090 163 VKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-Q---EVIE 237 (283)
T ss_pred EEeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-H---HHHH
Confidence 99999999976432211 111223345678999999998899999999999999999998 8888854321 1 1111
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
. ++.......+..++..+.+++.+||+.+|++||++.+|.++|.
T Consensus 238 ~-------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 238 M-------------VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred H-------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 0 0011111223345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.00 Aligned_cols=265 Identities=23% Similarity=0.370 Sum_probs=199.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
.+|...++||+|+||.||+|....++..||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 35777889999999999999998888899999986443 22345678999999999999999999999988899999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++ |+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~-~~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 85 LD-SDLKQYLDNC-----------GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred CC-cCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence 97 5998888432 234788899999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh--------
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL-------- 776 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~-------- 776 (911)
++...... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 150 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 225 (288)
T cd07871 150 ARAKSVPT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTE 225 (288)
T ss_pred eeeccCCC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence 87532211 11223457889999999875 568999999999999999999999996543221 111110
Q ss_pred --HHhhhcccCCcccccCccccC----CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 --WARVSRARGTVDQIVDPRLRG----KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 --~~~~~~~~~~~~~i~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|.... ..........+..+. ...+.....+.+++.+|++.||.+|||+.|++++
T Consensus 226 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 226 ETWPGIT-SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHhhccc-cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 10000 000001111111110 0011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=328.62 Aligned_cols=273 Identities=24% Similarity=0.368 Sum_probs=204.0
Q ss_pred cCCccceeecccCcEEEEEEEeecC--------------CeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecc
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG--------------SITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLG 611 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~--------------~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g 611 (911)
.+|...+.||+|+||.||++...+. ...||||.++.. .......|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4577778999999999999987542 235899998754 3344567999999999999999999999
Q ss_pred eeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCee
Q 002533 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNIL 691 (911)
Q Consensus 612 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 691 (911)
++......++||||+++++|.+++.................++|..+++++.|+++||+||| +.+++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 99999999999999999999999964322111111122345789999999999999999999 789999999999999
Q ss_pred ecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh--CCCCCCCCccch
Q 002533 692 LDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC--GRPPMINGAVRK 769 (911)
Q Consensus 692 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt--G~~p~~~~~~~~ 769 (911)
+++++.+||+|||+++....... ........++..|+|||++..+.++.++|||||||++|||++ +..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875432211 111222345678999999999999999999999999999998 556664322111
Q ss_pred hhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 770 EEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 770 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.+.......... ........+..++..+.+++.+||+.+|++||+|.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ---VIENTGEFFRNQ-------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHhhhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 010000000000 000111122334578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=303.65 Aligned_cols=248 Identities=28% Similarity=0.438 Sum_probs=207.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|..++.||+|-||.||.|+.+.+.-.||+|++..... +..+++.+|+++-+.|+||||+++++++.+....||++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 57779999999999999999998888999999875532 334679999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|.++|.|...|... ....++......+..|+|.||.|+| .++|+||||||+|+|++.++..||+|||
T Consensus 103 ya~~gel~k~L~~~----------~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 103 YAPRGELYKDLQEG----------RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred ecCCchHHHHHHhc----------ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 99999999999643 2334777788899999999999999 8999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
-+...+ .......+||..|.+||+..+..++.+.|+|++|++.||++.|.+||....... .+.+...
T Consensus 170 wsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI~k-- 236 (281)
T KOG0580|consen 170 WSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRIRK-- 236 (281)
T ss_pred ceeecC-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHHHH--
Confidence 987643 233356789999999999999999999999999999999999999996544111 1111111
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+..++........+++.+|+..+|.+|.+..||+..
T Consensus 237 ----------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 ----------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1122234445667899999999999999999999865
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=323.95 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=202.6
Q ss_pred CccceeecccCcEEEEEEEeecC---CeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCc-----
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGE----- 618 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~---~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~----- 618 (911)
|...++||+|+||.||+|.+... ...||||+++.. .......+.+|++.+++++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45567899999999999998643 367999998743 33445679999999999999999999998865544
Q ss_pred -eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 619 -MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 619 -~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
.++++||+++|+|..++...... .....+++..++.++.|++.||+||| +.+++||||||+||++++++.
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~------~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~ 151 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG------GLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMT 151 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc------CCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCe
Confidence 79999999999999998654321 12346899999999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~ 776 (911)
+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..
T Consensus 152 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~ 226 (273)
T cd05035 152 VCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYD 226 (273)
T ss_pred EEECCccceeeccccccc-cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence 999999999864332211 11122335678999999998999999999999999999999 88887543211 1111
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
+.. .. .....+..+...+.+++.+||+.||.+||++.||++.|+.+
T Consensus 227 ~~~---~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLR---HG----------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHH---cC----------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 00 01122334567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.72 Aligned_cols=250 Identities=30% Similarity=0.438 Sum_probs=198.8
Q ss_pred eeecccCcEEEEEEEeecCC---eEEEEEEccCCCh-hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGS---ITVAVKRLNTSSM-QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~---~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||+|.+...+ ..+|+|.+..... ...+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999875543 6899999876543 34567999999999999999999999876 4568999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|.+++... ..+++..++.++.|++.||+||| ..+++|+||||+|||++.++.+||+|||+++.
T Consensus 80 ~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~ 144 (257)
T cd05060 80 GPLLKYLKKR------------REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRA 144 (257)
T ss_pred CcHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccce
Confidence 9999999532 25889999999999999999999 78999999999999999999999999999986
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
...............++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+..+....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~~~------ 214 (257)
T cd05060 145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLESG------ 214 (257)
T ss_pred eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcC------
Confidence 5333222111222234567999999999999999999999999999998 9999854321 1111111100
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
.....+..++..+.+++.+||..+|++||++.+|++.|+.+
T Consensus 215 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 215 -------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01122334567788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=334.84 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=193.4
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHH---HhcccccEeeecceeccCCceEEE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMI---SELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l---~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
|...++||+|+||.||+|.+..++..||||+++... ....+.+.+|++++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 455678999999999999998888899999986432 22344566666654 567899999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++|+|..+++ ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 81 ~E~~~~~~L~~~~~-------------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 81 MEYAAGGDLMMHIH-------------TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred EcCCCCCcHHHHhh-------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCc
Confidence 99999999988873 235899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
||+++..... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... +. ..
T Consensus 145 fg~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----~~---~~-- 212 (324)
T cd05589 145 FGLCKEGMGF---GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----VF---DS-- 212 (324)
T ss_pred ccCCccCCCC---CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----HH---HH--
Confidence 9998753221 112234568999999999999999999999999999999999999996433111 00 00
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTW 830 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~ 830 (911)
+.... ...+..+...+.+++.+||+.||.+||+ +.++++
T Consensus 213 -------i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 213 -------IVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------HHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00000 1122334567789999999999999995 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.80 Aligned_cols=265 Identities=21% Similarity=0.299 Sum_probs=194.0
Q ss_pred CCccceeecccCcEEEEEEEee-cCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhc---ccccEeeecceec-----cC
Q 002533 548 DFADHCIIGSGGFGHVFKGYID-DGSITVAVKRLNTSS--MQGAREFRTEIEMISEL---RHLHIVSLLGFCD-----EH 616 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~-~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~-----~~ 616 (911)
+|...+.||+|+||.||+|+.. .++..||||+++... ......+.+|+++++++ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5777889999999999999974 345789999886432 22234566777777665 6999999999884 34
Q ss_pred CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC
Q 002533 617 GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 617 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 696 (911)
...++||||+. ++|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV----------PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSG 147 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCC
Confidence 56899999995 6999988532 2335889999999999999999999 78999999999999999999
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
.+||+|||+++..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........-..+..
T Consensus 148 ~~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 148 QIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred CEEEccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 9999999999764322 122345689999999999999999999999999999999999999965432211111111
Q ss_pred HHhhhcccCCc------ccccCcccc---CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 777 WARVSRARGTV------DQIVDPRLR---GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 777 ~~~~~~~~~~~------~~i~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
........... .....+... ....+.....+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 10000000000 000000000 0011234566789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=325.93 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=197.2
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
||+|+||+||++.....+..+|+|++..... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999988878999999864322 2345678899999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
..++..... ....+++..++.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~~~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDE--------ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccc--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 988854321 3346899999999999999999999 78999999999999999999999999999875433
Q ss_pred CCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+. . .+.
T Consensus 150 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~---------~~~ 214 (280)
T cd05608 150 GQS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---Q---------RIL 214 (280)
T ss_pred CCc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---H---------hhc
Confidence 221 1223468999999999999999999999999999999999999996432111111000 0 011
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
... ...+...+..+.+++.+||+.||++|| ++.+++++
T Consensus 215 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 110 112334566788999999999999999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=339.86 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=206.1
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+..++.||+|+-|.|.+|++..+++.+|||++... .......+.+||-+|+-|.|||++++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 34466899999999999999999999999998655 222344578999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++|-|.++|. ..+++.+.+..+++.||+.|+.|+| ..+|+||||||+|+|||.++.+||+|||+
T Consensus 94 v~gGELFdylv------------~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 94 VPGGELFDYLV------------RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred cCCchhHHHHH------------hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccce
Confidence 99999999995 3456999999999999999999999 79999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCC-CchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
|.+...+ .....-+|++.|.|||++.+.+| +.++||||.||+||.|+||+.||+++.... |.. + .+.
T Consensus 159 AsLe~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~----LLl--K--V~~ 226 (786)
T KOG0588|consen 159 ASLEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV----LLL--K--VQR 226 (786)
T ss_pred eecccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH----HHH--H--HHc
Confidence 9874332 23345679999999999999988 469999999999999999999997533211 111 0 001
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
|. -++|...+.+..+|+.+++..||++|.|+.||+++.
T Consensus 227 G~----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 GV----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred Cc----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 11 123455567778999999999999999999998763
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=332.45 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=191.1
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||+|...+++..||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999998888899999986432 23344556677777654 899999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~~~~~------------~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 81 GDLMFHIQSS------------GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 9999888432 34788889999999999999999 78999999999999999999999999999975
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... +. ......
T Consensus 146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----~~--~~i~~~----- 211 (316)
T cd05592 146 NMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----LF--DSILND----- 211 (316)
T ss_pred CCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----HH--HHHHcC-----
Confidence 32211 22234568999999999999999999999999999999999999996533111 10 000000
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHH-HHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG-DVT 829 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eVl 829 (911)
....+..+...+.+++.+||+.||.+||++. +++
T Consensus 212 -------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 -------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1122333456678999999999999999986 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=330.05 Aligned_cols=268 Identities=31% Similarity=0.513 Sum_probs=206.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCC--eEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGS--ITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~--~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 622 (911)
++|...+.||+|+||.||+|.+...+ ..+++|.++.. .....+.+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777889999999999999986544 35688887643 344556789999999999 899999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhccccc----ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQ----NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
|||+++|+|.++++......... .......+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999996543211110 0112346899999999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~ 777 (911)
||+|||+++...... ......++..|+|||++.+..++.++|||||||+||||+| |..||....... ..
T Consensus 164 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~-- 233 (303)
T cd05088 164 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LY-- 233 (303)
T ss_pred EeCccccCcccchhh----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH----HH--
Confidence 999999986421110 1111234567999999988889999999999999999998 999985432111 10
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhh
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 838 (911)
.... ...+...+..++..+.+++.+||+.+|++||++.++++.|+.++..
T Consensus 234 -~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 -EKLP----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred -HHHh----------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 0011112223456788999999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.79 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=204.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||.||+|+...++..||||+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36778889999999999999998777899999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++... ..+++..+..++.||+.||+||| ..+|+||||||+|||++.++.+||+||
T Consensus 81 e~~~~~~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 81 EYMPGGDLMNLLIRK------------DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred cCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecC
Confidence 999999999999532 35888999999999999999999 799999999999999999999999999
Q ss_pred CCccCCCCCC--------------------------CCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh
Q 002533 704 GLSRMGPSGM--------------------------SQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC 757 (911)
Q Consensus 704 Gla~~~~~~~--------------------------~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt 757 (911)
|+++...... ..........||..|+|||++.+..++.++|||||||+||||++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9997643322 00112234568999999999999999999999999999999999
Q ss_pred CCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-HHHHHHH
Q 002533 758 GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-MGDVTWG 831 (911)
Q Consensus 758 G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~eVl~~ 831 (911)
|+.||...........+..|. ..+........+..+.+++.+|+. +|.+||+ +.+++++
T Consensus 226 g~~Pf~~~~~~~~~~~i~~~~--------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 226 GFPPFYSDTLQETYNKIINWK--------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCCHHHHHHHHhccC--------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999996544211111111110 011111111145678899999997 9999999 9999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=327.61 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=200.9
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
|...++||+|+||.||++....++..||||++..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 6667899999999999999887778999999865422 2234578899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||+
T Consensus 82 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 82 MNGGDLKFHIYNM----------GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred cCCCcHHHHHHhc----------CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999888532 2235889999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 149 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~---- 217 (285)
T cd05605 149 AVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRV---- 217 (285)
T ss_pred ceecCCCC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHh----
Confidence 87643221 11234688999999999999999999999999999999999999965321110 00000000
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
. ......+...+..+.+++.+||+.||++|| ++.+++++
T Consensus 218 ------~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 218 ------K-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ------h-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 001122334456788999999999999999 78788665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=334.76 Aligned_cols=238 Identities=24% Similarity=0.361 Sum_probs=188.4
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHH-HHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIE-MISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||+|+...++..||+|++.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999998888899999986432 122344555654 57889999999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|..++.. ...+++..+..++.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 81 GELFFHLQR------------ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 999888842 234778888899999999999999 78999999999999999999999999999875
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ....
T Consensus 146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~--~~~i-------- 208 (321)
T cd05603 146 GVEP---EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----M--YDNI-------- 208 (321)
T ss_pred CCCC---CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----H--HHHH--------
Confidence 3211 112234568999999999999999999999999999999999999996533111 0 0010
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG 826 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 826 (911)
.... ...+......+.+++.+||+.||.+||+..
T Consensus 209 --~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 --LHKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --hcCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1000 112333456788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.08 Aligned_cols=259 Identities=31% Similarity=0.530 Sum_probs=200.4
Q ss_pred eecccCcEEEEEEEeecCCe--EEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCCC
Q 002533 554 IIGSGGFGHVFKGYIDDGSI--TVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~--~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
+||+|+||.||+|.+.+++. .+++|.++.. .....+.+.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 69999999999999876543 5789988753 344556789999999999 8999999999999999999999999999
Q ss_pred chhhHhhhhhhcccc----cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 630 NLRDHLYNSQKQNQN----QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 630 sL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+|.+++......... ........+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999654321110 00112345889999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++..... ........+..|+|||++....++.++|||||||++|||++ |..||....... .. ...
T Consensus 159 ~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~---~~~--- 224 (270)
T cd05047 159 SRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LY---EKL--- 224 (270)
T ss_pred ccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH----HH---HHH---
Confidence 8632111 11111234567999999998999999999999999999997 999985432111 00 000
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
....+...+..+...+.+++.+||+.+|.+||++.++++.|+.++
T Consensus 225 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 011111122334567889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=342.82 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=197.0
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||+|+||.||+++....+..||||++.... ......+.+|+++|++++|+||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6788899999999999999998888899999986432 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++|+|.+++.. ...+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~g~L~~~i~~------------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 82 YIPGGDMMSLLIR------------LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred CCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999843 234778888889999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCC----------------------------------------CccccccccCcccccChhhhcccCCCchhH
Q 002533 705 LSRMGPSGMS----------------------------------------QSHVSTVVKGSFGYVDPEYIRRQQLTEKSD 744 (911)
Q Consensus 705 la~~~~~~~~----------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~t~ksD 744 (911)
++........ .........||+.|||||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 9753210000 000112346999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-
Q 002533 745 VYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP- 823 (911)
Q Consensus 745 VwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP- 823 (911)
||||||+||||++|+.||...........+..|.. .+...........+.+++.+|+ .+|.+|+
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWET--------------TLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCc--------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 99999999999999999965432211111111110 0000111123445667777766 4999999
Q ss_pred --CHHHHHHH
Q 002533 824 --TMGDVTWG 831 (911)
Q Consensus 824 --s~~eVl~~ 831 (911)
++.+++.+
T Consensus 292 ~~t~~ell~h 301 (376)
T cd05598 292 KNGADEIKAH 301 (376)
T ss_pred CCCHHHHhCC
Confidence 88888766
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=321.67 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=203.6
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-----hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-----MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-----~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
++|...++||+|++|.||+|....++..+|+|.+.... ....+.+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46788889999999999999988777899999876432 2234578899999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
|+||+++++|.+++... ..+++.....++.|++.||.||| +.+++||||+|+||++++++.++|+
T Consensus 82 v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY------------GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred EEEECCCCcHHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999988432 34788889999999999999999 7899999999999999999999999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
|||+++................++..|+|||++.+..++.++||||||+++|||++|+.||....... ...+
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~---- 218 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----AIFK---- 218 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----HHHH----
Confidence 99998754322111111123457789999999999999999999999999999999999985432111 0000
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..........+..+...+.+++.+||..+|.+||++.+++++
T Consensus 219 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 --------IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111122344456678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=318.89 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=204.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||+|....++..|++|.+... .....+++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 466778999999999999999888889999987643 345567899999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||||+||++++++.++|+|||+
T Consensus 81 ~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~ 147 (256)
T cd08529 81 AENGDLHKLLKMQ----------RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGV 147 (256)
T ss_pred CCCCcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEccccc
Confidence 9999999999643 2345889999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
++....... ......|+..|+|||++.+..++.++|+|||||++|||++|+.||..... ..... ... .+
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~--~~~--~~ 216 (256)
T cd08529 148 AKLLSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALIL--KII--RG 216 (256)
T ss_pred ceeccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHH--HHH--cC
Confidence 886433211 12234578899999999999999999999999999999999999854331 11111 000 00
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.....+......+.+++.+||+.+|++||++.++++.
T Consensus 217 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 ---------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0111222445678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.87 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=200.2
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...++||+|+||+||+|+....++.||||++.... ......+.+|+++|.+++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999998888899999986432 234456889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 81 E~~~~g~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 81 EYLPGGDMMTLLMK------------KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred CCCCCcHHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeec
Confidence 99999999999853 234889999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCc-----------------------------------cccccccCcccccChhhhcccCCCchhHHHHH
Q 002533 704 GLSRMGPSGMSQS-----------------------------------HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSF 748 (911)
Q Consensus 704 Gla~~~~~~~~~~-----------------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSf 748 (911)
|+++......... .......||+.|+|||++.+..++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9987532211000 01112458999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC---H
Q 002533 749 GVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT---M 825 (911)
Q Consensus 749 GvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~ 825 (911)
||++|||++|+.||...........+..|.. .+...........+.+++.+|+. +|.+|++ +
T Consensus 226 G~il~el~~G~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDNPQETYRKIINWKE--------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred hhHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 9999999999999965432111111111110 00000011234567788999996 8999998 8
Q ss_pred HHHHHH
Q 002533 826 GDVTWG 831 (911)
Q Consensus 826 ~eVl~~ 831 (911)
.|++++
T Consensus 291 ~~ll~h 296 (364)
T cd05599 291 NEIKSH 296 (364)
T ss_pred HHHhcC
Confidence 888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=323.28 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=204.1
Q ss_pred CCccceeecccCcEEEEEEEeecCC---eEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGS---ITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~---~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
+|...+.||+|+||.||+|.+...+ ..||||.+... ......+|..|++++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4566789999999999999986543 36999998754 4445678999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++... ...+++.+++.++.|++.||+||| +.+++|+||||+|||++.++.+||+||
T Consensus 85 e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 85 EFMENGALDSFLRQN-----------DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ecCCCCcHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCC
Confidence 999999999998532 234889999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCcccccccc--CcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhh
Q 002533 704 GLSRMGPSGMSQSHVSTVVK--GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|+++................ .+..|+|||++.+..++.++|||||||++||+++ |..||...... ....+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i~- 225 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAIE- 225 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHHH-
Confidence 99876433222111111111 2457999999999999999999999999999987 99998543311 1111111
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
...+...+.+++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 226 ------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ------------QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------------cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122334567788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=328.46 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=204.4
Q ss_pred cCCccceeecccCcEEEEEEEee-----cCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCce
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID-----DGSITVAVKRLNTSS-MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 619 (911)
++|...+.||+|+||.||++... .....||||+++... ....+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 45777889999999999999852 234579999987543 34456799999999999 799999999999999999
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++||||+++|+|.++++.. ....+++.+++.++.|++.||+||| +.+|+|+||||+|||++.++.++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK----------RESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEE
Confidence 9999999999999998532 1223899999999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHH
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||........ ....
T Consensus 182 l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~~- 256 (302)
T cd05055 182 ICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYKL- 256 (302)
T ss_pred ECCCcccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHHH-
Confidence 999999986433221 111122345678999999999999999999999999999998 9999864332111 0000
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
.+...+...+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 257 ------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 ------------IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001111111223356788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.17 Aligned_cols=260 Identities=21% Similarity=0.323 Sum_probs=207.3
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||+|+||.||+|....++..++||.+... ......++.+|+++++.++|+||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 566677899999999999998777789999987643 23344678999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||
T Consensus 83 ~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 83 LADAGDLSRMIKHFKK--------QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred ecCCCCHHHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcch
Confidence 9999999999854321 2346899999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++........ ......++..|+|||++.+..++.++||||||+++|||++|..||....... ..+....
T Consensus 152 ~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~--- 220 (267)
T cd08229 152 LGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKI--- 220 (267)
T ss_pred hhhccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHhhhh---
Confidence 9876432211 1123458889999999999999999999999999999999999985432111 1111110
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
.....+. .........+.+++.+||+.+|.+||||.+|.+.+++.
T Consensus 221 ---~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 221 ---EQCDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---hcCCCCC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0111111 11223566788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.49 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=203.9
Q ss_pred cCCccceeecccCcEEEEEEEeecC---CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~---~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
.+|...+.||+|+||.||+|.+... ...+|+|.++... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4567788999999999999987532 3479999987543 34456799999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++++|.+++... ...+++.+++.++.|++.||+||| +.+++||||||+|||++.++.++|+|
T Consensus 84 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~d 149 (267)
T cd05066 84 TEYMENGSLDAFLRKH-----------DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSD 149 (267)
T ss_pred EEcCCCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCC
Confidence 9999999999999532 235889999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||+++................++..|+|||++.+..++.++|||||||++||+++ |+.||....... ......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~~-- 223 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAIE-- 223 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHHh--
Confidence 9999865432211111112233567999999999899999999999999999887 999986433111 111100
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
. + .+...+..++..+.+++.+||+.+|.+||+|.++++.|+.+
T Consensus 224 -~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 -E-G---------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C-C---------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0 11112233566788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=333.83 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=193.7
Q ss_pred eeecccCcEEEEEEEee---cCCeEEEEEEccCCC----hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 553 CIIGSGGFGHVFKGYID---DGSITVAVKRLNTSS----MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~---~~~~~vAvK~l~~~~----~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
++||+|+||.||+++.. ..+..||||+++... ......+.+|+++|++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 47999999999999863 345789999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++|+|.+++.. ...+.+..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~L~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 146 (323)
T cd05584 82 LSGGELFMHLER------------EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGL 146 (323)
T ss_pred CCCchHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcC
Confidence 999999998843 234677888889999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
++..... ........|++.|+|||++.+..++.++|||||||+||||++|+.||....... ....
T Consensus 147 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~------ 211 (323)
T cd05584 147 CKESIHE---GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDK------ 211 (323)
T ss_pred CeecccC---CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHH------
Confidence 8743221 112234568999999999999899999999999999999999999996533111 0001
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
+.... ...+......+.+++.+||+.+|++|| ++.++++.
T Consensus 212 ----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 212 ----ILKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ----HHcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11111 122334456788999999999999999 78887664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=326.50 Aligned_cols=264 Identities=24% Similarity=0.365 Sum_probs=203.6
Q ss_pred CccceeecccCcEEEEEEEeecC-----CeEEEEEEccCCCh-hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDG-----SITVAVKRLNTSSM-QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~-----~~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
|...+.||+|+||.||+|...++ ...||||+++.... ...+.+.+|+.++.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 44456899999999999987542 46899999975533 3346688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhccc----ccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQ----NQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
+||+++++|.+++........ .........+++..+++++.|++.||+||| +++|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 999999999999854321110 001112345889999999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~ 777 (911)
||+|||+++....... ........+++.|+|||.+.++.++.++|||||||++|||++ |..||..... . .+.
T Consensus 164 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~---~~~-- 236 (283)
T cd05091 164 KISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-Q---DVI-- 236 (283)
T ss_pred Eecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-H---HHH--
Confidence 9999999886432211 111223345678999999998899999999999999999998 7778754321 1 111
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
... .+.. ....+..++..+.+++.+||+.+|++||++.+|+..|+
T Consensus 237 -~~i---------~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 237 -EMI---------RNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred -HHH---------HcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 111 1111 11234456778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=338.27 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=199.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCC-eEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGS-ITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~-~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
.+|...+.||+|+||.||+|.+...+ ..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 35777889999999999999876543 68999988643 223455688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 110 ~Ey~~~g~L~~~i~~------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR------------NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred EeCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEec
Confidence 999999999999853 235888999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..+.....
T Consensus 175 FG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~ 242 (340)
T PTZ00426 175 FGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILE 242 (340)
T ss_pred CCCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhc
Confidence 9999764321 12346899999999999989999999999999999999999999653211 11111111
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
. . ...+......+.+++.+|++.||++|+ ++++++++
T Consensus 243 ~----------~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 243 G----------I--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C----------C--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1 0 012233345678999999999999995 88888765
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.24 Aligned_cols=238 Identities=25% Similarity=0.386 Sum_probs=189.0
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHH-HHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIE-MISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||+||+|+...++..||||++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999998888899999986432 222344555555 46789999999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 81 GELFFHLQR------------ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 999998843 235788899999999999999999 78999999999999999999999999999875
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
.... ........||..|+|||++.+..++.++|||||||++|||++|+.||....... + +.....
T Consensus 146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~--~~~i~~------ 210 (323)
T cd05575 146 GIEH---SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----M--YDNILN------ 210 (323)
T ss_pred cccC---CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----H--HHHHHc------
Confidence 3221 112234568999999999999999999999999999999999999996533111 0 001110
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG 826 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 826 (911)
... ..++.....+.+++.+||+.||.+||++.
T Consensus 211 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 211 ----KPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 000 11223356678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.60 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=212.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCc-eEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGE-MILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~-~~lV~E 624 (911)
+|...+++|+|+||.++..+++..+..+++|.+.-. .....+...+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 455667899999999999999888889999988644 33445578899999999999999999999998888 999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
||+||+|.+.+...+ ...+++..+++++.||+.|+.||| +..|+|||||+.||+++.+..+||+|||
T Consensus 85 Y~eGg~l~~~i~~~k----------~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK----------GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred ecCCCCHHHHHHHHh----------hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchh
Confidence 999999999996543 345888999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+|+...... .....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|....... ++.
T Consensus 152 laK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----Li~-------- 216 (426)
T KOG0589|consen 152 LAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----LIL-------- 216 (426)
T ss_pred hhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----HHH--------
Confidence 999865433 23346779999999999999999999999999999999999999996543221 111
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
++ .+.+....+......+..++..|++.+|..||++.+++.+.
T Consensus 217 ----ki-~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 217 ----KI-NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ----HH-hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 11 11223445666788899999999999999999999999883
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=331.79 Aligned_cols=242 Identities=23% Similarity=0.330 Sum_probs=194.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccc-cEeeecceeccCCceEEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHL-HIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~lV~ 623 (911)
+|...+.||+|+||.||+|...+++..||||++... .....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 467788999999999999999888889999998643 223456688899999999764 6888999998889999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 81 E~~~~g~L~~~~~~------------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 81 EYVNGGDLMYHIQQ------------VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred cCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeec
Confidence 99999999998843 234788999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++..... ........||..|+|||++.+..++.++|||||||++|||++|+.||....... +. ......
T Consensus 146 g~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~--~~i~~~ 216 (324)
T cd05587 146 GMCKENIFG---GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LF--QSIMEH 216 (324)
T ss_pred CcceecCCC---CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HH--HHHHcC
Confidence 998742211 112234568999999999999999999999999999999999999996533111 11 011000
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM 825 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 825 (911)
....+......+.+++.+||+.||.+|++.
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 ------------NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111223345677899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=320.97 Aligned_cols=251 Identities=30% Similarity=0.434 Sum_probs=199.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||+|+||.||+|...+. ..+|||.++.... ...+|.+|+.++++++||||++++++|......++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 456677899999999999988665 4699999875432 34679999999999999999999999998889999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.+++... ...++|..+++++.||+.||+||| +.+++|+||||+|||++.++.+||+|||+++
T Consensus 83 ~~~l~~~i~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 83 NGCLLNYLREH-----------GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred CCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccce
Confidence 99999998532 225899999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ......
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~--~~~~~~--- 217 (256)
T cd05113 149 YVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----TV--EKVSQG--- 217 (256)
T ss_pred ecCCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HH--HHHhcC---
Confidence 5432211 11122335678999999998889999999999999999999 999885432111 10 011000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.+...+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 218 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 --------LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112223567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=336.74 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=201.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||+||++.....+..||||+++... .+..+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36778889999999999999998888899999987542 234556889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 81 e~~~~~~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 81 EYQPGGDLLSLLNRY-----------EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred CCCCCCCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccC
Confidence 999999999998542 235889999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhc------ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR------RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
|+++....... .......||..|+|||++. ...++.++|||||||+||||++|+.||........ +
T Consensus 147 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~ 218 (330)
T cd05601 147 GSAARLTANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------Y 218 (330)
T ss_pred CCCeECCCCCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------H
Confidence 99976432211 1223346899999999987 45678999999999999999999999965432111 1
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
........ .+...........+.+++.+|++ +|++||++.+++.+
T Consensus 219 ~~i~~~~~--------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 219 NNIMNFQR--------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHcCCC--------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11111000 00111112345667899999998 99999999998764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.79 Aligned_cols=267 Identities=23% Similarity=0.347 Sum_probs=209.0
Q ss_pred ccCCccceeecccCcEEEEEEEeec----CCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceecc-CCce
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDD----GSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDE-HGEM 619 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~----~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~ 619 (911)
..+|...++||+|+||.||+|.+.. ....|++|++... .....+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4567778899999999999999876 2478999988754 34456678999999999999999999998865 5678
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++++||+++|+|.++|....... ......+++..++.++.|++.||+||| +.+++||||||+|||+++++.+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGE----ANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccc----cccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEE
Confidence 99999999999999986542211 012256899999999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHH
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++||+++ |+.||..... ..+..+.
T Consensus 158 l~d~g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~ 232 (280)
T cd05043 158 ITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYL 232 (280)
T ss_pred ECCCCCcccccCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHH
Confidence 999999985432211 111223346778999999999899999999999999999999 9999854321 1111111
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
. .. .+......++..+.+++.+||..+|++||++.+|++.|+.+.+
T Consensus 233 ~---~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 K---DG----------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred H---cC----------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 11 1111222345678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=337.72 Aligned_cols=205 Identities=26% Similarity=0.412 Sum_probs=175.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||+||++.....+..||||+++... ......+.+|++++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36788899999999999999998888899999986532 233456888999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 81 E~~~gg~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 81 EFLPGGDMMTLLMK------------KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred cCCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeec
Confidence 99999999999853 235889999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCC--------------------------------ccccccccCcccccChhhhcccCCCchhHHHHHHHH
Q 002533 704 GLSRMGPSGMSQ--------------------------------SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVV 751 (911)
Q Consensus 704 Gla~~~~~~~~~--------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvv 751 (911)
|+++........ ........||+.|+|||++.+..++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 998754221100 001123469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCc
Q 002533 752 LLEVLCGRPPMINGA 766 (911)
Q Consensus 752 L~ElltG~~p~~~~~ 766 (911)
||||++|+.||....
T Consensus 226 l~ell~G~~Pf~~~~ 240 (363)
T cd05628 226 MYEMLIGYPPFCSET 240 (363)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.22 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=202.0
Q ss_pred cCCccceeecccCcEEEEEEEeecCCe----EEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSI----TVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~----~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
.+|...++||+|+||+||+|.+...+. .||+|+++.. .....+++.+|+.+++.++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 456778899999999999998755443 4899998754 34445678999999999999999999999975 45789
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
++||+++|+|.++++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 86 ~~~~~~~g~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 86 VTQLMPYGCLLDYVREN-----------KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred EEEcCCCCCHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEEC
Confidence 99999999999998532 235889999999999999999999 7899999999999999999999999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhh
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..+...
T Consensus 152 dfG~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~ 226 (279)
T cd05109 152 DFGLARLLDIDETEY-HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLEK 226 (279)
T ss_pred CCCceeeccccccee-ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC
Confidence 999998653321111 1112234678999999999999999999999999999998 8888854321 111111110
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
......+..+...+.+++.+||+.||++||++.++++.|+.+.+
T Consensus 227 -------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 227 -------------GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -------------CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01111223356678899999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.29 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=206.7
Q ss_pred HHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceE
Q 002533 541 EIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 541 el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 620 (911)
|++.++.++....+||+|+||.||+|.+..++..|++|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34567777888889999999999999988888899999988777777788999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCC--chhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-CCc
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPL--TWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NWA 697 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l--~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~ 697 (911)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||+||| ..+|+||||||+||+++. ++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~ 147 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-----------GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGV 147 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-----------ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCe
Confidence 9999999999999995431 123 77888899999999999999 789999999999999986 679
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccC--CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ--LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
++|+|||++........ ......++..|+|||++.... ++.++||||||+++|||++|+.||....... ..
T Consensus 148 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~ 220 (268)
T cd06624 148 VKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AA 220 (268)
T ss_pred EEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hh
Confidence 99999999875432111 112235788999999987643 7899999999999999999999985422111 11
Q ss_pred hHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.|..... .....++..+...+.+++.+||+.+|.+||++.||+++
T Consensus 221 ~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 221 MFKVGMF-----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred Hhhhhhh-----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1111000 11122334456678899999999999999999999764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.00 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=192.2
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||+||+|.+..++..||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999998888899999986532 22344566788888764 899999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|.+++.. ...+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~l~~------------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 81 GDLMFHIQS------------CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 999999843 234788999999999999999999 78999999999999999999999999999874
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .....
T Consensus 146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~--~i~~~----- 211 (316)
T cd05619 146 NMLGD---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQ--SIRMD----- 211 (316)
T ss_pred CCCCC---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHH--HHHhC-----
Confidence 32111 1123456899999999999999999999999999999999999999653311 1111 00000
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHH-HHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG-DVTW 830 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eVl~ 830 (911)
.+ ..+......+.+++.+||+.||++||++. ++.+
T Consensus 212 ---~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 ---NP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01 11222345678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.93 Aligned_cols=272 Identities=28% Similarity=0.431 Sum_probs=209.5
Q ss_pred cCCccceeecccCcEEEEEEEeec-------CCeEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCC
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDD-------GSITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHG 617 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~-------~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 617 (911)
.+|...+.||+|+||.||+|+... ....||+|.+... .....+++.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 456677899999999999997521 2347999998754 334567799999999999 8999999999999999
Q ss_pred ceEEEEeecCCCchhhHhhhhhhccccc----ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeec
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQ----NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD 693 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 693 (911)
..++||||+++|+|.+++.......... .......++|.+++.++.||+.||+||| +++++||||||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~ 171 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVT 171 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEc
Confidence 9999999999999999997543211100 0112346899999999999999999999 78999999999999999
Q ss_pred CCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhh
Q 002533 694 ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEV 772 (911)
Q Consensus 694 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~ 772 (911)
+++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||...... +
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~-- 247 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-E-- 247 (304)
T ss_pred CCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-H--
Confidence 9999999999999865332211 11122345678999999999899999999999999999998 77777443211 1
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhh
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 839 (911)
+....... .+...+..++..+.+++.+||+.+|.+||++.||++.|+.++...
T Consensus 248 ----~~~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 ----LFKLLKEG----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ----HHHHHHcC----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111111 111223345678899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.85 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=196.5
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
++||+|+||.||++.....+..||+|+++.. .......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999999888889999998653 2234456788999999999999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|..++.. ...+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLSR------------ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 99988842 2358899999999999999999993 279999999999999999999999999998753
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 789 (911)
... ........||..|+|||++.+..++.++|||||||+||||++|+.||....... .... .....
T Consensus 147 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-~~~~-----i~~~~----- 212 (325)
T cd05594 147 IKD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFEL-----ILMEE----- 212 (325)
T ss_pred CCC---CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-HHHH-----HhcCC-----
Confidence 211 111223468999999999999999999999999999999999999996533111 0000 00000
Q ss_pred ccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 790 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
...+......+.+++.+||+.||++|+ ++.+++++
T Consensus 213 -------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 -------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 012223456678999999999999996 89998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.31 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=206.7
Q ss_pred cCCccceeecccCcEEEEEEEeecC-----CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG-----SITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 620 (911)
++|...+.||+|+||.||+|..... ...||+|.+.... ......+.+|+++++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 4677788999999999999998643 3689999987543 344567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||+++|+|.+++......... ......++|..++.++.|++.||.||| +.+++||||||+|||+++++.+||
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAEN--NPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhh--ccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence 999999999999999654321110 012345889999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||+++....... ........++..|+|||.+.++.++.++|||||||++|||++ |+.||..... .+ +..+..
T Consensus 161 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~---~~~~~~ 235 (277)
T cd05032 161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EE---VLKFVI 235 (277)
T ss_pred CCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HH---HHHHHh
Confidence 99999875432211 111223346788999999998899999999999999999998 8888854321 11 111110
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
. ......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ---~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ---D----------GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---c----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 0011223345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.12 Aligned_cols=272 Identities=28% Similarity=0.415 Sum_probs=208.9
Q ss_pred cCCccceeecccCcEEEEEEEeecC-------CeEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCC
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG-------SITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHG 617 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~-------~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 617 (911)
.+|...+.||+|+||.||++...+. ...+|+|.++.. ......++.+|+++++++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 4577888999999999999986432 246999998754 334556788999999999 7999999999999999
Q ss_pred ceEEEEeecCCCchhhHhhhhhhccccc----ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeec
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQ----NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD 693 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 693 (911)
..++||||+++|+|.+++.......... .......++|.++++++.|++.||+||| +.+++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999996543211000 0012235899999999999999999999 78999999999999999
Q ss_pred CCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhh
Q 002533 694 ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEV 772 (911)
Q Consensus 694 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~ 772 (911)
.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~~-- 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EE-- 250 (307)
T ss_pred CCCcEEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-HH--
Confidence 999999999999875432111 111112234568999999999999999999999999999998 8888754321 11
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhh
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 839 (911)
...... ...+...+..+...+.+++.+||+.+|.+||+|.+|++.|+.+++..
T Consensus 251 ----~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 ----LFKLLK----------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ----HHHHHH----------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 011111 11112233445678889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=339.28 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=200.8
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
...+|...++||+|+||.||+++...++..||+|++... .....+.+.+|+.+++.++||||+++++++..+...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 345788889999999999999999888889999998642 22334557889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
||||+++|+|.+++.. ..++...+..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 121 v~Ey~~gg~L~~~l~~-------------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~ 184 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-------------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 184 (370)
T ss_pred EEcCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEE
Confidence 9999999999998843 23677778889999999999999 7899999999999999999999999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhccc----CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ----QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
|||+++....... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+
T Consensus 185 DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~ 256 (370)
T cd05596 185 DFGTCMKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TY 256 (370)
T ss_pred eccceeeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HH
Confidence 9999976432111 112345699999999998753 47899999999999999999999996543211 11
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCC--CCCHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFR--RPTMGDVTWG 831 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~ 831 (911)
........ .+...........+.+++.+||+.+|.+ ||++.+++.+
T Consensus 257 ~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 SKIMDHKN--------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHcCCC--------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111100 0111111134567789999999999988 9999999776
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.30 Aligned_cols=267 Identities=19% Similarity=0.259 Sum_probs=197.9
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh-hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
.+|...+.||+|+||.||+|+...++..||||++..... .....+.+|++++++++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 568888899999999999999987778999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++ ++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 85 VH-TDLCQYMDKH-----------PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred CC-cCHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCc
Confidence 95 6888887432 234788889999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++...... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......+......+.......
T Consensus 150 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
T cd07869 150 ARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE 226 (303)
T ss_pred ceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCCh
Confidence 87532211 11223457899999999875 458899999999999999999999997543222211111110000000
Q ss_pred CC------cccc--------cCccccCCCC-hHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GT------VDQI--------VDPRLRGKIA-PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~------~~~i--------~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. .... ....+..... ......+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 0000 0000000000 0123457799999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=325.09 Aligned_cols=272 Identities=28% Similarity=0.415 Sum_probs=206.2
Q ss_pred CCccceeecccCcEEEEEEEeec----CCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceecc--CCceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDD----GSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDE--HGEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~----~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~ 620 (911)
+|...+.||+|+||.||+|.+.. .+..+|||++...... ..++|.+|++++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 34556789999999999999753 3578999998765443 56789999999999999999999999876 55789
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||+++++|.+++... ...++|..++.++.|++.||+||| +.+++|+||||+||+++.++.++|
T Consensus 85 lv~e~~~~~~l~~~l~~~-----------~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l 150 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH-----------RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKI 150 (284)
T ss_pred EEEecCCCCCHHHHHHhC-----------ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEE
Confidence 999999999999999543 124899999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
+|||++.................++..|+|||.+....++.++||||||+++|||++|+.|+......... ...-...
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~ 228 (284)
T cd05038 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQG 228 (284)
T ss_pred cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccc
Confidence 99999987543222212222234556799999999889999999999999999999999987543211100 0000000
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
......+.+.+....+...+..++..+.+++.+||+.+|++||+|.||+++|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 229 QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000001111111222223345567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.99 Aligned_cols=260 Identities=21% Similarity=0.327 Sum_probs=208.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||.||+|....++..||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4678888999999999999999877789999987532 2334567999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++..... ....+++.+++.++.+++.||+||| +.+++||||+|+||+++.++.++|+||
T Consensus 82 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 82 ELADAGDLSRMIKHFKK--------QKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ecCCCCCHHHHHHHhcc--------cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEecc
Confidence 99999999999854321 2345889999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...... +........
T Consensus 151 ~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~- 221 (267)
T cd08224 151 GLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIE- 221 (267)
T ss_pred ceeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHHHHhhhh-
Confidence 99875432211 112345788899999999989999999999999999999999998543211 111111100
Q ss_pred cCCcccccCccccCCCCh-HHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAP-VCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
.......+. .....+.+++.+||..+|++||++.+|+++|+.+
T Consensus 222 ---------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 222 ---------KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---------cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 001111222 4556788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.15 Aligned_cols=269 Identities=24% Similarity=0.382 Sum_probs=206.1
Q ss_pred HccCCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCc
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGE 618 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 618 (911)
...+|...++||+|+||.||+|...+ ....||+|.+.... ......+.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34578888899999999999997653 23579999886543 3344568899999999999999999999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
.++||||+++|+|.+++........ .......+++..+++++.|++.||.||| +++|+||||||+|||+++++.+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAE--NNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccc--cCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence 9999999999999999965432111 1112345678889999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~ 777 (911)
+|+|||+++....... ........++..|+|||.+.++.++.++|||||||++|||++ |..||...... + ...
T Consensus 159 ~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-~---~~~- 232 (288)
T cd05061 159 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-Q---VLK- 232 (288)
T ss_pred EECcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-H---HHH-
Confidence 9999999885432211 111122235678999999999999999999999999999999 77787542211 1 111
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
.. .+... ...+..++..+.+++.+||+.+|++||++.++++.|+..+
T Consensus 233 --~~---------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 --FV---------MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --HH---------HcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00 01000 1122334578899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.67 Aligned_cols=271 Identities=28% Similarity=0.396 Sum_probs=203.5
Q ss_pred cCCccceeecccCcEEEEEEEee-----cCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhc-ccccEeeecceecc-CCc
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID-----DGSITVAVKRLNTSS-MQGAREFRTEIEMISEL-RHLHIVSLLGFCDE-HGE 618 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~-~~~ 618 (911)
.+|...+.||+|+||.||+|.+. ..+..||||+++... ......+.+|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 35777889999999999999853 234689999997543 33456788999999999 78999999998854 456
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccc------------------------------------------------------
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQN------------------------------------------------------ 644 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~------------------------------------------------------ 644 (911)
.++||||+++|+|.++++........
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 79999999999999999653211000
Q ss_pred -cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCcccccccc
Q 002533 645 -QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723 (911)
Q Consensus 645 -~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 723 (911)
........++|.++++++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++....... ........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~ 242 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDAR 242 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCCC
Confidence 00001235789999999999999999999 78999999999999999999999999999876432211 11112234
Q ss_pred CcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChH
Q 002533 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPV 802 (911)
Q Consensus 724 gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 802 (911)
++..|+|||.+.+..++.++||||||+++|||++ |..||........ + ..... . ..+...+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~---~~~~~-~---------~~~~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F---CRRLK-E---------GTRMRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---H---HHHHh-c---------cCCCCCCCC
Confidence 5678999999999999999999999999999997 8888854321111 0 00000 0 011111222
Q ss_pred HHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 803 CLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 803 ~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
....+.+++.+||+.+|++||++.||++.|+.+++
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 34568899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.25 Aligned_cols=272 Identities=25% Similarity=0.356 Sum_probs=206.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCC----------------eEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGS----------------ITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSL 609 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~----------------~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l 609 (911)
.+|...+.||+|+||.||+|.+...+ ..||+|.+.... ....+++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 46777889999999999999876432 468999987543 3456679999999999999999999
Q ss_pred cceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCC
Q 002533 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTN 689 (911)
Q Consensus 610 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~N 689 (911)
+++|..++..+++|||+++++|.++|.......... ......+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-ACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 999999999999999999999999996543211110 123346899999999999999999999 7899999999999
Q ss_pred eeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh--CCCCCCCCcc
Q 002533 690 ILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC--GRPPMINGAV 767 (911)
Q Consensus 690 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt--G~~p~~~~~~ 767 (911)
|+++.++.++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875432211 112223446778999999998899999999999999999998 6667643221
Q ss_pred chhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 768 RKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 768 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
............... .......+..++..+.+++.+||+.||.+||++.||++.|+
T Consensus 240 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ----QQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ----HHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111100 01111122334578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.82 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=198.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||+|+||.||+|.+..+ ..+|+|.+..... ...+|.+|++++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~-~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCC-ccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 456677899999999999988654 5799999865432 34568899999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++... ...++|..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++
T Consensus 83 ~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 83 NGCLLNYLRER-----------KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred CCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccce
Confidence 99999998532 225889999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... + . +...
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~---~--~~~~------ 214 (256)
T cd05059 149 YVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-E---V--VESV------ 214 (256)
T ss_pred ecccccc--cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-H---H--HHHH------
Confidence 5432111 11111224457999999999999999999999999999999 78888543211 1 1 1110
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
....+...+..++..+.+++.+||..+|++||++.||++.|
T Consensus 215 -----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 215 -----SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01111222334577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=331.33 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=194.4
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCCC
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
+||+|+||.||+|+...++..||||+++.. .....+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 699999999999999888889999998653 223445677899998876 7999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 82 DLMFQIQRS------------RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred cHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999888432 34788999999999999999999 789999999999999999999999999998753
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 789 (911)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+ +.......
T Consensus 147 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~--~~~i~~~~----- 212 (321)
T cd05591 147 ILN---GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DL--FESILHDD----- 212 (321)
T ss_pred ccC---CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----HH--HHHHHcCC-----
Confidence 221 11223456899999999999999999999999999999999999999643311 11 11111100
Q ss_pred ccCccccCCCChHHHHHHHHHHHhcccccCCCCC-------CHHHHHHH
Q 002533 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-------TMGDVTWG 831 (911)
Q Consensus 790 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-------s~~eVl~~ 831 (911)
...+..+...+.+++.+||+.||++|| ++.+++++
T Consensus 213 -------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 -------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 011222356778999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=338.57 Aligned_cols=255 Identities=23% Similarity=0.292 Sum_probs=197.1
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||+||++....++..||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36778889999999999999998888899999986432 234466889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 81 E~~~gg~L~~~l~~------------~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 81 EFLPGGDLMTMLIK------------YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred eCCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeec
Confidence 99999999999853 234788888899999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCC--------------------------------------------ccccccccCcccccChhhhcccCC
Q 002533 704 GLSRMGPSGMSQ--------------------------------------------SHVSTVVKGSFGYVDPEYIRRQQL 739 (911)
Q Consensus 704 Gla~~~~~~~~~--------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~ 739 (911)
|+++........ ........||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 998632110000 000012459999999999999999
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccC
Q 002533 740 TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEG 819 (911)
Q Consensus 740 t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP 819 (911)
+.++|||||||+||||++|+.||...........+..|.. .+.-.........+.+++.+|+. +|
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE--------------TLYFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC--------------ccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence 9999999999999999999999965432111111111110 00000011234567789999997 66
Q ss_pred CCC---CCHHHHHHH
Q 002533 820 FRR---PTMGDVTWG 831 (911)
Q Consensus 820 ~~R---Ps~~eVl~~ 831 (911)
.+| +++.|++++
T Consensus 291 ~~r~~r~~~~~~l~h 305 (377)
T cd05629 291 ENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCHHHHhcC
Confidence 654 699998776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.82 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=200.2
Q ss_pred eecccCcEEEEEEEeec-CC--eEEEEEEccCCCh-hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 554 IIGSGGFGHVFKGYIDD-GS--ITVAVKRLNTSSM-QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~-~~--~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
+||+|++|.||+|.+.. ++ ..||||.+..... ...+.+.+|++++++++|+||+++++++.. ...++||||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 68999999999999854 22 3699999987665 566789999999999999999999999988 8899999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|.+++.... ...++|...+.++.|++.||+||| ..+++|+||||+||+++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 81 SLLDRLRKDA----------LGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred cHHHHHHhcc----------cccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccc
Confidence 9999985431 145899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||....... +..... ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~---~~~--- 217 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILKKID---KEG--- 217 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH---hcC---
Confidence 432221112223457788999999999999999999999999999999 999985432111 111000 000
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 218 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001112234567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.14 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=195.0
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
||+|+||.||++.....+..+|+|++..... ...+.+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999988888999999864321 2234566799999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||+++++.++|+|||++.....
T Consensus 81 ~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV----------GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc----------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 9888543 2334889999999999999999999 78999999999999999999999999999876432
Q ss_pred CCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ....+.. .
T Consensus 148 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~---~~~~~~~---------~ 211 (277)
T cd05607 148 GK----TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK---EELKRRT---------L 211 (277)
T ss_pred Cc----eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH---HHHHHHh---------h
Confidence 21 122345889999999999989999999999999999999999998643211111 1111110 0
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
...... ........+.+++.+||+.||++||++.|+++.+
T Consensus 212 ~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 212 EDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 001100 0112455678999999999999999998876444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.34 Aligned_cols=265 Identities=28% Similarity=0.436 Sum_probs=205.9
Q ss_pred CCccceeecccCcEEEEEEEee-----cCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYID-----DGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~-----~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
++...+.||+|+||.||++... ..+..+|+|.+..........|.+|++++++++|+||+++++++...+..+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4556778999999999999753 23467999999877777778899999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccc---cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQN---QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~---~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
|||+++|+|.+++......... ........+++..++.++.|++.||+||| +.+++||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEE
Confidence 9999999999999654321100 01112246899999999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHH
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. .
T Consensus 163 L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~---~-- 235 (280)
T cd05092 163 IGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AI---E-- 235 (280)
T ss_pred ECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-HH---H--
Confidence 999999875432111 111122335678999999999999999999999999999998 888885432111 10 0
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.... ......+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 236 -~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 -CITQ----------GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHc----------CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000 0011122345567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.97 Aligned_cols=249 Identities=29% Similarity=0.505 Sum_probs=203.2
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
++|...+.||.|+||.||+|...+ ..||||.++.... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~--~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRG--QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEecC--cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 456778899999999999998764 5799999976644 5678999999999999999999999999899999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++... ....++|..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||++
T Consensus 83 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 83 AKGSLVDYLRSR----------GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccc
Confidence 999999998543 2235899999999999999999999 789999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+....... ....+..|+|||++....++.++||||||+++||+++ |+.||....... +.. ...
T Consensus 150 ~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~---~~~--- 213 (256)
T cd05039 150 KEASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVP---HVE--- 213 (256)
T ss_pred cccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHH---HHh---
Confidence 86432211 2234567999999998899999999999999999998 999885432111 100 000
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
...+...+..++..+.+++.+||..+|++||++.+|+++|+.
T Consensus 214 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 214 -------KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -------cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 011112233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=354.00 Aligned_cols=272 Identities=21% Similarity=0.287 Sum_probs=208.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
.+|...++||+|+||.||+|.....+..||||++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 3677888999999999999999887889999998653 2234567999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++....... .........+++..+++++.||++||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~-~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKE-SLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhcc-ccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEec
Confidence 9999999999996532211 111112345778889999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCC---------------CccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccc
Q 002533 704 GLSRMGPSGMS---------------QSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVR 768 (911)
Q Consensus 704 Gla~~~~~~~~---------------~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~ 768 (911)
|+++....... .........||+.|||||++.+..++.++|||||||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99986421100 001112346999999999999999999999999999999999999998542211
Q ss_pred hhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-CHHHHHHHHHHHHh
Q 002533 769 KEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-TMGDVTWGLEFALQ 837 (911)
Q Consensus 769 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~eVl~~L~~~~~ 837 (911)
. + .+.. .+.++.-.. .....+..+.+++.+|++.||++|| ++.++.+.|+..++
T Consensus 238 k----i-~~~~---------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 K----I-SYRD---------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h----h-hhhh---------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0 0000 001110000 0123456688999999999999995 67778888877655
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.59 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=203.2
Q ss_pred CCccceeecccCcEEEEEEEee----cCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccC--CceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYID----DGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~----~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~ 620 (911)
.|...+.||+|+||.||++.+. ..+..||+|.++... ......+.+|++++++++|+||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 3566778999999999999853 345789999987553 44456799999999999999999999998765 5689
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||+++++|.+++... ...++|..++.++.|++.||+||| +.+++||||||+|||++.++.+||
T Consensus 85 lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l 150 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN-----------KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKI 150 (284)
T ss_pred EEEEccCCCCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEE
Confidence 999999999999998432 234899999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccc--------hhhh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVR--------KEEV 772 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~--------~~~~ 772 (911)
+|||+++................++..|+|||++.+..++.++|||||||++|||++++.|....... ..+.
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 99999986543322212223345677899999999889999999999999999999987764321100 0000
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
....+... .....+...+..++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 231 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRV----------LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHH----------HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00011110 001111122334667899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=332.48 Aligned_cols=245 Identities=21% Similarity=0.311 Sum_probs=192.5
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||++....++..+|+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3799999999999999888889999998753 233445678899988877 899999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|..++.. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~L~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 81 GDLMFHMQR------------QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 999888742 235889999999999999999999 78999999999999999999999999999875
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh-hhhHhhHHhhhcccCCc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE-EVSLVLWARVSRARGTV 787 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~ 787 (911)
.... ........||..|+|||++.+..++.++|||||||++|||++|+.||........ ......+.....
T Consensus 146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i----- 217 (329)
T cd05618 146 GLRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI----- 217 (329)
T ss_pred ccCC---CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-----
Confidence 3211 1122345689999999999999999999999999999999999999953211110 001111111110
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM 825 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 825 (911)
... ...++......+.+++.+||+.||++||+.
T Consensus 218 ---~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 218 ---LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---hcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111 112334455678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.58 Aligned_cols=262 Identities=19% Similarity=0.212 Sum_probs=198.3
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
..+|...+.||+|+||.||++.+..++..||||... ...+.+|+++|++|+||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999998888899999753 23577899999999999999999999989999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+. ++|.+++.. ...+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 165 ~~-~~L~~~l~~------------~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~ 228 (391)
T PHA03212 165 YK-TDLYCYLAA------------KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGA 228 (391)
T ss_pred CC-CCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCc
Confidence 84 788888742 234889999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccch----hhhhHhhHHhhh
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK----EEVSLVLWARVS 781 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~----~~~~l~~~~~~~ 781 (911)
++...... ........||+.|+|||++.+..++.++|||||||+||||++|+.|+....... ....+.......
T Consensus 229 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~ 306 (391)
T PHA03212 229 ACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS 306 (391)
T ss_pred cccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence 97532211 112234569999999999999999999999999999999999998875432110 000110000000
Q ss_pred cc---------cCCccccc---------CccccCCC--ChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 RA---------RGTVDQIV---------DPRLRGKI--APVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~---------~~~~~~i~---------d~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. ...+.++. .+..+... ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 00000000 00000000 01235578899999999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.31 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=200.9
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
|...++||+|+||.||++.....+..+|||.+.... ....+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566778999999999999999888899999986432 22335578899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++|+|.+++... ....+++.+++.++.|++.||.||| +.+|+||||||+||++++++.++|+|||+
T Consensus 82 ~~g~~L~~~l~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 82 MNGGDLKFHIYHM----------GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred cCCCcHHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999988543 2234889999999999999999999 79999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+........ .....|+..|+|||++.+..++.++|||||||++|||++|+.||............ .....
T Consensus 149 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~--- 218 (285)
T cd05630 149 AVHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVK--- 218 (285)
T ss_pred eeecCCCcc----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhh---
Confidence 875432211 12346899999999999999999999999999999999999999653211100000 00000
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-----HHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 831 (911)
......+..+...+.+++.+||+.||++||+ +.|++++
T Consensus 219 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 219 --------EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --------hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0011122334556789999999999999999 7888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.02 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=201.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||+|+...++..||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 35777889999999999999998777899999987655555667889999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.++++. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~L~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 89 GGGSLQDIYHV------------TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred CCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccc
Confidence 99999998843 234788999999999999999999 789999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhc---ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
+....... ......|+..|+|||.+. ...++.++|||||||++|||++|+.|+.......... .+..
T Consensus 154 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~~~---- 223 (267)
T cd06646 154 AKITATIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSK---- 223 (267)
T ss_pred eeeccccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---eeec----
Confidence 75432111 112345788999999884 4457889999999999999999999985432111100 0000
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.....+... ........+.+++.+||+.+|++||++++|++.|
T Consensus 224 ----~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 ----SNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ----CCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000011111 1112356788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.65 Aligned_cols=267 Identities=29% Similarity=0.432 Sum_probs=206.2
Q ss_pred ccCCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCce
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 619 (911)
.++|...+.||+|+||.||++...+ ....+|+|++.... ....++|.+|+.++++++||||++++++|..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4568888899999999999998753 35689999987543 34456799999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhhhhccccc----------ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCC
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQ----------NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTN 689 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~----------~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~N 689 (911)
++||||+++|+|.+++.......... .......+++.+++.++.|++.||+||| ..+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999996543211110 0112346889999999999999999999 7899999999999
Q ss_pred eeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccc
Q 002533 690 ILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVR 768 (911)
Q Consensus 690 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~ 768 (911)
||+++++.++|+|||+++....... .........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999875322111 111122234667999999999999999999999999999998 88887543211
Q ss_pred hhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 769 KEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 769 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
+ .. ..... + .. ...+..++..+.+++.+||+.+|++||++.||++.|+
T Consensus 240 -~---~~---~~~~~-~--------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 -E---VI---YYVRD-G--------NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -H---HH---HHHhc-C--------CC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 11 11110 1 11 1122345677899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.10 Aligned_cols=238 Identities=24% Similarity=0.343 Sum_probs=191.5
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCCC
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
+||+|+||.||+|+...++..||||++... .....+.+..|+.++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 699999999999999888889999998643 223445677888888876 6999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~L~~~i~~~------------~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 82 DLMFHIQKS------------RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred hHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999988432 34888999999999999999999 789999999999999999999999999998753
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 789 (911)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. .......
T Consensus 147 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~--~~i~~~~----- 212 (320)
T cd05590 147 IFN---GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLF--EAILNDE----- 212 (320)
T ss_pred CcC---CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHH--HHHhcCC-----
Confidence 211 11223456899999999999999999999999999999999999999643311 110 0111000
Q ss_pred ccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHH
Q 002533 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGD 827 (911)
Q Consensus 790 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 827 (911)
...+......+.+++.+||+.||++||++.+
T Consensus 213 -------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 213 -------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 0112234567789999999999999999833
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=319.75 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=205.3
Q ss_pred HHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--------------hhHHHHHHHHHHHHhcccccEeee
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--------------QGAREFRTEIEMISELRHLHIVSL 609 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--------------~~~~~f~~Ei~~l~~l~HpnIv~l 609 (911)
+.-++|.....||+|.||.|-+|+....+..||||++.+... ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345678888899999999999999998889999999864321 123578899999999999999999
Q ss_pred cceecc--CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCC-CchhhhhHHHHhHHHHHHHHhhCCCCcEEEeccc
Q 002533 610 LGFCDE--HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSP-LTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVK 686 (911)
Q Consensus 610 ~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~-l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlk 686 (911)
+.+..+ .+.+|||+|||..|.+...= ..++ |+..+..+++.++..||+||| .++|||||||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-------------~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIK 237 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-------------PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIK 237 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-------------CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccc
Confidence 999865 45799999999988875432 2334 899999999999999999999 7999999999
Q ss_pred CCCeeecCCCceEEeecCCccCCCCCCCC--ccccccccCcccccChhhhcccC----CCchhHHHHHHHHHHHHHhCCC
Q 002533 687 STNILLDENWAAKISDFGLSRMGPSGMSQ--SHVSTVVKGSFGYVDPEYIRRQQ----LTEKSDVYSFGVVLLEVLCGRP 760 (911)
Q Consensus 687 p~NILl~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~----~t~ksDVwSfGvvL~ElltG~~ 760 (911)
|+|+||++++++||+|||.+...+.+... ...-....||+.|+|||...++. .+.+.||||+||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 99999999999999999998765332111 11122367999999999987633 3568999999999999999999
Q ss_pred CCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 761 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
||.+... +.. .+.|++..+.-...++..+.+.+|+.++|+.||++|.+..+|..+.
T Consensus 318 PF~~~~~------~~l----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 318 PFFDDFE------LEL----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred CcccchH------HHH----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 9965331 111 2344444554444456678889999999999999999999997665
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=322.36 Aligned_cols=272 Identities=24% Similarity=0.376 Sum_probs=204.5
Q ss_pred cCCccceeecccCcEEEEEEEeec----------------CCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDD----------------GSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSL 609 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~----------------~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l 609 (911)
++|...+.||+|+||.||++...+ ....+|+|++... ......+|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 457778899999999999986432 2346999998754 33455689999999999999999999
Q ss_pred cceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCC
Q 002533 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTN 689 (911)
Q Consensus 610 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~N 689 (911)
++++...+..++||||+++|+|.+++......... .......+++.+++.++.|++.||+||| +.+++||||||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA-EKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCccccc-ccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 99999999999999999999999999654322111 1122345889999999999999999999 7899999999999
Q ss_pred eeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh--CCCCCCCCcc
Q 002533 690 ILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC--GRPPMINGAV 767 (911)
Q Consensus 690 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt--G~~p~~~~~~ 767 (911)
||++.++.++|+|||+++........ .......++..|++||....+.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999998754322111 11122234678999999988899999999999999999998 6677753321
Q ss_pred chhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 768 RKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 768 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.........+ ..... .......+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 240 ~~~~~~~~~~---~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEF---FRDQG-------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHH---Hhhcc-------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1100000000 00000 00011123345678899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.15 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=194.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.|...++||+|+||.||+|+....+..+|||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4777889999999999999998888899999986532 2344578899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
||++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 82 YIPGGDMMSLLIRM------------GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred CCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECC
Confidence 99999999998432 34778888899999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCC--------------------------------------------CccccccccCcccccChhhhcccCCC
Q 002533 705 LSRMGPSGMS--------------------------------------------QSHVSTVVKGSFGYVDPEYIRRQQLT 740 (911)
Q Consensus 705 la~~~~~~~~--------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~t 740 (911)
+++....... .........||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 9753210000 00011234689999999999999999
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCC
Q 002533 741 EKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGF 820 (911)
Q Consensus 741 ~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~ 820 (911)
.++|||||||+||||++|+.||...........+..|.. .+...........+.+++.+|+ .+|+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT--------------SLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC--------------CcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 999999999999999999999965432221111111110 0111111122344556666655 4899
Q ss_pred CCCC---HHHHHHH
Q 002533 821 RRPT---MGDVTWG 831 (911)
Q Consensus 821 ~RPs---~~eVl~~ 831 (911)
+|++ +.+++++
T Consensus 292 ~R~~~~~~~ei~~h 305 (382)
T cd05625 292 DRLGKNGADEIKAH 305 (382)
T ss_pred HcCCCCCHHHHhcC
Confidence 9997 7776653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.58 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=201.2
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||+|++.++ ..||+|+++... ...++|.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 4577788999999999999988766 469999987533 234578999999999999999999998754 5689999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.+++... ....++|..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++
T Consensus 83 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 83 SKGSLLDFLKGE----------MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CCCcHHHHHhhc----------cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCce
Confidence 999999999532 2235789999999999999999999 789999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+. +.....
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-~~~-----~~~~~~--- 218 (262)
T cd05071 150 RLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REV-----LDQVER--- 218 (262)
T ss_pred eecccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-HHH-----HHHHhc---
Confidence 75432211 11122346678999999998999999999999999999999 7778754321 110 111000
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
......+..++..+.+++.+||+.+|++||++.++++.|+..
T Consensus 219 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 --------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011122344567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.55 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=193.1
Q ss_pred eecccCcEEEEEEEeecC--CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCc
Q 002533 554 IIGSGGFGHVFKGYIDDG--SITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 630 (911)
.||+|+||.||+|...++ ...+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 599999999999987543 3579999887543 3444578999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCC
Q 002533 631 LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710 (911)
Q Consensus 631 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 710 (911)
|.++++..... ....+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 82 L~~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 82 LKGYLRSCRKA-------ELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred HHHHHHHhhhc-------ccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999654321 1234677888899999999999999 7899999999999999999999999999987532
Q ss_pred CCCCCccccccccCcccccChhhhccc-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhc
Q 002533 711 SGMSQSHVSTVVKGSFGYVDPEYIRRQ-------QLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 711 ~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
.... ........++..|+|||++.+. .++.++||||||+++|||++ |+.||........ ..+..
T Consensus 152 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----~~~~~--- 223 (269)
T cd05087 152 KEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV----LTYTV--- 223 (269)
T ss_pred Ccce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH----HHHHh---
Confidence 2211 1112234567889999998642 35789999999999999997 9999854331111 11100
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
......+.++.+. ......+.+++..|| .+|++|||+.||++.|+
T Consensus 224 -~~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 -REQQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -hcccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0011111122221 223456788999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.52 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=194.3
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
+|...++||+|+||.||+|....++..||||++.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999998888899999987532 23344567788888877 5899999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+||
T Consensus 81 E~~~~g~L~~~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 81 EYVNGGDLMYQIQQ------------VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccC
Confidence 99999999988843 234788999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ...
T Consensus 146 G~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~--~i~-- 214 (323)
T cd05616 146 GMCKENMWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQ--SIM-- 214 (323)
T ss_pred CCceecCCC---CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHH--HHH--
Confidence 998753211 11223456899999999999999999999999999999999999999653311 1110 111
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM 825 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 825 (911)
... ...+......+.+++.+|++.+|.+|++.
T Consensus 215 --------~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 215 --------EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --------hCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 001 11233345677899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.36 Aligned_cols=252 Identities=29% Similarity=0.487 Sum_probs=193.7
Q ss_pred eecccCcEEEEEEEeec---CCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceec-cCCceEEEEeecCC
Q 002533 554 IIGSGGFGHVFKGYIDD---GSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCD-EHGEMILVYEFMPR 628 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~---~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~~ 628 (911)
+||+|+||.||+|.+.+ ....||+|++... .....+.+.+|+.+++.++||||++++++|. .++..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 69999999999998743 2357999998543 3455678899999999999999999999875 45568999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|.+++... ...+.+..++.++.|++.||+||| ..+++||||||+|||+++++.+||+|||+++.
T Consensus 82 ~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 82 GDLRNFIRSE-----------THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARD 147 (262)
T ss_pred CCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcccccc
Confidence 9999998532 223677888999999999999999 78999999999999999999999999999975
Q ss_pred CCCCCCC-ccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCC-CCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 709 GPSGMSQ-SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGR-PPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 709 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~-~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
....... ........++..|+|||.+....++.++|||||||++|||++|. .||.... . ..+... ....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~---~~~~~~---~~~~-- 218 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-S---FDITVY---LLQG-- 218 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-H---HHHHHH---HhcC--
Confidence 4321110 11112334677899999999899999999999999999999965 4553321 1 111111 1100
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
.....+..++..+.+++.+||+.+|++||++.+|+..|+.+.
T Consensus 219 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 --------RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011112234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.51 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=196.6
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||++.....+..||||+++.. .....+.+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999999888889999998753 223445688999999998 799999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~~~~------------~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQR------------QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999988842 235899999999999999999999 78999999999999999999999999999874
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh-hhhHhhHHhhhcccCCc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE-EVSLVLWARVSRARGTV 787 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~ 787 (911)
.... ........||..|+|||++.+..++.++|||||||++|||++|+.||........ ......+.....
T Consensus 146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----- 217 (329)
T cd05588 146 GIRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI----- 217 (329)
T ss_pred cccC---CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-----
Confidence 2211 1122345689999999999999999999999999999999999999963221110 011111111111
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC------HHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT------MGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~eVl~~ 831 (911)
.... ...+..+...+.+++.+||+.||.+||+ +.+++++
T Consensus 218 ---~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 218 ---LEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ---HcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111 1123334567889999999999999998 5666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=343.34 Aligned_cols=266 Identities=22% Similarity=0.287 Sum_probs=196.1
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceecc--------CC
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDE--------HG 617 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--------~~ 617 (911)
..+|...++||+|+||.||+|.....+..||||++.... ....+|+.+|++++||||+++++++.. ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457888999999999999999998888899999885432 234579999999999999999887532 12
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC-
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW- 696 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~- 696 (911)
.+++||||++ ++|.+++..... ....+++..+..++.||+.||+||| +.+|+||||||+||||+.++
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~--------~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYAR--------NNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCC
Confidence 4679999997 478777754321 3346889999999999999999999 78999999999999999664
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||+||||++|++||.+......-..+.
T Consensus 209 ~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred ceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 79999999998643321 12234578999999998764 68999999999999999999999996543211111111
Q ss_pred hHH--------hhh---cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 776 LWA--------RVS---RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 ~~~--------~~~---~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
... ... ...-....+....++..++...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 000 00000111111222222333455678899999999999999999999876
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.74 Aligned_cols=241 Identities=23% Similarity=0.351 Sum_probs=191.9
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||+|++...+..||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999998888899999986532 22345567788888764 899999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|..++.. ...+++.++..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~i~~------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 81 GDLMFHIQD------------KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 999998843 234788899999999999999999 78999999999999999999999999999874
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
.... ........||..|+|||++.+..++.++|||||||++|||++|+.||...... .+ +......
T Consensus 146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~--~~~~~~~----- 211 (316)
T cd05620 146 NVFG---DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----EL--FESIRVD----- 211 (316)
T ss_pred cccC---CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HH--HHHHHhC-----
Confidence 2211 11223456899999999999999999999999999999999999999643311 11 1111000
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHH-HHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG-DVT 829 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eVl 829 (911)
. ...+..+...+.+++.+||+.||++||++. +++
T Consensus 212 ---~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 ---T----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---C----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 111223455678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.56 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=195.4
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||+|.+..++..||||+++.. .......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999888889999998753 223445677899999888 799999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|..++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~L~~~~~~------------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 81 GDLMFHIQR------------SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 999988843 235899999999999999999999 78999999999999999999999999999874
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+. ......
T Consensus 146 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~--~~i~~~----- 211 (318)
T cd05570 146 GILG---GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELF--QSILED----- 211 (318)
T ss_pred cCcC---CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHH--HHHHcC-----
Confidence 2211 11122346899999999999999999999999999999999999999643311 110 011000
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCH-----HHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM-----GDVTWG 831 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~eVl~~ 831 (911)
. ...+..+...+.+++.+||+.||.+||++ .++++.
T Consensus 212 -----~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 -----E--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -----C--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0 11223345678899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=327.20 Aligned_cols=271 Identities=27% Similarity=0.426 Sum_probs=207.6
Q ss_pred CCccceeecccCcEEEEEEEeec-------CCeEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCc
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDD-------GSITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGE 618 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~-------~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 618 (911)
+|...+.||+|+||.||++...+ ....||+|.++.. .....+++.+|+++++++ +|+||++++++|...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 46778899999999999998642 1246899988754 334567899999999999 89999999999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccc----cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQN----QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE 694 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 694 (911)
.+++|||+++|+|.++|......... ........++|.+++.++.|++.||+||| +.+++||||||+|||++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcC
Confidence 99999999999999999653211100 00112346899999999999999999999 789999999999999999
Q ss_pred CCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhh
Q 002533 695 NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVS 773 (911)
Q Consensus 695 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~ 773 (911)
++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||+||||++ |..||.......
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 99999999999975432211 111122234567999999999999999999999999999998 888875432111
Q ss_pred HhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhh
Q 002533 774 LVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 774 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 839 (911)
+...... ......+..+...+.+++.+||+.+|.+||++.|+++.|+.+....
T Consensus 245 ---~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 ---LFKLLKE----------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ---HHHHHHc----------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111110 1111223345667889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.07 Aligned_cols=262 Identities=26% Similarity=0.374 Sum_probs=202.8
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
+|...+.||+|+||.||++....++..+|+|.+... .....+++.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 678888999999999999999888888999988654 3344567889999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++... ..+++..+..++.|++.||.|||+ ..+++||||||+|||+++++.+||+|||++
T Consensus 82 ~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 82 DGGSLDQVLKKA------------GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCc
Confidence 999999999532 347888999999999999999994 368999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||....... ...+.........
T Consensus 148 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 218 (308)
T cd06615 148 GQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGE 218 (308)
T ss_pred cccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCcccccc
Confidence 754222 1223468889999999988889999999999999999999999985433111 1110000000000
Q ss_pred --------------------cccccCccc---cCCCC-hHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 787 --------------------VDQIVDPRL---RGKIA-PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 787 --------------------~~~i~d~~l---~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
..++.+... ....+ ......+.+++.+||+.+|++||++.+|++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 00111 12355688999999999999999999998774
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=329.38 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=205.9
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
.-+||+|.||+||-|++.++...+|||.+.....+..+-+..||.+-++|+|.|||+++|.|.+++.+-|.||-++||+|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 34899999999999999999999999999877777777799999999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCC--chhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeec-CCCceEEeecCCccC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPL--TWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRM 708 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l--~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 708 (911)
.++|...- ++| ++.++--+.+||.+||.||| +..|||||||-+|||++ -.|.+||+|||-++.
T Consensus 660 SsLLrskW-----------GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKR 725 (1226)
T KOG4279|consen 660 SSLLRSKW-----------GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKR 725 (1226)
T ss_pred HHHHHhcc-----------CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchh
Confidence 99995431 234 56677789999999999999 78999999999999996 578999999999886
Q ss_pred CCCCCCCccccccccCcccccChhhhccc--CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQ--QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
+.. -........||..|||||++..+ .|+.++|||||||++.||.||++||.........+ +
T Consensus 726 LAg---inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM----F--------- 789 (1226)
T KOG4279|consen 726 LAG---INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM----F--------- 789 (1226)
T ss_pred hcc---CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh----h---------
Confidence 432 12233456799999999999876 58899999999999999999999995332221111 1
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
++---.....+|.+...+...++.+|+.+||.+||+++++++.
T Consensus 790 --kVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 790 --KVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred --hhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 1111122355677788888999999999999999999999764
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.74 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=199.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||+|+||.||+|...++ ..+|+|.+..... ..+.|.+|++++++++|+|++++++++. ....+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HhhhhheeccccCceEEEEEecCC-ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 466677999999999999987755 5699999875433 3457999999999999999999999885 456899999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.++++.. ....+++.+++.++.|++.||+||| +.+++||||||+||++++++.++|+|||++.
T Consensus 84 ~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 84 KGSLLDFLKDG----------EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred CCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 99999998542 2235889999999999999999999 6899999999999999999999999999997
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....+ .
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~---~----- 216 (260)
T cd05070 151 LIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQ---V----- 216 (260)
T ss_pred eccCccc--ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH---H-----
Confidence 6432211 11112235567999999998899999999999999999999 88888543211 11111 0
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
........+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 217 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 -----ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111122334456778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.17 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=199.9
Q ss_pred HHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceeccC------
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEH------ 616 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~------ 616 (911)
.+++.|...+.||+|+||.||+|...+.++.||+|++.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35566777889999999999999998888899999986543 3446788999999998 799999999998642
Q ss_pred CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC
Q 002533 617 GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 617 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 696 (911)
...++||||+++|+|.+++... ....++|..+..++.|++.||+||| +.+|+|+||||+||++++++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~----------~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~ 148 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT----------KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 148 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCC
Confidence 4689999999999999998542 2235889999999999999999999 68999999999999999999
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhh
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~ 771 (911)
.++|+|||+++...... .......|+..|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 149 ~~~l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~ 225 (272)
T cd06637 149 EVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225 (272)
T ss_pred CEEEccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 99999999987543221 1123456888999999986 346888999999999999999999998543211110
Q ss_pred hhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 772 VSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. ... .. .. +......++..+.+++.+||..+|.+||++.+|++.
T Consensus 226 ~------~~~--~~-----~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 226 F------LIP--RN-----PA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred H------HHh--cC-----CC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 000 00 00 111122345678899999999999999999999753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=329.44 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=196.4
Q ss_pred CCccceeecccCcEEEEEEEee---cCCeEEEEEEccCCC----hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCce
Q 002533 548 DFADHCIIGSGGFGHVFKGYID---DGSITVAVKRLNTSS----MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~---~~~~~vAvK~l~~~~----~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 619 (911)
+|...+.||+|+||.||+++.. ..+..||+|++.... ....+.+..|++++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4677889999999999999864 345789999986432 23345678899999999 599999999999999999
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~k 145 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ------------RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVV 145 (332)
T ss_pred EEEEeCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEE
Confidence 999999999999999853 234888999999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+|||+++....... .......||..|+|||++.+. .++.++|||||||+||||++|+.||...........+ .
T Consensus 146 l~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~ 220 (332)
T cd05614 146 LTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---S 220 (332)
T ss_pred EeeCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---H
Confidence 999999975432211 112245689999999999865 4789999999999999999999999643211111111 1
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
..... .++ ..+......+.+++.+||+.||++|| ++.+++++
T Consensus 221 ~~~~~-------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 RRILK-------CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHhc-------CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 10000 111 12233456678999999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=334.14 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=198.3
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCC-----ceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG-----EMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~ 620 (911)
+|+..+.||+|+||.||++....++..||||++... .....+++.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467788999999999999998877789999998643 3344567889999999999999999999997766 789
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+|+||+. ++|.+.+. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 81 lv~e~~~-~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL 144 (372)
T cd07853 81 VVTELMQ-SDLHKIIV------------SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKI 144 (372)
T ss_pred EEeeccc-cCHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEe
Confidence 9999996 57877773 2345899999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||+++....... .......++..|+|||++.+. .++.++|||||||++|||++|+.||....... ....+...
T Consensus 145 ~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~- 220 (372)
T cd07853 145 CDFGLARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDL- 220 (372)
T ss_pred ccccceeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHH-
Confidence 99999986432211 112234578899999998874 57999999999999999999999996543211 11111000
Q ss_pred hhcccCCcc-----------cccC-----ccc--cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 VSRARGTVD-----------QIVD-----PRL--RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~~~~~~-----------~i~d-----~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
....... .+.. +.. ...........+.+++.+||+.||++|||+.|++++
T Consensus 221 --~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 221 --LGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred --cCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 0000 000 001122335678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=323.56 Aligned_cols=270 Identities=27% Similarity=0.443 Sum_probs=206.5
Q ss_pred cCCccceeecccCcEEEEEEEee-------cCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCC
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID-------DGSITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHG 617 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~-------~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 617 (911)
.+|...+.||+|+||.||+++.. .....+|+|.++.. ......++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45667889999999999999753 22357999998754 334566789999999999 6999999999999989
Q ss_pred ceEEEEeecCCCchhhHhhhhhhccccc----ccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeec
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQ----NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD 693 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 693 (911)
..++||||+++|+|.+++.......... .......++|.++++++.|++.||+||| +.+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 9999999999999999996543211100 0112346899999999999999999999 78999999999999999
Q ss_pred CCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhh
Q 002533 694 ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEV 772 (911)
Q Consensus 694 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~ 772 (911)
.++.+||+|||+++......... ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... +
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-~-- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-E-- 244 (314)
T ss_pred CCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-H--
Confidence 99999999999998643221111 1111224467999999999999999999999999999999 88888543211 1
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
+.. .... ......+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 245 -~~~---~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 -LFK---LLRE----------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -HHH---HHHc----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 110 0000 01112234456678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=314.63 Aligned_cols=257 Identities=32% Similarity=0.492 Sum_probs=205.3
Q ss_pred eeecccCcEEEEEEEeecC---CeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDG---SITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~---~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
+.||+|+||.||+|..... ...+++|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 3699999999999999865 678999999765433 367899999999999999999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
++|.+++....... .......+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++.
T Consensus 81 ~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 81 GDLLDYLRKSRPVF---PSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred CcHHHHHhhccccc---cccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99999996432110 0011356899999999999999999999 79999999999999999999999999999987
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
...... ........++..|+|||.+....++.++|||||||+++||++ |+.||...... .+. .....
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~---~~~~~---- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----EVL---EYLRK---- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----HHH---HHHHc----
Confidence 543321 122234457889999999998899999999999999999999 58888654211 111 10000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
..+...+..++..+.+++.+||+.+|.+||++.|++..|+
T Consensus 223 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 ------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112233445678899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.46 Aligned_cols=258 Identities=21% Similarity=0.291 Sum_probs=199.6
Q ss_pred HHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCc
Q 002533 542 IKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGE 618 (911)
Q Consensus 542 l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 618 (911)
+.....+|...++||+|+||.||++....++..+|+|++... .....+.+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 334456788899999999999999999888889999998642 22334568899999999999999999999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-------------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-------------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCE
Confidence 9999999999999998842 23678888999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhccc----CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ----QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l 774 (911)
||+|||+++...... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||.......
T Consensus 182 kL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~----- 254 (370)
T cd05621 182 KLADFGTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG----- 254 (370)
T ss_pred EEEecccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-----
Confidence 999999998643211 1112345699999999999764 37889999999999999999999996533111
Q ss_pred hhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCC--CCCHHHHHHH
Q 002533 775 VLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFR--RPTMGDVTWG 831 (911)
Q Consensus 775 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~ 831 (911)
.+........ .+...........+.+++.+|+..++.+ ||++.|++++
T Consensus 255 -~~~~i~~~~~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 255 -TYSKIMDHKN--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -HHHHHHhCCc--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111000 0111111123556778889999855544 8899998776
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.61 Aligned_cols=247 Identities=30% Similarity=0.483 Sum_probs=198.0
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeeccee-ccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC-DEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~lV~E~~ 626 (911)
+|...+.||+|+||.||++...+ ..+|+|.++... ..+.|.+|+.++++++|+|++++++++ ..++..++||||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~--~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcC--CcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 56777899999999999998764 479999886543 345789999999999999999999976 4556789999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.+++... ....+++..++.++.|++.||+||| ..+++||||||+||++++++.+||+|||++
T Consensus 83 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 83 AKGSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred CCCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccc
Confidence 999999998543 2235889999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+..+ ..
T Consensus 150 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~----~~~~~---~~--- 213 (256)
T cd05082 150 KEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR---VE--- 213 (256)
T ss_pred eeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---Hh---
Confidence 7532211 12234568999999999999999999999999999998 88888543211 11111 10
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
.......+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 214 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 214 -------KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 011112234456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=318.95 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=199.4
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
|...++||+|+||+||+|.....+..+|+|.+..... .....+.+|+++|++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5556789999999999999988888999999865422 2334578899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 82 MNGGDLKFHIYNM----------GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred ccCccHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCc
Confidence 9999999888542 2235899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+....... ......|+..|+|||++.+..++.++|+|||||++|||++|+.||....... ....+.......
T Consensus 149 ~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~- 220 (285)
T cd05632 149 AVKIPEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLET- 220 (285)
T ss_pred ceecCCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhcc-
Confidence 87543221 1123468999999999999999999999999999999999999996432111 111111111000
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-----HHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 831 (911)
...........+.+++..||+.||++||+ +.+++..
T Consensus 221 ----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 ----------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01122334556789999999999999999 5566554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.77 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=203.1
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||+|.....+..|++|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 35677788999999999999987777899999987665556678999999999999999999999999889999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++.. ..+++.+++.++.|++.||+||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~L~~~~~~-------------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 100 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred CCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 99999998832 23788899999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
+....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||....... .+..+. ..+.
T Consensus 164 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~~~----~~~~ 233 (296)
T cd06654 164 AQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIA----TNGT 233 (296)
T ss_pred hhcccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHHHh----cCCC
Confidence 75332211 1123458889999999999889999999999999999999999996433111 111100 0000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+. ...+......+.+++.+||+.+|++||++.+|++.
T Consensus 234 ------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 ------PE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ------CC--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 01122345668899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=315.98 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=196.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-----ChhhHHHHHHHHHHHHhcccccEeeecceecc--CCce
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-----SMQGAREFRTEIEMISELRHLHIVSLLGFCDE--HGEM 619 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-----~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~ 619 (911)
.+|...++||+|+||.||+|.....+..|++|++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999999887789999987532 22344578899999999999999999998754 4578
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++++||+++++|.+++... ..+++...+.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 82 ~l~~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY------------GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 8999999999999998432 34788899999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
|+|||+++................++..|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-------~ 219 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-------F 219 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-------H
Confidence 999999875432111111112345788999999999989999999999999999999999998643211100 0
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.... .......+......+.+++ +||..+|++||+++||+++
T Consensus 220 ~~~~---------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 220 KIAT---------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHhc---------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0000 0001122333445556666 7888999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.25 Aligned_cols=241 Identities=27% Similarity=0.379 Sum_probs=190.6
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHH-HHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIE-MISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||+|....++..+|||++... ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999999888889999998643 2233445566665 46779999999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|..++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~L~~~l~~------------~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 81 GELFFHLQR------------ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 999988842 235889999999999999999999 78999999999999999999999999999875
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... + +.....
T Consensus 146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~--~~~~~~------ 210 (325)
T cd05604 146 GIAQ---SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----M--YDNILH------ 210 (325)
T ss_pred CCCC---CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----H--HHHHHc------
Confidence 3211 112234568999999999999999999999999999999999999996533111 0 111110
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVT 829 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl 829 (911)
..+ ...+.....+.+++.+|++.+|.+||++.+.+
T Consensus 211 ----~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 211 ----KPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ----CCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 000 11222455678999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=331.00 Aligned_cols=239 Identities=26% Similarity=0.353 Sum_probs=191.8
Q ss_pred eeecccCcEEEEEEEee---cCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 553 CIIGSGGFGHVFKGYID---DGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~---~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+.||+|+||.||+++.. ..+..+|+|++.... ......+..|+++|++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 47999999999998763 345789999987532 2234457789999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~L~~~l~~------------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 146 (318)
T cd05582 82 GGDLFTRLSK------------EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146 (318)
T ss_pred CCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCc
Confidence 9999998843 234889999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .... ....
T Consensus 147 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~--~i~~----- 212 (318)
T cd05582 147 ESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMT--MILK----- 212 (318)
T ss_pred ccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHH--HHHc-----
Confidence 533221 1223456899999999999989999999999999999999999999643211 0100 0000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGD 827 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 827 (911)
.. ...+......+.+++.+||+.||++||++.+
T Consensus 213 -----~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 -----AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -----CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 1123334567789999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=351.62 Aligned_cols=270 Identities=29% Similarity=0.438 Sum_probs=213.7
Q ss_pred CccceeecccCcEEEEEEEeec-------CCeEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCce
Q 002533 549 FADHCIIGSGGFGHVFKGYIDD-------GSITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~-------~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 619 (911)
....+.||+|.||.|++|...+ ....||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|...+..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 3445589999999999998641 1468999999865 335667899999999999 699999999999999999
Q ss_pred EEEEeecCCCchhhHhhhhh-hcccccc-cCCC--CCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 620 ILVYEFMPRGNLRDHLYNSQ-KQNQNQN-QNQN--SPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~-~~~~~~~-~~~~--~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
++|+||+++|+|.++|+..+ ....... .... ..|+..+.+.++.|||.||+||+ +.++|||||.++|||+.++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCC
Confidence 99999999999999998776 1111000 0011 34999999999999999999999 7889999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhH
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSL 774 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l 774 (911)
..+||+|||++|................-...|||||.+....|+.|+|||||||+||||+| |..|+.+..... + +
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-~--l 531 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-E--L 531 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-H--H
Confidence 99999999999964332221111111113557999999999999999999999999999999 788885522111 1 1
Q ss_pred hhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 775 VLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 775 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
-+.+.+..|.+.|..|..++.++|+.||+.+|++||++.++++.++..++
T Consensus 532 -------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 -------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11233445666788889999999999999999999999999999998543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.46 Aligned_cols=246 Identities=28% Similarity=0.484 Sum_probs=196.6
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCCCh-hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchh
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 632 (911)
+||+|+||.||+|...+ +..+|+|.+..... .....+.+|++++++++||||++++++|...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecC-CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 69999999999999765 46899999876543 33456899999999999999999999999999999999999999999
Q ss_pred hHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCC
Q 002533 633 DHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 633 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 712 (911)
+++... ...+++..++.++.|++.+|.||| ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 81 SFLRKK-----------KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred HHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 988432 234789999999999999999999 789999999999999999999999999998753322
Q ss_pred CCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 713 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
.. .......++..|+|||++....++.++||||||+++||+++ |..||....... ... . .
T Consensus 147 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----~~~--~-~---------- 207 (250)
T cd05085 147 IY--SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----ARE--Q-V---------- 207 (250)
T ss_pred cc--ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----HHH--H-H----------
Confidence 11 11112234567999999998999999999999999999999 898985432111 000 0 0
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
....+...+..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 208 EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 001112223345678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=317.38 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=203.8
Q ss_pred CCccceeecccCcEEEEEEEeecCC----eEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGS----ITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~----~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
+|...+.||+|+||.||+|.+...+ ..+|+|.+.... .....++.+|++++++++|+||++++++|.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 4566789999999999999976543 368999887553 3455779999999999999999999999987 789999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++|+|.+++... ...+++..++.++.|++.||+||| +.+++||||||+|||+++++.+||+|
T Consensus 87 ~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 87 TQLMPLGCLLDYVRNH-----------KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred EecCCCCcHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECC
Confidence 9999999999998532 234899999999999999999999 68999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||+++........ .......++..|+|||.+....++.++|+||||+++||+++ |+.||....... + ....
T Consensus 153 fg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~---~~~~ 224 (279)
T cd05057 153 FGLAKLLDVDEKE-YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----I---PDLL 224 (279)
T ss_pred CcccccccCcccc-eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----H---HHHH
Confidence 9999865432211 11112224568999999988899999999999999999999 999986533111 1 1111
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.. ......+..+...+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 225 ~~----------~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 225 EK----------GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred hC----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 01112233345678899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.67 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=203.8
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceE
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 620 (911)
.-.+|...++||+|.||+|+++.++++++.+|||++++.. .++.+..+.|.+++... +||.|++|+.++...++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3457888999999999999999999999999999998763 35566778888888777 5999999999999999999
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||+.||++..+. ....+++....-++..++.||.||| +++||+||||-+|||||.+|.+||
T Consensus 446 fvmey~~Ggdm~~~~-------------~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI-------------HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred EEEEecCCCcEEEEE-------------ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEe
Confidence 999999999954443 2345888888999999999999999 899999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
+||||++.... ........+||+.|||||++.++.|+...|.|||||+||||+.|+.||.+... ++-
T Consensus 510 ADFGlcKe~m~---~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~--------- 576 (694)
T KOG0694|consen 510 ADFGLCKEGMG---QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEV--------- 576 (694)
T ss_pred cccccccccCC---CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHH---------
Confidence 99999997542 23345678899999999999999999999999999999999999999975431 111
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCH
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM 825 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 825 (911)
.+.|+..+ ..+|..+..+...++.+.+..+|++|--+
T Consensus 577 ------FdsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 ------FDSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------HHHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11111111 12445567778899999999999999877
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=318.53 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=198.3
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
+|...++||+|+||.||+|.+..++..||+|++... .....+++.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 466678999999999999999888889999998644 3445567999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|..+. .+++..+..++.|++.||+||| +.+|+|+||||+|||++.++.++|+|||++
T Consensus 82 ~~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 82 DGGSLDVYR----------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred CCCChHHhh----------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999996543 2677888899999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..............+.......
T Consensus 143 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 215 (279)
T cd06619 143 TQLVNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-- 215 (279)
T ss_pred eecccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--
Confidence 754321 1223468899999999999999999999999999999999999986432111111111111110000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..+.+ ........+.+++.+||+.+|++||++.|+++.
T Consensus 216 ----~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 216 ----DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00111 111234567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=313.59 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=199.1
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|.....||+|+||.||+|.+.++. .+|+|.+.... ...+.+.+|++++++++|+|++++++++.. +..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4666778999999999999987664 69999886543 234678899999999999999999998754 56889999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.++++.. ....++|..++.++.|++.||+||| +.+++|+||||+||++++++.++|+|||+++
T Consensus 84 ~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 84 KGSLLDFLKEG----------DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CCCHHHHHhhC----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccce
Confidence 99999999542 2234789999999999999999999 7899999999999999999999999999997
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+ ...+ .. .
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~---~~~~--~~-~--- 218 (260)
T cd05069 151 LIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-RE---VLEQ--VE-R--- 218 (260)
T ss_pred EccCCcc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HH---HHHH--HH-c---
Confidence 6432211 11122345678999999998999999999999999999999 8888864321 11 1111 00 0
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
......+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 219 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 -------GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112233456778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.57 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=202.5
Q ss_pred HHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceecc
Q 002533 539 LTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDE 615 (911)
Q Consensus 539 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~ 615 (911)
+.++....++|...+.||+|+||.||++....++..+|+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344555567899999999999999999999988889999998642 22334567889999999999999999999999
Q ss_pred CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 616 HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 616 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
+...++||||+++|+|.+++.. ..++...+..++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~ 178 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-------------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS 178 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCC
Confidence 9999999999999999998842 23677788899999999999999 7899999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc----CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhh
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ----QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~ 771 (911)
+.+||+|||+++...... ........||+.|+|||++... .++.++|||||||+||||++|+.||.......
T Consensus 179 ~~ikL~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-- 254 (371)
T cd05622 179 GHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-- 254 (371)
T ss_pred CCEEEEeCCceeEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--
Confidence 999999999997643221 1122345699999999999754 37899999999999999999999996533111
Q ss_pred hhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCC--CCCHHHHHHHH
Q 002533 772 VSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFR--RPTMGDVTWGL 832 (911)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~L 832 (911)
.+......... +...........+.+++.+|+..++.+ ||++.+++++.
T Consensus 255 ----~~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 255 ----TYSKIMNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----HHHHHHcCCCc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111100 111111234566788999999844433 78899888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.05 Aligned_cols=254 Identities=30% Similarity=0.436 Sum_probs=199.1
Q ss_pred eecccCcEEEEEEEeecCC------eEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 554 IIGSGGFGHVFKGYIDDGS------ITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~------~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.||+|+||.||+|+..+.. ..+|||.+.... .....++.+|++++++++||||++++++|......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 6999999999999986432 679999886543 344667899999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC-----ceEEe
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW-----AAKIS 701 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~ 701 (911)
++|+|.+++....... .....++|.+++.++.|++.||+||| +.+++|+||||+||+++.+. .++|+
T Consensus 82 ~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 82 EGGDLLSYLRDARVER-----FGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred CCCcHHHHHHHhhhcc-----cCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEEC
Confidence 9999999996543211 02345889999999999999999999 78999999999999999877 89999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhh
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|||+++....... ........++..|+|||++.++.++.++|||||||++|||++ |+.||..... .......
T Consensus 154 dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~-- 226 (269)
T cd05044 154 DFGLARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHV-- 226 (269)
T ss_pred Ccccccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHH--
Confidence 9999875432211 111122235678999999999999999999999999999998 9998853221 1111110
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
....+...+..++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 227 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 -----------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 001111223345678899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=314.51 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=189.8
Q ss_pred eecccCcEEEEEEEeecC--CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCc
Q 002533 554 IIGSGGFGHVFKGYIDDG--SITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 630 (911)
.||+|+||.||+|....+ ...+++|.+.... ......|.+|++.++.++|+||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 599999999999976443 3578899876543 3445678999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCC
Q 002533 631 LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710 (911)
Q Consensus 631 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 710 (911)
|.+++...... .....++...+.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++...
T Consensus 82 L~~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 82 LKNYLRSNRGM-------VAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred HHHHHHhcccc-------ccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999654321 1223567888999999999999999 7899999999999999999999999999987532
Q ss_pred CCCCCccccccccCcccccChhhhcc-------cCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhc
Q 002533 711 SGMSQSHVSTVVKGSFGYVDPEYIRR-------QQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 711 ~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
.... ........++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+ ... ....
T Consensus 152 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~---~~~--~~~~ 224 (269)
T cd05042 152 PEDY-YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQ---VLK--QVVR 224 (269)
T ss_pred cchh-eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-HH---HHH--HHhh
Confidence 2111 011122345678999998753 457889999999999999999 7777754321 11 100 0000
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.. ...+..+ ..+..+...+.+++..|| .||++||++++|++.|
T Consensus 225 -~~-~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 225 -EQ-DIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -cc-CccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00 0011111 122344566778889999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.17 Aligned_cols=239 Identities=23% Similarity=0.377 Sum_probs=187.6
Q ss_pred eecccCcEEEEEEEeec------------------------CCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeee
Q 002533 554 IIGSGGFGHVFKGYIDD------------------------GSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~------------------------~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l 609 (911)
.||+|+||.||+|.+.. ....|++|++.........+|.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998632 124689999876655556778999999999999999999
Q ss_pred cceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCC
Q 002533 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTN 689 (911)
Q Consensus 610 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~N 689 (911)
+++|.+....++||||+++|+|..++... ...+++..++.++.|+++||+||| +.+|+||||||+|
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~N 147 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-----------KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKN 147 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCccc
Confidence 99999999999999999999999888432 235788999999999999999999 7899999999999
Q ss_pred eeecCCC-------ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHH-hCCC
Q 002533 690 ILLDENW-------AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVL-CGRP 760 (911)
Q Consensus 690 ILl~~~~-------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~Ell-tG~~ 760 (911)
||++..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.
T Consensus 148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 220 (274)
T cd05076 148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220 (274)
T ss_pred EEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9997643 4899999987642211 12346778999998875 56899999999999999995 6888
Q ss_pred CCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 761 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
||...... +.. .+ ... .. ..+......+.+++.+||+.+|++||++.+|++.|
T Consensus 221 p~~~~~~~-~~~---~~---~~~----------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 221 PLKERTPS-EKE---RF---YEK----------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CccccChH-HHH---HH---HHh----------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 88543211 100 00 000 00 01111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=314.58 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=201.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...++||+|+||.||+|...++ ..||+|.+..... ...++.+|++++++++|+||+++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~-~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCC-ceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 4577788999999999999997665 5799999875443 3467899999999999999999999874 45789999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.+++... ....+++.+++.++.|++.||+||| +.+++||||||+||++++++.++|+|||++
T Consensus 83 ~~~~L~~~~~~~----------~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 83 ENGSLVDFLKTP----------EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred CCCCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcce
Confidence 999999998532 2345889999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
........ .......++..|+|||++....++.++||||||+++|||++ |+.||....... +.. ..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~---~~---- 216 (260)
T cd05067 150 RLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----VIQ---NL---- 216 (260)
T ss_pred eecCCCCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH----HHH---HH----
Confidence 76432111 11122345678999999998999999999999999999999 999986433111 110 00
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
....+...+..++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 217 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 217 ------ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111112223345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.82 Aligned_cols=251 Identities=21% Similarity=0.337 Sum_probs=202.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
+|...+.||+|+||.||++....++..+|+|.++.. .....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 466778999999999999999888889999988543 3345567889999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.+++... ....+++...+.++.|++.||+||| +.+++|+||||+||++++++.++|+|||++
T Consensus 81 ~~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 81 DGGDLMQKIKLQ----------RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred CCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcc
Confidence 999999988532 2334788899999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
+...... .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||....... . .+ ... .+.
T Consensus 148 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~-~~--~~~-~~~ 216 (255)
T cd08219 148 RLLTSPG---AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----L-IL--KVC-QGS 216 (255)
T ss_pred eeecccc---cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----H-HH--HHh-cCC
Confidence 7543221 11223458889999999999999999999999999999999999996432111 0 00 000 000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
....+..+...+.+++.+||+.||++||++.+|+..
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 ---------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223345678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=313.92 Aligned_cols=239 Identities=24% Similarity=0.380 Sum_probs=188.3
Q ss_pred eecccCcEEEEEEEeecC------------CeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 554 IIGSGGFGHVFKGYIDDG------------SITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~------------~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
.||+|+||.||+|+.... ...|++|.+..........|.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 689999999999986422 23689999876655566678999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc----
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA---- 697 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---- 697 (911)
||||+++|+|..++... ...+++..+++++.||++||+||| +.+|+||||||+|||++.++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK-----------SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred EEecccCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCC
Confidence 99999999998887432 235889999999999999999999 789999999999999987654
Q ss_pred ---eEEeecCCccCCCCCCCCccccccccCcccccChhhhc-ccCCCchhHHHHHHHHHHHHH-hCCCCCCCCccchhhh
Q 002533 698 ---AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR-RQQLTEKSDVYSFGVVLLEVL-CGRPPMINGAVRKEEV 772 (911)
Q Consensus 698 ---~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDVwSfGvvL~Ell-tG~~p~~~~~~~~~~~ 772 (911)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+...... +.
T Consensus 148 ~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~- 218 (262)
T cd05077 148 GPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-EK- 218 (262)
T ss_pred CceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-HH-
Confidence 899999998753211 1234778899999887 467899999999999999998 477776432211 10
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
..... .... ........+.+|+.+||+.||.+||++.+|++.|
T Consensus 219 -----~~~~~----------~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 -----ERFYE----------GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----HHHHh----------cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000 0000 1111245688999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=317.71 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=200.1
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
|...+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 444567999999999999998777899999987443 3445678999999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++. ...+++..+..++.|+++||.||| ..+++|+||+|+||++++++.++|+|||+++
T Consensus 86 ~~~L~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 86 GGSALDLLK-------------PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CCcHHHHhh-------------cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccc
Confidence 999999883 234788999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.|+....... ...+
T Consensus 150 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~---------- 212 (277)
T cd06642 150 QLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VLFL---------- 212 (277)
T ss_pred cccCcc---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HHhh----------
Confidence 643221 11123457889999999999999999999999999999999999985432110 0000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
............++..+.+++.+||+.+|++||+|.+|+++
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 213 ---IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00011112223345678899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=313.23 Aligned_cols=255 Identities=30% Similarity=0.477 Sum_probs=203.8
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
..+|...++||+|+||.||+|.++++ ..+|||.+.... ...+++.+|++++++++|+||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 35677888999999999999998655 679999987543 3356799999999999999999999999988899999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++... ....+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||+
T Consensus 83 ~~~~~L~~~i~~~----------~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 83 MSKGSLLDFLKSG----------EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred cCCCCHHHHHhcc----------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECcccc
Confidence 9999999999542 2245899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++...... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+ ... ..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~---~~~--~~---- 217 (261)
T cd05034 150 ARLIEDDE--YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-RE---VLE--QV---- 217 (261)
T ss_pred ceeccchh--hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HH---HHH--HH----
Confidence 87643211 111112234568999999999899999999999999999999 9999854321 11 110 00
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
....+...+..++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 218 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 -------ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -------HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011112233346678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=314.51 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=203.6
Q ss_pred cCCccceeecccCcEEEEEEEeecC---CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~---~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
.+|...++||+|+||.||+|.+.+. ...|+||...... ....+.+.+|++++++++||||++++++|.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 3466778999999999999987543 3569999887654 4556789999999999999999999999875 467899
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++|+|.+++... ...+++..++.++.|++.||+||| +.+++|+||||+|||++.++.+||+|
T Consensus 85 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 85 MELAPLGELRSYLQVN-----------KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred EEcCCCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEcc
Confidence 9999999999999532 224899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||+++....... .......++..|+|||.+....++.++|||||||++||+++ |+.||....... ...+..
T Consensus 151 ~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~~~~~-- 222 (270)
T cd05056 151 FGLSRYLEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----VIGRIE-- 222 (270)
T ss_pred Cceeeecccccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHH--
Confidence 999876433211 11122234567999999988889999999999999999996 999986443111 111100
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.. .+...+..++..+.+++.+|+..+|.+|||+.++++.|+.+..
T Consensus 223 -~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 223 -NG----------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -cC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 0112234456788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=316.61 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=200.2
Q ss_pred ccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
...+.||+|+||.||+|.....+..+++|.+........+.+.+|+++++.++|+||+++++++..+...++||||++++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 34567999999999999998888899999997776677788999999999999999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|..++... ..++++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++...
T Consensus 88 ~l~~~~~~~-----------~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 88 AVDAVMLEL-----------ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred cHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence 999887532 235899999999999999999999 789999999999999999999999999998753
Q ss_pred CCCCCCccccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
.... .......++..|+|||++. +..++.++|||||||++|||++|+.||....... ....... ..
T Consensus 154 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~---~~ 224 (282)
T cd06643 154 TRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKIAK---SE 224 (282)
T ss_pred cccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHHhh---cC
Confidence 3211 1123346888999999984 4567889999999999999999999985432111 0001000 00
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+. ...+..++..+.+++.+||+.+|.+||++.++++.
T Consensus 225 -------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 -------PPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -------CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01122345678899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.18 Aligned_cols=245 Identities=20% Similarity=0.294 Sum_probs=193.0
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
++||+|+||.||+|....++..+|||+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999998888899999997542 23445688999999888 699999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|..++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~L~~~~~~------------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 81 GDLMFHMQR------------QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 999988842 235899999999999999999999 78999999999999999999999999999874
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
.... ........||..|+|||++.+..++.++|||||||+||||++|+.||....... ......+.....
T Consensus 146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~------ 215 (327)
T cd05617 146 GLGP---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVI------ 215 (327)
T ss_pred ccCC---CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHH------
Confidence 2211 112234568999999999999999999999999999999999999995422111 111111111110
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG 826 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 826 (911)
.... ...+......+.+++.+||+.||++||++.
T Consensus 216 --~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 216 --LEKP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --HhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0111 112333456678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.32 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=197.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccC---C--ceEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEH---G--EMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~---~--~~~l 621 (911)
-.|...+++|.|.||.||+|.+...++.||||+.-.... --.+|+++|+++.|||||+|+-++... + ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 345667899999999999999998888999998754432 223689999999999999999887332 2 4578
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC-CceEE
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKI 700 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl 700 (911)
|||||+. +|.+.++..-. .+..++...+.-+..||.+||+||| .++|+||||||.|+|+|.+ +.+||
T Consensus 100 VleymP~-tL~~~~r~~~~--------~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTR--------ANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred HHHhchH-HHHHHHHHHhh--------cCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEe
Confidence 9999976 99999865322 2345777788889999999999999 7999999999999999976 99999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
||||.|+....+... .....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.. ..++ ++...+
T Consensus 168 cDFGSAK~L~~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQ--L~eIik 240 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQ--LVEIIK 240 (364)
T ss_pred ccCCcceeeccCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHH--HHHHHH
Confidence 999999976544322 23346788999999886 579999999999999999999999886643 2222 222111
Q ss_pred hhcc--cCCc-------ccccCccccC-----CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 VSRA--RGTV-------DQIVDPRLRG-----KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~--~~~~-------~~i~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.... ...+ .+...+.+.. ........+.++++.+|++.+|.+|.++.|++.+
T Consensus 241 ~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 241 VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1110 0000 1111122211 1334456788899999999999999999999876
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=326.33 Aligned_cols=241 Identities=23% Similarity=0.353 Sum_probs=189.4
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHH-HHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIE-MISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
.||+|+||+||+|....++..||+|++.... ......+..|.. +++.++|+||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999998888899999986432 122334444544 567889999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|.+++... ..+.+.....++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~L~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 82 ELFYHLQRE------------RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred cHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999988432 34677788889999999999999 789999999999999999999999999998753
Q ss_pred CCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 789 (911)
... ........||..|+|||++.+..++.++|||||||++|||++|+.||....... . +......
T Consensus 147 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~--~~~i~~~------ 211 (325)
T cd05602 147 IEH---NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----M--YDNILNK------ 211 (325)
T ss_pred ccC---CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----H--HHHHHhC------
Confidence 211 112234568999999999999999999999999999999999999996433111 1 1111110
Q ss_pred ccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 790 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
. ....+.....+.+++.+|++.+|.+||++.+.+.
T Consensus 212 ----~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 212 ----P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ----C--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0 1122234566789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=320.95 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=200.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCe----EEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSI----TVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~----~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
.+|...+.||+|+||.||+|.+..++. .||+|.+.... .....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 356667789999999999999865443 57999887543 33345788999999999999999999998754 5679
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
++||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 86 v~e~~~~g~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH-----------KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred eehhcCCCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEc
Confidence 99999999999998532 234788999999999999999999 7899999999999999999999999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhh
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+ ...+..
T Consensus 152 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~---~~~~~~- 225 (303)
T cd05110 152 DFGLARLLEGDEKE-YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-RE---IPDLLE- 225 (303)
T ss_pred cccccccccCcccc-cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HH---HHHHHH-
Confidence 99999864322211 11122345678999999999999999999999999999998 8888854321 11 111111
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.. .+...+..+...+.+++.+||..+|++||++.+|++.|+.+..
T Consensus 226 --~~----------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 226 --KG----------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred --CC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 0111123345678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.27 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=201.4
Q ss_pred CCccceeecccCcEEEEEEEeec-CCeEEEEEEccCC----------ChhhHHHHHHHHHHHHh-cccccEeeecceecc
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDD-GSITVAVKRLNTS----------SMQGAREFRTEIEMISE-LRHLHIVSLLGFCDE 615 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~-~~~~vAvK~l~~~----------~~~~~~~f~~Ei~~l~~-l~HpnIv~l~g~~~~ 615 (911)
+|...+.||+|+||.||+|.+.. ++..+|+|.+... ......++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36667789999999999999977 5678999987532 22334567789988875 799999999999999
Q ss_pred CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 616 HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 616 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
++..++||||+++++|.+++..... ....+++..+++++.|++.||.|||+ ..+++|+||+|+|||++.+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE--------KKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGED 150 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCC
Confidence 9999999999999999998854321 23458889999999999999999993 3689999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
+.+||+|||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 151 ~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------ 220 (269)
T cd08528 151 DKVTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------ 220 (269)
T ss_pred CcEEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------
Confidence 999999999997643321 2234468889999999999889999999999999999999999985432111
Q ss_pred hHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
..... .+..........+...+.+++.+||+.||++||++.||.++++
T Consensus 221 -~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 221 -LATKI---------VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -HHHHH---------hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01110 0111111111123567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=329.03 Aligned_cols=194 Identities=23% Similarity=0.325 Sum_probs=166.5
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
...+|...+.||+|+||.||+|+....+..||+|..... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999999888889999985433 23468999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
++ .++|.+++.. ....++|..++.|+.||+.||+||| .++|+||||||+|||++.++.+||+|||
T Consensus 138 ~~-~~~l~~~l~~-----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG 202 (357)
T PHA03209 138 HY-SSDLYTYLTK-----------RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG 202 (357)
T ss_pred cc-CCcHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCc
Confidence 99 5688888843 2345899999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMI 763 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~ 763 (911)
+++..... .......||..|+|||++.+..++.++|||||||+||||+++..++.
T Consensus 203 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 203 AAQFPVVA----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccC----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 99752211 11223468999999999999999999999999999999999766553
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=318.34 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=193.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhc---ccccEeeecceecc-----CC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISEL---RHLHIVSLLGFCDE-----HG 617 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~-----~~ 617 (911)
+|...+.||+|+||.||+|....++..||+|.++.... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 36677899999999999999988888999998864321 1223456677777665 69999999998754 34
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++||||++ ++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV----------PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQ 146 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence 5799999997 5888888532 2234889999999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
+||+|||+++...... ......|+..|+|||++.+..++.++|||||||++|||++|++||...........+..+
T Consensus 147 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (288)
T cd07863 147 VKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222 (288)
T ss_pred EEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence 9999999998643221 122345788999999999999999999999999999999999998654322111111111
Q ss_pred HhhhcccCCc------ccccCcccc---CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 778 ARVSRARGTV------DQIVDPRLR---GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 778 ~~~~~~~~~~------~~i~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
.......... .....+... ....+.....+.+++.+|++.||++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 000000000 0111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.41 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=193.8
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~ 623 (911)
+|...++||+|+||.||+|....++..||||++... .....+.+..|.+++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366678999999999999999888889999998643 2233456788999988885 577888999998889999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++.. ...+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 81 Ey~~~g~L~~~i~~------------~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 81 EYVNGGDLMYHIQQ------------VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEecc
Confidence 99999999998843 235889999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++..... ........||..|+|||++.+..++.++|||||||+||||++|+.||...... .+.. .
T Consensus 146 g~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~--~---- 212 (323)
T cd05615 146 GMCKEHMVD---GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQ--S---- 212 (323)
T ss_pred ccccccCCC---CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHH--H----
Confidence 998753221 11223446899999999999999999999999999999999999999653311 1110 0
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG 826 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 826 (911)
+.... ...+......+.+++.+||+.+|.+|++..
T Consensus 213 ------i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 213 ------IMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ------HHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 00000 112233456778999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.79 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=197.6
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-----ChhhHHHHHHHHHHHHhcccccEeeecceeccC--Cce
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-----SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEM 619 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-----~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 619 (911)
.+|...++||+|+||.||+|....++..||||.+... .....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4678888999999999999999887889999987532 123456788999999999999999999988653 467
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
+++|||+++++|.+++... ..+++...++++.|++.||+||| +.+++|+||||+|||++.++.++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY------------GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred EEEEEecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEE
Confidence 8999999999999998432 24788888999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
|+|||+++................++..|+|||.+.+..++.++|||||||++|||++|+.||....... .+ ..
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~---~~ 220 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AI---FK 220 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HH---HH
Confidence 9999998754321111111223458889999999998889999999999999999999999985432111 00 00
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. .........+......+.+++.+|+. +|++||+++||++.
T Consensus 221 ~----------~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 221 I----------ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred H----------hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 00011122334445667789999985 89999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=311.89 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=206.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||+|.||+|-+|.....+..||||.++.. +.++.-.+.+||++|+.|+||||++++.+|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 344556899999999999998777789999998765 44555668899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|..+|.|++++.. ...|++.+..+++.||..|+.|+| +++++|||||.+|||||.|+.+||+|||
T Consensus 134 YaS~GeLYDYiSe------------r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 134 YASGGELYDYISE------------RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred ecCCccHHHHHHH------------hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccc
Confidence 9999999999953 345999999999999999999999 8999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCC-CchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+.+... .......+|++-|.+||.+.+.+| .+..|-|||||+||-|+.|..||++.+.. .++
T Consensus 199 LSNly~~----~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----~lv-------- 262 (668)
T KOG0611|consen 199 LSNLYAD----KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----RLV-------- 262 (668)
T ss_pred hhhhhcc----ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----HHH--------
Confidence 9987433 334456789999999999999988 47899999999999999999999754321 111
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.++-....+ .+..+....-||+|+|-.+|++|-|+.+|..+.
T Consensus 263 ----rQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 263 ----RQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----HHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 222222222 223345566899999999999999999997664
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.31 Aligned_cols=239 Identities=26% Similarity=0.406 Sum_probs=189.6
Q ss_pred eecccCcEEEEEEEeecCC-------eEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 554 IIGSGGFGHVFKGYIDDGS-------ITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~-------~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.||+|+||.||+|.....+ ..+++|.+........+++.+|+.+++.++||||+++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 6999999999999875432 348899887665566678899999999999999999999999888999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc--------e
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA--------A 698 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~ 698 (911)
++|+|.+++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++. +
T Consensus 82 ~~g~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 82 KFGSLDTYLKKN-----------KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred CCCcHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceE
Confidence 999999999532 225889999999999999999999 789999999999999987765 6
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCC-CCCCCCccchhhhhHhh
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGR-PPMINGAVRKEEVSLVL 776 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~-~p~~~~~~~~~~~~l~~ 776 (911)
+++|||++..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+.... ......
T Consensus 148 ~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~~--- 216 (258)
T cd05078 148 KLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQ--- 216 (258)
T ss_pred EecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHHH---
Confidence 9999998864321 122457788999999986 45799999999999999999995 4443211 111110
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.... +...+......+.+++.+||+.+|++|||++++++.|
T Consensus 217 ---~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 217 ---FYED------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---HHHc------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 1112223345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=325.52 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=196.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||.||+++....+..||+|++... .......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3677888999999999999999888889999998643 2223445888999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 81 Ey~~gg~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 81 DYYVGGDLLTLLSKF-----------EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred eCCCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEec
Confidence 999999999999542 234788889999999999999999 799999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcc-----cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-----QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+++....... .......|++.|+|||++.+ +.++.++|||||||+||||++|+.||....... .+.
T Consensus 147 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~ 218 (331)
T cd05624 147 GSCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYG 218 (331)
T ss_pred cceeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHH
Confidence 99875432211 11223468999999999876 568899999999999999999999996433111 011
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCC--CCCHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFR--RPTMGDVTWG 831 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~ 831 (911)
......... .+. .........+.+++.+|+..++.+ |+++.+++.+
T Consensus 219 ~i~~~~~~~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 219 KIMNHEERF------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHcCCCcc------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111100000 000 001123566788999988865544 4678877655
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.57 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=203.1
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
++|...+.||+|+||.||+|....++..+++|.+..... .+++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 467778899999999999999988778999999865432 678999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++... ...++|..+..++.|++.||.||| ..+++|+||+|+||++++++.+||+|||++
T Consensus 81 ~~~~L~~~l~~~-----------~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 81 GAGSVSDIMKIT-----------NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred CCCcHHHHHHhC-----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccc
Confidence 999999998432 345899999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
........ ......++..|+|||++.+..++.++|||||||++|||++|+.||.......... .. .
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---~~-----~--- 212 (256)
T cd06612 147 GQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---MI-----P--- 212 (256)
T ss_pred hhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---hh-----c---
Confidence 86433211 2233457889999999999999999999999999999999999986432111100 00 0
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
....+. ...+......+.+++.+||+.+|++||++.||++
T Consensus 213 --~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 --NKPPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --cCCCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000000 1112234567889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=335.54 Aligned_cols=263 Identities=21% Similarity=0.240 Sum_probs=196.6
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||+|.+...+..||||.... ..+.+|+++|++|+|+||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 358888999999999999999998888999996432 34678999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
.++|.+++... ...++|.+++.|+.|+++||+||| ..+|+||||||+||||+.++.+||+|||++
T Consensus 243 -~~~L~~~l~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 243 -RSDLYTYLGAR-----------LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred -CCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 57898888432 235899999999999999999999 789999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh-------hhhHhhHHh
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE-------EVSLVLWAR 779 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~-------~~~l~~~~~ 779 (911)
+....... ........||..|+|||++.+..++.++|||||||+||||++|..++........ -..++.+..
T Consensus 308 ~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~ 386 (461)
T PHA03211 308 CFARGSWS-TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386 (461)
T ss_pred eecccccc-cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence 86432211 1122345699999999999999999999999999999999998876643321110 011111111
Q ss_pred hhccc--C----Ccc-cccC---ccccCCCC-------hHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 VSRAR--G----TVD-QIVD---PRLRGKIA-------PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~~--~----~~~-~i~d---~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..... . .+. .... ...+.... ......+.+|+.+||+.||.+|||+.||+++
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0 000 0000 00000000 0122367789999999999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=328.35 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=196.8
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCC------
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG------ 617 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 617 (911)
..+|...+.||+|+||.||++.....+..||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 35788889999999999999999888889999998643 3344567889999999999999999999885433
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++||||+++ +|.+.++. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--------------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--------------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCC
Confidence 57999999965 66665521 2678888999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh--
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV-- 775 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~-- 775 (911)
+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...........+.
T Consensus 162 ~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 237 (359)
T cd07876 162 LKILDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237 (359)
T ss_pred EEEecCCCccccccC----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999999753221 12233468899999999999999999999999999999999999996543111000000
Q ss_pred -------------hHHhhh-cccC-----CcccccCccc---cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 776 -------------LWARVS-RARG-----TVDQIVDPRL---RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 776 -------------~~~~~~-~~~~-----~~~~i~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
...... .... ...+...... ...........+.+++.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000 0000 0000000000 0001112345688999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.69 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=200.5
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHH--HHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR--EFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~--~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|...+.||+|+||+||++.....+..+|+|++......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 34567999999999999999999889999999877554433 3456999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.++|.. ...+++..++.++.|+++||++|| +.+++|+||||+||++++++.++|+|||++
T Consensus 81 ~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 81 PGGSLQDYLQK------------NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp TTEBHHHHHHH------------HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccc------------cccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 99999999962 234899999999999999999999 689999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhc-ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIR-RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
.... ..........++..|+|||++. +...+.++||||+|+++|+|++|+.||........ ..... ......
T Consensus 146 ~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~--~~~~~~- 218 (260)
T PF00069_consen 146 VKLS---ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIE--KILKRP- 218 (260)
T ss_dssp EEST---STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHH--HHHHTH-
T ss_pred cccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh-hhhhh--hccccc-
Confidence 7531 1122234456888999999998 88999999999999999999999999875421111 11110 000000
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.... ..........+.+++.+||+.||++||++.+++++
T Consensus 219 -----~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 219 -----LPSS--SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -----HHHH--TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -----cccc--ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000113788999999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.13 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=204.3
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccC--CChhhHHHHHHHHHHHHhcccccEeeecceecc-----CCceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNT--SSMQGAREFRTEIEMISELRHLHIVSLLGFCDE-----HGEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~--~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~~~ 620 (911)
.|...+.||+|+||.|..+....+++.||||++.. ...-..++-.+|+++|++++|+||+.+.+.... -...|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 34445689999999999999999989999999873 345566778899999999999999999998754 34689
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+|+|+| .-+|...++ .+..|+.....-+..||.+||.|+| +.+|+||||||+|+|++.+...||
T Consensus 103 iV~elM-etDL~~iik------------~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIK------------SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred EehhHH-hhHHHHHHH------------cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEe
Confidence 999999 568888884 3344888889999999999999999 799999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhc-ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR-RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+||||||..... ......+....|..|.|||.+. ...|+...||||.||+|.||++|++-|.+.. .-++..++...-
T Consensus 167 ~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 167 CDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-YVHQLQLILELL 244 (359)
T ss_pred ccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-hHHHHHHHHHhc
Confidence 999999986543 3344456677899999999875 4689999999999999999999999886544 223333332211
Q ss_pred hhcccCCcccccCcc---------------ccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 VSRARGTVDQIVDPR---------------LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~---------------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
....+..+..+-.+. +...+ +.......+|+.++|..||.+|+|++|.+++
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111111111100 00111 2334566799999999999999999998876
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.81 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=203.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||.|+||.||+|.....+..|++|.+........+.+.+|+.+++.++|+||+++++++......++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 57778899999999999999887778999999876555556778999999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++.. ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 100 ~~~L~~~~~~-------------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 100 GGSLTDVVTE-------------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred CCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccch
Confidence 9999998832 34889999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ . ..... . ..
T Consensus 164 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~--~~~~~----~-~~ 232 (296)
T cd06655 164 QITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L--YLIAT----N-GT 232 (296)
T ss_pred hcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H--HHHHh----c-CC
Confidence 5432211 12234588899999999998999999999999999999999999965432111 1 00000 0 00
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+. ...+..+...+.+++.+||..||.+||++.+|+..
T Consensus 233 -----~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 233 -----PE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -----cc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 11122345678899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.12 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=203.0
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.|...+.||+|+||.||+|.+...+..||||.+.... ......+.+|+++++++.|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3455668999999999999998877899999986542 445677999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.+++.. ..+++.+...++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||++
T Consensus 85 ~~~~L~~~i~~-------------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 85 GGGSALDLLRA-------------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred CCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccc
Confidence 99999998832 34788889999999999999999 789999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
........ ......++..|+|||++.+..++.++|||||||++|||++|+.|+....... ..
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~-------------- 210 (277)
T cd06640 149 GQLTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VL-------------- 210 (277)
T ss_pred eeccCCcc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-Hh--------------
Confidence 76432211 1223457888999999999899999999999999999999999985433111 00
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..............++..+.+++.+||+.+|++||++.+++..
T Consensus 211 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 --FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0001111223344567788999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=315.38 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=201.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
+|...+.||.|+||.||+|....++..||+|++.... ......+.+|++++++++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4666778999999999999998888899999986543 445567899999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++.. ..+++..+..++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~~L~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 82 GGGSCLDLLKP-------------GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred CCCcHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 99999999842 25899999999999999999999 789999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
+...... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... . .. .... ..
T Consensus 146 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~---~~---~~~~-~~- 213 (274)
T cd06609 146 GQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-R---VL---FLIP-KN- 213 (274)
T ss_pred eeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-H---HH---HHhh-hc-
Confidence 8654321 1122345788899999999989999999999999999999999998543211 0 00 0000 00
Q ss_pred cccccCccccCCCChH-HHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPV-CLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..+. .... ++..+.+++.+||..+|++||++++++++
T Consensus 214 ----~~~~----~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 214 ----NPPS----LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----CCCC----CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0111 1111 45578899999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.80 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=199.5
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---------hhHHHHHHHHHHHHhcccccEeeecceeccCCce
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---------QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 619 (911)
|.....||+|+||.||+|.....+..+|+|.+..... +..+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 4556789999999999999887778999998864322 1235688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+++||||+|+||++++++.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~------------~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN------------YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred EEEEEecCCCCHHHHHHh------------ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEE
Confidence 999999999999999943 234788899999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCc---cccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 700 ISDFGLSRMGPSGMSQS---HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
|+|||+++......... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ . .
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~-~ 222 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---I-F 222 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---H-H
Confidence 99999998654221111 111234578899999999998999999999999999999999999964321110 0 0
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
++.. ......+...+..+.+++.+||+.||.+||++.+|++
T Consensus 223 ------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ------------KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------------HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 1112233345677889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.59 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=203.2
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||+|.....+..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 46777889999999999999987777899999987665556677899999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++.. ..+++.++..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++
T Consensus 99 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 99 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred CCCCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccc
Confidence 99999998832 24788899999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
........ ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ +.. ..
T Consensus 163 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~----~~---- 228 (297)
T cd06656 163 AQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYL----IA---- 228 (297)
T ss_pred eEccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eee----ec----
Confidence 75432211 11234578899999999999999999999999999999999999954331110 000 00
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.........+......+.+++.+||+.+|++||++.+|++.
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 229 ----TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011122345667899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=322.53 Aligned_cols=265 Identities=21% Similarity=0.375 Sum_probs=198.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh-hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
.+|...+.||+|+||.||+|+....+..||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 357778899999999999999988888999999864432 2334678899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++ +|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~-~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 86 LDK-DLKQYMDDC-----------GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred CCC-CHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcccc
Confidence 974 888877432 234788899999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh--------
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL-------- 776 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~-------- 776 (911)
++...... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 151 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~ 226 (309)
T cd07872 151 ARAKSVPT---KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTE 226 (309)
T ss_pred ceecCCCc---cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence 87532211 11123357889999998865 468999999999999999999999996544221 111111
Q ss_pred --HHhhhcccCCcccccCccccC----CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 --WARVSRARGTVDQIVDPRLRG----KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 --~~~~~~~~~~~~~i~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|....... .....-.+.... ...+.....+.+++.+|++.||.+|||+.|++++
T Consensus 227 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 227 ETWPGISSND-EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHHhhhcchh-hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 11000000 000000000000 0112235567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=327.38 Aligned_cols=264 Identities=22% Similarity=0.267 Sum_probs=197.4
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC------C
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH------G 617 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 617 (911)
..+|...+.||+|+||.||++.....+..||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 45788889999999999999998877789999998753 334456788999999999999999999987543 3
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++||||+++ +|.+.+.. .+++..+..++.|+++||+||| +.+|+||||||+|||++.++.
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~ 157 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCC
Confidence 57999999964 67666621 2788889999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh-
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL- 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~- 776 (911)
+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 158 ~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (355)
T cd07874 158 LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_pred EEEeeCcccccCCCc----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999864321 122334688999999999999999999999999999999999999965432111000000
Q ss_pred -------H--------HhhhcccCCcccccCccc--------cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 -------W--------ARVSRARGTVDQIVDPRL--------RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 -------~--------~~~~~~~~~~~~i~d~~l--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+ ............+..+.. ...........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 000000000000000000 001112234577899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=345.79 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=199.7
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceecc--CCceE
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDE--HGEMI 620 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~ 620 (911)
...+|...+.||+|+||+||++.+...+..+|+|.+... .......|..|+.+|++|+|||||++++++.. ...++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 345788889999999999999999888889999988643 33445678999999999999999999998743 45789
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCC----CCcEEEecccCCCeeecC--
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGA----KHTIIHRDVKSTNILLDE-- 694 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~----~~~ivHrDlkp~NILl~~-- 694 (911)
|||||+++|+|.++|..... ....+++..++.|+.||+.||+|||... ..+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~--------~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYK--------MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 99999999999999965321 2346899999999999999999999522 146999999999999964
Q ss_pred ---------------CCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc--cCCCchhHHHHHHHHHHHHHh
Q 002533 695 ---------------NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR--QQLTEKSDVYSFGVVLLEVLC 757 (911)
Q Consensus 695 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSfGvvL~Ellt 757 (911)
...+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccccccCCCCceEEccCCcccccccc----ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 335899999999864321 12234468999999999864 458999999999999999999
Q ss_pred CCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 758 GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 758 G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|+.||....... ......... +.+. ....+..+.+|+..||+.+|.+||++.|++..
T Consensus 239 Gk~PF~~~~~~~------qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 239 GKTPFHKANNFS------QLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCCCcCCcHH------HHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 999996432111 011111100 0110 11235678899999999999999999999854
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.13 Aligned_cols=265 Identities=17% Similarity=0.213 Sum_probs=195.2
Q ss_pred ceeeccc--CcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 552 HCIIGSG--GFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 552 ~~~LG~G--~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
.++||+| +|++||++....++..||||+++... ....+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3579999 78999999999888999999987542 3344567789999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++++||+...
T Consensus 83 ~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 83 YGSAKDLICTH----------FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred CCcHHHHHHhh----------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 99999998532 1234889999999999999999999 7899999999999999999999999998654
Q ss_pred CCCCCCCC----ccccccccCcccccChhhhcc--cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh
Q 002533 708 MGPSGMSQ----SHVSTVVKGSFGYVDPEYIRR--QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 708 ~~~~~~~~----~~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
........ ........++..|+|||++.+ ..++.++|||||||++|||++|+.||............ .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCc
Confidence 32111100 001122346778999999976 46899999999999999999999999643211100000 00000
Q ss_pred c------------------c---cCCccc--c-------cCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 R------------------A---RGTVDQ--I-------VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~------------------~---~~~~~~--i-------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. . .....+ . ................+.+++.+||+.||++|||+.||++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 0 000000 0 00000011122345678899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=319.42 Aligned_cols=259 Identities=23% Similarity=0.330 Sum_probs=204.2
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
+|...+.||+|+||+||++....++..+|+|++.... ....+.+.+|+++++.++||||+++++++......++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 4555678999999999999998777889999876543 344678999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++.. ...+++..+..++.+++.||.|||+ .++++||||||+||++++++.++|+|||++
T Consensus 86 ~~~~L~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 86 DCGSLDRIYKK------------GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred CCCCHHHHHHh------------ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 99999998843 2358899999999999999999994 368999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh----hhhHhhHHhhhc
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE----EVSLVLWARVSR 782 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~----~~~l~~~~~~~~ 782 (911)
....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......+ ...+..+.....
T Consensus 152 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd06620 152 GELINSI-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226 (284)
T ss_pred cchhhhc-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence 6532211 1234688999999999888999999999999999999999999975432211 111111111111
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
. ..........++..+.+++.+||+.||++||++.||+++...
T Consensus 227 ~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 227 Q---------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred h---------ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 1 000000111245678899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=317.08 Aligned_cols=266 Identities=26% Similarity=0.346 Sum_probs=205.6
Q ss_pred CCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceec-
Q 002533 537 FSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCD- 614 (911)
Q Consensus 537 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~- 614 (911)
+.+.++..+.++|...+.||+|+||.||++.....+..+|+|+++... ....++.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 444566677889999999999999999999998888899999886532 2235688899999999 6999999999873
Q ss_pred ----cCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCe
Q 002533 615 ----EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNI 690 (911)
Q Consensus 615 ----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NI 690 (911)
.++..++||||+++++|.+++..... ....+++..+..++.|+++||.||| +.+++||||||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~ni 155 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK--------RGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNI 155 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc--------cCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhE
Confidence 34578999999999999998854311 2345888999999999999999999 78999999999999
Q ss_pred eecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-----cCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 691 LLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-----QQLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 691 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
++++++.+||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+...
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EECCCCCEEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999987543221 11223458899999998853 45788999999999999999999998643
Q ss_pred ccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 766 AVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 766 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.... .+... . . ...+.+ ..+..+...+.+++.+||+.+|++||++.||++.+
T Consensus 233 ~~~~---~~~~~---~--~-----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 233 HPMR---ALFKI---P--R-----NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred chhH---HHhhc---c--c-----cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 2111 00000 0 0 000000 11222345788999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.99 Aligned_cols=247 Identities=30% Similarity=0.504 Sum_probs=198.0
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchh
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 632 (911)
+||+|+||.||++.+.+ +..|++|++...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 69999999999999887 678999998765433 5668999999999999999999999999999999999999999999
Q ss_pred hHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCC
Q 002533 633 DHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 633 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 712 (911)
+++... ...+++..++.++.+++.||+||| +.+++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~l~~~-----------~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 81 TFLRKK-----------KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred HHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 998532 224788999999999999999999 789999999999999999999999999998754321
Q ss_pred CCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 713 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
.. .........+..|+|||.+.++.++.++|+|||||++|||++ |..||........ . .. +
T Consensus 147 ~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~----~---~~----------~ 208 (251)
T cd05041 147 IY-TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT----R---ER----------I 208 (251)
T ss_pred cc-eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH----H---HH----------H
Confidence 11 111112234567999999998899999999999999999999 7888754331110 0 00 0
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
....+...+..++..+.+++.+||+.+|.+||++.||++.|+
T Consensus 209 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 011111223345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.87 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=200.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceecc-CCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDE-HGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~lV~E 624 (911)
+|...+.||+|++|.||++....+++.+|+|++... .....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 366788999999999999999887789999998643 33455678999999999999999999988754 456899999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++++|.+++... ....+++.+++.++.+++.||+||| +.+++||||||+||+++.++.++|+|||
T Consensus 81 ~~~~~~l~~~l~~~----------~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 81 FCEGGDLYHKLKEQ----------KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred ccCCCcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEeccc
Confidence 99999999999542 2345899999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++....... .......++..|+|||++.+..++.++||||||++++||++|+.||....... +..... .
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-------~~~~~~-~ 216 (257)
T cd08223 148 IARVLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-------LVYRII-E 216 (257)
T ss_pred ceEEecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHH-h
Confidence 987643221 12233457889999999999999999999999999999999999985432111 000000 0
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+.. ...+......+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 GKL---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCC---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 110 11223445678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.15 Aligned_cols=237 Identities=26% Similarity=0.428 Sum_probs=189.1
Q ss_pred eecccCcEEEEEEEeecCC----------eEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 554 IIGSGGFGHVFKGYIDDGS----------ITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~----------~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
.||+|+||.||+|.+...+ ..+++|.+...... ...|.+|+.++++++||||++++++|.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6999999999999997665 45888887655433 6789999999999999999999999987 7789999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC-------
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW------- 696 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~------- 696 (911)
||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 80 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 80 EYVKFGPLDVFLHREK-----------NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred EcCCCCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCce
Confidence 9999999999985431 25889999999999999999999 78999999999999999887
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc--CCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhh
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ--QLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVS 773 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~ 773 (911)
.+||+|||+++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+.... ..+
T Consensus 146 ~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~--- 214 (259)
T cd05037 146 FIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSE--- 214 (259)
T ss_pred eEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chh---
Confidence 799999999876332 1223466789999999876 78999999999999999999 466664432 111
Q ss_pred HhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 774 LVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 774 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
+........ ..+......+.+++.+||..+|.+||++.+|++.|
T Consensus 215 ---~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 215 ---KERFYQDQH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---HHHHHhcCC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 111100000 00111126788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.79 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=204.2
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...++||.|+||.||.++....+..+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 366778999999999999999888889999987643 345567789999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++|+|.+++... ....+++.++..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||+
T Consensus 81 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 81 ANGGTLYDKIVRQ----------KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred cCCCcHHHHHHhc----------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcc
Confidence 9999999998532 1345889999999999999999999 68999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
++....... ......++..|+|||++.+..++.++||||||+++|||++|+.||....... .. .... .+
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~---~~~~-~~ 216 (256)
T cd08221 148 SKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----LV---VKIV-QG 216 (256)
T ss_pred eEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----HH---HHHH-cC
Confidence 986433221 2233458899999999998889999999999999999999999985432111 00 0000 00
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.. ...+..+...+.+++.+||+.+|.+||++.++++.+
T Consensus 217 --------~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 217 --------NY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --------CC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01 111233456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.54 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=201.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
.|...+.||+|+||.||+|+....+..+++|.+........+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 45567789999999999999988888999999987777778889999999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|..++... ...+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~l~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 93 GGAVDAIMLEL-----------DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CCcHHHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 99998887432 235889999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
...... .......++..|+|||++. ...++.++|||||||++|||++|+.||....... ....+ .
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~----~ 228 (292)
T cd06644 159 KNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKI----A 228 (292)
T ss_pred eccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---HHHHH----h
Confidence 532211 1122345788999999884 3457889999999999999999999985432111 00000 0
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. ..+.+ ..+..+...+.+++.+||+.+|++||++.+|++.
T Consensus 229 ~~------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 KS------EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cC------CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 00011 1122345578899999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.05 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=195.2
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||.||+++....+..||||++... .....+.+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3677888999999999999999888889999998642 2233456889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 81 e~~~g~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 81 DYYVGGDLLTLLSKF-----------EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred ecCCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEEC
Confidence 999999999998532 234788889999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcc-----cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-----QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+++....... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ +.
T Consensus 147 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~ 218 (331)
T cd05597 147 GSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YG 218 (331)
T ss_pred CceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HH
Confidence 99875332211 11223458999999999873 4578899999999999999999999965331111 11
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccc--cCCCCCCHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDE--EGFRRPTMGDVTWG 831 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~eVl~~ 831 (911)
.......... +. ......+..+.+++.+|+.. ++..||++.+++.+
T Consensus 219 ~i~~~~~~~~------~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 219 KIMNHKEHFQ------FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHcCCCccc------CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111110000 00 01112345667788776644 44458899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=330.63 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=195.6
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||+|+||.||++.....+..||||+++.. .......+.+|++++.+++|+||+++++++...+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 577788999999999999999888889999998643 22334568889999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~gg~L~~~l~~------------~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 82 FLPGGDMMTLLMK------------KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred CCCCccHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeecc
Confidence 9999999999843 235888899999999999999999 7999999999999999999999999999
Q ss_pred CccCCCCCCCC--------------------------------ccccccccCcccccChhhhcccCCCchhHHHHHHHHH
Q 002533 705 LSRMGPSGMSQ--------------------------------SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVL 752 (911)
Q Consensus 705 la~~~~~~~~~--------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL 752 (911)
+++........ ........||+.|+|||++.+..++.++|||||||+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98743221100 0011234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC---HHHHH
Q 002533 753 LEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT---MGDVT 829 (911)
Q Consensus 753 ~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~eVl 829 (911)
|||++|+.||...........+..| ...+ ...+ .......+.+++.+|+. +|.+|++ +.+++
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~------~~~~--~~p~------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNW------KETL--VFPP------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcC------CCce--ecCC------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 9999999999654321111111111 0000 0000 01124456777777664 9999986 45554
Q ss_pred HH
Q 002533 830 WG 831 (911)
Q Consensus 830 ~~ 831 (911)
++
T Consensus 292 ~h 293 (360)
T cd05627 292 SH 293 (360)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.44 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=206.6
Q ss_pred CCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceecc
Q 002533 537 FSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDE 615 (911)
Q Consensus 537 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~ 615 (911)
+++.++..++++|...+.||+|+||.||++....++..+|+|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 566777788899999999999999999999998888899999986543 2345678899999999 89999999999864
Q ss_pred C-----CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCe
Q 002533 616 H-----GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNI 690 (911)
Q Consensus 616 ~-----~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NI 690 (911)
. +..++||||+++|+|.++++.... ....+++..++.++.|++.||+||| ..+++||||||+||
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~ni 159 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI--------CGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNI 159 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhh--------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHE
Confidence 3 368999999999999998854321 2345889999999999999999999 78999999999999
Q ss_pred eecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc-----CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 691 LLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-----QLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 691 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
++++++.+||+|||+++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 160 li~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 160 LLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEcCCCCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999875432211 11234578899999998653 3688999999999999999999998643
Q ss_pred ccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 766 AVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 766 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.... .+..+.+ .....+. .+......+.+++.+||+.+|++||++.|++++
T Consensus 237 ~~~~---~~~~~~~-----~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 237 HPVK---TLFKIPR-----NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cHHH---HHHHHhc-----CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 3111 1111100 0000111 112234568899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.11 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=195.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...++||+|+||.||++++..++..+|+|++... .......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 677888999999999999999988889999998642 22233458889999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 82 y~~~g~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 82 YYVGGDLLTLLSKF-----------EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred ccCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecc
Confidence 99999999999542 234788889999999999999999 7999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+++...... ........||+.|+|||++. ...++.++|||||||+||||++|+.||........ ...
T Consensus 148 ~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~ 219 (332)
T cd05623 148 SCLKLMEDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGK 219 (332)
T ss_pred hheecccCC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHH
Confidence 987532211 11122346899999999986 34688999999999999999999999965331111 111
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccC--CCCCCHHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEG--FRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP--~~RPs~~eVl~~ 831 (911)
........ .. ......+...+.+++.+|+..++ ..||++.|++++
T Consensus 220 i~~~~~~~------~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 220 IMNHKERF------QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhCCCccc------cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11100000 00 01112345667788888775544 447899998776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.49 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=200.0
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||+|+||.||+|+....+..||+|.++.........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 45556789999999999999988888999999876655556678899999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++.. ...+++.+++.++.|++.||.||| ..+++|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~L~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 90 GGSLQDIYHV------------TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred CCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeee
Confidence 9999998843 235889999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhc---ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||........ . ..... .
T Consensus 155 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~--~~~~~----~ 224 (267)
T cd06645 155 QITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-L--FLMTK----S 224 (267)
T ss_pred EccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-H--Hhhhc----c
Confidence 543211 1123346889999999985 45688999999999999999999999854331111 0 00000 0
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
....+.... ...++..+.+++.+||+.+|++||++.+|+++
T Consensus 225 ----~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 ----NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ----CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000011110 01234567899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=337.93 Aligned_cols=269 Identities=20% Similarity=0.324 Sum_probs=196.5
Q ss_pred HHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccc------cEeeeccee
Q 002533 540 TEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHL------HIVSLLGFC 613 (911)
Q Consensus 540 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~Hp------nIv~l~g~~ 613 (911)
+++...+.+|...++||+|+||+||+|.+...+..||||+++... ...+++..|++++++++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 345556788999999999999999999998888899999986432 2334566788888777654 588888888
Q ss_pred ccC-CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee
Q 002533 614 DEH-GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL 692 (911)
Q Consensus 614 ~~~-~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 692 (911)
... ...++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ +.+||||||||+|||+
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~------------~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl 265 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK------------HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILM 265 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEE
Confidence 654 5789999988 7789888843 2358899999999999999999993 2599999999999999
Q ss_pred cCCC----------------ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHH
Q 002533 693 DENW----------------AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756 (911)
Q Consensus 693 ~~~~----------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ell 756 (911)
+.++ .+||+|||++.... .......||..|+|||++.+..++.++|||||||+||||+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 266 ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred ecCCcccccccccccCCCCceEEECCCCccccCc------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 8765 49999999876421 1223457899999999999999999999999999999999
Q ss_pred hCCCCCCCCccchhhhhHhh---------HHhhhc---------ccCCcccccCccc-------cCCCChHHHHHHHHHH
Q 002533 757 CGRPPMINGAVRKEEVSLVL---------WARVSR---------ARGTVDQIVDPRL-------RGKIAPVCLNKFVEIA 811 (911)
Q Consensus 757 tG~~p~~~~~~~~~~~~l~~---------~~~~~~---------~~~~~~~i~d~~l-------~~~~~~~~~~~l~~li 811 (911)
+|+.||..... .+...+.. |..... ..+.+....++.. ...........+.+|+
T Consensus 340 tG~~pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 418 (467)
T PTZ00284 340 TGKLLYDTHDN-LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418 (467)
T ss_pred hCCCCCCCCCh-HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHH
Confidence 99999965431 11111110 110000 0000000001000 0000011235678999
Q ss_pred HhcccccCCCCCCHHHHHHH
Q 002533 812 GSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 812 ~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+||+.||++|||+.|++++
T Consensus 419 ~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 419 YGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHhCCcChhhCCCHHHHhcC
Confidence 99999999999999999875
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.69 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=197.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||+|+...++..||||+++... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4667789999999999999998777899999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++ ++|.+++.... ....+++..+..++.|++.||+||| ..+++||||||+|||++.++.+||+|||+
T Consensus 81 ~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 81 LS-MDLKKYLDSLP---------KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CC-CCHHHHHhcCC---------CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccc
Confidence 97 68988884321 2346899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh--------
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL-------- 776 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~-------- 776 (911)
++..... ........++..|+|||.+.+. .++.++|||||||++|||+||+.||..............
T Consensus 148 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 148 ARAFGIP---VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224 (285)
T ss_pred eeecCCC---cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 8753221 1111233467889999988654 578999999999999999999999865332111111000
Q ss_pred -HHhhhcc---cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 777 -WARVSRA---RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 777 -~~~~~~~---~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
|...... ...........+. .........+.+++.+||+.||++|||+.+|+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0000000000000 011124567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.56 Aligned_cols=246 Identities=31% Similarity=0.515 Sum_probs=196.1
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||+|+||.||+|...+ ..+|+|.++... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~--~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTG--QKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HceeeeeeccCCCCceEecccCC--CceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 46677899999999999998643 479999986542 345789999999999999999999998654 5799999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.+++... ....+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 82 KGNLVNFLRTR----------GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CCCHHHHHHhc----------CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccce
Confidence 99999999543 2235789999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||....... +.....
T Consensus 149 ~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~---- 211 (254)
T cd05083 149 VGSMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVE---- 211 (254)
T ss_pred eccccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHh----
Confidence 532211 11234567999999998899999999999999999998 898885433111 111111
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
...+...+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus 212 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 ------KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ------CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111112223456778899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.04 Aligned_cols=250 Identities=30% Similarity=0.479 Sum_probs=198.2
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||+|+||.||+|.+..+ ..+|+|.+..... ...+|.+|++++++++|||++++++++......++||||++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~-~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCC-CeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 566678999999999999988654 5799998865432 34578999999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++... ...+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++
T Consensus 83 ~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 83 HGCLSDYLRAQ-----------RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred CCcHHHHHHhC-----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCccee
Confidence 99999998532 234789999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
....... .......++.+|+|||++.++.++.++||||||+++|||++ |+.||...... .+.. ....
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~---~~~~--- 216 (256)
T cd05112 149 FVLDDQY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVE---TINA--- 216 (256)
T ss_pred ecccCcc--cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHH---HHhC---
Confidence 5432211 11112234578999999998999999999999999999998 89988543211 1111 0000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
..+...+...+..+.+++.+||+.+|++||++.+|+++|
T Consensus 217 -------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 217 -------GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 001111222356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=300.97 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=197.9
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh-hhH-HHHHHHHHHHHhcccccEeeecceec--cCCceEEEEe
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGA-REFRTEIEMISELRHLHIVSLLGFCD--EHGEMILVYE 624 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~~-~~f~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~lV~E 624 (911)
|...+.|++|.||.||+|+++.+++.||+|+++.... .+. -.-++||.+|.+++|||||.+-.+.. .-+..|||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 4446789999999999999999999999999975431 111 13578999999999999999988763 3457999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
||++ +|...|.... .++...+..-++.|+.+|++||| ...|+|||||++|+|+...|.+||+|||
T Consensus 158 ~~Eh-DLksl~d~m~-----------q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMK-----------QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred HHHh-hHHHHHHhcc-----------CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccc
Confidence 9976 8999886542 35788888899999999999999 7999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh-------
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL------- 776 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~------- 776 (911)
|||..... ....+...-|.-|.|||.+.+ ..|+...|+||+||++.||+++++.|.+.. .-++.+.+-
T Consensus 223 LAR~ygsp---~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 223 LAREYGSP---LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFKLLGTPS 298 (419)
T ss_pred hhhhhcCC---cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHHHhCCCc
Confidence 99975443 222355668899999999887 469999999999999999999998876533 222222211
Q ss_pred ---HHhhhccc----CCcccccCccccCCCChH-HHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 ---WARVSRAR----GTVDQIVDPRLRGKIAPV-CLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ---~~~~~~~~----~~~~~i~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|....... -...+.--..++..+... ..+.-++|+...+..||.+|-|+.|.+++
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11000000 000001111122222221 34566789999999999999999998765
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.44 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=204.6
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceec--cCCceEEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCD--EHGEMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~lV~ 623 (911)
+|...+.||.|+||.||++....++..+|+|++... .....+++.+|++++++++|+||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366678999999999999999888789999988643 3445567899999999999999999999874 345679999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCC--CCcEEEecccCCCeeecCCCceEEe
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGA--KHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
||+++++|.+++..... ....+++..++.++.|++.||+|||..+ +.+++|+||||+||++++++.+||+
T Consensus 81 e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK--------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred hhccCCCHHHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 99999999999965421 3456899999999999999999999543 5789999999999999999999999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+.. ..
T Consensus 153 d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~---~~ 222 (265)
T cd08217 153 DFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLAS---KI 222 (265)
T ss_pred cccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHH---HH
Confidence 9999986543221 12234588899999999998999999999999999999999999864331 11111 10
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. .......+......+.+++.+|++.+|++||++.+|+++
T Consensus 223 ~----------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 K----------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred h----------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 011112333456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.64 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=205.2
Q ss_pred CCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceecc
Q 002533 537 FSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDE 615 (911)
Q Consensus 537 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~ 615 (911)
.++.++..+...|...+.||+|+||.||+|.+...++.+|+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 467777778888999999999999999999998888899999986543 3446788999999998 79999999999842
Q ss_pred ------CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCC
Q 002533 616 ------HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTN 689 (911)
Q Consensus 616 ------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~N 689 (911)
....+++|||+++|+|.+++... ....+++..++.++.|++.||+||| +.+|+|+||||+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~n 151 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT----------KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQN 151 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHH
Confidence 45789999999999999988542 2234778888999999999999999 7899999999999
Q ss_pred eeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002533 690 ILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764 (911)
Q Consensus 690 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG~~p~~~ 764 (911)
|++++++.++|+|||+++...... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 152 ili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 152 VLLTENAEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EEECCCCCEEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 999999999999999987532211 1122345888999999886 35688899999999999999999999854
Q ss_pred CccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 765 GAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 765 ~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
..... .... +............++..+.+++.+||+.||.+||++.||++
T Consensus 229 ~~~~~-~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 229 MHPMR-ALFL---------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cCHHh-hhhh---------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 32111 0000 00000011112234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.52 Aligned_cols=204 Identities=24% Similarity=0.408 Sum_probs=162.3
Q ss_pred ceeecccCcEEEEEEEeec--CCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceec--cCCceEEEEeecC
Q 002533 552 HCIIGSGGFGHVFKGYIDD--GSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD--EHGEMILVYEFMP 627 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~lV~E~~~ 627 (911)
+.+||+|+||.||+|+..+ ....||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4589999999999999754 34689999986543 2345788999999999999999999884 4567899999986
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee----cCCCceEEeec
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDF 703 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DF 703 (911)
++|.+++....... .......+++..+..++.||+.||+||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 84 -~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 84 -HDLWHIIKFHRASK---ANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred -CcHHHHHHhhhccc---cCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 57888775332111 0112345889999999999999999999 7899999999999999 56679999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMIN 764 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~ 764 (911)
|+++................||..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 999865433222222234568899999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.23 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=200.8
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
+|...+.||+|+||.||++.....+..+|+|.+... .......+.+|++++++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 456677899999999999999877789999988653 3344567999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|..++.... ....+++..+..++.|++.||.|||+ +.+|+|+||||+||+++.++.+||+|||++
T Consensus 82 ~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 82 DAGSLDKLYAGGV---------ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred CCCCHHHHHHhcc---------ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 9999998885321 12358999999999999999999994 368999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhccc------CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ------QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
...... ......++..|+|||.+.+. .++.++|+|||||++|||++|+.||...........+
T Consensus 151 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~------ 219 (286)
T cd06622 151 GNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL------ 219 (286)
T ss_pred ccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH------
Confidence 754221 12233578899999998654 3588999999999999999999998643211100000
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..+.+. .....+..+...+.+++.+||+.+|++||++.+++..
T Consensus 220 -------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 220 -------SAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------HHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 001110 0112334466778899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.71 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=200.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||++.+.++ ..+++|.+.... ...+.|.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCC-ccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4577788999999999999987655 479999887543 345678999999999999999999999877 7789999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++|+|.+++... ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 83 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 83 AKGSLLDFLKSD----------EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred CCCcHHHHHHhC----------CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcce
Confidence 999999998542 2335788999999999999999999 689999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+....... .......++..|+|||++....++.++|+|||||++||+++ |+.||...... .+..+.. .
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~----~- 218 (260)
T cd05073 150 RVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALE----R- 218 (260)
T ss_pred eeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHh----C-
Confidence 76432211 11122345677999999998899999999999999999999 88888543211 1111100 0
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
..........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 219 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 219 --------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --------CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111223345678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.84 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=203.0
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||++....++..+|+|++... .....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 366788999999999999999887789999998643 334456789999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++... ....+++.++++++.|++.||+||| +.+++|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~l~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~ 147 (256)
T cd08218 81 CEGGDLYKKINAQ----------RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGI 147 (256)
T ss_pred CCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccc
Confidence 9999999988532 2234788999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+....... .......|+..|+|||++.++..+.++|||||||+++||++|+.||....... . ...... +
T Consensus 148 ~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~---~~~~~~-~ 216 (256)
T cd08218 148 ARVLNSTV---ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----L---VLKIIR-G 216 (256)
T ss_pred eeecCcch---hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----H---HHHHhc-C
Confidence 87643221 11223457889999999999999999999999999999999999986432111 0 000000 0
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.....+......+.+++.+||+.+|.+||+|.+|+++
T Consensus 217 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 ---------SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---------CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0111233456678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=319.20 Aligned_cols=245 Identities=29% Similarity=0.428 Sum_probs=202.1
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
|...+.||.|.||.||-+++..+.+.||||++.-. +.+...+++.|+..|.+|+|||++.+.||+..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44556799999999999999988899999998754 345567899999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
| -|+-.|.|.-. .++|-..++..|+.+.+.||+||| +++.||||||+.||||++.+.|||+|||.
T Consensus 108 C-lGSAsDlleVh-----------kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 108 C-LGSASDLLEVH-----------KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred H-hccHHHHHHHH-----------hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccc
Confidence 9 66777877433 456889999999999999999999 79999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhc---ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
|.+... .....||+.|||||++. .+.|+-|+||||||++..||.-.++|+.+...-. ...+...
T Consensus 173 Asi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIAQ 239 (948)
T KOG0577|consen 173 ASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ 239 (948)
T ss_pred hhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHHh
Confidence 876322 23457999999999986 4789999999999999999999999986543111 1111122
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+ .|.+. ..+....+++++..||+.-|.+|||..+++.+
T Consensus 240 Ne-------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 240 NE-------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred cC-------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11 12222 45667889999999999999999999887653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=295.57 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=207.4
Q ss_pred HHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--------hhhHHHHHHHHHHHHhc-ccccEeeeccee
Q 002533 543 KQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--------MQGAREFRTEIEMISEL-RHLHIVSLLGFC 613 (911)
Q Consensus 543 ~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--------~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~ 613 (911)
+...++|...++||.|..+.|.++.++.++...|+|++.... ..-.++-.+|+.+|+++ -||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 445566777889999999999999999888899999885321 12234466899999998 699999999999
Q ss_pred ccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeec
Q 002533 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD 693 (911)
Q Consensus 614 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 693 (911)
+.+..+++|+|.|+.|.|.|+|. ..-.+++++..+|+.|+.+|++||| ..+||||||||+|||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLt------------s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT------------SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLD 157 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh------------hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeec
Confidence 99999999999999999999994 3446899999999999999999999 79999999999999999
Q ss_pred CCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc------CCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Q 002533 694 ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ------QLTEKSDVYSFGVVLLEVLCGRPPMINGAV 767 (911)
Q Consensus 694 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~t~ksDVwSfGvvL~ElltG~~p~~~~~~ 767 (911)
++.++||+|||+++....+. .....+||++|+|||.++.. .|+...|+|+.||+||-|+.|.+||....
T Consensus 158 dn~~i~isDFGFa~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk- 232 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK- 232 (411)
T ss_pred cccceEEeccceeeccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-
Confidence 99999999999999765543 23567899999999998753 57889999999999999999999996422
Q ss_pred chhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 768 RKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 768 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
+ +......+...- ..+.+.-.+......+|+.+||+.||.+|.|.+|++++--
T Consensus 233 ---Q--mlMLR~ImeGky--------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 233 ---Q--MLMLRMIMEGKY--------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred ---H--HHHHHHHHhccc--------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 1 111111111110 0111112234566789999999999999999999988743
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.22 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=201.6
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||+|.+.+++..|+||+++.. .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 577788999999999999999888889999988653 233456789999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++++.|..++. ....+++.++..++.|++.||+||| ..+++|+||+|+||++++++.+||+|||+
T Consensus 82 ~~~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 82 VERTLLELLEA------------SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred CCCCHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeec
Confidence 99877765542 2234889999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh-----
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR----- 779 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~----- 779 (911)
+........ .......++..|+|||++... .++.++||||||++||||++|+.||...........+.....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07833 147 ARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS 224 (288)
T ss_pred ccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 886443221 122234578889999999888 889999999999999999999999864332111111100000
Q ss_pred ---hhcccCCc-----ccccCcc-ccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 ---VSRARGTV-----DQIVDPR-LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ---~~~~~~~~-----~~i~d~~-l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
........ .+..++. +....+..++..+.+++.+||+.+|++||++++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 0000000 0111223346788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=318.04 Aligned_cols=204 Identities=25% Similarity=0.409 Sum_probs=162.0
Q ss_pred ceeecccCcEEEEEEEeec--CCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceecc--CCceEEEEeecC
Q 002533 552 HCIIGSGGFGHVFKGYIDD--GSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDE--HGEMILVYEFMP 627 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 627 (911)
.++||+|+||.||+|+..+ ....+|+|.+.... ....+.+|+++|++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 4579999999999999753 45789999986543 23457789999999999999999998743 456899999985
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee----cCCCceEEeec
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDF 703 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DF 703 (911)
++|.+++....... .......+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 84 -~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 84 -HDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred -CCHHHHHHhccccc---ccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 58888875332111 0112235888999999999999999999 7899999999999999 45678999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMIN 764 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~ 764 (911)
|+++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 999865433222222234568999999999977 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.20 Aligned_cols=263 Identities=24% Similarity=0.425 Sum_probs=203.5
Q ss_pred cCCccceeecccCcEEEEEEEeec-----CCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~-----~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 620 (911)
.+|.....||+|+||.||+|+.+. ....|++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 467778899999999999999753 3457999988765433 4567999999999999999999999999989999
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||+++|+|.+++........ ......+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~---~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDE---KLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccc---cccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEE
Confidence 99999999999999964431100 011235899999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||+++...... ........++..|+|||.+.+...+.++||||||+++|||++ |..||...... .....
T Consensus 159 ~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~-- 230 (275)
T cd05046 159 SLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNR-- 230 (275)
T ss_pred cccccccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----HHHHH--
Confidence 9999987432111 111122345678999999998889999999999999999999 77887532211 11111
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.. ...+....+..++..+.+++.+||+.+|.+||++.|++..|+
T Consensus 231 ~~----------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQ----------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HH----------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 011111122345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.37 Aligned_cols=251 Identities=32% Similarity=0.489 Sum_probs=200.5
Q ss_pred ccceeecccCcEEEEEEEeecCC----eEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGS----ITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vykg~~~~~~----~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
...+.||.|+||.||+++....+ ..||+|++...... ..+.+.+|++++.+++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 34568999999999999997754 78999999765443 56789999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++++|.+++..... ..+++.++..++.|++.||+||| +.+++|+||||+||++++++.++|+|||
T Consensus 82 ~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 82 YMEGGDLLDYLRKNRP----------KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred ccCCCCHHHHHHhhhh----------ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccC
Confidence 9999999999954321 12899999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
+++......... .....++..|+|||.+....++.++||||||++++||++ |+.||..... ..+... ...
T Consensus 149 ~~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~---~~~ 219 (258)
T smart00219 149 LSRDLYDDDYYK--KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEY---LKK 219 (258)
T ss_pred Cceecccccccc--cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH---Hhc
Confidence 998654331111 112336789999999988889999999999999999999 7777754221 111111 000
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
. .....+..++..+.+++.+|+..+|++|||+.|+++.|
T Consensus 220 ~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 220 G----------YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C----------CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 01112223567789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.59 Aligned_cols=266 Identities=23% Similarity=0.335 Sum_probs=199.8
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...++||+|+||.||+|.+.+++..+|+|++..... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 56777899999999999999987778999998764322 2345688999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.++... ...++|.+++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||+
T Consensus 82 ~~~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 82 VDHTVLDDLEKY------------PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred CCccHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeee
Confidence 999988876632 234899999999999999999999 68999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc-
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA- 783 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~- 783 (911)
+....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+..+......
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07846 147 ARTLAAPG---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223 (286)
T ss_pred eeeccCCc---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence 87643321 11223457889999999875 45788999999999999999999888543321111111111000000
Q ss_pred -------cCCcccccCcccc-----CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 -------RGTVDQIVDPRLR-----GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 -------~~~~~~i~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
......+..+... ....+..+..+.+++.+||+.+|++||++.+|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000001100 00122346778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.89 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=203.0
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||.|+||.||+|.+...+..+|+|.+........+.|.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 34666778999999999999998777899999998776677788999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++... ...+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++
T Consensus 85 ~~~~L~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 85 DGGALDSIMLEL-----------ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred CCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccc
Confidence 999999998532 235889999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
....... .......++..|+|||.+. ...++.++||||||+++|||++|+.||....... .+..+
T Consensus 151 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~---- 220 (280)
T cd06611 151 AKNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKI---- 220 (280)
T ss_pred hhhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHH----
Confidence 7533221 1122345888999999985 3457789999999999999999999986432111 11111
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. . ..+. ...+..+...+.+++.+||+.+|.+||++.+|++.
T Consensus 221 ~~-~-----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 LK-S-----EPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred hc-C-----CCCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 0 0000 11123345678899999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.97 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=204.8
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||+|....++..+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 46778889999999999999998777889999988766666788999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++... ...+++.++..++.|++.||+||| ..+++|+||||+||++++++.+||+|||++
T Consensus 83 ~~~~l~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 83 GGGSLQDIYQVT-----------RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred CCCcHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccc
Confidence 999999988532 235889999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhccc---CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ---QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
....... .......++..|+|||.+... .++.++|||||||++|||++|+.||.......... ....
T Consensus 149 ~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~---~~~~---- 218 (262)
T cd06613 149 AQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LISK---- 218 (262)
T ss_pred hhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh----
Confidence 7543211 112234578889999999877 88999999999999999999999986533111110 0000
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
. ....+.+ ......+..+.+++.+||..+|.+||++.+|+.
T Consensus 219 -~---~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 219 -S---NFPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -c---cCCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000011 112334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=324.61 Aligned_cols=264 Identities=21% Similarity=0.268 Sum_probs=196.6
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC------C
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH------G 617 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 617 (911)
..+|...+.||+|+||.||++.....+..||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 35688889999999999999999888889999998653 234456788999999999999999999987543 3
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--------------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCc
Confidence 57999999964 77776621 2778889999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh-
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL- 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~- 776 (911)
+||+|||+++..... .......+|..|+|||++.+..++.++|||||||+||||++|+.||...........+..
T Consensus 165 ~kL~DfG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 165 LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred EEEEeCCCccccCCC----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999999864221 112334688999999999999999999999999999999999999965432111100000
Q ss_pred -------HHh--------hhcccCCc-----ccccCccc---cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 -------WAR--------VSRARGTV-----DQIVDPRL---RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 -------~~~--------~~~~~~~~-----~~i~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+.. ........ .++....+ ...........+.+++.+|++.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00000000 00000000 001111224567899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.17 Aligned_cols=266 Identities=21% Similarity=0.260 Sum_probs=199.2
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||+|.+...+..||+|++.... ....+.+.+|++++++++|+||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5677789999999999999998777899999886432 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++++.|..++. ....++|..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 82 CDHTVLNELEK------------NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred cCccHHHHHHh------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECcccc
Confidence 99988887763 2235899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh---
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS--- 781 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~--- 781 (911)
+........ ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 147 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 147 ARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred ceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 986533221 1123347788999999876 567899999999999999999999996543211111111000000
Q ss_pred ----c-ccCCcccccCccccCCC-----ChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 ----R-ARGTVDQIVDPRLRGKI-----APVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ----~-~~~~~~~i~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. ..........+...... .......+.+++.+||+.+|++||++.|++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00000000111110000 01235678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.18 Aligned_cols=266 Identities=21% Similarity=0.350 Sum_probs=198.6
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
.+|...+.||+|+||.||+|....++..||+|.++... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 35777889999999999999998877899999986442 22334677899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++ ++|.+++... ...+++..+..++.|++.||+||| +.+|+|+||||+|||+++++.+||+|||+
T Consensus 86 ~~-~~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 86 LD-KDLKQYLDDC-----------GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred cc-cCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 96 6898888432 234788899999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh---------
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV--------- 775 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~--------- 775 (911)
++...... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||.............
T Consensus 151 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 227 (301)
T cd07873 151 ARAKSIPT---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE 227 (301)
T ss_pred hhccCCCC---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 87532211 111223468899999998754 57889999999999999999999996543211100000
Q ss_pred hHHhhhcccCCcccccCccccC----CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 776 LWARVSRARGTVDQIVDPRLRG----KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.|....... .....-.+.... .....+...+.+++.+|++.||.+|||+.|++++
T Consensus 228 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 228 TWPGILSNE-EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hchhhhccc-cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 010000000 000000011100 1112345577899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=327.24 Aligned_cols=264 Identities=21% Similarity=0.227 Sum_probs=198.6
Q ss_pred cCCccceeecccCcEEEEEEEeec--CCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDD--GSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~--~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.+|...+.||+|+||.||++...+ ....||||.+... +.+.+|+++|++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 468888999999999999997643 3467999988643 245689999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
++. ++|.+++. ....++|.+++.++.||+.||+||| ..+|+||||||+|||++.++.++|+|||
T Consensus 167 ~~~-~~l~~~l~------------~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 167 KYK-CDLFTYVD------------RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred hcC-CCHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCc
Confidence 985 68888882 2345899999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+++....... ........||..|+|||++....++.++|||||||+||||++|+.||...........+..-.+.....
T Consensus 231 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~ 309 (392)
T PHA03207 231 AACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309 (392)
T ss_pred cccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence 9975433221 112234569999999999999999999999999999999999999997644322111111111110000
Q ss_pred C-Ccc-----------cccCccccCCC--C-----hHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 785 G-TVD-----------QIVDPRLRGKI--A-----PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 785 ~-~~~-----------~i~d~~l~~~~--~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
. ... ..+....+... + ......+.+++.+||..||++||++.|++.+-
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 310 PLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred ccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0 000 00000011100 0 11245677899999999999999999998763
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.77 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=201.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||++.....+..+|||++... .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 366778999999999999999888889999998654 334567799999999999999999999999888999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC-CceEEeecC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKISDFG 704 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG 704 (911)
+++++|.+++... ....+++..+++++.+++.||+||| +.+++|+||||+||+++++ ..+||+|||
T Consensus 81 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 81 APGGTLAEYIQKR----------CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred CCCCCHHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCC
Confidence 9999999999543 2335889999999999999999999 7899999999999999854 468999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ......
T Consensus 148 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~~~~~----- 214 (256)
T cd08220 148 ISKILSSKSK----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LVLKIM----- 214 (256)
T ss_pred CceecCCCcc----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HHHHHH-----
Confidence 9986433211 123457889999999998889999999999999999999999985433111 111100
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. ......+..+...+.+++.+||+.+|++|||+.|++++
T Consensus 215 -------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 215 -------S-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -------h-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 00111222345678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=308.75 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=198.4
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh----------hhHHHHHHHHHHHHhcccccEeeecceeccCCc
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM----------QGAREFRTEIEMISELRHLHIVSLLGFCDEHGE 618 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~----------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 618 (911)
|...+.||+|+||.||+|.....+..+|||.++.... ...+.+.+|++++++++|+|++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 5567789999999999999887778999998753211 123468889999999999999999999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY------------GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGIC 147 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeE
Confidence 99999999999999998432 35888899999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccC--CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ--LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
+|+|||+++........ .......++..|+|||.+.... ++.++||||||+++||+++|..||....... .
T Consensus 148 ~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~ 220 (272)
T cd06629 148 KISDFGISKKSDDIYDN-DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------A 220 (272)
T ss_pred EEeeccccccccccccc-cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------H
Confidence 99999999764322111 1123345888999999987654 8899999999999999999999985432111 0
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
...... ........ ......++..+.+++.+||..+|.+||++.+|+++
T Consensus 221 ~~~~~~--~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 221 MFKLGN--KRSAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHhhc--cccCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000 00011111 11222346778899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.57 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=199.6
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-----hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-----MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-----~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
|...++||+|+||.||+|.....+..|++|.+.... .+..+.+.+|++++++++|+||+++++++..+...+++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 556678999999999999998667799999875432 345577999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++++|.+++.. ...+++..++.++.|++.||+||| ..+++|+||+|+||+++.++.+||+||
T Consensus 82 e~~~~~~L~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 82 ELVPGGSLAKLLKK------------YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred EecCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccC
Confidence 99999999999843 234789999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccC-CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ-LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
|++....... ......++..|++||.+.... ++.++|+|||||++|||++|+.||..... .. .. +.. .
T Consensus 147 ~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~--~~--~~~--~ 215 (258)
T cd06632 147 GMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VA--AV--FKI--G 215 (258)
T ss_pred ccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HH--HH--HHH--H
Confidence 9987643222 123445888999999998776 89999999999999999999999864331 11 00 100 0
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
.... ....+..+...+.+++.+||+.+|.+||++.+++.
T Consensus 216 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 RSKE---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred hccc---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000 11223334567789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=315.89 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=200.8
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||+|+||.||+|...+.+..+|||.+..... ...+.+..|++++++++|+||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 57778899999999999999988778999999875432 245678999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+.+++|.+++... ....+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||
T Consensus 82 ~~~~~~L~~~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 82 YCPGGELFRLLQRQ----------PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred ecCCCCHHHHHHhC----------CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecc
Confidence 99999999998532 2345889999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCc--------------------------cccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhC
Q 002533 705 LSRMGPSGMSQS--------------------------HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCG 758 (911)
Q Consensus 705 la~~~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG 758 (911)
++.......... .......|+..|+|||++.+..++.++||||||+++|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 987532211100 011123578899999999999999999999999999999999
Q ss_pred CCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC----HHHHHH
Q 002533 759 RPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT----MGDVTW 830 (911)
Q Consensus 759 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~eVl~ 830 (911)
+.||....... .+.. +.+...........+..+.+++.+||+.+|++||+ +.+++.
T Consensus 229 ~~pf~~~~~~~------~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 229 TTPFKGSNRDE------TFSN----------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCCchHH------HHHH----------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99986433111 0111 11111111111114677899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.70 Aligned_cols=252 Identities=24% Similarity=0.460 Sum_probs=197.7
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC------hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS------MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~------~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
+|...+.||+|+||.||+|.... +..+|||.++... ....+.+.+|++++++++|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~-~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEcC-CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 35667899999999999998754 4689999876432 2234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.++|+
T Consensus 80 v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 80 FMEFVPGGSISSILNRF------------GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred EEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEec
Confidence 99999999999998432 34788899999999999999999 7899999999999999999999999
Q ss_pred ecCCccCCCCCC---CCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 702 DFGLSRMGPSGM---SQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 702 DFGla~~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
|||+++...... ..........++..|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~--- 218 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MF--- 218 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HH---
Confidence 999987532111 111122334588899999999998999999999999999999999999964321110 00
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
....... .....+......+.+++.+||+.+|.+||++.+++.
T Consensus 219 ~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 219 YIGAHRG---------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HhhhccC---------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 011123345567889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.82 Aligned_cols=241 Identities=23% Similarity=0.336 Sum_probs=186.3
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhc---ccccEeeecceeccCCceEEEEeecCC
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISEL---RHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
||+|+||+||+|+....+..||||++..... .....+..|..++.++ +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999988888999999864321 2233455677777665 699999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|.+++.. ...+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~l~~------------~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 81 GELFWHLQK------------EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred ChHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 999988842 234889999999999999999999 78999999999999999999999999999875
Q ss_pred CCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
..... .......||..|+|||++.+. .++.++|||||||+||||++|+.||....... .+.......
T Consensus 146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~~~--- 213 (330)
T cd05586 146 NLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAFGK--- 213 (330)
T ss_pred CCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHcCC---
Confidence 32211 122345689999999998764 48999999999999999999999996532111 011111110
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC----HHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT----MGDVTW 830 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~eVl~ 830 (911)
..+. .......+.+++.+||+.||.+||+ +.++++
T Consensus 214 -----~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 214 -----VRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----CCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0010 0123456779999999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=313.82 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=202.1
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||.||++.....+..|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36777889999999999999998888899999987543 233457889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++++|.+++.. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+||
T Consensus 81 e~~~g~~L~~~l~~------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~df 145 (305)
T cd05609 81 EYVEGGDCATLLKN------------IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDF 145 (305)
T ss_pred ecCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeC
Confidence 99999999999943 234889999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCC------------ccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhh
Q 002533 704 GLSRMGPSGMSQ------------SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771 (911)
Q Consensus 704 Gla~~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~ 771 (911)
|+++........ ........++..|+|||.+.+..++.++|+|||||++|||++|+.||.+.... +
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~- 223 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-E- 223 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H-
Confidence 998742111100 00111235788899999999889999999999999999999999998643211 1
Q ss_pred hhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 772 VSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
+ +...... ....+.. ...++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 --~--~~~~~~~-----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 --L--FGQVISD-----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --H--HHHHHhc-----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 0000000 0001111 11345668899999999999999998777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=318.06 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=201.1
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc-cc-----cEeeecceeccCCceEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HL-----HIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-Hp-----nIv~l~g~~~~~~~~~l 621 (911)
+|.+.++||+|.||.|-||.+..+++.||||+++... .-.++-..|+.+|.+|+ |. |+|++++|+...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6788889999999999999999999999999998653 33456678999999997 43 89999999999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC--CCceE
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE--NWAAK 699 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~k 699 (911)
|+|.+ .-+|.++|... ....++...+..|+.||+.||.+|| +.+|||+||||+||||.+ ...+|
T Consensus 266 VfELL-~~NLYellK~n----------~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN----------KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred eehhh-hhhHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCcee
Confidence 99998 55999999654 4456899999999999999999999 799999999999999965 34899
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH-
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA- 778 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~- 778 (911)
|+|||.++.... ... ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.. +.++...+.-.
T Consensus 332 VIDFGSSc~~~q-----~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n-e~DQl~~I~e~l 404 (586)
T KOG0667|consen 332 VIDFGSSCFESQ-----RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN-EYDQLARIIEVL 404 (586)
T ss_pred EEecccccccCC-----cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC-HHHHHHHHHHHh
Confidence 999999986322 222 3446778999999999999999999999999999999976664432 33332222110
Q ss_pred ------------hh--hccc--CCc-------------------------ccccCc-cc---cCCCChHHHHHHHHHHHh
Q 002533 779 ------------RV--SRAR--GTV-------------------------DQIVDP-RL---RGKIAPVCLNKFVEIAGS 813 (911)
Q Consensus 779 ------------~~--~~~~--~~~-------------------------~~i~d~-~l---~~~~~~~~~~~l~~li~~ 813 (911)
+. .... +.. .+..-| .. ...........+.+++.+
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 00 0000 000 000001 00 001111335678999999
Q ss_pred cccccCCCCCCHHHHHHH
Q 002533 814 CTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 814 Cl~~dP~~RPs~~eVl~~ 831 (911)
|++.||.+|+|..|.+++
T Consensus 485 ~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNH 502 (586)
T ss_pred HhccCchhcCCHHHHhcC
Confidence 999999999999999876
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=306.67 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=201.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC------hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS------MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~------~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
+|+..+.||+|+||.||+|....++..+|+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 3667789999999999999987777899999886432 1234678999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC-ceEE
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW-AAKI 700 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl 700 (911)
||||+++++|.+++... .++++..++.++.|++.||+||| +.+++|+||||+||+++.++ .+||
T Consensus 81 v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY------------GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred EEeccCCCcHHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEE
Confidence 99999999999998432 35788999999999999999999 78999999999999998775 6999
Q ss_pred eecCCccCCCCCCCC-ccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQ-SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||++......... ........++..|+|||.+.+..++.++||||+|+++|||++|+.||........ .... .+
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~--~~ 222 (268)
T cd06630 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALI--FK 222 (268)
T ss_pred cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHH--HH
Confidence 999998764332111 1112234578899999999888999999999999999999999999854332111 1110 00
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
+.........+......+.+++.+||+.+|++||++.+++.
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 ----------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----------HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00001112233445677889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.62 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=205.6
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
++|...+.||.|+||+||+|....++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..+...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36778889999999999999988777899999986432 33567899999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++.... ....+++.....++.|++.||+||| +.+++|+||||+||++++++.++|+|||+
T Consensus 81 ~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 81 LSGGSLLDIMKSSY---------PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred cCCCcHHHHHHHhc---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccch
Confidence 99999999995431 1245889999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCc-cccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 706 SRMGPSGMSQS-HVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 706 a~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
+.......... .......|+..|+|||++... .++.++|+|||||++|||++|+.||........ .. .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~---~~~~~ 222 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV---LM---LTLQN 222 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh---HH---HHhcC
Confidence 87644332211 122344588899999999877 789999999999999999999999864321110 10 10000
Q ss_pred cCCcccccCccccCCC-ChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKI-APVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..+.+.... ....+..+.+++.+||+.||++||++.+|++.
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011111111 12345778899999999999999999999763
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=305.01 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=200.6
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|...+.||+|+||.||+|.....+..|++|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 5667899999999999999887778999999875543 36678999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++.. ...+++..+..++.+++.||+||| +.+++|+||+|+||++++++.+||+|||++
T Consensus 82 ~~~~L~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 82 SGGTLEELLEH------------GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred CCCcHHHHHhh------------cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 99999999843 234788899999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccc-cccccCcccccChhhhcccC---CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 707 RMGPSGMSQSHV-STVVKGSFGYVDPEYIRRQQ---LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 707 ~~~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~---~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
............ .....++..|+|||++.... .+.++||||||+++||+++|+.||....... ... +....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~-~~~~~- 221 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIM-FHVGA- 221 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHH-HHHhc-
Confidence 865433221111 12345788999999998766 8999999999999999999999996432111 111 00000
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
+ ..+.+. ....+...+.+++.+||+.+|.+||++.+++.
T Consensus 222 --~-----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 --G-----HKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --C-----CCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 001111 11123566789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=307.07 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=198.5
Q ss_pred CccceeecccCcEEEEEEEeec---CCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCC------
Q 002533 549 FADHCIIGSGGFGHVFKGYIDD---GSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG------ 617 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~---~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 617 (911)
|...++||+|+||.||+|.+.. .+..||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4456789999999999998743 3578999988654 3445677899999999999999999999875432
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++++||+++|+|.+++...... .....+++...+.++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~ 151 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG------EEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMT 151 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCC
Confidence 247899999999999988543211 11234788899999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhhhHhh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~~l~~ 776 (911)
+||+|||+++....... ........++..|++||.+....++.++|||||||++|||++ |+.||..... ..+..
T Consensus 152 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~ 226 (273)
T cd05074 152 VCVADFGLSKKIYSGDY-YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYN 226 (273)
T ss_pred EEECcccccccccCCcc-eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHH
Confidence 99999999886432211 111122335678999999999999999999999999999999 8888754321 11111
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
+.. .... ...+..+...+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 227 ~~~---~~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLI---KGNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHH---cCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 0000 011223456889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=314.28 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=198.3
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchh
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 632 (911)
..||+|+||.||++.....+..||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 46999999999999998777899999987666666677999999999999999999999999999999999999999999
Q ss_pred hHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCC
Q 002533 633 DHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 633 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 712 (911)
+++. ...+++.+++.++.||+.||+||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 108 ~~~~-------------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 108 DIVT-------------HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred HHHh-------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 9873 224788999999999999999999 689999999999999999999999999998754322
Q ss_pred CCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccC
Q 002533 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVD 792 (911)
Q Consensus 713 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 792 (911)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... . +... .....
T Consensus 172 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~--~~~~----------~~~~~ 235 (292)
T cd06658 172 VP---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-A--MRRI----------RDNLP 235 (292)
T ss_pred cc---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H--HHHH----------HhcCC
Confidence 11 1123458889999999998899999999999999999999999986432111 0 0000 00111
Q ss_pred ccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 793 PRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 793 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+.+.. .......+.+++.+||..||.+|||+.++++.
T Consensus 236 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 236 PRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred Ccccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111 11234567899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=319.98 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=196.1
Q ss_pred HHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccC-----
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEH----- 616 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~----- 616 (911)
....+|...+.||+|+||.||+|....++..||||++.... ....+.+.+|+++|++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34567888889999999999999998888899999986532 23445678999999999999999999987533
Q ss_pred -CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 617 -GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 617 -~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
...++++|++ +++|.+++. ...+++..+..++.||+.||+||| +.+|+||||||+|||++++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~ 154 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-------------CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNED 154 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCC
Confidence 4578999988 789988773 234889999999999999999999 7899999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhH
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l 774 (911)
+.+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 155 ~~~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 155 CELRILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCEEEcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999864321 123458899999999877 57899999999999999999999998653311110000
Q ss_pred hhHHhhh-------cccC-------CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 775 VLWARVS-------RARG-------TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 775 ~~~~~~~-------~~~~-------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
....... .... .+...-...+.. ........+.+++.+|++.||.+|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000 000000000000 001123457799999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.10 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=189.0
Q ss_pred eecccCcEEEEEEEeecC--CeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCc
Q 002533 554 IIGSGGFGHVFKGYIDDG--SITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 630 (911)
.||+|+||.||+|....+ ...+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999986443 2356777766443 3456789999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCC
Q 002533 631 LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710 (911)
Q Consensus 631 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 710 (911)
|.++++.... ....+.+..+..++.||++||+||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 82 L~~~l~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 82 LKSYLSQEQW--------HRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred HHHHHHhhhc--------ccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccC
Confidence 9999965321 1234667778899999999999999 7899999999999999999999999999986421
Q ss_pred CCCCCccccccccCcccccChhhhcc-------cCCCchhHHHHHHHHHHHHHhC-CCCCCCCccchhhhhHhhHHhhhc
Q 002533 711 SGMSQSHVSTVVKGSFGYVDPEYIRR-------QQLTEKSDVYSFGVVLLEVLCG-RPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 711 ~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~t~ksDVwSfGvvL~ElltG-~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
... .........++..|+|||++.. ..++.++|||||||++|||+++ ..||.... ..+.. ....
T Consensus 151 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~-----~~~~- 222 (268)
T cd05086 151 KED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVL-----NHVI- 222 (268)
T ss_pred cch-hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHH-----HHHH-
Confidence 111 1111223457889999998853 2457899999999999999974 56764322 11111 1111
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
. +....+.++.+. ......+.+++..|| .+|++||++++|++.|.
T Consensus 223 ~-~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 K-DQQVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred h-hcccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 111122233332 224466788999999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.42 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=202.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceecc--CCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDE--HGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~lV~E 624 (911)
+|...+.||.|++|.||++.+...+..+|+|.+.... .....++.+|++++++++||||++++++|.. .+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5677789999999999999998888899999987542 3455679999999999999999999998854 446899999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++++|.+++..... ....+++.....++.|++.||+||| ..+++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 82 YCEGGSLDSIYKKVKK--------RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred ecCCCCHHHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecc
Confidence 9999999998854321 2345788899999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccc-hhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVR-KEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~-~~~~~l~~~~~~~~~ 783 (911)
++....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..|.....
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 224 (287)
T cd06621 151 VSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP- 224 (287)
T ss_pred ccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-
Confidence 987533221 12335778899999999999999999999999999999999998654211 11112222211100
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
...+.+ .. .........+.+++.+||+.+|.+|||+.||++.
T Consensus 225 ---~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 225 ---NPELKD-EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ---chhhcc-CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000000 00 0012245678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.67 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=199.9
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
|...+.||+|+||.||+|.....+..+|||.+.... ....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 455678999999999999987777899999876443 3445678999999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++. ...+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 86 ~~~l~~~i~-------------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 86 GGSALDLLE-------------PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred CCcHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccce
Confidence 999999883 234789999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
...... .......++..|+|||.+.+..++.++|||||||++|||++|..|+...... ... .....
T Consensus 150 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~---~~~~~---- 215 (277)
T cd06641 150 QLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----KVL---FLIPK---- 215 (277)
T ss_pred ecccch---hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HHH---HHHhc----
Confidence 543221 1112345788899999999888999999999999999999999998542211 000 00000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.........++..+.+++.+||+.+|.+||++.+++++
T Consensus 216 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 ------NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00111223345678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=311.40 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=197.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||+|+....+..||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4677889999999999999998777899999886432 22335788999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+. ++|.+++... ....+++..++.++.|++.||+||| ..+++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~-~~l~~~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 81 LH-QDLKKFMDAS----------PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred cc-cCHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 95 6898888542 2345899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccC-CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc--
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ-LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR-- 782 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~-- 782 (911)
++....... ......++..|+|||++.+.. ++.++|||||||++|||+||+.||...........+..+.....
T Consensus 147 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07860 147 ARAFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223 (284)
T ss_pred hhhcccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 875432211 112234678899999887644 68899999999999999999999865432211111111100000
Q ss_pred ----------ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 783 ----------ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ----------~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
......+.....+. ...+.....+.+++.+||+.||++||++++++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000000 0011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=313.83 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=198.1
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
...||+|+||.||++.....+..||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 33699999999999998877789999998765555566788999999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
.+++. ...+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 106 ~~~~~-------------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 106 TDIVS-------------QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred HHHHh-------------hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 98773 234789999999999999999999 78999999999999999999999999999875432
Q ss_pred CCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... +. +... ... .
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~--~~~~----~~~-~----- 233 (297)
T cd06659 170 DVP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QA--MKRL----RDS-P----- 233 (297)
T ss_pred ccc---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH--HHHH----hcc-C-----
Confidence 211 122345889999999999989999999999999999999999998643211 11 1000 000 0
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+.. .........+.+++.+||+.+|++||++.+|++.
T Consensus 234 ~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0112234567899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=323.82 Aligned_cols=244 Identities=24% Similarity=0.395 Sum_probs=194.3
Q ss_pred eeecccCcEEEEEEEeecCCeEEE---EEEcc-CCChhhHHHHHHHHHHHHhcccccEeeecceeccCCc--eEEEEeec
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVA---VKRLN-TSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGE--MILVYEFM 626 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vA---vK~l~-~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~--~~lV~E~~ 626 (911)
.+||+|+|-+||||.+...+..|| ||.-+ ..+....++|..|+.+|+.|+|+||++++.++.+... ..+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 379999999999999988888887 33211 1244556889999999999999999999999976554 78999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-CCceEEeecCC
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NWAAKISDFGL 705 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGl 705 (911)
..|+|+.|+.+.+ .++.+.+..||.||.+||.|||+. .++|||||||.+||+|+. -|.|||+|+||
T Consensus 126 TSGtLr~Y~kk~~------------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 126 TSGTLREYRKKHR------------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred cCCcHHHHHHHhc------------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 9999999996543 478889999999999999999974 689999999999999975 58999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
|...... +. ..+.||+.+||||++. ..|++..||||||++|+||+|+..||.-+..... +..-+-.-.+..
T Consensus 193 Atl~r~s----~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ---IYKKV~SGiKP~ 263 (632)
T KOG0584|consen 193 ATLLRKS----HA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ---IYKKVTSGIKPA 263 (632)
T ss_pred HHHhhcc----cc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH---HHHHHHcCCCHH
Confidence 9874332 22 3477999999999998 8899999999999999999999999965442211 110011112222
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+..+-||+ +.++|.+|+.. ..+|||+.|++..
T Consensus 264 sl~kV~dPe------------vr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 264 ALSKVKDPE------------VREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HhhccCCHH------------HHHHHHHHhcC-chhccCHHHHhhC
Confidence 344444444 45999999999 9999999999865
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=309.64 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=195.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHH-HHhcccccEeeecceeccCCceEEEEe
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEM-ISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
++|...+.||+|+||.||++....++..||+|+++... .....++..|+.. ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36778889999999999999998888899999987542 2334456667665 566789999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCC-cEEEecccCCCeeecCCCceEEeec
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKH-TIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
|++ |+|.+++..... ....+++..++.++.|++.||+||| +. +++||||||+|||++.++.+||+||
T Consensus 81 ~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 81 VMD-TSLDKFYKKVYD--------KGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred hhc-ccHHHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeec
Confidence 996 788888854321 2346899999999999999999999 55 8999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcc----cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR----QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
|+++...... ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.......+. +. .
T Consensus 149 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~---~ 219 (283)
T cd06617 149 GISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--LK---Q 219 (283)
T ss_pred cccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH--HH---H
Confidence 9987643211 1123457889999998865 45688999999999999999999998542211111 10 0
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
... + ..+.+. ...++..+.+++.+||..+|++||++.+|++.
T Consensus 220 ~~~--~-----~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 VVE--E-----PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHh--c-----CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 001110 11245678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=310.72 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=202.2
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|...+.||+|+||.||+|....++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 45677789999999999999987777789999987655555677899999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++++|.+++.. ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 99 ~~~~L~~~~~~-------------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 99 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred CCCcHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 99999999842 24788899999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
........ ......++..|+|||.+.++.++.++|||||||++||+++|+.||........ . ... ..
T Consensus 163 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~--~~~----~~--- 229 (293)
T cd06647 163 AQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L--YLI----AT--- 229 (293)
T ss_pred eccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-e--eeh----hc---
Confidence 75432211 11234588899999999988899999999999999999999999964331110 0 000 00
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+......+......+.+++.+||+.+|++||++.+++.+
T Consensus 230 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 -----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001122234568899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=309.46 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=196.1
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|...+.||+|+||.||+|.....+..+|+|++.... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 566778999999999999998877899999986432 222356788999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
+ ++|.+++... ...+++..++.++.||++||.||| ..+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 82 D-QDLKKYFDSC-----------NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred C-CCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchh
Confidence 6 5888877432 235899999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh----------
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV---------- 775 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~---------- 775 (911)
+....... ......++..|+|||++.+. .++.++|||||||++|||++|+.|+.......+.....
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07839 147 RAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223 (284)
T ss_pred hccCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChH
Confidence 75432211 11233467899999998765 47899999999999999999999875433221111100
Q ss_pred hHHhhhcccCC-cccccCccc-cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 776 LWARVSRARGT-VDQIVDPRL-RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 ~~~~~~~~~~~-~~~i~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.|......... ......... .....+.....+.+++.+||+.||.+|||+.+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 01000000000 000000000 001112345678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.20 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=206.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh-hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
++|...+.||+|++|.||+|+....+..|+||++..... ...+.+.+|++.+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 357778899999999999999998778999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCC-CcEEEecccCCCeeecCCCceEEeecC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAK-HTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
+++++|.+++... ..+++..++.++.|+++||+||| . .+++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~~~L~~~l~~~------------~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~ 145 (264)
T cd06623 81 MDGGSLADLLKKV------------GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFG 145 (264)
T ss_pred cCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999432 45889999999999999999999 7 999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++......... .....++..|+|||.+....++.++||||||+++|||++|+.||..... .....+..+..
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~----- 216 (264)
T cd06623 146 ISKVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAIC----- 216 (264)
T ss_pred cceecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHh-----
Confidence 98864332211 1234578899999999999999999999999999999999999855431 11111111111
Q ss_pred CCcccccCccccCCCChH-HHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPV-CLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
... ....+.. ++..+.+++.+||..+|++||++.++++.
T Consensus 217 -------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 -------DGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------cCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 1112222 56788999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.91 Aligned_cols=266 Identities=19% Similarity=0.284 Sum_probs=196.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
++|...+.||+|+||.||+|.....++.||||.+...... ....+.+|++++++++|+||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 4577788999999999999999877789999998654322 234577899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++ ++|.+++... ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~-~~L~~~~~~~-----------~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 85 LD-TDLKQYMDDC-----------GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred CC-CCHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECcccc
Confidence 97 5999988532 235788999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++...... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......+..............
T Consensus 150 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07844 150 ARAKSVPS---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE 226 (291)
T ss_pred ccccCCCC---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCCh
Confidence 87532111 11122346788999999875 458999999999999999999999986543222221111100000000
Q ss_pred CCccc--------------ccCccccCCCC-hHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 785 GTVDQ--------------IVDPRLRGKIA-PVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 785 ~~~~~--------------i~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
..... .....+....+ ......+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00000100000 011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=305.92 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=201.8
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
+|...+.||+|+||.||++.+...+..+++|++.... ....+++.+|++++++++||||+++++++......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4566678999999999999998777899999987653 345567899999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCC-CcEEEecccCCCeeecCCCceEEeecCC
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAK-HTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++++|.+++... ...+++..+.+++.|++.||+||| + .+++|+||||+||++++++.++|+|||+
T Consensus 82 ~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 82 DGGSLDKILKEV-----------QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred CCCcHHHHHHHc-----------cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999998532 145788899999999999999999 6 8999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......+. .........
T Consensus 148 ~~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~--- 217 (265)
T cd06605 148 SGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELLQYIV--- 217 (265)
T ss_pred chhhHHHHh-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHHHHHHHh---
Confidence 875322111 1155788999999999999999999999999999999999998654211111 111111110
Q ss_pred CcccccCccccCCCChH-HHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPV-CLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
... ....+.. ....+.+++.+||..+|++||++.+++..
T Consensus 218 ------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 ------NEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ------cCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 0111111 45678899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=306.36 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=201.3
Q ss_pred HHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceeccCC-----
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHG----- 617 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~----- 617 (911)
.++++|...+.||+|+||.||+|.....+..+++|++..... ..+++.+|+++++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356788889999999999999999987778999999876543 346799999999999 7999999999986544
Q ss_pred -ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC
Q 002533 618 -EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 618 -~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 696 (911)
..++||||+++++|.+++..... ....+++..+..++.|++.||+||| +.+++|+||+|+||++++++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK--------KGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNA 150 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh--------cCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCC
Confidence 48999999999999999854321 2346889999999999999999999 78999999999999999999
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-----cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhh
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-----QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~ 771 (911)
.+||+|||++....... .......|+..|+|||++.. ..++.++|||||||+||||++|+.||........
T Consensus 151 ~~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~- 226 (275)
T cd06608 151 EVKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA- 226 (275)
T ss_pred eEEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-
Confidence 99999999987543221 11223458889999998753 3577899999999999999999999864321111
Q ss_pred hhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 772 VSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
+. .. .... .+. ...+......+.+++.+||..||++|||+.+|++
T Consensus 227 --~~---~~--~~~~-----~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 227 --LF---KI--PRNP-----PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --HH---Hh--hccC-----CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 00 0000 001 1112234567889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.29 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=197.0
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh-----hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-----GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-----~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
|...+.||+|+||.||+|.....+..||||+++..... ....+..|++++++++|+||+++++++......++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 56677899999999999999877789999998755322 3345778999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+ +|+|.+++... ...+++..++.++.||++||.||| ..+|+|+||||+|||++.++.++|+||
T Consensus 82 e~~-~~~L~~~i~~~-----------~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 82 EFM-ETDLEKVIKDK-----------SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred ccc-CCCHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccc
Confidence 999 99999998432 125899999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh-
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS- 781 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~- 781 (911)
|+++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|...........+.......
T Consensus 147 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 223 (298)
T cd07841 147 GLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223 (298)
T ss_pred eeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCc
Confidence 99976433211 1122346778999998865 467899999999999999999977765432111100000000000
Q ss_pred ----cccCCcccccCccccC-----CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 ----RARGTVDQIVDPRLRG-----KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ----~~~~~~~~i~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
................ .........+.+++.+||+.+|++||++.||+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000000 0112335678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=317.98 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=197.7
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccC-----Cce
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH-----GEM 619 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~ 619 (911)
..+|...+.||+|+||.||+|....++..||||++... .......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 35788889999999999999999888889999998643 223456688999999999999999999987543 357
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++|+||++ ++|.+++. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 84 ~lv~e~~~-~~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 84 YIVQELME-TDLYKLIK-------------TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred EEEehhcc-cCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEE
Confidence 99999996 48877762 235889999999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+|||+++................|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +..+.
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~ 223 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLIL 223 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 9999998764332222222233468889999998754 5689999999999999999999999965332110 00000
Q ss_pred hhhcc--cCCcccccCccc---------cCC-----CChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 779 RVSRA--RGTVDQIVDPRL---------RGK-----IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 779 ~~~~~--~~~~~~i~d~~l---------~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..... ......+.+... ... ..+.....+.+++.+||+.+|++||++.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000111111000 000 011234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.33 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=198.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcc---cccEeeecceeccCCceEEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELR---HLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV~ 623 (911)
.|+..+.||+|+||.||+|.+...+..+|+|.++.. ......++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 355667899999999999999877789999998654 3345567889999999997 999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++++|.+++.. ..+++...+.++.|++.||.||| ..+|+|+||+|+||++++++.++|+||
T Consensus 82 e~~~~~~L~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 82 EYAEGGSVRTLMKA-------------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred ecCCCCcHHHHHHc-------------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccC
Confidence 99999999998832 25889999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
|++........ ......|+..|+|||.+..+ .++.++|||||||++|||++|+.||....... +....
T Consensus 146 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~~~- 214 (277)
T cd06917 146 GVAALLNQNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMMLI- 214 (277)
T ss_pred CceeecCCCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhhcc-
Confidence 99876543221 12234588899999998754 56899999999999999999999986432111 00000
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.....+.+.. ......+.+++.+||+.||++||++.+++.+
T Consensus 215 -----~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 215 -----PKSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -----ccCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0001111111 1145678899999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.17 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=200.1
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||+|.+..++..|+||++.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3667789999999999999998777899999987543 23356789999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+ +++|.+++... ...+++.+++.++.||++||+||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 81 ~-~~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 81 M-PSDLSEVLRDE-----------ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred c-CCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeee
Confidence 9 99999998532 245899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhH-h--------
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL-V-------- 775 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l-~-------- 775 (911)
+........ .......++..|+|||++.+. .++.++|||||||++|||++|+++|.... ..+.... .
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~~~~~~~~~~~~~ 222 (286)
T cd07832 146 ARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQLAIVFRTLGTPNE 222 (286)
T ss_pred cccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHHHHHHHHcCCCCh
Confidence 986543221 112234588899999998654 46899999999999999999977764322 1111000 0
Q ss_pred -hHHhhhcccCCcccccCcccc----CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 776 -LWARVSRARGTVDQIVDPRLR----GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 -~~~~~~~~~~~~~~i~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.|....... ....+..+... ....+.....+.+++.+||+.+|.+||++++++++
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 223 ETWPGLTSLP-DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHhhccCcc-hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 010000000 00000000000 01112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.68 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=200.3
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
|...+.||+|++|.||++.....+..+++|++........+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44456899999999999998777789999998766555666789999999999999999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
++|.+++.. ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++..
T Consensus 101 ~~L~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 101 GALTDIVTH-------------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred CCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 999999842 34788999999999999999999 78999999999999999999999999998875
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... + ........
T Consensus 165 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~------~~~~~~~~---- 230 (285)
T cd06648 165 VSKEV---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-Q------AMKRIRDN---- 230 (285)
T ss_pred hccCC---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-H------HHHHHHhc----
Confidence 33221 1112345888999999999888999999999999999999999998543211 0 01111100
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..+.+. ....+...+.+++.+||+.+|++||++.++++.
T Consensus 231 --~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 231 --LPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --CCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 001111 112245678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.61 Aligned_cols=245 Identities=23% Similarity=0.381 Sum_probs=200.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||+|+||.||++.....++.+|+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5777889999999999999998878899999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++++|.+++... ..+++..+..++.|++.||+||| +.+++|+||+|+|||++.++.+||+|||
T Consensus 82 ~~~~~~L~~~~~~~------------~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 82 YVPGGELFSHLRKS------------GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred cCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999998432 35889999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+++..... .....++..|+|||.+.+...+.++||||||+++|||++|+.||...... ..+......
T Consensus 147 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~- 213 (290)
T cd05580 147 FAKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEG- 213 (290)
T ss_pred CccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcC-
Confidence 98864332 22345888999999998888999999999999999999999998643311 011111100
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
....+......+.+++.+||+.+|.+|| +++|+++.
T Consensus 214 -----------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 -----------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -----------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0112233456788999999999999999 66676543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.63 Aligned_cols=247 Identities=28% Similarity=0.400 Sum_probs=196.3
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.|...+.||+|+||.||+|....++..||+|++... .....+++.+|++++++++||||+++.++|...+..++|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 466677899999999999999877789999988643 23444678899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|++ |+|.+++... ...+++..+..++.|++.||.||| ..+++||||+|+||++++++.++|+|||
T Consensus 96 ~~~-g~l~~~~~~~-----------~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 96 YCL-GSASDILEVH-----------KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred hhC-CCHHHHHHHc-----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecC
Confidence 996 6777776422 235899999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhc---ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
++...... ....++..|+|||++. ...++.++||||||+++|||++|+.||........ ... ..
T Consensus 161 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----~~~--~~ 227 (307)
T cd06607 161 SASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYH--IA 227 (307)
T ss_pred cceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----HHH--Hh
Confidence 98754321 1235778899999874 45688999999999999999999999864331110 000 00
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
... .+. .....+...+.+++.+||+.+|++||++.+|+.+.
T Consensus 228 ~~~-------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 228 QND-------SPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred cCC-------CCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000 001 11223566789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.61 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=197.1
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|...+.||+|++|.||+|....++..||+|++.... ......+.+|++++++++|+|++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 455678999999999999998777899999986442 223356889999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
+ ++|.+++... ....+++..++.++.|+++||+||| +++++||||+|+||+++.++.++|+|||++
T Consensus 81 ~-~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~ 146 (283)
T cd07835 81 D-LDLKKYMDSS----------PLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLA 146 (283)
T ss_pred C-cCHHHHHhhC----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence 4 6899988532 1135899999999999999999999 689999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh------
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR------ 779 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~------ 779 (911)
+....... ......++..|+|||++.+. .++.++||||||+++|||++|+.||.......+......+..
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 147 RAFGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223 (283)
T ss_pred cccCCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 75432211 11223467889999988664 578999999999999999999999865432221111111100
Q ss_pred ---hhcccC---CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 ---VSRARG---TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ---~~~~~~---~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.....+ .......... ..........+.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 0000000000 01122334678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.06 Aligned_cols=265 Identities=21% Similarity=0.300 Sum_probs=195.2
Q ss_pred cceeecccCcEEEEEEEeecCCeEEEEEEccCCCh-hh-HHHHHHHHHHHHhccccc-EeeecceeccCC------ceEE
Q 002533 551 DHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QG-AREFRTEIEMISELRHLH-IVSLLGFCDEHG------EMIL 621 (911)
Q Consensus 551 ~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~-~~~f~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~------~~~l 621 (911)
..+.||+|.||+||+|+....+..||+|+++-... ++ -....+|+.+|++|+|+| |++|++++.... .+++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 34469999999999999998888999999876543 22 234678999999999999 999999997766 7899
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
|+||+ .-+|..++...... ...++-..+..++.||++||+||| +++|+||||||.||||++++.+||+
T Consensus 95 vfe~~-d~DL~~ymd~~~~~--------~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 95 VFEFL-DRDLKKYMDSLPKK--------PQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred EEEee-cccHHHHHHhcccc--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeee
Confidence 99999 55999999544321 023555788999999999999999 8999999999999999999999999
Q ss_pred ecCCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|||+|+...-. ....+...+|.-|.|||++.+. .|+...||||+||++.||++++.-|.+... .++...+--...
T Consensus 163 DFGlAra~~ip---~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lG 238 (323)
T KOG0594|consen 163 DFGLARAFSIP---MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLG 238 (323)
T ss_pred ccchHHHhcCC---cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcC
Confidence 99999954321 1223445688889999999886 799999999999999999998888765442 111111100000
Q ss_pred hc-ccCCc--ccccCc--cccC-----CCC---hHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 781 SR-ARGTV--DQIVDP--RLRG-----KIA---PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 781 ~~-~~~~~--~~i~d~--~l~~-----~~~---~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. .+.+- ....+- ..+. ... +.......+++.+|++.+|.+|.|++..+++
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 00000 000010 0000 000 1111467899999999999999999999876
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.07 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=200.6
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||+|.....+..+|+|.+... .....+.+.+|++++++++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 466788999999999999999887788999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC-ceEEeecC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW-AAKISDFG 704 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG 704 (911)
+++++|.+++... ....+++..++.++.|++.||+||| ..+++|+||||+||++++++ .+||+|||
T Consensus 81 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~ 147 (257)
T cd08225 81 CDGGDLMKRINRQ----------RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFG 147 (257)
T ss_pred CCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccc
Confidence 9999999998532 2235789999999999999999999 78999999999999999875 56999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++........ ......|+..|+|||++.+..++.++||||||+++|||++|+.||....... +......
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~- 216 (257)
T cd08225 148 IARQLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-------LVLKICQ- 216 (257)
T ss_pred cchhccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHhc-
Confidence 9876433211 1123458889999999998889999999999999999999999985432111 1111100
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
... ..........+.+++.+||+.+|++||++.+|+..
T Consensus 217 ~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 GYF---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ccC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 11122345678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.06 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=205.3
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
.+.||+|.-|+||++++.+.+..+|+|++.+... ....+.+.|-+||+.+.||.+..|++.++.+...|+|||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 5689999999999999999988999999987643 4455677899999999999999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|...++.. ..+.++...+.=++..+.-||+||| ..|||.|||||+||||.++|++-|+||.|+..
T Consensus 162 GdL~~LrqkQ----------p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 162 GDLHSLRQKQ----------PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred ccHHHHHhhC----------CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999888543 4556888888889999999999999 89999999999999999999999999999753
Q ss_pred CCCC---------------------------------CC--------------------CccccccccCcccccChhhhc
Q 002533 709 GPSG---------------------------------MS--------------------QSHVSTVVKGSFGYVDPEYIR 735 (911)
Q Consensus 709 ~~~~---------------------------------~~--------------------~~~~~~~~~gt~~y~APE~~~ 735 (911)
.... .. ....+....||-.|+|||+++
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 2110 00 001122346899999999999
Q ss_pred ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcc
Q 002533 736 RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCT 815 (911)
Q Consensus 736 ~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl 815 (911)
+...+.+.|.|+|||+||||+.|..||.+..... .+..++-+.+.-...+.....+.+||++.|
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 9999999999999999999999999997654221 233344444443333455678899999999
Q ss_pred cccCCCCCC----HHHHHHH
Q 002533 816 DEEGFRRPT----MGDVTWG 831 (911)
Q Consensus 816 ~~dP~~RPs----~~eVl~~ 831 (911)
..||.+|-. +.||-++
T Consensus 373 vKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ccChhhhhccccchHHhhcC
Confidence 999999988 7777544
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=310.50 Aligned_cols=272 Identities=19% Similarity=0.265 Sum_probs=198.3
Q ss_pred CccceeecccCcEEEEEEEeec--CCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccC--CceEE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDD--GSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEMIL 621 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~--~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~l 621 (911)
|...+.||+|+||.||+|.... .+..||||.+.... ....+.+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 6677889999999999999977 67899999987632 33345678899999999999999999999877 78999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC----CCc
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE----NWA 697 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~----~~~ 697 (911)
||||+++ +|.+++...... ....+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.
T Consensus 82 v~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQA-------KRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred EEeCCCc-CHHHHHHhhccC-------CCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccce
Confidence 9999964 777776433211 2236888999999999999999999 789999999999999999 999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccch------h
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK------E 770 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~------~ 770 (911)
+||+|||+++................++..|+|||++.+. .++.++|||||||+|+||++|+.||....... .
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 9999999998654332212222344678899999988764 57999999999999999999999986543221 0
Q ss_pred hhhHhhHHhhhccc-----------CCcccccCccccCCCC-----------hHHHHHHHHHHHhcccccCCCCCCHHHH
Q 002533 771 EVSLVLWARVSRAR-----------GTVDQIVDPRLRGKIA-----------PVCLNKFVEIAGSCTDEEGFRRPTMGDV 828 (911)
Q Consensus 771 ~~~l~~~~~~~~~~-----------~~~~~i~d~~l~~~~~-----------~~~~~~l~~li~~Cl~~dP~~RPs~~eV 828 (911)
...+.......... .......+.......+ ......+.+++.+||+.||++|||+.|+
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 00111110000000 0000000000000011 0234568899999999999999999999
Q ss_pred HHH
Q 002533 829 TWG 831 (911)
Q Consensus 829 l~~ 831 (911)
+++
T Consensus 311 l~~ 313 (316)
T cd07842 311 LEH 313 (316)
T ss_pred hcC
Confidence 753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=303.07 Aligned_cols=266 Identities=20% Similarity=0.321 Sum_probs=199.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
+|...+.||+|++|.||+|+...++..||||+++..... ....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 467788999999999999999887889999998755332 3456778999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
+ ++|.+++.... ....+++..+..++.|++.||+||| ..+++||||||+||++++++.++|+|||++
T Consensus 81 ~-~~l~~~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 81 D-KDLKKYMDTHG---------VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred C-ccHHHHHHhcC---------CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 7 48888885331 1245899999999999999999999 689999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh---------
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL--------- 776 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~--------- 776 (911)
+...... .......++..|++||++.+. .++.++|||||||++|||++|+.||...........+..
T Consensus 148 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07836 148 RAFGIPV---NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST 224 (284)
T ss_pred hhhcCCc---cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 7532211 111233467889999988664 578999999999999999999999865442221111111
Q ss_pred HHhhhccc---CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 777 WARVSRAR---GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 777 ~~~~~~~~---~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
|....... .......+.. .....+.+...+.+++.+|++.||.+||++.+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 225 WPGISQLPEYKPTFPRYPPQD-LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHhcCchhcccccCCChHH-HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 10000000 0000000000 01112234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=300.95 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=198.6
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-----ChhhHHHHHHHHHHHHhcccccEeeecceeccC--Cce
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-----SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEM 619 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-----~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 619 (911)
.+|...++||+|+||.||+|.....+..||+|.+... ..+..+.+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4678889999999999999999887789999987422 234456789999999999999999999998653 468
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++++||+++++|.+++.. ...+++...++++.|++.||+||| +.+++|+||||+||+++.++.++
T Consensus 82 ~~v~e~~~~~~L~~~~~~------------~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA------------YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEEEEeCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEE
Confidence 899999999999999842 234788889999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
|+|||+++................++..|+|||++.+..++.++|+|||||++|||++|+.||....... ...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~--- 219 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----AIF--- 219 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----HHH---
Confidence 9999999864321111111223458889999999998889999999999999999999999985432111 000
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
++.....+...+......+.+++.+||+ +|.+||+..+++.
T Consensus 220 ---------~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 220 ---------KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---------HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0011111222344456778899999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.96 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=195.4
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|...+.||+|+||.||++.....+..+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 334568999999999999998888899999986542 344567899999999996 999999999999889999999998
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
. ++|.++...... .....+++..+..++.+++.||+|||+ ..+++||||||+|||++.++.+||+|||++
T Consensus 86 ~-~~l~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 86 D-ISLDKFYKYVYE-------VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred c-CCHHHHHHHHHH-------hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 5 465554321110 123458999999999999999999994 458999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhccc---CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ---QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
+...... ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.......+ -......
T Consensus 156 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~ 225 (288)
T cd06616 156 GQLVDSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD------QLTQVVK 225 (288)
T ss_pred HHhccCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH------HHhhhcC
Confidence 7533221 11233578899999999876 689999999999999999999999854320000 0000000
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
...+.+.......++..+.+++.+||+.+|++||++.+|+..
T Consensus 226 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 226 ------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122222223456778999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.47 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=201.5
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+|...+.||.|+||.||+|....++..+|+|.+.... ....+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999998777899999986432 2456789999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++++|.+++.. ..++++..+..++.|+++||.||| ..+++|+||+|+||++++++.++|+|||
T Consensus 81 ~~~~~~L~~~l~~------------~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 81 LLLGGDLRYHLSQ------------KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred CCCCCCHHHHHHh------------cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecc
Confidence 9999999999842 235888999999999999999999 7899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++....... ......|+..|+|||.+....++.++|+||||+++|+|++|+.||....... ...+ .. ....
T Consensus 146 ~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~---~~-~~~~ 216 (258)
T cd05578 146 IATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQI---RA-KQET 216 (258)
T ss_pred cccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHH---HH-Hhcc
Confidence 987643321 1233457889999999998889999999999999999999999986543210 0000 00 0000
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCH--HHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM--GDVT 829 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~--~eVl 829 (911)
.....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 217 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122333445788899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.52 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=206.9
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh---hHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ---GAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~---~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV 622 (911)
..|...+.||.|.||.||+++.+.++..+|+|.+...... ..+...+|+++|++|. |||||.+.+.++.....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 3455667899999999999999998899999998765443 3458899999999998 99999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC----Cce
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN----WAA 698 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~ 698 (911)
||++.+|.|.+.+... .+++.....++.|++.+++||| ..+|+||||||+|+|+... +.+
T Consensus 115 mEL~~GGeLfd~i~~~-------------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-------------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEecCCchHHHHHHHc-------------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcE
Confidence 9999999999999432 2888999999999999999999 7999999999999999643 479
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
|++|||++..... ........||+.|+|||++....|+..+||||+||++|.|++|..||..........
T Consensus 179 k~~DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------ 248 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------ 248 (382)
T ss_pred EEeeCCCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------
Confidence 9999999987543 233456789999999999999999999999999999999999999997644222111
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.....+ .......-........+++..|+..||.+|+|+.+++++
T Consensus 249 ~i~~~~--------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 AILRGD--------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHcCC--------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111110 012222233446677899999999999999999999884
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=308.99 Aligned_cols=247 Identities=28% Similarity=0.395 Sum_probs=196.2
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
|...+.||+|+||.||+|+...++..+|+|++... ......++.+|++++++++|+|++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55567899999999999999877789999998643 233445788999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
++ |+|.+.+... ...++|.++..++.|++.||.||| +.+|+||||+|+||+++.++.+||+|||+
T Consensus 107 ~~-g~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 107 CL-GSASDLLEVH-----------KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred CC-CCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCC
Confidence 96 5887777432 235899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhc---ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
+...... ....++..|+|||++. .+.++.++|||||||++|||++|+.||........ +..+..
T Consensus 172 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~--- 238 (317)
T cd06635 172 ASIASPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQ--- 238 (317)
T ss_pred ccccCCc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHh---
Confidence 8753221 2335788999999974 45789999999999999999999999854321110 101100
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
..........+...+.+++.+||+.+|.+||++.+|++.+-
T Consensus 239 ----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 239 ----------NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ----------ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00011112234567889999999999999999999988653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.40 Aligned_cols=243 Identities=24% Similarity=0.318 Sum_probs=196.2
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
||.|+||.||+++....+..+++|++.... ....+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999998777899999986532 23446799999999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
.+++... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~~~l~~~------------~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRDR------------GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 9999532 34788999999999999999999 78999999999999999999999999999986543
Q ss_pred CCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
.. ......++..|++||.+.+..++.++|+||||+++|||++|..||....... ... + . ++.
T Consensus 146 ~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~--~-~---------~~~ 207 (262)
T cd05572 146 GQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEI--Y-N---------DIL 207 (262)
T ss_pred cc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHH--H-H---------HHh
Confidence 21 1223457889999999988889999999999999999999999996543111 100 0 1 111
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCC-----HHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTW 830 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~ 830 (911)
+.......+..+...+.+++.+||+.+|++||+ +.|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 208 KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111122233344678899999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=304.66 Aligned_cols=267 Identities=20% Similarity=0.273 Sum_probs=196.0
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++.+|...+.||+|+||.||+|.....+..||+|++...... ....+.+|++++++++|+||+++.+++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 356788889999999999999999877789999998654322 2346788999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+. ++|.+++... ...+.+..+..++.|++.||+||| ..+|+|+||||+|||++.++.+||+||
T Consensus 83 e~~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Df 147 (291)
T cd07870 83 EYMH-TDLAQYMIQH-----------PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADF 147 (291)
T ss_pred eccc-CCHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecc
Confidence 9995 6777776322 234778888899999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh-
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS- 781 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~- 781 (911)
|+++...... .......++..|+|||++.+. .++.++|||||||++|||++|+.||.......+.. ...|...-
T Consensus 148 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~-~~~~~~~~~ 223 (291)
T cd07870 148 GLARAKSIPS---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL-EKIWTVLGV 223 (291)
T ss_pred ccccccCCCC---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH-HHHHHHcCC
Confidence 9987532211 111223468899999998764 57889999999999999999999996543211111 01111000
Q ss_pred ----------cccCCcccccCccccCCC-----ChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 782 ----------RARGTVDQIVDPRLRGKI-----APVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 782 ----------~~~~~~~~i~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
.......+.......... .......+.+++.+|++.||.+|||+.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000 0012456789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.58 Aligned_cols=251 Identities=29% Similarity=0.423 Sum_probs=203.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+|...+.||+|++|.||++....++..+++|++........+.+.+|++++++++|+|++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 36667899999999999999987778999999987665567789999999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++... ...+++..+..++.|++.||+||| ..+++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~L~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 81 GGSLKDLLKST-----------NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred CCcHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccc
Confidence 99999998432 145899999999999999999999 7999999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
....... .....++..|+|||.+.....+.++||||||++++||++|+.||........ +... . . ...
T Consensus 147 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~-~---~-~~~ 214 (253)
T cd05122 147 QLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKI-A---T-NGP 214 (253)
T ss_pred ccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHH-H---h-cCC
Confidence 6543221 2344578899999999988899999999999999999999999864321110 0000 0 0 000
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. +. ....+...+.+++.+||+.||++|||+.+++++
T Consensus 215 ~~-----~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 215 PG-----LR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CC-----cC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00 111125678899999999999999999999753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=288.05 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=199.6
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|+..++||+|.|+.||++....+++.+|+|+++.. +..+.+++.+|+++.+.|+|||||+|.....+.+..+||+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 344556899999999999999888889999987533 344677899999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC---CCceEEee
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE---NWAAKISD 702 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~D 702 (911)
|.||+|..-+-.. -..++...-..+.||.++|.|+| ..+|||||+||.|+||.. .--+||+|
T Consensus 92 m~G~dl~~eIV~R------------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 92 VTGGELFEDIVAR------------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred ccchHHHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecc
Confidence 9999997766322 12567777889999999999999 799999999999999954 34689999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
||+|..... ........||++|||||+++..+|+..+|||+-||+||-|+.|+.||.+....+- +.+...
T Consensus 157 FGvAi~l~~----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~ 226 (355)
T KOG0033|consen 157 FGLAIEVND----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKA 226 (355)
T ss_pred cceEEEeCC----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhc
Confidence 999987652 2233456799999999999999999999999999999999999999976442221 111111
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. .-+++.. -....+...+|+++||..||.+|.|+.|.+.+
T Consensus 227 g~----yd~~~~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 227 GA----YDYPSPE----WDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cc----cCCCCcc----cCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11 1122211 12334556799999999999999999988654
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=305.52 Aligned_cols=266 Identities=21% Similarity=0.296 Sum_probs=198.2
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccC--CceEEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~ 623 (911)
+|...+.||+|+||.||+|.....+..+++|.++.... .....+.+|++++.+++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 56667789999999999999988778999999865432 2234577899999999999999999998766 8999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||++ ++|.+++... ...+++..++.++.|++.||+||| +.+++|+||||+|||++.++.+||+||
T Consensus 86 e~~~-~~L~~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~ 150 (293)
T cd07843 86 EYVE-HDLKSLMETM-----------KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDF 150 (293)
T ss_pred hhcC-cCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeec
Confidence 9996 5998888532 225899999999999999999999 789999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh-------
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV------- 775 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~------- 775 (911)
|+++....... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...........+.
T Consensus 151 g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 151 GLAREYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred CceeeccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 99886433211 11233467889999998764 46899999999999999999999986543211111110
Q ss_pred --hHHhhhccc----CCcccccCccccCCCChH-HHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 776 --LWARVSRAR----GTVDQIVDPRLRGKIAPV-CLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 --~~~~~~~~~----~~~~~i~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.|....... ..........+...++.. ....+.+++.+||+.+|++|||+.|++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011100000 001111111122222222 35678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=297.52 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=208.7
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
|++...||+|.||.|||+.++..++.+|||++.-. .+.+++..|+.+|++...|++|+++|.+-....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55667899999999999999999999999998643 4567899999999999999999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|++.+.++. .+++|++.++..++...++||+||| ...-+|||||+.||||+-+|.+||+|||.|-.
T Consensus 113 GSiSDI~R~-----------R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 113 GSISDIMRA-----------RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred CcHHHHHHH-----------hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccch
Confidence 999999853 4567999999999999999999999 67789999999999999999999999999875
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
+.+.+ .....+.||+.|||||+++.-.|..++||||||++..||.-|++||.+...-+.-. + +.
T Consensus 179 LTDTM---AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------M-----IP 242 (502)
T KOG0574|consen 179 LTDTM---AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------M-----IP 242 (502)
T ss_pred hhhhH---HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------e-----cc
Confidence 43322 23345779999999999999999999999999999999999999996543211000 0 00
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
-.|.-.-..+......+-+++++||-..|++|-|+.+++++
T Consensus 243 --T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 243 --TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 01111122456678899999999999999999999988765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=297.39 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=204.6
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|+||.||++.....+..+++|.+... ......++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 366778999999999999998877789999998653 234456788999999999999999999999988999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||+|+||++++++.+||+|||+
T Consensus 81 ~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 81 APFGDLSKAISKRKK--------KRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred cCCCCHHHHHHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 999999999865321 2346899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
++..... ......++..|++||.+.+..++.++|+||||+++|||++|+.||...... .+.. .. .
T Consensus 150 ~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~---~~-~-- 214 (256)
T cd08530 150 SKVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRY---KV-Q-- 214 (256)
T ss_pred hhhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HH-h--
Confidence 9865433 112345788999999999999999999999999999999999998543311 1110 00 0
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.......+......+.+++.+||+.+|++||++.++++.
T Consensus 215 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 215 -------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011112233456778999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=304.66 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=204.4
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.++.|...+.||+|+||.||+|.+...+..+++|++..... ..+.+.+|++++++++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 44556667789999999999999987778899999976544 56678999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++++|.+++.... ..+++..++.++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||
T Consensus 96 ~~~~~~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 96 YMDGGSLTDIITQNF-----------VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred ccCCCcHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccc
Confidence 999999999995431 25899999999999999999999 7999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++........ ......++..|++||.+.+..++.++|||||||++|||++|+.||........ .... ..
T Consensus 162 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~~~---~~-- 230 (286)
T cd06614 162 FAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LFLI---TT-- 230 (286)
T ss_pred hhhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---Hh--
Confidence 9865332211 11233477889999999988999999999999999999999999854321111 0000 00
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.... . ......++..+.+++.+||+.+|.+||++.+|+++.
T Consensus 231 ~~~~-----~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 231 KGIP-----P--LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred cCCC-----C--CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 0000 0 011122456788999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=295.54 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=205.4
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccC--CceEEEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~ 623 (911)
+|+..+.||+|++|.||+|....++..|++|++.... ....+.+.+|++++++++|+||+++++++... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999998777899999987554 25567899999999999999999999999887 8899999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++++|.+++... ..+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+||
T Consensus 81 e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 81 EYVSGGSLSSLLKKF------------GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred EecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccc
Confidence 999999999998432 26899999999999999999999 689999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|.+......... .......++..|+|||.+.....+.++||||||++++||++|+.||....... ...+
T Consensus 146 ~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~------ 214 (260)
T cd06606 146 GCAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AALY------ 214 (260)
T ss_pred ccEEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHH------
Confidence 998865433211 01233457889999999998889999999999999999999999986543100 0011
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+.........+......+.+++.+|++.+|.+||++.+++..
T Consensus 215 -----~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 215 -----KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0111111222334446788999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=303.87 Aligned_cols=269 Identities=20% Similarity=0.267 Sum_probs=196.3
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcc-cccEeeecceeccCCc-----e
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGE-----M 619 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~-----~ 619 (911)
+|...+.||+|+||.||+|.+..++..||||+++... ......+.+|+.++++++ |+||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5777889999999999999998888899999876432 223456888999999995 6999999999876655 8
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-CCce
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NWAA 698 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~ 698 (911)
++||||+++ +|.+++...... ....+++..++.++.||+.||+||| ..+|+||||||+||+++. ++.+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~ 150 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRG-------PGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLL 150 (295)
T ss_pred EEEeeccCc-CHHHHHHHhccc-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeE
Confidence 999999975 898888543211 1346899999999999999999999 789999999999999998 8899
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
||+|||+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||.......+...+...
T Consensus 151 kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 227 (295)
T cd07837 151 KIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227 (295)
T ss_pred EEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 9999999875422111 1122346788999998865 45799999999999999999999998654322211111110
Q ss_pred HhhhcccCCccccc---C----cc----ccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 778 ARVSRARGTVDQIV---D----PR----LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 ~~~~~~~~~~~~i~---d----~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.... ......... + +. ......+.....+.+++.+||+.||.+||++.|++.+
T Consensus 228 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 228 LGTP-TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCCC-ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000000000 0 00 0000112345678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=308.24 Aligned_cols=266 Identities=20% Similarity=0.279 Sum_probs=196.3
Q ss_pred eeccc--CcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 554 IIGSG--GFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 554 ~LG~G--~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
.||+| +||+||++.+...+..||||++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999999877889999998643 3334567889999999999999999999999999999999999999
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++++||+.+...
T Consensus 85 ~l~~~l~~~~----------~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 85 SANSLLKTYF----------PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred CHHHHHHhhc----------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 9999885431 234788899999999999999999 789999999999999999999999999865432
Q ss_pred CCCCCCcc----ccccccCcccccChhhhccc--CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH------
Q 002533 710 PSGMSQSH----VSTVVKGSFGYVDPEYIRRQ--QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW------ 777 (911)
Q Consensus 710 ~~~~~~~~----~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~------ 777 (911)
........ ......++..|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence 11111000 01112345679999999764 4789999999999999999999999654321111100000
Q ss_pred Hhh-----------------------hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 778 ARV-----------------------SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 778 ~~~-----------------------~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
... .........+.+..++......+...+.+++.+||+.||++|||+.|+++.-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000 0000000011122223333445677899999999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.75 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=193.1
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
||+|+||+||++.....+..+|+|.+.... ....+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999988877899999986432 22344577899999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
.+++... ....+++.+++.++.|++.||.||| ..+++||||+|+||++++++.++|+|||+++....
T Consensus 81 ~~~l~~~----------~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 81 KYHIYNV----------GEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred HHHHHHc----------CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 9998543 1235889999999999999999999 78999999999999999999999999999875432
Q ss_pred CCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
. .......++..|+|||++.+..++.++|||||||++|||++|+.||...........+. .. ..
T Consensus 148 ~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~---------~~ 211 (277)
T cd05577 148 G----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RR---------TL 211 (277)
T ss_pred C----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hc---------cc
Confidence 1 11223457788999999998889999999999999999999999986533211111000 00 00
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTW 830 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~ 830 (911)
......+......+.+++.+||+.+|.+|| ++.+++.
T Consensus 212 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 212 --EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 001122333466788999999999999999 5555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=296.55 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=205.8
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||.|+||.||++....++..+++|++..... ...+++.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 46677899999999999999987778999999875533 5567789999999999999999999999888999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++..... ....+++..++.++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 81 ADGGDLSQKIKKQKK--------EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred cCCCcHHHHHHHhhc--------cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccc
Confidence 999999999965321 2356899999999999999999999 68999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... +. ....
T Consensus 150 ~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~---~~~~--- 216 (258)
T cd08215 150 SKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----LA---LKIL--- 216 (258)
T ss_pred eeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----HH---HHHh---
Confidence 97643322 12233457889999999999999999999999999999999999985433111 10 0000
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. .....+..+...+.+++.+||..+|++||++.++++.
T Consensus 217 ------~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 217 ------KG-QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ------cC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0112233456778899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.18 Aligned_cols=268 Identities=21% Similarity=0.288 Sum_probs=195.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
++|...+.||+|++|.||+|....+++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 35777889999999999999998777899999886432 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-CCceEEeec
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NWAAKISDF 703 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DF 703 (911)
|++ ++|.+++... ....+++.....++.||+.||+||| +.+++|+||+|+||+++. ++.+||+||
T Consensus 82 ~~~-~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 82 YLD-LDLKKHMDSS----------PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred ccc-ccHHHHHHhC----------CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccc
Confidence 995 5888877432 1223577888899999999999999 789999999999999985 567999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
|+++...... .......++..|+|||++.+ ..++.++|||||||++|||+||+.||.......+......+.....
T Consensus 148 g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 224 (294)
T PLN00009 148 GLARAFGIPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224 (294)
T ss_pred ccccccCCCc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9997543211 11123346789999999876 4578999999999999999999999965432211111110000000
Q ss_pred cc-----CCccccc--CccccC----CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 783 AR-----GTVDQIV--DPRLRG----KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ~~-----~~~~~i~--d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. ..+.... -+..+. ...+.....+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000000 000000 0112234568899999999999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=301.15 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=197.9
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccC--CceEEEEe
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEMILVYE 624 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~E 624 (911)
|...+.||+|+||.||+|.....+..+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 455678999999999999998877899999997653 33345688999999999999999999999877 89999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|++ ++|.+++... ...+++..++.++.|++.||+||| ..+++|+||||+||++++++.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 81 YMD-HDLTGLLDSP-----------EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred ccc-ccHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEcccc
Confidence 997 4888887432 235899999999999999999999 6899999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.........
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07840 146 LARPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223 (287)
T ss_pred ceeeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 9986433221 11223346778999998765 46789999999999999999999998654321111111100000000
Q ss_pred c--CCc-----------ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 R--GTV-----------DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~--~~~-----------~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. ... .......+.......+...+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000 00001111111112236678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=311.11 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=198.2
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC------C
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH------G 617 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 617 (911)
..+|...+.||+|+||.||+|....++..||||++... ......++.+|++++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 45788889999999999999999888889999998643 334456778899999999999999999987543 3
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++||||+. ++|.+.+.. .+++..+..++.|++.||+||| ..+|+||||||+|||++.++.
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM--------------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCC
Confidence 5799999995 588887731 1778888999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh-
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL- 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~- 776 (911)
+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 157 ~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 232 (353)
T cd07850 157 LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232 (353)
T ss_pred EEEccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 9999999998643221 12234578899999999999999999999999999999999999865432111000000
Q ss_pred -------HH--------hhhccc-----CCcccccCccc----cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 -------WA--------RVSRAR-----GTVDQIVDPRL----RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 -------~~--------~~~~~~-----~~~~~i~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+. ...... ....++....+ ...........+.+++.+||+.||++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 00111111111 011122345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=301.82 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=187.9
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHH---hcccccEeeecceeccCCceEEEEeecC
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMIS---ELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~---~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+||+|+||.||++.....+..+|+|.+..... .....+.+|..+++ ..+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999988778999998865321 22233445544433 3479999999999998899999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.+++.. ...+++..+..++.|++.||+||| ..+|+||||||+|||+++++.++|+|||++.
T Consensus 81 ~~~L~~~i~~------------~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 81 GGDLHYHLSQ------------HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred CCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 9999998842 235899999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
...... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..+ ....
T Consensus 146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~---~~~~----- 211 (279)
T cd05633 146 DFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI---DRMT----- 211 (279)
T ss_pred eccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHH---HHHh-----
Confidence 532211 123358899999999864 5689999999999999999999999964321111 000 0000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
.......+......+.+++.+||+.||++|| ++++++++
T Consensus 212 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 212 ------LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011123334566788999999999999999 59988776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=299.13 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=196.2
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
||+|+||.||++....++..+++|.+..... ...+.+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999988778999999865433 4556788999999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
.+++... ..+++..++.++.|++.||+||| ..+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~~------------~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENV------------GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 9998532 25899999999999999999999 78999999999999999999999999999875432
Q ss_pred CCCC-----ccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 712 GMSQ-----SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 712 ~~~~-----~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
.... ........++..|+|||.+.....+.++||||||+++|||++|+.||....... .. .....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~---~~~~~--- 215 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IF---QNILN--- 215 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HH---HHHhc---
Confidence 2110 111233457788999999998889999999999999999999999986433111 00 00000
Q ss_pred cccccCccccCCCChH--HHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPV--CLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~--~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
... ..+.. ....+.+++.+||+.+|++||++.+|.+.|+
T Consensus 216 ------~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 216 ------GKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ------CCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000 01111 2567889999999999999999966665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=310.03 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=197.8
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhc-ccccEeeecceecc--CCceE
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDE--HGEMI 620 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~--~~~~~ 620 (911)
..+|...+.||+|+||.||+|.+..++..+|||++... .......+.+|+.+++++ +|+||++++++|.. ....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 34677778999999999999999877789999988542 334455678899999999 99999999999854 34689
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||++ ++|..++.. ..++|..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 86 lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-------------NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred EEecccc-cCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEE
Confidence 9999996 599888732 25788999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCC--ccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 701 SDFGLSRMGPSGMSQ--SHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 701 ~DFGla~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
+|||+++........ ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..+
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999864332211 112233458889999998765 46789999999999999999999998654322111111110
Q ss_pred Hhhh-------cccCCcccccC----cccc--CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 778 ARVS-------RARGTVDQIVD----PRLR--GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 ~~~~-------~~~~~~~~i~d----~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.... .......++++ .... ....+.++..+.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 00000000110 0000 01112246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.74 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=203.0
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+|...+.||+|++|.||+++....+..+++|.+..... ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 36667899999999999999987778999999876643 4567899999999999999999999999988999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~L~~~~~~~------------~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 81 AENGSLRQIIKKF------------GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred CCCCcHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEecccc
Confidence 9999999998432 45899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+......... .....++..|+|||.+.+...+.++|||+||+++|||++|+.|+...... ...|.....
T Consensus 146 ~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~--- 214 (254)
T cd06627 146 ATKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIVQD--- 214 (254)
T ss_pred ceecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhcc---
Confidence 9865432221 22345788999999998888899999999999999999999998643211 111111100
Q ss_pred CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
.....+......+.+++.+||..+|++||++.+++.
T Consensus 215 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 ---------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 011223334567889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.79 Aligned_cols=259 Identities=22% Similarity=0.239 Sum_probs=192.3
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcc-cccEeeecceeccC--CceEEEEe
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELR-HLHIVSLLGFCDEH--GEMILVYE 624 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~lV~E 624 (911)
|...+.||+|+||.||+|.....+..+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 345678999999999999998777899999986532 222234557899999985 99999999999877 88999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|++ |+|.+++... ...++|.+++.++.|++.||+||| ..+++||||||+||+++. +.+||+|||
T Consensus 81 ~~~-~~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 81 LMD-MNLYELIKGR-----------KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred cCC-ccHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecc
Confidence 996 5888887432 235899999999999999999999 789999999999999999 999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
+++....... .....++..|+|||++.. +.++.++|||||||++|||++|+.||....... ...+......
T Consensus 145 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~----~~~~~~~~~~ 216 (282)
T cd07831 145 SCRGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD----QIAKIHDVLG 216 (282)
T ss_pred cccccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH----HHHHHHHHcC
Confidence 9976432211 122347889999997654 567899999999999999999999996533211 1111111000
Q ss_pred c-----------CCcccccCccccC----CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 R-----------GTVDQIVDPRLRG----KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~-----------~~~~~i~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
. ........+.... ......+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 0000000000000 0112346789999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=302.56 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=197.6
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchh
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 632 (911)
.+||+|+||.||++.....+..||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 36999999999999998888899999987655556677999999999999999999999999999999999999999999
Q ss_pred hHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCC
Q 002533 633 DHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 633 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 712 (911)
+++. ...+++.....++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 106 ~~~~-------------~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 106 DIVT-------------HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred HHHh-------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 8873 224788999999999999999999 789999999999999999999999999998754322
Q ss_pred CCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccC
Q 002533 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVD 792 (911)
Q Consensus 713 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 792 (911)
. .......++..|+|||.+.+..++.++|+|||||++|||++|..||....... .... ... ...
T Consensus 170 ~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-~~~~---~~~---------~~~ 233 (292)
T cd06657 170 V---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKM---IRD---------NLP 233 (292)
T ss_pred c---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH---HHh---------hCC
Confidence 1 11233457889999999988889999999999999999999999986432111 1000 000 001
Q ss_pred ccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 793 PRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 793 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+.+. ....+...+.+++.+||+.+|.+||++.+|+++
T Consensus 234 ~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 234 PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1110 011234567899999999999999999998774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=282.41 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=198.3
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEEeecCCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
...||.|..|.|++++...++..+|||.+... +.+..++++..++++.+-+ +|.||+.+||+..+...++.||.|. -
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 44699999999999999998899999998755 5566677888888877664 8999999999999999999999883 3
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
.+..+|.. ...++++.-+-++...++.||.||.+ +++|+|||+||+|||+|+.|.+|+||||++-.+
T Consensus 176 C~ekLlkr-----------ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 176 CAEKLLKR-----------IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHH-----------hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccccccee
Confidence 45555532 23458888888999999999999996 899999999999999999999999999998754
Q ss_pred CCCCCCccccccccCcccccChhhhcc---cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRR---QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
-+. ...+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.....+-+.+..+.-
T Consensus 243 vdS----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--------- 309 (391)
T KOG0983|consen 243 VDS----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--------- 309 (391)
T ss_pred ecc----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---------
Confidence 332 22345568899999998864 46889999999999999999999999877655544433221
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
-..|.|++.. .....+.+++..||..|+.+||...+++++
T Consensus 310 ---~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 ---EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 0112333221 256788999999999999999999999875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.53 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=196.9
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCC-----
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHG----- 617 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----- 617 (911)
+..+|...+.||+|+||.||+|....+++.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567888899999999999999998877899999986542 223346778999999999999999999986654
Q ss_pred -----ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee
Q 002533 618 -----EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL 692 (911)
Q Consensus 618 -----~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 692 (911)
..++|+||+++ +|...+.. ....+++..++.++.|++.||+||| ..+|+|+||||+||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~-----------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili 149 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES-----------GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILL 149 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc-----------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 78999999975 77776632 1235899999999999999999999 7899999999999999
Q ss_pred cCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhh
Q 002533 693 DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771 (911)
Q Consensus 693 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~ 771 (911)
++++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-- 225 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-- 225 (302)
T ss_pred CCCCcEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--
Confidence 9999999999999986533221 11122345778999998865 457899999999999999999999986433111
Q ss_pred hhHhhHHhhhcc--cCCcccc--------------cCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 772 VSLVLWARVSRA--RGTVDQI--------------VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 772 ~~l~~~~~~~~~--~~~~~~i--------------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+......... ......+ .....+.. ....+..+.+++.+||+.+|.+||++.+|++.
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 226 -QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred -HHHHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111000 0000000 00011111 11235678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.45 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=202.8
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
...||.|+||.||||..++.+...|-|++...+.+..++|+-||++|....||+||+|++.+..++.++|+.|||.||-+
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 34699999999999999988888889999988889999999999999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
...+..- ...|+..++.-+|.|++.||.||| +..|||||||+.|||++-+|.++|+|||.+.....
T Consensus 117 DaimlEL-----------~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 117 DAIMLEL-----------GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred hHHHHHh-----------ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 8887543 346899999999999999999999 79999999999999999999999999999754211
Q ss_pred CCCCccccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
.........||+.|||||+.. ..+|+.++||||||++|.||..+.+|...-. .+.... .....
T Consensus 183 ---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVll--KiaKS--- 250 (1187)
T KOG0579|consen 183 ---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLL--KIAKS--- 250 (1187)
T ss_pred ---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHH--HHhhc---
Confidence 122234567999999999865 5689999999999999999999999864221 111100 00000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
-.|.| .-+......+.+++.+||..||..||++.+++++
T Consensus 251 ----ePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 251 ----EPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----CCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 01111 1244567789999999999999999999998653
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.56 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=196.5
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh-hhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|...+.||+|+||+||+|+..+.+..|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4556789999999999999988778999999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
+|+|.+++... ....+++..++.++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++
T Consensus 81 -~~~l~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 81 -EGNLYQLMKDR----------KGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred -CCCHHHHHHhc----------ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccc
Confidence 88999988543 1235899999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh---------
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL--------- 776 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~--------- 776 (911)
+....... .....++..|+|||++.. ..++.++|+||||+++|||++|+.||..............
T Consensus 147 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd07830 147 REIRSRPP----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222 (283)
T ss_pred eeccCCCC----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence 75432211 123357888999998754 4578999999999999999999999865432221111111
Q ss_pred HHhhhcccCCcccc----cCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 WARVSRARGTVDQI----VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ~~~~~~~~~~~~~i----~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|............. ....+. ...+.....+.+++.+||+.+|++||++.|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 223 WPEGYKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhHhhhhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11111000000000 000111 0111124678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.93 Aligned_cols=260 Identities=17% Similarity=0.166 Sum_probs=183.8
Q ss_pred cCCccceeecccCcEEEEEEEeecC---CeEEEEEEccCCChhhH-----------HHHHHHHHHHHhcccccEeeecce
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTSSMQGA-----------REFRTEIEMISELRHLHIVSLLGF 612 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~---~~~vAvK~l~~~~~~~~-----------~~f~~Ei~~l~~l~HpnIv~l~g~ 612 (911)
.+|...++||+|+||.||+|...++ ...+|+|+......... .....++..+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4678888999999999999998766 55677776432221110 112233445566789999999997
Q ss_pred eccCC----ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCC
Q 002533 613 CDEHG----EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKST 688 (911)
Q Consensus 613 ~~~~~----~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~ 688 (911)
+.... ..++++|++. .++.+.+... ...++..+..|+.|++.||+||| +.+|+||||||+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~ 155 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI------------KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPE 155 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh------------ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 65433 3467777763 3565555221 22467778899999999999999 789999999999
Q ss_pred CeeecCCCceEEeecCCccCCCCCCCCc----cccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002533 689 NILLDENWAAKISDFGLSRMGPSGMSQS----HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764 (911)
Q Consensus 689 NILl~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~ 764 (911)
|||++.++.++|+|||+++......... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999997643211110 111234699999999999999999999999999999999999999965
Q ss_pred CccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 765 GAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 765 ~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.............. ...++....+. ...++..+.+++..|+..+|++||++.++++.|
T Consensus 236 ~~~~~~~~~~~~~~-------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 236 FGHNGNLIHAAKCD-------FIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cccchHHHHHhHHH-------HHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 42222111111000 01111111111 123467788999999999999999999998876
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=309.68 Aligned_cols=266 Identities=20% Similarity=0.289 Sum_probs=198.3
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC-----Cc
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH-----GE 618 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~ 618 (911)
.++|...+.||+|+||.||+|+...++..||||.+... .......+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34688888999999999999999888889999998653 233445678899999999999999999988543 35
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
.++||||+. ++|.+++. ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+
T Consensus 84 ~~lv~e~~~-~~L~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~ 147 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR------------SSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDL 147 (337)
T ss_pred EEEEEeCCC-CCHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCE
Confidence 799999995 78888873 2345889999999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
||+|||+++...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+...
T Consensus 148 kL~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 224 (337)
T cd07858 148 KICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224 (337)
T ss_pred EECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence 999999998643221 11223457889999998865 46899999999999999999999998643311110000000
Q ss_pred Hhh-------hcccCCccc-------ccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 778 ARV-------SRARGTVDQ-------IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 ~~~-------~~~~~~~~~-------i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
... ........+ ..++.+. ...+.+...+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 000000000 0001111 1112356678899999999999999999999877
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=297.98 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=199.3
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|...+.||.|++|.||+|....++..+++|++..... .....+.+|++++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 3456689999999999999987788999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
++ +|.+++... ...+++..++.++.|++.||+||| ..+|+|+||||+||++++++.++|+|||.+
T Consensus 81 ~~-~l~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 81 DT-DLYKLIKDR-----------QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred CC-CHHHHHHhh-----------cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeee
Confidence 65 888887432 235899999999999999999999 789999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+..... .....
T Consensus 146 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~ 221 (283)
T cd05118 146 RSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG-TPDPE 221 (283)
T ss_pred EecCCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCchH
Confidence 7654322 111234577889999998876 789999999999999999999999865432111111100000 00000
Q ss_pred CcccccC---------ccc----cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 TVDQIVD---------PRL----RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 ~~~~i~d---------~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
......+ +.. .....+.....+.+++.+||+.||.+||++.+++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 000 011123456788999999999999999999999753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=312.53 Aligned_cols=268 Identities=26% Similarity=0.387 Sum_probs=202.0
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccC------CceEEEEe
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH------GEMILVYE 624 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~lV~E 624 (911)
.+.||+|+||.||+|+.+.++..||||.++.. .....+...+|+++|++|+|+|||++++.-+.. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 34799999999999999999999999998764 344566788999999999999999999986543 35789999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeec--C--CCceEE
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD--E--NWAAKI 700 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~--~--~~~~kl 700 (911)
||.+|||+..|.... ....|++.+.+.+..+++.||.||| +++|+||||||.||++- + .-..||
T Consensus 98 yC~gGsL~~~L~~PE---------N~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE---------NAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred ecCCCcHHHHhcCcc---------cccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEee
Confidence 999999999995442 3456999999999999999999999 79999999999999993 2 336799
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||.||..+.+ .....+.||..|++||++.. +.|+..+|.|||||++||++||..||.....++.. .-+.|..
T Consensus 166 tDfG~Arel~d~----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~-~~~~~~~ 240 (732)
T KOG4250|consen 166 TDFGAARELDDN----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN-KEIMWHI 240 (732)
T ss_pred ecccccccCCCC----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc-chhhhhh
Confidence 999999976543 35567889999999999995 88999999999999999999999999765433221 1233444
Q ss_pred hhcccCCcccccCccccC------------CCChHHHHHHHHHHHhcccccCCCCC--CHHHHHHHHHHHH
Q 002533 780 VSRARGTVDQIVDPRLRG------------KIAPVCLNKFVEIAGSCTDEEGFRRP--TMGDVTWGLEFAL 836 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~------------~~~~~~~~~l~~li~~Cl~~dP~~RP--s~~eVl~~L~~~~ 836 (911)
...+...+.-...++..+ .........+-......+..+|++|- ...+.-..+..++
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 333332222222222221 11223344555666667777888887 5444444444444
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=301.53 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=192.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCC--------
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHG-------- 617 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~-------- 617 (911)
+|...+.||+|+||.||+|.....+..||||++.... ......+.+|++++++++||||++++++|....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 5778889999999999999998888899999885432 222335678999999999999999999986543
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++||||+. ++|.+.+.. ....+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~-----------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSN-----------KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGI 157 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCc
Confidence 4599999996 588877742 2235899999999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCC-ccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 698 AKISDFGLSRMGPSGMSQ-SHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
+||+|||++......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ......
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~ 236 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLI 236 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 999999999764322211 1111233577889999988764 4788999999999999999999998654321 111111
Q ss_pred hHHhhhcccC------------------CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 776 LWARVSRARG------------------TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 ~~~~~~~~~~------------------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.......... .........+.. ......+.+++.+||..||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP---YVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhccc---ccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1100000000 000000001111 1123466799999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.90 Aligned_cols=273 Identities=22% Similarity=0.300 Sum_probs=205.0
Q ss_pred cCcCCHHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecc
Q 002533 534 CRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLG 611 (911)
Q Consensus 534 ~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g 611 (911)
.++....++...+.+|...+.||+|+||.||+|....++..||+|++... .....+.+.+|++++++++|+||+++++
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 45667788888999999999999999999999998877789999998753 2333466889999999999999999999
Q ss_pred eeccC------CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecc
Q 002533 612 FCDEH------GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDV 685 (911)
Q Consensus 612 ~~~~~------~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl 685 (911)
++... ...+++++++ +++|.+++. ...+++..+..++.|+++||+||| +.+|+||||
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dl 146 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVK-------------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDL 146 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCC
Confidence 87532 3468888877 789988773 234889999999999999999999 789999999
Q ss_pred cCCCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002533 686 KSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMIN 764 (911)
Q Consensus 686 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~ 764 (911)
||+||++++++.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 147 kp~NIll~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 147 KPSNLAVNEDCELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred ChHHEEEcCCCCEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998753221 123457889999999876 5688999999999999999999999854
Q ss_pred CccchhhhhHhhHHhhhcccCCccccc---------------CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHH
Q 002533 765 GAVRKEEVSLVLWARVSRARGTVDQIV---------------DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVT 829 (911)
Q Consensus 765 ~~~~~~~~~l~~~~~~~~~~~~~~~i~---------------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl 829 (911)
.........+..... .........+. ..... .........+.+++.+|++.||.+||++.+++
T Consensus 221 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 221 TDHIDQLKLILRLVG-TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred CCHHHHHHHHHHHhC-CCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 332111111111000 00000000000 00000 00012345678999999999999999999998
Q ss_pred HH
Q 002533 830 WG 831 (911)
Q Consensus 830 ~~ 831 (911)
.+
T Consensus 299 ~h 300 (345)
T cd07877 299 AH 300 (345)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=308.16 Aligned_cols=268 Identities=24% Similarity=0.310 Sum_probs=201.0
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCC-----ceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHG-----EMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~ 620 (911)
+|...+.||.|+||.||+|+....+..+|||++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3667789999999999999998777899999987643 344567899999999999999999999987765 789
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||++ ++|.+++.. ...+++..++.++.|++.||+||| ..+|+||||||+|||++.++.++|
T Consensus 81 lv~e~~~-~~l~~~l~~------------~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L 144 (330)
T cd07834 81 IVTELME-TDLHKVIKS------------PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKI 144 (330)
T ss_pred EEecchh-hhHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEE
Confidence 9999997 588888742 236899999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||++.................++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+.....
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 224 (330)
T cd07834 145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224 (330)
T ss_pred cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence 9999998654332111122334578889999999887 889999999999999999999999865432111000000000
Q ss_pred hhc-------ccCCcccccC---ccc---cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 780 VSR-------ARGTVDQIVD---PRL---RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~-------~~~~~~~i~d---~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
... ........+. ... .....+.....+.+++.+||+.+|.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 0000000000 000 000112245678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=295.10 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=192.2
Q ss_pred HHHHHHccCCccceee--cccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceeccC
Q 002533 540 TEIKQATCDFADHCII--GSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEH 616 (911)
Q Consensus 540 ~el~~at~~f~~~~~L--G~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 616 (911)
.++....++|...+.+ |+|+||.||++....++..+|+|.+....... . |+.....+ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444445566665555 99999999999998888899999986432111 1 22222222 699999999999999
Q ss_pred CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC
Q 002533 617 GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 617 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 696 (911)
+..++||||+++|+|.+++... ..++|.++..++.|+++||.||| +.+++||||||+||+++.++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE------------GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAK 146 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCC
Confidence 9999999999999999998432 26899999999999999999999 78999999999999999988
Q ss_pred -ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 697 -AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 697 -~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
.++|+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... .+.....
T Consensus 147 ~~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~--~~~~~~~ 217 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE--DEELDLE 217 (267)
T ss_pred CeEEEecCccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--cchhhHH
Confidence 9999999998754321 12357889999999999999999999999999999999999996332 1222222
Q ss_pred hHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-HHHHHH
Q 002533 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-MGDVTW 830 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~eVl~ 830 (911)
.|...... . ..........+.+++.+||+.+|.+||+ ++++++
T Consensus 218 ~~~~~~~~----------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 SLLKRQQK----------K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhhcc----------c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 22221110 0 0112235667889999999999999996 688864
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=297.63 Aligned_cols=246 Identities=22% Similarity=0.359 Sum_probs=205.3
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhh--HHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG--AREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|+.++.||+|.|..|-+|++--+++.||||++.+..... ...+.+|++.|+.++|||||+|+.+......+|||.|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 444558999999999999998888999999998765443 346789999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee-cCCCceEEeecCC
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL-DENWAAKISDFGL 705 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGl 705 (911)
.+|+|.+|+.... ..+.+....+++.||..|+.|+| +..+|||||||+||.+ ..-|-+||.|||+
T Consensus 100 D~GDl~DyImKHe-----------~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE-----------EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred CCchHHHHHHhhh-----------ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccc
Confidence 9999999996543 34888888999999999999999 7899999999999876 4568899999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhcccCCC-chhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhccc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+..+..+. ..+..+|+..|.|||.+.+..|+ ++.|||||||+||.|+||+.||.... +.+
T Consensus 166 SNkf~PG~----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-DSE-------------- 226 (864)
T KOG4717|consen 166 SNKFQPGK----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-DSE-------------- 226 (864)
T ss_pred cccCCCcc----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-chh--------------
Confidence 87654433 23456799999999999998886 58999999999999999999996432 221
Q ss_pred CCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
.+..++|-.. .+|.....++.+||..||..||++|.+.++|+.
T Consensus 227 -TLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 -TLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -hhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2334555443 356667788899999999999999999998853
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=308.43 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=198.8
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceecc----CCceE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDE----HGEMI 620 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~ 620 (911)
.+|...+.||+|+||.||+|.....+..||+|++.... ......+.+|+.+|++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888889999999999999998888899999986542 2345667889999999999999999998753 35689
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+||||+. |+|.+++.. ...+++..+..++.|++.||+||| ..+|+||||||+|||+++++.+||
T Consensus 85 lv~e~~~-~~l~~~~~~------------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 85 VVMDLME-SDLHHIIHS------------DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEehhh-hhHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEe
Confidence 9999995 689888842 334899999999999999999999 789999999999999999999999
Q ss_pred eecCCccCCCCCCC-CccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 701 SDFGLSRMGPSGMS-QSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 701 ~DFGla~~~~~~~~-~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
+|||+++....... .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......-.
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~ 227 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSV 227 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHH
Confidence 99999875432211 1112233468889999999865 46899999999999999999999999653321 111100000
Q ss_pred hhhc--------ccCCcccccC---cccc---CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 779 RVSR--------ARGTVDQIVD---PRLR---GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 779 ~~~~--------~~~~~~~i~d---~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.... ....+.+..+ .... ....+..+..+.+++.+||+.+|.+||++.+++...
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000 0000000000 0000 001123467789999999999999999999988763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=293.58 Aligned_cols=244 Identities=23% Similarity=0.302 Sum_probs=189.3
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHH-HhcccccEeeecceeccCCceEEEEeecCC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMI-SELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l-~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
+.||+|+||.||+|.....+..||||++..... .....+..|..++ ..++|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 369999999999999987778999999865432 2223445555544 445899999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 82 GDCASLIKTL------------GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 9999998432 34788899999999999999999 78999999999999999999999999999875
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
... .....++..|+|||.+.+..++.++||||||+++|||++|..||...... . .+........
T Consensus 147 ~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~-----~~~~~~~~~~--- 210 (260)
T cd05611 147 GLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-A-----VFDNILSRRI--- 210 (260)
T ss_pred ccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-H-----HHHHHHhccc---
Confidence 322 12345788999999999888999999999999999999999998543211 0 1111111000
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.........++..+.+++.+||+.+|++||++.++.+.|
T Consensus 211 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 211 -----NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred -----CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 001111223567788999999999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=300.84 Aligned_cols=260 Identities=21% Similarity=0.227 Sum_probs=189.3
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchh
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 632 (911)
+|.|++ ||+++....+..||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|.
T Consensus 10 ~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 10 FEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 444444 455544446678999998654 4456678999999999999999999999999999999999999999999
Q ss_pred hHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCC
Q 002533 633 DHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 633 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 712 (911)
+++... ....+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+......
T Consensus 88 ~~l~~~----------~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~ 154 (314)
T cd08216 88 DLLKTH----------FPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH 154 (314)
T ss_pred HHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccc
Confidence 999643 1234788888999999999999999 789999999999999999999999999998643221
Q ss_pred CC----CccccccccCcccccChhhhcc--cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc----
Q 002533 713 MS----QSHVSTVVKGSFGYVDPEYIRR--QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR---- 782 (911)
Q Consensus 713 ~~----~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~---- 782 (911)
.. .........++..|+|||++.. ..++.++|||||||++|||++|+.||........ +..-.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 231 (314)
T cd08216 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM---LLEKVRGTVPCLL 231 (314)
T ss_pred cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCcccc
Confidence 11 1111233457778999999876 3588999999999999999999999965432111 000000000
Q ss_pred -------ccCCccc----ccCccc----cCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 783 -------ARGTVDQ----IVDPRL----RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 783 -------~~~~~~~----i~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
......+ ..++.. ...........+.+++.+||+.||++|||+.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0000000 000000 1111223456788999999999999999999998863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=321.74 Aligned_cols=273 Identities=18% Similarity=0.190 Sum_probs=189.2
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCe-EEEE------------------EEccCCChhhHHHHHHHHHHHHhccccc
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSI-TVAV------------------KRLNTSSMQGAREFRTEIEMISELRHLH 605 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~-~vAv------------------K~l~~~~~~~~~~f~~Ei~~l~~l~Hpn 605 (911)
...+|...+.||+|+||+||++.++.... ..++ |.+. ........+.+|+++|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999987653321 1111 1111 12233456889999999999999
Q ss_pred EeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecc
Q 002533 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDV 685 (911)
Q Consensus 606 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl 685 (911)
|+++++++...+..++|+|++ .++|.+++...... ........+...|+.||+.||+||| +++|+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDL 293 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFD-------WKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDI 293 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhcccc-------ccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 999999999999999999998 56788877543211 1122345567789999999999999 789999999
Q ss_pred cCCCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 686 KSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 686 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
||+|||++.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||+||||++|..++...
T Consensus 294 KP~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 294 KLENIFLNCDGKIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CHHHEEECCCCCEEEEeCCCceecCccc--ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999999999999999998643321 11223356899999999999999999999999999999999988544322
Q ss_pred ccchhhhhHhhHHhhhc-ccCC-------cccccCcc-c---cCCC-----ChHHHHHHHHHHHhcccccCCCCCCHHHH
Q 002533 766 AVRKEEVSLVLWARVSR-ARGT-------VDQIVDPR-L---RGKI-----APVCLNKFVEIAGSCTDEEGFRRPTMGDV 828 (911)
Q Consensus 766 ~~~~~~~~l~~~~~~~~-~~~~-------~~~i~d~~-l---~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eV 828 (911)
........+........ .... +.+.++.. + .... .......+.+++.+||+.||.+|||+.|+
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el 451 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence 21111111111111000 0000 00000000 0 0000 00123457788999999999999999999
Q ss_pred HHH
Q 002533 829 TWG 831 (911)
Q Consensus 829 l~~ 831 (911)
+.+
T Consensus 452 L~h 454 (501)
T PHA03210 452 LAL 454 (501)
T ss_pred hhC
Confidence 875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=299.43 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=193.9
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEEe
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.+|...+.||+|+||.||+|.+...+..||||+++... .....++..|+.++.++. |+||++++++|......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 34666789999999999999998877899999987543 334456777888777775 9999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|++ ++|.+++... ...+++..+..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+|||
T Consensus 95 ~~~-~~l~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 95 LMS-TCLDKLLKRI-----------QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred ccC-cCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 984 4776666332 2358999999999999999999994 3689999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcccC----CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ----LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
++........ .....++..|+|||++.+.. ++.++||||||+++|||++|+.||.......+ .+. +.
T Consensus 161 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~---~~ 231 (296)
T cd06618 161 ISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VLT---KI 231 (296)
T ss_pred cchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HHH---HH
Confidence 9875432211 12234778899999987554 78899999999999999999999854321111 010 00
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
.... . +.+ .....+...+.+++.+||+.||.+||++.+++++.
T Consensus 232 ~~~~--~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 232 LQEE--P-----PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred hcCC--C-----CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000 0 000 01112456789999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=296.13 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=193.3
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhc---ccccEeeecceeccCCc-----
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISEL---RHLHIVSLLGFCDEHGE----- 618 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~~~~----- 618 (911)
|...+.||+|+||.||+|+....+..+|+|+++.... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567789999999999999987778999999864322 2234566788877766 59999999999987766
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
.+++|||+. ++|.+++... ....+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~----------~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC----------PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCE
Confidence 899999996 5898888542 1235899999999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
||+|||++........ .....++..|+|||++.+..++.++|+|||||++|||++|+.||...... + .+..+.
T Consensus 147 ~l~dfg~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~--~~~~~~ 219 (287)
T cd07838 147 KIADFGLARIYSFEMA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-D--QLDKIF 219 (287)
T ss_pred EEeccCcceeccCCcc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-H--HHHHHH
Confidence 9999999876432211 12234788899999999999999999999999999999999888643311 1 111111
Q ss_pred hhhcccCCc---------ccccCcccc---CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 779 RVSRARGTV---------DQIVDPRLR---GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 779 ~~~~~~~~~---------~~i~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
......... ......... ....+.....+.+++.+||+.||.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 220 DVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 100000000 000000000 1111233467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=309.08 Aligned_cols=267 Identities=22% Similarity=0.308 Sum_probs=195.8
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccC----------
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEH---------- 616 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~---------- 616 (911)
.+|...+.||.|+||.||+|.....+..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5688888999999999999999888889999998776656667889999999999999999999876543
Q ss_pred ----CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee
Q 002533 617 ----GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL 692 (911)
Q Consensus 617 ----~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 692 (911)
...++||||++ ++|.+++. ...+++.....++.||+.||+||| +.+|+||||||+||++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~-------------~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili 147 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE-------------QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFI 147 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH-------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 35789999996 58888773 224788999999999999999999 7899999999999999
Q ss_pred c-CCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh
Q 002533 693 D-ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE 770 (911)
Q Consensus 693 ~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~ 770 (911)
+ +++.+||+|||+++................++..|+|||.+.. ..++.++|||||||++|||++|+.||........
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 227 (342)
T cd07854 148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227 (342)
T ss_pred cCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 7 4567899999999754322221111223357888999998754 5688899999999999999999999965432111
Q ss_pred hhhHhhHHhhhccc---CC----cccccC-ccccC-----CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 771 EVSLVLWARVSRAR---GT----VDQIVD-PRLRG-----KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 771 ~~~l~~~~~~~~~~---~~----~~~i~d-~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.... ......... .. ...... ..... ...+.....+.+++.+||+.||++||++.+++.+
T Consensus 228 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 228 MQLI-LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHH-HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 1110 000000000 00 000000 00000 0111234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=302.33 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=194.8
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccC--CceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEH--GEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV 622 (911)
.+|...+.||+|+||.||+|.....+..||+|+++.... .....+.+|++++++++|+||+++++++... +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 467888899999999999999988788999999864322 1223567899999999999999999998654 568999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+. ++|.+++... ...+++.+++.++.|++.||+||| ..+++||||||+||++++++.+||+|
T Consensus 87 ~e~~~-~~l~~~l~~~-----------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 87 MEYCE-QDLASLLDNM-----------PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred EecCC-CCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 99996 5888888432 245899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||+++...... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..+...
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~- 227 (309)
T cd07845 152 FGLARTYGLPA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT- 227 (309)
T ss_pred cceeeecCCcc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC-
Confidence 99998643221 11122335778999999875 56799999999999999999999999654321111111110000
Q ss_pred cccCC---cc------c--ccCcccc--CCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 RARGT---VD------Q--IVDPRLR--GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~~~~---~~------~--i~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..... .. . .-..... ..........+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00 0 0000000 00001124567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=307.28 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=192.2
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC------C
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH------G 617 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 617 (911)
..+|...+.||+|+||.||+|.....+..||||++... .......+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36888889999999999999998877789999998643 222345688999999999999999999998654 3
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++|+||+. .+|..++ ...+++..+..++.|++.||+||| ..+++||||||+|||++.++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~--------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~ 155 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM--------------GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCE 155 (342)
T ss_pred eEEEEecccc-cCHHHHH--------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCC
Confidence 4699999985 3666554 124788999999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 156 ~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~ 228 (342)
T cd07879 156 LKILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQIL 228 (342)
T ss_pred EEEeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 999999998753221 123356788999999876 468999999999999999999999996533111 111000
Q ss_pred HHhhhc--------ccCCcccc-------cCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 WARVSR--------ARGTVDQI-------VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ~~~~~~--------~~~~~~~i-------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
...... ........ ....+. ...+.....+.+++.+||+.||++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00000000 000000 0011234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=295.69 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=201.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV 622 (911)
++|...+.||+|+||.||+|....++..||+|++... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3577788999999999999999877789999998653 2344567889999999998 99999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+++++|.+++... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|
T Consensus 81 ~e~~~~~~L~~~l~~~------------~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 81 LEYAPNGELLQYIRKY------------GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred EcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecC
Confidence 9999999999998432 35899999999999999999999 78999999999999999999999999
Q ss_pred cCCccCCCCCCCC-----------------ccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 703 FGLSRMGPSGMSQ-----------------SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 703 FGla~~~~~~~~~-----------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
||++......... ........++..|+|||.+....++.++||||||++++|+++|+.||...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9998754332211 01122345788999999999888999999999999999999999998643
Q ss_pred ccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCH----HHHHH
Q 002533 766 AVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM----GDVTW 830 (911)
Q Consensus 766 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~eVl~ 830 (911)
.. ...+ .... ......+...+..+.+++.+||+.+|.+||++ .+++.
T Consensus 226 ~~---~~~~---~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 226 NE---YLTF---QKIL------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred cH---HHHH---HHHH------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 31 0000 0000 01112233346678899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=295.32 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=188.0
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHH---HHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIE---MISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~---~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
+||+|+||.||++.....++.||+|.+..... .....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999988778999998865422 11223444443 3444579999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|+|.+++.. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 81 g~~L~~~l~~------------~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 81 GGDLHYHLSQ------------HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred CCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 9999988842 235899999999999999999999 7899999999999999999999999999987
Q ss_pred CCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
...... .....|+..|+|||++.++ .++.++|||||||++|||++|+.||.......... . ....
T Consensus 146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~---~~~~----- 211 (278)
T cd05606 146 DFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I---DRMT----- 211 (278)
T ss_pred ccCccC-----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-H---HHHh-----
Confidence 543221 1234588999999999754 68999999999999999999999996543211100 0 0000
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
.......+..+...+.+++.+|+..+|.+|| ++.+++++
T Consensus 212 ------~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 212 ------LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ------hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0011122333456788999999999999999 89998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=298.78 Aligned_cols=245 Identities=27% Similarity=0.418 Sum_probs=193.1
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
|...+.||+|+||+||+|+...++..|++|++... .....+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44456799999999999999877889999998643 223445788999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+. |+|.+++.. ...++++.+++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 103 ~~-~~l~~~l~~-----------~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 103 CL-GSASDLLEV-----------HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred CC-CCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCC
Confidence 95 678777743 2235899999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhc---ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
+..... .....|+..|+|||++. ...++.++|||||||++|||++|+.|+....... .... ..
T Consensus 168 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~~~---~~ 233 (313)
T cd06633 168 ASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH---IA 233 (313)
T ss_pred CcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHH---HH
Confidence 864211 12345788999999984 4568899999999999999999999986533111 1110 00
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. .. +.. ........+.+++.+||+.+|.+||++.+++..
T Consensus 234 ~~-~~-----~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 234 QN-DS-----PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred hc-CC-----CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 001 112234567899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=301.78 Aligned_cols=268 Identities=22% Similarity=0.286 Sum_probs=199.2
Q ss_pred HHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceecc-CC
Q 002533 541 EIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDE-HG 617 (911)
Q Consensus 541 el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~-~~ 617 (911)
++...+++|...+.||+|+||.||++.....+..||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3455778899999999999999999999888889999987542 22344678899999999999999999998865 56
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++|+||+ +++|.+++. ...+++.....++.|+++||+||| ..+|+||||+|+|||+++++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~-------------~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~ 146 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT-------------SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCD 146 (328)
T ss_pred cEEEEeehh-ccCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCC
Confidence 789999998 568888773 224677888899999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
++|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 147 ~~l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~ 220 (328)
T cd07856 147 LKICDFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220 (328)
T ss_pred EEeCccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999998753221 122346788999998766 5789999999999999999999999865432111111111
Q ss_pred H--------HhhhcccCCcccccCccccCCCC-----hHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 W--------ARVSRARGTVDQIVDPRLRGKIA-----PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ~--------~~~~~~~~~~~~i~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+ ............+..-......+ +.+...+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000000000000011111 1245678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=300.12 Aligned_cols=246 Identities=30% Similarity=0.403 Sum_probs=194.2
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
|...+.||+|+||.||+|+...++..+|+|.+... .....+++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 55566799999999999999877789999987532 334456788999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+. |+|.+.+... ...+++.++..++.|++.||.||| ..+++||||||+|||++.++.++|+|||+
T Consensus 97 ~~-~~l~~~~~~~-----------~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 97 CL-GSASDLLEVH-----------KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred cC-CCHHHHHHHc-----------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCccc
Confidence 96 6888777422 234788999999999999999999 78999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccCcccccChhhhc---ccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
+...... ....++..|+|||.+. ...++.++|||||||++|||++|+.|+........ +..+..
T Consensus 162 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~--- 228 (308)
T cd06634 162 ASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQ--- 228 (308)
T ss_pred ceeecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH---HHHHhh---
Confidence 8753221 2335788999999975 35678899999999999999999999854321110 000000
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
... +. .....+...+.+++.+||+.+|++||++.+|+...
T Consensus 229 --~~~-----~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 229 --NES-----PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --cCC-----CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 000 01 11223456688999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=291.90 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=196.0
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC-----ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-----SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-----~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
|...+.||+|+||.||++........+++|.++.. ......++..|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 56677999999999999998766555666665432 2233446778999999999999999999999989999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++++|.+++..... ....+++.+++.++.|++.||.||| +.+++|+||||+||++++ +.++|+||
T Consensus 82 e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 82 EYCEGRDLDCKLEELKH--------TGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred EeCCCCCHHHHHHHHhh--------cccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeeccc
Confidence 99999999999864321 3346899999999999999999999 789999999999999986 46999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .... ...
T Consensus 150 g~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~---~~~-- 217 (260)
T cd08222 150 GVSRLLMGSC---DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----LSVV---LRI-- 217 (260)
T ss_pred CceeecCCCc---ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHH---HHH--
Confidence 9987643221 122234578899999999888899999999999999999999999853221 1110 000
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. ......+..+...+.+++.+||+.+|++||++.++++.
T Consensus 218 -------~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 218 -------VE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------Hc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00 01111234456778899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-34 Score=334.96 Aligned_cols=256 Identities=24% Similarity=0.319 Sum_probs=200.6
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccC--CChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNT--SSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~--~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
.+-+++....||.|.||.||-|...++++..|+|-++- ..........+|+.+|..|+|||+|+.+|+-..++..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34456667789999999999999999888999997643 3344556788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
||||++|+|.+.+...+ .+++.....+..|++.|++||| +++||||||||.||||+.+|.+|++|
T Consensus 1313 MEyC~~GsLa~ll~~gr------------i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR------------IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred HHHhccCcHHHHHHhcc------------hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeec
Confidence 99999999999995443 2455555668899999999999 89999999999999999999999999
Q ss_pred cCCccCCCCCC-CCccccccccCcccccChhhhccc---CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 703 FGLSRMGPSGM-SQSHVSTVVKGSFGYVDPEYIRRQ---QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 703 FGla~~~~~~~-~~~~~~~~~~gt~~y~APE~~~~~---~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
||.|+...... .....-....||+.|||||++.+. ....+.||||+|||++||+||+.||...+. .|+
T Consensus 1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~a 1449 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWA 1449 (1509)
T ss_pred ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhH
Confidence 99998754432 111222356799999999999764 356689999999999999999999954331 122
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
-... +-..-.+.+|......=.+++.+|++.||++|.++.|+++.
T Consensus 1450 IMy~--------V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1450 IMYH--------VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHhH--------HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1110 00111233444455666799999999999999888877654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=302.64 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=192.9
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhh--------------HHHHHHHHHHHHhcccccEeeecceeccCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG--------------AREFRTEIEMISELRHLHIVSLLGFCDEHG 617 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~--------------~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 617 (911)
.+.||.|+||+||+|.+...++.||||++....... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999998777899999886442211 124778999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 697 (911)
..++||||+. |+|.+++.. ...+++.....++.|++.||+||| +.+++|+||+|+||+++.++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~------------~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDR------------KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred cEEEEEeccc-cCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCC
Confidence 9999999996 689888842 234788999999999999999999 789999999999999999999
Q ss_pred eEEeecCCccCCCCCC-----------CCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 698 AKISDFGLSRMGPSGM-----------SQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~-----------~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
++|+|||+++...... ..........++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987543110 001111223467889999998764 4689999999999999999999998654
Q ss_pred ccchhhhhHhhHHhhhcccCCccc------------ccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 766 AVRKEEVSLVLWARVSRARGTVDQ------------IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 766 ~~~~~~~~l~~~~~~~~~~~~~~~------------i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
........+........ .....+ ...+... .....+...+.+++.+||+.+|++||++.|++.+
T Consensus 238 ~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPN-EDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CHHHHHHHHHHHhCCCc-hhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 32111111111000000 000000 0000110 1112335678899999999999999999999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=300.21 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=197.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEcc--CCChhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN--TSSMQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~--~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~ 623 (911)
..|...+.||+||.+.||++...+.+ .+|+|++. ..+.+...-|.+|+..|.+|+ |.+|++|++|-..++.+||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 44666778999999999999887664 57777653 345667788999999999995 899999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||= ..+|..+|... ......| .+..+..|++.++.++| .++|||.||||.|.|+-. |.+||+||
T Consensus 440 E~G-d~DL~kiL~k~----------~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDF 503 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKK----------KSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDF 503 (677)
T ss_pred ecc-cccHHHHHHhc----------cCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeee
Confidence 975 66999999644 2223445 66678899999999999 799999999999999974 58999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhccc-----------CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhh
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-----------QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEV 772 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~ 772 (911)
|+|...... ..........||+.||+||.+... +.+.++||||+||+||+|+.|+.||....
T Consensus 504 GIA~aI~~D-TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------ 576 (677)
T KOG0596|consen 504 GIANAIQPD-TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------ 576 (677)
T ss_pred chhcccCcc-ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------
Confidence 999876543 334455667899999999998643 36679999999999999999999984321
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHH-HHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLN-KFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~-~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
-.|++ +..+.||.-.-+++..-.. .+.++|..||+.||.+||+..+|+++
T Consensus 577 --n~~aK-------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 --NQIAK-------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHHH-------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12222 3445555443333322111 28999999999999999999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=294.62 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=197.5
Q ss_pred CCccceeecccCcEEEEEEEee---cCCeEEEEEEccCCC----hhhHHHHHHHHHHHHhc-ccccEeeecceeccCCce
Q 002533 548 DFADHCIIGSGGFGHVFKGYID---DGSITVAVKRLNTSS----MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~---~~~~~vAvK~l~~~~----~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 619 (911)
+|...+.||+|+||.||+++.. ..+..||||.++... ....+.+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3566789999999999999864 234689999986432 22345688999999999 599999999999988999
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++||||+++|+|.+++.. ...+++..+..++.|+++||.||| ..+++||||||+||+++.++.++
T Consensus 81 ~lv~e~~~~~~L~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~ 145 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ------------REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVV 145 (288)
T ss_pred EEEEecCCCCcHHHHHhh------------cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEE
Confidence 999999999999999842 234788899999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhcccC--CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ--LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
|+|||+++....... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||......... ...
T Consensus 146 l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~ 220 (288)
T cd05583 146 LTDFGLSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEI 220 (288)
T ss_pred EEECccccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHH
Confidence 999999876433211 1122345788999999987665 788999999999999999999998532211111 111
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
.+.... .....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 221 ~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 SRRILK-----------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHc-----------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111100 0111223345567899999999999999999988776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=300.79 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=197.5
Q ss_pred HHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCC----
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG---- 617 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~---- 617 (911)
....+|...+.||+|+||.||+|.....+..||||++... .......+.+|+++|++++|+||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3456788889999999999999998877889999998543 2333456889999999999999999999886543
Q ss_pred --ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 618 --EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 618 --~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
..++||||+ +++|.+++. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~ 154 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK-------------HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNED 154 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCC
Confidence 458999998 779988773 234889999999999999999999 7899999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhH
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l 774 (911)
+.+||+|||+++..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+
T Consensus 155 ~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 155 CELKILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228 (343)
T ss_pred CCEEEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999998754321 123357888999999876 46889999999999999999999999654321111111
Q ss_pred hh--------HHhhhcccC------CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 775 VL--------WARVSRARG------TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 775 ~~--------~~~~~~~~~------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. |........ .+.......+ ....+.+...+.+++.+|++.||++|||+.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 229 MKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000 0000000000 01112345568899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=297.63 Aligned_cols=269 Identities=22% Similarity=0.292 Sum_probs=193.8
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh--hhHHHHHHHHHHHHhcccccEeeecceeccC-------
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEH------- 616 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------- 616 (911)
..+|...++||+|+||.||+|.....+..+|||++..... .....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 3578888999999999999999988778999998864322 1234577899999999999999999987433
Q ss_pred -CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 617 -GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 617 -~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
..+++|+||+.+ +|...+.. ....+++..+..++.|+++||+||| ..+|+|+||||+|||++++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~-----------~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~ 151 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN-----------PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQ 151 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc-----------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 346999999964 67776642 2235899999999999999999999 7899999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCc--------cccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCc
Q 002533 696 WAAKISDFGLSRMGPSGMSQS--------HVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGA 766 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~--------~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~ 766 (911)
+.+||+|||+++......... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999997543221111 111234567889999988654 58999999999999999999999986543
Q ss_pred cchhhhhHhhHHhhhcc-----cCCcccc--------cCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 767 VRKEEVSLVLWARVSRA-----RGTVDQI--------VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 767 ~~~~~~~l~~~~~~~~~-----~~~~~~i--------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
.......+......... ...+... ..+.+... .......+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 22111111100000000 0000000 00111100 0112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=292.97 Aligned_cols=264 Identities=23% Similarity=0.356 Sum_probs=198.1
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
|...+.||+|+||.||+|+....++.+|+|++.... ....+.+..|++++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 344568999999999999998877899999987653 333467889999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
+ ++|.+++.... ..+++..+++++.|++.||+||| +.+|+||||+|+||++++++.++|+|||++
T Consensus 81 ~-~~l~~~i~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 81 D-MDLKKYLDKRP-----------GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred C-cCHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcc
Confidence 7 59999985431 35899999999999999999999 689999999999999999999999999998
Q ss_pred cCCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh---------
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL--------- 776 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~--------- 776 (911)
+....... ......++..|+|||.+... .++.++|||||||++|||++|+.||...........+..
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
T cd07829 146 RAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222 (282)
T ss_pred cccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence 76433221 11223456789999998776 889999999999999999999999865432111111110
Q ss_pred HHhhhcc---cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 WARVSRA---RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ~~~~~~~---~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|...... ................ +.....+.+++.+||+.+|++||++.+|+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 223 WPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 1000000 0000000000010111 1225678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-33 Score=294.38 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=201.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
+.|..-++||+||||.||-++...++..+|.|++.+... ++....++|-.+|.+++.+.||.+--.++..+.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 568888999999999999999999999999999865432 34455789999999999999999988899999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
..|.||+|.-+|++. ..+.+++...+-++.+|+.||++|| ..+||.|||||+|||||+.|+++|+|.
T Consensus 265 tlMNGGDLkfHiyn~----------g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNH----------GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred EeecCCceeEEeecc----------CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeecc
Confidence 999999999999765 3456899999999999999999999 799999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|||...+.+.. .....||.+|||||++.++.|+...|.||+||+||||+.|+.||..-. +. +.|..
T Consensus 332 GLAvei~~g~~----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---eK---vk~eE---- 397 (591)
T KOG0986|consen 332 GLAVEIPEGKP----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---EK---VKREE---- 397 (591)
T ss_pred ceEEecCCCCc----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---hh---hhHHH----
Confidence 99997665432 223479999999999999999999999999999999999999995422 11 11110
Q ss_pred cCCcccccCccc---cCCCChHHHHHHHHHHHhcccccCCCCCCHH
Q 002533 784 RGTVDQIVDPRL---RGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG 826 (911)
Q Consensus 784 ~~~~~~i~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 826 (911)
+|.+. ..+++....+....|.+..|..||.+|--..
T Consensus 398 -------vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 398 -------VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -------HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11111 1123344456667888889999999987543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=301.64 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=204.2
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
....|.....||+|.|++|.+|++..++..||||.+++.. ....+.+.+|+++|+.|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3456777889999999999999999888999999998663 33445588999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+.+|.|.++|.... .+.......+..|+.++++||| .+.|||||||++||||+.+..+||+|
T Consensus 134 ~eya~~ge~~~yl~~~g------------r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG------------RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred EEeccCchhHHHHHhcc------------cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeec
Confidence 99999999999996543 2455677788999999999999 79999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCC-CchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||++..+.. .......+|++.|.|||++.+..+ ++++|+||+|++||-|++|..||++...
T Consensus 199 fgfS~~~~~----~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------- 260 (596)
T KOG0586|consen 199 FGFSTFFDY----GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------- 260 (596)
T ss_pred cccceeecc----cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------
Confidence 999987543 334456689999999999998776 5799999999999999999999975432
Q ss_pred cccCCcccccCccccCC--CChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGK--IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.++-++.+++. ++--....+.+++++.+..+|.+|++++++.+.
T Consensus 261 ------k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 261 ------KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ------ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11122222221 122234456789999999999999999988543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=292.22 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=193.7
Q ss_pred CCccceeecccCcEEEEEEEee---cCCeEEEEEEccCCCh----hhHHHHHHHHHHHHhc-ccccEeeecceeccCCce
Q 002533 548 DFADHCIIGSGGFGHVFKGYID---DGSITVAVKRLNTSSM----QGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~---~~~~~vAvK~l~~~~~----~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 619 (911)
+|...+.||+|+||.||++... ..+..||+|++..... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 3566789999999999999874 2456899999865322 2345688999999999 589999999999988899
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceE
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 699 (911)
++||||+++++|.+++.. ...+++..+..++.|+++||.||| +.+++||||+|+|||++.++.+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~------------~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~k 145 (290)
T cd05613 81 HLILDYINGGELFTHLSQ------------RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVV 145 (290)
T ss_pred EEEEecCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEE
Confidence 999999999999999843 234788889999999999999999 78999999999999999999999
Q ss_pred EeecCCccCCCCCCCCccccccccCcccccChhhhccc--CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ--QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 700 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
|+|||+++....... .......|+..|+|||.+... .++.++||||||+++|||++|+.||....... ....+
T Consensus 146 l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~ 220 (290)
T cd05613 146 LTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEI 220 (290)
T ss_pred EeeCccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHH
Confidence 999999876432211 111234588899999998753 46889999999999999999999985322111 11111
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
....... ....+..+...+.+++.+||+.+|++|| +..+++..
T Consensus 221 ~~~~~~~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 221 SRRILKS-----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHhhcc-----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1111000 0112334556788999999999999997 56666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=303.87 Aligned_cols=263 Identities=20% Similarity=0.297 Sum_probs=197.6
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCc----
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGE---- 618 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~---- 618 (911)
..++|...+.||+|+||.||+|+...++..||||++... .....+.+.+|+.++++++|+||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 456788889999999999999999888889999998643 23344667889999999999999999998766554
Q ss_pred --eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC
Q 002533 619 --MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 619 --~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 696 (911)
.++|+||+ +++|.+++. ...+++..+..++.|+++||+||| +.+|+||||||+||++++++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-------------~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~ 155 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-------------CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDC 155 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCC
Confidence 89999998 679988883 235899999999999999999999 78999999999999999999
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHh
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 156 ~~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~ 229 (343)
T cd07851 156 ELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM 229 (343)
T ss_pred CEEEcccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999998764321 123357888999999865 367899999999999999999999996543211111110
Q ss_pred hH--------HhhhcccCCcccccC---ccccC---CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 776 LW--------ARVSRARGTVDQIVD---PRLRG---KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 ~~--------~~~~~~~~~~~~i~d---~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.. ....... .....+. ...+. .........+.+++.+||+.+|++|||+.+|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 230 NLVGTPDEELLQKISSE-SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhcCCCCHHHHhhccch-hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 0000000 0000000 00000 0011235678899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=297.68 Aligned_cols=267 Identities=21% Similarity=0.266 Sum_probs=192.4
Q ss_pred CCccceeecccCcEEEEEEEeecC--CeEEEEEEccCC--ChhhHHHHHHHHHHHHhc-ccccEeeecceecc----CCc
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDG--SITVAVKRLNTS--SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDE----HGE 618 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~----~~~ 618 (911)
+|...+.||+|+||.||++..... +..+|||++... .....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 366778999999999999999876 778999988643 223355688999999999 59999999987532 245
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCce
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 698 (911)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+||| ..+++||||||+|||++.++.+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~ 144 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS------------GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCEL 144 (332)
T ss_pred EEEEEeccc-CCHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCE
Confidence 788889885 689888842 345889999999999999999999 7899999999999999999999
Q ss_pred EEeecCCccCCCCCCCC-ccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 699 KISDFGLSRMGPSGMSQ-SHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 699 kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
||+|||+++........ ........|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||........-.....
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~ 224 (332)
T cd07857 145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224 (332)
T ss_pred EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence 99999999754322111 111223468899999998765 4689999999999999999999999865331110000000
Q ss_pred --------HHhhhcccC------CcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 --------WARVSRARG------TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 --------~~~~~~~~~------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+........ .....-...+ ....+.+...+.+++.+|++.||++|||+.+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhCCCCHHHHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0000000000 01111234678899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.97 Aligned_cols=237 Identities=26% Similarity=0.368 Sum_probs=193.0
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
||+|+||.||++.....+..+++|++..... .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999987778999999865432 2456789999999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSKE------------GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 9998432 25899999999999999999999 79999999999999999999999999999876432
Q ss_pred CCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
.. .......++..|++||.+.+...+.++|+||||+++|||++|+.||..... ..+.. . +.
T Consensus 146 ~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~--~----------~~ 206 (250)
T cd05123 146 EG---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYE--K----------IL 206 (250)
T ss_pred CC---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHH--H----------Hh
Confidence 21 122344578899999999988899999999999999999999999854321 11110 0 00
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGD 827 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 827 (911)
. .....+...+..+.+++.+||..||++||++.+
T Consensus 207 ~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 207 K--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred c--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0 011223333567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=278.06 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=199.8
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
++|...++||+|.||+|-+++-+.++..+|+|++++. .......-+.|-++|+..+||.+..|.-.+...+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 4677788999999999999999999899999999865 3344555678999999999999999988899999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||..||.|.-+|... ..+++....-+-..|+.||.||| +.+||.||||.+|.|||.+|++||+||
T Consensus 248 eyanGGeLf~HLsre------------r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE------------RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred EEccCceEeeehhhh------------hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeec
Confidence 999999999998533 34666666667889999999999 799999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
||++.. ..........+||+.|+|||++....|....|.|.+||++|||+||+.||...+... -..++
T Consensus 313 GLCKE~---I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-LFeLI-------- 380 (516)
T KOG0690|consen 313 GLCKEE---IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-LFELI-------- 380 (516)
T ss_pred ccchhc---ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-HHHHH--------
Confidence 999863 333445567889999999999999999999999999999999999999997644221 01111
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC-----CHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 831 (911)
+-..++ +|.........|....|..||.+|- .+.||.+.
T Consensus 381 -------l~ed~k--FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 381 -------LMEDLK--FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -------Hhhhcc--CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 111111 2223334455777888999999995 35555443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=317.50 Aligned_cols=255 Identities=25% Similarity=0.335 Sum_probs=185.0
Q ss_pred HHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhcccccEeeecceeccC------
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH------ 616 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------ 616 (911)
+-.++|.+..+||+||||.|||++.+-++..+|||++.-. +........+|+.+|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3446777888999999999999999888889999998755 344556788999999999999999987321100
Q ss_pred --------------------------------------------------------------------------------
Q 002533 617 -------------------------------------------------------------------------------- 616 (911)
Q Consensus 617 -------------------------------------------------------------------------------- 616 (911)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHH
Q 002533 617 ---------------------------------GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663 (911)
Q Consensus 617 ---------------------------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~ 663 (911)
..+||-||||+.-.|++++...... -.-...++++.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----------~~~d~~wrLFr 704 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----------SQRDEAWRLFR 704 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----------hhhHHHHHHHH
Confidence 1257888888887777777433110 03456789999
Q ss_pred hHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCC------------C---CCCCccccccccCcccc
Q 002533 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP------------S---GMSQSHVSTVVKGSFGY 728 (911)
Q Consensus 664 ~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~------------~---~~~~~~~~~~~~gt~~y 728 (911)
+|++||+|+| +.+||||||||.||+|+++..+||+|||+|+... . ........+...||.-|
T Consensus 705 eIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 705 EILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred HHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence 9999999999 7899999999999999999999999999998611 0 00111123456799999
Q ss_pred cChhhhccc---CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCC--CChHH
Q 002533 729 VDPEYIRRQ---QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGK--IAPVC 803 (911)
Q Consensus 729 ~APE~~~~~---~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~ 803 (911)
+|||++.+. +|+.|+|+||+||||+||+. ||.... |-.... ..+.+..+..+ +....
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---ERa~iL------------~~LR~g~iP~~~~f~~~~ 843 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---ERASIL------------TNLRKGSIPEPADFFDPE 843 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH---HHHHHH------------HhcccCCCCCCccccccc
Confidence 999999865 49999999999999999984 453222 111111 11111111111 11112
Q ss_pred HHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 804 LNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 804 ~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
...=..+++++++.||.+|||+.|++.
T Consensus 844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 844 HPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 223358999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-33 Score=276.96 Aligned_cols=254 Identities=28% Similarity=0.333 Sum_probs=193.5
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCCh-hhHHHHHHHHHHHHh-cccccEeeecceeccCCceEEEEeecCCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREFRTEIEMISE-LRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~-l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
...||.|+||+|+|-.++..++..|||+++.... ...++++.|.+...+ -+.||||+++|.+-.++..|+.||.| .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 3469999999999999999999999999986644 566778889887544 57999999999999999999999999 45
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
||..+-..--. .+...+++.-+-+|+....+||.||.+ +..|||||+||+||||+..|.+||||||++-.+
T Consensus 148 SlDklYk~vy~-------vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 148 SLDKLYKRVYS-------VQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred hHHHHHHHHHH-------HHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 66554321110 133458888888999999999999986 788999999999999999999999999998653
Q ss_pred CCCCCCccccccccCcccccChhhhcc--cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 710 PSGMSQSHVSTVVKGSFGYVDPEYIRR--QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 710 ~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
.. +...+...|-..|||||.+.. ..|+.+|||||||++|+|+.||+.|+......-++...+. .+..
T Consensus 219 v~----SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-------~gdp 287 (361)
T KOG1006|consen 219 VD----SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-------IGDP 287 (361)
T ss_pred HH----HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-------cCCC
Confidence 22 223345568889999999864 3589999999999999999999999854332111111110 0111
Q ss_pred ccccCccccC-CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 788 DQIVDPRLRG-KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 788 ~~i~d~~l~~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|.+.. ....+....+..++..|+-.|-.+||...++.++
T Consensus 288 -----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 -----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111 1112345678899999999999999999998765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=278.22 Aligned_cols=223 Identities=20% Similarity=0.165 Sum_probs=178.7
Q ss_pred cCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchhhHhhh
Q 002533 558 GGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYN 637 (911)
Q Consensus 558 G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 637 (911)
|.||.||++.+..++..+|+|++.... .+.+|...+....||||+++++++......++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999998888899999986543 234455556666799999999999999999999999999999999843
Q ss_pred hhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCcc
Q 002533 638 SQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717 (911)
Q Consensus 638 ~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 717 (911)
. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++|||++......
T Consensus 79 ~------------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 79 F------------LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred h------------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 2 24889999999999999999999 789999999999999999999999999987653221
Q ss_pred ccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccC
Q 002533 718 VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRG 797 (911)
Q Consensus 718 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 797 (911)
.....++..|+|||.+....++.++||||+|+++|||++|+.|+....... . .....
T Consensus 139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~----~~~~~ 195 (237)
T cd05576 139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------N----THTTL 195 (237)
T ss_pred -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------c----ccccc
Confidence 122345677999999988889999999999999999999998764321000 0 00001
Q ss_pred CCChHHHHHHHHHHHhcccccCCCCCCHHHH
Q 002533 798 KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828 (911)
Q Consensus 798 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eV 828 (911)
..+......+.+++.+|++.||++||++.+.
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 1223345678899999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=271.45 Aligned_cols=207 Identities=23% Similarity=0.368 Sum_probs=171.3
Q ss_pred CCccceeecccCcEEEEEEEeecCC----eEEEEEEccCCChh--hHHHHHHHHHHHHhcccccEeeecceecc-CCceE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGS----ITVAVKRLNTSSMQ--GAREFRTEIEMISELRHLHIVSLLGFCDE-HGEMI 620 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~----~~vAvK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~ 620 (911)
.|.....||+|.||.||||.-.+++ ..+|||+++..... -.....+|+.++++|+||||+.|..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3666778999999999999765442 37899999765221 12346789999999999999999999866 88899
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC----C
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN----W 696 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~ 696 (911)
|++||.++ +|...++-.+.. ....++-.....|+.||+.|+.||| +.-|+||||||.|||+..+ |
T Consensus 105 l~fdYAEh-DL~~II~fHr~~-------~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRAS-------KAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred EEehhhhh-hHHHHHHHhccc-------hhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccC
Confidence 99999977 888888655432 2346888889999999999999999 7889999999999999877 8
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
++||+|+|++|..............+.-|+-|.|||.+.+ ..||.+.|||+.||+..||+|-++.|.+.
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999999987665554445566778999999999887 57999999999999999999988877543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=314.02 Aligned_cols=146 Identities=27% Similarity=0.390 Sum_probs=130.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
.+|...+.||+|+||.||+|.+...+..||||+++... ......+..|+++++.++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46778889999999999999998777899999986532 333467889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
||+++++|.+++... ..+++..++.|+.||+.||+||| ..+|+||||||+||||+.++.+||+||
T Consensus 84 Ey~~g~~L~~li~~~------------~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 84 EYLIGGDVKSLLHIY------------GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred eCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeC
Confidence 999999999998532 24788889999999999999999 689999999999999999999999999
Q ss_pred CCcc
Q 002533 704 GLSR 707 (911)
Q Consensus 704 Gla~ 707 (911)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=270.35 Aligned_cols=238 Identities=27% Similarity=0.376 Sum_probs=192.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEccCCChhh-HHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchhhHhhh
Q 002533 559 GFGHVFKGYIDDGSITVAVKRLNTSSMQG-AREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYN 637 (911)
Q Consensus 559 ~fG~Vykg~~~~~~~~vAvK~l~~~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 637 (911)
+||.||+|+..+.+..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998877899999997665544 67899999999999999999999999998999999999999999999843
Q ss_pred hhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCcc
Q 002533 638 SQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717 (911)
Q Consensus 638 ~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 717 (911)
. ..+++..++.++.+++++|.||| ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~------------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---- 141 (244)
T smart00220 81 R------------GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---- 141 (244)
T ss_pred c------------cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----
Confidence 2 12788999999999999999999 6899999999999999999999999999998654321
Q ss_pred ccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccC
Q 002533 718 VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRG 797 (911)
Q Consensus 718 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 797 (911)
......++..|++||.+....++.++|||+||+++|||++|..||...... ..+..+.. . .....
T Consensus 142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~~~---~---------~~~~~ 206 (244)
T smart00220 142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKKIG---K---------PKPPF 206 (244)
T ss_pred ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHh---c---------cCCCC
Confidence 223445788999999999888999999999999999999999998542111 11111100 0 00000
Q ss_pred C-CChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 798 K-IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 798 ~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
. ....++..+.+++.+|+..+|++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 00014567889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=294.50 Aligned_cols=258 Identities=25% Similarity=0.352 Sum_probs=209.4
Q ss_pred HHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceec-----c
Q 002533 542 IKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCD-----E 615 (911)
Q Consensus 542 l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~-----~ 615 (911)
+..-+.-|.+..+||.|.+|.||+++....++.+|||++.... ...++.+.|.++|+.+ .|||++.++|++. .
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3334556777889999999999999998888889999887543 3446778899999888 6999999999983 4
Q ss_pred CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 616 HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 616 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
++++|||||||.+|+..|++.+.. ...+.|..+..|+..+++||.+|| ...++|||||-.||||+.+
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~----------g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK----------GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTEN 159 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc----------ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEecc
Confidence 678999999999999999997653 345899999999999999999999 7899999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc-----CCCchhHHHHHHHHHHHHHhCCCCCCCCccchh
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-----QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE 770 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~ 770 (911)
+.+||+|||.+...... ........||+.|||||++... .|+.++|+||||++..||.-|.+|+.+...-+
T Consensus 160 ~~VKLvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr- 235 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR- 235 (953)
T ss_pred CcEEEeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-
Confidence 99999999998764332 2222345699999999998653 57789999999999999999999987654221
Q ss_pred hhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 771 EVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+. .-.-+|.....-+....+.+.++|..||..|.++||++.+++++
T Consensus 236 ---------aLF-----~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ---------ALF-----LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------hhc-----cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111 11123333344566778899999999999999999999998754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.64 Aligned_cols=267 Identities=21% Similarity=0.304 Sum_probs=200.5
Q ss_pred HHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc-cccEeeecceeccCC
Q 002533 539 LTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGFCDEHG 617 (911)
Q Consensus 539 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~ 617 (911)
++|+-+.|.+ +||+|+|+.|--+....++..+|||++.+.......+..+|++++.+.+ |+||++|+.+++++.
T Consensus 75 F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 5566666643 8999999999999988888899999998876677778899999999984 999999999999999
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC-
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW- 696 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~- 696 (911)
..|||||-|.||+|..++++. +.+++.+.-++..+||.||.||| .++|.||||||+|||-....
T Consensus 150 ~FYLVfEKm~GGplLshI~~~------------~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR------------KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNK 214 (463)
T ss_pred eEEEEEecccCchHHHHHHHh------------hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCC
Confidence 999999999999999999643 45889999999999999999999 89999999999999997654
Q ss_pred --ceEEeecCCccCCCCCCCCcc----ccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 697 --AAKISDFGLSRMGPSGMSQSH----VSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 697 --~~kl~DFGla~~~~~~~~~~~----~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
-+|||||.|..-......-.. ......|+..|||||+.. ...|+.++|.|||||+||-|++|.+||.+.
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 479999998753211111111 112346888999999864 346899999999999999999999999643
Q ss_pred ccchhhhhHhhHHhhhcccC---CcccccCccccCCCCh----HHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 766 AVRKEEVSLVLWARVSRARG---TVDQIVDPRLRGKIAP----VCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 766 ~~~~~~~~l~~~~~~~~~~~---~~~~i~d~~l~~~~~~----~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
-. .-..|.+....+. .+.+-+... .-++|. .....-.+++...+..|+.+|-++.+++..
T Consensus 295 Cg-----~dCGWdrGe~Cr~CQ~~LFesIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 295 CG-----ADCGWDRGEVCRVCQNKLFESIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cC-----CcCCccCCCccHHHHHHHHHHHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 21 1112322111110 000000000 011222 224456678888899999999999888763
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=265.95 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=194.3
Q ss_pred ccCCcc-ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceec----cCCce
Q 002533 546 TCDFAD-HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCD----EHGEM 619 (911)
Q Consensus 546 t~~f~~-~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~----~~~~~ 619 (911)
|.+|.+ .++||-|-.|+|-.+..+.+++.+|+|+|... ...++|+++--.. .|||||.+++++. ....+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 445544 35899999999999999999999999998643 3345677764333 6999999999874 34678
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC---CC
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE---NW 696 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~ 696 (911)
++|||+|+||.|...+... ....+++.+.-+|+.||+.|+.||| ..+|.||||||+|+|... |-
T Consensus 135 LiVmE~meGGeLfsriq~~----------g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR----------GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred EeeeecccchHHHHHHHHc----------ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCc
Confidence 9999999999999998644 4456999999999999999999999 799999999999999964 56
Q ss_pred ceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
.+||+|||+|+.-.. ......-+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....... +.
T Consensus 202 ~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----is- 272 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----IS- 272 (400)
T ss_pred ceEecccccccccCC----CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CC-
Confidence 899999999986321 222234467899999999999999999999999999999999999997543211 00
Q ss_pred HHhhhcccCCcccccCcc--ccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPR--LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~--l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+.-..+.... +..+.-....+...++|+..|..+|.+|-|+.++...
T Consensus 273 -------pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 -------PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -------hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 00001111110 1111123446677899999999999999999998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=291.01 Aligned_cols=241 Identities=21% Similarity=0.254 Sum_probs=193.6
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEe
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+..|.....+|.|+|+.|-++.+..+++..+||++.... .+-.+|+.++.+. +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 455666667999999999999999888899999997652 2344577666655 79999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee-cCCCceEEeec
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL-DENWAAKISDF 703 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DF 703 (911)
.+.+|-|.+.+.... ....++..|+.+|+.++.||| .+++|||||||+|||+ ++.++++|+||
T Consensus 397 ~l~g~ell~ri~~~~-------------~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-------------EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred hccccHHHHHHHhcc-------------hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEe
Confidence 999998888774321 222677789999999999999 7999999999999999 68899999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|.++..... ....+-|..|.|||++....+++++|+||||++||||++|+.||.......
T Consensus 461 G~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-------------- 520 (612)
T KOG0603|consen 461 GFWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-------------- 520 (612)
T ss_pred chhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--------------
Confidence 999875443 223346788999999999999999999999999999999999997655321
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
++......+.+.........+|+.+||+.||.+||+|.++..+
T Consensus 521 -----ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 521 -----EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 0111111222224445667799999999999999999998754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=290.03 Aligned_cols=272 Identities=21% Similarity=0.238 Sum_probs=185.5
Q ss_pred HccCCccceeecccCcEEEEEEEee----------------cCCeEEEEEEccCCChhhHHH--------------HHHH
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYID----------------DGSITVAVKRLNTSSMQGARE--------------FRTE 594 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~----------------~~~~~vAvK~l~~~~~~~~~~--------------f~~E 594 (911)
..++|...++||+|+||.||+|.+. ..+..||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 223579999987544333333 3447
Q ss_pred HHHHHhcccccE-----eeecceecc--------CCceEEEEeecCCCchhhHhhhhhhccc------------ccccCC
Q 002533 595 IEMISELRHLHI-----VSLLGFCDE--------HGEMILVYEFMPRGNLRDHLYNSQKQNQ------------NQNQNQ 649 (911)
Q Consensus 595 i~~l~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~L~~~~~~~~------------~~~~~~ 649 (911)
+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++|+....... ......
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 677888753 3578999999999999999975321100 000112
Q ss_pred CCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCccccccccCccccc
Q 002533 650 NSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729 (911)
Q Consensus 650 ~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~ 729 (911)
...++|..+..++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++........ ......+++.|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~ 377 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--NPLYGMLDPRYS 377 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--CccccCCCccee
Confidence 234678889999999999999999 789999999999999999999999999999754322111 111223578999
Q ss_pred ChhhhcccCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCCCccchh-----hhhHhhHHhhh
Q 002533 730 DPEYIRRQQL----------------------TEKSDVYSFGVVLLEVLCGRP-PMINGAVRKE-----EVSLVLWARVS 781 (911)
Q Consensus 730 APE~~~~~~~----------------------t~ksDVwSfGvvL~ElltG~~-p~~~~~~~~~-----~~~l~~~~~~~ 781 (911)
|||.+..... ..+.||||+||+|+||++|.. |+........ ...+..|....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 9998754321 235799999999999999875 6543211111 11222232211
Q ss_pred cccCCcccccCccccCCCChHHHHHHHHHHHhcccccC---CCCCCHHHHHHH
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEG---FRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~eVl~~ 831 (911)
... ..-...........+++.+++..+| .+|+|++|++++
T Consensus 458 ~~~----------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQK----------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccC----------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 1111112234567789999998765 689999999865
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=304.34 Aligned_cols=259 Identities=23% Similarity=0.301 Sum_probs=202.6
Q ss_pred HHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecceecc
Q 002533 539 LTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLGFCDE 615 (911)
Q Consensus 539 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~ 615 (911)
..+++-...+|.+.++||+|+||.|..++++.++..+|+|++++... ....-|..|-++|..-..+-|++|.-.+.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34566667889999999999999999999999999999999987533 334568899999999999999999999999
Q ss_pred CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC
Q 002533 616 HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695 (911)
Q Consensus 616 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 695 (911)
+.++|+|||||+||+|..+|... .+++.....-++..|.-||.-|| +.|+|||||||+|||||..
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~------------~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~ 211 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF------------DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKS 211 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc------------CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEeccc
Confidence 99999999999999999999433 25777777777888999999999 8999999999999999999
Q ss_pred CceEEeecCCccCCCCCCCCccccccccCcccccChhhhcc-----cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-----QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE 770 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~ 770 (911)
|++||+|||-+-.+... ..-.+....|||-|++||+++. +.|+..+|.||+||++|||+.|..||+....-.
T Consensus 212 GHikLADFGsClkm~~d--G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve- 288 (1317)
T KOG0612|consen 212 GHIKLADFGSCLKMDAD--GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE- 288 (1317)
T ss_pred CcEeeccchhHHhcCCC--CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-
Confidence 99999999988654422 2233455679999999999963 578999999999999999999999996533221
Q ss_pred hhhHhhHHhhhcccCCcccccCccccCCCC--hHHHHHHHHHHHhcccccCCCCCC---HHHHHHH
Q 002533 771 EVSLVLWARVSRARGTVDQIVDPRLRGKIA--PVCLNKFVEIAGSCTDEEGFRRPT---MGDVTWG 831 (911)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~RPs---~~eVl~~ 831 (911)
.+.+ |++..-...+| .+.++...+||++.+. +|+.|-. +.++-.+
T Consensus 289 -----TY~K----------Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 289 -----TYGK----------IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -----HHHH----------HhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1222 22221111122 2245566677776544 5667766 7777554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=272.15 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=193.9
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccC---CChhh----HHHHHHHHHHHHhcccccEeeecceec-cCCceE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNT---SSMQG----AREFRTEIEMISELRHLHIVSLLGFCD-EHGEMI 620 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~---~~~~~----~~~f~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~ 620 (911)
|-..++||+|||+.|||+.+......||||+-.. +..+. .+...+|.++-+.|.||.||++++|+. +.+..|
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 3345689999999999999988888999997532 22222 234678999999999999999999985 556789
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC---CCc
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE---NWA 697 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~ 697 (911)
-|.|||+|.+|.-+|.. .+.+++++...|++||+.||.||.+ .+.+|||-||||.||||-+ -|.
T Consensus 545 TVLEYceGNDLDFYLKQ------------hklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQ------------HKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred eeeeecCCCchhHHHHh------------hhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccce
Confidence 99999999999999953 3458999999999999999999985 4689999999999999954 578
Q ss_pred eEEeecCCccCCCCCCCC----ccccccccCcccccChhhhccc----CCCchhHHHHHHHHHHHHHhCCCCCCCCccch
Q 002533 698 AKISDFGLSRMGPSGMSQ----SHVSTVVKGSFGYVDPEYIRRQ----QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK 769 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~~~~~----~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~ 769 (911)
+||.||||++++...... ........||..|++||++.-+ +.+.|.||||.||++|.++.|+.||....
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--- 688 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--- 688 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch---
Confidence 999999999987544222 2234556799999999988543 57899999999999999999999996533
Q ss_pred hhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHH
Q 002533 770 EEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVT 829 (911)
Q Consensus 770 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl 829 (911)
.+.++......... .+..-+.-+........+|++||+..-++|-...++.
T Consensus 689 sQQdILqeNTIlkA---------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 689 SQQDILQENTILKA---------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hHHHHHhhhchhcc---------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 12222221111110 0111111223445667899999999999998766653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=279.34 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=194.2
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
.++||.|.||+||-|+++.+++.||||++.+. ...+..++++|+.+|++++||.||.+.--|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 45899999999999999999999999998754 3344567899999999999999999999999999999999999 66
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC---CceEEeecCCc
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN---WAAKISDFGLS 706 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla 706 (911)
+..+++... ....|+...-.-+..||+.||.||| .++|+|+||||+||||... -.+||||||+|
T Consensus 648 DMLEMILSs----------EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 648 DMLEMILSS----------EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred hHHHHHHHh----------hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccce
Confidence 777777544 2345777777778899999999999 7999999999999999653 47999999999
Q ss_pred cCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCC
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
|.... ......+.||+.|+|||+++++.|...-|+||.||++|--++|..||..+....++..-. ..
T Consensus 715 RiIgE----ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA---aF------ 781 (888)
T KOG4236|consen 715 RIIGE----KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA---AF------ 781 (888)
T ss_pred eecch----hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc---cc------
Confidence 98543 334456789999999999999999999999999999999999999996433222221111 11
Q ss_pred cccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
++.+.-. .+......+||...|+..-.+|-+...-+.
T Consensus 782 ---MyPp~PW----~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 782 ---MYPPNPW----SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ---ccCCCch----hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1111111 223345568888888888888888776543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=268.89 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=194.8
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 622 (911)
.+|....+||+|.||+|-+|..+++.+.+|||+|+..-. .+.+--+.|-++|... +-|.++++..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 467888899999999999999999999999999976521 2223344566777665 568899999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
|||+.+|+|--++++- ..+.+...+-+|..||-||-+|| +++|+.||||.+|||||.+|++||+|
T Consensus 429 MEyvnGGDLMyhiQQ~------------GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV------------GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred EEEecCchhhhHHHHh------------cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeee
Confidence 9999999998888543 34667778889999999999999 89999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
||+++..-. ........+||+.|+|||.+..++|+...|.|||||+||||+.|++||++.+.+. . +
T Consensus 494 FGmcKEni~---~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--l----F----- 559 (683)
T KOG0696|consen 494 FGMCKENIF---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--L----F----- 559 (683)
T ss_pred ccccccccc---CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--H----H-----
Confidence 999986322 2333456789999999999999999999999999999999999999997654211 1 1
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT 824 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 824 (911)
..+.+.. -.++.....+...++...+...|.+|-.
T Consensus 560 -----~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 560 -----QAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----HHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1122222 1244455666778888889999999853
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=295.74 Aligned_cols=272 Identities=20% Similarity=0.230 Sum_probs=173.1
Q ss_pred HccCCccceeecccCcEEEEEEEeecC----CeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecce------ec
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDG----SITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF------CD 614 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~----~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~------~~ 614 (911)
..++|...++||+|+||.||+|.+..+ +..||||++...... +.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 456888999999999999999999877 789999998643221 111111 1222222222222211 34
Q ss_pred cCCceEEEEeecCCCchhhHhhhhhhcccc--------cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEeccc
Q 002533 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQN--------QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVK 686 (911)
Q Consensus 615 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~--------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlk 686 (911)
.+...++||||+++++|.+++......... .............+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 567899999999999999998643210000 00001111223445679999999999999 7899999999
Q ss_pred CCCeeecC-CCceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc----------------------CCCchh
Q 002533 687 STNILLDE-NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ----------------------QLTEKS 743 (911)
Q Consensus 687 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~t~ks 743 (911)
|+|||++. ++.+||+|||+++...... ........+++.|||||.+... .++.++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999986 5799999999998543322 1223345688999999966432 244567
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCcc------chhhhhHhhHHhhhcccCCcccccCccccC--CCChHHHHHHHHHHHhcc
Q 002533 744 DVYSFGVVLLEVLCGRPPMINGAV------RKEEVSLVLWARVSRARGTVDQIVDPRLRG--KIAPVCLNKFVEIAGSCT 815 (911)
Q Consensus 744 DVwSfGvvL~ElltG~~p~~~~~~------~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~--~~~~~~~~~l~~li~~Cl 815 (911)
|||||||+||||+++..+...... ......+..|....... ..+.++. ...........+|+.+||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999997765432110 00011122222211110 0000000 000011234568999999
Q ss_pred cccCCCCCCHHHHHHH
Q 002533 816 DEEGFRRPTMGDVTWG 831 (911)
Q Consensus 816 ~~dP~~RPs~~eVl~~ 831 (911)
+.||++|||+.|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=268.48 Aligned_cols=262 Identities=20% Similarity=0.307 Sum_probs=200.3
Q ss_pred ccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc-c-c----cEeeecceeccCCce
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-H-L----HIVSLLGFCDEHGEM 619 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-H-p----nIv~l~g~~~~~~~~ 619 (911)
+++|.+...+|+|.||.|-++.+...+..||||+++.-.. -.+.-+-|+++|.+|. + | -+|++.++++-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 5677788899999999999999988889999999975432 2345667999999993 2 2 478889999999999
Q ss_pred EEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-----
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE----- 694 (911)
Q Consensus 620 ~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~----- 694 (911)
|||+|.+ |-|+.++|... ...+.+..++..|+.|++++++||| +.+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N----------~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN----------NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EEEEecc-ChhHHHHhccC----------CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEE
Confidence 9999998 66999999543 4457888999999999999999999 799999999999999921
Q ss_pred ---------------CCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCC
Q 002533 695 ---------------NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGR 759 (911)
Q Consensus 695 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~ 759 (911)
+..+||+|||.|+.... .+ ..+..|..|.|||++.+..++.++||||+||+|.||+||.
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e----~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE----HH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceecc----Cc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 34689999999986321 11 4566899999999999999999999999999999999999
Q ss_pred CCCCCCccchhhhhHhhHHhhhcc----------------cCCc-----------ccccCccc----cCCCChHHHHHHH
Q 002533 760 PPMINGAVRKEEVSLVLWARVSRA----------------RGTV-----------DQIVDPRL----RGKIAPVCLNKFV 808 (911)
Q Consensus 760 ~p~~~~~~~~~~~~l~~~~~~~~~----------------~~~~-----------~~i~d~~l----~~~~~~~~~~~l~ 808 (911)
..|...+ ..|.+ ....+.... .+.+ ..+.++-. .......+...|.
T Consensus 307 ~LFqtHe-n~EHL--aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 307 TLFQTHE-NLEHL--AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred eecccCC-cHHHH--HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 9886544 23322 111111110 0000 00000000 0111234466899
Q ss_pred HHHHhcccccCCCCCCHHHHHHH
Q 002533 809 EIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 809 ~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+|++++|..||.+|+|+.|++++
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHccCccccccHHHHhcC
Confidence 99999999999999999999865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=274.41 Aligned_cols=228 Identities=24% Similarity=0.392 Sum_probs=185.6
Q ss_pred CHHHHHHHcc---CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh---hhHHHHHHHHHHHHhcccccEeeecc
Q 002533 538 SLTEIKQATC---DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVSLLG 611 (911)
Q Consensus 538 ~~~el~~at~---~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g 611 (911)
.|..|+++.- -|-..+.||-|+||+|.++...++...+|+|.|++.+. ........|-+||..-..+-||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 4455666553 36677889999999999999988888899999976532 33445778999999999999999999
Q ss_pred eeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCee
Q 002533 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNIL 691 (911)
Q Consensus 612 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 691 (911)
.+.+.+.+|+||||++||++-.+|.+.+ .+.+....-++..+.+|+++.| +.|+|||||||+|||
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg------------IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNIL 761 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG------------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNIL 761 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhc------------cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceE
Confidence 9999999999999999999999996543 2555555556678999999999 899999999999999
Q ss_pred ecCCCceEEeecCCccCCC---------CCC-------CC-----------------------ccccccccCcccccChh
Q 002533 692 LDENWAAKISDFGLSRMGP---------SGM-------SQ-----------------------SHVSTVVKGSFGYVDPE 732 (911)
Q Consensus 692 l~~~~~~kl~DFGla~~~~---------~~~-------~~-----------------------~~~~~~~~gt~~y~APE 732 (911)
||.+|++||.||||+.-+. .+. .. ........||..|+|||
T Consensus 762 IDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiape 841 (1034)
T KOG0608|consen 762 IDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPE 841 (1034)
T ss_pred EccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChH
Confidence 9999999999999985211 000 00 00112246999999999
Q ss_pred hhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 733 YIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 733 ~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
++....++..+|.||.||+||||+.|+.||........+..+..|...
T Consensus 842 vl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 842 VLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred HhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhc
Confidence 999999999999999999999999999999887766667777777553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=244.42 Aligned_cols=208 Identities=25% Similarity=0.360 Sum_probs=171.1
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC-ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEe
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
.+......||+|++|.|-+-++...++..|+|++... ..+..++.+.|+++..+- .+|.+|.++|...+++..++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3344455799999999999999888889999998754 445667788899886554 79999999999999999999999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
.| .-||..+-.+-. .....+++..+-+||..+..||.|||+ +..++|||+||+|||++.+|++||||||
T Consensus 126 ~M-~tSldkfy~~v~--------~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVL--------KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred Hh-hhhHHHHHHHHH--------hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccc
Confidence 99 457876654332 245668888999999999999999997 7889999999999999999999999999
Q ss_pred CccCCCCCCCCccccccccCcccccChhhhcc----cCCCchhHHHHHHHHHHHHHhCCCCCCCCccch
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR----QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK 769 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~ 769 (911)
++-.+.+. -..+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.||.....+-
T Consensus 195 IsG~L~dS----iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 195 ISGYLVDS----IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred cceeehhh----hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 98764332 22333568888999998853 478999999999999999999999997655443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=283.09 Aligned_cols=265 Identities=27% Similarity=0.370 Sum_probs=197.7
Q ss_pred CCccceeecccCcEE-EEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGH-VFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~-Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
-|...+++|.|+-|+ ||+|...+. .||||++-... ..-..+|+..|+.- .|||||++++.-.++..+||..|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R--~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGR--EVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCc--eehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 456677899999987 899999764 89999985432 23456899999887 699999999888889999999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-----CCceEE
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-----NWAAKI 700 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl 700 (911)
| ..+|.+++....... ....-...+.+..|++.||++|| +.+||||||||.||||+. ..+++|
T Consensus 585 C-~~sL~dlie~~~~d~--------~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDV--------EMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred h-hhhHHHHHhccccch--------hhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEe
Confidence 9 669999996541110 00111445678899999999999 799999999999999975 358999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhC-CCCCCCCccchhhhhHhhHHh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCG-RPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG-~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||+++....+...-.......||-+|+|||++....-+...||||+||++|++++| .+||.+....+ . .
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~------N 724 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--A------N 724 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--h------h
Confidence 9999999877665544445567899999999999998889999999999999999995 89996533111 1 1
Q ss_pred hhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH---------HHHHHHhhhHhhhccC
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW---------GLEFALQLQEAAEKSD 846 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~---------~L~~~~~~~~~~~~~~ 846 (911)
.......+..+. ...+| ...+||.+++..+|..||++.+|+. +|+....+.+..+...
T Consensus 725 Il~~~~~L~~L~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~ 791 (903)
T KOG1027|consen 725 ILTGNYTLVHLE-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKEN 791 (903)
T ss_pred hhcCccceeeec-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhh
Confidence 111111111111 11122 5679999999999999999999963 4555555444444433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=254.13 Aligned_cols=261 Identities=22% Similarity=0.373 Sum_probs=188.2
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccC-CChhh-HHHHHHHHHHHHhcccccEeeecceecc--------CCceEE
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNT-SSMQG-AREFRTEIEMISELRHLHIVSLLGFCDE--------HGEMIL 621 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~-~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--------~~~~~l 621 (911)
..+||+|.||.||+|+..+++..||+|+.-- ....+ -..-.+|+++|..|+|+|++.++..|.. ...+++
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 3479999999999999998888899886532 21122 2345789999999999999999999843 235899
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
||.+|++ +|.-.|.+ ....++..++.+++.++..||.|+| ...|+|||+||.|+||+.++.+||+
T Consensus 102 Vf~~ceh-DLaGlLsn-----------~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSN-----------RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred eHHHhhh-hHHHHhcC-----------ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEee
Confidence 9999976 88877732 2245788899999999999999999 7899999999999999999999999
Q ss_pred ecCCccCCCCCCC-CccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh---
Q 002533 702 DFGLSRMGPSGMS-QSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL--- 776 (911)
Q Consensus 702 DFGla~~~~~~~~-~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~--- 776 (911)
|||+++....... .....+...-|..|.+||.+.+ ..++++.|||+-||+|.||+||.+-+.+.. ...+..++.
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-eqqql~~Is~Lc 245 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-EQQQLHLISQLC 245 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh-HHHHHHHHHHHh
Confidence 9999986432211 1111234456889999998876 579999999999999999999988775433 222222222
Q ss_pred ----------------HHhhhcc--cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 777 ----------------WARVSRA--RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ----------------~~~~~~~--~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
|.....+ .......+..+++.... ...-++|+..++..||.+|++..+++.+
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~k---d~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVK---DDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccC---ChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111000 00000011111111111 2245688999999999999999988755
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=232.65 Aligned_cols=264 Identities=21% Similarity=0.283 Sum_probs=191.0
Q ss_pred ccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
..-+.||+|.||+||||+..++.+.||+|+++-. ....-...++||.+|+.|+|.|||+++++...+..+-+|+|||
T Consensus 5 dkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c- 83 (292)
T KOG0662|consen 5 DKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC- 83 (292)
T ss_pred HHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-
Confidence 3345799999999999999999899999987643 2222345789999999999999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
..+|..+... -+..++-.....++.|+.+||.++| ++++.||||||.|.|++.+|+.|++|||+++
T Consensus 84 dqdlkkyfds-----------lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 84 DQDLKKYFDS-----------LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred hHHHHHHHHh-----------cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhh
Confidence 4588877732 2345788888899999999999999 7999999999999999999999999999998
Q ss_pred CCCCCCCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccC-
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG- 785 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~- 785 (911)
...-.. .-.....-|.-|.+|.++.+. -|+...|+||-||++.|+.....|...+....++..-+-|.-....+.
T Consensus 150 afgipv---rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 150 AFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred hcCCce---EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 643211 111223467889999998875 589999999999999999984444443332333333333332222111
Q ss_pred --CcccccCccccCCCC---------hHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 786 --TVDQIVDPRLRGKIA---------PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 786 --~~~~i~d~~l~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
.+.++-|-.....++ +.....=.++.++.+.-+|.+|.++++.++.
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 122222222222111 1111233456667777799999998876543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=249.44 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=197.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 622 (911)
++|...++||+|.|.+|-.+++..+.+.+|+|++++. ..++.+..+.|-.+..+. +||.+|-|..++..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5788889999999999999999999999999998754 334455567777777766 799999999999999999999
Q ss_pred EeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
.||+++|+|--++.+ ...|++....-+...|+-||.||| +.+||.||||.+|||||..+++||.|
T Consensus 330 ieyv~ggdlmfhmqr------------qrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR------------QRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred EEEecCcceeeehhh------------hhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecc
Confidence 999999999877743 345888888888899999999999 79999999999999999999999999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhc
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
+|+++..- .........+||+.|+|||.+++..|....|.|++||+++||+.|+.||+--.....+.+...+..
T Consensus 395 ygmcke~l---~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf--- 468 (593)
T KOG0695|consen 395 YGMCKEGL---GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF--- 468 (593)
T ss_pred cchhhcCC---CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH---
Confidence 99998643 233344567899999999999999999999999999999999999999964333332222222211
Q ss_pred ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCC
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP 823 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 823 (911)
.-+++..+| ++....-+...+.+.-|..||.+|-
T Consensus 469 -----qvilekqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 469 -----QVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----HHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 112222232 2222333455677888999999885
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=262.07 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=197.0
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
...||-|+||.|=+...+.....+|+|.+++. .....+....|-++|.+.+.|.||+|+-.+.+....|++||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 44799999999999998877656889888654 334456678899999999999999999999999999999999999
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|.|...|.. +..++.....-++..+.+|++||| .++||.|||||+|++|+.+|-+||.|||+|+.
T Consensus 505 GElWTiLrd------------Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 505 GELWTILRD------------RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred chhhhhhhh------------cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHH
Confidence 999999953 344666667778889999999999 89999999999999999999999999999997
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
...+. .+...+||+.|.|||.+.++..+..+|.||||++++||++|.+||...+.-.. +...... ++
T Consensus 570 i~~g~----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt------Yn~ILkG---id 636 (732)
T KOG0614|consen 570 IGSGR----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT------YNLILKG---ID 636 (732)
T ss_pred hccCC----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH------HHHHHhh---hh
Confidence 65443 33456899999999999999999999999999999999999999976542211 1111111 11
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCC-----HHHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG 831 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 831 (911)
. ..+|........+|+++.+..+|.+|-- +.+|.++
T Consensus 637 ~-------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 K-------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred h-------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1 1233344556678999999999999975 5555444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-27 Score=239.64 Aligned_cols=211 Identities=33% Similarity=0.544 Sum_probs=182.8
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchhh
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRD 633 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 633 (911)
||+|.+|.||++...+++..+++|++...... ..+.+.+|++.+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999876789999998765433 35679999999999999999999999998899999999999999999
Q ss_pred HhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-CCceEEeecCCccCCCCC
Q 002533 634 HLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 634 ~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 712 (911)
++.... ..+++..++.++.+++++|++|| ..+++|+||+|.||+++. +..++|+|||.+......
T Consensus 81 ~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE-----------GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 984321 35889999999999999999999 689999999999999999 899999999999864332
Q ss_pred CCCccccccccCcccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCccccc
Q 002533 713 MSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791 (911)
Q Consensus 713 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 791 (911)
.. ......+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 147 ~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------ 187 (215)
T cd00180 147 KS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------ 187 (215)
T ss_pred cc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence 21 12234477789999999887 888999999999999999
Q ss_pred CccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 792 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 456799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-28 Score=244.92 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=190.0
Q ss_pred cceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC-----CceEEEE
Q 002533 551 DHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH-----GEMILVY 623 (911)
Q Consensus 551 ~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~lV~ 623 (911)
..+.||-|+||.||..++..+++.||+|++..- +....+.+.+|+++|+-++|.|++..++...-. .++|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 356899999999999999888889999998643 334456788999999999999999998876433 3678888
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
|.| ..+|...+- ...+|+-..+.-+..||.+||+||| +.+|.||||||.|.|++.|...|||||
T Consensus 137 ELm-QSDLHKIIV------------SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 137 ELM-QSDLHKIIV------------SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHH-Hhhhhheec------------cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccc
Confidence 988 447776662 3445777777888999999999999 799999999999999999999999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH-----
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW----- 777 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~----- 777 (911)
||+|..... ...-++...-|..|.|||.+.+ ..|+.+.||||.||++.||+..+..|.... +-++..++.-
T Consensus 201 GLARvee~d--~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 201 GLARTWDQR--DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-PIEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccchh--hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-hHHHHHHHHHHhCCC
Confidence 999974332 2233345557889999999987 479999999999999999998887775433 2222222211
Q ss_pred ---HhhhcccCCcccccCccccC---------CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 778 ---ARVSRARGTVDQIVDPRLRG---------KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 778 ---~~~~~~~~~~~~i~d~~l~~---------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
+.....++.-..++....+. .-+......-+.+..+++..||.+|.+..+.+..+
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00111111111222211111 00112223445677788999999999988876654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=235.22 Aligned_cols=200 Identities=32% Similarity=0.477 Sum_probs=171.7
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecC
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
|...+.||+|++|.||++...+++..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 34567899999999999999886789999999876554 67789999999999999999999999998899999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+++|.+++.... ..+++.....++.+++++|.+|| ..+++|+||+++||+++.++.++|+|||++.
T Consensus 81 ~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 81 GGDLFDYLRKKG-----------GKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred CCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 999999985321 11788999999999999999999 6799999999999999999999999999988
Q ss_pred CCCCCCCCccccccccCcccccChhhh-cccCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~-~~~~~t~ksDVwSfGvvL~ElltG~~p~~~ 764 (911)
....... .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 6543320 012334577789999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=240.79 Aligned_cols=132 Identities=26% Similarity=0.364 Sum_probs=112.6
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc-----c---ccEeeecceec----
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-----H---LHIVSLLGFCD---- 614 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-----H---pnIv~l~g~~~---- 614 (911)
.+|...++||.|-|++||++.+....+.||+|+.+.. ..-.+.-+.||++|++++ | .+||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788899999999999999999988899999998643 233455788999999984 3 37999999985
Q ss_pred cCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee
Q 002533 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL 692 (911)
Q Consensus 615 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 692 (911)
.+.+.|||+|++ |.+|..++... ..+.++...+.+||.||+.||.|||. +.+|||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s----------~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS----------NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh----------CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 456899999999 77999988655 34458889999999999999999997 5699999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=252.63 Aligned_cols=198 Identities=24% Similarity=0.394 Sum_probs=168.7
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhh--------HHHHHHHHHHHHhcc---cccEeeecceecc
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG--------AREFRTEIEMISELR---HLHIVSLLGFCDE 615 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~--------~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~ 615 (911)
.+|...+.+|+|+||.|+.|.++.....|+||.+.+...-. .-..-.||++|..|+ |+||+++++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45777889999999999999999888899999886543211 112456999999997 9999999999999
Q ss_pred CCceEEEEeecC-CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC
Q 002533 616 HGEMILVYEFMP-RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE 694 (911)
Q Consensus 616 ~~~~~lV~E~~~-~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 694 (911)
++.+||+||-.. +-+|.+++. ..+.+++.+...|..|++.|+++|| +.+|||||||-+||.++.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE------------~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE------------FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDS 705 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh------------ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEec
Confidence 999999999753 458888883 4456999999999999999999999 899999999999999999
Q ss_pred CCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 002533 695 NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMIN 764 (911)
Q Consensus 695 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSfGvvL~ElltG~~p~~~ 764 (911)
+|.+||+|||.+.+...+.- ...+||..|.|||++.+.+| ...-|||++|++||-++....||.+
T Consensus 706 ~g~~klidfgsaa~~ksgpf-----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSGPF-----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CCeEEEeeccchhhhcCCCc-----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999876443322 34579999999999999887 4568999999999999999888854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=223.56 Aligned_cols=261 Identities=19% Similarity=0.291 Sum_probs=194.4
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc-cccEeeecceeccC--CceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGFCDEH--GEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~lV~ 623 (911)
.+|...+.+|+|.|++||.|.....++.++||++++- ..+.+.+|+.+|..|+ ||||++|++...+. ....||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 4566677899999999999998777789999999754 4566889999999997 99999999998654 4568999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-CCceEEee
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NWAAKISD 702 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~D 702 (911)
||+.+-+..... +.|+-..+..++.+++.||.|+| +.||+|||+||.|+++|. .-..+|+|
T Consensus 115 E~v~n~Dfk~ly---------------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 115 EYVNNTDFKQLY---------------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred hhhccccHHHHh---------------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeee
Confidence 999887776544 23677788889999999999999 899999999999999986 45799999
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhcc-cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh-----
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL----- 776 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~----- 776 (911)
+|||...-.+... .....+..|.-||.+.. +.|+..-|+|||||+|.+|+..+.||..+....++.-.+.
T Consensus 177 WGLAEFYHp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 177 WGLAEFYHPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred cchHhhcCCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence 9999875433221 22345667889998875 5688899999999999999999999987764443321111
Q ss_pred -----HHhhh--cccCCcccccCccccC--------CCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHH
Q 002533 777 -----WARVS--RARGTVDQIVDPRLRG--------KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGL 832 (911)
Q Consensus 777 -----~~~~~--~~~~~~~~i~d~~l~~--------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 832 (911)
+.... ..+.....++....+. +.......+..+++.+.|..|-.+|||++|...+-
T Consensus 253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 11111 1111222222211111 00111235667899999999999999999987663
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=225.62 Aligned_cols=251 Identities=19% Similarity=0.318 Sum_probs=185.2
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecce-eccCCceEEEEee
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGF-CDEHGEMILVYEF 625 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~-~~~~~~~~lV~E~ 625 (911)
.|.+.+.||+|.||.+-++++++.++.+++|-+... ....++|.+|...--.| .|.||+.-++. +...+...+++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 567778999999999999999999999999988643 34567899998775555 68999988776 4666788899999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeec--CCCceEEeec
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD--ENWAAKISDF 703 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DF 703 (911)
++.|+|...+. ...+.+....+++.|++.||.||| ++++||||||.+||||- +..++|||||
T Consensus 104 aP~gdL~snv~-------------~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 104 APRGDLRSNVE-------------AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred CccchhhhhcC-------------cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeec
Confidence 99999998883 334777888899999999999999 79999999999999993 3458999999
Q ss_pred CCccCCCCCCCCccccccccCcccccChhhhccc-----CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHH
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-----QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
|+.+.... .-....-+..|.+||..... ...+.+|+|.||++++.++||+.||.... ..+.....|.
T Consensus 168 G~t~k~g~------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~~~ 239 (378)
T KOG1345|consen 168 GLTRKVGT------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWEWE 239 (378)
T ss_pred ccccccCc------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHHHH
Confidence 99875221 11223345679999987532 45778999999999999999999997322 1222233333
Q ss_pred hhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
...... . +++...+. ...+++..+.++-+..++++|--..++-.+
T Consensus 240 ~w~~rk--~-----~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 240 QWLKRK--N-----PALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHhccc--C-----ccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 222111 1 11111111 124566778889999999999555555444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=257.75 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=203.3
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeec
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 626 (911)
.+|....++|.|.||.|||+++...++..|||+++-.......-..+|+-+++..+|+||+.++|.+..++.+++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 45666778999999999999999888999999998777777777889999999999999999999999999999999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
.+|+|++.-+ ...+|++.++-.+++...+||+||| ..+=+|||||-.|||+++.+.+|++|||.+
T Consensus 95 gggslQdiy~------------~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 95 GGGSLQDIYH------------VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred CCCcccceee------------ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCch
Confidence 9999998774 3456899999999999999999999 788899999999999999999999999987
Q ss_pred cCCCCCCCCccccccccCcccccChhhh---cccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~---~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
-... ..-.......||+.|||||+. +.+.|..++|||+.|+...|+---++|..+-..-+ .+...-....+
T Consensus 160 aqit---ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr---~l~LmTkS~~q 233 (829)
T KOG0576|consen 160 AQIT---ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR---ALFLMTKSGFQ 233 (829)
T ss_pred hhhh---hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH---HHHHhhccCCC
Confidence 5422 112233456799999999976 45679999999999999999998888865432111 11111111111
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
. +.++ -.....+.+.++++.|+-.+|++||++..++.
T Consensus 234 p--------p~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 P--------PTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C--------Cccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 1111 11234677889999999999999999987754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=232.14 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=189.9
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhcccccEeeecceeccC------CceE
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEH------GEMI 620 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~ 620 (911)
|.....+|.|.- .|--+.+.-.+.+||+|++... .....+...+|..++..++|+||++++.++.-. .+.|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 444556788877 6666766666678999987543 233456677899999999999999999998543 3679
Q ss_pred EEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEE
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 700 (911)
+|||+| .++|...++.. ++-..+-.|..|+++|++||| +.+|+||||||+||++..+..+||
T Consensus 98 ~v~e~m-~~nl~~vi~~e--------------lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 98 LVMELM-DANLCQVILME--------------LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred HHHHhh-hhHHHHHHHHh--------------cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheee
Confidence 999999 66998888522 566778899999999999999 799999999999999999999999
Q ss_pred eecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
.|||+|+.... ....+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+... +-.|.+.
T Consensus 160 ~dfg~ar~e~~----~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~------idQ~~ki 229 (369)
T KOG0665|consen 160 LDFGLARTEDT----DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH------IDQWNKI 229 (369)
T ss_pred ccchhhcccCc----ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH------HHHHHHH
Confidence 99999986322 2344566788899999999998899999999999999999999988764332 1122221
Q ss_pred hcccCCc---------------------------ccc-cCccccC--CCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 781 SRARGTV---------------------------DQI-VDPRLRG--KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 781 ~~~~~~~---------------------------~~i-~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
....+.. .+. -|...+. +.++.......+++.++|..+|++|-+..++++
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1111100 000 0111111 112223456778999999999999999999987
Q ss_pred H
Q 002533 831 G 831 (911)
Q Consensus 831 ~ 831 (911)
+
T Consensus 310 H 310 (369)
T KOG0665|consen 310 H 310 (369)
T ss_pred C
Confidence 6
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=241.46 Aligned_cols=202 Identities=24% Similarity=0.296 Sum_probs=167.9
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc------cccEeeecceeccCCc
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR------HLHIVSLLGFCDEHGE 618 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~------HpnIv~l~g~~~~~~~ 618 (911)
....|.+....|+|-|++|-+|.+...+..||||++...... .+.=+.|+++|++|. --|.++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 346677777899999999999999877779999999865432 344567999999995 3478899999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC-Cc
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WA 697 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~ 697 (911)
+|||+|-+ .-+|++.|...+ .+-.|....+..++.|+.-||..|. ..+|+|.||||+|||+++. ..
T Consensus 509 LClVFE~L-slNLRevLKKyG---------~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYG---------RNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred eEEEehhh-hchHHHHHHHhC---------cccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcce
Confidence 99999987 669999997664 3345788889999999999999998 7899999999999999874 57
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMING 765 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~ 765 (911)
+||||||.|-...... .+...-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+.
T Consensus 576 LKLCDfGSA~~~~ene-----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE-----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred eeeccCcccccccccc-----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 8999999987533221 12233456799999999999999999999999999999999988654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=233.25 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=197.6
Q ss_pred HHHccCCccceeecccCcEEEEEEEeec---CCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCc
Q 002533 543 KQATCDFADHCIIGSGGFGHVFKGYIDD---GSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGE 618 (911)
Q Consensus 543 ~~at~~f~~~~~LG~G~fG~Vykg~~~~---~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 618 (911)
....+.|...++||+|.|++||++.+.. ....||+|.+...+. -....+|+++|..+ -+.||+++.++....+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445678888999999999999999876 678999999876543 34588999999999 58999999999999999
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-CCc
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NWA 697 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~ 697 (911)
..+|+||+++....+++.. ++..++..+...+..||+++| ..|||||||||+|+|.+. .+.
T Consensus 110 v~ivlp~~~H~~f~~l~~~---------------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---------------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred eEEEecccCccCHHHHHhc---------------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCC
Confidence 9999999999999888732 667888899999999999999 899999999999999985 467
Q ss_pred eEEeecCCccCCC-----------------C--C----------------------CCCccccccccCcccccChhhhcc
Q 002533 698 AKISDFGLSRMGP-----------------S--G----------------------MSQSHVSTVVKGSFGYVDPEYIRR 736 (911)
Q Consensus 698 ~kl~DFGla~~~~-----------------~--~----------------------~~~~~~~~~~~gt~~y~APE~~~~ 736 (911)
-.|.|||||.... . + ...........||+||.|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 8899999986100 0 0 000001123469999999999865
Q ss_pred -cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh----hhhHhhHHh---hhcccCC--ccc---------c------c
Q 002533 737 -QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE----EVSLVLWAR---VSRARGT--VDQ---------I------V 791 (911)
Q Consensus 737 -~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~----~~~l~~~~~---~~~~~~~--~~~---------i------~ 791 (911)
...+.+.||||-||+++.+++++.||.....+-+ ...+..|.. .....+. +.+ + +
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 5679999999999999999999999975442211 111111110 0000111 000 0 0
Q ss_pred C-ccc--------cCC-CChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 792 D-PRL--------RGK-IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 792 d-~~l--------~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
+ +.+ ... .....+..++++..+|+..||.+|.|+++.+.+
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 000 001 111123478899999999999999999998765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=220.70 Aligned_cols=245 Identities=21% Similarity=0.363 Sum_probs=193.8
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEcc--CCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCch
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLN--TSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~--~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
+|.+...|+.|+|++.+.+ +++|++. .......++|..|.-.|+-+.||||+.++|.|.....+.++..||+.|+|
T Consensus 197 kl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 6888999999999998874 5666654 33455567899999999999999999999999999999999999999999
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
...||.. ..-.++..+.++++.++|+|++|||+. ++-|.---|.++.|++|++.+++|+ .+-++.
T Consensus 275 ynvlhe~----------t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kf--- 339 (448)
T KOG0195|consen 275 YNVLHEQ----------TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKF--- 339 (448)
T ss_pred HHHHhcC----------ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-ccccee---
Confidence 9999764 334577788999999999999999963 3445556799999999999998874 111111
Q ss_pred CCCCccccccccCcccccChhhhcccCCC---chhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLT---EKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t---~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
+ .......-.+.||+||.++.++-+ ..+|+|||.++||||.|...||.+-..-+-. .
T Consensus 340 --s--fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------m 399 (448)
T KOG0195|consen 340 --S--FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------M 399 (448)
T ss_pred --e--eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------h
Confidence 0 001112235679999999876543 4799999999999999999999654321111 2
Q ss_pred cccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
++.-+.+|..+++.....+.+|+.-|...||.+||.+..|+-.||+.
T Consensus 400 kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 400 KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 33445677888888899999999999999999999999999998864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-25 Score=271.10 Aligned_cols=198 Identities=18% Similarity=0.190 Sum_probs=138.4
Q ss_pred Hhccc-ccEeeeccee-------ccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHH
Q 002533 599 SELRH-LHIVSLLGFC-------DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670 (911)
Q Consensus 599 ~~l~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~ 670 (911)
+.++| +||++++++| .+...+++++||+ +++|.++|.. ....+++.+++.++.||++||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~al~ 94 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-----------PDRSVDAFECFHVFRQIVEIVN 94 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-----------ccccccHHHHHHHHHHHHHHHH
Confidence 34566 6888888887 2334677888987 6699999942 2345899999999999999999
Q ss_pred HHhhCCCCcEEEecccCCCeeecCC-------------------CceEEeecCCccCCCCCCC-------------Cccc
Q 002533 671 YLHAGAKHTIIHRDVKSTNILLDEN-------------------WAAKISDFGLSRMGPSGMS-------------QSHV 718 (911)
Q Consensus 671 yLH~~~~~~ivHrDlkp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~-------------~~~~ 718 (911)
||| +++|+||||||+||||+.. +.+||+|||+++....... ....
T Consensus 95 ~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (793)
T PLN00181 95 AAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMK 171 (793)
T ss_pred HHH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccc
Confidence 999 7999999999999999654 4455666666653210000 0000
Q ss_pred cccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCC
Q 002533 719 STVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGK 798 (911)
Q Consensus 719 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 798 (911)
.....||+.|||||++.+..++.++|||||||+||||++|..|+.... ..+..... ....+..
T Consensus 172 ~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~---------~~~~~~~--- 234 (793)
T PLN00181 172 QILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRH---------RVLPPQI--- 234 (793)
T ss_pred ccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHH---------hhcChhh---
Confidence 011347888999999999999999999999999999999988753211 00111100 0111111
Q ss_pred CChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 799 IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 799 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
........+++.+||+.+|.+||+|.||++
T Consensus 235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred --hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 011234568889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=206.71 Aligned_cols=168 Identities=25% Similarity=0.257 Sum_probs=124.2
Q ss_pred CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+|.+++... ...++|.+++.|+.|+++||+||| +.+ ||+|||++.++.+|+ ||+++.
T Consensus 1 GsL~~~l~~~-----------~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~ 58 (176)
T smart00750 1 VSLADILEVR-----------GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAF 58 (176)
T ss_pred CcHHHHHHHh-----------CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEe
Confidence 6888988532 345999999999999999999999 444 999999999999999 999876
Q ss_pred CCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcc
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 788 (911)
.... ...|++.|||||++.+..++.++|||||||++|||++|+.||........ .+..+.......
T Consensus 59 ~~~~--------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~---- 124 (176)
T smart00750 59 KTPE--------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD---- 124 (176)
T ss_pred eccc--------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC----
Confidence 4321 12588999999999999999999999999999999999999854321111 111111111000
Q ss_pred cccCccccCCCChHHHH--HHHHHHHhcccccCCCCCCHHHHHHHHHHHH
Q 002533 789 QIVDPRLRGKIAPVCLN--KFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 789 ~i~d~~l~~~~~~~~~~--~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 836 (911)
++..+ ........ .+.+++.+||+.+|.+||++.|+++++....
T Consensus 125 ---~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 125 ---DPRDR-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ---Ccccc-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00000 01112222 6899999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-21 Score=213.98 Aligned_cols=263 Identities=20% Similarity=0.228 Sum_probs=196.8
Q ss_pred CCccceeecccCcEEEEEEEeecCC-eEEEEEEccCCChhhHHHHHHHHHHHHhccc----ccEeeeccee-ccCCceEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGS-ITVAVKRLNTSSMQGAREFRTEIEMISELRH----LHIVSLLGFC-DEHGEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~-~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H----pnIv~l~g~~-~~~~~~~l 621 (911)
+|...+.||+|+||.||++...... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7888999999999999999987653 5788887665433333367789999988873 5788888887 57778999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC-----C
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-----W 696 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~ 696 (911)
||+.+ +.+|.++.... ....++..+.++|+.|++.+|++|| +.+++||||||.|+++... .
T Consensus 99 VM~l~-G~sL~dl~~~~----------~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~ 164 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN----------PPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVR 164 (322)
T ss_pred EEecc-CccHHHHHHhC----------CCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccc
Confidence 99987 88999977433 2356899999999999999999999 8999999999999999865 4
Q ss_pred ceEEeecCCcc--CCCCCCC----Cccc-cccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccch
Q 002533 697 AAKISDFGLSR--MGPSGMS----QSHV-STVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK 769 (911)
Q Consensus 697 ~~kl~DFGla~--~~~~~~~----~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~ 769 (911)
.+.|.|||+++ ....... .... .....||..|+++..+.+...+.+.|+||++.++.|++.|..||.......
T Consensus 165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 69999999998 3211111 1111 234569999999999999999999999999999999999999986544322
Q ss_pred hhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 770 EEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 770 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
+...+....... .... .....+..+.++...+-..+...+|....+...|+....
T Consensus 245 ~~~~~~~~~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 245 LKSKFEKDPRKL--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hHHHHHHHhhhh--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 211111111100 0000 222334566677777777899999999999998876654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=220.24 Aligned_cols=168 Identities=20% Similarity=0.222 Sum_probs=129.1
Q ss_pred HHccCCccceeecccCcEEEEEEEeec-CCeEEEEEEccCC-----ChhhHHHHHHHHHHHHhcccccEee-ecceeccC
Q 002533 544 QATCDFADHCIIGSGGFGHVFKGYIDD-GSITVAVKRLNTS-----SMQGAREFRTEIEMISELRHLHIVS-LLGFCDEH 616 (911)
Q Consensus 544 ~at~~f~~~~~LG~G~fG~Vykg~~~~-~~~~vAvK~l~~~-----~~~~~~~f~~Ei~~l~~l~HpnIv~-l~g~~~~~ 616 (911)
....+|...++||+|+||+||+|.+.. ++..||||++... .....+.|.+|+++|++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 345678888999999999999998865 5567899986532 1223556999999999999999985 4432
Q ss_pred CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecc-cCCCeeecCC
Q 002533 617 GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDV-KSTNILLDEN 695 (911)
Q Consensus 617 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~ 695 (911)
+..+|||||+++++|.. +. ... ...++.+++++|+||| ..+|+|||| ||+|||++.+
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~------------~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR------------PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPD 148 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC------------ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCC
Confidence 46799999999999962 20 000 1357889999999999 789999999 9999999999
Q ss_pred CceEEeecCCccCCCCCCCCccc-----cccccCcccccChhhhccc
Q 002533 696 WAAKISDFGLSRMGPSGMSQSHV-----STVVKGSFGYVDPEYIRRQ 737 (911)
Q Consensus 696 ~~~kl~DFGla~~~~~~~~~~~~-----~~~~~gt~~y~APE~~~~~ 737 (911)
+.+||+|||+++........... -....+++.|+|||++...
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999999865443222221 1355688899999998653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-20 Score=192.28 Aligned_cols=268 Identities=19% Similarity=0.210 Sum_probs=205.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEEEEee
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
-.|.++++||+|.||.++.|+.--.++.||||.-... ....++..|.+..+.| ..++|-..+-+..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3678899999999999999998777789999964332 3345677888888888 468888888887888888999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC-----CceEE
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-----WAAKI 700 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl 700 (911)
+ |-+|.|++.-+ ...++.++.+.||+|++.-++|+| ++.+|.|||||+|.||... ..+.|
T Consensus 106 L-GPSLEDLFD~C-----------gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi 170 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC-----------GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHI 170 (449)
T ss_pred h-CcCHHHHHHHh-----------cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEE
Confidence 8 88999987433 345899999999999999999999 7999999999999999643 46899
Q ss_pred eecCCccCCCCCCCCcccc----ccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 701 SDFGLSRMGPSGMSQSHVS----TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~----~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
+|||+|+...+.....++. ....||.+||+-..+.+...+.+.|+-|+|-++...+.|..||.+-.......
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---- 246 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---- 246 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH----
Confidence 9999999876655544443 45679999999999999999999999999999999999999998755433211
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHhhhHh
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEA 841 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~~ 841 (911)
..++.+...+....+ .+....+.++...+...-..+-.+-|...-+...+..++.....
T Consensus 247 ---kYeKIGe~Kr~T~i~---~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 247 ---KYEKIGETKRSTPIE---VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred ---HHHHhccccccCCHH---HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 111111111111100 11223456677777777777888899999988888777665433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=188.23 Aligned_cols=268 Identities=19% Similarity=0.237 Sum_probs=205.5
Q ss_pred HHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhccc-ccEeeecceeccCC
Q 002533 539 LTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRH-LHIVSLLGFCDEHG 617 (911)
Q Consensus 539 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H-pnIv~l~g~~~~~~ 617 (911)
++++.. -.+|...+.||.|+||.+|.|.....++.||||.-... ....++.-|..+.+.|+| ..|..+..|..+..
T Consensus 8 ~~~~iv-~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 8 LEELIV-GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hhhhee-ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 344433 34678888999999999999999888899999985433 234567788999999976 56777788888889
Q ss_pred ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC--
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-- 695 (911)
Q Consensus 618 ~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-- 695 (911)
.-.+||+.+ +-+|.+++.-+. ..++.++.+-++-|++.-++|+| .++++||||||+|.|..-+
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~-----------R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh 149 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCS-----------RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRH 149 (341)
T ss_pred cceeeeecc-CccHHHHHHHHh-----------hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccc
Confidence 999999998 889999885442 34788899999999999999999 7999999999999999754
Q ss_pred -CceEEeecCCccCCCCCCCCccc----cccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchh
Q 002533 696 -WAAKISDFGLSRMGPSGMSQSHV----STVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE 770 (911)
Q Consensus 696 -~~~kl~DFGla~~~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~ 770 (911)
..+.++||||++...+.....++ .....||.+|.+-..+.+...+.+.|+-|+|.+|..+-.|..||.+......
T Consensus 150 ~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 150 CNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred cceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 46889999999876554443333 2456799999999888888889999999999999999999999977553322
Q ss_pred hhhHhhHHhhhcccCCcccccCccccCC---CChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 771 EVSLVLWARVSRARGTVDQIVDPRLRGK---IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
.. .+. .+.+..+... .....+.++.-.+..|-...-++-|...-+.+.++-+..
T Consensus 230 ~Q---KyE----------kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 230 KQ---KYE----------KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HH---HHH----------HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11 111 1112222111 122346778889999999999999999888877765543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-19 Score=196.91 Aligned_cols=263 Identities=27% Similarity=0.390 Sum_probs=194.8
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh---hHHHHHHHHHHHHhcccc-cEeeecceeccCCceEEEEe
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ---GAREFRTEIEMISELRHL-HIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~---~~~~f~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~lV~E 624 (911)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 455678999999999999987 57899988755332 367799999999999988 79999999977777899999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC-ceEEeec
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW-AAKISDF 703 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DF 703 (911)
++.+++|.+++...... ..+.......+..|++.+++|+| ..+++|||+||+||+++... .++++||
T Consensus 79 ~~~~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK---------GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred cCCCCcHHHHHHhcccc---------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEecc
Confidence 99999999666432110 35788899999999999999999 78899999999999999988 7999999
Q ss_pred CCccCCCCCCCCc---cccccccCcccccChhhhcc---cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhH
Q 002533 704 GLSRMGPSGMSQS---HVSTVVKGSFGYVDPEYIRR---QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 704 Gla~~~~~~~~~~---~~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
|+++......... .......|+..|+|||.+.. .......|+|++|++++++++|..|+............ +
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~--~ 224 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT--L 224 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH--H
Confidence 9998544332221 13356679999999999987 57899999999999999999999996443311000011 1
Q ss_pred HhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
......... .................+.+++..|+..+|..|.++.+....
T Consensus 225 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 225 KIILELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111000 000000000002223567899999999999999999987765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-20 Score=207.18 Aligned_cols=219 Identities=24% Similarity=0.412 Sum_probs=163.3
Q ss_pred HHhcccccEeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCC
Q 002533 598 ISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAK 677 (911)
Q Consensus 598 l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~ 677 (911)
|+.+.|.|+.+++|.|.++...++|.+||..|+|.|.+.. ....++|.-...+..+|+.||+|||. +
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-----------~~~~~d~~F~~s~~rdi~~Gl~ylh~--s 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-----------EDIKLDYFFILSFIRDISKGLAYLHN--S 67 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-----------cccCccHHHHHHHHHHHHHHHHHHhc--C
Confidence 4678999999999999999999999999999999999954 23459999999999999999999994 3
Q ss_pred CcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc-------CCCchhHHHHHHH
Q 002533 678 HTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-------QLTEKSDVYSFGV 750 (911)
Q Consensus 678 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~t~ksDVwSfGv 750 (911)
.-..|+.++++|+++|..+.+||+|||+......... ........-..-|.|||.+... ..+.+.||||||+
T Consensus 68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~i 146 (484)
T KOG1023|consen 68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGI 146 (484)
T ss_pred cceeeeeeccccceeeeeEEEEechhhhccccccccc-ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHH
Confidence 3349999999999999999999999999876532111 1111122234569999999763 2577899999999
Q ss_pred HHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 751 VLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 751 vL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
+++|+++.+.||.......+...++.+.+. .......|.+.... +....+..++.+||..+|.+||++.+|..
T Consensus 147 i~~ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 147 IMYEILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHHHHHhccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 999999999999764433332233333222 01111222221111 34447889999999999999999999987
Q ss_pred HHHHHHh
Q 002533 831 GLEFALQ 837 (911)
Q Consensus 831 ~L~~~~~ 837 (911)
.++.+..
T Consensus 220 ~~~~~~~ 226 (484)
T KOG1023|consen 220 KLLTINK 226 (484)
T ss_pred hhhhhcc
Confidence 7765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=218.69 Aligned_cols=255 Identities=22% Similarity=0.247 Sum_probs=186.0
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEcc----C-CChhh-HHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLN----T-SSMQG-AREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~----~-~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
..++|.|++|.|+...........+.|... . ..... ...+..|+.+-..|+|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 568999999987777664443334444322 1 11111 12266788888889999999888888776666666999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
|++ +|..++... ..++-.++..+..|+..|++||| ..+|.|||||++|++++.++.+||+|||.
T Consensus 403 ~~~-Dlf~~~~~~------------~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN------------GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred ccH-HHHHHHhcc------------cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCc
Confidence 999 999998432 34777888899999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCC-CccccccccCcccccChhhhcccCCCc-hhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcc
Q 002533 706 SRMGPSGMS-QSHVSTVVKGSFGYVDPEYIRRQQLTE-KSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 706 a~~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~t~-ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
+........ .........|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+...... .
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------~- 539 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------N- 539 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------c-
Confidence 976544332 224556778999999999999999876 5899999999999999999996544322211000 0
Q ss_pred cCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHH
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 831 (911)
...+.....-...+....+.....++.++|+.+|.+|-|+++|++.
T Consensus 540 --~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 540 --YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000000000011223446677789999999999999999999764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=183.12 Aligned_cols=236 Identities=22% Similarity=0.304 Sum_probs=153.3
Q ss_pred ccceeecccCcEEEEEEEeecCCeEEEEEEccCC---ChhhHHHHHHHHHHHHhcc----------cccEeeecceec--
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELR----------HLHIVSLLGFCD-- 614 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~~~~~~~f~~Ei~~l~~l~----------HpnIv~l~g~~~-- 614 (911)
.....||.|+++.||.+++.++++.+|||+.... .....+++++|.-....+. |-.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3467899999999999999999999999986432 3345667777776655532 223332222221
Q ss_pred -------cC---C-----ceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCc
Q 002533 615 -------EH---G-----EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHT 679 (911)
Q Consensus 615 -------~~---~-----~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ 679 (911)
.. . ..+++|+-+ .++|.+++..-..... ....+....++.+..|+++.+++|| ..+
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-----~~~~l~~~arl~lT~Q~I~lvA~Lh---~~G 165 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-----THSPLAFAARLSLTVQMIRLVANLH---SYG 165 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-----TSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-----ccchhHHHHHHHHHHHHHHHHHHHh---hcc
Confidence 11 1 346788877 6789888643222111 1234667788899999999999999 799
Q ss_pred EEEecccCCCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhccc--------CCCchhHHHHHHHH
Q 002533 680 IIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ--------QLTEKSDVYSFGVV 751 (911)
Q Consensus 680 ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~t~ksDVwSfGvv 751 (911)
++|+||+|+|+|++.+|.++|+||+....... .... ...+..|.+||..... .++.+.|.|++|++
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCc-----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99999999999999999999999988764221 1111 2345779999977542 57899999999999
Q ss_pred HHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCC
Q 002533 752 LLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRR 822 (911)
Q Consensus 752 L~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 822 (911)
+|.|+||+.||......... .| .+ ..+. +.++.+..|+...|+.+|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~----~~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADP----EW----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTS----GG----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccc----cc----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999643211110 00 11 2333 678889999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-19 Score=183.06 Aligned_cols=171 Identities=15% Similarity=0.135 Sum_probs=131.3
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHH---------HHHHHHHHHHhcccccEeeecceecc
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR---------EFRTEIEMISELRHLHIVSLLGFCDE 615 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~---------~f~~Ei~~l~~l~HpnIv~l~g~~~~ 615 (911)
..++|...++||.|+||.||+.... ...+|||.+.+......+ .+.+|++.+.+++|++|..+..++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4678999999999999999997653 347999999754322222 26899999999999999998887542
Q ss_pred --------CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccC
Q 002533 616 --------HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKS 687 (911)
Q Consensus 616 --------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp 687 (911)
.+..+|||||++|.+|.++.. ++. ....+++.+|..|| ..+++|||+||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp 163 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------------ISE----DVKAKIKASIESLH---QHGMVSGDPHK 163 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----------------ccH----HHHHHHHHHHHHHH---HcCCccCCCCh
Confidence 246899999999999987641 111 24568999999999 79999999999
Q ss_pred CCeeecCCCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHH
Q 002533 688 TNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756 (911)
Q Consensus 688 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ell 756 (911)
+||+++.++ ++|+|||..+....... ...+.....+..++|+|+||+.+.-+.
T Consensus 164 ~Nili~~~g-i~liDfg~~~~~~e~~a---------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 164 GNFIVSKNG-LRIIDLSGKRCTAQRKA---------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HHEEEeCCC-EEEEECCCcccccchhh---------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 999999988 99999998765321100 011444556778999999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.5e-19 Score=179.81 Aligned_cols=137 Identities=18% Similarity=0.195 Sum_probs=105.3
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChh--h-------HHH-----------------HHHHHHHHHhcccccE
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ--G-------ARE-----------------FRTEIEMISELRHLHI 606 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~--~-------~~~-----------------f~~Ei~~l~~l~HpnI 606 (911)
..||+|+||.||+|... ++..||||+++..... . ... ...|++.|.++.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 47999999999999987 5579999998654211 1 112 2359999999988776
Q ss_pred eeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHH-hhCCCCcEEEecc
Q 002533 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL-HAGAKHTIIHRDV 685 (911)
Q Consensus 607 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yL-H~~~~~~ivHrDl 685 (911)
.....+. ....+|||||+++++|...+. ....+++.+...++.|++.+|.|| | ..+|+||||
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDl 144 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL------------KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADL 144 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh------------hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 4333222 123489999999887765431 123578889999999999999999 6 679999999
Q ss_pred cCCCeeecCCCceEEeecCCccC
Q 002533 686 KSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 686 kp~NILl~~~~~~kl~DFGla~~ 708 (911)
||+|||++ ++.++|+|||++..
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CHHHEEEE-CCcEEEEEcccccc
Confidence 99999998 47899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-19 Score=209.08 Aligned_cols=249 Identities=20% Similarity=0.229 Sum_probs=176.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC-hhhHHHHHHHHHH--HHhcccccEeeecceeccCCceEEEEe
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEM--ISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~-~~~~~~f~~Ei~~--l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+++..+.||.+.|=+|.+|++++| .|+||++-+.. .-..+.|.++++- ...++|||.+++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 455667899999999999999888 48899875432 2334444444433 445689999999888777788899999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|..+ +|+|.|. .++-|...+..-|+.|+..||.-+| +.+|+|||||.+||||+.=.=+.|+||.
T Consensus 102 yvkh-nLyDRlS------------TRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS------------TRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HHhh-hhhhhhc------------cchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhccc
Confidence 9854 8999882 4556777788889999999999999 8999999999999999976668899998
Q ss_pred CccCCCCC-CCCcccc---ccccCcccccChhhhccc-----------CCCchhHHHHHHHHHHHHHh-CCCCCCCCccc
Q 002533 705 LSRMGPSG-MSQSHVS---TVVKGSFGYVDPEYIRRQ-----------QLTEKSDVYSFGVVLLEVLC-GRPPMINGAVR 768 (911)
Q Consensus 705 la~~~~~~-~~~~~~~---~~~~gt~~y~APE~~~~~-----------~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~ 768 (911)
--+...-. ..+.... ..-..-..|+|||.+... ..+++.||||+||++.||++ |+++|.-
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---- 241 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---- 241 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----
Confidence 76532111 1111111 111223469999977531 26789999999999999999 6777731
Q ss_pred hhhhhHhhHHhhhc--ccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHH
Q 002533 769 KEEVSLVLWARVSR--ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833 (911)
Q Consensus 769 ~~~~~l~~~~~~~~--~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 833 (911)
.+|..+..... .+..++++-|+ .+.+++..|++.||++|-++.+.++.-+
T Consensus 242 ---SQL~aYr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 242 ---SQLLAYRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ---HHHHhHhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 12222222110 00112223333 4569999999999999999999988743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=171.75 Aligned_cols=141 Identities=18% Similarity=0.149 Sum_probs=107.6
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChh--------------------------hHHHHHHHHHHHHhccccc
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ--------------------------GAREFRTEIEMISELRHLH 605 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~--------------------------~~~~f~~Ei~~l~~l~Hpn 605 (911)
...||+|+||.||+|.+. +++.||||+++..... ....+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 357999999999999987 5579999998754211 0122457899999999998
Q ss_pred EeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecc
Q 002533 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDV 685 (911)
Q Consensus 606 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl 685 (911)
+.....+... ..+|||||++++++...+. ....++..+..+++.|++.+|.+||+ ..+|+||||
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l------------~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDl 144 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL------------KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDL 144 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh------------hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCC
Confidence 7443333222 2489999999886544321 11236677889999999999999993 289999999
Q ss_pred cCCCeeecCCCceEEeecCCccCCC
Q 002533 686 KSTNILLDENWAAKISDFGLSRMGP 710 (911)
Q Consensus 686 kp~NILl~~~~~~kl~DFGla~~~~ 710 (911)
||+|||++ ++.++|+|||+++...
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999 7899999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=167.45 Aligned_cols=187 Identities=17% Similarity=0.132 Sum_probs=138.0
Q ss_pred ccceeecccCcEEEEEEEeecCCeEEEEEEccCCChh----hHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEEe
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ----GAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~----~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E 624 (911)
....+|++|+||+||.+.. .+.+++.+.+...... ....|.+|+++|++|. |+++.+++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3456899999999997665 3457888877655331 1225889999999995 5788888886 34699999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecc-cCCCeeecCCCceEEeec
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDV-KSTNILLDENWAAKISDF 703 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DF 703 (911)
|+++.+|...+.. ....++.|++++|+++| ..+|+|||| ||.|||++.++.++|+||
T Consensus 79 yI~G~~L~~~~~~-------------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDF 136 (218)
T PRK12274 79 YLAGAAMYQRPPR-------------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDF 136 (218)
T ss_pred eecCccHHhhhhh-------------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEEC
Confidence 9999888654310 11346789999999999 799999999 799999999999999999
Q ss_pred CCccCCCCCCCC------cc----ccccccCcccccChhhhccc-CCC-chhHHHHHHHHHHHHHhCCCCCCC
Q 002533 704 GLSRMGPSGMSQ------SH----VSTVVKGSFGYVDPEYIRRQ-QLT-EKSDVYSFGVVLLEVLCGRPPMIN 764 (911)
Q Consensus 704 Gla~~~~~~~~~------~~----~~~~~~gt~~y~APE~~~~~-~~t-~ksDVwSfGvvL~ElltG~~p~~~ 764 (911)
|++......... .. .......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+...
T Consensus 137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 999854332210 00 01122357778888755432 233 567899999999999999987643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=196.13 Aligned_cols=256 Identities=21% Similarity=0.181 Sum_probs=183.9
Q ss_pred HHHHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc---cccEeeecceecc
Q 002533 539 LTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR---HLHIVSLLGFCDE 615 (911)
Q Consensus 539 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~ 615 (911)
..+++.....|.+.+.||+|+||.||+|...+ +..||||+-+..+... |.--.+++.||+ -+.|+.+...+.-
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34455566778899999999999999999988 5789999987765442 222233444444 2345555555666
Q ss_pred CCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC-
Q 002533 616 HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE- 694 (911)
Q Consensus 616 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~- 694 (911)
.+..+||+||.+.|+|.+++. ..+.++|...+.++.|+++-+++|| ..+|||+||||+|.||..
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N------------~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN------------TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRRE 830 (974)
T ss_pred CCcceeeeeccccccHHHhhc------------cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecc
Confidence 778899999999999999994 3456999999999999999999999 899999999999999942
Q ss_pred ------CCceEEeecCCccCCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccc
Q 002533 695 ------NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVR 768 (911)
Q Consensus 695 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~ 768 (911)
+..++|+|||.+-.+..-... ..-....+|-.+-.+|+..++.++.+.|.|.|..+++-|+.|+..-
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------ 903 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------ 903 (974)
T ss_pred cCCCCcccceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------
Confidence 456899999998643221111 2224556888899999999999999999999999999999997531
Q ss_pred hhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHHHh
Q 002533 769 KEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 769 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 837 (911)
...+.. ..++..++.-...+...++.++ .|..|-..=|...++...+++.+.
T Consensus 904 -------------~~~g~~-~~~~~~~~Ry~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 904 -------------VKNGSS-WMVKTNFPRYWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -------------hcCCcc-eeccccchhhhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHHHHHH
Confidence 001111 1112222222233334444444 444555556888888888877655
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-17 Score=168.26 Aligned_cols=136 Identities=16% Similarity=0.215 Sum_probs=105.5
Q ss_pred ccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-----ccccEeeecceeccCC---c-eE
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-----RHLHIVSLLGFCDEHG---E-MI 620 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-----~HpnIv~l~g~~~~~~---~-~~ 620 (911)
....+||+|+||.||. +..... .+||++........+.+.+|+++++++ .||||++++|++..+. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4466899999999996 544443 469988765445567899999999999 5799999999997763 3 34
Q ss_pred EEEee--cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHH-HHHhhCCCCcEEEecccCCCeeecC---
Q 002533 621 LVYEF--MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL-HYLHAGAKHTIIHRDVKSTNILLDE--- 694 (911)
Q Consensus 621 lV~E~--~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL-~yLH~~~~~~ivHrDlkp~NILl~~--- 694 (911)
+|+|| +++|+|.+++... .+++. ..++.+++.++ +||| +++|+||||||+|||++.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-------------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-------------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISE 143 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-------------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCC
Confidence 78999 5579999999421 23433 35677888777 9999 799999999999999974
Q ss_pred -CCceEEeecCCc
Q 002533 695 -NWAAKISDFGLS 706 (911)
Q Consensus 695 -~~~~kl~DFGla 706 (911)
+..++|+||+.+
T Consensus 144 ~~~~~~LiDg~G~ 156 (210)
T PRK10345 144 SEVIPVVCDNIGE 156 (210)
T ss_pred CCCcEEEEECCCC
Confidence 348999995543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.8e-16 Score=165.37 Aligned_cols=200 Identities=20% Similarity=0.239 Sum_probs=139.9
Q ss_pred ccccEeeecceeccC---------------------------CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCc
Q 002533 602 RHLHIVSLLGFCDEH---------------------------GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLT 654 (911)
Q Consensus 602 ~HpnIv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~ 654 (911)
+|||||++.+++.+. ..+|+||.-++ .+|+++|.. ...+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-------------~~~s 339 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-------------RHRS 339 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-------------CCCc
Confidence 599999998876431 25789998774 489999832 3355
Q ss_pred hhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeee--cCCC--ceEEeecCCccCCCCC-CCC--ccccccccCccc
Q 002533 655 WKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL--DENW--AAKISDFGLSRMGPSG-MSQ--SHVSTVVKGSFG 727 (911)
Q Consensus 655 ~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl--~~~~--~~kl~DFGla~~~~~~-~~~--~~~~~~~~gt~~ 727 (911)
.....-|..|+.+|+.||| +++|.|||+|++|||| |+|. ...|+|||++-....- ... ..-.....|...
T Consensus 340 ~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~ 416 (598)
T KOG4158|consen 340 YRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAK 416 (598)
T ss_pred hHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcce
Confidence 6666778899999999999 8999999999999999 3443 4678999997542211 111 111123357778
Q ss_pred ccChhhhcccC------CCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCCh
Q 002533 728 YVDPEYIRRQQ------LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAP 801 (911)
Q Consensus 728 y~APE~~~~~~------~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 801 (911)
-||||+....+ --.|+|.|+.|.+.||+++...||.. +.++.+.. +. +.+......+.
T Consensus 417 lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~----rGem~L~~--r~----------Yqe~qLPalp~ 480 (598)
T KOG4158|consen 417 LMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK----RGEMLLDT--RT----------YQESQLPALPS 480 (598)
T ss_pred ecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc----cchheech--hh----------hhhhhCCCCcc
Confidence 99999886432 13489999999999999999999965 11111110 00 11111234556
Q ss_pred HHHHHHHHHHHhcccccCCCCCCHHHHHHHHHH
Q 002533 802 VCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 802 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 834 (911)
.|+..+.+|+...++.||.+||+..-....|.-
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 677788899999999999999997766555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-17 Score=186.99 Aligned_cols=226 Identities=23% Similarity=0.293 Sum_probs=171.0
Q ss_pred eecccCcEEEEEEEe---ecCCeEEEEEEccCCChhh--HHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEEeecC
Q 002533 554 IIGSGGFGHVFKGYI---DDGSITVAVKRLNTSSMQG--AREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~---~~~~~~vAvK~l~~~~~~~--~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 627 (911)
++|+|.||.|+++.- .+.+..+|+|.++...... ......|..++...+ ||.+|++.-.+..+..++++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999987543 2334678888876542211 114556888888887 9999999999999999999999999
Q ss_pred CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCcc
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 707 (911)
+|.|...+... ...+......+...+|-++++|| +.+|+|||+|++||+++.+|++++.|||+++
T Consensus 81 gg~lft~l~~~------------~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglsk 145 (612)
T KOG0603|consen 81 GGDLFTRLSKE------------VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSK 145 (612)
T ss_pred cchhhhccccC------------CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhh
Confidence 99999888432 33555555666777889999999 8999999999999999999999999999998
Q ss_pred CCCCCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCc
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
..-.. ...+||..|||||++. ......|-||||++++||+||..||.. +....
T Consensus 146 e~v~~-------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~------------- 198 (612)
T KOG0603|consen 146 EAVKE-------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKR------------- 198 (612)
T ss_pred HhHhh-------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHH-------------
Confidence 63221 1127899999999998 567899999999999999999999854 11111
Q ss_pred ccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCH
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTM 825 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 825 (911)
+. +.....+.........++...+..+|.+|--.
T Consensus 199 --Il--~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 199 --IL--KAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --Hh--hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11 11123344555566677777778888888655
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.3e-16 Score=163.07 Aligned_cols=134 Identities=22% Similarity=0.321 Sum_probs=111.2
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCCh--------hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--------QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
+.||+|++|.||+|...+ ..++||+...... .....+.+|++++.+++|+++.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~--~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCC--CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 479999999999998844 4688887653321 112457889999999999998877777767778899999
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+++++|.+++... .+ .+..++.+++.+|.+|| ..+++|+|++|.|||++ ++.++|+|||
T Consensus 80 ~~~G~~L~~~~~~~---------------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 80 YIEGEPLKDLINSN---------------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred EeCCcCHHHHHHhc---------------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECC
Confidence 99999999988321 12 78899999999999999 78999999999999999 7899999999
Q ss_pred CccC
Q 002533 705 LSRM 708 (911)
Q Consensus 705 la~~ 708 (911)
+++.
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 9875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.9e-16 Score=162.98 Aligned_cols=142 Identities=19% Similarity=0.176 Sum_probs=108.3
Q ss_pred cCCccceeecccCcEEEEEEE-eecCCeEEEEEEccCCChh------------------------hHHHHHHHHHHHHhc
Q 002533 547 CDFADHCIIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQ------------------------GAREFRTEIEMISEL 601 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~-~~~~~~~vAvK~l~~~~~~------------------------~~~~f~~Ei~~l~~l 601 (911)
..|...+.||+|+||.||+|. ....++.||||+++..... ....+..|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 346677899999999999998 5455679999988643210 112356899999999
Q ss_pred cccc--EeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCc
Q 002533 602 RHLH--IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHT 679 (911)
Q Consensus 602 ~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ 679 (911)
.+.+ +.+++++ ...++||||+++++|...+.. ...+...+...++.|++.+|++|| ..+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH---~~g 168 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK------------DVEPEEEEEFELYDDILEEMRKLY---KEG 168 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc------------cCCcchHHHHHHHHHHHHHHHHHH---hcC
Confidence 7633 3344432 235899999999888765421 123455567889999999999999 788
Q ss_pred -EEEecccCCCeeecCCCceEEeecCCccC
Q 002533 680 -IIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 680 -ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|+||||||+||+++ ++.++|+|||++..
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 99999999999999 88999999999875
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.1e-16 Score=156.16 Aligned_cols=137 Identities=24% Similarity=0.350 Sum_probs=83.6
Q ss_pred EEEEeecCCCcccCCCCCccccccccCCCceeccCCCCcc-CCCCCceeecCCCCCccChhHHHHhhhccCCCCCCccce
Q 002533 239 TAYRLNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTP-HLPGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKY 317 (911)
Q Consensus 239 ~~~R~n~Gg~~~~~~~dd~~~R~W~~d~~~~~~~~s~~~~-~~~~~~i~~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~ 317 (911)
.++|+||||... +|..+..|++|..+..+...-... ........ .......+.+..+|||+|....
T Consensus 1 ~~~~IN~Gg~~~----~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~-~~~~i~~t~d~~Lyqt~R~g~~-------- 67 (174)
T PF11721_consen 1 VVLRINAGGPAY----TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSS-TNSSIPGTTDDPLYQTERYGPS-------- 67 (174)
T ss_dssp EEEEEEETSSSE----EETTTEEE-SSSSSTTSS-----------SSTT-S--TTS-HHHHHTTT-----SS--------
T ss_pred CEEEEECCCCcc----cCCCCCEEcCCCCCCCCCccccccccccccccc-ccccccCCCchhhhHhhcCCCC--------
Confidence 368999999985 455999999999886544300000 00000000 0011123668899999998222
Q ss_pred eeeEEee-cCCCCceEEEEeeeeeeeec----cccCcEEEEEEEcCeeccccccchhccCCCCccEEEEE-EEEeecc
Q 002533 318 NLTWNFS-VDPGFNYLVRLHFCETQLEI----TRENQRVFSIFINNQTAENDADVIHWSGGSGIPVFKDY-VVWVPID 389 (911)
Q Consensus 318 ~lt~~~~-~~~~~~y~v~lhFae~~~~~----~~~~~R~F~i~ing~~~~~~~~i~~~~~~~~~p~~~~~-~v~~~~~ 389 (911)
+|+|.+| +.+| .|.|+|||||+...- ...++|+|||+|||+++..+|||.+++++...|+++.| +|.+.+.
T Consensus 68 ~f~Y~ip~~~~G-~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg 144 (174)
T PF11721_consen 68 SFSYDIPVVPNG-TYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDG 144 (174)
T ss_dssp SEEEEEE--S-E-EEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETT
T ss_pred ceEEEEecCCCc-EEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCC
Confidence 3999999 5556 899999999998531 23899999999999999999999999998887777777 7766443
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=155.94 Aligned_cols=130 Identities=21% Similarity=0.309 Sum_probs=104.9
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCCCh--------hhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--------QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~--------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
+||+|+||.||+|.+.+ ..|++|+...... ....++.+|++++..++|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~~~--~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG--LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecCC--ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999999654 4788887543211 1235678899999999988765555555566677999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++++|.+++.... . .++.+++.+|.+|| ..+++|+|++|.||+++ ++.+++.|||+
T Consensus 79 ~~g~~l~~~~~~~~-------------~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-------------D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred ECCccHHHHHhhcH-------------H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCC
Confidence 99999998873210 0 78999999999999 79999999999999999 78999999999
Q ss_pred ccC
Q 002533 706 SRM 708 (911)
Q Consensus 706 a~~ 708 (911)
++.
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 876
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-16 Score=175.75 Aligned_cols=176 Identities=24% Similarity=0.335 Sum_probs=129.5
Q ss_pred CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC
Q 002533 617 GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 617 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 696 (911)
..+++.|++|...+|.+||.+.+ .....+|...+.++.|++.|++| ++.+|+|+||.||+...+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~---------~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~ 393 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR---------TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDD 393 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC---------cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccch
Confidence 35889999999999999996442 33457888999999999999999 5789999999999999999
Q ss_pred ceEEeecCCccCCCCCC---CCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHh-CCCCCCCCccchhhh
Q 002533 697 AAKISDFGLSRMGPSGM---SQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEV 772 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~Ellt-G~~p~~~~~~~~~~~ 772 (911)
.+||+|||+........ ......+...||..||+||.+.+..|+.|+||||||++|+||+. -...+....
T Consensus 394 q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------ 467 (516)
T KOG1033|consen 394 QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------ 467 (516)
T ss_pred hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------
Confidence 99999999987644332 11223456679999999999999999999999999999999997 222221100
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHH
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGD 827 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 827 (911)
.....-+.++++......+.+ ..++.+++...|.+||++.+
T Consensus 468 ---------t~~d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 468 ---------TLTDIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---------hhhhhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHH
Confidence 000011122222332233322 36888999999999994433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=181.34 Aligned_cols=137 Identities=20% Similarity=0.264 Sum_probs=109.9
Q ss_pred CCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC------hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEE
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS------MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~------~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 621 (911)
.|...++||+|+||+||+|.+.+....+.++..+... ....+.+.+|++++++++|++++....++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 3455678999999999999987654322222221111 1123568899999999999999888877777778899
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEe
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 701 (911)
||||+++++|.+++. ...+++.+++++|.||| +.+++||||||+|||+ .++.++|+
T Consensus 414 v~E~~~g~~L~~~l~--------------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEEecCCCcHHHHHH--------------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEE
Confidence 999999999999883 24678999999999999 7899999999999999 57799999
Q ss_pred ecCCccC
Q 002533 702 DFGLSRM 708 (911)
Q Consensus 702 DFGla~~ 708 (911)
|||+++.
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999975
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=153.50 Aligned_cols=142 Identities=18% Similarity=0.118 Sum_probs=108.5
Q ss_pred HHHHHccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh----------------------hhHHHHHHHHHHH
Q 002533 541 EIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM----------------------QGAREFRTEIEMI 598 (911)
Q Consensus 541 el~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~----------------------~~~~~f~~Ei~~l 598 (911)
++.....-|...+.||+|+||.||++...+ ++.||||++..... .....+..|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPD-GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCC-CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 444444446677899999999999998864 57899998654320 0112367789999
Q ss_pred Hhccccc--EeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCC
Q 002533 599 SELRHLH--IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGA 676 (911)
Q Consensus 599 ~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~ 676 (911)
.++.|++ +...++ ....++||||+++++|..... .....+++.+++.++.+||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------------------~~~~~~~~~~i~~~l~~lh--- 142 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------------------LEDPEEVLDEILEEIVKAY--- 142 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc------------------cccHHHHHHHHHHHHHHHH---
Confidence 9998874 344443 235589999999999876541 0234578899999999999
Q ss_pred CCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 677 KHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 677 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
..+|+||||||+||++++++.++|+|||++..
T Consensus 143 ~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 143 KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred HCCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 68999999999999999999999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.9e-16 Score=180.14 Aligned_cols=213 Identities=25% Similarity=0.399 Sum_probs=144.3
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEe
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 624 (911)
...+|...++|-.|+||.||..+++...+++|+|+-+..- ++ +||+.+.+ ..+.|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------------il-----Rnilt~a~------npfvv-- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------------IL-----RNILTFAG------NPFVV-- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccch------------hh-----hccccccC------Cccee--
Confidence 3467888999999999999999999888899995433211 11 12222221 12222
Q ss_pred ecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 ~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
|+=...+... ++++ .+++.+++||| ..+|+|||+||+|.||+.-|++|+.|||
T Consensus 136 ----gDc~tllk~~------------g~lP--------vdmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfg 188 (1205)
T KOG0606|consen 136 ----GDCATLLKNI------------GPLP--------VDMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFG 188 (1205)
T ss_pred ----chhhhhcccC------------CCCc--------chhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchh
Confidence 3333333211 1222 12277899999 8999999999999999999999999999
Q ss_pred CccCCCCCC------------CCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhh
Q 002533 705 LSRMGPSGM------------SQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEV 772 (911)
Q Consensus 705 la~~~~~~~------------~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~ 772 (911)
+++.+.... ...-....++||+.|+|||++..+.|....|.|++|+++||.+-|+.||++... ++-.
T Consensus 189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelf 267 (1205)
T KOG0606|consen 189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELF 267 (1205)
T ss_pred hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHH
Confidence 997643221 112223557899999999999999999999999999999999999999976542 2211
Q ss_pred hHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCC
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT 824 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 824 (911)
..+.- +++..+ +.....+.+..+++.+.|+.+|..|--
T Consensus 268 g~vis----------d~i~wp----E~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 268 GQVIS----------DDIEWP----EEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhhh----------hhcccc----ccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 11110 011111 112223445678889999999999953
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.6e-14 Score=136.40 Aligned_cols=134 Identities=19% Similarity=0.199 Sum_probs=112.6
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhccc--ccEeeecceeccCCceEEEEeecCCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRH--LHIVSLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~g 629 (911)
.+.||+|.++.||++...+ ..++||....... ...+.+|+..+..++| .++.+++++....+..+++|||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4579999999999999866 4799999865543 4678899999999987 48889998888888899999999887
Q ss_pred chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 630 NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 630 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
.+..+ ++.....++.+++++|++||.....+++|+|++|+|||+++.+.+++.|||+++.
T Consensus 79 ~~~~~-------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77542 3445567889999999999954446899999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=146.33 Aligned_cols=135 Identities=16% Similarity=0.181 Sum_probs=103.7
Q ss_pred ceeec-ccCcEEEEEEEeecCCeEEEEEEccCCC-------------hhhHHHHHHHHHHHHhcccccE--eeecceecc
Q 002533 552 HCIIG-SGGFGHVFKGYIDDGSITVAVKRLNTSS-------------MQGAREFRTEIEMISELRHLHI--VSLLGFCDE 615 (911)
Q Consensus 552 ~~~LG-~G~fG~Vykg~~~~~~~~vAvK~l~~~~-------------~~~~~~f~~Ei~~l~~l~HpnI--v~l~g~~~~ 615 (911)
..+|| .|+.|+||+....+ ..++||+..... ......+.+|++++.+|+|++| .+.++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~--~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPG--VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeCC--ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35788 99999999998864 478998775321 1233467889999999998875 667766533
Q ss_pred CC----ceEEEEeecCC-CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCe
Q 002533 616 HG----EMILVYEFMPR-GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNI 690 (911)
Q Consensus 616 ~~----~~~lV~E~~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NI 690 (911)
.. ..++|||++++ .+|.+++.. ..++. ..+.+++.+|.+|| ..+|+||||||.||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-------------~~l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NI 173 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-------------APLSE----EQWQAIGQLIARFH---DAGVYHADLNAHNI 173 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-------------CCCCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhE
Confidence 22 23599999997 689888732 12332 23578999999999 79999999999999
Q ss_pred eecCCCceEEeecCCccC
Q 002533 691 LLDENWAAKISDFGLSRM 708 (911)
Q Consensus 691 Ll~~~~~~kl~DFGla~~ 708 (911)
|++.++.++|+|||.++.
T Consensus 174 Lv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 174 LLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEcCCCCEEEEECCCccc
Confidence 999988999999998875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=9e-14 Score=141.76 Aligned_cols=135 Identities=19% Similarity=0.195 Sum_probs=95.2
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChh--hHHH----------------------HHHHHHHHHhccccc--
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ--GARE----------------------FRTEIEMISELRHLH-- 605 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~--~~~~----------------------f~~Ei~~l~~l~Hpn-- 605 (911)
.+.||+|+||.||+|.+. +++.||||+++..... .... ...|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 357999999999999987 4578999987653211 1111 134555566664433
Q ss_pred EeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCC-CcEEEec
Q 002533 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAK-HTIIHRD 684 (911)
Q Consensus 606 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~-~~ivHrD 684 (911)
+.+.+++ ...++||||++++.+........ ... .+...++.+++.++.+|| . .+|+|+|
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------------~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~D 140 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------------RLL-EDPEELYDQILELMRKLY---REAGLVHGD 140 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh------------hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCC
Confidence 3333332 24689999999965432211110 011 566789999999999999 5 8999999
Q ss_pred ccCCCeeecCCCceEEeecCCccC
Q 002533 685 VKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 685 lkp~NILl~~~~~~kl~DFGla~~ 708 (911)
|||+||+++ ++.++|+|||.+..
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred CChhhEEEE-CCcEEEEECccccc
Confidence 999999999 88999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=136.38 Aligned_cols=206 Identities=22% Similarity=0.308 Sum_probs=140.7
Q ss_pred HHHHhcccccEeeecceeccC-----CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHH
Q 002533 596 EMISELRHLHIVSLLGFCDEH-----GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670 (911)
Q Consensus 596 ~~l~~l~HpnIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~ 670 (911)
.-|-++-|-|||++..|+.+. .+..++.|||..|+|..+|++.+. ....+......+++.||..||.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--------~~~a~~~~~wkkw~tqIlsal~ 190 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--------NQKALFQKAWKKWCTQILSALS 190 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--------hhhhhhHHHHHHHHHHHHhhhh
Confidence 345566799999999998543 357899999999999999987654 3445677777899999999999
Q ss_pred HHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCC-CCCccccccccCcccccChhhhcccCCCchhHHHHHH
Q 002533 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG-MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFG 749 (911)
Q Consensus 671 yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfG 749 (911)
|||+ +.+.|+|+++..+-|++..++-+||+----....+.- ...........+-++|.+||+=...+.+..+|||+||
T Consensus 191 yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 191 YLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred hhhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 9996 6799999999999999999988887421111100000 0001112223467899999987777888899999999
Q ss_pred HHHHHHHhCCCCCCCCccchh-hhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHH
Q 002533 750 VVLLEVLCGRPPMINGAVRKE-EVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828 (911)
Q Consensus 750 vvL~ElltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eV 828 (911)
+..+||.-+..--..+....+ +..+ + ..+.-.-+..- ..++..|++.+|..||+|+++
T Consensus 270 mcAlemailEiq~tnseS~~~~ee~i---a------~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 270 MCALEMAILEIQSTNSESKVEVEENI---A------NVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred HHHHHHHHheeccCCCcceeehhhhh---h------hheeeccCccc------------cCcCcccccCCCCCCcchhhh
Confidence 999999887643211110000 0000 0 00000111111 256789999999999999998
Q ss_pred HHH
Q 002533 829 TWG 831 (911)
Q Consensus 829 l~~ 831 (911)
+.+
T Consensus 329 lfH 331 (458)
T KOG1266|consen 329 LFH 331 (458)
T ss_pred hcC
Confidence 654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-13 Score=163.15 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=183.1
Q ss_pred CccceeecccCcEEEEEEEeec-CCeEEEEEEccCCC--hhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEEe
Q 002533 549 FADHCIIGSGGFGHVFKGYIDD-GSITVAVKRLNTSS--MQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~-~~~~vAvK~l~~~~--~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E 624 (911)
|...+.||+|.|+.|-...... ....+|+|.+.... .........|..+-..+. |+|++++++.....+..+++.|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 3334469999999998887633 34567777665443 222334445777766676 9999999999999999999999
Q ss_pred ecCCCchhhHh-hhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC-ceEEee
Q 002533 625 FMPRGNLRDHL-YNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW-AAKISD 702 (911)
Q Consensus 625 ~~~~gsL~~~L-~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~D 702 (911)
|..++++.+.+ +.. ....+-...-.+..|+..++.|+|. ..++.|+||||+|.+++..+ ..+++|
T Consensus 102 ~s~g~~~f~~i~~~~-----------~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPD-----------STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred cccccccccccccCC-----------ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCC
Confidence 99999998877 221 1134455566788999999999994 57899999999999999999 999999
Q ss_pred cCCccCCCCCCCCccccccccC-cccccChhhhccc-CCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhh
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKG-SFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~g-t~~y~APE~~~~~-~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
||+|.................| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|...
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~ 246 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSN 246 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccc
Confidence 9999876552222333445567 9999999998874 55678999999999999999999986543221 111112111
Q ss_pred hcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
. ..... ...........++..+++..+|..|.+.+++..
T Consensus 247 ~---~~~~~--------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 247 K---GRFTQ--------LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c---ccccc--------CccccCChhhhhcccccccCCchhccccccccc
Confidence 1 00000 011122345567888899999999999887743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.6e-11 Score=141.32 Aligned_cols=140 Identities=23% Similarity=0.223 Sum_probs=99.0
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhH----------------------------------------HHH
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA----------------------------------------REF 591 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~----------------------------------------~~f 591 (911)
.+.||.|++|.||+|++.++ +.||||+.++.-.... -+|
T Consensus 122 ~~plasaSigQVh~A~l~~G-~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDG-KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEecCC-CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999999876 6899999876421110 024
Q ss_pred HHHHHHHHhcc----cccEeeeccee-ccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHH
Q 002533 592 RTEIEMISELR----HLHIVSLLGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666 (911)
Q Consensus 592 ~~Ei~~l~~l~----HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia 666 (911)
.+|.+.+.+++ |.+-+.+-.++ ......+|||||++|++|.+++..... .. .+.+++..++
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-----------~~---~~~~ia~~~~ 266 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-----------GL---DRKALAENLA 266 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-----------CC---CHHHHHHHHH
Confidence 45555555552 22223333333 334567999999999999987642210 01 2455667666
Q ss_pred H-HHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCC
Q 002533 667 R-GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 667 ~-gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 709 (911)
+ .+..+| ..+++|+|++|.||+++.++.++++|||++...
T Consensus 267 ~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 267 RSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 6 467888 789999999999999999999999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-11 Score=124.01 Aligned_cols=152 Identities=24% Similarity=0.317 Sum_probs=89.0
Q ss_pred EEEecCCCCCccCCCCCeecCCCCCcccCCC-CCc----c-cccccccccCCCCCCCCccceeeeccCcceEee-eCCCC
Q 002533 35 ILIICGESSNTTSSDGRNWDGDAHSKFSSSN-SAT----K-SFTSRASFQENSVPQVPYMTARVFPEEFTYTFP-VSPGP 107 (911)
Q Consensus 35 ~~i~cG~~~~~~~~~~~~~~~D~~~~~g~~~-~~~----~-~~~~~~~~~~~~~~~~~~~t~R~f~~~~~Y~~~-~~~g~ 107 (911)
++||||+..+ ++..|+.|.+|..|.+|... ... . ..... ..-....++..|+|.|.=|..+.|.|| ++.|.
T Consensus 3 ~~IN~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~-~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G~ 80 (174)
T PF11721_consen 3 LRINAGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTN-SSIPGTTDDPLYQTERYGPSSFSYDIPVVPNGT 80 (174)
T ss_dssp EEEEETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS---TTS-HHHHHTTT-----SSSEEEEEE--S-EE
T ss_pred EEEECCCCcc-cCCCCCEEcCCCCCCCCCccccccccccccccccc-ccccCCCchhhhHhhcCCCCceEEEEecCCCcE
Confidence 7999998777 77889999999999655540 000 0 00000 000112233559999998778999999 57888
Q ss_pred eEEEEeecCCccccccccCCCCCccccccceEEEEeCceEEeeccCccccccccCCCccceEEEE-EEecCCCCeEEEEE
Q 002533 108 KFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEF-IISVSSSQMLNLTF 186 (911)
Q Consensus 108 ~~lR~~f~~~~~~~~~~~g~~d~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~i~~~~~~~~~v~~ 186 (911)
+-|||||.+..+.. -.+...+..--|+|.+||-.++.+||....+.... ..++++| -|.| .++.|.|+|
T Consensus 81 Y~V~L~FaE~~~~~------~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~---~~~~~~~~~v~v-~dg~L~i~f 150 (174)
T PF11721_consen 81 YTVRLHFAELYFGA------SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFN---KAAVRRFFNVTV-TDGTLNIQF 150 (174)
T ss_dssp EEEEEEEE-SSS--------------SSSS-EEEEETTEEEEEEE-HHHHHSSSS------EEEEEEEEE-ETTEEETTE
T ss_pred EEEEEEeccccccc------cccccCCCceEEEEEecceEEEeccCHHHHcCCCc---eEEEEEEEEEEE-eCCcEEEEE
Confidence 77799999775432 11222345566999999999999999988765422 3466666 4666 447899999
Q ss_pred e------------cCCCCcceeeeee
Q 002533 187 S------------PSSSSSYAFINGI 200 (911)
Q Consensus 187 ~------------~~~~~~~~fi~~i 200 (911)
. +.. +.|.||||
T Consensus 151 ~~~~~~~~~i~~~~~~--~~p~IsaI 174 (174)
T PF11721_consen 151 VWAGKGTLCIPFIGSY--GNPLISAI 174 (174)
T ss_dssp EEE--SEEEEEEESSS--SSSSEEEE
T ss_pred EecCCCcEEeeccccC--CCcEEeeC
Confidence 8 333 34888887
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-11 Score=137.65 Aligned_cols=249 Identities=22% Similarity=0.225 Sum_probs=175.3
Q ss_pred Cccceeecc--cCcEEEEEEEe--ecCCeEEEEEEccCC--ChhhHHHHHHHHHHHHhc-ccccEeeecceeccCCceEE
Q 002533 549 FADHCIIGS--GGFGHVFKGYI--DDGSITVAVKRLNTS--SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 549 f~~~~~LG~--G~fG~Vykg~~--~~~~~~vAvK~l~~~--~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 621 (911)
|...+.+|. |.+|.||.+.. ......+|+|+-+.. .......=.+|+....++ .|+|.++....+...+.+++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 344567999 99999999998 777788999984432 223333344566666666 59999998888999999999
Q ss_pred EEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHH----HHHHHhhCCCCcEEEecccCCCeeecCC-C
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR----GLHYLHAGAKHTIIHRDVKSTNILLDEN-W 696 (911)
Q Consensus 622 V~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~----gL~yLH~~~~~~ivHrDlkp~NILl~~~-~ 696 (911)
-+|++ +.+|..+.+.. ...++....+.+..+..+ ||.++| ...++|-|+||.||++..+ .
T Consensus 196 qtE~~-~~sl~~~~~~~-----------~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 196 QTELC-GESLQSYCHTP-----------CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred eeccc-cchhHHhhhcc-----------cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccc
Confidence 99998 57887777532 223455555666666666 999999 7899999999999999999 8
Q ss_pred ceEEeecCCccCCCCCCCCc--cccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhH
Q 002533 697 AAKISDFGLSRMGPSGMSQS--HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 697 ~~kl~DFGla~~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l 774 (911)
..+++|||+........-.. .......|...|++||..+ +.++.++|+|++|.+.+|..++......+...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------ 333 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------ 333 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------
Confidence 89999999987654432111 1112225777899999875 46788999999999999999988765433211
Q ss_pred hhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHH
Q 002533 775 VLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTW 830 (911)
Q Consensus 775 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 830 (911)
.|... +... +..++.......+..++.++++.+|..|++.+.+..
T Consensus 334 -~W~~~-------r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 -SWSQL-------RQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -Ccccc-------cccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 12111 1111 111111112344555888999999999998877644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.2e-10 Score=127.83 Aligned_cols=171 Identities=19% Similarity=0.221 Sum_probs=126.8
Q ss_pred EEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccc
Q 002533 565 KGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQN 644 (911)
Q Consensus 565 kg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~ 644 (911)
.|..+..+.+|.|+..+...........+.++.|+.||||||++++...+..+.+|||+|-+ -.|..+|..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------
Confidence 45555556788888887665544455677889999999999999999999999999999987 346666632
Q ss_pred cccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCccccccccC
Q 002533 645 QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724 (911)
Q Consensus 645 ~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g 724 (911)
+.-....-.+.||+.||.|||+ +.+++|++|.-..|++++.|+.||++|.++......... .....-
T Consensus 101 --------l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~---~~~~~~ 167 (690)
T KOG1243|consen 101 --------LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP---AKSLYL 167 (690)
T ss_pred --------hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc---cccchh
Confidence 2233445578899999999996 678999999999999999999999999988643221110 011111
Q ss_pred cccccChhhhcccCCCchhHHHHHHHHHHHHHhCC
Q 002533 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGR 759 (911)
Q Consensus 725 t~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~ 759 (911)
-..|..|+.+.... -..|.|.|||++||++.|.
T Consensus 168 ~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 168 IESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 22466676543322 3569999999999999983
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.1e-10 Score=113.61 Aligned_cols=130 Identities=18% Similarity=0.122 Sum_probs=94.7
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEee-ecceeccCCceEEEEeecCCCch
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVS-LLGFCDEHGEMILVYEFMPRGNL 631 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~-l~g~~~~~~~~~lV~E~~~~gsL 631 (911)
+.|+.|.++.||++...+ ..+++|....... ....+..|+++++.+.+.++++ ++.+. ....++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~~--~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVAN--KKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEECC--eEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 468999999999998763 4799998755432 2235678999999987665543 44433 2345899999999887
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCC--CCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGA--KHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
.+.. . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-----------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 0 11245678999999999422 22369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.1e-10 Score=133.44 Aligned_cols=158 Identities=21% Similarity=0.243 Sum_probs=103.6
Q ss_pred eEEEecCCCC------CccCCC--CCeecCCCCCcccC--CCCCcccccccccccCCCCCCCCccceeeeccC---cceE
Q 002533 34 YILIICGESS------NTTSSD--GRNWDGDAHSKFSS--SNSATKSFTSRASFQENSVPQVPYMTARVFPEE---FTYT 100 (911)
Q Consensus 34 ~~~i~cG~~~------~~~~~~--~~~~~~D~~~~~g~--~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~---~~Y~ 100 (911)
.++||||+.. +.+|.- .|.|.+|..|-.+. ..+....+... .......|...|+|||.+... .+|.
T Consensus 193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~-~~~~~~~P~~VyqTA~~~~~~~~~lty~ 271 (623)
T PLN03150 193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKA-SNAPNFYPESLYQSALVSTDTQPDLSYT 271 (623)
T ss_pred EEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccc-cCCCccChHHHhhhhccccCCCCceEEE
Confidence 5799999732 222222 79999998873221 11111111111 011111233459999999863 8899
Q ss_pred eeeCCC-CeEEEEeecCCccccccccCCCCCccccccceEEEEeCceEEeeccCccccccccCCCccceEEEEEEecCCC
Q 002533 101 FPVSPG-PKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSS 179 (911)
Q Consensus 101 ~~~~~g-~~~lR~~f~~~~~~~~~~~g~~d~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~i~~~~~ 179 (911)
|++.++ .+++|+||++.... .....+..|+|.+|+...+++++....... ...++++++.+.+..
T Consensus 272 ~~v~~~~~Y~VrLhFaEi~~~----------~~~~~~R~F~V~ing~~~~~~~di~~~~g~---~~~~~~~~~~v~~~~- 337 (623)
T PLN03150 272 MDVDPNRNYSVWLHFAEIDNS----------ITAEGKRVFDVLINGDTAFKDVDIVKMSGE---RYTALVLNKTVAVSG- 337 (623)
T ss_pred eecCCCCCEEEEEEEEeccCc----------cCCCceEEEEEEECCEEeecccChhhhcCC---cccceEEEeEEeecC-
Confidence 999655 55559999976421 111234568899999999988876443221 246889999999875
Q ss_pred CeEEEEEecCCCCcceeeeeeEeEecCC
Q 002533 180 QMLNLTFSPSSSSSYAFINGIEVVSMPD 207 (911)
Q Consensus 180 ~~~~v~~~~~~~~~~~fi~~iE~~~~~~ 207 (911)
+.+.|+|+|..++ .||||||||+.+-.
T Consensus 338 g~l~isl~p~~~s-~pilNaiEI~~~~~ 364 (623)
T PLN03150 338 RTLTIVLQPKKGT-HAIINAIEVFEIIT 364 (623)
T ss_pred CeEEEEEeeCCCC-cceeeeeeeeeccc
Confidence 7899999997654 59999999999876
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.8e-10 Score=131.34 Aligned_cols=146 Identities=18% Similarity=0.150 Sum_probs=91.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhh----------------------------------HH---
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG----------------------------------AR--- 589 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~----------------------------------~~--- 589 (911)
.+|+. +.||.|++|.||+|++.++++.||||++++.-.+. .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 68999999999999998856799999997542110 11
Q ss_pred ---HHHHHHHHHHhcc----cccEeeeccee-ccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHH
Q 002533 590 ---EFRTEIEMISELR----HLHIVSLLGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661 (911)
Q Consensus 590 ---~f~~Ei~~l~~l~----HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i 661 (911)
+|.+|..-+.+++ +.+.+.+-.++ .-....+|||||++|+.|.+.-.-.. ...+ +..+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-----------~g~d---~~~l 264 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-----------AGTD---MKLL 264 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-----------cCCC---HHHH
Confidence 1334444444442 33333333332 22456789999999999987421110 0011 1122
Q ss_pred HHhHHHH-HHHHhhCCCCcEEEecccCCCeeecCCC----ceEEeecCCccCCC
Q 002533 662 SIGAARG-LHYLHAGAKHTIIHRDVKSTNILLDENW----AAKISDFGLSRMGP 710 (911)
Q Consensus 662 a~~ia~g-L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~ 710 (911)
+...++. +..++ ..+++|+|+||.||+++.++ ++++.|||++....
T Consensus 265 a~~~v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 265 AERGVEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 2222211 22233 57999999999999999888 99999999987543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-09 Score=109.15 Aligned_cols=136 Identities=14% Similarity=0.157 Sum_probs=95.1
Q ss_pred eeecccCcEEEEEEEeec------CCeEEEEEEccCCCh----------------------hhHHHHH----HHHHHHHh
Q 002533 553 CIIGSGGFGHVFKGYIDD------GSITVAVKRLNTSSM----------------------QGAREFR----TEIEMISE 600 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~------~~~~vAvK~l~~~~~----------------------~~~~~f~----~Ei~~l~~ 600 (911)
.+||.|--+.||.|...+ .+..+|||+.+.... ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998654 236899997642110 0012233 79999998
Q ss_pred ccc--ccEeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHH-hhCCC
Q 002533 601 LRH--LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL-HAGAK 677 (911)
Q Consensus 601 l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yL-H~~~~ 677 (911)
+.. -++.+++++ ..-+|||||+.++.+..-.. ....++..+..++..+++.+|..| | +
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L------------kd~~~~~~~~~~i~~~i~~~l~~l~H---~ 143 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL------------KDAKLNDEEMKNAYYQVLSMMKQLYK---E 143 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh------------hccccCHHHHHHHHHHHHHHHHHHHH---h
Confidence 853 344445543 46789999997654422110 111233445567789999999999 7 7
Q ss_pred CcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 678 HTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 678 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
.++||+||++.|||+++ +.+.|+|||.+..
T Consensus 144 ~glVHGDLs~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 144 CNLVHADLSEYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred CCeecCCCCHHHEEEEC-CcEEEEECCCcee
Confidence 89999999999999974 6799999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.3e-10 Score=126.92 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=177.8
Q ss_pred HHHccCCccceeecccCcEEEEEEEee-cCCeEEEEEEccCCChhhHHH--HHHHHHHHHhc-ccccEeeecceeccCCc
Q 002533 543 KQATCDFADHCIIGSGGFGHVFKGYID-DGSITVAVKRLNTSSMQGARE--FRTEIEMISEL-RHLHIVSLLGFCDEHGE 618 (911)
Q Consensus 543 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~~vAvK~l~~~~~~~~~~--f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 618 (911)
..-+.+|.....||.|.|+.|++...+ .++..+++|.+.+.......+ -..|+-+...+ .|.+++.....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 334567888889999999999998766 566789999876553322222 23566666555 58888888888877778
Q ss_pred eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCC-Cc
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WA 697 (911)
Q Consensus 619 ~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~ 697 (911)
.++--|||+++++...+.- ...++...++++..|++.++.++| ++.++|+|+||+||++..+ +.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~------------~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT------------SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFF 405 (524)
T ss_pred ccCchhhhcCcchhhhhHH------------HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhh
Confidence 8899999999998776621 123677788999999999999999 8999999999999999886 78
Q ss_pred eEEeecCCccCCCCCCCCccccccccCcccc-cChhhhcccCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhh
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGY-VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 698 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y-~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
.+++|||++....... ......+..| .+++......+..+.|+++||..+.|.+++..--... ..
T Consensus 406 ~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------~~ 471 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---------VQ 471 (524)
T ss_pred hhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc---------cc
Confidence 8999999986321110 0111122334 3666667778899999999999999999987532111 11
Q ss_pred HHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhcccccCCCCCCHHHHHHHHHHH
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 835 (911)
|.. +....+ ... ......+..+.......++..||.+.++..+.+..
T Consensus 472 ~~~----------i~~~~~-p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 SLT----------IRSGDT-PNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cee----------eecccc-cCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111 000000 011 11225667788888999999999999887776554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.3e-09 Score=110.86 Aligned_cols=142 Identities=19% Similarity=0.311 Sum_probs=102.2
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCCh-hhHHHHHHHHHHHHhcccc--cEeeecceeccC---CceEEEEeec
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREFRTEIEMISELRHL--HIVSLLGFCDEH---GEMILVYEFM 626 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~-~~~~~f~~Ei~~l~~l~Hp--nIv~l~g~~~~~---~~~~lV~E~~ 626 (911)
+.|+.|..+.||++...++ ..+++|....... ....++..|.++++.+++. ++.+++.++... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g-~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGG-RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCC-cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 4689999999999988663 5799998765432 2345788999999999763 456677776553 3568999999
Q ss_pred CCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhC-------------------------------
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAG------------------------------- 675 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~------------------------------- 675 (911)
++.+|.+.+.. ..++..++..++.++++.|..||+.
T Consensus 83 ~G~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 83 DGRVLRDRLLR-------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred CCEecCCCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 99988775520 1234444555555555555555521
Q ss_pred ----------------------CCCcEEEecccCCCeeecC--CCceEEeecCCccC
Q 002533 676 ----------------------AKHTIIHRDVKSTNILLDE--NWAAKISDFGLSRM 708 (911)
Q Consensus 676 ----------------------~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 708 (911)
....++|+|+++.||+++. +..+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356899999999999998 66789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-08 Score=100.29 Aligned_cols=130 Identities=21% Similarity=0.287 Sum_probs=98.9
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEc-cCC-Chh------hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEee
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRL-NTS-SMQ------GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l-~~~-~~~------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 625 (911)
.+++|+-+.+|.+.+.+. .+++|.- .+. ... ..+.-.+|..+|.+++--.|.-.+=+..+.....|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~g~--~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL--PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeeccCc--ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 588999999999987654 4666642 211 111 123466899999998765554444455677788999999
Q ss_pred cCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCC
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 705 (911)
+++..|.+.|... +..++..+-+-+.-|| +.+|+|+||.++||++..+. +.++||||
T Consensus 81 I~G~~lkd~l~~~-------------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGL 137 (204)
T COG3642 81 IEGELLKDALEEA-------------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGL 137 (204)
T ss_pred eCChhHHHHHHhc-------------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCc
Confidence 9999999888321 3567778888889999 89999999999999998765 99999999
Q ss_pred ccC
Q 002533 706 SRM 708 (911)
Q Consensus 706 a~~ 708 (911)
+..
T Consensus 138 g~~ 140 (204)
T COG3642 138 GEF 140 (204)
T ss_pred ccc
Confidence 875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.1e-08 Score=110.02 Aligned_cols=178 Identities=17% Similarity=0.218 Sum_probs=133.6
Q ss_pred EEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEeeecceec----cCCceEEEEeecCC-CchhhHh
Q 002533 561 GHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD----EHGEMILVYEFMPR-GNLRDHL 635 (911)
Q Consensus 561 G~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~L 635 (911)
.+.||+...-++..+++|+++....+.......-+++++++.|.|+|++..++. .+..+++||+|+++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578999988777889999995443333333345678899999999999998875 34578999999987 7888776
Q ss_pred hhhhhcc---cccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCC
Q 002533 636 YNSQKQN---QNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 636 ~~~~~~~---~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 712 (911)
....... ..........+++..+|.++.|++.||.++| +.|+.-+-|.+++||++.+.+++|+..|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 5443322 1111224456788999999999999999999 788888999999999999999999999887654322
Q ss_pred CCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCC
Q 002533 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761 (911)
Q Consensus 713 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p 761 (911)
. . |-+.. -.+-|.=.||.+++.|.||...
T Consensus 447 ~---------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 P---------------T--EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred C---------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 1 0 11111 2367888999999999999653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.8e-09 Score=128.30 Aligned_cols=249 Identities=19% Similarity=0.198 Sum_probs=161.5
Q ss_pred cCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCC---hhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEEE
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 623 (911)
.+|...+-+-.|.++.++.+.-...+...++|...... ....+....+-.++-..+||-++...--+.-.....|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 44555667889999999887765554444444432211 111222222333333334566665554445567889999
Q ss_pred eecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeec
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 703 (911)
+|..+++|...|+.... ++..-.......+..+++||| ...+.|+|++|.|+|...++..+++||
T Consensus 884 ~~~~~~~~~Skl~~~~~------------~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC------------LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred HHhccCCchhhhhcCCC------------cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcc
Confidence 99999999999976531 222222233445677899999 566899999999999999999999999
Q ss_pred CCccCCC-C--------------------C-------CCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHH
Q 002533 704 GLSRMGP-S--------------------G-------MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV 755 (911)
Q Consensus 704 Gla~~~~-~--------------------~-------~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~El 755 (911)
|...... . . ...........||..|.+||.+.+......+|.|++|++++|.
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence 8432110 0 0 0001123345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCcccc-CCCChHHHHHHHHHHHhcccccCCCCCCHH
Q 002533 756 LCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLR-GKIAPVCLNKFVEIAGSCTDEEGFRRPTMG 826 (911)
Q Consensus 756 ltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 826 (911)
++|..||......+.- +.+....+. ...+........+++...+..+|.+|-.|.
T Consensus 1029 l~g~pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hcCCCCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999654422211 111111111 112233345566788888899999997765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.1e-08 Score=94.54 Aligned_cols=143 Identities=20% Similarity=0.253 Sum_probs=102.5
Q ss_pred cceeecccCcEEEEEEEeecCCeEEEEEEc-cCC-------ChhhHHHHHHHHHHHHhcccccEeeecceeccCCceEEE
Q 002533 551 DHCIIGSGGFGHVFKGYIDDGSITVAVKRL-NTS-------SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 551 ~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l-~~~-------~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 622 (911)
...+|-+|+-+.|+++.+.+. ...||.- .+. ..-..++..+|.+.|.+++--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge--~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE--AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCc--eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 455899999999999998764 5666642 211 111234577899999998755554444455566667899
Q ss_pred EeecCC-CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC---ce
Q 002533 623 YEFMPR-GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW---AA 698 (911)
Q Consensus 623 ~E~~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~ 698 (911)
|||+++ -++.+++..... ....-.....++..|-+.+.-|| ..+|+|+||..+||+|..++ .+
T Consensus 89 ME~~~g~~~vk~~i~~~~~----------~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~ 155 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME----------DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITP 155 (229)
T ss_pred EEeccchhHHHHHHHHHcc----------CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCce
Confidence 999966 488888854421 11222223678889999999999 89999999999999996543 56
Q ss_pred EEeecCCccC
Q 002533 699 KISDFGLSRM 708 (911)
Q Consensus 699 kl~DFGla~~ 708 (911)
.++|||++..
T Consensus 156 ~lIdfgls~~ 165 (229)
T KOG3087|consen 156 ILIDFGLSSV 165 (229)
T ss_pred EEEeecchhc
Confidence 8999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.4e-07 Score=97.36 Aligned_cols=140 Identities=13% Similarity=0.091 Sum_probs=98.2
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCCChh-hH----------HHHHHHHHHHHhcccccE--eeecceecc-----
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQ-GA----------REFRTEIEMISELRHLHI--VSLLGFCDE----- 615 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~----------~~f~~Ei~~l~~l~HpnI--v~l~g~~~~----- 615 (911)
++-+-.-..|.+..+.+ ..+.||+....... .. ..+.+|.+.+.+|...+| ..++++...
T Consensus 29 ~v~~~~~rrvvr~~~~g--~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFELAG--KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEECC--EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 45544445577776643 47999977543311 11 137789999988854433 344445432
Q ss_pred CCceEEEEeecCCC-chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecC
Q 002533 616 HGEMILVYEFMPRG-NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE 694 (911)
Q Consensus 616 ~~~~~lV~E~~~~g-sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 694 (911)
....+||+|++++- +|.+++.... ....+...+..++.+++..+.-|| ..+|+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~----------~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA----------TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHL 173 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc----------ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEec
Confidence 23578999999885 8998884321 122344566789999999999999 799999999999999975
Q ss_pred -------CCceEEeecCCccC
Q 002533 695 -------NWAAKISDFGLSRM 708 (911)
Q Consensus 695 -------~~~~kl~DFGla~~ 708 (911)
+..+.++||+.++.
T Consensus 174 ~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 174 PFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cccCCCCCceEEEEECCcccc
Confidence 56899999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.7e-07 Score=91.06 Aligned_cols=124 Identities=23% Similarity=0.260 Sum_probs=79.6
Q ss_pred EEEEEEeecCCeEEEEEEccCCCh--------------------------hhHHHHHHHHHHHHhcccc--cEeeeccee
Q 002533 562 HVFKGYIDDGSITVAVKRLNTSSM--------------------------QGAREFRTEIEMISELRHL--HIVSLLGFC 613 (911)
Q Consensus 562 ~Vykg~~~~~~~~vAvK~l~~~~~--------------------------~~~~~f~~Ei~~l~~l~Hp--nIv~l~g~~ 613 (911)
.||.|...++ ..+|||..+.... .......+|.+.|.++..- ++-+++++
T Consensus 1 ~Vy~~~~~~~-~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDPDG-EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEECTT-EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECCCC-CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899988666 5899997643200 0122467899999999755 34455543
Q ss_pred ccCCceEEEEeecC--CCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHH-HhhCCCCcEEEecccCCCe
Q 002533 614 DEHGEMILVYEFMP--RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY-LHAGAKHTIIHRDVKSTNI 690 (911)
Q Consensus 614 ~~~~~~~lV~E~~~--~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~y-LH~~~~~~ivHrDlkp~NI 690 (911)
...+|||||++ +..+..+. .. .++......++.+++..+.. +| ..+|+|+||.+.||
T Consensus 79 ---~~~~ivME~I~~~G~~~~~l~-~~-------------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NI 138 (188)
T PF01163_consen 79 ---NRNVIVMEYIGEDGVPLPRLK-DV-------------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNI 138 (188)
T ss_dssp ---ETTEEEEE--EETTEEGGCHH-HC-------------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSE
T ss_pred ---eCCEEEEEecCCCccchhhHH-hc-------------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhE
Confidence 24579999998 54454332 11 12234556777888886665 46 78999999999999
Q ss_pred eecCCCceEEeecCCccC
Q 002533 691 LLDENWAAKISDFGLSRM 708 (911)
Q Consensus 691 Ll~~~~~~kl~DFGla~~ 708 (911)
|++++ .+.|+|||.+..
T Consensus 139 lv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 139 LVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp EEETT-CEEE--GTTEEE
T ss_pred Eeecc-eEEEEecCccee
Confidence 99988 999999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2e-06 Score=93.46 Aligned_cols=259 Identities=14% Similarity=0.186 Sum_probs=155.8
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhc-ccccEeeecce------eccCC-ceEEEE
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGF------CDEHG-EMILVY 623 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~------~~~~~-~~~lV~ 623 (911)
.+-||+|+-+.+|-.---.+ .+-|+..........+ .+..|... .||-+-.-+.+ ..+++ ..-++|
T Consensus 16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45799999999996433222 2345554433322222 22333333 45533221111 11222 256778
Q ss_pred eecCCC-chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEee
Q 002533 624 EFMPRG-NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 624 E~~~~g-sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 702 (911)
+.+.+. -+.+++ .... .+...+..+|.-.++.+..+|.+.+-|| ..|.+-+|+.++|+|+.++..+.|.|
T Consensus 90 P~v~g~~pI~~~y-~p~t-----RRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 90 PKVSGKEPIHMIY-SPAT-----RRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ccCCCccchhhhc-Cchh-----hcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEc
Confidence 877664 233333 2111 1124567899999999999999999999 78999999999999999999999987
Q ss_pred cCCccCCCCCCCCccccccccCcccccChhhhc-----ccCCCchhHHHHHHHHHHHHHhC-CCCCCCCccchhh-----
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCG-RPPMINGAVRKEE----- 771 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSfGvvL~ElltG-~~p~~~~~~~~~~----- 771 (911)
-..-.+...+ ....--.|...|.+||... +..-+...|.|.+||++++|+.| ++||.+.......
T Consensus 161 sDsfqi~~ng----~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 161 SDSFQINANG----TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred ccceeeccCC----ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 5443332111 1122235778899999765 33457789999999999999986 8999764322211
Q ss_pred hhHhhHHhhhcccCCcccccC--cccc---CCCC-hHHHHHHHHHHHhccccc--CCCCCCHHHHHHHHHHHHh
Q 002533 772 VSLVLWARVSRARGTVDQIVD--PRLR---GKIA-PVCLNKFVEIAGSCTDEE--GFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~d--~~l~---~~~~-~~~~~~l~~li~~Cl~~d--P~~RPs~~eVl~~L~~~~~ 837 (911)
..+.. +....--+ +.++ ...+ ...+..+..|..+|+... +.-||+++..+..|..+.+
T Consensus 237 ~~Ia~--------g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 237 TDIAH--------GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhhhc--------ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 11111 00000001 0010 1111 123456677788888643 6789999999888876544
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.1e-07 Score=100.32 Aligned_cols=158 Identities=23% Similarity=0.349 Sum_probs=97.2
Q ss_pred ceEEEecCCCC----CccCCCCCeecCCCCCcccCCCCCcccccccccccCCCCCCCCccceeeeccC-----cceEeee
Q 002533 33 DYILIICGESS----NTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEE-----FTYTFPV 103 (911)
Q Consensus 33 ~~~~i~cG~~~----~~~~~~~~~~~~D~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~-----~~Y~~~~ 103 (911)
-.+|+|||++. +.+|.-+|.|.+............+..+.....+..-..|...|+|||.-... ..|.+ +
T Consensus 179 ~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~~nltw~~-~ 257 (347)
T PF12819_consen 179 TVYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDPLNLTWSF-V 257 (347)
T ss_pred EEEeecCCCcccccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHhhhcccccccceEEEecc-C
Confidence 37899999753 66777899999642111111111111111011111223344449999987655 45666 6
Q ss_pred CCCCeEE-EEeecCCccccccccCCCCCccccccceEEEEeCceEEeeccCccccccccCCCccceEEEEEEecCCCCeE
Q 002533 104 SPGPKFL-RLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISVSSSQML 182 (911)
Q Consensus 104 ~~g~~~l-R~~f~~~~~~~~~~~g~~d~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~ 182 (911)
.++..|+ |+||++..... ....+..|+|..|+......++.. . ......++|+++++.+..++.+
T Consensus 258 ~~~~~y~v~lHFaEi~~~~----------~~~~~R~F~IyiN~~~~~~~~~~~--~--~~~~~~~~~~d~~~~~~~~~~~ 323 (347)
T PF12819_consen 258 DPGFSYYVRLHFAEIQSLS----------PNNNQREFDIYINGQTAYSDVSPP--Y--LGADTVPYYSDYVVNVPDSGFL 323 (347)
T ss_pred CCCccEEEEEEEeeccccc----------CCCCeEEEEEEECCeEccCccCcc--c--ccCcceEeecceEEEecCCCEE
Confidence 7887777 99999764321 011245678888888777533221 1 1123456799999999887899
Q ss_pred EEEEecCCCC-cceeeeeeEeEec
Q 002533 183 NLTFSPSSSS-SYAFINGIEVVSM 205 (911)
Q Consensus 183 ~v~~~~~~~~-~~~fi~~iE~~~~ 205 (911)
.|+|.|+.++ --|+|||+||+.|
T Consensus 324 ~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 324 NISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EEEEEeCCCCCcCceeEeeeeEeC
Confidence 9999987663 2699999999864
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.3e-07 Score=108.94 Aligned_cols=153 Identities=18% Similarity=0.249 Sum_probs=102.9
Q ss_pred HhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCC------CccccccccCcccccChhhhcc
Q 002533 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS------QSHVSTVVKGSFGYVDPEYIRR 736 (911)
Q Consensus 663 ~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~~gt~~y~APE~~~~ 736 (911)
.+++.||.|||. +.++||++|.|++|.++.++..||+.|+.+........ ....+.-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 445699999996 78899999999999999999999999998764322111 0111112234457999999999
Q ss_pred cCCCchhHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhccc
Q 002533 737 QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTD 816 (911)
Q Consensus 737 ~~~t~ksDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~ 816 (911)
...+.++|+||+||+++-+..|..+............ .....+..-...+....+.++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHHhc
Confidence 8899999999999999999955544322111111000 001111111112234456677788888999
Q ss_pred ccCCCCCCHHHHHH
Q 002533 817 EEGFRRPTMGDVTW 830 (911)
Q Consensus 817 ~dP~~RPs~~eVl~ 830 (911)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877743
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.5e-06 Score=83.12 Aligned_cols=138 Identities=20% Similarity=0.172 Sum_probs=102.9
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCC---C---hhhHHHHHHHHHHHHhccccc--Eeeecceec-c----CCceEE
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTS---S---MQGAREFRTEIEMISELRHLH--IVSLLGFCD-E----HGEMIL 621 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~---~---~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~g~~~-~----~~~~~l 621 (911)
-|+||-+.|++-.+.+. .+-||+.... + +.+...|.+|+..|.+|...+ +.+++ ++. . .-.-+|
T Consensus 26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 46788999999877665 5889987522 1 346678999999999996433 44444 332 1 124689
Q ss_pred EEeecCC-CchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCc--e
Q 002533 622 VYEFMPR-GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA--A 698 (911)
Q Consensus 622 V~E~~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~ 698 (911)
|+|-+++ -+|.+++... ...+.+...+..+..+++..+.-|| ..++.|+|+.+.|||++.++. +
T Consensus 103 VTe~L~g~~~L~~~l~~~----------~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH----------AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred EEEeCCCCccHHHHHhcC----------CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeE
Confidence 9997764 6888887432 1224566677899999999999999 799999999999999986666 9
Q ss_pred EEeecCCccC
Q 002533 699 KISDFGLSRM 708 (911)
Q Consensus 699 kl~DFGla~~ 708 (911)
+++||.-++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999987764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.8e-06 Score=86.18 Aligned_cols=135 Identities=20% Similarity=0.155 Sum_probs=92.3
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEccCCCh----------------------hhHHHHHHHHHHHHhcccc--
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM----------------------QGAREFRTEIEMISELRHL-- 604 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~----------------------~~~~~f~~Ei~~l~~l~Hp-- 604 (911)
...+..||.|--+.||.|....+ .++|||.=+.... -.....++|.+.|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g-~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKG-RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCCC-CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34456899999999999999866 4799995322110 0123456888999988654
Q ss_pred cEeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEec
Q 002533 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRD 684 (911)
Q Consensus 605 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrD 684 (911)
.+.+.+++ +.-.+||||+++--|...- ++-...-.|+..|.+-+.-+- ..||||+|
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------------~~~en~~~il~~il~~~~~~~---~~GiVHGD 227 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----------------LDVENPDEILDKILEEVRKAY---RRGIVHGD 227 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----------------CcccCHHHHHHHHHHHHHHHH---HcCccccC
Confidence 55555543 4567999999886554321 122223334444444444443 47899999
Q ss_pred ccCCCeeecCCCceEEeecCCccC
Q 002533 685 VKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 685 lkp~NILl~~~~~~kl~DFGla~~ 708 (911)
+.+-||++++++.+.++||-.+..
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred CchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.13 E-value=9.5e-06 Score=84.11 Aligned_cols=106 Identities=25% Similarity=0.291 Sum_probs=81.2
Q ss_pred HHHHHHHHHHHHhcccc--cEeeecceeccC----CceEEEEeecCC-CchhhHhhhhhhcccccccCCCCCCchhhhhH
Q 002533 588 AREFRTEIEMISELRHL--HIVSLLGFCDEH----GEMILVYEFMPR-GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660 (911)
Q Consensus 588 ~~~f~~Ei~~l~~l~Hp--nIv~l~g~~~~~----~~~~lV~E~~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ 660 (911)
.....+|...+.+|+.. ...+.+++.... ...++|+|++++ -+|.+++.... .++......
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------------~~~~~~~~~ 122 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------------QLDPSQRRE 122 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------------ccchhhHHH
Confidence 34577888888888543 334555555432 245899999988 48999885321 144556778
Q ss_pred HHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCC---ceEEeecCCccC
Q 002533 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW---AAKISDFGLSRM 708 (911)
Q Consensus 661 ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 708 (911)
++.++++.++-|| ..+|+|+|+++.|||++.+. .+.++||+.++.
T Consensus 123 ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 123 LLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999 79999999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.10 E-value=3e-05 Score=81.43 Aligned_cols=149 Identities=15% Similarity=0.214 Sum_probs=85.1
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccE--eeecceeccCCceEEEEeecCCCc
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHI--VSLLGFCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI--v~l~g~~~~~~~~~lV~E~~~~gs 630 (911)
..||+|..+.||+.. + ..+++|...... ......+|.++++.+..-.+ .+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~~---~-~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---T-GKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec---C-CCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 368999999999842 2 257788876533 23446789999998864433 566777777777889999998863
Q ss_pred -hhhHhhhh-----------hhcccccccCCCCCCchhhhhH-H----------HHhHH-HHHHHHhh-CCCCcEEEecc
Q 002533 631 -LRDHLYNS-----------QKQNQNQNQNQNSPLTWKRRLE-I----------SIGAA-RGLHYLHA-GAKHTIIHRDV 685 (911)
Q Consensus 631 -L~~~L~~~-----------~~~~~~~~~~~~~~l~~~~~l~-i----------a~~ia-~gL~yLH~-~~~~~ivHrDl 685 (911)
+.+.+... .......+...........+.. + ...+. ....+|.. .....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22222100 0000000000000001010000 0 00011 11222221 12346789999
Q ss_pred cCCCeeecCCCceEEeecCCccC
Q 002533 686 KSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 686 kp~NILl~~~~~~kl~DFGla~~ 708 (911)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999887 99999998865
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.5e-05 Score=88.75 Aligned_cols=139 Identities=19% Similarity=0.231 Sum_probs=90.7
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhH------------------------------H----------HHH
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA------------------------------R----------EFR 592 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~------------------------------~----------~f~ 592 (911)
+-|+.++-|.||+|+++++ +.||||+.++.-.+.. + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~sG-~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKSG-EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecCC-CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4799999999999999985 6899999876522110 1 133
Q ss_pred HHHHHHHhcc-----cccEeeecce-eccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHH
Q 002533 593 TEIEMISELR-----HLHIVSLLGF-CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666 (911)
Q Consensus 593 ~Ei~~l~~l~-----HpnIv~l~g~-~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia 666 (911)
+|..-+.+++ .+++ ++=.+ ++-.+...|+|||++|-.+.+...... ..++ +..++..++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----------~g~d---~k~ia~~~~ 274 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----------AGID---RKELAELLV 274 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-----------cCCC---HHHHHHHHH
Confidence 4444444442 2222 22222 234567899999999999888752221 1123 223333333
Q ss_pred HH-HHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCC
Q 002533 667 RG-LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710 (911)
Q Consensus 667 ~g-L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 710 (911)
++ +..+- ..++.|.|..|.||+++.++++.+.|||+....+
T Consensus 275 ~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 275 RAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 32 22222 4689999999999999999999999999987543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00018 Score=73.10 Aligned_cols=104 Identities=21% Similarity=0.250 Sum_probs=81.7
Q ss_pred HHHHHHHHhccc-ccEeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHH
Q 002533 592 RTEIEMISELRH-LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670 (911)
Q Consensus 592 ~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~ 670 (911)
..|.-+|+.+++ +++.+++|+|.. ++|.||...+++...-.. ...-..-+|..|.+||.++++.++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~---------l~~~~~~~w~~R~~iA~~lL~~l~ 73 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP---------LSQFLQSPWEQRAKIALQLLELLE 73 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc---------cccccccCHHHHHHHHHHHHHHHH
Confidence 357888888876 699999999943 678999987766432000 001123689999999999999999
Q ss_pred HHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 671 yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
+|++.....+.-.|++++|+-+++++++|+.|...+..
T Consensus 74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99965556688899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.9e-06 Score=98.25 Aligned_cols=180 Identities=19% Similarity=0.183 Sum_probs=130.7
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhccccc-EeeecceeccCCceEEEEeecCCC-ch
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLH-IVSLLGFCDEHGEMILVYEFMPRG-NL 631 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~g-sL 631 (911)
-+++|++++++|.+...... ..++.+... ....-++++|.+++||| .+..++-++.+...+++++++..| +-
T Consensus 249 ~fvK~altknpKkRptaekl-L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKL-LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHhcCCCccCCChhhh-eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 47899999999988755543 235554332 34456889999999999 677777777788899999999877 22
Q ss_pred hhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCC
Q 002533 632 RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711 (911)
Q Consensus 632 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 711 (911)
..-... ....+...+...++..-.+++++||+ ..=+|+| |||..+ ...+..||+....+..
T Consensus 323 ~~~~~~-----------se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 323 ALEMTV-----------SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred cccCCh-----------hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCc
Confidence 221111 11224444556677778899999993 3347888 887776 5789999998876544
Q ss_pred CCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCC
Q 002533 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762 (911)
Q Consensus 712 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~ 762 (911)
.. ......++..|+|||+.....+..+.|+|+.|+--.++.-|-+|-
T Consensus 384 ~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 384 TM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 43 234456899999999999999999999999998777777666554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0001 Score=77.39 Aligned_cols=152 Identities=23% Similarity=0.248 Sum_probs=85.3
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhccccc--Eeeeccee---ccCCceEEEEeecC
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLH--IVSLLGFC---DEHGEMILVYEFMP 627 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~g~~---~~~~~~~lV~E~~~ 627 (911)
+.|+.|..+.||+....++ .+++|..... .....+..|..+++.|.... +.+++.++ ......+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~~--~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDG--RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETTS--EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECCc--EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4789999999999998774 7999987544 45567888999988885443 34555543 22335789999999
Q ss_pred CCchhh---------Hhhhhhhcccc--cccCCCCCCch-h--------hhhHH------------HHhHHH-HHHHHhh
Q 002533 628 RGNLRD---------HLYNSQKQNQN--QNQNQNSPLTW-K--------RRLEI------------SIGAAR-GLHYLHA 674 (911)
Q Consensus 628 ~gsL~~---------~L~~~~~~~~~--~~~~~~~~l~~-~--------~~l~i------------a~~ia~-gL~yLH~ 674 (911)
+..+.. .+......-.. ..........+ . ..... ...+.+ .++.++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988887 00000000000 00000011111 1 00000 111222 2333332
Q ss_pred ----CCCCcEEEecccCCCeeec-CCCceEEeecCCccC
Q 002533 675 ----GAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRM 708 (911)
Q Consensus 675 ----~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 708 (911)
.....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2357799999999999999 666678999997653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00015 Score=74.29 Aligned_cols=138 Identities=17% Similarity=0.169 Sum_probs=91.9
Q ss_pred HccCCccceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHH---------HHHHHHHHHhccccc---Eeeecce
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---------FRTEIEMISELRHLH---IVSLLGF 612 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~---------f~~Ei~~l~~l~Hpn---Iv~l~g~ 612 (911)
..++|...+++-......|.+-..++ ...++|..+.......+. ..+++..+.+++... .+.++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~--~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG--KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC--cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 44677777788877777777766655 478999877654333332 234455455554322 2222222
Q ss_pred ec-----cCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccC
Q 002533 613 CD-----EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKS 687 (911)
Q Consensus 613 ~~-----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp 687 (911)
+. -....+|+|||++|..|.+... ++. .++..++.+|.-|| +.|+.|+|..|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hp 163 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----------------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHP 163 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----------------cCH----HHHHHHHHHHHHHH---HcCCccCCCCc
Confidence 22 2235578999999988876541 111 34566778899999 79999999999
Q ss_pred CCeeecCCCceEEeecCCccC
Q 002533 688 TNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 688 ~NILl~~~~~~kl~DFGla~~ 708 (911)
.|++++++ .+++.||+..+.
T Consensus 164 gNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 164 GNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred CcEEEECC-cEEEEECccccc
Confidence 99999965 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00013 Score=91.25 Aligned_cols=81 Identities=15% Similarity=0.314 Sum_probs=58.5
Q ss_pred ceeecccCcEEEEEEEeecCC--eEEEEEEccCCC-hhhHHHHHHHHHHHHhcc-cccE--eeecceeccC---CceEEE
Q 002533 552 HCIIGSGGFGHVFKGYIDDGS--ITVAVKRLNTSS-MQGAREFRTEIEMISELR-HLHI--VSLLGFCDEH---GEMILV 622 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~--~~vAvK~l~~~~-~~~~~~f~~Ei~~l~~l~-HpnI--v~l~g~~~~~---~~~~lV 622 (911)
...|+.|.+..+|+....+++ ..+++|+..... ......+.+|.++|+.|. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 456899999999998776542 357777764332 223457889999999995 6664 6778888664 467899
Q ss_pred EeecCCCchh
Q 002533 623 YEFMPRGNLR 632 (911)
Q Consensus 623 ~E~~~~gsL~ 632 (911)
|||+++..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999886543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00019 Score=76.48 Aligned_cols=149 Identities=17% Similarity=0.175 Sum_probs=85.6
Q ss_pred ecccCc-EEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc-cccEeeecceeccCCceEEEEeecCCCchh
Q 002533 555 IGSGGF-GHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEMILVYEFMPRGNLR 632 (911)
Q Consensus 555 LG~G~f-G~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 632 (911)
|-.|.. ..||+....+ ..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKN--PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCC--CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 455555 7899997654 478889875443 345678999988884 333446677666666789999999998876
Q ss_pred hHhhh---------hhhccc-ccccCC-CCCCc--hhhhhHHH--------------------HhHHHHHHHHhh----C
Q 002533 633 DHLYN---------SQKQNQ-NQNQNQ-NSPLT--WKRRLEIS--------------------IGAARGLHYLHA----G 675 (911)
Q Consensus 633 ~~L~~---------~~~~~~-~~~~~~-~~~l~--~~~~l~ia--------------------~~ia~gL~yLH~----~ 675 (911)
..... ....-. ...... ..+.. +..++... ..+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 54210 000000 000000 00100 00000000 001111222211 1
Q ss_pred CCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 676 AKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 676 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
....++|+|+.|.|||++++....|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 245699999999999999987788999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00024 Score=73.63 Aligned_cols=154 Identities=20% Similarity=0.219 Sum_probs=94.7
Q ss_pred cCcCCHHHHHHHccCCccce---eecccCcEEEEEEEeecCCeEEEEEEccCCChhhH-------------------H--
Q 002533 534 CRRFSLTEIKQATCDFADHC---IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA-------------------R-- 589 (911)
Q Consensus 534 ~~~~~~~el~~at~~f~~~~---~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~-------------------~-- 589 (911)
....++..|......-.... .|..|.-..||+|...++ ..+|||+.+....... +
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~-~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDG-RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCC-ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 34556666666555544433 566777888999987544 5899998864322110 0
Q ss_pred ---HHHHHHHHHHhcccc--cEeeecceeccCCceEEEEeecCCCc-hhhHhhhhhhcccccccCCCCCCchhhhhHHHH
Q 002533 590 ---EFRTEIEMISELRHL--HIVSLLGFCDEHGEMILVYEFMPRGN-LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663 (911)
Q Consensus 590 ---~f~~Ei~~l~~l~Hp--nIv~l~g~~~~~~~~~lV~E~~~~gs-L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~ 663 (911)
....|+.-|.++..- .+-+.+++ ..-.|||||+...- -.-.| ...++...+...+..
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~L-------------kDv~~e~~e~~~~~~ 173 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRL-------------KDVPLELEEAEGLYE 173 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCc-------------ccCCcCchhHHHHHH
Confidence 123455555554322 22222222 23479999996531 11111 122223324566677
Q ss_pred hHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 664 ~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
++++.+.-|-. ..++||+||..=|||+. ++.+.|+|+|.|..
T Consensus 174 ~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 174 DVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 78888888872 47899999999999999 78999999998875
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00059 Score=79.29 Aligned_cols=141 Identities=18% Similarity=0.171 Sum_probs=88.8
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhh-------------------------------HH------HHHHHH
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG-------------------------------AR------EFRTEI 595 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~-------------------------------~~------~f~~Ei 595 (911)
+.||.-..|.||+|+++++ +.||||+.++.-... .+ +|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~G-~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNG-EDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecCC-CEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4799999999999999995 689999987542211 00 244444
Q ss_pred HHHHhc----cccc---Eeeeccee-ccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHH
Q 002533 596 EMISEL----RHLH---IVSLLGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667 (911)
Q Consensus 596 ~~l~~l----~Hpn---Iv~l~g~~-~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~ 667 (911)
+-..+. +|-+ -|.+=.++ .-.....|+||||+|..+.+.-.-.. ..++-. +|+..+.+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-----------~gi~~~---~i~~~l~~ 311 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-----------RGISPH---DILNKLVE 311 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-----------cCCCHH---HHHHHHHH
Confidence 433332 3444 12222222 33457899999999998877642221 113333 33333333
Q ss_pred HHHHHhhCCCCcEEEecccCCCeeecC----CCceEEeecCCccCCC
Q 002533 668 GLHYLHAGAKHTIIHRDVKSTNILLDE----NWAAKISDFGLSRMGP 710 (911)
Q Consensus 668 gL~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~~ 710 (911)
+...+ -...|++|+|=.|.||++.. ++++.+-|||+.....
T Consensus 312 ~~~~q--If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 312 AYLEQ--IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHH--HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 22211 12468999999999999983 6789999999987543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0011 Score=67.79 Aligned_cols=129 Identities=23% Similarity=0.305 Sum_probs=88.6
Q ss_pred cceeecccCcEEEEEEEeecCCeEEEEEEccCCC----------------hhhHHHHHHHHHHHHhcc------cccEee
Q 002533 551 DHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS----------------MQGAREFRTEIEMISELR------HLHIVS 608 (911)
Q Consensus 551 ~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~----------------~~~~~~f~~Ei~~l~~l~------HpnIv~ 608 (911)
....||+|+.-.||.--. . ....||+..... ....+++.+|+.....+. +.+|.+
T Consensus 5 ~~~~i~~G~~R~cy~HP~--d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD--D-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEECCC--C-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 355899999999997333 2 347788876554 223566777887777766 789999
Q ss_pred ecceeccCCceEEEEeecCC--C----chhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEE
Q 002533 609 LLGFCDEHGEMILVYEFMPR--G----NLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIH 682 (911)
Q Consensus 609 l~g~~~~~~~~~lV~E~~~~--g----sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivH 682 (911)
++|+.+.+.-.-+|+|.+.+ | +|.+++.. ..++. ...+.+ -+-..||- ...|+.
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-------------~~~~~-~~~~~L---~~f~~~l~---~~~Iv~ 141 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-------------GGLTE-ELRQAL---DEFKRYLL---DHHIVI 141 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-------------CCccH-HHHHHH---HHHHHHHH---HcCCee
Confidence 99999988888999998654 3 46666622 22443 333333 33345555 577999
Q ss_pred ecccCCCeeecCC---C-ceEEee
Q 002533 683 RDVKSTNILLDEN---W-AAKISD 702 (911)
Q Consensus 683 rDlkp~NILl~~~---~-~~kl~D 702 (911)
+||+|.||++..+ . .+.|+|
T Consensus 142 ~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 142 RDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cCCCcccEEEEecCCCceEEEEEe
Confidence 9999999999543 2 566766
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0011 Score=70.08 Aligned_cols=73 Identities=18% Similarity=0.166 Sum_probs=45.1
Q ss_pred eecccCcE-EEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccc---cEeeecceeccC---CceEEEEeec
Q 002533 554 IIGSGGFG-HVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHL---HIVSLLGFCDEH---GEMILVYEFM 626 (911)
Q Consensus 554 ~LG~G~fG-~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~Hp---nIv~l~g~~~~~---~~~~lV~E~~ 626 (911)
.|+.|+.. .||+.. . .+++|..... .....+.+|.++|..|... -+.++++.+... ...+++||++
T Consensus 4 ~~~~gG~~n~vy~~~---~--~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 4 PVDSGGTDNATFRLG---D--DMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eccCCCcccceEEcC---C--ceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 57777776 499752 1 4667765432 2345788899999887532 223334333322 2458899999
Q ss_pred CCCchhh
Q 002533 627 PRGNLRD 633 (911)
Q Consensus 627 ~~gsL~~ 633 (911)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9987753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0013 Score=72.09 Aligned_cols=76 Identities=13% Similarity=0.123 Sum_probs=55.6
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhccc---ccEeeecceecc---CCceEEEEee
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRH---LHIVSLLGFCDE---HGEMILVYEF 625 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~H---pnIv~l~g~~~~---~~~~~lV~E~ 625 (911)
.+.||+|..+.||+....++ .+.+|..+.. .....|..|.+.|+.|.- ..+.+++++|.. .+..+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG--NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCCC--CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 45799999999999876555 4667774331 123578899999988843 356777877754 4668999999
Q ss_pred cCCCch
Q 002533 626 MPRGNL 631 (911)
Q Consensus 626 ~~~gsL 631 (911)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998766
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0029 Score=71.63 Aligned_cols=81 Identities=22% Similarity=0.208 Sum_probs=55.0
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC------C-hhhHHHHHHHHHHHHhcc---cccEeeecceeccCCceEEE
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS------S-MQGAREFRTEIEMISELR---HLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~------~-~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV 622 (911)
+.||.|.+..||++...++...++||.-.+. . ....+++..|.+.|..+. ..++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4699999999999999776567999974321 1 123456677888888763 2345666665 33557899
Q ss_pred EeecCCCc-hhhHh
Q 002533 623 YEFMPRGN-LRDHL 635 (911)
Q Consensus 623 ~E~~~~gs-L~~~L 635 (911)
|||+++.. +++.|
T Consensus 110 ME~L~~~~~lr~~L 123 (401)
T PRK09550 110 MEDLSDHKILRKGL 123 (401)
T ss_pred EecCCCccHHHHHH
Confidence 99998743 43333
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00072 Score=66.44 Aligned_cols=126 Identities=19% Similarity=0.232 Sum_probs=85.0
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEee-ecceeccCCceEEEEeecCCCc
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVS-LLGFCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~-l~g~~~~~~~~~lV~E~~~~gs 630 (911)
.+.|++|.+|.||+|.+.+. .+|+|+-+..+ ....+..|.++|..+.-.++.+ ++.|- +..+.|||+.|-.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG--EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhcccccEEEEeeccCc--eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 45799999999999999876 79999876554 3467889999999987666543 33332 2235599998888
Q ss_pred hhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccC--CCeeecCCCceEEeecCCccC
Q 002533 631 LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKS--TNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 631 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp--~NILl~~~~~~kl~DFGla~~ 708 (911)
|.+.-... +-.+.+ .+++.---|. ..+|-|+.|.- .||++..+ .+.|+||.-|+.
T Consensus 99 L~~~~~~~---------------~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG---------------DRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc---------------cHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 87765221 112222 3333322233 56788888764 45555554 899999998874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0021 Score=67.88 Aligned_cols=75 Identities=17% Similarity=0.171 Sum_probs=47.9
Q ss_pred eeecccCcEEEEEEEeec-CCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEe-eecceeccCCceEEEEeecCCCc
Q 002533 553 CIIGSGGFGHVFKGYIDD-GSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV-SLLGFCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~-~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~gs 630 (911)
+.|..|-...+|+....+ .+..+++|+....... ..+..+|+.+++.+...+++ ++++.+. -.+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457788888999987654 2347888976543221 12334788888888544443 3333332 237999999977
Q ss_pred hh
Q 002533 631 LR 632 (911)
Q Consensus 631 L~ 632 (911)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0013 Score=70.72 Aligned_cols=147 Identities=14% Similarity=0.130 Sum_probs=77.9
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEe-eecceeccCCceEEEEeecCCCchhh
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV-SLLGFCDEHGEMILVYEFMPRGNLRD 633 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~gsL~~ 633 (911)
+..|-...+|+.... +..+++|........-.-+..+|.++++.+....++ ++++.+. -.+||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~--~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHP--GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeC--CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 556778899988743 346888876543222112356788888888643332 2333322 368999999877643
Q ss_pred H-------hhhhhhc-ccccccC-CCCCCchhhhh-HHH---------HhHHHHHHHHhh-----CCCCcEEEecccCCC
Q 002533 634 H-------LYNSQKQ-NQNQNQN-QNSPLTWKRRL-EIS---------IGAARGLHYLHA-----GAKHTIIHRDVKSTN 689 (911)
Q Consensus 634 ~-------L~~~~~~-~~~~~~~-~~~~l~~~~~l-~ia---------~~ia~gL~yLH~-----~~~~~ivHrDlkp~N 689 (911)
. +..-... ....... ...+++...++ .+. ..+.+-++.+-. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1000000 0000000 01111211111 110 111111222211 113468999999999
Q ss_pred eeecCCCceEEeecCCccC
Q 002533 690 ILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 690 ILl~~~~~~kl~DFGla~~ 708 (911)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.001 Score=81.51 Aligned_cols=197 Identities=17% Similarity=0.190 Sum_probs=131.8
Q ss_pred HHHHHHHHHHhcccccEeeecceeccCCc----eEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhH
Q 002533 590 EFRTEIEMISELRHLHIVSLLGFCDEHGE----MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665 (911)
Q Consensus 590 ~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~----~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~i 665 (911)
...-|++.+.++.|+|++.+++|..++.. ..+..|++..-++...+. ....++......++.++
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q------------~v~~i~~~~~r~~~~~~ 295 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ------------SVGSIPLETLRILHQKL 295 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh------------hccccCHHHHHHHHHHH
Confidence 34567778889999999999988754332 234457777777777773 23456777888899999
Q ss_pred HHHHHHHhhCCCCcEEEecccCC---CeeecCCCceEEe--ecCCccCCCCCCCCccccccccCcccccChhhhcccCCC
Q 002533 666 ARGLHYLHAGAKHTIIHRDVKST---NILLDENWAAKIS--DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLT 740 (911)
Q Consensus 666 a~gL~yLH~~~~~~ivHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t 740 (911)
.+||+|+|+ ....|.-|..+ +...+..+...++ ||+..+..+..... .....+..|.++|......+.
T Consensus 296 ~~GL~~~h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~ 368 (1351)
T KOG1035|consen 296 LEGLAYLHS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAK 368 (1351)
T ss_pred hhhHHHHHH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccch
Confidence 999999994 45566656555 5555666777777 88887764432211 112234457888887766555
Q ss_pred ch--hHHHHHHHHHHHHHhCCCCCCCCccchhhhhHhhHHhhhcccCCcccccCccccCCCChHHHHHHHHHHHhccccc
Q 002533 741 EK--SDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEE 818 (911)
Q Consensus 741 ~k--sDVwSfGvvL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~d 818 (911)
.+ .|+|.+|..+..+..|..+-..... ...++ +..+...+.+...+|+..+
T Consensus 369 ~~r~~dL~~lgll~~~~~~~~~i~~~~~~-------------------~~~~l--------~~~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 369 KSRLTDLWCLGLLLLQLSQGEDISEKSAV-------------------PVSLL--------DVLSTSELLDALPKCLDED 421 (1351)
T ss_pred hhhhhHHHHHHHHHhhhhhcCcccccccc-------------------hhhhh--------ccccchhhhhhhhhhcchh
Confidence 44 7999999999999988754311110 00111 1111124567788999999
Q ss_pred CCCCCCHHHHHHHH
Q 002533 819 GFRRPTMGDVTWGL 832 (911)
Q Consensus 819 P~~RPs~~eVl~~L 832 (911)
+++|++..+++.+.
T Consensus 422 ~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 422 SEERLSALELLTHP 435 (1351)
T ss_pred hhhccchhhhhhch
Confidence 99999999998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0045 Score=67.87 Aligned_cols=151 Identities=19% Similarity=0.194 Sum_probs=88.2
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhccccc--Eeeeccee------ccCCceEEEE
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLH--IVSLLGFC------DEHGEMILVY 623 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~g~~------~~~~~~~lV~ 623 (911)
.+.|..|....+|+....++ .+++|+... ....+...|++++..|.+.+ +.+++... ...+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~--~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG--RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCC--cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 44677788789999876544 688898764 22345667888888885433 34443321 2234568999
Q ss_pred eecCCCchhh----Hh----------hhhhhcccccccCCCCCCchhhhh----------HHHHhHHHHHHHHhh----C
Q 002533 624 EFMPRGNLRD----HL----------YNSQKQNQNQNQNQNSPLTWKRRL----------EISIGAARGLHYLHA----G 675 (911)
Q Consensus 624 E~~~~gsL~~----~L----------~~~~~~~~~~~~~~~~~l~~~~~l----------~ia~~ia~gL~yLH~----~ 675 (911)
+|++|..+.. .+ |....... ..........|.... .....+...+.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFP-GERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCC-ccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9999877643 11 11100000 000011122333221 011123344455442 1
Q ss_pred CCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 676 AKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 676 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
...+++|+|+.|.|||++++..+.|.||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 245799999999999999987788999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.01 Score=65.92 Aligned_cols=150 Identities=14% Similarity=0.141 Sum_probs=78.9
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhccccc--Eeeecce------eccCCceEEEEe
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLH--IVSLLGF------CDEHGEMILVYE 624 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~g~------~~~~~~~~lV~E 624 (911)
+.|+.|....+|+....++ .+++|+.+... .+....|++++..|...+ +.+.+.. ....+..++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g--~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG--EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCC--cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 3466777788999876554 58889875222 233344556666653222 2222211 122456789999
Q ss_pred ecCCCchhh-----H---------hhhhhhcccccccCCCCCCch-hhhhHHH-------------HhHHHHHHHHhh--
Q 002533 625 FMPRGNLRD-----H---------LYNSQKQNQNQNQNQNSPLTW-KRRLEIS-------------IGAARGLHYLHA-- 674 (911)
Q Consensus 625 ~~~~gsL~~-----~---------L~~~~~~~~~~~~~~~~~l~~-~~~l~ia-------------~~ia~gL~yLH~-- 674 (911)
|++|..+.. . ||...... .........+.| ...+.-. ..+...++.+..
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDF-PLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999875421 1 11111000 000001112222 2211111 111112223221
Q ss_pred --CCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 675 --GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 675 --~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
....++||+|+.+.|||++.+...-|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1246899999999999999776668999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.01 Score=65.59 Aligned_cols=152 Identities=15% Similarity=0.146 Sum_probs=83.9
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhccccc--Eeeeccee------ccCCceEEEEe
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLH--IVSLLGFC------DEHGEMILVYE 624 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~g~~------~~~~~~~lV~E 624 (911)
+.++.|.-..+|+....++ .+++|+..... ..++...|++++..|.... +.+++... ...+..++++|
T Consensus 28 ~~~~~G~~n~~y~v~t~~~--~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG--RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred cccCCccccceEEEEeCCC--cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 4567777789999875444 57788765432 1234556777777774322 33443321 22456789999
Q ss_pred ecCCCchhhH--------------hhhhhhcccccccCCCCCCchhhhh------------HHHHhHHHHHHHHhh----
Q 002533 625 FMPRGNLRDH--------------LYNSQKQNQNQNQNQNSPLTWKRRL------------EISIGAARGLHYLHA---- 674 (911)
Q Consensus 625 ~~~~gsL~~~--------------L~~~~~~~~~~~~~~~~~l~~~~~l------------~ia~~ia~gL~yLH~---- 674 (911)
|++|..+... ||................-.|.... .....+.+.+++|..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654211 1111100000000000011222111 111223344555532
Q ss_pred CCCCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 675 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
....+++|+|+.+.||+++.+....|.||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2357899999999999999887778999998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.018 Score=58.65 Aligned_cols=125 Identities=28% Similarity=0.303 Sum_probs=86.6
Q ss_pred cCCccceeecccCc-EEEEEEEeecCCeEEEEEEccCC---Ch------------------hhHHHHHHHHHHHHhcc--
Q 002533 547 CDFADHCIIGSGGF-GHVFKGYIDDGSITVAVKRLNTS---SM------------------QGAREFRTEIEMISELR-- 602 (911)
Q Consensus 547 ~~f~~~~~LG~G~f-G~Vykg~~~~~~~~vAvK~l~~~---~~------------------~~~~~f~~Ei~~l~~l~-- 602 (911)
.++...+.||.|.- |.|||++..+. .+|||.++.. .. ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~--~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR--IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe--EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 66777889999999 99999998765 8999993211 00 11224788998888774
Q ss_pred -cccE--eeecceeccC------------------CceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHH
Q 002533 603 -HLHI--VSLLGFCDEH------------------GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661 (911)
Q Consensus 603 -HpnI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i 661 (911)
+.++ |+.+||..-. ....||.||++... ....+-
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------------------~~~~~~ 169 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------------------PLQIRD 169 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------------------ccchhH
Confidence 4456 8888886211 12346666654422 112234
Q ss_pred HHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCc
Q 002533 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 662 a~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 706 (911)
+.+|.+-|..|| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 170 ~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 556777788899 899999999999975 3589999854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.025 Score=61.96 Aligned_cols=148 Identities=16% Similarity=0.263 Sum_probs=80.8
Q ss_pred EEEEEEEeecCCeEEEEEEcc-CCChhhHHHHHHHHHHHHhccc--ccEeeecceeccCC--ceEEEEeecCCCchhhHh
Q 002533 561 GHVFKGYIDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRH--LHIVSLLGFCDEHG--EMILVYEFMPRGNLRDHL 635 (911)
Q Consensus 561 G~Vykg~~~~~~~~vAvK~l~-~~~~~~~~~f~~Ei~~l~~l~H--pnIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~L 635 (911)
-.+|..... +++.+|++-. ...........+|.++|+.+.- --+-..+++|.++. ..+.||+|+++..+.+.+
T Consensus 39 n~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 39 NDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred cceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 344544443 3467777221 1223344556678888877642 23345577786665 779999999885443333
Q ss_pred hhhhhc---------------------c---cccc--cCCCCCCchhhhhHHH--------HhHHHHHHHHhhC-----C
Q 002533 636 YNSQKQ---------------------N---QNQN--QNQNSPLTWKRRLEIS--------IGAARGLHYLHAG-----A 676 (911)
Q Consensus 636 ~~~~~~---------------------~---~~~~--~~~~~~l~~~~~l~ia--------~~ia~gL~yLH~~-----~ 676 (911)
...... . .... ....+.-.|...++.+ -...+-..+|++. .
T Consensus 117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~ 196 (321)
T COG3173 117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG 196 (321)
T ss_pred CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence 111000 0 0000 0001111222222111 1122334555432 2
Q ss_pred CCcEEEecccCCCeeecCCCceEEeecCCccCCC
Q 002533 677 KHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710 (911)
Q Consensus 677 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 710 (911)
...++|+|+.+.|++++.+.-+-|.||+++.+++
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 4579999999999999998889999999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.016 Score=63.88 Aligned_cols=150 Identities=20% Similarity=0.247 Sum_probs=84.0
Q ss_pred eecccCcEEEEEEEeecC------CeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEe-eecceeccCCceEEEEeec
Q 002533 554 IIGSGGFGHVFKGYIDDG------SITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV-SLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~------~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~lV~E~~ 626 (911)
.|..|--..+|+....++ +..+++|+..... ....+..+|.+++..+....+. ++++++. + .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 466677778999887542 3578899865543 2234556788888888543333 3444443 2 3589999
Q ss_pred CCCchhhHhhhh-------hhcc---cccccC--C----CCCCchhhhhH--------------------------HHHh
Q 002533 627 PRGNLRDHLYNS-------QKQN---QNQNQN--Q----NSPLTWKRRLE--------------------------ISIG 664 (911)
Q Consensus 627 ~~gsL~~~L~~~-------~~~~---~~~~~~--~----~~~l~~~~~l~--------------------------ia~~ 664 (911)
+|..+....... ...- ...... . ..+.-|..+-+ +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 988775421100 0000 000000 0 00111111100 1112
Q ss_pred HHHHHHHHhh------CCCCcEEEecccCCCeeecCC----CceEEeecCCccC
Q 002533 665 AARGLHYLHA------GAKHTIIHRDVKSTNILLDEN----WAAKISDFGLSRM 708 (911)
Q Consensus 665 ia~gL~yLH~------~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 708 (911)
+..-+..|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2223334431 135679999999999999985 7899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.00089 Score=83.58 Aligned_cols=191 Identities=13% Similarity=0.044 Sum_probs=124.9
Q ss_pred EEEEEEEeecCCe-EEEEEEccCCChhh-----HHHHHHHHHHHHhcccccEeeeccee--ccCCceEEEEeecCCCchh
Q 002533 561 GHVFKGYIDDGSI-TVAVKRLNTSSMQG-----AREFRTEIEMISELRHLHIVSLLGFC--DEHGEMILVYEFMPRGNLR 632 (911)
Q Consensus 561 G~Vykg~~~~~~~-~vAvK~l~~~~~~~-----~~~f~~Ei~~l~~l~HpnIv~l~g~~--~~~~~~~lV~E~~~~gsL~ 632 (911)
+.-+|+.+-.... -+.+|+.+....+. .+....|.+.+++..|+++.....-. .+..+.+..++|+..|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 3444555432211 24566655443332 23344555566667899887665544 2345678999999999999
Q ss_pred hHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhh--CCCCcEEEecccCCCeeecCCCceEEeecCCccCCC
Q 002533 633 DHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA--GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710 (911)
Q Consensus 633 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~--~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 710 (911)
+.|.++..+ .+.++..-+...-.+......-.|. ....-.+|++||+.|.+|..+..+|++++|+.+...
T Consensus 1320 ~iIikg~ee--------~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn 1391 (2724)
T KOG1826|consen 1320 SIIIKGLEE--------SPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN 1391 (2724)
T ss_pred HHHHhcccc--------CCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC
Confidence 999765432 2233333333333332334444442 223457899999999999999999999999998422
Q ss_pred CCCCCccccccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCCCC
Q 002533 711 SGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPM 762 (911)
Q Consensus 711 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~p~ 762 (911)
.. ........+++-|+.|+....-.++.++|+|..|+.+++..-|..+|
T Consensus 1392 p~---~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1392 PV---LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ch---HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 21 11223345777899999988889999999999999999998887765
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.0057 Score=69.21 Aligned_cols=47 Identities=23% Similarity=0.358 Sum_probs=36.9
Q ss_pred HHHHHHHHHHHhcccccEeeecceecc-CCceEEEEeecCCCchhhHhh
Q 002533 589 REFRTEIEMISELRHLHIVSLLGFCDE-HGEMILVYEFMPRGNLRDHLY 636 (911)
Q Consensus 589 ~~f~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~L~ 636 (911)
.+.+-..++++.+.|+|+...+.+... .....+|+|++ +-||.+.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 445667788999999999999887643 34578899998 679998884
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.035 Score=60.40 Aligned_cols=148 Identities=20% Similarity=0.253 Sum_probs=72.7
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcc---cccEeeecceeccCCceEEEEeecCC
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR---HLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV~E~~~~ 628 (911)
.+.|+.|....+|+.. .++..+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 4568989999999977 344579999865 234456888998888883 33566778877666677999999987
Q ss_pred C--c------hhh---Hhhh-hhhccccc---------ccCCCCCCchhh-----hhHHHHhHH--------------HH
Q 002533 629 G--N------LRD---HLYN-SQKQNQNQ---------NQNQNSPLTWKR-----RLEISIGAA--------------RG 668 (911)
Q Consensus 629 g--s------L~~---~L~~-~~~~~~~~---------~~~~~~~l~~~~-----~l~ia~~ia--------------~g 668 (911)
+ + |-. .||. .....-.- .......-+|.. |+.-..+.+ +.
T Consensus 97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~ 176 (288)
T PF03881_consen 97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER 176 (288)
T ss_dssp ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence 7 1 111 1333 11000000 001111223432 222222111 11
Q ss_pred HH-HHhh-CCCCcEEEecccCCCeeecCCCceEEeecC
Q 002533 669 LH-YLHA-GAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 669 L~-yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 704 (911)
+. .|+. ...+..+|+||.+.|++.+.++.+.|.|=.
T Consensus 177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 11 1221 124678999999999999999889998754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.11 Score=57.63 Aligned_cols=149 Identities=20% Similarity=0.261 Sum_probs=85.1
Q ss_pred ecccCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccccE---ee---ecc----eeccCCceEEEEe
Q 002533 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHI---VS---LLG----FCDEHGEMILVYE 624 (911)
Q Consensus 555 LG~G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI---v~---l~g----~~~~~~~~~lV~E 624 (911)
|.+ .-..+|+....++. .++|..+.. ....+...|+..|..|.-..| ++ +=| ........+-+++
T Consensus 34 l~s-~eN~~f~~~~~~g~--~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGR--YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCC--eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 45679998887774 488887765 344566678888888742222 12 111 1111137788999
Q ss_pred ecCCCchhh-H--------------hhhhhhcccccccCCCCCCchh-------------hhhHHHHhHHHHHHHHhhC-
Q 002533 625 FMPRGNLRD-H--------------LYNSQKQNQNQNQNQNSPLTWK-------------RRLEISIGAARGLHYLHAG- 675 (911)
Q Consensus 625 ~~~~gsL~~-~--------------L~~~~~~~~~~~~~~~~~l~~~-------------~~l~ia~~ia~gL~yLH~~- 675 (911)
|++|..+.. . ||...+..............|. .......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988873 1 1111111100011111223343 1112333444445544431
Q ss_pred ---CCCc---EEEecccCCCeeecCCCc-eEEeecCCccC
Q 002533 676 ---AKHT---IIHRDVKSTNILLDENWA-AKISDFGLSRM 708 (911)
Q Consensus 676 ---~~~~---ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 708 (911)
.... +||+|+.+.|||++.+.. +.+.||+-+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1223 999999999999998874 88999998764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.1 Score=58.61 Aligned_cols=150 Identities=19% Similarity=0.189 Sum_probs=81.5
Q ss_pred eecccCcEEEEEEEeecC----CeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEe-eecceeccCCceEEEEeecCC
Q 002533 554 IIGSGGFGHVFKGYIDDG----SITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV-SLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~----~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~ 628 (911)
.|-.|-.-.+|+....++ ...+++|+......... +-.+|..+++.+..-++. ++++++.. + .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 455577778999875432 35788998765432222 236788888888655544 34454432 2 58999987
Q ss_pred CchhhH-hhhh------hhc---ccccc-cCCCCCCchhhhhHHHHh-----------------HHHHHHHH----hh-C
Q 002533 629 GNLRDH-LYNS------QKQ---NQNQN-QNQNSPLTWKRRLEISIG-----------------AARGLHYL----HA-G 675 (911)
Q Consensus 629 gsL~~~-L~~~------~~~---~~~~~-~~~~~~l~~~~~l~ia~~-----------------ia~gL~yL----H~-~ 675 (911)
.+|... +... ... -.... ........|.++.++..+ +...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776422 1000 000 00000 000111223322222211 11112222 11 2
Q ss_pred CCCcEEEecccCCCeeecC-CCceEEeecCCccC
Q 002533 676 AKHTIIHRDVKSTNILLDE-NWAAKISDFGLSRM 708 (911)
Q Consensus 676 ~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 708 (911)
....++|+|+++.|||+++ +..+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2457899999999999986 46899999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.15 Score=55.39 Aligned_cols=32 Identities=22% Similarity=0.482 Sum_probs=26.6
Q ss_pred CCcEEEecccCCCeeecCCCc-eEEeecCCccC
Q 002533 677 KHTIIHRDVKSTNILLDENWA-AKISDFGLSRM 708 (911)
Q Consensus 677 ~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 708 (911)
...++|+|+++.|||++++++ .-|.||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 346899999999999997555 56999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.016 Score=62.33 Aligned_cols=133 Identities=16% Similarity=0.141 Sum_probs=85.5
Q ss_pred CccceeecccCcEEEEEEEeecCCeEEEEEEcc--CCChh--------------------hHHHHHHHHHHHHhccc--c
Q 002533 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN--TSSMQ--------------------GAREFRTEIEMISELRH--L 604 (911)
Q Consensus 549 f~~~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~--~~~~~--------------------~~~~f~~Ei~~l~~l~H--p 604 (911)
++.++.||-|.-+.||.+....+. +.++|.-+ ..+.. ..-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~-~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGN-PLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCCCC-chhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456788999999999999988774 67777422 11110 01123467777777743 2
Q ss_pred cEeeecceeccCCceEEEEeecCCCchhhHhhhhhhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEec
Q 002533 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRD 684 (911)
Q Consensus 605 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrD 684 (911)
-+.+.+++ +..++|||++.+-.|...-+- .+-.+ +...+..-+.-|- .+|+||+|
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---------------~d~~~---ly~~lm~~Iv~la---~~GlIHgD 227 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV---------------EDPPT---LYDDLMGLIVRLA---NHGLIHGD 227 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec---------------CChHH---HHHHHHHHHHHHH---HcCceecc
Confidence 23344443 456799999988777543311 11122 2222222333343 68999999
Q ss_pred ccCCCeeecCCCceEEeecCCcc
Q 002533 685 VKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 685 lkp~NILl~~~~~~kl~DFGla~ 707 (911)
..-=||+++++..++++||-.+.
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cchheeEEecCCCEEEeechHhh
Confidence 99999999999999999997654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.069 Score=59.43 Aligned_cols=81 Identities=20% Similarity=0.186 Sum_probs=49.7
Q ss_pred eecccCcEEEEEEEeecCCeEEEEEEccCC-------ChhhHHHHHHHHHHHHhcc--cccEe-eecceeccCCceEEEE
Q 002533 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTS-------SMQGAREFRTEIEMISELR--HLHIV-SLLGFCDEHGEMILVY 623 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-------~~~~~~~f~~Ei~~l~~l~--HpnIv-~l~g~~~~~~~~~lV~ 623 (911)
.||.|....||++...+++..|+||.-.+. -+-..++..-|.+.|+... -|..+ +++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999998765457999964211 1222334455667776652 34333 3443 3445567999
Q ss_pred eecCC-CchhhHhh
Q 002533 624 EFMPR-GNLRDHLY 636 (911)
Q Consensus 624 E~~~~-gsL~~~L~ 636 (911)
|+++. ..|+..|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 99865 34555553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.13 Score=56.61 Aligned_cols=31 Identities=26% Similarity=0.374 Sum_probs=26.8
Q ss_pred CCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 677 KHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 677 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
..+++|+|+.+.||+++. +.+.|.||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 468999999999999998 5789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.16 Score=57.61 Aligned_cols=80 Identities=14% Similarity=0.101 Sum_probs=51.2
Q ss_pred ceeecccCcEEEEEEEeecCCeEEEEEEccCC----Ch---hhHHHHHHHHHHHHhcc---cccEeeecceeccCCceEE
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS----SM---QGAREFRTEIEMISELR---HLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 552 ~~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~----~~---~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~l 621 (911)
.+.||.|....||+....+ ..++||+-... .. ....+-..|.+.|+.+. ..++.+++.+|. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~~--~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSS--GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcCC--ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3468999999999988643 36889975421 10 12233334566666553 246777888887 44678
Q ss_pred EEeecCC--CchhhHh
Q 002533 622 VYEFMPR--GNLRDHL 635 (911)
Q Consensus 622 V~E~~~~--gsL~~~L 635 (911)
+||++++ ..|++.|
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999977 3455555
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.083 Score=54.78 Aligned_cols=31 Identities=26% Similarity=0.455 Sum_probs=22.1
Q ss_pred CcEEEecccCCCeee-cCCCceEEeecCCccC
Q 002533 678 HTIIHRDVKSTNILL-DENWAAKISDFGLSRM 708 (911)
Q Consensus 678 ~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~ 708 (911)
..++|+|+.+.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 568899999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.68 Score=51.54 Aligned_cols=72 Identities=17% Similarity=0.119 Sum_probs=43.2
Q ss_pred cCcEEEEEEEeecCCeEEEEEEccCCChhhHHHHHHHHHHHHhcccc--cEeeec---c--eeccCCceEEEEeecCCCc
Q 002533 558 GGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHL--HIVSLL---G--FCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 558 G~fG~Vykg~~~~~~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--nIv~l~---g--~~~~~~~~~lV~E~~~~gs 630 (911)
+.-..||+....++ ..+++|..+... ....+...|++.+..|... .++..+ | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~-~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDG-RRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCC-CEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 44567999887655 368888775332 2345666788887777422 122222 1 1222456788999998765
Q ss_pred h
Q 002533 631 L 631 (911)
Q Consensus 631 L 631 (911)
+
T Consensus 114 ~ 114 (325)
T PRK11768 114 P 114 (325)
T ss_pred C
Confidence 3
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.26 Score=54.48 Aligned_cols=32 Identities=16% Similarity=0.370 Sum_probs=29.1
Q ss_pred CCcEEEecccCCCeeecCCCceEEeecCCccC
Q 002533 677 KHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 677 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 708 (911)
..+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999998999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.13 Score=58.03 Aligned_cols=82 Identities=21% Similarity=0.208 Sum_probs=50.7
Q ss_pred eeecccCcEEEEEEEeecCCeEEEEEEccCC-----C-hhhHHHHHHHHHHHHhcc--cccEe-eecceeccCCceEEEE
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-----S-MQGAREFRTEIEMISELR--HLHIV-SLLGFCDEHGEMILVY 623 (911)
Q Consensus 553 ~~LG~G~fG~Vykg~~~~~~~~vAvK~l~~~-----~-~~~~~~f~~Ei~~l~~l~--HpnIv-~l~g~~~~~~~~~lV~ 623 (911)
+.||.|.-..||++.+..+...|+||.-.+. + +-..++..-|.+.|+.+. .|..| +++. .++....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence 4689999999999998533357999964221 1 223345556777777652 34333 4443 3445667899
Q ss_pred eecCC-CchhhHhh
Q 002533 624 EFMPR-GNLRDHLY 636 (911)
Q Consensus 624 E~~~~-gsL~~~L~ 636 (911)
|+++. ..|++.|.
T Consensus 113 EdL~~~~ilR~~Li 126 (409)
T PRK12396 113 EDLSDHTILRTALI 126 (409)
T ss_pred HhCcccHHHHHHHH
Confidence 99864 34555553
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.2 Score=51.25 Aligned_cols=151 Identities=17% Similarity=0.194 Sum_probs=93.7
Q ss_pred cEEEEEEEeecCCeEEEEEEccCCChh-hHHHHHHHHHHHHhcccccEeeecceeccCCceEEEEeecCCCchhhHhhhh
Q 002533 560 FGHVFKGYIDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNS 638 (911)
Q Consensus 560 fG~Vykg~~~~~~~~vAvK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~ 638 (911)
-.+.-+++-+-+ +..+|++...... ...-|..+.+++++++ .|++|.. ...-..-++.|.|-.-.
T Consensus 75 NsTl~~~kt~iG--~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~-------- 140 (308)
T PF07387_consen 75 NSTLLIGKTKIG--PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIK-------- 140 (308)
T ss_pred ceEEEEeccccc--hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcc--------
Confidence 344444443333 4667777654333 4456788899998876 4677762 23334568888873211
Q ss_pred hhcccccccCCCCCCchhhhhHHHHhHHHHHHHHhhCCCCcEEEecccCCCeeecCCCceEEeecCCccCCCCCCCCccc
Q 002533 639 QKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV 718 (911)
Q Consensus 639 ~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 718 (911)
... .-.|..+ ...|.-.|++ ..+.+|+|..|+||+-|..|-+||.|-+.--.
T Consensus 141 --------------i~~--~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---------- 192 (308)
T PF07387_consen 141 --------------INF--SNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---------- 192 (308)
T ss_pred --------------cch--hHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh----------
Confidence 100 0111222 4567778854 57899999999999999999999999875321
Q ss_pred cccccCcccccChhhhcccCCCchhHHHHHHHHHHHHHhCCC
Q 002533 719 STVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760 (911)
Q Consensus 719 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSfGvvL~ElltG~~ 760 (911)
.+.-|.--| ....|.++.+=+|=.-++++.....
T Consensus 193 -----~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 193 -----NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred -----heeeEEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 111233211 2346888899888888888886543
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.65 Score=51.81 Aligned_cols=150 Identities=18% Similarity=0.240 Sum_probs=80.1
Q ss_pred eecccCcEEEEEEEeecC---CeEEEEEEccCCChhhHHHHHHHHHHHHhcccccEe-eecceeccCCceEEEEeecCCC
Q 002533 554 IIGSGGFGHVFKGYIDDG---SITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV-SLLGFCDEHGEMILVYEFMPRG 629 (911)
Q Consensus 554 ~LG~G~fG~Vykg~~~~~---~~~vAvK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~g 629 (911)
.|..|--..+|+....+. ...+++|+....... .-+-.+|..+++.+..-++. ++++++. .+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 455577778998876543 237889987654322 22345788888888765554 4455543 22 589999776
Q ss_pred chhhH-------hhhhhh---cccccccC-CCCCCchhhhhHHHHh----------------------HHHHHHHHhh--
Q 002533 630 NLRDH-------LYNSQK---QNQNQNQN-QNSPLTWKRRLEISIG----------------------AARGLHYLHA-- 674 (911)
Q Consensus 630 sL~~~-------L~~~~~---~~~~~~~~-~~~~l~~~~~l~ia~~----------------------ia~gL~yLH~-- 674 (911)
.|..- +..-.. .-...... ...+--|..+.++..+ +..-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 100000 00000000 0111123322222111 1111222211
Q ss_pred ---CCCCcEEEecccCCCeeecC-CCceEEeecCCccC
Q 002533 675 ---GAKHTIIHRDVKSTNILLDE-NWAAKISDFGLSRM 708 (911)
Q Consensus 675 ---~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 708 (911)
....-++|.|+.+.|||+++ ++.++++||..|-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 12345799999999999975 57899999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 911 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-76 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-76 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 519 bits (1338), Expect = e-179
Identities = 163/322 (50%), Positives = 208/322 (64%), Gaps = 14/322 (4%)
Query: 521 TNTNTASSLPSDLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRL 580
+ ++S L R L ++++AT +F +IG G FG V+KG + DG+ VA+KR
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRR 71
Query: 581 NTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQK 640
S QG EF TEIE +S RH H+VSL+GFCDE EMIL+Y++M GNL+ HLY S
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 641 QNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700
++W++RLEI IGAARGLHYLH A IIHRDVKS NILLDEN+ KI
Sbjct: 132 PTM--------SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+DFG+S+ G Q+H+STVVKG+ GY+DPEY + +LTEKSDVYSFGVVL EVLC R
Sbjct: 181 TDFGISKKGTEL-DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGF 820
I ++ +E V+L WA S G ++QIVDP L KI P L KF + A C
Sbjct: 240 A-IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 821 RRPTMGDVTWGLEFALQLQEAA 842
RP+MGDV W LE+AL+LQE+
Sbjct: 299 DRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 383 bits (986), Expect = e-126
Identities = 109/296 (36%), Positives = 173/296 (58%), Gaps = 13/296 (4%)
Query: 535 RRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA-REFRT 593
+RFSL E++ A+ +F++ I+G GGFG V+KG + DG++ VAVKRL QG +F+T
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-VAVKRLKEERTQGGELQFQT 76
Query: 594 EIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPL 653
E+EMIS H +++ L GFC E +LVY +M G++ L + PL
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ--------PPL 128
Query: 654 TWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGM 713
W +R I++G+ARGL YLH IIHRDVK+ NILLDE + A + DFGL+++
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK- 187
Query: 714 SQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPM-INGAVRKEEV 772
+HV+T V+G+ G++ PEY+ + +EK+DV+ +GV+LLE++ G+ + ++V
Sbjct: 188 -DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
L+ W + ++ +VD L+G + + +++A CT RP M +V
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-126
Identities = 103/311 (33%), Positives = 170/311 (54%), Gaps = 31/311 (9%)
Query: 535 RRFSLTEIKQATCDFADHC------IIGSGGFGHVFKGYIDDGSITVAVKRLNT----SS 584
FS E+K T +F + +G GGFG V+KGY+++ TVAVK+L ++
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITT 70
Query: 585 MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQN 644
+ ++F EI+++++ +H ++V LLGF + ++ LVY +MP G+L D L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--- 127
Query: 645 QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704
PL+W R +I+ GAA G+++LH ++ IHRD+KS NILLDE + AKISDFG
Sbjct: 128 ------PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
L+R +Q+ +++ + G+ Y+ PE + R ++T KSD+YSFGVVLLE++ G P +
Sbjct: 179 LARASEKF-AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 765 GAVRKEEVSLVLWAR-VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP 823
+E L+ + T++ +D ++ + +A C E+ +RP
Sbjct: 237 ---HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRP 292
Query: 824 TMGDVTWGLEF 834
+ V L+
Sbjct: 293 DIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 5e-82
Identities = 70/319 (21%), Positives = 122/319 (38%), Gaps = 40/319 (12%)
Query: 537 FSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE 596
+ + + G FG V+K + + VAVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSW-QNEYEVY 70
Query: 597 MISELRHLHIVSLLGFCDE----HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSP 652
+ ++H +I+ +G ++ L+ F +G+L D L + +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-------------KANV 117
Query: 653 LTWKRRLEISIGAARGLHYLHA-------GAKHTIIHRDVKSTNILLDENWAAKISDFGL 705
++W I+ ARGL YLH G K I HRD+KS N+LL N A I+DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRP 760
+ +G + + G+ Y+ PE + ++ + D+Y+ G+VL E+
Sbjct: 178 ALKFEAG-KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIV-----DPRLRGKIAP-VCLNKFVEIAGSC 814
+G V + + + + ++V P LR + E C
Sbjct: 237 A-ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 815 TDEEGFRRPTMGDVTWGLE 833
D + R + G V +
Sbjct: 296 WDHDAEARLSAGCVGERIT 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-68
Identities = 77/340 (22%), Positives = 129/340 (37%), Gaps = 47/340 (13%)
Query: 538 SLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEM 597
SL I + ++G G FG V K VA+K++ + S + + F E+
Sbjct: 1 SLHMIDYK--EIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESER--KAFIVELRQ 54
Query: 598 ISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
+S + H +IV L G C + LV E+ G+L + L T
Sbjct: 55 LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL---------HGAEPLPYYTAAH 103
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW-AAKISDFGLSRMGPSGMSQS 716
+ + ++G+ YLH+ +IHRD+K N+LL KI DFG + + M
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--- 160
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
T KGS ++ PE +EK DV+S+G++L EV+ R P
Sbjct: 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--------------- 202
Query: 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836
+ + + V R + + C ++ +RP+M ++ +
Sbjct: 203 FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT--- 259
Query: 837 QLQEAAEKSDQGRP-----FVPRGEVITSSTTTDSDEPFS 871
L +D+ +P GE D E +
Sbjct: 260 HLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYR 299
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-67
Identities = 85/336 (25%), Positives = 134/336 (39%), Gaps = 47/336 (13%)
Query: 503 VKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQATCDFADHCIIGSGGFGH 562
+K + T N ++ D +I D IG+G FG
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDM------DIPWC--DLNIKEKIGAGSFGT 52
Query: 563 VFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620
V + VAVK L EF E+ ++ LRH +IV +G + +
Sbjct: 53 VHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTI 680
+V E++ RG+L L L +RRL ++ A+G++YLH I
Sbjct: 111 IVTEYLSRGSLYRLL---------HKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 681 IHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLT 740
+HR++KS N+L+D+ + K+ DFGLSR+ S S G+ ++ PE +R +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS---SKSAAGTPEWMAPEVLRDEPSN 217
Query: 741 EKSDVYSFGVVLLEVLCGRPP---MINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRG 797
EKSDVYSFGV+L E+ + P + V V + R
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQV-------------------VAAVGFKCKRL 258
Query: 798 KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+I + I C E ++RP+ + L
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 4e-64
Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 56/298 (18%)
Query: 554 IIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGA-------REFRTEIEMISELRHLH 605
IG GGFG V KG + D S VA+K L +G +EF+ E+ ++S L H +
Sbjct: 26 QIGKGGFGLVHKGRLVKDKS-VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
IV L G +V EF+P G+L L ++ P+ W +L + +
Sbjct: 85 IVKLYGLMHN--PPRMVMEFVPCGDLYHRL-----------LDKAHPIKWSVKLRLMLDI 131
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWA-----AKISDFGLSRMGPSGMSQSHVST 720
A G+ Y+ I+HRD++S NI L AK++DFGLS+ H +
Sbjct: 132 ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------SVHSVS 184
Query: 721 VVKGSFGYVDPEYIRRQQL--TEKSDVYSFGVVLLEVLCGRPP---MINGAVRKEEVSLV 775
+ G+F ++ PE I ++ TEK+D YSF ++L +L G P G ++
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK------- 237
Query: 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
++ I + LR I C + + C + +RP + L
Sbjct: 238 ----------FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 6e-64
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 54/295 (18%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA----REFRTEIEMISELRHLHIVSL 609
IIG GGFG V++ + VAVK + R E ++ + L+H +I++L
Sbjct: 14 IIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G C + + LV EF G L L + + ++ ARG+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL-------------SGKRIPPDILVNWAVQIARGM 118
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDE--------NWAAKISDFGLSRMGPSGMSQSHVSTV 721
+YLH A IIHRD+KS+NIL+ + N KI+DFGL+R ++ +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSA 174
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP---MINGAVRKEEVSLVLWA 778
G++ ++ PE IR ++ SDV+S+GV+L E+L G P + AV
Sbjct: 175 A-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----------- 222
Query: 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+ +L I C F ++ C + + RP+ ++ L
Sbjct: 223 --------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-63
Identities = 81/287 (28%), Positives = 134/287 (46%), Gaps = 42/287 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLGF 612
IGSG FG V+KG VAVK LN ++ + F+ E+ ++ + RH++I+ +G+
Sbjct: 32 IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
I V ++ +L HL + K+ ++I+ ARG+ YL
Sbjct: 89 STAPQLAI-VTQWCEGSSLYHHL-----------HASETKFEMKKLIDIARQTARGMDYL 136
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
HA +IIHRD+KS NI L E+ KI DFGL+ S S SH + GS ++ PE
Sbjct: 137 HA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK-SRWSGSHQFEQLSGSILWMAPE 192
Query: 733 YIRRQQL---TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789
IR Q + +SDVY+FG+VL E++ G+ P ++ ++ ++
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---------------YSNINNRDQIIEM 237
Query: 790 IVDPRLRGKIAPV---CLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+ L ++ V C + + C ++ RP+ + +E
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-62
Identities = 72/305 (23%), Positives = 121/305 (39%), Gaps = 41/305 (13%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG K + + +K L + R F E++++ L H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + + E++ G LR + ++ +S W +R+ + A G+ YLH
Sbjct: 78 KDKRLNFITEYIKGGTLRGII-----------KSMDSQYPWSQRVSFAKDIASGMAYLH- 125
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK----------- 723
IIHRD+ S N L+ EN ++DFGL+R+ +Q +K
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783
G+ ++ PE I + EK DV+SFG+VL E++ + R + L
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235
Query: 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE-FALQLQEAA 842
V L P C F I C D + +RP+ + LE + L
Sbjct: 236 -------VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288
Query: 843 EKSDQ 847
Q
Sbjct: 289 PLGPQ 293
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 7e-62
Identities = 55/290 (18%), Positives = 109/290 (37%), Gaps = 50/290 (17%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLG 611
+ G ++KG + VK L R+F E + H +++ +LG
Sbjct: 17 KLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 612 FCDE--HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
C L+ +MP G+L + L+ N + + ++ ++ ARG+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHE----------GTNFVVDQSQAVKFALDMARGM 124
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
+LH + I + S ++++DE+ A+IS + S S + +V
Sbjct: 125 AFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF--------SFQSPGRMYAPAWV 175
Query: 730 DPEYIRRQQL---TEKSDVYSFGVVLLEVLCGRPP---MINGAVRKEEVSLVLWARVSRA 783
PE ++++ +D++SF V+L E++ P + N +
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------------- 219
Query: 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
++ LR I P ++ C +E+ +RP + LE
Sbjct: 220 ---GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 5e-61
Identities = 70/352 (19%), Positives = 124/352 (35%), Gaps = 58/352 (16%)
Query: 537 FSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE 596
+ +E + +IG G +G V+KG +D+ VAVK + ++ Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQ---NFINEKN 57
Query: 597 M--ISELRHLHIVSLLGFC-----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQ 649
+ + + H +I + D E +LV E+ P G+L +L
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-------------S 104
Query: 650 NSPLTWKRRLEISIGAARGLHYLHA------GAKHTIIHRDVKSTNILLDENWAAKISDF 703
W ++ RGL YLH K I HRD+ S N+L+ + ISDF
Sbjct: 105 LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164
Query: 704 GLSRMGPSGM-----SQSHVSTVVKGSFGYVDPEYIR-------RQQLTEKSDVYSFGVV 751
GLS + + + G+ Y+ PE + + ++ D+Y+ G++
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224
Query: 752 LLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ----IVDPRLRGKI------AP 801
E+ + G E + + T + + + R K
Sbjct: 225 YWEIFMRCTDLFPGESVPE--YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 802 VCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSDQGRPFVP 853
+ + E C D++ R T + +L E++ P
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMA---ELMMIWERNKSVSPTAH 331
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-60
Identities = 58/297 (19%), Positives = 110/297 (37%), Gaps = 55/297 (18%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLG 611
+IG G FG V+ G VA++ ++ + F+ E+ + RH ++V +G
Sbjct: 40 LIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
C + ++ L + ++ L + +I+ +G+ Y
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV-----------RDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM--GPSGMSQSHVSTVVKGSFGYV 729
LHA I+H+D+KS N+ D N I+DFGL + + + G ++
Sbjct: 146 LHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 730 DPEYIRRQQL---------TEKSDVYSFGVVLLEVLCGRPP---MINGAVRKEEVSLVLW 777
PE IR+ ++ SDV++ G + E+ P A ++W
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--------IIW 253
Query: 778 ARVSRARGTVDQIVDPRLRGKIAPV-CLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+ ++ ++ + + +I C E RPT + LE
Sbjct: 254 Q------------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-53
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 46/300 (15%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IG G +G V+ G VAVK T+ + TEI +RH +I+ +
Sbjct: 44 QIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 614 ----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
++ L+ ++ G+L D+L +++ L K L+++ + GL
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL-------------KSTTLDAKSMLKLAYSSVSGL 147
Query: 670 HYLHA-----GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG-MSQSHVSTVVK 723
+LH K I HRD+KS NIL+ +N I+D GL+ S
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 724 GSFGYVDPE------YIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777
G+ Y+ PE Q +D+YSFG++L EV + + +
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ-----LPY 262
Query: 778 ARVSRARGTVDQIVDPRLRGKIAPV---------CLNKFVEIAGSCTDEEGFRRPTMGDV 828
+ + + + + + K+ P CL + ++ C R T V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-52
Identities = 67/302 (22%), Positives = 116/302 (38%), Gaps = 50/302 (16%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEM--ISELRHLHIVSLLG 611
+G G +G V++G VAVK ++ + + + E E+ LRH +I+ +
Sbjct: 15 CVGKGRYGEVWRGSWQG--ENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 612 FC----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
++ L+ + G+L D+L Q + L L I + A
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-------------QLTTLDTVSCLRIVLSIAS 116
Query: 668 GLHYLHA-----GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV-STV 721
GL +LH K I HRD+KS NIL+ +N I+D GL+ M +Q V +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 722 VKGSFGYVDPEYIRRQ------QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775
G+ Y+ PE + ++ D+++FG+VL EV NG V +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--NGIVEDYKPP-- 232
Query: 776 LWARVSRARGTVDQIVD--------PRLRGKIAPV-CLNKFVEIAGSCTDEEGFRRPTMG 826
+ V + + + P + + L ++ C + R T
Sbjct: 233 -FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
Query: 827 DV 828
+
Sbjct: 292 RI 293
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-49
Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 46/300 (15%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IG G FG V++G VAVK ++ + EI LRH +I+ +
Sbjct: 49 SIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105
Query: 614 ----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
++ LV ++ G+L D+L +T + +++++ A GL
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL-------------NRYTVTVEGMIKLALSTASGL 152
Query: 670 HYLHA-----GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG-MSQSHVSTVVK 723
+LH K I HRD+KS NIL+ +N I+D GL+ S +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 724 GSFGYVDPEYIR------RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777
G+ Y+ PE + + +++D+Y+ G+V E+ G ++ +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--GGIHEDYQLP---Y 267
Query: 778 ARVSRARGTVDQIVDPRLRGKIAPV---------CLNKFVEIAGSCTDEEGFRRPTMGDV 828
+ + +V+++ K+ P L +I C G R T +
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-43
Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 26/222 (11%)
Query: 554 IIGSGGFGHVFKGYI--DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHLHIVSL 609
+IG G FG V K I D + A+KR+ + + +F E+E++ +L H +I++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQN----SPLTWKRRLEISIGA 665
LG C+ G + L E+ P GNL D L S+ + S L+ ++ L +
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
ARG+ YL ++ IHRD+ + NIL+ EN+ AKI+DFGLSR VK +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---------EVYVKKT 199
Query: 726 FGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
G + E + T SDV+S+GV+L E++ G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-42
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 46/287 (16%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLGFC 613
IG G FG VF G + + VAVK + + +F E ++ + H +IV L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ + +V E + G+ L + + + L K L++ AA G+ YL
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-----------RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV---VKGSFGYVD 730
IHRD+ + N L+ E KISDFG+SR G+ + VK +
Sbjct: 231 ---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----A 283
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRKEEVSLVLWARVSRARGT 786
PE + + + +SDV+SFG++L E G P + N R+
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF---------------- 327
Query: 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
V+ R +C + + C E +RP+ + L+
Sbjct: 328 ----VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 45/232 (19%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG VF + VAVK L ++ ++F+ E E+++ L+H HIV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHL----YNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
G C + +I+V+E+M G+L L ++ Q + L + L I+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---------MGPSG---- 712
A G+ YL A +HRD+ + N L+ N KI DFG+SR +G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 713 --MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
M PE I ++ T +SDV+SFGV+L E+ +P
Sbjct: 200 RWMP----------------PESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-42
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 37/223 (16%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHLHI 606
+G+G FG V + +D + VAVK L +++ + +E++++S L +H +I
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNS--QKQNQNQNQNQNSPLTWKRRLEISIG 664
V+LLG C G ++++ E+ G+L + L + NS + + L S
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
A+G+ +L A IHRDV + N+LL AKI DFGL+R ++
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMND 217
Query: 725 SFGYVD------------PEYIRRQQLTEKSDVYSFGVVLLEV 755
S Y+ PE I T +SDV+S+G++L E+
Sbjct: 218 SN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 44/231 (19%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG VF + + VAVK L +S ++F+ E E+++ L+H HIV
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQN---SPLTWKRRLEISIGAA 666
G C E +++V+E+M G+L L + + ++ PL + L ++ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---------MGPSG----- 712
G+ YL A +HRD+ + N L+ + KI DFG+SR +G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 713 -MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
M PE I ++ T +SDV+SFGVVL E+ +P
Sbjct: 226 WMP----------------PESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIV 607
+G G FG V K G TVAVK L ++ + +E ++ ++ H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHL------------YNSQKQNQNQNQNQNSPLTW 655
L G C + G ++L+ E+ G+LR L + + + + LT
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ 715
+ + ++G+ YL A+ ++HRD+ + NIL+ E KISDFGLSR
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE--- 203
Query: 716 SHVSTVVKGSFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEV 755
+ VK S G + E + T +SDV+SFGV+L E+
Sbjct: 204 ---DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHLHI 606
+G+G FG V + D ++TVAVK L S+ R +E++++S L H++I
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHL------YNSQKQNQNQNQNQNSPLTWKRRLE 660
V+LLG C G +++ E+ G+L + L + K + ++ L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
S A+G+ +L A IHRD+ + NILL KI DFGL+R +
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD----IKNDSN-- 200
Query: 721 VVKGSFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEV 755
V + PE I T +SDV+S+G+ L E+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-41
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHLHI 606
++GSG FG V SI VAVK L + R +E++M+++L H +I
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHL-----------YNSQKQNQNQNQNQNSPLTW 655
V+LLG C G + L++E+ G+L ++L + Q + + + + LT+
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ 715
+ L + A+G+ +L + +HRD+ + N+L+ KI DFGL+R +
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD----IMS 224
Query: 716 SHVSTVVKGSFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEV 755
V + PE + T KSDV+S+G++L E+
Sbjct: 225 DSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-41
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 555 IGSGGFGHVFKGYI-------DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHLH 605
+G G FG V ++TVAVK L + + + +E+EM+ + +H +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNS----QKQNQNQNQNQNSPLTWKRRLEI 661
I++LLG C + G + ++ E+ +GNLR++L + + + N+ +T+K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ ARG+ YL A IHRD+ + N+L+ EN KI+DFGL+R +
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI------DYY 213
Query: 722 VKGSFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEV 755
K + G + PE + + T +SDV+SFGV++ E+
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 44/230 (19%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIV 607
+G G FG V++G D+ VA+K +N ++ R EF E ++ E H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
LLG + +++ E M RG+L+ +L + + N +P + + ++++ A
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP--AMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---------MGPSG------ 712
G+ YL + +HRD+ + N ++ E++ KI DFG++R G G
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
MS PE ++ T SDV+SFGVVL E+ L +P
Sbjct: 207 MS----------------PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG V D+ VAVK+L S+ + R+F EIE++ L+H +IV
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 610 LGFCDEHGE--MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
G C G + L+ E++P G+LRD+L +++ + + L+ + +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----------IDHIKLLQYTSQICK 125
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YL IHRD+ + NIL++ KI DFGL+++ P V +
Sbjct: 126 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ PE + + + SDV+SFGVVL E+
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 46/233 (19%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
+G FG V+KG++ + + VA+K L + R EFR E + + L+H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHL----YNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
LLG + + +++ + G+L + L +S + + ++ S L + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---------MGPSG--- 712
A G+ YL + H ++H+D+ + N+L+ + KISD GL R + +
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 713 ---MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
M+ PE I + + SD++S+GVVL EV +P
Sbjct: 194 IRWMA----------------PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 81/312 (25%), Positives = 139/312 (44%), Gaps = 51/312 (16%)
Query: 554 IIGSGGFGHVFKGYI-------DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHL 604
+G G FG V ++TVAVK L + + + +E+EM+ + +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNS----QKQNQNQNQNQNSPLTWKRRLE 660
+I++LLG C + G + ++ E+ +GNLR++L + + + N+ +T+K +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
+ ARG+ YL A IHRD+ + N+L+ EN KI+DFGL+R +
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI------DY 258
Query: 721 VVKGSFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP---MINGAVRKEE 771
K + G + PE + + T +SDV+SFGV++ E+ G P + EE
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----EE 313
Query: 772 VSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831
+ +L + +D+ P C N+ + C +RPT +
Sbjct: 314 LFKLL-----KEGHRMDK---P-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
Query: 832 LEFALQLQEAAE 843
L+ L L E
Sbjct: 359 LDRILTLTTNEE 370
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG V D+ VAVK+L S+ + R+F EIE++ L+H +IV
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 610 LGFCDEHGE--MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
G C G + L+ E++P G+LRD+L +++ + + L+ + +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----------IDHIKLLQYTSQICK 156
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YL IHRD+ + NIL++ KI DFGL+++ P V +
Sbjct: 157 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ PE + + + SDV+SFGVVL E+
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHLHI 606
+G G FG V + TVAVK L + +E++++ + HL++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 607 VSLLGFC-DEHGEMILVYEFMPRGNLRDHLYNS----QKQNQNQNQNQNSPLTWKRRLEI 661
V+LLG C G ++++ EF GNL +L + LT + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
S A+G+ +L A IHRD+ + NILL E KI DFGL+R + +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPD--Y 204
Query: 722 VKGSFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEV 755
V+ + PE I + T +SDV+SFGV+L E+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 554 IIGSGGFGHVFKGYI----DDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG V D+ VAVK+L S R+F+ EI+++ L IV
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 610 LGFCDEHGE--MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
G G + LV E++P G LRD L Q + L R L S +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYSSQICK 138
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YL + +HRD+ + NIL++ KI+DFGL+++ P V +
Sbjct: 139 GMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
+ PE + + +SDV+SFGVVL E+ C +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
++GSG FG V+KG + I VA+K L ++ A E E +++ + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG C + + + MP G L D++ +++++ + + L + A+G
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYV----REHKDN-------IGSQYLLNWCVQIAKG 129
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
++YL ++HRD+ + N+L+ KI+DFGL+++ + + + + K +
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKW 185
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+ E I + T +SDV+S+GV + E++ G P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G G +G V++G S+TVAVK L +M+ EF E ++ E++H ++V LLG C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
++ EFM GNL D+L +Q ++ L ++ + + YL
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQE----------VSAVVLLYMATQISSAMEYL- 127
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV--VKGSFGYVDP 731
K IHRD+ + N L+ EN K++DFGLSR+ +H +K + P
Sbjct: 128 --EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTAP 181
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
E + + + KSDV++FGV+L E+ G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC- 613
+G GGF +V A+KR+ Q E + E +M H +I+ L+ +C
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 614 ---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
E L+ F RG L + + + +++ + LT + L + +G RGL
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEI--------ERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK------G 724
+H HRD+K TNILL + + D G + S + ++
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 725 SFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ Y PE + E++DV+S G VL ++ G P
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 54/241 (22%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
IG G FG VF+ + VAVK L + + +F+ E +++E + +IV
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHL------------YNSQKQNQNQNQNQNSPLTWK 656
LLG C M L++E+M G+L + L ++ + PL+
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 657 RRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR--------- 707
+L I+ A G+ YL ++ +HRD+ + N L+ EN KI+DFGLSR
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 708 MGPSG------MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEV--LCGR 759
+ M PE I + T +SDV+++GVVL E+ +
Sbjct: 232 ADGNDAIPIRWMP----------------PESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 760 P 760
P
Sbjct: 276 P 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-39
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 555 IGSGGFGHVFKGYI-------DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHLH 605
+G G FG V + VAVK L + + + + +E+EM+ + +H +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNS----QKQNQNQNQNQNSPLTWKRRLEI 661
I++LLG C + G + ++ E+ +GNLR++L + + N + N L+ K +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ ARG+ YL A IHRD+ + N+L+ E+ KI+DFGL+R
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI------DYY 247
Query: 722 VKGSFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEV 755
K + G + PE + + T +SDV+SFGV+L E+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHLHIVS 608
+G G FG V D+ VAVK L S + + EIE++ L H +IV
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 609 LLGFCDEHGE--MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
G C E G + L+ EF+P G+L+++L ++ + + K++L+ ++
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----------INLKQQLKYAVQIC 136
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
+G+ YL + +HRD+ + N+L++ KI DFGL++ + V
Sbjct: 137 KGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ PE + + + SDV+SFGV L E+L
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-39
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 20/220 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G G +G V++G S+TVAVK L +M+ EF E ++ E++H ++V LLG C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
++ EFM GNL D+L +Q ++ L ++ + + YL
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQ----------EVSAVVLLYMATQISSAMEYL- 334
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
K IHR++ + N L+ EN K++DFGLSR+ +H K + PE
Sbjct: 335 --EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA--KFPIKWTAPES 390
Query: 734 IRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
+ + + KSDV++FGV+L E+ G P + V +
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 59/231 (25%), Positives = 91/231 (39%), Gaps = 50/231 (21%)
Query: 554 IIGSGGFGHVFKG-------YIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHI 606
+G G F +FKG Y V +K L+ + + F M+S+L H H+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V G C E ILV EF+ G+L +L + + + +LE++ A
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL-----------KKNKNCINILWKLEVAKQLA 123
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLD--------ENWAAKISDFGLSRMGPSGMSQSHV 718
+H+L ++T+IH +V + NILL K+SD G+S
Sbjct: 124 AAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI----------- 169
Query: 719 STVVKGSFGYVD------PEYIR-RQQLTEKSDVYSFGVVLLEVL-CGRPP 761
V + PE I + L +D +SFG L E+ G P
Sbjct: 170 --TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHIVSL 609
+IG G FG V+ G I A+K L+ + MQ F E ++ L H ++++L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 610 LGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
+G G ++ +M G+L + ++ T K + + ARG
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFI-----------RSPQRNPTVKDLISFGLQVARG 136
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL A+ +HRD+ + N +LDE++ K++DFGL+R + +V +
Sbjct: 137 MEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARD----ILDREYYSVQQHRHAR 189
Query: 729 V-----DPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+ E ++ + T KSDV+SFGV+L E+L G PP
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 22/222 (9%)
Query: 555 IGSGGFGHVFKGY--IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLG 611
+G G FG V +G + I VA+K L + + E E +++ +L + +IV L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
C M+ V E G L L +++ + E+ + G+ Y
Sbjct: 78 VCQAEALML-VMEMAGGGPLHKFLVGKREE-----------IPVSNVAELLHQVSMGMKY 125
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
L + +HRD+ + N+LL AKISDFGLS+ + S + K + P
Sbjct: 126 L---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
E I ++ + +SDV+S+GV + E L G+ P M V
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
I+G G FG V++G I VAVK + +F +E ++ L H HIV L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+G +E I + E P G L +L ++N+N L + S+ + +
Sbjct: 79 IGIIEEEPTWI-IMELYPYGELGHYL----ERNKNS-------LKVLTLVLYSLQICKAM 126
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF--G 727
YL +HRD+ NIL+ K+ DFGLSR +
Sbjct: 127 AYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRY----IEDEDYYKASVTRLPIK 179
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
++ PE I ++ T SDV+ F V + E+L G+ P + N V
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 225
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 29/219 (13%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHIVSL 609
+IG G FG V+ G D I AVK LN + + +F TE ++ + H +++SL
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 610 LGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LG C G ++V +M G+LR+ + +N+ T K + + A+G
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFI-----------RNETHNPTVKDLIGFGLQVAKG 140
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL A +HRD+ + N +LDE + K++DFGL+R M +V +
Sbjct: 141 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 193
Query: 729 V-----DPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
+ E ++ Q+ T KSDV+SFGV+L E++ G PP
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 554 IIGSGGFGHVFKGY--IDDGSITVAVKRLNTSSMQGAR--EFRTEIEMISELRHLHIVSL 609
+GSG FG V KGY + TVAVK L + A E E ++ +L + +IV +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+G C+ M+ V E G L +L QN + K +E+ + G+
Sbjct: 84 IGICEAESWML-VMEMAELGPLNKYL------------QQNRHVKDKNIIELVHQVSMGM 130
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YL + +HRD+ + N+LL AKISDFGLS+ + + T K +
Sbjct: 131 KYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
PE I + + KSDV+SFGV++ E G+ P
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G+G FG V+ GY + G VAVK L SM F E ++ +L+H +V L
Sbjct: 20 RLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ I + E+M G+L D L LT + L+++ A G+ ++
Sbjct: 78 TQEPIYI-ITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGMAFI- 125
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV--VKGSFGYVDP 731
+ IHRD+++ NIL+ + + KI+DFGL+R+ + +K + P
Sbjct: 126 --EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WTAP 179
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
E I T KSDV+SFG++L E++ GR P M N V +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 554 IIGSGGFGHVFKGYI----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
+G G FG V D VAVK L + R ++ EI+++ L H HI+
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 609 LLGFCDEHGE--MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
G C++ G + LV E++P G+LRD+L + + L +
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL-------------PRHSIGLAQLLLFAQQIC 144
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
G+ YLHA +H IHRD+ + N+LLD + KI DFGL++ P G V
Sbjct: 145 EGMAYLHA--QH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+ PE ++ + SDV+SFGV L E+L
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELL 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIV 607
+G G FG V++G + D + VAVK L + +F E +IS+ H +IV
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+G + ++ E M G+L+ L ++ + +Q S L L ++ A
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP-----SQPSSLAMLDLLHVARDIAC 151
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLD---ENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
G YL ++ IHRD+ + N LL AKI DFG++R S KG
Sbjct: 152 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA------SYYRKG 202
Query: 725 SFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
+ PE T K+D +SFGV+L E+ L P
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 554 IIGSGGFGHVFKGYI---DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
IIGSG G V G + + VA+K L + R +F +E ++ + H +I+ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G ++V E+M G+L L + + T + + + G G+
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFL-----------RTHDGQFTIMQLVGMLRGVGAGM 164
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YL + +HRD+ + N+L+D N K+SDFGLSR+ ++ +T K +
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
PE I + + SDV+SFGVV+ EVL G P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 51/234 (21%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLN--TSSMQGAREFRTEIEMISELRHLHIVS 608
I+G G FG V +G D S+ VAVK + SS + EF +E + + H +++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 609 LLGFCDEHG-----EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
LLG C E + +++ FM G+L +L S+ + + + + L+ +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK------HIPLQTLLKFMV 154
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR---------MGPSG-- 712
A G+ YL + +HRD+ + N +L ++ ++DFGLS+ G
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 713 ----MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
++ E + + T KSDV++FGV + E+ G P
Sbjct: 212 PVKWIA----------------IESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IGSG FG V GY VA+K + +M +F E E++ +L H +V L G C
Sbjct: 15 EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
E + LV EFM G L D+L + Q + L + + G+ YL
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL-----------RTQRGLFAAETLLGMCLDVCEGMAYL- 120
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV--VKGSFGYVDP 731
+ +IHRD+ + N L+ EN K+SDFG++R S T VK + P
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WASP 174
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
E + + KSDV+SFGV++ EV G+ P
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 22/215 (10%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLNTSSMQGA---REFRTEIEMISELRHLHIV 607
+G G FG V +G +++VAVK L + +F E+ + L H +++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
L G + V E P G+L D L Q ++ A
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-----------FLLGTLSRYAVQVAE 132
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
G+ YL IHRD+ + N+LL KI DFGL R P + K F
Sbjct: 133 GMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+ PE ++ + + SD + FGV L E+ G+ P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-38
Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 29/219 (13%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHIVSL 609
+IG G FG V+ G D I AVK LN + + +F TE ++ + H +++SL
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 610 LGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LG C G ++V +M G+LR+ + +N+ T K + + A+G
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFI-----------RNETHNPTVKDLIGFGLQVAKG 204
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ +L A +HRD+ + N +LDE + K++DFGL+R M +V +
Sbjct: 205 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD----MYDKEFDSVHNKTGAK 257
Query: 729 V-----DPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
+ E ++ Q+ T KSDV+SFGV+L E++ G PP
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 35/215 (16%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IG G FG V G VAVK + + A+ F E ++++LRH ++V LLG
Sbjct: 28 TIGKGEFGDVMLGDYRG--NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 614 -DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+E G + +V E+M +G+L D+L + + L L+ S+ + YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDVCEAMEYL 133
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV-----VKGSFG 727
+ +HRD+ + N+L+ E+ AK+SDFGL++ ++ + VK
Sbjct: 134 ---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVK---- 179
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+ PE +R ++ + KSDV+SFG++L E+ GR P
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIV---- 607
IG G F V+KG + ++ VA L + + F+ E EM+ L+H +IV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
S ++LV E M G L+ +L + ++ W R +I +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS------WCR--QI----LK 140
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
GL +LH IIHRD+K NI + + KI D GL+ + S V+ G+
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVI-GTP 194
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
++ PE ++ E DVY+FG+ +LE+ P
Sbjct: 195 EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-38
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIV 607
+G G FG V++G + D + VAVK L + +F E +IS+ H +IV
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+G + ++ E M G+L+ L ++ + +Q S L L ++ A
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-----SQPSSLAMLDLLHVARDIAC 192
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLD---ENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
G YL ++ IHRD+ + N LL AKI DFG++R KG
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA------GYYRKG 243
Query: 725 SFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEV--LCGRP 760
+ PE T K+D +SFGV+L E+ L P
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-38
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G G FG V+ G + G+ VA+K L +M F E +++ +LRH +V L
Sbjct: 191 KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
E I V E+M +G+L D L + L + ++++ A G+ Y+
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKGETGKY----------LRLPQLVDMAAQIASGMAYV- 296
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ +HRD+++ NIL+ EN K++DFGL+R+ + K + PE
Sbjct: 297 --ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA--KFPIKWTAPEA 352
Query: 734 IRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
+ T KSDV+SFG++L E+ GR P M+N V
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 392
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-38
Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
++GSG FG V+KG + I VA+K L ++ A E E +++ + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG C + + + MP G L D++ + + + L + A+G
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN-----------IGSQYLLNWCVQIAKG 129
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
++YL ++HRD+ + N+L+ KI+DFGL+++ + + + + K +
Sbjct: 130 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKW 185
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+ E I + T +SDV+S+GV + E++ G P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G+G FG V G G VA+K + SM EF E +++ L H +V L G C
Sbjct: 31 ELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ + ++ E+M G L ++L + ++ LE+ + YL
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL-----------REMRHRFQTQQLLEMCKDVCEAMEYL- 136
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV--VKGSFGYVDP 731
+HRD+ + N L+++ K+SDFGLSR S V + V+ + P
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPP 190
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
E + + + KSD+++FGV++ E+ G+ P N +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 32/225 (14%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRL--NTSSMQGAREFRTEIEMISELRHLHIVS 608
++G G FG V + D + VAVK L + + EF E + E H H+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 609 LLGFC------DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
L+G +++ FM G+L L S+ L + +
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP------FNLPLQTLVRFM 143
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
+ A G+ YL + IHRD+ + N +L E+ ++DFGLSR SG
Sbjct: 144 VDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG------DYYR 194
Query: 723 KGSFGYV-----DPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+G + E + T SDV++FGV + E++ G+ P
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+GSG FG V G G VAVK + SM EF E + + +L H +V G C
Sbjct: 15 ELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ + +V E++ G L ++L ++ L + LE+ G+ +L
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYL-----------RSHGKGLEPSQLLEMCYDVCEGMAFL- 120
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV--VKGSFGYVDP 731
H IHRD+ + N L+D + K+SDFG++R S V T VK + P
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK----WSAP 174
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
E + + KSDV++FG+++ EV G+ P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 64/226 (28%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
IG G FG V +G ++ ++ VA+K + R +F E + + H HIV L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+G E+ I + E G LR L Q + L + + + L
Sbjct: 82 IGVITENPVWI-IMELCTLGELRSFL-----------QVRKYSLDLASLILYAYQLSTAL 129
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF--G 727
YL +HRD+ + N+L+ N K+ DFGLSR M S KG
Sbjct: 130 AYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY----MEDSTYYKASKGKLPIK 182
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
++ PE I ++ T SDV+ FGV + E+L G P + N V
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 22/224 (9%)
Query: 554 IIGSGGFGHVFKGYI---DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
++G+G FG V G + I+VA+K L + R +F E ++ + H +I+ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
G + +++V E+M G+L L + ++ T + + + G A G+
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL-----------RKHDAQFTVIQLVGMLRGIASGM 160
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YL + +HRD+ + NIL++ N K+SDFGL R+ ++ + K +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
PE I ++ T SDV+S+G+VL EV+ G P M N V K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSM-QGAREF-RTEIEMISELRHLHIVSLL 610
IG+G +G K DG I + K L+ SM + ++ +E+ ++ EL+H +IV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKI-LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 611 G-FCDEHGEMI-LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
D + +V E+ G+L + + + L + L +
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVI--------TKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 669 LHYLHA--GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
L H HT++HRD+K N+ LD K+ DFGL+R+ S + T V G+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GTP 180
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE + R EKSD++S G +L E+ PP
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-37
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IG G FG V G VAVK + + + F E ++++LRH ++V LLG
Sbjct: 200 TIGKGEFGDVMLGDYRG--NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 614 -DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+E G + +V E+M +G+L D+L + + L L+ S+ + YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDVCEAMEYL 305
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
+ +HRD+ + N+L+ E+ AK+SDFGL++ S + VK + PE
Sbjct: 306 ---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VK----WTAPE 356
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+R ++ + KSDV+SFG++L E+ GR P
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-37
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 22/220 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G+G FG V+ + VAVK + SM F E ++ L+H +V L
Sbjct: 195 KLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+ I + EFM +G+L D L + + + ++ S A G+ ++
Sbjct: 253 TKEPIYI-ITEFMAKGSLLDFLKSDEGSK----------QPLPKLIDFSAQIAEGMAFI- 300
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ IHRD+++ NIL+ + KI+DFGL+R+ + K + PE
Sbjct: 301 --EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA--KFPIKWTAPEA 356
Query: 734 IRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
I T KSDV+SFG++L+E++ GR P M N V +
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 396
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 23/225 (10%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
+IG+G FG V+KG + VA+K L + R +F E ++ + H +I+
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L G ++ M+++ E+M G L L ++ + + + + + G A G
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL----REKDGE-------FSVLQLVGMLRGIAAG 159
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL A +HRD+ + NIL++ N K+SDFGLSR+ ++ ++ K +
Sbjct: 160 MKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
PE I ++ T SDV+SFG+V+ EV+ G P + N V K
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 554 IIGSGGFGHVFKGY----IDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHIVS 608
++GSG FG V KG + I V +K + S Q + + I L H HIV
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG C + V +++P G+L DH+ + L + L + A+G
Sbjct: 80 LLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA-----------LGPQLLLNWGVQIAKG 127
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
++YL +H ++HR++ + N+LL +++DFG++ + P + + + K +
Sbjct: 128 MYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIKW 183
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+ E I + T +SDV+S+GV + E++ G P
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 5e-37
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G G FG V+ G + G+ VA+K L +M F E +++ +LRH +V L
Sbjct: 274 KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
E I V E+M +G+L D L + L + ++++ A G+ Y+
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGETGKY----------LRLPQLVDMAAQIASGMAYV- 379
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
+ +HRD+++ NIL+ EN K++DFGL+R+ + K + PE
Sbjct: 380 --ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA--KFPIKWTAPEA 435
Query: 734 IRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
+ T KSDV+SFG++L E+ GR P
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-37
Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 554 IIGSGGFGHVFKGY---IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSL 609
IG G FG V +G ++ ++ VA+K + R +F E + + H HIV L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+G E+ I + E G LR L + + L + + + L
Sbjct: 457 IGVITENPVWI-IMELCTLGELRSFL----QVRKFS-------LDLASLILYAYQLSTAL 504
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF--G 727
YL +HRD+ + N+L+ N K+ DFGLSR M S KG
Sbjct: 505 AYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY----MEDSTYYKASKGKLPIK 557
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP---MINGAVRK 769
++ PE I ++ T SDV+ FGV + E+L G P + N V
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-36
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 555 IGSGGFGHVFKGY--IDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLG 611
+G G FG V +G + I VA+K L + + E E +++ +L + +IV L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
C M+ V E G L L +++ + E+ + G+ Y
Sbjct: 404 VCQAEALML-VMEMAGGGPLHKFLVGKREE-----------IPVSNVAELLHQVSMGMKY 451
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
L + +HR++ + N+LL AKISDFGLS+ + S + K + P
Sbjct: 452 L---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVL-CGRPP 761
E I ++ + +SDV+S+GV + E L G+ P
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-36
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLL 610
IG G FG +DG +K +N S M E R E+ +++ ++H +IV
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQ-YVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+E+G + +V ++ G+L + N + + L+ + L
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRI----------NAQKGVLFQEDQILDWFVQICLALK 139
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
++H I+HRD+KS NI L ++ ++ DFG++R+ S + + + G+ Y+
Sbjct: 140 HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACI-GTPYYLS 193
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE + KSD+++ G VL E+ +
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSI--TVAVK--RLNTSSMQGARE-FRTEIEMISELRHLHIVSL 609
+G GG V+ D + VA+K + + + F E+ S+L H +IVS+
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+ +E LV E++ L +++ + PL+ + + G+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI------------ESHGPLSVDTAINFTNQILDGI 124
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVKGSFGY 728
+ H I+HRD+K NIL+D N KI DFG+++ + + ++Q+ + V+ G+ Y
Sbjct: 125 KHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT--NHVL-GTVQY 178
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE + + E +D+YS G+VL E+L G PP
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSI--TVAVKRLNT--SSMQGARE-FRTEIEMISELRHLHIVSL 609
+G GG G V++ D VA+K ++ SS R + E L+ H+V +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
F + G++ + + +L L + PL R + I L
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML------------RRQGPLAPPRAVAIVRQIGSAL 147
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVKGSFGY 728
HA HRDVK NIL+ + A + DFG++ ++Q V G+ Y
Sbjct: 148 DAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL--GNTV-GTLYY 201
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE T ++D+Y+ VL E L G PP
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHLHIVSLL 610
IG G F V++ + DG VA+K++ + A+ EI+++ +L H +++
Sbjct: 40 IGRGQFSEVYRAACLLDGVP-VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
E E+ +V E G+L + + +KQ + + WK +++ L
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT----VWKYFVQL----CSALE 150
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
++H ++HRD+K N+ + K+ D GL R S + +H ++V G+ Y+
Sbjct: 151 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH--SLV-GTPYYMS 204
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE I KSD++S G +L E+ + P
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 70/319 (21%), Positives = 113/319 (35%), Gaps = 37/319 (11%)
Query: 489 RKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQATCD 548
V+ + +S P + + T S D R S +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ-----S 58
Query: 549 FADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISEL-RHL 604
F +G G +G VFK +DG + AVKR + E+ ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRL-YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
V L +E G + L E +L+ H + + + Q W +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQ----VWGYLRDT--- 166
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
L +LH ++H DVK NI L K+ DFGL + + V +G
Sbjct: 167 -LLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE----LGTAGAGEVQEG 218
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMING----AVRKEEVSLVLWARV 780
Y+ PE + + +DV+S G+ +LEV C G +R+ + A +
Sbjct: 219 DPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL 277
Query: 781 SR-ARGTVDQ--IVDPRLR 796
S R + DP+LR
Sbjct: 278 SSELRSVLVMMLEPDPKLR 296
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 31/223 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGF 612
I+G G +VF+G A+K N S + E E++ +L H +IV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 613 CDEHG--EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+E +L+ EF P G+L L ++ N L L + G++
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAY-----GLPESEFLIVLRDVVGGMN 126
Query: 671 YLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
+L ++ I+HR++K NI+ D K++DFG +R + + G+
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE----LEDDEQFVSLYGTE 179
Query: 727 GYVDPEYIRRQQL--------TEKSDVYSFGVVLLEVLCGRPP 761
Y+ P+ R L D++S GV G P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 50/230 (21%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRH--LHIVSLL 610
IGSGG VF+ + I A+K +N +R EI +++L+ I+ L
Sbjct: 36 IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR--- 667
+ + +V E +L L K++ I +
Sbjct: 95 DYEITDQYIYMVMECG-NIDLNSWL--------------------KKKKSIDPWERKSYW 133
Query: 668 -----GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
+H +H +H I+H D+K N L+ + K+ DFG++ + + V
Sbjct: 134 KNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 723 KGSFGYVDPEYIRRQ-----------QLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE I+ +++ KSDV+S G +L + G+ P
Sbjct: 190 -GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSI--TVAVK--RLNTSSMQGARE-FRTEIEMISELRHLHIVSL 609
+G GG V D VAVK R + + FR E + + L H IV++
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 610 L--GFCDEHGEMI--LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
G + + +V E++ LRD + + P+T KR +E+ A
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV------------HTEGPMTPKRAIEVIADA 125
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVKG 724
+ L++ H ++ IIHRDVK NI++ A K+ DFG++R + SG S + + V+ G
Sbjct: 126 CQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-G 181
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ Y+ PE R + +SDVYS G VL EVL G PP
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 63/270 (23%), Positives = 109/270 (40%), Gaps = 43/270 (15%)
Query: 548 DFADHCIIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHI 606
DF + +IGSGGFG VFK DG +KR+ ++ + RE ++ +++L H++I
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKT-YVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 607 VSLLGFCDEHGEMI----------------LVYEFMPRGNLRDHLYNSQKQNQNQNQNQN 650
V G D + EF +G L + + +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI----------EKRRG 116
Query: 651 SPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGP 710
L LE+ +G+ Y+H +I+RD+K +NI L + KI DFGL
Sbjct: 117 EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-- 171
Query: 711 SGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRK 769
+ T KG+ Y+ PE I Q ++ D+Y+ G++L E+L
Sbjct: 172 --LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT 229
Query: 770 EEVSLVLWARVSR-ARGTVDQI--VDPRLR 796
+ ++ + + + ++ P R
Sbjct: 230 DLRDGIISDIFDKKEKTLLQKLLSKKPEDR 259
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRH--LHIVSLL 610
IGSGG VF+ + I A+K +N Q +R EI +++L+ I+ L
Sbjct: 17 IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+ + +V E +L L + + + ++ WK LE +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-----YWKNMLE-------AVH 122
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
+H +H I+H D+K N L+ + K+ DFG++ + + V G+ Y+
Sbjct: 123 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMP 177
Query: 731 PEYIRRQ-----------QLTEKSDVYSFGVVLLEVLCGRPP 761
PE I+ +++ KSDV+S G +L + G+ P
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 58/286 (20%), Positives = 111/286 (38%), Gaps = 54/286 (18%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHI 606
DF + ++G G FG V K D A+K++ + + +E+ +++ L H ++
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRY-YAIKKIRHTEEK-LSTILSEVMLLASLNHQYV 64
Query: 607 VSLLG-FCDEHGEMI------------LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPL 653
V + + + + E+ G L D + ++N NQ ++
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-----HSENLNQQRDEYW 119
Query: 654 TWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGM 713
R++ L Y+H IIHRD+K NI +DE+ KI DFGL++ +
Sbjct: 120 RLFRQI------LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 714 ------------SQSHVSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRP 760
S ++++ + G+ YV E + EK D+YS G++ E++
Sbjct: 171 DILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS 229
Query: 761 PMINGA-----VRKEEVSL--VLWARVSR-ARGTVDQI--VDPRLR 796
+ +R + + + + + DP R
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRH--LHIVSLL 610
IGSGG VF+ + I A+K +N Q +R EI +++L+ I+ L
Sbjct: 64 IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+ + +V E +L L + + + ++ WK LE +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-----YWKNMLE-------AVH 169
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
+H +H I+H D+K N L+ + K+ DFG++ + + V G+ Y+
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMP 224
Query: 731 PEYIRRQ-----------QLTEKSDVYSFGVVLLEVLCGRPP 761
PE I+ +++ KSDV+S G +L + G+ P
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 31/223 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGF 612
I+G G +VF+G A+K N S + E E++ +L H +IV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 613 --CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+L+ EF P G+L L ++ N L L + G++
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAY-----GLPESEFLIVLRDVVGGMN 126
Query: 671 YLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
+L ++ I+HR++K NI+ D K++DFG +R + + G+
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE----LEDDEQFVSLYGTE 179
Query: 727 GYVDPEYIRRQQL--------TEKSDVYSFGVVLLEVLCGRPP 761
Y+ P+ R L D++S GV G P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 36/233 (15%)
Query: 548 DFADHCIIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLH 605
DF +G GGFG VF+ D A+KR+ + + ARE E++ +++L H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCN-YAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 606 IVSLLG-FCDE-----------HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPL 653
IV + ++ + + + + NL+D + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---------NGRCTIEER 115
Query: 654 TWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM----- 708
L I + A + +LH ++HRD+K +NI + K+ DFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 709 ----GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC 757
+ M T G+ Y+ PE I + K D++S G++L E+L
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 7e-33
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGF 612
+G+GGFG+V + D VA+K+ RE + EI+++ +L H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 613 CDEHGEM------ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWK--RRLEISIG 664
D ++ +L E+ G+LR +L NQ +N L R L I
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYL--------NQFENCCG-LKEGPIRTLLSDIS 131
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA---KISDFGLSRMGPSGMSQSHVSTV 721
+A L YLH ++ IIHRD+K NI+L KI D G ++ + Q + T
Sbjct: 132 SA--LRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE----LDQGELCTE 182
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE + +++ T D +SFG + E + G P
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-33
Identities = 44/226 (19%), Positives = 92/226 (40%), Gaps = 32/226 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREF-----------------RTEIEM 597
+ G F + D A+K+ S ++ R+F + E+++
Sbjct: 39 LNQGKFNKIILCE-KDNKF-YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 598 ISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
I+++++ + ++ G + E+ ++YE+M ++ ++N +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
+ Y+H + I HRDVK +NIL+D+N K+SDFG S +
Sbjct: 157 IKSV----LNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG- 209
Query: 718 VSTVVKGSFGYVDPEYIRRQQLT--EKSDVYSFGVVLLEVLCGRPP 761
+G++ ++ PE+ + K D++S G+ L + P
Sbjct: 210 ----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 32/228 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGFC 613
+ GGF V++ A+KRL ++ + R E+ + +L H +IV
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 614 --------DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
E +L+ E +G L + L + + PL+ L+I
Sbjct: 96 SIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRG---------PLSCDTVLKIFYQT 145
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS---RMGPSGMSQSHVSTVV 722
R + ++H K IIHRD+K N+LL K+ DFG + P + +V
Sbjct: 146 CRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 723 K------GSFGYVDPEYI---RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + Y PE I + EK D+++ G +L + + P
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR---EFRTEIEMISELRHLHIVSLLG 611
+G G FG+V+ +A+K L + ++ A + R E+E+ S LRH +I+ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+ + + L+ E+ P G + L K ++ + + L A L Y
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------------ANALSY 124
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
H +IHRD+K N+LL KI+DFG S PS + G+ Y+ P
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLC-GTLDYLPP 176
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E I + EK D++S GV+ E L G+PP
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612
++G G +G V+ G + + +A+K + + ++ EI + L+H +IV LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVR-IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
E+G + + E +P G+L L +++ N +I GL YL
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQIL----EGLKYL 138
Query: 673 HAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSR--MGPSGMSQSHVSTVVKGSFGYV 729
H + I+HRD+K N+L++ + KISDFG S+ G + +++ G+ Y+
Sbjct: 139 H---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-----FTGTLQYM 190
Query: 730 DPEYIRRQQL--TEKSDVYSFGVVLLEVLCGRPP 761
PE I + + +D++S G ++E+ G+PP
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 27/212 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612
+G G FG V + AVK RL ++ E+ + L IV L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
E + + E + G+L + +++ A GL YL
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY------------YLGQALEGLEYL 166
Query: 673 HAGAKHTIIHRDVKSTNILLDEN-WAAKISDFGLS-RMGPSGMSQSHVSTV-VKGSFGYV 729
H I+H DVK+ N+LL + A + DFG + + P G+ +S ++ + G+ ++
Sbjct: 167 HT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE + + K D++S ++L +L G P
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-31
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 29/218 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGF 612
++G G G + + D VAVKR+ A E++++ E H +++
Sbjct: 31 VLGHGAEGTIVYRGMFDNR-DVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT 86
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ + E L++++ + ++ + + GL +L
Sbjct: 87 EKDRQFQYIAIELCA-ATLQEYV-----------EQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 673 HAGAKHTIIHRDVKSTNILLDENWA-----AKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
H I+HRD+K NIL+ A A ISDFGL + G + V G+ G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 728 YVDPEYIRR---QQLTEKSDVYSFGVVLLEVLC-GRPP 761
++ PE + + T D++S G V V+ G P
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR---EFRTEIEMISELRHLHIVSLLG 611
+G GGF F+ D A K + S + + EI + L H H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
F +++ + +V E R +L + + + + R I G Y
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE----------ARYYLRQI--VLGCQY 130
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH ++ +IHRD+K N+ L+E+ KI DFGL+ V+ G+ Y+ P
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK---VEYDGERKKVLCGTPNYIAP 184
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E + ++ + + DV+S G ++ +L G+PP
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR---EFRTEIEMISELRHLHIVSLLG 611
+G G FG+V+ +A+K L S ++ + R EIE+ S LRH +I+ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+ + + L+ EF PRG L L + ++ + + A LHY
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR----------SATFMEEL--ADALHY 129
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
H + +IHRD+K N+L+ KI+DFG S PS + T+ G+ Y+ P
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----TMC-GTLDYLPP 181
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E I + EK D++ GV+ E L G PP
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 34/238 (14%), Positives = 71/238 (29%), Gaps = 27/238 (11%)
Query: 540 TEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSIT-----VAVKRLNTSSMQGAREFRTE 594
TE + + H ++G G F V++ D + +K ++
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 595 IEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLT 654
+E + + +LV E G L + + N K + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEK------VMP 170
Query: 655 WKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL-----------DENWAAKISDF 703
+ ++ + +H IIH D+K N +L D + + D
Sbjct: 171 QGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G S + + + G+ E + + + D + + +L G
Sbjct: 228 GQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHI 606
DF +G+G G VFK + +A K ++ + E++++ E +I
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 607 VSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
V G F + GE+ + E M G+L D + + + ++SI
Sbjct: 94 VGFYGAFYSD-GEISICMEHMDGGSL-DQVLKKAG-----------RIPEQILGKVSIAV 140
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+GL YL KH I+HRDVK +NIL++ K+ DFG+S M+ S V G+
Sbjct: 141 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GT 193
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE ++ + +SD++S G+ L+E+ GR P
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-31
Identities = 49/217 (22%), Positives = 84/217 (38%), Gaps = 39/217 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSI---TVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLL 610
I GG G ++ D ++ V +K L S A+ E + ++E+ H IV +
Sbjct: 88 IAHGGLGWIYLAL--DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 611 GF---CDEHGEMI--LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
F D HG+ + +V E++ +L+ L + +
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--------------GQKLPVAEAIAYLLEI 191
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVKG 724
L YLH+ +++ D+K NI+L E K+ D G + G + G
Sbjct: 192 LPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY--------LYG 239
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G+ PE I R T +D+Y+ G L + P
Sbjct: 240 TPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 66/280 (23%), Positives = 111/280 (39%), Gaps = 51/280 (18%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGF 612
I+G G G V G VAVKR+ A EI++++E H +++
Sbjct: 22 ILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ + E NL+D + +++N + + + A G+ +L
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLV-----ESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 673 HAGAKHTIIHRDVKSTNILLD-------------ENWAAKISDFGLSRMGPSGMS--QSH 717
H IIHRD+K NIL+ EN ISDFGL + SG S +++
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 718 VSTVVKGSFGYVDPEYIR-------RQQLTEKSDVYSFGVVLLEVLC-GRPP-------- 761
++ G+ G+ PE + +++LT D++S G V +L G+ P
Sbjct: 189 LNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 762 --MINGAVRKEEVSLVLWARVSR-ARGTVDQ--IVDPRLR 796
+I G +E+ + + A + Q DP R
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR---EFRTEIEMISELRHLHIVSLLG 611
+G GGF F+ D A K + S + + EI + L H H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
F +++ + +V E R +L + + + + R I G Y
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE----------ARYYLRQI--VLGCQY 156
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH ++ +IHRD+K N+ L+E+ KI DFGL+ V+ G+ Y+ P
Sbjct: 157 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK---VEYDGERKKVLCGTPNYIAP 210
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E + ++ + + DV+S G ++ +L G+PP
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-30
Identities = 26/194 (13%), Positives = 56/194 (28%), Gaps = 26/194 (13%)
Query: 235 VALETAYRLNVGGAHVSAKDDTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAY 294
+A + + +N GG + D + D
Sbjct: 2 LADKVIWAVNAGGESHVDVHG----IHYRKDPLEGRVGRASDYGMKLPILRSNPEDQV-- 55
Query: 295 IAPVIVYTTSRTMGKDPNINKKYNLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSI 354
+Y T R + + ++ + Y++ L F E + Q+VF +
Sbjct: 56 -----LYQTERYN--------EDSFGYDIPIKEEGEYVLVLKFAEVY--FAQSQQKVFDV 100
Query: 355 FINNQTAENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQDFWLALHPFLDLD-PLP 413
+N T D D+ G + + + + + + + L ++
Sbjct: 101 RVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTF---TGKLSVEFVKG 156
Query: 414 KYADAILNGLEIFK 427
Y + + L I K
Sbjct: 157 YYDNPKVCALFIMK 170
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-17
Identities = 25/179 (13%), Positives = 51/179 (28%), Gaps = 33/179 (18%)
Query: 39 CGESSNTTSSDGRNWDGDAHSKFSSSNSATKSFTSRASFQENSVPQVPYMTARVFPEEFT 98
G + G ++ D A+ + N QV Y T R + F
Sbjct: 12 AG-GESHVDVHGIHYRKD--PLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFG 68
Query: 99 YTFPV-SPGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLT 157
Y P+ G L L F + F V N +T++++
Sbjct: 69 YDIPIKEEGEYVLVLKFAEVYF------------AQSQQKVFDVRVNGHTVVKDLD---- 112
Query: 158 VSAIIPPVAYFFKEFIISVSSSQM------------LNLTFSPSSSSSYAFINGIEVVS 204
+ + + IS+ ++ L++ F + + + ++
Sbjct: 113 IFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN-PKVCALFIMK 170
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR---EFRTEIEMISELRHLHIVSLLG 611
+G G F V++ + VA+K ++ +M A + E+++ +L+H I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR---- 667
+ ++ + LV E G + +L +N+ P + A
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL-----------KNRVKPFSENE-------ARHFMHQ 120
Query: 668 ---GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
G+ YLH H I+HRD+ +N+LL N KI+DFGL+ + + T+ G
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLC-G 174
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ Y+ PE R +SDV+S G + +L GRPP
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVS 608
+ IG G G V+ VA++++N EI ++ E ++ +IV+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA--- 665
L E+ +V E++ G+L D + + + E I A
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV-------------TETCMD-----EGQIAAVCR 123
Query: 666 --ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
+ L +LH + +IHRD+KS NILL + + K++DFG S+ T+V
Sbjct: 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV- 177
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
G+ ++ PE + R+ K D++S G++ +E++ G PP +N
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 22/238 (9%), Positives = 45/238 (18%), Gaps = 44/238 (18%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLL 610
+ G VF + A+K S + L
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 611 GFC-----------------------DEHGEMILVYEFMPR--GNLRDHLYNSQKQNQNQ 645
+ + MP +L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 646 NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705
++ R L + ++H N+ + + + D
Sbjct: 189 -----GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ--QLTEKSDVYSFGVVLLEVLCGRPP 761
Y E++ T + + G+ + V C P
Sbjct: 241 LW------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 54/245 (22%), Positives = 91/245 (37%), Gaps = 41/245 (16%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-----FRTEIEMISELRHLHIVSL 609
IG G +G V + A+K +N + ++ +TE+ ++ +L H +I L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG----- 664
++ + LV E G+L D L + + E +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 665 ----------------AAR-------GLHYLHAGAKHTIIHRDVKSTNILL--DENWAAK 699
+ LHYLH I HRD+K N L ++++ K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 700 ISDFGLSRM-GPSGMSQSHVSTVVKGSFGYVDPEYIR--RQQLTEKSDVYSFGVVLLEVL 756
+ DFGLS+ + + T G+ +V PE + + K D +S GV+L +L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 757 CGRPP 761
G P
Sbjct: 271 MGAVP 275
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGFC 613
+GSG FG V + +K +N Q E EIE++ L H +I+ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
+++ M +V E G L + + ++Q + + ++ + L + L Y H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ--------MMNALAYFH 141
Query: 674 AGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
++H+D+K NIL + KI DFGL+ + ST G+ Y+
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL----FKSDEHSTNAAGTALYMA 194
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE +R +T K D++S GVV+ +L G P
Sbjct: 195 PEVFKR-DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 72/292 (24%), Positives = 124/292 (42%), Gaps = 45/292 (15%)
Query: 530 PSDLCRRFSLTE---IKQATCDFADH----CIIGSGGFGHVFKGYIDDGSITVAVKRLNT 582
P + T ++ +T F+D ++G G FG V AVK ++
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61
Query: 583 SSMQGARE---FRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQ 639
++ + E++++ +L H +I+ L F ++ G LV E G L D + + +
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121
Query: 640 KQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL---DENW 696
+ ++ R+ + G+ Y+H K+ I+HRD+K N+LL ++
Sbjct: 122 RFSEVD----------AARIIRQV--LSGITYMH---KNKIVHRDLKPENLLLESKSKDA 166
Query: 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL 756
+I DFGLS S G+ Y+ PE + EK DV+S GV+L +L
Sbjct: 167 NIRIIDFGLSTH----FEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILL 221
Query: 757 CGRPP-------MINGAVRKEEVSLVL--WARVSR-ARGTVDQI--VDPRLR 796
G PP I V K + + L W +VS A+ + ++ P +R
Sbjct: 222 SGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMR 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 51/242 (21%), Positives = 87/242 (35%), Gaps = 43/242 (17%)
Query: 548 DFADHCIIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGA--REFRTEIEMISEL-RH 603
+F + IGSG FG VFK DG I A+KR + E+ + L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCI-YAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
H+V E M++ E+ G+L D + +N L++
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI----SENYRIMSYFKEAELKDLLLQV-- 124
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-------------------WAAKISDFG 704
RGL Y+H +++H D+K +NI + KI D G
Sbjct: 125 --GRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMI 763
S + +G ++ E ++ K+D+++ + ++ P
Sbjct: 180 HVTRISSPQVE-------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
Query: 764 NG 765
NG
Sbjct: 233 NG 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVS 608
+ IG G G V VAVK ++ Q E+ ++ + +H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA-- 666
+ E+ ++ EF+ G L D + L E I
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV-------------SQVRLN-----EEQIATVCE 148
Query: 667 ---RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
+ L YLH +IHRD+KS +ILL + K+SDFG + + ++V
Sbjct: 149 AVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV- 202
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
G+ ++ PE I R + D++S G++++E++ G PP +
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN-TSSMQGAREFRTEIEMISELRHLHI 606
D+ +IGSG V Y VA+KR+N E EI+ +S+ H +I
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 607 VSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
VS F + E+ LV + + G++ D + K + ++++ L E +I
Sbjct: 76 VSYYTSFVVKD-ELWLVMKLLSGGSVLDII----KHIVAKGEHKSGVLD-----ESTIAT 125
Query: 666 A-----RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM---GPSGMSQSH 717
GL YLH K+ IHRDVK+ NILL E+ + +I+DFG+S G
Sbjct: 126 ILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 718 VSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMIN 764
T V G+ ++ PE + + + K+D++SFG+ +E+ G P
Sbjct: 183 RKTFV-GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-29
Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 43/277 (15%)
Query: 542 IKQATCDFADH----CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE--FRTEI 595
I ++ +GSG +G V + A+K + +S+ + E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 596 EMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
++ L H +I+ L F ++ LV E G L D + + K N+
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD---------- 137
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSG 712
+ + G+ YLH KH I+HRD+K N+LL +++ KI DFGLS +
Sbjct: 138 AAVIIKQV--LSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---- 188
Query: 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEV 772
G+ Y+ PE +R++ EK DV+S GV+L +L G PP G +E +
Sbjct: 189 FENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPP-FGGQTDQEIL 246
Query: 773 SLVL----------WARVSR-ARGTVDQI--VDPRLR 796
V W VS A+ + Q+ D + R
Sbjct: 247 RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
++GSG F VF A+K + S EI ++ +++H +IV+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWK--RRLEISIGAARGLHY 671
+ LV + + G L D + T K + + + Y
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGV------------YTEKDASLVIQQV--LSAVKY 121
Query: 672 LHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
LH ++ I+HRD+K N+L +EN I+DFGLS+M +G+ +ST G+ GY
Sbjct: 122 LH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTAC-GTPGY 173
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
V PE + ++ ++ D +S GV+ +LCG PP
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 37/218 (16%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IG G +G V I A K++ ++ F+ EIE++ L H +I+ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR------ 667
+++ ++ LV E G L + + + + ++ AAR
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESD-------------------AARIMKDVL 116
Query: 668 -GLHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
+ Y H K + HRD+K N L + K+ DFGL+ +
Sbjct: 117 SAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR----FKPGKMMRTKV 169
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ YV P+ + + D +S GV++ +LCG PP
Sbjct: 170 GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 74/294 (25%), Positives = 114/294 (38%), Gaps = 66/294 (22%)
Query: 542 IKQATCDFADH----CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-------- 589
+++ + +GSG +G V +G A+K + S R
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 590 -----EFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQN 644
E EI ++ L H +I+ L ++ LV EF G L + + N K ++
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 645 QNQNQNSPLTWKRRLEISIGAAR-------GLHYLHAGAKHTIIHRDVKSTNILL---DE 694
AA G+ YLH KH I+HRD+K NILL +
Sbjct: 147 D-------------------AANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNS 184
Query: 695 NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLE 754
KI DFGLS S+ + G+ Y+ PE +++ + EK DV+S GV++
Sbjct: 185 LLNIKIVDFGLSSF----FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYI 239
Query: 755 VLCGRPP-------MINGAVRKEEVSLVL--WARVSR-ARGTVDQI--VDPRLR 796
+LCG PP I V K + W +S A+ + + D R
Sbjct: 240 LLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKR 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVS 608
F +G G +G V+K + VA+K++ +E EI ++ + H+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI---GA 665
G ++ ++ +V E+ G++ D + + +N LT EI+
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII-----------RLRNKTLT---EDEIATILQST 134
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+GL YLH IHRD+K+ NILL+ AK++DFG++ M++ + TV+ G+
Sbjct: 135 LKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN--TVI-GT 188
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
++ PE I+ +D++S G+ +E+ G+PP +
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 28/224 (12%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVS 608
+ +G G FG V+K + A K + T S + ++ EIE+++ H +IV
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI---GA 665
LLG G++ ++ EF P G + + + LT +I +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM-----------LELDRGLT---EPQIQVVCRQM 126
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
L++LH IIHRD+K+ N+L+ +++DFG+S + + + + G+
Sbjct: 127 LEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD--SFI-GT 180
Query: 726 FGYVDPEYIRRQQLTE-----KSDVYSFGVVLLEVLCGRPPMIN 764
++ PE + + + + K+D++S G+ L+E+ PP
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHI 606
F IG G FG VFKG + VA+K ++ + E + EI ++S+ ++
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA- 665
G + ++ ++ E++ G+ D L + PL E I
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLL-------------EPGPLD-----ETQIATI 124
Query: 666 ----ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+GL YLH IHRD+K+ N+LL E+ K++DFG++ + + T
Sbjct: 125 LREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TF 179
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
V G+ ++ PE I++ K+D++S G+ +E+ G PP
Sbjct: 180 V-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 46/222 (20%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+GSG FG V + K +NT + EI ++++L H +++L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 615 EHGEMILVYEFMPRGNL------RDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR- 667
+ EM+L+ EF+ G L D+ + +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAE------------------------VINY 154
Query: 668 ------GLHYLHAGAKHTIIHRDVKSTNILL--DENWAAKISDFGLSRMGPSGMSQSHVS 719
GL ++H +H+I+H D+K NI+ + + KI DFGL+ ++ +
Sbjct: 155 MRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK----LNPDEIV 207
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
V + + PE + R+ + +D+++ GV+ +L G P
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 73/267 (27%), Positives = 114/267 (42%), Gaps = 51/267 (19%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLG 611
++G G FG V K AVK +N +S + E+E++ +L H +I+ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR---- 667
++ +V E G L D + ++ +++ AAR
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-------------------AARIIKQ 129
Query: 668 ---GLHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTV 721
G+ Y+H KH I+HRD+K NILL +++ KI DFGLS Q+
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC----FQQNTKMKD 182
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP-------MINGAVRKEEVSL 774
G+ Y+ PE +R EK DV+S GV+L +L G PP I V + +
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241
Query: 775 VL--WARVSR-ARGTVDQI--VDPRLR 796
L W +S A+ + ++ P LR
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSLR 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 30/242 (12%), Positives = 71/242 (29%), Gaps = 44/242 (18%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA---REFRTEIEMISELRHLH----- 605
++G + + + V + + ++ + E+ + LR +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 606 -----------IVSLLGFC--------DEHGEMILVYEFMPR--GNLRDHLYNSQKQNQN 644
+V + ++ + PR NL+ +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 645 QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704
L RL++++ R L LH + ++H ++ +I+LD+ ++ F
Sbjct: 205 HK-----SLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ-----LTEKSDVYSFGVVLLEVLCGR 759
G S + Q +T D ++ G+ + + C
Sbjct: 257 HLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 760 PP 761
P
Sbjct: 315 LP 316
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 34/244 (13%), Positives = 73/244 (29%), Gaps = 47/244 (19%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612
++G + + G V + + + E + LR L +
Sbjct: 80 VLGQEDPYAYLEATDQETGES-FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQN------------------------ 648
H I ++ + + + + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 649 QNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708
+ L RL++++ R L LH + ++H ++ +I+LD+ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 709 GPSGMSQSHVSTVVKGSFGYVDPEYI-----------RRQQLTEKSDVYSFGVVLLEVLC 757
+ V S G+ PE RR +T D ++ G+V+ + C
Sbjct: 255 ------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 758 GRPP 761
P
Sbjct: 309 ADLP 312
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 58/292 (19%), Positives = 104/292 (35%), Gaps = 52/292 (17%)
Query: 489 RKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQATC- 547
+ R NE+ +P T+ + P+ R KQ
Sbjct: 29 DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRI--VTAKQGAVN 86
Query: 548 ---DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHL 604
+ I+G G FG V K + +A K + T M+ E + EI ++++L H
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNL------RDHLYNSQKQNQNQNQNQNSPLTWKRR 658
+++ L + +++LV E++ G L +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD------------------ 188
Query: 659 LEISIGAAR-------GLHYLHAGAKHTIIHRDVKSTNILL--DENWAAKISDFGLSRMG 709
G+ ++H + I+H D+K NIL + KI DFGL+R
Sbjct: 189 ------TILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR- 238
Query: 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
V G+ ++ PE + ++ +D++S GV+ +L G P
Sbjct: 239 ---YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 66/254 (25%), Positives = 113/254 (44%), Gaps = 35/254 (13%)
Query: 526 ASSLPSDLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM 585
AS P+ L+ ++ F ++G+G +G V+KG A+K ++ +
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG- 61
Query: 586 QGAREFRTEIEMISEL-RHLHIVSLLG------FCDEHGEMILVYEFMPRGNLRDHLYNS 638
E + EI M+ + H +I + G ++ LV EF G++ D L +
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKN 120
Query: 639 QKQNQNQNQNQNSPLTWKRRLEISI---GAARGLHYLHAGAKHTIIHRDVKSTNILLDEN 695
K N L I+ RGL +LH +H +IHRD+K N+LL EN
Sbjct: 121 TKGN---------TLK---EEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTEN 165
Query: 696 WAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTE-----KSDVYSFGV 750
K+ DFG+S + + + T + G+ ++ PE I + + KSD++S G+
Sbjct: 166 AEVKLVDFGVSAQLDRTVGRRN--TFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
Query: 751 VLLEVLCGRPPMIN 764
+E+ G PP+ +
Sbjct: 223 TAIEMAEGAPPLCD 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE--FRTEIEMISELRHLHIVSLLG 611
++G G FG V K AVK +N +S + E+E++ +L H +I+ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
++ +V E G L D + ++ + I G+ Y
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR------------FSEHDAARIIKQVFSGITY 136
Query: 672 LHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+H KH I+HRD+K NILL +++ KI DFGLS + + + G+ Y
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRI-GTAYY 189
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE +R EK DV+S GV+L +L G PP
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 60/286 (20%), Positives = 111/286 (38%), Gaps = 42/286 (14%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN-TSSMQGAREFRTEIEMI-SELRHLH 605
D +G G +G V K +AVKR+ T + Q + ++++ +
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
V+ G G++ + E M +L + Q ++ +I++
Sbjct: 68 TVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG--------KIAVSI 118
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+ L +LH+ K ++IHRDVK +N+L++ K+ DFG+S + + G
Sbjct: 119 VKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGY----LVDDVAKDIDAGC 172
Query: 726 FGYVDPEYIRRQQL----TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781
Y+ PE I + + KSD++S G+ ++E+ R P + W
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS------------WGTPF 220
Query: 782 RARGTVDQIVD---PRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT 824
+ + Q+V+ P+L F C + RPT
Sbjct: 221 QQ---LKQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPT 260
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 45/234 (19%), Positives = 81/234 (34%), Gaps = 37/234 (15%)
Query: 548 DFADHCIIGSG--GFGHVFKGYIDDGSITVAVKRLN--TSSMQGAREFRTEIEMISELRH 603
+ +IG G V V V+R+N S + + E+ + H
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
+IV E+ +V FM G+ +D + + + E++I
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLI----------CTHFMDGMN-----ELAI 130
Query: 664 G-----AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV 718
+ L Y+H +HR VK+++IL+ + +S + S + V
Sbjct: 131 AYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 719 STVVKGSFGYVD------PEYIRRQQL--TEKSDVYSFGVVLLEVLCGRPPMIN 764
V PE +++ KSD+YS G+ E+ G P +
Sbjct: 188 VHDFPKYS--VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG--AREFRTEIEMISELRHLHIVSLLG 611
+G G F V + + A K +NT + ++ E + +L+H +IV L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWK--RRLEISIGAARGL 669
E LV++ + G L + + + + I +
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREF------------YSEADASHCIQQI--LESI 118
Query: 670 HYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
Y H + I+HR++K N+LL + A K++DFGL+ G+
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFA-GTP 171
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
GY+ PE +++ ++ D+++ GV+L +L G PP
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 33/262 (12%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-----EFRTEIEMISELRHLHIVS 608
+IG G F V + + AVK ++ + + + + E + L+H HIV
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LL G + +V+EFM +L + ++ S ++ LE
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM-RQILE-------A 142
Query: 669 LHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
L Y H + IIHRDVK +LL + + K+ FG++ V G+
Sbjct: 143 LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRV-GT 196
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP------MINGAVRKEEVSLV--LW 777
++ PE ++R+ + DV+ GV+L +L G P + + K + + W
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW 256
Query: 778 ARVSR-ARGTVDQ--IVDPRLR 796
+ +S A+ V + ++DP R
Sbjct: 257 SHISESAKDLVRRMLMLDPAER 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 52/252 (20%), Positives = 98/252 (38%), Gaps = 42/252 (16%)
Query: 526 ASSLPSDLCRRFSLTEIKQATCDFADH----CIIGSGGFGHVFKGYIDDGSITVAVKRLN 581
+S+ + A+ F+D+ +G G F V + + A K +N
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 582 TSSMQGARE--FRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQ 639
T + E + +L+H +IV L E LV++ + G L + + +
Sbjct: 64 TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123
Query: 640 KQNQNQNQNQNSPLTWKRRLEISIGAAR-------GLHYLHAGAKHTIIHRDVKSTNILL 692
++ A+ + Y H + I+HR++K N+LL
Sbjct: 124 FYSEAD-------------------ASHCIQQILESIAYCH---SNGIVHRNLKPENLLL 161
Query: 693 ---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFG 749
+ A K++DFGL+ G+ GY+ PE +++ ++ D+++ G
Sbjct: 162 ASKAKGAAVKLADFGLAIEVNDS---EAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACG 217
Query: 750 VVLLEVLCGRPP 761
V+L +L G PP
Sbjct: 218 VILYILLVGYPP 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 20/220 (9%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN-TSSMQGAREFRTEIEMI-SELRHLH 605
D D IG G +G V K +AVKR+ T + ++ +++++ +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
IV G G+ + E M + D Y + + + +I++
Sbjct: 83 IVQFYGALFREGDCWICMELMS-TSF-DKFYKYVYSVLDD------VIPEEILGKITLAT 134
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+ L++L IIHRD+K +NILLD + K+ DFG+S + S T G
Sbjct: 135 VKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ----LVDSIAKTRDAGC 188
Query: 726 FGYVDPEYIRRQQL----TEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE I +SDV+S G+ L E+ GR P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 54/249 (21%), Positives = 106/249 (42%), Gaps = 24/249 (9%)
Query: 519 TATNTNTASSLPSDLCRRFSLTEIKQATCDFADH----CIIGSGGFGHVFKGYIDDGSIT 574
T ++ + D+ +++ ++ DH +G+G FG V +
Sbjct: 125 KGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNN 184
Query: 575 VAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDH 634
A K + T R EI+ +S LRH +V+L ++ EM+++YEFM G L +
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 635 LYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILL-- 692
+ + +++ ++ +E +GL ++H ++ +H D+K NI+
Sbjct: 245 VAD-----------EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTT 290
Query: 693 DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVL 752
+ K+ DFGL+ + V G+ + PE + + +D++S GV+
Sbjct: 291 KRSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
Query: 753 LEVLCGRPP 761
+L G P
Sbjct: 347 YILLSGLSP 355
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 55/229 (24%), Positives = 92/229 (40%), Gaps = 48/229 (20%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE--------FRTEIEMISELRHLH 605
+GSG G V + VA+K ++ TEIE++ +L H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
I+ + F D + +V E M G L D + +++ +
Sbjct: 77 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEAT-------------------C 116
Query: 666 AR-------GLHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQ 715
+ YLH ++ IIHRD+K N+LL +E+ KI+DFG S++ + +
Sbjct: 117 KLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI----LGE 169
Query: 716 SHVSTVVKGSFGYVDPEYIR---RQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + + G+ Y+ PE + D +S GV+L L G PP
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT--EIEMISELRHLHIVSLLGF 612
IG G F V VA+K ++ + + + E+ ++ L H +IV L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ + L+ E+ G + D+L + + + R I +A + Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE----------ARSKFRQIVSA--VQYC 130
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H + I+HRD+K+ N+LLD + KI+DFG S G + G+ Y PE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFC-GAPPYAAPE 183
Query: 733 YIRRQQLT-EKSDVYSFGVVLLEVLCGRPPM 762
+ ++ + DV+S GV+L ++ G P
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE--FRTEIEMISELRHLHIVSLLG 611
+G G F V + A +NT + E + L+H +IV L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR---- 667
E G L+++ + G L + + + ++ A+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD-------------------ASHCIQQ 118
Query: 668 ---GLHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ + H + ++HR++K N+LL + A K++DFGL+ Q
Sbjct: 119 ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGF 173
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ GY+ PE +R+ + D+++ GV+L +L G PP
Sbjct: 174 A-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 61/315 (19%), Positives = 96/315 (30%), Gaps = 70/315 (22%)
Query: 548 DFADHCIIGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLH 605
DF +G GGFG VF+ D A+KR+ + + ARE E++ +++L H
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCN-YAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQN--------------------- 644
IV E E +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 645 ---------------------------QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAK 677
+ L I I A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 678 HTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS---------TVVKGSFGY 728
++HRD+K +NI + K+ DFGL + V T G+ Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP-----MINGAVRKEEVSLVLWARVSRA 783
+ PE I + K D++S G++L E+L I VR + L+ + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQE 302
Query: 784 RGTVDQI--VDPRLR 796
V + P R
Sbjct: 303 HMMVQDMLSPSPTER 317
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 27/222 (12%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN-TSSMQGAREFRTEIE-MISELRHLH 605
D + +GSG G V+K +AVK++ + + + + +++ ++ +
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85
Query: 606 IVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
IV G F ++ + E M + + +++
Sbjct: 86 IVQCFGTFITN-TDVFIAMELMGTCAEKLKKRMQGPIPERILGK------------MTVA 132
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
+ L+YL KH +IHRDVK +NILLDE K+ DFG+S + G
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGR----LVDDKAKDRSAG 186
Query: 725 SFGYVDPEYIRRQQLTE-----KSDVYSFGVVLLEVLCGRPP 761
Y+ PE I T+ ++DV+S G+ L+E+ G+ P
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGF 612
+G G +G V VAVK ++ E + EI + L H ++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL---EISIGAARGL 669
E L E+ G L D + + +R ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD----------AQRFFHQLMA-----GV 118
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YLH I HRD+K N+LLDE KISDFGL+ + + ++ + G+ YV
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 730 DPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
PE ++R++ E DV+S G+VL +L G P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 34/221 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE--------FRTEIEMISELRHLHI 606
+GSG G V + VA++ ++ TEIE++ +L H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
+ + F D + +V E M G L D + +++ + + +
Sbjct: 203 IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEAT----------CKLYFYQM--L 249
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
+ YLH ++ IIHRD+K N+LL +E+ KI+DFG S++ S + T+
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLC- 302
Query: 724 GSFGYVDPEYIRRQQL---TEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE + D +S GV+L L G PP
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 34/225 (15%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRT---EIEMISELRHLH 605
F+D IG G FG V+ S VA+K+++ S Q +++ E+ + +LRH +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI-- 663
+ G LV E+ G+ D L +K PL +EI+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----------PLQ---EVEIAAVT 160
Query: 664 -GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
GA +GL YLH H +IHRDVK+ NILL E K+ DFG + S M+ ++ + V
Sbjct: 161 HGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPAN--SFV 211
Query: 723 KGSFGYVDPEYIRRQQLTE---KSDVYSFGVVLLEVLCGRPPMIN 764
G+ ++ PE I + K DV+S G+ +E+ +PP+ N
Sbjct: 212 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHL-HIVSLLG 611
+G G F V + A K L E EI ++ + +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+ E+IL+ E+ G + + + ++N L K+ LE G++Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLI-KQILE-------GVYY 146
Query: 672 LHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
LH ++ I+H D+K NILL KI DFG+SR + + + G+ Y
Sbjct: 147 LH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK----IGHACELREIMGTPEY 199
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ PE + +T +D+++ G++ +L P
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 36/218 (16%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGF 612
+G G +G V VAVK ++ E + EI + L H ++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR----- 667
E L E+ G L D + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--------------------AQRFFHQ 113
Query: 668 ---GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
G+ YLH I HRD+K N+LLDE KISDFGL+ + + ++ + G
Sbjct: 114 LMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-G 169
Query: 725 SFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
+ YV PE ++R++ E DV+S G+VL +L G P
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 57/231 (24%)
Query: 555 IGSGGFGHVFKGYIDDGS-ITVAVKRLNTSSMQGAR------EFRTEIEMISELRHLHIV 607
+GSG F V K G+ A K + + +R E E+ ++ E+RH +I+
Sbjct: 13 LGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 608 SLLGFCDEHGEMILVYEFMPRGNL------RDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661
+L + +++L+ E + G L ++ L ++ +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESL--TEDE-------------------- 109
Query: 662 SIGAAR-------GLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSRMGP 710
A + G+HYLH I H D+K NI+L N K+ DFG++
Sbjct: 110 ---ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-- 161
Query: 711 SGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + + G+ +V PE + + L ++D++S GV+ +L G P
Sbjct: 162 --IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 60/255 (23%), Positives = 100/255 (39%), Gaps = 42/255 (16%)
Query: 521 TNTNTASSLPSDLCRRFSLTEIKQATCDFADH----CIIGSGGFGHVFKGYIDDGSITVA 576
++ TAS+ P +D +G G V++ A
Sbjct: 23 MSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYA 82
Query: 577 VKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLY 636
+K L + + + RTEI ++ L H +I+ L + E+ LV E + G L D +
Sbjct: 83 LKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV 140
Query: 637 NSQKQNQNQNQNQNSPLTWKRRLEISIGAAR-------GLHYLHAGAKHTIIHRDVKSTN 689
++ AA + YLH ++ I+HRD+K N
Sbjct: 141 EKGYYSERD-------------------AADAVKQILEAVAYLH---ENGIVHRDLKPEN 178
Query: 690 ILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVY 746
+L + KI+DFGLS++ + TV G+ GY PE +R + D++
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVC-GTPGYCAPEILRGCAYGPEVDMW 234
Query: 747 SFGVVLLEVLCGRPP 761
S G++ +LCG P
Sbjct: 235 SVGIITYILLCGFEP 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 40/216 (18%), Positives = 81/216 (37%), Gaps = 35/216 (16%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG V + T K + + EI +++ RH +I+ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR------- 667
E+++++EF+ ++ + + L +
Sbjct: 72 SMEELVMIFEFISGLDIFERI-----------NTSAFELNERE-------IVSYVHQVCE 113
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILL--DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
L +LH H I H D++ NI+ + KI +FG +R + ++ +
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----LKPGDNFRLLFTA 166
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y PE + ++ +D++S G ++ +L G P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 49/231 (21%), Positives = 95/231 (41%), Gaps = 57/231 (24%)
Query: 555 IGSGGFGHVFKGYIDDGS-ITVAVKRLNTSSMQGAR------EFRTEIEMISELRHLHIV 607
+GSG F V K + + + A K + + +R + E+ ++ E++H +++
Sbjct: 19 LGSGQFAVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 608 SLLGFCDEHGEMILVYEFMPRGNL------RDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661
+L + ++IL+ E + G L ++ L ++++
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEEE-------------------- 115
Query: 662 SIGAAR-------GLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSRMGP 710
A G++YLH I H D+K NI+L KI DFGL+
Sbjct: 116 ---ATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-- 167
Query: 711 SGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + + G+ +V PE + + L ++D++S GV+ +L G P
Sbjct: 168 --IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/288 (21%), Positives = 113/288 (39%), Gaps = 55/288 (19%)
Query: 543 KQATCDFADH----CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-------- 590
+T F ++ I+G G V + AVK ++ +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 591 -FRTEIEMISEL-RHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQN 648
E++++ ++ H +I+ L + + LV++ M +G L D+L
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-------- 120
Query: 649 QNSPLTWK--RRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706
L+ K R++ ++ + LH K I+HRD+K NILLD++ K++DFG S
Sbjct: 121 ----LSEKETRKIMRAL--LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL------TEKSDVYSFGVVLLEVLCGRP 760
G + V G+ Y+ PE I ++ D++S GV++ +L G P
Sbjct: 172 CQLDPG---EKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
Query: 761 P-------MINGAVRKEEVSLVL--WARVSR-ARGTVDQ--IVDPRLR 796
P ++ + W S + V + +V P+ R
Sbjct: 228 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKR 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 43/225 (19%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR------EFRTEIEMISELRHLHIV 607
+GSG F V K + A K + + +R E E+ ++ ++ H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+L + +++L+ E + G L D L + ++ + A
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------------------ATS 119
Query: 668 -------GLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSRMGPSGMSQS 716
G++YLH I H D+K NI+L K+ DFGL+ +
Sbjct: 120 FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE----IEDG 172
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G+ +V PE + + L ++D++S GV+ +L G P
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 43/224 (19%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR------EFRTEIEMISELRHLHIVS 608
+GSG F V K + A K + + +R E E+ ++ ++ H +I++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR- 667
L + +++L+ E + G L D L + ++ + A
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------------------ATSF 120
Query: 668 ------GLHYLHAGAKHTIIHRDVKSTNILL----DENWAAKISDFGLSRMGPSGMSQSH 717
G++YLH I H D+K NI+L K+ DFGL+ +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE----IEDGV 173
Query: 718 VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G+ +V PE + + L ++D++S GV+ +L G P
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 49/227 (21%), Positives = 90/227 (39%), Gaps = 49/227 (21%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLN------TSSMQGAREFRTEIEMISELRHL--H 605
+GSGGFG V+ G + D VA+K + + E+ ++ ++
Sbjct: 51 LGSGGFGSVYSGIRVSDNL-PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 606 IVSLLGFCDEHGEMILVYEF-MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
++ LL + + +L+ E P +L D + +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------------- 150
Query: 665 AAR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWA-AKISDFGLSRMGPSGMSQ 715
AR + + H ++HRD+K NIL+D N K+ DFG + +
Sbjct: 151 -ARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKD 202
Query: 716 SHVSTVVKGSFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
+ + G+ Y PE+IR + + V+S G++L +++CG P
Sbjct: 203 TVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 66/293 (22%), Positives = 120/293 (40%), Gaps = 43/293 (14%)
Query: 490 KKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQATCDF 549
+++R S + ++S+ A T + + L + A +F
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EF 92
Query: 550 ADH----CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE--------FRTEIEM 597
+IG G V + AVK + ++ + + E R E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 598 ISELR-HLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWK 656
+ ++ H HI++L+ + M LV++ M +G L D+L L+ K
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA------------LSEK 200
Query: 657 --RRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS 714
R + S+ + +LH + I+HRD+K NILLD+N ++SDFG S G
Sbjct: 201 ETRSIMRSL--LEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-- 253
Query: 715 QSHVSTVVKGSFGYVDPEYIRRQQL------TEKSDVYSFGVVLLEVLCGRPP 761
+ + G+ GY+ PE ++ ++ D+++ GV+L +L G PP
Sbjct: 254 -EKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 61/273 (22%), Positives = 97/273 (35%), Gaps = 71/273 (26%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISEL-RHLHI 606
+G G FG V + TVAVK L + +E++++ + HL++
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 607 VSLLGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQN-----------QNSPLT 654
V+LLG C G ++++ EF GNL +L + + + P+
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 655 WKRRLEI----------SIGAARGLHYLHAGAKHTIIHRDVKST---------------- 688
KRRL+ + L + +++D +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 689 --------------NILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD---- 730
NILL E KI DFGL+R V+ +
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD------PDYVRKGDARLPLKWM 262
Query: 731 -PEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPP 761
PE I + T +SDV+SFGV+L E+ G P
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 61/260 (23%), Positives = 99/260 (38%), Gaps = 35/260 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGF 612
++G G V S AVK + E+EM+ + + H +++ L+ F
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+E LV+E M G++ H+ + ++ N+ + S + + + A L +L
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHI----HKRRHFNELEASVVV--QDV------ASALDFL 127
Query: 673 HAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVS-----TVVKG 724
H I HRD+K NIL ++ KI DF L S +S T G
Sbjct: 128 H---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183
Query: 725 SFGYVDPEYIRRQQLTEKS-----DVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779
S Y+ PE + D++S GV+L +L G PP S W R
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF-----VGRCGSDCGWDR 238
Query: 780 VSRARGTVDQIVDPRLRGKI 799
+ + + GK
Sbjct: 239 GEACPACQNMLFESIQEGKY 258
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE-MISELRHLHIVSLLGF 612
++G G G V + + A+K L S R E++ HIV +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDV 90
Query: 613 CDEHGEMI----LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
+ ++ E M G L + ++ +Q + + + + R +
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIM--RDI------GTA 140
Query: 669 LHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+ +LH H I HRDVK N+L +++ K++DFG ++ + T +
Sbjct: 141 IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPC-YT 192
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
YV PE + ++ + D++S GV++ +LCG PP
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 64/219 (29%), Positives = 93/219 (42%), Gaps = 39/219 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREF---RTEIEMISELRHLHIVSLLG 611
+G G FG V G VAVK LN ++ + EI+ + RH HI+ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR---- 667
+ +V E++ G L D++ R+ AR
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICK------------------HGRV--EEMEARRLFQ 118
Query: 668 ----GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
+ Y H +H ++HRD+K N+LLD + AKI+DFGLS M G + T
Sbjct: 119 QILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC- 171
Query: 724 GSFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
GS Y PE I + + D++S GV+L +LCG P
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 36/313 (11%), Positives = 88/313 (28%), Gaps = 72/313 (23%)
Query: 555 IGSGGFGHVFKGYIDDGSI--TVAVKRLNTSSMQGA---REFRTEIEMISELRHLHIVSL 609
G ++ D ++ VA+ ++ + +E + +S + + +
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
L ++V E++ G+L++ ++ + + A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA--------------DTSPSPVGAIRAMQSLAAAA 142
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
H + + + + + ++ M
Sbjct: 143 DAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPAT--MPD------------------A 179
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789
+P+ D+ G L +L R P+ A + ++ R T Q
Sbjct: 180 NPQ----------DDIRGIGASLYALLVNRWPL-PEAGVRSGLAPAE-------RDTAGQ 221
Query: 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSDQGR 849
++P + P ++ +A +G R +Q+A +D+
Sbjct: 222 PIEPADIDRDIPFQIS---AVAARSVQGDGGIRSAS-------TLLNLMQQATAVADRTE 271
Query: 850 PFVPRGEVITSST 862
P E S+
Sbjct: 272 VLGPIDEAPVSAA 284
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 47/218 (21%), Positives = 82/218 (37%), Gaps = 31/218 (14%)
Query: 555 IGSGGFGHVFKG-YIDDGSITVAVK-----RLNTSSMQGAREFRT---EIEMISELRHLH 605
+GSG FG V+ + V VK ++ + EI ++S + H +
Sbjct: 32 LGSGAFGFVWTAVDKEKNK-EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGN-LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
I+ +L + G LV E G L + + ++ + +
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL----------ASYIFRQL- 139
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
+ YL IIHRD+K NI++ E++ K+ DFG + G T G
Sbjct: 140 -VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFC-G 191
Query: 725 SFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
+ Y PE + + +++S GV L ++ P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGF 612
+G G F K + AVK ++ ++ EI + H +IV L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV 74
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ LV E + G L + + K+ ++ ++ + S + R+L + ++
Sbjct: 75 FHDQLHTFLVMELLNGGELFERI----KKKKHFSETEASYIM--RKL------VSAVSHM 122
Query: 673 HAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
H ++HRD+K N+L ++N KI DFG +R+ P + T + Y
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPC-FTLHYA 176
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE + + E D++S GV+L +L G+ P
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 52/237 (21%), Positives = 95/237 (40%), Gaps = 45/237 (18%)
Query: 541 EIKQATCDFADH----CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE 596
++ + + F D IG G + + ++ AVK ++ S EIE
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIE 67
Query: 597 -MISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
++ +H +I++L D+ + +V E M G L D + + ++ +
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE---------- 117
Query: 656 KRRLEISIGAAR-------GLHYLHAGAKHTIIHRDVKSTNILL---DENWAA-KISDFG 704
A+ + YLH ++HRD+K +NIL N + +I DFG
Sbjct: 118 ---------ASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
++ + + T + +V PE + RQ D++S GV+L +L G P
Sbjct: 166 FAKQLRAE--NGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 53/230 (23%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLN------TSSMQGAREFRTEIEMISELR----H 603
+G GGFG VF G+ + D VA+K + S + + E+ ++ ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRL-QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGN-LRDHLYNSQKQNQNQNQNQNSPLTWKRRL-EI 661
++ LL + + +LV E L D++ T K L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI------------------TEKGPLGE- 138
Query: 662 SIGAAR--------GLHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRMGPSG 712
G +R + + H ++HRD+K NIL+D AK+ DFG +
Sbjct: 139 --GPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
Query: 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
+ G+ Y PE+I R Q + V+S G++L +++CG P
Sbjct: 194 ----PYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTS---SMQGAREFRTE---IEMISE 600
DF+ H IIG GGFG V+ D G + A+K L+ QG E + ++S
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 601 LRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660
IV + ++ + + M G+L HL ++ + + E
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA--------E 300
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
I + GL ++H +++RD+K NILLDE+ +ISD GL+ + V T
Sbjct: 301 IIL----GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 353
Query: 721 VVKGSFGYVDPEYIRRQQLTEKS-DVYSFGVVLLEVLCGRPP 761
GY+ PE +++ + S D +S G +L ++L G P
Sbjct: 354 H-----GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 45/226 (19%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK-----RLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G +G V + + AVK +L A + EI+++ LRH +++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQL 71
Query: 610 LG--FCDEHGEMILVYEFMPRGN--LRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+ + +E +M +V E+ G + D + ++R +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-------------------EKRF--PVCQ 110
Query: 666 AR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
A GL YLH I+H+D+K N+LL KIS G++ +
Sbjct: 111 AHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 718 VSTVVKGSFGYVDPEYIRRQQLTE--KSDVYSFGVVLLEVLCGRPP 761
T GS + PE K D++S GV L + G P
Sbjct: 168 CRTSQ-GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-22
Identities = 66/219 (30%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREF---RTEIEMISELRHLHIVSLLG 611
+G G FG V G + VAVK LN ++ R EI+ + RH HI+ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR---- 667
++ +V E++ G L D++ RL+ +R
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICK------------------NGRLDEK--ESRRLFQ 123
Query: 668 ----GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
G+ Y H +H ++HRD+K N+LLD + AKI+DFGLS M G + T
Sbjct: 124 QILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC- 176
Query: 724 GSFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
GS Y PE I + + D++S GV+L +LCG P
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK-----RLNTSSMQGAREFRTEIEMISELRHLHIVSL 609
+G G FG V VA+K L S M R R EI + LRH HI+ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM-RVER-EISYLKLLRHPHIIKL 74
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR-- 667
++++V E+ G L D++ K+R+ + R
Sbjct: 75 YDVITTPTDIVMVIEYAG-GELFDYIVE------------------KKRM--TEDEGRRF 113
Query: 668 ------GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ Y H +H I+HRD+K N+LLD+N KI+DFGLS + G + + T
Sbjct: 114 FQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTS 167
Query: 722 VKGSFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
GS Y PE I + + DV+S G+VL +L GR P
Sbjct: 168 C-GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-21
Identities = 62/218 (28%), Positives = 84/218 (38%), Gaps = 39/218 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IGSG FG VAVK + + R EI LRH +IV
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVIL 86
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR------- 667
+ ++ E+ G L + + N R S AR
Sbjct: 87 TPTHLAIIMEYASGGELYERICN------------------AGRF--SEDEARFFFQQLL 126
Query: 668 -GLHYLHAGAKHTIIHRDVKSTNILLDENWAA--KISDFGLSRMGPSGMSQSHVSTVVKG 724
G+ Y H I HRD+K N LLD + A KI DFG S+ S + V G
Sbjct: 127 SGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTV-G 179
Query: 725 SFGYVDPEYIRRQQLT-EKSDVYSFGVVLLEVLCGRPP 761
+ Y+ PE + RQ+ + +DV+S GV L +L G P
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFR---TEIEMISELRHL 604
F IG G FG V +D A+K +N E R E++++ L H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 605 HIVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL---E 660
+V+L F DE +M +V + + G+LR HL + + +L E
Sbjct: 76 FLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHLQQNVHFKEETV-----------KLFICE 123
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
+ + L YL IIHRD+K NILLDE+ I+DF ++ M P + ++
Sbjct: 124 LVMA----LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA- 175
Query: 721 VVKGSFGYVDPEYIRRQQLTEKS---DVYSFGVVLLEVLCGRPP 761
G+ Y+ PE ++ S D +S GV E+L GR P
Sbjct: 176 ---GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-20
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRH 603
F D ++G GGFG VF G + A K+LN +G + E ++++++
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKL-YACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 604 LHIVSLLGFCDEHGEMI-LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL--- 659
IVSL + E + LV M G++R H+YN + N + +
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
+I G L +LH + II+RD+K N+LLD++ +ISD GL+ +G Q+
Sbjct: 297 QIVSG----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTK 347
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ G++ PE + ++ D ++ GV L E++ R P
Sbjct: 348 GYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 37/226 (16%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREF---RTEIEMISELRH 603
DF I+G G F V + A+K L + + E +++S L H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSRE-YAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
V L + ++ + G L ++
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--------------------FDE 129
Query: 664 GAAR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ 715
R L YLH IIHRD+K NILL+E+ +I+DFG +++ Q
Sbjct: 130 TCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 716 SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ ++ V G+ YV PE + + + SD+++ G ++ +++ G PP
Sbjct: 187 ARANSFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE-MISELRHLHIVSLLGF 612
++G G G V + + A+K L R E+E + HIV ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123
Query: 613 CDEHGEMI----LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
+ +V E + G L + + +Q + + S + + +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIM--KSI------GEA 173
Query: 669 LHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+ YLH I HRDVK N+L N K++DFG ++ S + ++T +
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPC-YT 226
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
YV PE + ++ + D++S GV++ +LCG PP
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-19
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRH 603
F + ++G GGFG V G + A K+L +G E +++ ++
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKM-YACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 604 LHIVSLLGFCDEHGEMI-LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL--- 659
+VS L + E + + LV M G+L+ H+Y+ + + +
Sbjct: 244 RFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA---------VFYAA 293
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
EI GL LH + I++RD+K NILLD++ +ISD GL+ P G + +
Sbjct: 294 EICC----GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IK 343
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
V G+ GY+ PE ++ ++ T D ++ G +L E++ G+ P
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVSLLGF 612
+IG+G FG V++ + D VA+K++ +Q R + R E++++ +L H +IV L F
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNR-ELQIMRKLDHCNIVRLRYF 115
Query: 613 CDEHGEMI------LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL-EISIGA 665
GE LV +++P + +Y + Q + K + ++
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTL-PVIYVKLYMYQL---- 165
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
R L Y+H I HRD+K N+LLD + K+ DFG ++ G + +VS +
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYIC-- 218
Query: 725 SFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
S Y PE I T DV+S G VL E+L G+P
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLH 605
+ + IGSG G V Y VA+K+L+ + R +R E+ ++ + H +
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122
Query: 606 IVSLL------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
I+SLL +E ++ LV E M N Q L +R
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD---------------ANLCQVIQMELDHERMS 167
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
+ G+ +LH+ IIHRD+K +NI++ + KI DFGL+R S +
Sbjct: 168 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMM 220
Query: 720 TVVKGSFGYVD------PEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
T YV PE I E D++S G ++ E++ +
Sbjct: 221 T------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+IG+G FG VF+ S VA+K++ +Q R E++++ ++H ++V L F
Sbjct: 47 VIGNGSFGVVFQA-KLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 614 DEHGEMI------LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL-EISIGAA 666
+G+ LV E++P + + K Q L K + ++
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTM-----PMLLIKLYMYQL----L 151
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAA-KISDFGLSRMGPSGMSQSHVSTVVKGS 725
R L Y+H+ I HRD+K N+LLD K+ DFG +++ +G + +VS + S
Sbjct: 152 RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYIC--S 204
Query: 726 FGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
Y PE I T D++S G V+ E++ G+P
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLH 605
+ + IGSG G V Y VA+K+L+ + R +R E+ ++ + H +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85
Query: 606 IVSLL------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
I+ LL +E ++ +V E M + L + L +R
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA----N-LCQVIQM----------ELDHERMS 130
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
+ G+ +LH+ IIHRD+K +NI++ + KI DFGL+R S +
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMM 183
Query: 720 TVVKGSFGYVD------PEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
T YV PE I E D++S G ++ E++ G
Sbjct: 184 T------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+ G G FG V G ++VA+K++ RE + ++ ++ L H +IV L +
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88
Query: 614 DEHGE-------MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL-EISIGA 665
GE + +V E++P D L+ + + P+ K L ++
Sbjct: 89 YTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQV-APPPILIKVFLFQL---- 138
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
R + LH + + HRD+K N+L++ + K+ DFG ++ + +V+ +
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYIC-- 193
Query: 725 SFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
S Y PE I Q T D++S G + E++ G P
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 47/222 (21%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLL- 610
+GSG +G V VA+K+L+ S + R +R E+ ++ ++H +++ LL
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 611 -----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+ LV FM D L + ++ +
Sbjct: 91 VFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGL----------KFSEEKIQYLVYQM 135
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST----- 720
+GL Y+H+ ++HRD+K N+ ++E+ KI DFGL+R + M+ +V T
Sbjct: 136 LKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-YVVTRWYRA 191
Query: 721 --VVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
V+ Y + D++S G ++ E+L G+
Sbjct: 192 PEVILSWMHY-----------NQTVDIWSVGCIMAEMLTGKT 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 60/304 (19%), Positives = 119/304 (39%), Gaps = 78/304 (25%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREF----------------------- 591
IG G +G V Y ++ + A+K L+ + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 592 ---RTEIEMISELRHLHIVSL---LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQ 645
EI ++ +L H ++V L L +E + +V+E + +G + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVME------------ 127
Query: 646 NQNQNSPLTWKRRLEISIGAAR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWA 697
+ + L S AR G+ YLH IIHRD+K +N+L+ E+
Sbjct: 128 -------VPTLKPL--SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGH 175
Query: 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLT---EKSDVYSFGVVLLE 754
KI+DFG+S + +S V G+ ++ PE + + + DV++ GV L
Sbjct: 176 IKIADFGVSNEFKGS--DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 755 VLCGRPP-------MINGAVRKEEVSLVLWARVSR-ARGTVDQI--VDPRLRGKIAPVCL 804
+ G+ P ++ ++ + + ++ + + ++ +P R + + L
Sbjct: 233 FVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
Query: 805 NKFV 808
+ +V
Sbjct: 293 HPWV 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 55/231 (23%), Positives = 86/231 (37%), Gaps = 51/231 (22%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA------------REFRTEIEMISEL 601
I SG +G V G +D I VA+KR+ + G R R EI +++
Sbjct: 29 FISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHF 86
Query: 602 RHLHIVSLL-----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWK 656
H +I+ L ++ LV E M D L + ++ +
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRI-------VISPQ 134
Query: 657 RRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS 716
GLH LH ++HRD+ NILL +N I DF L+R +
Sbjct: 135 HIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR----EDTAD 187
Query: 717 HVSTVVKGSFGYVD------PEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
T YV PE + + + T+ D++S G V+ E+ +
Sbjct: 188 ANKT------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 56/228 (24%), Positives = 87/228 (38%), Gaps = 34/228 (14%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHL 604
DF +IG G F V + A+K +N M E FR E +++
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 605 HIVSLL-GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR--RLEI 661
I L F DE + LV E+ G+L L + P R EI
Sbjct: 122 WITQLHFAFQDE-NYLYLVMEYYVGGDLLTLL---------SKFGERIPAEMARFYLAEI 171
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMSQSHVST 720
+ + +H + +HRD+K NILLD +++DFG ++ G +S
Sbjct: 172 VMA----IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL--V 222
Query: 721 VVKGSFGYVDPEYIRRQQLTEKSDVY-------SFGVVLLEVLCGRPP 761
V G+ Y+ PE ++ + Y + GV E+ G+ P
Sbjct: 223 AV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLN--TSSMQGAREFRTEIEMISELRHLHIVSLL- 610
++G G +G V VA+K++ + R R EI+++ +H +I+++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 611 ----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
+ E+ ++ E M D L+ L+
Sbjct: 77 IQRPDSFENFNEVYIIQELMQT----D-LHRVISTQ---------MLSDDHIQYFIYQTL 122
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
R + LH +IHRD+K +N+L++ N K+ DFGL+R+ + + T +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 727 -GYVD------PEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
+V PE + + + DV+S G +L E+ RP
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHL 604
+ D +GSG +G V VA+K+L S + R +R E+ ++ +RH
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHE 84
Query: 605 HIVSLL------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRR 658
+++ LL D+ + LV FM +L L + L R
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLG-KLMKHE------------KLGEDRI 130
Query: 659 LEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHV 718
+ +GL Y+HA IIHRD+K N+ ++E+ KI DFGL+R S M+ +V
Sbjct: 131 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-YV 186
Query: 719 STVVKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
T Y PE I + T+ D++S G ++ E++ G+
Sbjct: 187 VTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLN--TSSMQGAREFRTEIEMISELRHLHIVSLL-- 610
IG G +G V Y + + VA+K+++ R R EI+++ RH +I+ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 611 ---GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
++ ++ +V + M +L L +Q L+ R
Sbjct: 94 IRAPTIEQMKDVYIVQDLME-TDLY-KLLKTQ------------HLSNDHICYFLYQILR 139
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
GL Y+H+ ++HRD+K +N+LL+ KI DFGL+R+ + T
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------E 190
Query: 728 YVD------PEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
YV PE + + T+ D++S G +L E+L RP
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 21/159 (13%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGA-----REFRTEIEMISELRHLHIVS 608
+G+G + V+KG G VA+K + S +G RE I ++ EL+H +IV
Sbjct: 13 LGNGTYATVYKGLNKTTGVY-VALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVR 67
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L ++ LV+EFM +L+ ++ + N + N ++ +L +G
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL------LQG 120
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
L + H ++ I+HRD+K N+L+++ K+ DFGL+R
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 44/232 (18%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHL 604
DF +IG G FG V + + A+K LN M E FR E +++
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 605 HIVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
I +L F D+ + LV ++ G+L L K +
Sbjct: 135 WITTLHYAFQDD-NNLYLVMDYYVGGDLLTLLS-------------------KFEDRLPE 174
Query: 664 GAAR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMS 714
AR + +H + +HRD+K NIL+D N +++DFG ++ G
Sbjct: 175 EMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 715 QSHVSTVVKGSFGYVDPEYIRRQQLTEKS-----DVYSFGVVLLEVLCGRPP 761
QS V G+ Y+ PE ++ + + D +S GV + E+L G P
Sbjct: 232 QSS--VAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLH 605
+ + +GSG +G V + + VAVK+L+ S + R +R E+ ++ ++H +
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 89
Query: 606 IVSLL------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
++ LL +E ++ LV M D L N K LT
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA----D-LNNIVKCQ---------KLTDDHVQ 135
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
+ RGL Y+H+ IIHRD+K +N+ ++E+ KI DFGL+R M+ +V+
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-YVA 191
Query: 720 TVVKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
T Y PE + + D++S G ++ E+L GR
Sbjct: 192 TRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 19/156 (12%)
Query: 555 IGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFRT--EIEMISELRHLHIVSLLG 611
IG G +G VFK D G I VA+K+ S + EI M+ +L+H ++V+LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQI-VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
+ LV+E+ + L + I+ + +++
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHEL-----------DRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
H KH IHRDVK NIL+ ++ K+ DFG +R
Sbjct: 118 CH---KHNCIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 27/160 (16%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
+G G +G V K D G I VA+K+ + R EI+++ +LRH ++V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRI-VAIKKFL---ESDDDKMVKKIAMR-EIKLLKQLRHENLV 87
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
+LL C + LV+EF+ + D L + + L ++ +
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDL-----------ELFPNGLDYQVVQKYLFQIIN 135
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
G+ + H H IIHRD+K NIL+ ++ K+ DFG +R
Sbjct: 136 GIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 48/243 (19%), Positives = 101/243 (41%), Gaps = 42/243 (17%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVS 608
++ +G+G FG V + + + A+K++ + R E++++ L H++I+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYKNR-ELDIMKVLDHVNIIK 64
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNS-------------PLTW 655
L+ + G+ P + + N+ N +++ N P T
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 656 KRRLEISIGAA----------------RGLHYLHAGAKHTIIHRDVKSTNILLD-ENWAA 698
+ L+ I + R + ++H+ I HRD+K N+L++ ++
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTL 181
Query: 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI-RRQQLTEKSDVYSFGVVLLEVLC 757
K+ DFG ++ + V+ + S Y PE + + T D++S G V E++
Sbjct: 182 KLCDFGSAKKLIPS--EPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 758 GRP 760
G+P
Sbjct: 238 GKP 240
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 59/284 (20%), Positives = 108/284 (38%), Gaps = 30/284 (10%)
Query: 485 FFFLRKKKRVNVNESASEVKTKSSQSWVPFSYALTATNTNTASSLPSDLCRRFSLTEIKQ 544
F ++R + V + + + ++ + + ++ +
Sbjct: 88 FHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTM 147
Query: 545 ATCDFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREF---RTEIEMISE 600
+F ++G G FG V G A+K L + E TE ++
Sbjct: 148 N--EFEYLKLLGKGTFGKVILVKEKATGRY-YAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 601 LRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL- 659
RH + +L H + V E+ G L HL + ++++ R
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-----------RFY 253
Query: 660 --EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
EI L YLH ++ +++RD+K N++LD++ KI+DFGL + G+
Sbjct: 254 GAEIVS----ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGA 304
Query: 718 VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE + D + GVV+ E++CGR P
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 45/231 (19%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHL 604
D+ +IG G FG V A+K L+ M + F E ++++
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 605 HIVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
+V L F D+ + +V E+MP G+L + + ++
Sbjct: 130 WVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLM---------------------SNYDVPE 167
Query: 664 GAAR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS-RMGPSGMS 714
AR L +H IHRDVK N+LLD++ K++DFG +M GM
Sbjct: 168 KWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 715 QSHVSTVVKGSFGYVDPEYIRRQQLTEK----SDVYSFGVVLLEVLCGRPP 761
+ T V G+ Y+ PE ++ Q D +S GV L E+L G P
Sbjct: 225 RCD--TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 549 FADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA-REFRTEIEMISELRHLHIV 607
+ D +G GG G VF +D VA+K++ + Q R EI++I L H +IV
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71
Query: 608 SLL--------------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPL 653
+ G E + +V E+M D L N +Q PL
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANVLEQG---------PL 117
Query: 654 TWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRMGPSG 712
+ RGL Y+H+ ++HRD+K N+ ++ E+ KI DFGL+R+
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 713 MSQSHVSTVVKGSFGYVD------PEYI-RRQQLTEKSDVYSFGVVLLEVLCGRP 760
S + + P + T+ D+++ G + E+L G+
Sbjct: 175 YSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 7e-17
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 26/160 (16%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
IG G +G V+K G + VA+K++ + E R EI ++ EL H +IV
Sbjct: 11 IGEGTYGVVYKARNKLTGEV-VALKKIR---LDTETEGVPSTAIR-EISLLKELNHPNIV 65
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
LL ++ LV+EF+ + +L+ + S + ++ +L +
Sbjct: 66 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK----SYLFQL------LQ 114
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
GL + H H ++HRD+K N+L++ A K++DFGL+R
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
+G G F V+K + I VA+K++ A++ R EI+++ EL H +I+
Sbjct: 18 LGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNII 75
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLT------WKRRLEI 661
LL + LV++FM +L + ++ + LT +
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVII-----------KDNSLVLTPSHIKAYMLMT-- 121
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
+GL YLH +H I+HRD+K N+LLDEN K++DFGL++
Sbjct: 122 ----LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 26/159 (16%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIVS 608
IG G +G V+K + G A+K++ ++ E R EI ++ EL+H +IV
Sbjct: 10 IGEGTYGVVYKAQNNYGET-FALKKIR---LEKEDEGIPSTTIR-EISILKELKHSNIVK 64
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L ++LV+E + + +L+ L L + G
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLL-----------DVCEGGLESVTAKSFLLQLLNG 112
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
+ Y H ++HRD+K N+L++ KI+DFGL+R
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA-----REFRTEIEMISELRHLHIVSL 609
+G G + V+KG VA+K + +GA RE + ++ +L+H +IV+L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIVTL 65
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+ LV+E++ + +L+ +L + + + RGL
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYL-----------DDCGNIINMHNVKLFLFQLLRGL 113
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
Y H + ++HRD+K N+L++E K++DFGL+R
Sbjct: 114 AYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSI--TVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLL 610
+G G +GHV+K DG A+K++ + SM RE I ++ EL+H +++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84
Query: 611 GFCDEHGEMI--LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
H + L++++ +L + + N+ Q K L + G
Sbjct: 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---DG 140
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAA----KISDFGLSRM-GPSGMSQSHVSTVV 722
+HYLH + ++HRD+K NIL+ KI+D G +R+ + + VV
Sbjct: 141 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 26/159 (16%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIVS 608
+G G +G V+K G I VA+KR+ + E R EI ++ EL H +IVS
Sbjct: 29 VGEGTYGVVYKAKDSQGRI-VALKRIR---LDAEDEGIPSTAIR-EISLLKELHHPNIVS 83
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L+ + LV+EFM + +L+ L + L + RG
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVL-----------DENKTGLQDSQIKIYLYQLLRG 131
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
+ + H +H I+HRD+K N+L++ + A K++DFGL+R
Sbjct: 132 VAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 27/160 (16%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
IG G +G VFK + I VA+KR+ + E R EI ++ EL+H +IV
Sbjct: 10 IGEGTYGTVFKAKNRETHEI-VALKRV---RLDDDDEGVPSSALR-EICLLKELKHKNIV 64
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
L ++ LV+EF + +L+ + + N L + +
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYF-----------DSCNGDLDPEIVKSFLFQLLK 112
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
GL + H ++HRD+K N+L++ N K+++FGL+R
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 7e-16
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 548 DFADHCIIGSGGFGHVF----KGYIDDGSITVAVKRLNTSSMQGAREFRTEIE--MISEL 601
F ++G G FG VF D + A+K L ++++ RT++E ++ E+
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQL-YAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 602 RHLHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRR 658
H IV L + + + L+ +F+ G+L L + +
Sbjct: 84 NHPFIVKLH-YAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDV-----------K 129
Query: 659 L---EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ 715
E+++ L +LH II+RD+K NILLDE K++DFGLS+ +
Sbjct: 130 FYLAELALA----LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE---SIDH 179
Query: 716 SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G+ Y+ PE + R+ T+ +D +SFGV++ E+L G P
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLL 610
+IG G +G+V+ Y + VA+K++N + R R EI +++ L+ +I+ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLY 91
Query: 611 -----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+ E+ +V E D L K LT + I
Sbjct: 92 DLIIPDDLLKFDELYIVLEIADS----D-LKKLFKTPI--------FLTEEHIKTILYNL 138
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
G +++H IIHRD+K N LL+++ + K+ DFGL+R + +++ ++ +
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR-TINSEKDTNIVNDLEEN 194
Query: 726 FGYVDPEYIRRQQLTE 741
++QLT
Sbjct: 195 EEPGPHNKNLKKQLTS 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 43/172 (25%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
IG G FG VFK G VA+K++ M+ +E R EI+++ L+H ++V
Sbjct: 25 IGQGTFGEVFKARHRKTGQK-VALKKVL---MENEKEGFPITALR-EIKILQLLKHENVV 79
Query: 608 SLLG--------FCDEHGEMILVYEFMPRGNLRDH----LYNSQKQNQNQNQNQNSPLTW 655
+L+ + G + LV++F +H L ++ ++ +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIK----RV 129
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
+ L GL+Y+H ++ I+HRD+K+ N+L+ + K++DFGL+R
Sbjct: 130 MQML------LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 44/225 (19%), Positives = 87/225 (38%), Gaps = 40/225 (17%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREF---RTEIEMISELRHL 604
F +G+G FG V + A+K L+ + ++ E ++ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+V L ++ + +V E++ G + HL + ++
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH------------------- 142
Query: 665 AAR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS 716
AR YLH +I+RD+K N+L+D+ +++DFG ++
Sbjct: 143 -ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----G 193
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
T+ G+ + PE I + + D ++ GV++ E+ G PP
Sbjct: 194 RTWTLC-GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 38/165 (23%), Positives = 74/165 (44%), Gaps = 33/165 (20%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLHIV 607
+G G +G V+K VA+KR+ ++ E R E+ ++ EL+H +I+
Sbjct: 42 LGEGTYGEVYKAIDTVTNET-VAIKRIR---LEHEEEGVPGTAIR-EVSLLKELQHRNII 96
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
L + + L++E+ +L+ ++ ++N ++ +
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYM------------DKNPDVSMRVIKSFLYQLIN 143
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAA-----KISDFGLSR 707
G+++ H +HRD+K N+LL + A+ KI DFGL+R
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 35/224 (15%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREF---RTEIEMISELRH 603
DF ++G G FG V G A+K L + E TE ++ RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRY-YAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 604 LHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL- 659
+ +L + + + V E+ G L HL + + + R
Sbjct: 65 PFLTALK-YAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERA-----------RFY 110
Query: 660 --EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
EI L YLH +++RD+K N++LD++ KI+DFGL + G+S
Sbjct: 111 GAEIVSA----LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGA 160
Query: 718 VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE + D + GVV+ E++CGR P
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 29/200 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELRHLHIVSLL 610
+IG+G +GHV + Y VA+K++ + R R EI +++ L H H+V +L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVL 118
Query: 611 -----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
++ E+ +V E D + LT +
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADS----D-FKKLFRTPV--------YLTELHIKTLLYNL 165
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR----MGPSGMSQSHVSTV 721
G+ Y+H+ I+HRD+K N L++++ + K+ DFGL+R
Sbjct: 166 LVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 722 VKGSFGYVDPEYIRRQQLTE 741
+ ++QLT
Sbjct: 223 DDMNLVTFPHTKNLKRQLTG 242
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRL-NTSSM--QGAREFRTEIEMISELRHL------ 604
+IG G FG V K Y VA+K + N + Q + E+ ++ +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKY 116
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+IV L + LV+E + NL D L + + ++ + +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLL----RNTNFR------GVSLNLTRKFAQQ 165
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILL--DENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
L +L + +IIH D+K NILL + A KI DF G S + +
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDF-----GSSCQLGQRIYQYI 219
Query: 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+ F Y PE + D++S G +L+E+ G P
Sbjct: 220 QSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-15
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 39/228 (17%)
Query: 548 DFADHCIIGSGGFGHVF----KGYIDDGSITVAVKRLNTSS-MQGAREF---RTEIEMIS 599
F ++G GG+G VF + G I A+K L + ++ A++ + E ++
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKI-FAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 600 ELRHLHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWK 656
E++H IV L+ + + L+ E++ G L L ++
Sbjct: 77 EVKHPFIVDLI-YAFQTGGK--LYLILEYLSGGELFMQLEREGIFMEDTA---------- 123
Query: 657 RRL---EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGM 713
EIS+ L +LH + II+RD+K NI+L+ K++DFGL + +
Sbjct: 124 -CFYLAEISMA----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SI 172
Query: 714 SQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
V+ G+ Y+ PE + R D +S G ++ ++L G PP
Sbjct: 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 69/245 (28%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLN---TSSMQGAREFRTEIEMISELR-HLHIVSL 609
+G G +G V+K VAVK++ +S R FR EI +++EL H +IV+L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 610 LGFC--DEHGEMILVYEFMP-------RGNL--RDH----LYNSQKQNQNQNQNQNSPLT 654
L D ++ LV+++M R N+ H +Y
Sbjct: 75 LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ----------------- 117
Query: 655 WKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS 714
+ + YLH+G ++HRD+K +NILL+ K++DFGLSR +
Sbjct: 118 ----------LIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 715 QSHVSTVVKGSF------------GYVD------PEYI-RRQQLTEKSDVYSFGVVLLEV 755
++ + YV PE + + T+ D++S G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 756 LCGRP 760
LCG+P
Sbjct: 225 LCGKP 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 50/230 (21%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREF---RTEIEMISELRH 603
DF +G+G FG V +G A+K L + ++ E M+S + H
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRY-YAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
I+ + G + ++ ++ +++ G L L SQ+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV------------------ 107
Query: 664 GAAR--------GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ 715
A+ L YLH II+RD+K NILLD+N KI+DFG ++ P
Sbjct: 108 --AKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY- 161
Query: 716 SHVSTVVKGSF-G---YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G Y+ PE + + + D +SFG+++ E+L G P
Sbjct: 162 ---------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHL------HI 606
+IG G FG V K Y VA+K + N R+ EI ++ LR ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
+ +L + + +E + NL + + +N+ Q L R+ SI
Sbjct: 162 IHMLENFTFRNHICMTFELL-SMNLYELI--------KKNKFQGFSLPLVRKFAHSI--L 210
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAA--KISDFGLSRMGPSGMSQSHVSTVVKG 724
+ L LH K+ IIH D+K NILL + + K+ DFG S V T ++
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-----YEHQRVYTYIQS 262
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
F Y PE I + D++S G +L E+L G P
Sbjct: 263 RF-YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREF-RTEIE---MISELR 602
DF +IG G FG V + + AVK L ++ +E E ++ ++
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVF-YAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 603 HLHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
H +V L F + + V +++ G L HL + + + R
Sbjct: 98 HPFLVGLH-FSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRA-----------RF 143
Query: 660 ---EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS 716
EI+ L YLH I++RD+K NILLD ++DFGL + + +
Sbjct: 144 YAAEIASA----LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHN 193
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
++ G+ Y+ PE + +Q D + G VL E+L G PP
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 31/168 (18%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQGAREF------RTEIEMISELR---HL 604
IG G +G V+K G VA+K + + G R E+ ++ L H
Sbjct: 17 IGVGAYGTVYKARDPHSGHF-VALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHP 74
Query: 605 HIVSLL-----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
++V L+ D ++ LV+E + + +LR +L + + R+
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK----DLMRQF 129
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
RGL +LH + I+HRD+K NIL+ K++DFGL+R
Sbjct: 130 ------LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 47/231 (20%), Positives = 87/231 (37%), Gaps = 47/231 (20%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHL-------- 604
+G G F V+ + VA+K + A E EI+++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED--EIKLLQRVNDADNTKEDSM 83
Query: 605 ---HIVSLL------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
HI+ LL G H +++V+E + NL + K+ +++ +
Sbjct: 84 GANHILKLLDHFNHKGPNGVH--VVMVFEVL-GENLLALI----KKYEHR------GIPL 130
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE------NWAAKISDFGLSRMG 709
+IS GL Y+H IIH D+K N+L++ KI+D G +
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 710 PSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
H + ++ Y PE + +D++S ++ E++ G
Sbjct: 189 D-----EHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREF-RTEIE---MISELR 602
DF H ++G G FG VF + A+K L + + T +E +
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQF-FAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 603 HLHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
H + + E+ + V E++ G+L H+ + K + ++
Sbjct: 77 HPFLTHMF-CTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSR-----------ATF 122
Query: 660 ---EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS 716
EI +G L +LH I++RD+K NILLD++ KI+DFG+ + M
Sbjct: 123 YAAEIILG----LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGD 172
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G+ Y+ PE + Q+ D +SFGV+L E+L G+ P
Sbjct: 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 48/222 (21%), Positives = 78/222 (35%), Gaps = 63/222 (28%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE-MISELRHLHIVSLLGF 612
++G G G V + + A+K L R E+E + HIV ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 79
Query: 613 CDEHGEMI----LVYEFMPRGNL------RDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
+ +V E + G L R ++++ + S
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--------------ASEIMKS 125
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVS 719
IG A + YLH I HRDVK N+L N K++DFG +
Sbjct: 126 IGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------- 167
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E ++ + D++S GV++ +LCG PP
Sbjct: 168 -----------KE-TTGEKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 37/170 (21%)
Query: 555 IGSGGFGHVFKGYIDDGSIT---VAVKRLNTSSMQGARE------FRTEIEMISELR--- 602
IG G +G VFK D VA+KR+ +Q E R E+ ++ L
Sbjct: 19 IGEGAYGKVFKAR--DLKNGGRFVALKRVR---VQTGEEGMPLSTIR-EVAVLRHLETFE 72
Query: 603 HLHIVSLL-----GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
H ++V L D ++ LV+E + + +L +L + +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK----DMMF 127
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707
+L RGL +LH H ++HRD+K NIL+ + K++DFGL+R
Sbjct: 128 QL------LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREF-RTEIE---MISELR 602
DF +IG G + V I A+K + + + + E
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRI-YAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 603 HLHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
H +V L C + + V E++ G+L H+ +K + R
Sbjct: 69 HPFLVGLH-SCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHA-----------RF 114
Query: 660 ---EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR--MGPSGMS 714
EIS+ L+YLH + II+RD+K N+LLD K++D+G+ + + P +
Sbjct: 115 YSAEISLA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
Query: 715 QSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ T Y+ PE +R + D ++ GV++ E++ GR P
Sbjct: 168 STFCGTP-----NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 48/220 (21%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLG-F 612
+G G + VF+ + V VK L + + R EI+++ LR +I++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKR-EIKILENLRGGPNIITLADIV 100
Query: 613 CDEHGEM-ILVYEFMPRGNLRDHLYNSQKQNQNQN---QNQNSPLTWKRRLEISIGAARG 668
D LV+E + + + LY + + + +
Sbjct: 101 KDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYMYE-----------------ILKA 142
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRMGPSGMSQSH-VSTVVKGSF 726
L Y H+ I+HRDVK N+++D E+ ++ D+GL+ G + V++
Sbjct: 143 LDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 195
Query: 727 GYVDPEYIRRQQLTEKS-DVYSFGVVLLEVLCGRPPMING 765
+ PE + Q+ + S D++S G +L ++ + P +G
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 52/233 (22%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFRTEIE-MISE----- 600
DF ++G G FG V + AVK L + ++E + E
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDEL-YAVKILKKDVVIQ----DDDVECTMVEKRVLA 75
Query: 601 --LRHLHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
+ + L C + + V E++ G+L H+ + +
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKEPHA--------- 123
Query: 656 KRRL---EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712
EI+IG L +L II+RD+K N++LD KI+DFG+ +
Sbjct: 124 --VFYAAEIAIG----LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174
Query: 713 MSQSHVSTVVKGSF-G---YVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ +F G Y+ PE I Q + D ++FGV+L E+L G+ P
Sbjct: 175 GVTTK-------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 7e-13
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 30/222 (13%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFR-TEIE---MISELR 602
DF ++G G FG V + AVK L + + T +E + +
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDEL-YAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 603 HLHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
+ L C + + V E++ G+L H+ + + +
Sbjct: 401 PPFLTQLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-------- 449
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
EI+IG L +L II+RD+K N++LD KI+DFG+ + + +
Sbjct: 450 EIAIG----LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTT 499
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE I Q + D ++FGV+L E+L G+ P
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGSITVAVKRLNTSSMQGAREFRTEIE-MISE----- 600
+F ++G G FG V + G + AVK L + ++E ++E
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDL-YAVKVLKKDVILQ----DDDVECTMTEKRILS 78
Query: 601 --LRHLHIVSLLGFC---DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTW 655
H + L C + + V EF+ G+L H+ S++ ++ +
Sbjct: 79 LARNHPFLTQLF-CCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARA--------- 126
Query: 656 KRRL---EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712
R EI L +LH II+RD+K N+LLD K++DFG+ + G
Sbjct: 127 --RFYAAEIISA----LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE---G 174
Query: 713 MSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + G+ Y+ PE ++ D ++ GV+L E+LCG P
Sbjct: 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR--MGPSGMSQSH 717
EIS+ L+YLH + II+RD+K N+LLD K++D+G+ + + P + +
Sbjct: 161 EISLA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 213
Query: 718 VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
T Y+ PE +R + D ++ GV++ E++ GR P
Sbjct: 214 CGTP-----NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 45/233 (19%)
Query: 548 DFADHCIIGSGGFGHVF----KGYIDDGSITVAVKRLNTSSMQGAREF----RTEIEMIS 599
+F ++G+G +G VF D G + A+K L +++ + RTE +++
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKL-YAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 600 ELRHLH-IVSLLG-FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
+R +V+L F E ++ L+ +++ G L HL ++ +++
Sbjct: 114 HIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEV----------- 161
Query: 658 RL---EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS 714
++ EI + L +LH K II+RD+K NILLD N ++DFGLS+ ++
Sbjct: 162 QIYVGEIVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVA 211
Query: 715 QSHVSTVVKGSF-G---YVDPEYIRRQQL--TEKSDVYSFGVVLLEVLCGRPP 761
F G Y+ P+ +R + D +S GV++ E+L G P
Sbjct: 212 DETERA---YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 3e-11
Identities = 37/187 (19%), Positives = 53/187 (28%), Gaps = 38/187 (20%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRL--------NTSSMQGAREFRTEIEMISELRHLHI 606
IG G FG VF+ D VA+K + N S + E EI + EL L
Sbjct: 28 IGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 607 VSLL---GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSP----------- 652
GF + + + P YNS K + N +
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 653 ------------LTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700
+ I L A HRD+ N+LL + K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLLKKTSLKKL 203
Query: 701 SDFGLSR 707
+
Sbjct: 204 HYTLNGK 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 52/234 (22%), Positives = 87/234 (37%), Gaps = 49/234 (20%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHL------H 605
+G G FG V + G VA+K + N + A R EI ++ +++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--RLEINVLKKIKEKDKENKFL 83
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
V + + + HG M + +E + N + L K+N Q P ++
Sbjct: 84 CVLMSDWFNFHGHMCIAFELL-GKNTFEFL----KENNFQ------PYPLPHVRHMAYQL 132
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA-------------------KISDFGLS 706
L +LH ++ + H D+K NIL + +++DFG S
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-S 188
Query: 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+ H +T+V Y PE I + DV+S G +L E G
Sbjct: 189 ----ATFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 46/233 (19%), Positives = 82/233 (35%), Gaps = 43/233 (18%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHL-----HIV 607
+G G FG V D AVK + N + + E +++ ++++ +IV
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA--KIEADILKKIQNDDINNNNIV 99
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
G + M L++E + +L + + +N + I +
Sbjct: 100 KYHGKFMYYDHMCLIFEPL-GPSLYEII----TRNNYN------GFHIEDIKLYCIEILK 148
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS----------- 716
L+YL K ++ H D+K NILLD+ + K +
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 717 ---------HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+ +++ Y PE I SD++SFG VL E+ G
Sbjct: 206 FGCATFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 54/234 (23%), Positives = 91/234 (38%), Gaps = 49/234 (20%)
Query: 554 IIGSGGFGHVFKGY-IDDGSITVAVKRL-NTSSMQGAREFRTEIEMISELRHL------H 605
+G G FG V + G VAVK + N A R+EI+++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--RSEIQVLEHLNTTDPNSTFR 78
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
V +L + + HG + +V+E + + D + K+N P +++
Sbjct: 79 CVQMLEWFEHHGHICIVFELL-GLSTYDFI----KENGFL------PFRLDHIRKMAYQI 127
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA-------------------KISDFGLS 706
+ +++LH + + H D+K NIL ++ K+ DFG S
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-S 183
Query: 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
+ H ST+V Y PE I ++ DV+S G +L+E G
Sbjct: 184 ----ATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 2e-08
Identities = 61/429 (14%), Positives = 125/429 (29%), Gaps = 114/429 (26%)
Query: 455 NVKNNKGRVILIIIIAAVLGSIFALVSLLYFFFLRKKKRVNVNESASEVKTKSSQSWVP- 513
K+ + + + F+ + R+N S +KT+ Q +
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQE------EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109
Query: 514 --FSYALTATNTNTASSLPSDLCRRFSLTEIKQATCDFADHCII---GSGGFGHVFKGYI 568
+ + ++ R +++QA + + G G G K
Sbjct: 110 RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K--- 163
Query: 569 DDGSITV-AVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI-----LV 622
T A+ + +Q +F +I ++ L C+ ++ L+
Sbjct: 164 -----TWVALDVCLSYKVQCKMDF--KIFWLN----------LKNCNSPETVLEMLQKLL 206
Query: 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIH 682
Y+ P R ++ K + Q RRL +
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQA------ELRRL--------------------LKS 240
Query: 683 RDVKSTNILLDENWAAKISD-FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTE 741
+ ++ ++L AK + F LS + ++T R +Q+T+
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLS-------CKILLTT--------------RFKQVTD 279
Query: 742 KSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVD--PRLRGKI 799
+ + L+ + + +E L + +D PR
Sbjct: 280 FLSAATTTHISLD-------HHSMTLTPDE-VKSLLLKY------LDCRPQDLPREVLTT 325
Query: 800 APVCLNKFVEIAGSCTDE----EGFRRPTMGDVTWGLEFALQLQEAAEKSDQGRPFV--P 853
P L+ IA S D + ++ +T +E +L + E AE P
Sbjct: 326 NPRRLSI---IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 854 RGEVITSST 862
I +
Sbjct: 383 PSAHIPTIL 391
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 46/240 (19%), Positives = 82/240 (34%), Gaps = 55/240 (22%)
Query: 555 IGSGGFGHVFKGYIDDGS-----ITVAVKRLNTSSMQGAREFRT-----EIEMISELRHL 604
IG GGFG ++ ++ VK + + E + + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 605 HIVSLLGFCD-----EHGEMILVYEF--MPR-G-NLRDHLYNSQKQNQNQNQNQNSPLTW 655
+ LG H + Y F M R G +L+ + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIY-----------EANAKRFSR 151
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI--SDFGLSRMGPSGM 713
K L++S+ L Y+H +H +H D+K++N+LL+ ++ D+GL+
Sbjct: 152 KTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 714 SQSHVSTVVKGSF-GYVDPEYI-----------RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ K G E+ RR D+ G +++ L G P
Sbjct: 209 VHKAYAADPKRCHDG--TIEFTSIDAHNGVAPSRR------GDLEILGYCMIQWLTGHLP 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 50/270 (18%), Positives = 81/270 (30%), Gaps = 85/270 (31%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR--------HLHI 606
+G G F V+ + G VA+K + S+ EI ++ +R +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 607 VSLL------GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLE 660
V LL G H + +V+E + HL ++ Q L +
Sbjct: 104 VQLLDDFKISGVNGTH--ICMVFEVL-----GHHLLKWIIKSNYQ------GLPLPCVKK 150
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILL---------------------------- 692
I +GL YLH + IIH D+K NILL
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 693 ---------------------DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
E KI+D G + ++ + T Y
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED-IQTRQ-----YRSL 262
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E + +D++S + E+ G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 33/171 (19%), Positives = 68/171 (39%), Gaps = 25/171 (14%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHLHIVSLLGF 612
IG G FG +F+G + VA+K + + Q E+RT + I ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGIPNVYYF 74
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
E +LV + + +L D L ++ + K + + +
Sbjct: 75 GQEGLHNVLVIDLLGP-SLEDLLDLCGRK-----------FSVKTVAMAAKQMLARVQSI 122
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAK-----ISDFGLSRMGPSGMSQSHV 718
H + ++++RD+K N L+ + + DFG+ + +++ H+
Sbjct: 123 H---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 36/163 (22%), Positives = 59/163 (36%), Gaps = 31/163 (19%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHL----HIVS 608
IGSG FG ++ G VA+K + T Q E + + + I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-------YKMMQGGVGIPT 69
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
+ E ++V E + +L D + + K L ++
Sbjct: 70 IRWCGAEGDYNVMVMELLGP-SLEDLF-----------NFCSRKFSLKTVLLLADQMISR 117
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAK---ISDFGLSRM 708
+ Y+H+ IHRDVK N L+ I DFGL++
Sbjct: 118 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 49/238 (20%), Positives = 78/238 (32%), Gaps = 54/238 (22%)
Query: 555 IGSGGFGHVFKGY-IDDGSI--TVAVKRLNTSSMQGAREFRTEI-----EMISELRHLHI 606
IGSGGFG ++ + + VK + E + + I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 607 VSLLGF-----CDEHGEMILVYEF--MPR-G-NLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
+ LG Y F M R G +L+ QN
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKIS------------GQNGTFKKST 152
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI--SDFGLSRMGPSGMSQ 715
L++ I L Y+H ++ +H D+K+ N+LL ++ +D+GLS +
Sbjct: 153 VLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 716 SHVSTVVKGSF-GYVDPEYI-----------RRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ G E+ RR SDV G +L LCG+ P
Sbjct: 210 KQYQENPRKGHNG--TIEFTSLDAHKGVALSRR------SDVEILGYCMLRWLCGKLP 259
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 40/162 (24%), Positives = 66/162 (40%), Gaps = 31/162 (19%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRHL----HIVS 608
IGSG FG ++ G + VA+K + T Q E + R L I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI-------YRILQGGTGIPN 67
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
+ F E +LV + + +L D L+N + L+ K L ++
Sbjct: 68 VRWFGVEGDYNVLVMDLLGP-SLED-LFNFCSR----------KLSLKTVLMLADQMINR 115
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAK---ISDFGLSR 707
+ ++H + +HRD+K N L+ A I DFGL++
Sbjct: 116 VEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 24/177 (13%), Positives = 61/177 (34%), Gaps = 41/177 (23%)
Query: 555 IGSGGFGHVFKGY--------IDDGSITVAVKRLNTSSMQGAREFRT-----EIEMISEL 601
G +++ ++K L+ + E + +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 602 RHLHIVSLLGF-----CDEHGEM--ILVYEFMPR--GNLRDHLYNSQKQNQNQNQNQNSP 652
+ L+ LL H + LV +P +L+ L + +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQSAL----------DVSPKHV 155
Query: 653 LTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI--SDFGLSR 707
L+ + L+++ L +LH ++ +H +V + NI +D +++ + +G +
Sbjct: 156 LSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 36/162 (22%), Positives = 59/162 (36%), Gaps = 29/162 (17%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVK--RLNTSSMQGAREFRTEIEMISELRH-LHIVSLL 610
IG G FG + G + VA+K + + + Q E +L I +
Sbjct: 17 IGCGNFGELRLGKNLYTNEY-VAIKLEPMKSRAPQ----LHLEYRFYKQLGSGDGIPQVY 71
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
F +V E + +L D L++ + + K L I+I +
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLED-LFDLCDRT----------FSLKTVLMIAIQLISRME 119
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAK-----ISDFGLSR 707
Y+H +I+RDVK N L+ I DF L++
Sbjct: 120 YVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 911 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 2e-68
Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 36/284 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGF 612
IGSG FG V+KG VAVK LN ++ Q + F+ E+ ++ + RH++I+ +G+
Sbjct: 16 IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
++ +V ++ +L HL + + ++I+ A+G+ YL
Sbjct: 73 STAP-QLAIVTQWCEGSSLYHHL-----------HIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H +IIHRD+KS NI L E+ KI DFGL+ + S SH + GS ++ PE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPE 176
Query: 733 YIRRQQ---LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789
IR Q + +SDVY+FG+VL E++ G+ P ++ RG
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-------SNINNRDQIIFMVGRG---- 225
Query: 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+ P L K+ C + C ++ RP + +E
Sbjct: 226 YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 9e-63
Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 32/294 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G G +G V++G S+TVAVK L +M+ EF E ++ E++H ++V LLG C
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
++ EFM GNL D+L +Q ++ L ++ + + YL
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNRQ----------EVSAVVLLYMATQISSAMEYLE 132
Query: 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEY 733
K IHRD+ + N L+ EN K++DFGLSR+ K + PE
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES 187
Query: 734 IRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDP 793
+ + + KSDV++FGV+L E+ G + V ++++
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEK 231
Query: 794 RLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAAEKSDQ 847
R + C K E+ +C RP+ ++ E Q +++ ++
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 5e-62
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHI 606
DF +G+G G VFK + +A K ++ R E++++ E +I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAA 666
V G GE+ + E M G+L L + + + ++SI
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL------------KKAGRIPEQILGKVSIAVI 114
Query: 667 RGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
+GL YL KH I+HRDVK +NIL++ K+ DFG+S M+ S V G+
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 167
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y+ PE ++ + +SD++S G+ L+E+ GR P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-61
Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 34/279 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G+G FG V+ GY + + VAVK L SM F E ++ +L+H +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ + ++ E+M G+L D L LT + L+++ A G+ ++
Sbjct: 79 Q-EPIYIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGMAFIE- 126
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ IHRD+++ NIL+ + + KI+DFGL+R+ ++ K + PE I
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI 182
Query: 735 RRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPR 794
T KSDV+SFG++L E++ G E + +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---------------- 226
Query: 795 LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
R C + ++ C E RPT + LE
Sbjct: 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 7e-61
Identities = 64/299 (21%), Positives = 117/299 (39%), Gaps = 36/299 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G FG V++G G VAVK ++ + + EI LRH +I+ + +
Sbjct: 11 IGKGRFGEVWRG-KWRGEE-VAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 615 EHG----EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
+ ++ LV ++ G+L D+L +T + +++++ A GL
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-------------NRYTVTVEGMIKLALSTASGLA 114
Query: 671 YLHAGAKHT-----IIHRDVKSTNILLDENWAAKISDFGL-SRMGPSGMSQSHVSTVVKG 724
+LH T I HRD+KS NIL+ +N I+D GL R + + G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 725 SFGYVDPEYIRRQ------QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRK---EEVSLV 775
+ Y+ PE + + +++D+Y+ G+V E+ + ++
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 776 LWARVSRARGTVDQIVDPRLRGKIAPV-CLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+ + +Q + P + + L +I C G R T + L
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 8e-61
Identities = 73/306 (23%), Positives = 130/306 (42%), Gaps = 37/306 (12%)
Query: 540 TEIKQATCDFADHCIIGSGGFGHVFKGYIDDGS----ITVAVKRLNTSSMQGAR-EFRTE 594
TEI +IG+G FG V+KG + S + VA+K L + R +F E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 595 IEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLT 654
++ + H +I+ L G ++ M+++ E+M G L + ++ +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-----------LREKDGEFS 108
Query: 655 WKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMS 714
+ + + G A G+ YL +HRD+ + NIL++ N K+SDFGLSR+
Sbjct: 109 VLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165
Query: 715 QSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774
++ ++ K + PE I ++ T SDV+SFG+V+ EV+ E
Sbjct: 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---- 221
Query: 775 VLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834
V + ++ R C + ++ C +E RRP D+ L+
Sbjct: 222 ------------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
Query: 835 ALQLQE 840
++ +
Sbjct: 270 LIRAPD 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-60
Identities = 77/287 (26%), Positives = 116/287 (40%), Gaps = 37/287 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IGSG FG V GY + VA+K + + +F E E++ +L H +V L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDK-VAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E + LV+EFM G L D+ + Q + L + + G+ YL
Sbjct: 71 EQAPICLVFEFMEHGCLSDY-----------LRTQRGLFAAETLLGMCLDVCEGMAYLE- 118
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ +IHRD+ + N L+ EN K+SDFG++R Q ST K + PE
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVF 174
Query: 735 RRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPR 794
+ + KSDV+SFGV++ EV E V + ++ PR
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------RLYKPR 225
Query: 795 LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEA 841
L +I C E RP + L ++ E+
Sbjct: 226 L-------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA---EIAES 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (518), Expect = 1e-59
Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 47/317 (14%)
Query: 537 FSLTEIKQATCDFADHC---------IIGSGGFGHVFKGYIDDGS---ITVAVKRLNTS- 583
F+ + +A +FA +IG+G FG V G++ I VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 584 SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQ 643
+ + R+F +E ++ + H +++ L G + ++++ EFM G+L L + Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 644 NQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703
T + + + G A G+ YL +HRD+ + NIL++ N K+SDF
Sbjct: 126 ----------TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDF 172
Query: 704 GLSRMGPSGMSQSHVSTVV--KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRP 760
GLSR S ++ + K + PE I+ ++ T SDV+S+G+V+ EV+ G
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
Query: 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGF 820
P + ++ V ++ R C + ++ C ++
Sbjct: 233 P---------------YWDMTNQD--VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRN 275
Query: 821 RRPTMGDVTWGLEFALQ 837
RP G + L+ ++
Sbjct: 276 HRPKFGQIVNTLDKMIR 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 76/284 (26%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 555 IGSGGFGHVFKGYIDDGSI--TVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLL 610
+GSG FG V KGY + TVAVK L + A E E ++ +L + +IV ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
G C E +LV E G L +L QN + K +E+ + G+
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQ------------QNRHVKDKNIIELVHQVSMGMK 121
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YL + +HRD+ + N+LL AKISDFGLS+ + + T K +
Sbjct: 122 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789
PE I + + KSDV+SFGV++ E G+ P + + + V
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---------------YRGMKGSE--VTA 221
Query: 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+++ R C + ++ C + RP V L
Sbjct: 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-59
Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 36/283 (12%)
Query: 555 IGSGGFGHVFKGY--IDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLG 611
+G G FG V +G + I VA+K L + + E E +++ +L + +IV L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
C + ++LV E G L L + + E+ + G+ Y
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVG-----------KREEIPVSNVAELLHQVSMGMKY 124
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
L + +HRD+ + N+LL AKISDFGLS+ + S + K + P
Sbjct: 125 LE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVL-CGRPPMINGAVRKEEVSLVLWARVSRARGTVDQI 790
E I ++ + +SDV+S+GV + E L G+ P + ++ V
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP---------------YKKMKGPE--VMAF 224
Query: 791 VDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
++ R + P C + + C + RP V +
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-59
Identities = 71/281 (25%), Positives = 118/281 (41%), Gaps = 40/281 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
IG G FG V G VAVK + + + F E ++++LRH ++V LLG
Sbjct: 14 TIGKGEFGDVMLGDYRGN--KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 614 -DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+E G + +V E+M +G+L D+L + S L L+ S+ + YL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRS----------RGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
+ +HRD+ + N+L+ E+ AK+SDFGL++ S + PE
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPE 170
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVD 792
+R ++ + KSDV+SFG++L E+ K+ V V+
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVE 214
Query: 793 PRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+ C E+ +C + RP+ + LE
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 6e-59
Identities = 73/304 (24%), Positives = 121/304 (39%), Gaps = 41/304 (13%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
IG G FG VF+ + VAVK L + + +F+ E +++E + +IV
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQN------------QNQNQNQNSPLTWK 656
LLG C M L++E+M G+L + L + + PL+
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 657 RRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQS 716
+L I+ A G+ YL + +HRD+ + N L+ EN KI+DFGLSR S
Sbjct: 141 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-DYY 196
Query: 717 HVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776
++ PE I + T +SDV+++GVVL E+ G +E
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------ 250
Query: 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836
+ + D + C + + C + RP+ + L+
Sbjct: 251 ---------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ--- 297
Query: 837 QLQE 840
++ E
Sbjct: 298 RMCE 301
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 9e-59
Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 39/294 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGS-----ITVAVKRLNTSSMQGARE-FRTEIEMISEL-RHLHI 606
++GSG FG V S I VAVK L + RE +E++M+++L H +I
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQK-----------QNQNQNQNQNSPLTW 655
V+LLG C G + L++E+ G+L ++L + ++ Q + + + + LT+
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 656 KRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQ 715
+ L + A+G+ +L + +HRD+ + N+L+ KI DFGL+R S S
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-SN 219
Query: 716 SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPPMINGAVRKEEVSL 774
V + ++ PE + T KSDV+S+G++L E+ G P V
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN---- 275
Query: 775 VLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
+++ + + I SC + +RP+ ++
Sbjct: 276 ------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-58
Identities = 81/301 (26%), Positives = 137/301 (45%), Gaps = 31/301 (10%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGS--ITVAVKRLN-TSSMQGAREFRTEIEMISEL-RH 603
D +IG G FG V K I + A+KR+ +S R+F E+E++ +L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQN----QNQNQNSPLTWKRRL 659
+I++LLG C+ G + L E+ P GNL D L S+ + + S L+ ++ L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
+ ARG+ YL + IHRD+ + NIL+ EN+ AKI+DFGLSR +
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK----K 183
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779
T+ + ++ E + T SDV+S+GV+L E++ G E
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------- 234
Query: 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839
+ + + R + C ++ ++ C E+ + RP+ + L L+ +
Sbjct: 235 -------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 840 E 840
+
Sbjct: 288 K 288
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 75/297 (25%), Positives = 119/297 (40%), Gaps = 48/297 (16%)
Query: 535 RRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA---REF 591
R+++L DF +G G FG+V+ +A+K L + ++ A +
Sbjct: 1 RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 592 RTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNS 651
R E+E+ S LRH +I+ L G+ + + L+ E+ P G + L + S
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL------------QKLS 101
Query: 652 PLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPS 711
+R A L Y H +IHRD+K N+LL KI+DFG S PS
Sbjct: 102 KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158
Query: 712 GMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771
+ G+ Y+ PE I + EK D++S GV+ E L G+PP +
Sbjct: 159 SRRTTLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF------EAN 207
Query: 772 VSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
+ R+SR T V R ++ +RP + +V
Sbjct: 208 TYQETYKRISRVEFTFPDFVTEGAR------------DLISRLLKHNPSQRPMLREV 252
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-58
Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 32/297 (10%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGARE-FRTEIEMISEL-RHLHI 606
+G+G FG V + D ++TVAVK L S+ RE +E++++S L H++I
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 607 VSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQ------KQNQNQNQNQNSPLTWKRRLE 660
V+LLG C G +++ E+ G+L + L + K + ++ L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
S A+G+ +L IHRD+ + NILL KI DFGL+R + S V
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN-DSNYVVKG 205
Query: 721 VVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780
+ ++ PE I T +SDV+S+G+ L E+ G +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256
Query: 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837
+++ R + +I +C D + +RPT + +E +
Sbjct: 257 ------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-58
Identities = 79/313 (25%), Positives = 134/313 (42%), Gaps = 36/313 (11%)
Query: 527 SSLPSDLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGS---ITVAVKRLNTS 583
S+L +L + I ++ + +IG G FG V+ G + D I AVK LN
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66
Query: 584 SMQG-AREFRTEIEMISELRHLHIVSLLGFC-DEHGEMILVYEFMPRGNLRDHLYNSQKQ 641
+ G +F TE ++ + H +++SLLG C G ++V +M G+LR+
Sbjct: 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF------- 119
Query: 642 NQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701
+N+ T K + + A+G+ +L +HRD+ + N +LDE + K++
Sbjct: 120 ----IRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVA 172
Query: 702 DFGLSR-MGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760
DFGL+R M H T K ++ E ++ Q+ T KSDV+SFGV+L E++
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
Query: 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGF 820
P + +L R R C + E+ C +
Sbjct: 233 PPYPDVNTFDITVYLLQGR----------------RLLQPEYCPDPLYEVMLKCWHPKAE 276
Query: 821 RRPTMGDVTWGLE 833
RP+ ++ +
Sbjct: 277 MRPSFSELVSRIS 289
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 6e-58
Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 36/287 (12%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV 607
D +G+G FG V G VA+K + SM EF E +++ L H +V
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 62
Query: 608 SLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
L G C + + ++ E+M G L ++L + ++ LE+
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-----------RFQTQQLLEMCKDVCE 111
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFG 727
+ YL +HRD+ + N L+++ K+SDFGLSR + S K
Sbjct: 112 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVR 166
Query: 728 YVDPEYIRRQQLTEKSDVYSFGVVLLEVL-CGRPPMINGAVRKEEVSLVLWARVSRARGT 786
+ PE + + + KSD+++FGV++ E+ G+ P + R + +
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---------------YERFTNSE-- 209
Query: 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
+ + LR + K I SC E+ RPT + +
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-57
Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 34/279 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG V+ G + + VA+K L +M F E +++ +LRH +V L
Sbjct: 25 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV- 81
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ +V E+M +G+L D L + + ++++ A G+ Y+
Sbjct: 82 SEEPIYIVTEYMSKGSLLDFLKGETGKYLR----------LPQLVDMAAQIASGMAYVE- 130
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ +HRD+++ NIL+ EN K++DFGL+R+ ++ K + PE
Sbjct: 131 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAA 186
Query: 735 RRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPR 794
+ T KSDV+SFG++L E+ G V +E V V+
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERG 230
Query: 795 LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
R P C ++ C +E RPT + LE
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 9e-57
Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 41/282 (14%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLG 611
IG G F V+KG + ++ VA L + + F+ E EM+ L+H +IV
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 612 FC----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAAR 667
++LV E M G L+ +L + + K +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL------------KRFKVMKIKVLRSWCRQILK 123
Query: 668 GLHYLHAGAKHTIIHRDVKSTNILL-DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSF 726
GL +LH IIHRD+K NI + + KI D GL+ + + +++ V G+
Sbjct: 124 GLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-----VIGTP 177
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786
++ PE ++ E DVY+FG+ +LE+ P ++ A
Sbjct: 178 EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQI 221
Query: 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
++ V + + EI C + R ++ D+
Sbjct: 222 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 64/287 (22%), Positives = 118/287 (41%), Gaps = 34/287 (11%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLH 605
D+ IG+G +G K + K L+ SM A + +E+ ++ EL+H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 606 IVSLLGFC--DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
IV + + +V E+ G+L + K+ Q L + L +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ--------YLDEEFVLRVMT 116
Query: 664 GAARGLHYLH--AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
L H + HT++HRD+K N+ LD K+ DFGL+R+ + +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKA 173
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781
G+ Y+ PE + R EKSD++S G +L E+ PP + ++
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------------ 221
Query: 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
+I + + R +I ++ EI + + + RP++ ++
Sbjct: 222 ----LAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 33/275 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG V+K + S+ A K ++T S + ++ EI++++ H +IV LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ ++ EF G + + ++ PLT + + L+YLH
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER-----------PLTESQIQVVCKQTLDALNYLH- 127
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ IIHRD+K+ NIL + K++DFG+S + + G+ ++ PE +
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVV 182
Query: 735 -----RRQQLTEKSDVYSFGVVLLEVLCGRPP--------MINGAVRKEEVSLVLWARVS 781
+ + K+DV+S G+ L+E+ PP ++ + E +L +R S
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 782 R-ARGTVDQI--VDPRLRGKIAPVCLNKFVEIAGS 813
+ + + + R + + + FV + +
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 74/331 (22%), Positives = 137/331 (41%), Gaps = 46/331 (13%)
Query: 548 DFADHCIIGSGGFGHVFKG-YIDDGS---ITVAVKRLN-TSSMQGAREFRTEIEMISELR 602
+F ++GSG FG V+KG +I +G I VA+K L +S + +E E +++ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 603 HLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEIS 662
+ H+ LLG C + L+ + MP G L D++ + + L
Sbjct: 70 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI-----------GSQYLLNWC 117
Query: 663 IGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVV 722
+ A+G++YL ++HRD+ + N+L+ KI+DFGL+++ + + + +
Sbjct: 118 VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGG 173
Query: 723 KGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782
K ++ E I + T +SDV+S+GV + E++ +G E
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------ 221
Query: 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEAA 842
+ I++ R P+C I C + RP ++
Sbjct: 222 ----ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA------ 271
Query: 843 EKSDQGRPFVPRGEVITSSTTTDSDEPFSRS 873
+ Q + E + + TDS F R+
Sbjct: 272 -RDPQRYLVIQGDERMHLPSPTDS--NFYRA 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-55
Identities = 71/292 (24%), Positives = 111/292 (38%), Gaps = 41/292 (14%)
Query: 555 IGSGGFGHVFKGYIDDGS---ITVAVKRLNTSSM---QGAREFRTEIEMISELRHLHIVS 608
+G G FG V +G D S ++VAVK L + + +F E+ + L H +++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L G M +V E P G+L D L Q ++ A G
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL IHRD+ + N+LL KI DFGL R P + K F +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTV 787
PE ++ + + SD + FGV L E+ G+ P W ++ ++ +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------------WIGLNGSQ-IL 224
Query: 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839
+I R C + C + RPT + +F L+ Q
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLEAQ 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 2e-54
Identities = 68/280 (24%), Positives = 103/280 (36%), Gaps = 44/280 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG---AREFRTEIEMISELRHLHIVSLLG 611
IG G FG V+ S VA+K+++ S Q ++ E+ + +LRH + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHY 671
LV E+ + PL ++ GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVH------------KKPLQEVEIAAVTHGALQGLAY 130
Query: 672 LHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
LH H +IHRDVK+ NILL E K+ DFG + + S G+ ++ P
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------FVGTPYWMAP 180
Query: 732 EYIR---RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788
E I Q K DV+S G+ +E+ +PP+ N A +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------------MNAMSALY 224
Query: 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
I + F SC + RPT +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 7e-53
Identities = 68/292 (23%), Positives = 113/292 (38%), Gaps = 37/292 (12%)
Query: 554 IIGSGGFGHVFKGYI---DDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSL 609
IG G FG V +G ++ ++ VA+K + RE F E + + H HIV L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 610 LGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGL 669
+G E+ + ++ E G LR Q + L + + + L
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSF-----------LQVRKYSLDLASLILYAYQLSTAL 121
Query: 670 HYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
YL +HRD+ + N+L+ N K+ DFGLSR S + ++ K ++
Sbjct: 122 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM 176
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789
PE I ++ T SDV+ FGV + E+L G + + +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---------- 226
Query: 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQEA 841
R + P C + C + RRP ++ L L+ ++A
Sbjct: 227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-52
Identities = 64/277 (23%), Positives = 102/277 (36%), Gaps = 33/277 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGF 612
+G G +G V VAVK ++ E + EI + L H ++V G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
E L E+ G L D + + + G+ YL
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H I HRD+K N+LLDE KISDFGL+ + + ++ + G+ YV PE
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 175
Query: 733 YIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIV 791
++R++ E DV+S G+VL +L G P + +E S
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------DWK 220
Query: 792 DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
+ + + + + E R T+ D+
Sbjct: 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 1e-51
Identities = 54/274 (19%), Positives = 109/274 (39%), Gaps = 34/274 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IG G G V+ VA++++N EI ++ E ++ +IV+ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E+ +V E++ G+L D + + + + + + L +LH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT-------------ETCMDEGQIAAVCRECLQALEFLH- 133
Query: 675 GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYI 734
+ +IHRD+KS NILL + + K++DFG + + + G+ ++ PE +
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVV 188
Query: 735 RRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVDPR 794
R+ K D++S G++ +E++ G PP + + R +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP---------------YLNENPLRALYLIATNGT 233
Query: 795 LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
+ F + C D + +R + ++
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 3e-51
Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 33/298 (11%)
Query: 554 IIGSGGFGHVFKGY-------IDDGSITVAVKRLNTSSMQ-GAREFRTEIEMISEL-RHL 604
+G G FG V + VAVK L + + + + +E+EM+ + +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQN----QNQNQNQNSPLTWKRRLE 660
+I++LLG C + G + ++ E+ +GNLR++L + N + N L+ K +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 661 ISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVST 720
+ ARG+ YL IHRD+ + N+L+ E+ KI+DFGL+R +T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTT 195
Query: 721 VVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780
+ ++ PE + + T +SDV+SFGV+L E+ G +E
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 245
Query: 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838
+ +++ R C N+ + C +RPT + L+ + L
Sbjct: 246 ------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 3e-51
Identities = 64/289 (22%), Positives = 123/289 (42%), Gaps = 28/289 (9%)
Query: 555 IGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQGAR-EFRTEIEMISELRHLHIVS 608
+G G FG V++G D+ VA+K +N ++ R EF E ++ E H+V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LLG + +++ E M RG+L+ +L + + N P + + ++++ A G
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA--PPSLSKMIQMAGEIADG 145
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
+ YL+ + +HRD+ + N ++ E++ KI DFG++R +
Sbjct: 146 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPVRW 201
Query: 729 VDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVD 788
+ PE ++ T SDV+SFGVVL E+ G ++ +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------------VLR 246
Query: 789 QIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837
+++ L C + E+ C RP+ ++ ++ ++
Sbjct: 247 FVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 75/296 (25%), Positives = 116/296 (39%), Gaps = 31/296 (10%)
Query: 554 IIGSGGFGHVFKGYI-----DDGSITVAVKRLNTSSMQG-AREFRTEIE-MISELRHLHI 606
+G G FG V + TVAVK L + R +E++ +I HL++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 607 VSLLGFCDEHGEMI-LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNS----PLTWKRRLEI 661
V+LLG C + G + ++ EF GNL +L + + + LT + +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
S A+G+ +L IHRD+ + NILL E KI DFGL+R
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 722 VKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781
++ PE I + T +SDV+SFGV+L E+ G EE
Sbjct: 197 R-LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------- 245
Query: 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837
+ + R + + + C E +RPT ++ L LQ
Sbjct: 246 -----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 4e-50
Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFC 613
+G+G FG V + A K + T R EI+ +S LRH +V+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
++ EM+++YEFM G L + + ++++ ++ +E +GL ++H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVA-----------DEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 674 AGAKHTIIHRDVKSTNILL--DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDP 731
++ +H D+K NI+ + K+ DFGL+ + V G+ + P
Sbjct: 142 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAP 194
Query: 732 EYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
E + + +D++S GV+ +L G P
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-50
Identities = 54/257 (21%), Positives = 100/257 (38%), Gaps = 25/257 (9%)
Query: 543 KQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMIS 599
K+ DF I+G G F V S A+K L + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 600 ELRHLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
L H V L + ++ + G L ++
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG------------SFDETCTR 111
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
+ L YLH IIHRD+K NILL+E+ +I+DFG +++ Q+ +
Sbjct: 112 FYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779
+ V G+ YV PE + + + SD+++ G ++ +++ G PP + +++ +
Sbjct: 169 SFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF------RAGNEYLIFQK 221
Query: 780 VSRARGTVDQIVDPRLR 796
+ + + P+ R
Sbjct: 222 IIKLEYDFPEKFFPKAR 238
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (439), Expect = 3e-48
Identities = 49/209 (23%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+GSG FG V + K +NT + EI ++++L H +++L +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
+ EM+L+ EF+ G L D + ++ ++ + A GL ++H
Sbjct: 97 DKYEMVLILEFLSGGELFDRI-----------AAEDYKMSEAEVINYMRQACEGLKHMH- 144
Query: 675 GAKHTIIHRDVKSTNILLD--ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
+H+I+H D+K NI+ + + + KI DFGL+ ++ + V + + PE
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK----LNPDEIVKVTTATAEFAAPE 198
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ R+ + +D+++ GV+ +L G P
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (429), Expect = 9e-48
Identities = 71/239 (29%), Positives = 103/239 (43%), Gaps = 34/239 (14%)
Query: 530 PSDLCRRFSLTEIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA- 588
PS L R+ L EI +G GG V VAVK L +
Sbjct: 2 PSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS 49
Query: 589 --REFRTEIEMISELRHLHIVSLLGFCDEHGE----MILVYEFMPRGNLRDHLYNSQKQN 642
FR E + + L H IV++ + +V E++ LRD ++
Sbjct: 50 FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--- 106
Query: 643 QNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702
P+T KR +E+ A + L++ H ++ IIHRDVK NI++ A K+ D
Sbjct: 107 ---------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMD 154
Query: 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
FG++R + + V G+ Y+ PE R + +SDVYS G VL EVL G PP
Sbjct: 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-47
Identities = 59/349 (16%), Positives = 123/349 (35%), Gaps = 46/349 (13%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G FG V + T K + + EI +++ RH +I+ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA 674
E+++++EF+ ++ + + L + + L +LH
Sbjct: 72 SMEELVMIFEFISGLDIFERI-----------NTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 675 GAKHTIIHRDVKSTNILLD--ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H I H D++ NI+ + KI +FG +R + ++ + Y PE
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----LKPGDNFRLLFTAPEYYAPE 173
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQIVD 792
+ ++ +D++S G ++ +L G P E + + + A T D+
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPF------LAETNQQIIENIMNAEYTFDEEAF 227
Query: 793 PRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ---LQEAAEKSDQGR 849
+ + ++ +E R T + ALQ L++ E+
Sbjct: 228 KEIS--------IEAMDFVDRLLVKERKSRMTASE-------ALQHPWLKQKIERVSTKV 272
Query: 850 PFVPRGEVITSSTTTDSDEPFSRSSGQVSESRSNTTSSGADGERIRVRS 898
+ T D S+ ++S + + G +++V S
Sbjct: 273 IRTLKHRRY-YHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVAS 320
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 8e-46
Identities = 61/279 (21%), Positives = 113/279 (40%), Gaps = 37/279 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGF 612
++G+G F V VA+K + +++G EI ++ +++H +IV+L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ G + L+ + + G L D + + T + + + YL
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIV------------EKGFYTERDASRLIFQVLDAVKYL 123
Query: 673 HAGAKHTIIHRDVKSTNILL---DENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
H I+HRD+K N+L DE+ ISDFGLS+M V + G+ GYV
Sbjct: 124 H---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYV 176
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGTVDQ 789
PE + ++ ++ D +S GV+ +LCG PP +E L+ ++ +A
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF------YDENDAKLFEQILKA------ 224
Query: 790 IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
+ + + +++ +R T
Sbjct: 225 --EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 3e-43
Identities = 73/339 (21%), Positives = 124/339 (36%), Gaps = 46/339 (13%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHL 604
DF+ H IIG GGFG V+ D A+K L+ + QG E M+S +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 605 ---HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661
IV + ++ + + M G+L HL +Q+ +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL------------SQHGVFSEADMRFY 112
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTV 721
+ GL ++H +++RD+K NILLDE+ +ISD GL+
Sbjct: 113 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHA 164
Query: 722 VKGSFGYVDPEYIRRQQ-LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780
G+ GY+ PE +++ +D +S G +L ++L G P K + +
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ---HKTKDKHEIDRMT 221
Query: 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTD---EEGFRRPTMGDVTWGLEFALQ 837
+ P LR + L + V C +E P + W + F +
Sbjct: 222 LTMAVELPDSFSPELRSLLE-GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 280
Query: 838 LQEAAEKSDQGRPFVPRGEVITSSTTTDS---DEPFSRS 873
P +P + ++ D DE ++
Sbjct: 281 YPP---------PLIPPRGEVNAADAFDIGSFDEEDTKG 310
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-43
Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 22/218 (10%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMIS-ELRH 603
DF H ++G G FG VF + A+K L + E ++S H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
+ + + V E++ G+L H+ R +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI------------QSCHKFDLSRATFYAA 110
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
GL +LH I++RD+K NILLD++ KI+DFG+ + G +++
Sbjct: 111 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFC 164
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
G+ Y+ PE + Q+ D +SFGV+L E+L G+ P
Sbjct: 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (393), Expect = 6e-43
Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 35/230 (15%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA---------REFRTEIEMI 598
++ I+G G V + AVK ++ + E++++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 599 SELR-HLHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKR 657
++ H +I+ L + + LV++ M +G L D+L + L+ K
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL------------TEKVTLSEKE 111
Query: 658 RLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH 717
+I + LH K I+HRD+K NILLD++ K++DFG S +
Sbjct: 112 TRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ----LDPGE 164
Query: 718 VSTVVKGSFGYVDPEYIR------RQQLTEKSDVYSFGVVLLEVLCGRPP 761
V G+ Y+ PE I ++ D++S GV++ +L G PP
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (392), Expect = 2e-42
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 24/217 (11%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRTEIEMISELRHL 604
DF +G+G FG V A+K L + + E M+S + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
I+ + G + ++ ++ +++ G L L SQ+ +
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF------------PNPVAKFYAAE 112
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
L YLH II+RD+K NILLD+N KI+DFG ++ P + G
Sbjct: 113 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YTLCG 163
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ Y+ PE + + + D +SFG+++ E+L G P
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-42
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 14/210 (6%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-FRTEIEMISELRHLHIVSLLGF 612
IG G +G V Y + + VA+K+++ Q + EI+++ RH +I+ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ ++ + LY K L+ RGL Y+
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---------HLSNDHICYFLYQILRGLKYI 125
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H ++HRD+K +N+LL+ KI DFGL+R+ + T + Y PE
Sbjct: 126 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 733 YIRRQQL-TEKSDVYSFGVVLLEVLCGRPP 761
+ + T+ D++S G +L E+L RP
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 6e-42
Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 40/295 (13%)
Query: 555 IGSGGFGHVFKGY-IDDGSITVAVKRLNTSSMQG--AREFRTEIEMISEL---RHLHIVS 608
IG G +G VFK + +G VA+KR+ + + E+ ++ L H ++V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 609 LLGFC-----DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISI 663
L C D ++ LV+E + + + + + ++
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----------GVPTETIKDMMF 123
Query: 664 GAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVK 723
RGL +LH H ++HRD+K NIL+ + K++DFGL+R+ S T V
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQMALTSVV 176
Query: 724 GSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL------- 776
+ Y PE + + D++S G + E+ +P G+ +++ +L
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPG 235
Query: 777 ---WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
W R + K ++ C +R +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE-----FRTEIEMISELRHLHIVS 608
+G G F V+K + + VA+K++ A++ EI+++ EL H +I+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
LL + LV++FM ++ + LT + +G
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII------------KDNSLVLTPSHIKAYMLMTLQG 112
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGY 728
L YLH +H I+HRD+K N+LLDEN K++DFGL++ S T + Y
Sbjct: 113 LEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYTHQVVTRWY 166
Query: 729 VDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPP 761
PE + ++ D+++ G +L E+L P
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-40
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 26/221 (11%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV 607
+ D +IG+G FG V++ + D VA+K++ Q R E++++ +L H +IV
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 608 SLLGFCDEHGE------MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEI 661
L F GE + LV +++P R + S+ + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---------TLPVIYVKLY 127
Query: 662 SIGAARGLHYLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRMGPSGMSQSHVST 720
R L Y+H I HRD+K N+LLD + K+ DFG ++ G +
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVS 181
Query: 721 VVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + T DV+S G VL E+L G+P
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 18/216 (8%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLH 605
+F IG G +G V+K VA+K++ + EI ++ EL H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
IV LL ++ LV+EF+ + + + + +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMD-----------ASALTGIPLPLIKSYLFQL 111
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+GL + H H ++HRD+K N+L++ A K++DFGL+R G+ + V
Sbjct: 112 LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTL 166
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + + + D++S G + E++ R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 9e-40
Identities = 48/287 (16%), Positives = 90/287 (31%), Gaps = 35/287 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
IGSG FG ++ G VA+K + + E ++ ++ + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 615 EHGEM-ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
G+ ++V E + + S+ + K L ++ + Y+H
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSR------------KFSLKTVLLLADQMISRIEYIH 120
Query: 674 AGAKHTIIHRDVKSTNIL---LDENWAAKISDFGLSRMGPSGMSQSHV----STVVKGSF 726
IHRDVK N L + I DFGL++ + H+ + + G+
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 727 GYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786
Y + + + D+ S G VL+ G P + + + R
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW------QGLKAATKRQKYERISEK 231
Query: 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLE 833
L +F C +P +
Sbjct: 232 KMSTPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 30/216 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIE-MISELRHLHIVSLLGF 612
++G G G V + + A+K L R E+E + HIV ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 613 CD----EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
+ +++V E + G L + + T + EI
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRI----------QDRGDQAFTEREASEIMKSIGEA 123
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLD---ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+ YLH I HRDVK N+L N K++DFG ++ S S + +
Sbjct: 124 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----T 176
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
YV PE + ++ + D++S GV++ +LCG PP
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 43/284 (15%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAR------EFRTEIEMISELRHLHIVS 608
+GSG F V K + A K + + +R + E+ ++ E++H ++++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 609 LLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARG 668
L + ++IL+ E + G L D + LT + E G
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDF------------LAEKESLTEEEATEFLKQILNG 125
Query: 669 LHYLHAGAKHTIIHRDVKSTNILLDENWAA----KISDFGLSRMGPSGMSQSHVSTVVKG 724
++YLH I H D+K NI+L + KI DFGL+ + + + G
Sbjct: 126 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----IDFGNEFKNIFG 178
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784
+ +V PE + + L ++D++S GV+ +L G P + + A VS
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG------DTKQETLANVSA-- 230
Query: 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
V+ + + ++ +R T+ D
Sbjct: 231 ------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (366), Expect = 3e-39
Identities = 43/293 (14%), Positives = 92/293 (31%), Gaps = 37/293 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHL-HIVSLLGFC 613
IG G FG +F+G + VA+K S + R E L I ++ F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 614 DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLH 673
E +LV + + + K + + +H
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLL------------DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 674 AGAKHTIIHRDVKSTNILLDE-----NWAAKISDFGLSRMGPSGMSQSHV----STVVKG 724
+ ++++RD+K N L+ + DFG+ + +++ H+ + G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784
+ Y+ ++ + + D+ + G V + L G P K + + R+ +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW---QGLKAATNKQKYERIGEKK 232
Query: 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837
++ +F + + P + L+
Sbjct: 233 -------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-39
Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 44/273 (16%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE------FRTEIEMISELRHLH-- 605
++GSGGFG V+ G ++ VA+K + + E E+ ++ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
++ LL + + +L+ E + L +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQV 119
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
+ + H ++HRD+K NIL+D N K+ DFG + + G
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-----G 171
Query: 725 SFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPP------MINGAVR-KEEVS--- 773
+ Y PE+IR + + V+S G++L +++CG P +I G V ++ VS
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
Query: 774 --LV--LWARVSRARGTVDQIV-DPRLRGKIAP 801
L+ A R T ++I P ++ + P
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 6e-39
Identities = 50/288 (17%), Positives = 101/288 (35%), Gaps = 33/288 (11%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGF 612
IG G +G V+K + G A+K++ EI ++ EL+H +IV L
Sbjct: 10 IGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
++LV+E + + + L + G+ Y
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVC------------EGGLESVTAKSFLLQLLNGIAYC 116
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H ++HRD+K N+L++ KI+DFGL+R G+ + + +
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDV 171
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL----------WARVSR 782
+ ++ + D++S G + E++ G P G +++ + W V+
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 783 ARGTVDQ--IVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
+ +P +++ + +R T
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-38
Identities = 56/217 (25%), Positives = 87/217 (40%), Gaps = 21/217 (9%)
Query: 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHL 604
DF ++G G FG V A+K L + E TE ++ RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 605 HIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
+ +L H + V E+ G L HL ++ T +R
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHL------------SRERVFTEERARFYGAE 113
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKG 724
L YLH +++RD+K N++LD++ KI+DFGL + G+S G
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 167
Query: 725 SFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ Y+ PE + D + GVV+ E++CGR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGA--REFRTEIEMISELRHLHIVSLLGF 612
IG G FG VFK VA+K++ + + EI+++ L+H ++V+L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 613 CDEH--------GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIG 664
C G + LV++F N T +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------------NVLVKFTLSEIKRVMQM 125
Query: 665 AARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR-MGPSGMSQSHVSTVVK 723
GL+Y+H ++ I+HRD+K+ N+L+ + K++DFGL+R + SQ + T
Sbjct: 126 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 724 GSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPM 762
+ Y PE + ++ D++ G ++ E+ P M
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (344), Expect = 3e-36
Identities = 53/288 (18%), Positives = 104/288 (36%), Gaps = 31/288 (10%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGF 612
IG G +G VFK + VA+KR+ EI ++ EL+H +IV L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
++ LV+EF + + + N L + +GL +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYF------------DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H ++HRD+K N+L++ N K+++FGL+R G+ S V +
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDV 172
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL----------WARVSR 782
+ + D++S G + E+ P+ G +++ + W +++
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 783 ARGTVDQIVDPRLRG--KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDV 828
+ P + P ++ + +R + +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 3e-36
Identities = 40/211 (18%), Positives = 83/211 (39%), Gaps = 24/211 (11%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGARE---FRTEIEMISELRHLHIVSLL 610
+G+G FG V + A+K L+ + ++ E ++ + +V L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 611 GFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
++ + +V E++ G + HL + + +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARFYAAQIVLTFE 155
Query: 671 YLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVD 730
YLH +I+RD+K N+L+D+ +++DFG ++ + G+ +
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT------WTLCGTPEALA 206
Query: 731 PEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE I + + D ++ GV++ E+ G PP
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-36
Identities = 60/286 (20%), Positives = 106/286 (37%), Gaps = 40/286 (13%)
Query: 537 FSLTEIKQATCDFADH----CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGARE 590
F E+ + + +GSG +G V VA+K+L A+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 591 FRTEIEMISELRHLHIVSLLGFC------DEHGEMILVYEFMPRGNLRDHLYNSQKQNQN 644
E+ ++ +RH +++ LL D+ + LV FM G L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----- 116
Query: 645 QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704
L R + +GL Y+H IIHRD+K N+ ++E+ KI DFG
Sbjct: 117 -------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 166
Query: 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMIN 764
L+R + S ++ V + + + T+ D++S G ++ E++ G+
Sbjct: 167 LARQ-----ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 765 GAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEI 810
L + + GT RL+ A + E+
Sbjct: 222 ------SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 261
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-32
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 554 IIGSGGFGHVFKGYIDDGSIT---VAVKRLNTSSM----QGAREFRTEIEMISELRHL-H 605
++G+G +G VF G T A+K L +++ + RTE +++ +R
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 606 IVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+V+L ++ L+ +++ G L HL ++ ++ E+ I
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH---------------EVQIYV 135
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
+ L K II+RD+K NILLD N ++DFGLS+ + ++
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ D + D +S GV++ E+L G P
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 30/216 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLG 611
IGSG G V Y VA+K+L+ A+ E+ ++ + H +I+SLL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 612 FC------DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGA 665
+E ++ LV E M + +R +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---------------DHERMSYLLYQM 128
Query: 666 ARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGS 725
G+ +LH IIHRD+K +NI++ + KI DFGL+R S + T +
Sbjct: 129 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVT 181
Query: 726 FGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
Y PE I E D++S G ++ E++ +
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 45/217 (20%), Positives = 83/217 (38%), Gaps = 30/217 (13%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGF 612
+G G + VF+ + V VK L + + + EI+++ LR +I++L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 98
Query: 613 C--DEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
LV+E + + + LT + L
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY---------------QTLTDYDIRFYMYEILKALD 143
Query: 671 YLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
Y H I+HRDVK N+++D E+ ++ D+GL+ G + S +
Sbjct: 144 YCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV----RVASRYFK 196
Query: 730 DPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMING 765
PE + Q+ D++S G +L ++ + P +G
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-29
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGF 612
+GSG +G V + + VAVK+L+ S+ A+ E+ ++ ++H +++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYL 672
+ + +L N+ + Q LT + RGL Y+
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYI 137
Query: 673 HAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPE 732
H IIHRD+K +N+ ++E+ KI DFGL+R + ++ V +
Sbjct: 138 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEI 189
Query: 733 YIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
+ + D++S G ++ E+L GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 9e-29
Identities = 33/212 (15%), Positives = 76/212 (35%), Gaps = 9/212 (4%)
Query: 555 IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCD 614
+G G F V+ + VA+K + + EI+++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 615 EHG-EMILVYEFMPRGNLRDHL---YNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLH 670
H +++ + + + + + ++ + +IS GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 671 YLHAGAKHTIIHRDVKSTNILLD-ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYV 729
Y+H + IIH D+K N+L++ + + ++ +G + H T + Y
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSIQTREYR 196
Query: 730 DPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPP 761
PE + +D++S ++ E++ G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 1e-17
Identities = 30/215 (13%), Positives = 53/215 (24%), Gaps = 44/215 (20%)
Query: 554 IIGSGGFGHVFKGYIDDGSITVAVKRLNTSS----------MQGAREFRTEIEMISELRH 603
++G G VF Y + VK G F +
Sbjct: 7 LMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 604 LHIVSLLGFCD----EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRL 659
+ L G ++ E + L +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------------------RVENPD 106
Query: 660 EISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVS 719
E+ + + I+H D+ N+L+ E I DF S + +
Sbjct: 107 EVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE 162
Query: 720 TVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLE 754
V+ Y R + D+ S +L+
Sbjct: 163 RDVR-----NIITYFSRTY-RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 911 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.41 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.92 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.77 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 96.0 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 95.42 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=392.35 Aligned_cols=272 Identities=26% Similarity=0.455 Sum_probs=217.6
Q ss_pred CCHHHHHHHCCC---------CCCCEEECCCCCEEEEEEEEECCC---EEEEEEECCCC-CHHHHHHHHHHHHHHHHCCC
Q ss_conf 797899987048---------766303222693799999960588---08999982578-85658999999999872032
Q 002533 537 FSLTEIKQATCD---------FADHCIIGSGGFGHVFKGYIDDGS---ITVAVKRLNTS-SMQGAREFRTEIEMISELRH 603 (911)
Q Consensus 537 ~~~~el~~at~~---------f~~~~~LG~G~fG~Vy~g~~~~~~---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H 603 (911)
++++++++++.+ |...++||+|+||+||+|.+...+ ..||||++... .....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 88798999996046220800427856980278829999999579978899999997844598999999999999985799
Q ss_pred CCEEEECCEECCCCCEEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEE
Q ss_conf 31754233002587057999526998535676432110112346899987144344778868799999760799958973
Q 002533 604 LHIVSLLGFCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHR 683 (911)
Q Consensus 604 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~ 683 (911)
||||+++|+|...+..++|||||++|+|.+++.. ....++|.+++.++.|+|.||+||| +++|+||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-----------~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHr 152 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-----------NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHR 152 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-----------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCC
T ss_conf 8886189999628877999972279853002104-----------5679999999999999999889885---2798357
Q ss_pred CCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCC
Q ss_conf 3247985656899669952277567999998763--1123348655457132301588963578989999999994-999
Q 002533 684 DVKSTNILLDENWAAKISDFGLSRMGPSGMSQSH--VSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRP 760 (911)
Q Consensus 684 DLkp~NILl~~~~~vki~DFGla~~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~ 760 (911)
||||+|||++.++.+||+|||+++.......... ......|++.|+|||.+.++.++.++|||||||+||||+| |+.
T Consensus 153 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~ 232 (299)
T d1jpaa_ 153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232 (299)
T ss_dssp CCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCCEEEECCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 61504489889991998884431575677776536502566688300387888369978612144535789999867999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 9989863100033766776530258710004921128889487999999998444335999999889999999989646
Q 002533 761 PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 761 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~~ 839 (911)
||.+... .+ +... +....+...+..++..+.+++.+||+.||++||||.+|++.|+.+++-+
T Consensus 233 Pf~~~~~-~~---~~~~-------------i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 233 PYWDMTN-QD---VINA-------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp TTTTCCH-HH---HHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCCCCCH-HH---HHHH-------------HHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCH
T ss_conf 9999999-99---9999-------------9737889997422699999999975879768929999999999984186
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.83 Aligned_cols=264 Identities=26% Similarity=0.437 Sum_probs=216.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCC----EEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEE
Q ss_conf 48766303222693799999960588----08999982578-85658999999999872032317542330025870579
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGS----ITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 621 (911)
..|...++||+|+||.||+|.+..++ ..||||++... ......+|.+|++++++++|||||+++|+|.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEE
Q ss_conf 99526998535676432110112346899987144344778868799999760799958973324798565689966995
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~ 701 (911)
|+||+.+|+|.+++.. ....++|.++++++.|+|.||+||| +++|+||||||+|||++.++.+||+
T Consensus 87 v~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~ 152 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE-----------KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVS 152 (283)
T ss_dssp EEECCTTEEHHHHHHH-----------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred EEEECCCCCCHHHHHC-----------CCCCCCHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCEEEECCCCEEEEC
T ss_conf 9972135740222102-----------3454208999999999998541212---1234257656442788899849984
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 22775679999987631123348655457132301588963578989999999994999998986310003376677653
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
|||+++................||..|+|||++.++.++.++|||||||++|||+++..|+.......+....
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~------- 225 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA------- 225 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------
T ss_pred CCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHH-------
T ss_conf 5510300357876526742677773434888870499997355634489899999679886556899999999-------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 02587100049211288894879999999984443359999998899999999896468
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQE 840 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~~~ 840 (911)
+....+...+..++..+.+|+.+||+.||++||+|.+|++.|+.+++.++
T Consensus 226 ---------i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 226 ---------INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp ---------HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---------HHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf ---------86357899850457999999999776797689399999999999866956
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=386.72 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=216.0
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEE
Q ss_conf 04876630322269379999996058808999982578856589999999998720323175423300258705799952
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 625 (911)
..+|...+.||+|+||+||+|.+..++..||||+++... ...++|.+|+++|++++||||++++|+|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf 799398659820888089999999999699999977761-0399999999999867999882677527457854787631
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf 69985356764321101123468999871443447788687999997607999589733247985656899669952277
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGl 705 (911)
+++|+|.++|... ....+++..++.|+.|+|.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~g~l~~~l~~~----------~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 95 MTYGNLLDYLREC----------NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp CTTCBHHHHHHHS----------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred CCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf 4676067775303----------5541579999999999999788898---78930576045768998999289832445
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 56799999876311233486554571323015889635789899999999949999989863100033766776530258
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
++..... .........|+..|+|||++.++.++.++|||||||++|||++|..|+.......+...
T Consensus 162 a~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~------------ 227 (287)
T d1opja_ 162 SRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE------------ 227 (287)
T ss_dssp TTTCCSS--SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH------------
T ss_pred EEECCCC--CCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------------
T ss_conf 4653788--72210355665466692787279998104302178999999867998877425999999------------
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7100049211288894879999999984443359999998899999999896
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
.+....+...+..++..+.+++.+||+.||++||||.+|++.|+.+.+
T Consensus 228 ----~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 228 ----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----HHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----985588888874330999999999757797689399999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.00 Aligned_cols=261 Identities=30% Similarity=0.521 Sum_probs=208.3
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEE
Q ss_conf 04876630322269379999996058808999982578--8565899999999987203231754233002587057999
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 623 (911)
..+|...+.||+|+||+||+|+..+ .||||+++.. ..+..+.|.+|++++++++||||++++|++.+ +.+++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECC---EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEE
T ss_conf 4518998898307885899999999---89999997346998999999999999984799878645679715-5899999
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf 52699853567643211011234689998714434477886879999976079995897332479856568996699522
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DF 703 (911)
||+++|+|.++|+. ....+++..++.|+.|+|.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 83 Ey~~~g~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI-----------IETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp ECCCEEEHHHHHHT-----------SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred ECCCCCCHHHHHHH-----------CCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCHHHEEECCCCCEEECCC
T ss_conf 65899888999852-----------3578999999999999999988875---099951614789979818997887500
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 775679999987631123348655457132301---58896357898999999999499999898631000337667765
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR---QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|+++....... ........||+.|||||++.+ ..++.++|||||||+||||+||+.||.+...... ..... ..
T Consensus 149 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~--~~ 224 (276)
T d1uwha_ 149 GLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMV--GR 224 (276)
T ss_dssp CCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHH--HH
T ss_pred CCEEECCCCCC-CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHH--HC
T ss_conf 22133355677-6312566557431799999505689999531516359999999978899899896999-99999--65
Q ss_pred HCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 302587100049211288894879999999984443359999998899999999896
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
....+.+ ...+..++..+.+++.+||+.||++||||.+|++.|+.+.+
T Consensus 225 --------~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 225 --------GYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --------TSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCC-HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --------8889860-00365554999999999758897689299999999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.65 Aligned_cols=260 Identities=26% Similarity=0.387 Sum_probs=210.3
Q ss_pred CCCCCCE-EECCCCCEEEEEEEEE--CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEE
Q ss_conf 4876630-3222693799999960--58808999982578-856589999999998720323175423300258705799
Q 002533 547 CDFADHC-IIGSGGFGHVFKGYID--DGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~-~LG~G~fG~Vy~g~~~--~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 622 (911)
.++.... .||+|+||+||+|.+. +.+..||||+++.. .....++|.+|+++|++++||||++++|+|.. +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEE
Q ss_conf 95269985356764321101123468999871443447788687999997607999589733247985656899669952
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~D 702 (911)
|||+++|+|.+++.. .+..+++..++.++.|+|.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 87 mE~~~~g~L~~~l~~-----------~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~D 152 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG-----------KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISD 152 (285)
T ss_dssp EECCTTEEHHHHHTT-----------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECC
T ss_pred EEECCCCCHHHHHHC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEECCCCCEEECC
T ss_conf 980789968997521-----------2569999999999999999878998---68810576764660454688542033
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 2775679999987631123348655457132301588963578989999999994-999998986310003376677653
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
||+++................|+..|+|||++.++.++.++|||||||++|||+| |+.||...... + +.. ..
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~---~~~--~i- 225 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-E---VMA--FI- 225 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-H---HHH--HH-
T ss_pred CHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH-H---HHH--HH-
T ss_conf 1342115543432113562113743358688727999954123220178999993899999997999-9---999--99-
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 025871000492112888948799999999844433599999988999999998964
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~ 838 (911)
....+...++.++..+.+++.+||+.||++||+|.+|++.|+.+...
T Consensus 226 ----------~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 226 ----------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ----------81899999976789999999997577976890999999999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.89 Aligned_cols=269 Identities=26% Similarity=0.392 Sum_probs=214.0
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCC-----EEEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCEEEECCEECCCCC
Q ss_conf 048766303222693799999960588-----08999982578-856589999999998720-32317542330025870
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGS-----ITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGE 618 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 618 (911)
.++|...++||+|+||+||+|++.+.+ ..||+|++... .......+.+|+.++.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred EEEEEEECCCCCHHHHHHHHHHCCCC-----------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCC
Q ss_conf 57999526998535676432110112-----------3468999871443447788687999997607999589733247
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQN-----------QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKS 687 (911)
Q Consensus 619 ~~lV~Ey~~~gsL~~~L~~~~~~~~~-----------~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp 687 (911)
+++|||||++|+|.++|+........ ........+++..++.|+.|++.||+||| +++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997---39905052703
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 9856568996699522775679999987631123348655457132301588963578989999999994-999998986
Q 002533 688 TNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGA 766 (911)
Q Consensus 688 ~NILl~~~~~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~ 766 (911)
+|||++.++.+||+|||+++....... ........||+.|||||++.++.++.++|||||||+||||+| |+.||.+..
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCC-EEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 214434598289851422220457786-1562343578765783887279999633030003999999838999999989
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 31000337667765302587100049211288894879999999984443359999998899999999
Q 002533 767 VRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 767 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~ 834 (911)
....-. +++....+...+..++..+.+|+.+||+.||++||||.||+++|.-
T Consensus 272 ~~~~~~----------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDANFY----------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHHHH----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH----------------HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 899999----------------9985699899887678999999999758896689399999999748
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.52 Aligned_cols=257 Identities=29% Similarity=0.416 Sum_probs=209.7
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEEC
Q ss_conf 48766303222693799999960588089999825788565899999999987203231754233002587057999526
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 626 (911)
.+|...+.||+|+||+||+|.+.++ ..||||+++... ...++|.+|++++++++||||++++|+|...+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTT-EEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 9958888982088829999998899-999999987886-76899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99853567643211011234689998714434477886879999976079995897332479856568996699522775
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla 706 (911)
++|+|.+++.. ....++|..++.|+.|+|.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~g~L~~~l~~-----------~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 83 EHGCLSDYLRT-----------QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp TTCBHHHHHHT-----------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred CCCCHHHHHHC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCHHHEEECCCCCEEECCCCHH
T ss_conf 99918997520-----------1347889999999999999877653---164310443153266668877686553210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 67999998763112334865545713230158896357898999999999499999898631000337667765302587
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
+...... ........|+..|+|||++.+..++.++|||||||++|||+|+..|+.......+....+.
T Consensus 149 ~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~---------- 216 (263)
T d1sm2a_ 149 RFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---------- 216 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH----------
T ss_pred EECCCCC--CEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----------
T ss_conf 0236887--3350430017666785786079998403321059999999878988877899999999998----------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 100049211288894879999999984443359999998899999999896
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
...+...+..++..+.+++.+||+.||++||||++|+++|+.+.+
T Consensus 217 ------~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 217 ------TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------068889954367999999999765797689199999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.09 Aligned_cols=251 Identities=29% Similarity=0.405 Sum_probs=205.8
Q ss_pred EEECCCCCEEEEEEEEECC--CEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEECCC
Q ss_conf 0322269379999996058--808999982578--856589999999998720323175423300258705799952699
Q 002533 553 CIIGSGGFGHVFKGYIDDG--SITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMPR 628 (911)
Q Consensus 553 ~~LG~G~fG~Vy~g~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 628 (911)
+.||+|+||+||+|.+... +..||||+++.. .....++|.+|+++|++++||||++++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 85356764321101123468999871443447788687999997607999589733247985656899669952277567
Q 002533 629 GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 629 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla~~ 708 (911)
|+|.+++.. ...+++..++.|+.|||.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 92 g~L~~~l~~------------~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 92 GPLNKYLQQ------------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156 (277)
T ss_dssp EEHHHHHHH------------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCHHHHHHH------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHH
T ss_conf 968999752------------257899999999999999976687---47955677761131023567512341345331
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
Q ss_conf 9999987631123348655457132301588963578989999999994-999998986310003376677653025871
Q 002533 709 GPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRARGTV 787 (911)
Q Consensus 709 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 787 (911)
...............||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+... .+ +...
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~---~~~~---------- 222 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SE---VTAM---------- 222 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH---HHHH----------
T ss_pred CCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH-HH---HHHH----------
T ss_conf 343234432244567784203916653799984344303403132896589999999899-99---9999----------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 0004921128889487999999998444335999999889999999989
Q 002533 788 DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 788 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~ 836 (911)
+....+...+..++..+.+|+.+||+.||++||||.+|++.|+...
T Consensus 223 ---i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 223 ---LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf ---9828999998656799999999975889768909899999852887
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.81 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=208.0
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEE
Q ss_conf 04876630322269379999996058808999982578856589999999998720323175423300258705799952
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 625 (911)
..+|...+.||+|+||+||+|.++++ ..||||+++... ...++|.+|++++++++||||++++|+|.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCC-CEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEE
T ss_conf 89938867981079828999999999-999999986476-888999999999986799988578731045-976999995
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf 69985356764321101123468999871443447788687999997607999589733247985656899669952277
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGl 705 (911)
+++|+|.+++.... ...++|..+++|+.|||.||+||| +++|+||||||+||||++++.+||+|||+
T Consensus 89 ~~~g~L~~~~~~~~----------~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 89 MENGSLVDFLKTPS----------GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp CTTCBHHHHTTSHH----------HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCCCCHHHHHHHCC----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEEECCCCEEECCCCC
T ss_conf 78982888875147----------898878899999999999999997---48954675642251562024404234101
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 56799999876311233486554571323015889635789899999999949999989863100033766776530258
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
++..... .........|+..|+|||++.++.++.++|||||||++|||+||..|+.......+.... .
T Consensus 156 a~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-----i----- 223 (272)
T d1qpca_ 156 ARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-----L----- 223 (272)
T ss_dssp CEECSSS--CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----H-----
T ss_pred EEECCCC--CCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-----H-----
T ss_conf 4773588--644203567744445828983799982456452579999999689888888899999999-----9-----
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7100049211288894879999999984443359999998899999999896
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
....+...+..++..+.+++.+||+.||++||||.+|++.|+....
T Consensus 224 ------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 224 ------ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------7068888965571999999999758897689399999998611321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.49 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=207.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEEC
Q ss_conf 48766303222693799999960588089999825788565899999999987203231754233002587057999526
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 626 (911)
.+|...+.||+|+||+||+|.+..++..||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99853567643211011234689998714434477886879999976079995897332479856568996699522775
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla 706 (911)
++|+|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 100 ~gg~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 100 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp TTCBHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCHHHHHHC-------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHHH
T ss_conf 79808988641-------------59999999999999999999999---879722677688868878996864251564
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 67999998763112334865545713230158896357898999999999499999898631000337667765302587
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
+..... ........||+.|+|||++.++.++.++|||||||++|||++|+.||.+..... .. +.......
T Consensus 164 ~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~----~~~~~~~~-- 233 (293)
T d1yhwa1 164 AQITPE---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-AL----YLIATNGT-- 233 (293)
T ss_dssp EECCST---TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH----HHHHHHCS--
T ss_pred EEECCC---CCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH-HH----HHHHHCCC--
T ss_conf 132136---664444444777368266447998801203137299999804889989979999-99----99985799--
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 100049211288894879999999984443359999998899999
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.....+..++..+.+++.+||+.||.+|||+.|++++
T Consensus 234 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 234 --------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --------9888855379999999999866996689099999649
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=365.44 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=208.9
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEEC
Q ss_conf 48766303222693799999960588089999825788565899999999987203231754233002587057999526
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 626 (911)
++|...+.||+|+||.||+|.+..++..||||++........+.+.+|+++|++++||||+++++++.+.+.+++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 57589889840768199999988999899999984524316999999999998679979992999999899999999857
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC--CCCEEEEECC
Q ss_conf 99853567643211011234689998714434477886879999976079995897332479856568--9966995227
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE--NWAAKISDFG 704 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~vki~DFG 704 (911)
++|+|.+++.. ....+++..+..|+.||+.||+||| +++|+||||||+|||++. ++.+||+|||
T Consensus 106 ~gg~L~~~l~~-----------~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 106 SGGELFEKVAD-----------EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp CSCBHHHHHTC-----------TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred CCCCHHHHHHH-----------HCCCCCHHHHHHHHHHHHHHHHHHH---HCCCEEEEECHHHEEECCCCCCEEEEEECC
T ss_conf 99889999976-----------2378999999999999999999997---569760001546736416889869995452
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 75679999987631123348655457132301588963578989999999994999998986310003376677653025
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+++..... .......||+.|||||++.+..++.++|||||||++|||++|+.||.+... .+.. .......
T Consensus 172 ~a~~~~~~----~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~-----~~i~~~~ 241 (350)
T d1koaa2 172 LTAHLDPK----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETL-----RNVKSCD 241 (350)
T ss_dssp TCEECCTT----SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH-----HHHHHTC
T ss_pred HHEECCCC----CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHH-----HHHHHCC
T ss_conf 10442565----432000686242188997589987267655465999999859899899799-9999-----9998478
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 87100049211288894879999999984443359999998899999
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.. .........+..+.+++.+||..||++|||+.|++++
T Consensus 242 ~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 WN--------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CC--------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CC--------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 89--------8942235899999999999756896679089998629
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=362.89 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=209.1
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEEC
Q ss_conf 48766303222693799999960588089999825788565899999999987203231754233002587057999526
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 626 (911)
.+|...+.||+|+||.||+|.+..++..||||++........+.+.+|+++|++++||||+++++++.+++.+++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 03599899931778299999998999799999988726467999999999998679979891999999899999999828
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC--CCCCEEEEECC
Q ss_conf 9985356764321101123468999871443447788687999997607999589733247985656--89966995227
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD--ENWAAKISDFG 704 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~vki~DFG 704 (911)
++|+|.+++.. ....+++..+..|+.||+.||+||| +++|+||||||+|||++ .++.+||+|||
T Consensus 109 ~gg~L~~~~~~-----------~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 109 SGGELFDRIAA-----------EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp CCCBHHHHTTC-----------TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred CCCHHHHHHHH-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCCCCCCCCEEEEEECC
T ss_conf 99808888986-----------3899899999999999999999999---779265131445531134678848995256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 75679999987631123348655457132301588963578989999999994999998986310003376677653025
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
+++.... ........|++.|+|||++.+..++.++||||+||++|||+||+.||.+.... +. .......
T Consensus 175 la~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~-----~~~i~~~- 243 (352)
T d1koba_ 175 LATKLNP----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ET-----LQNVKRC- 243 (352)
T ss_dssp TCEECCT----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HH-----HHHHHHC-
T ss_pred CCEECCC----CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-HH-----HHHHHHC-
T ss_conf 3034378----87201004764534899974799897633389899999999688998997999-99-----9999847-
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 87100049211288894879999999984443359999998899999
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
+...........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 244 -------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 -------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -------CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------8898930024799999999999756996689189999609
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.29 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=210.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCC----EEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEE
Q ss_conf 48766303222693799999960588----08999982578-85658999999999872032317542330025870579
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGS----ITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 621 (911)
.+|+..++||+|+||+||+|.+..++ ..||+|+++.. ..+..++|.+|++++++++||||++++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEE
Q ss_conf 99526998535676432110112346899987144344778868799999760799958973324798565689966995
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~ 701 (911)
++||+.+|+|.+++.. ....+++..+++++.|||.||+||| +++|+||||||+|||++.++.+||+
T Consensus 88 v~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~ 153 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-----------HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKIT 153 (317)
T ss_dssp EEECCTTCBHHHHHHH-----------TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEEECCCCCCCCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCHHHCCEECCCCCEEEE
T ss_conf 9984268740101113-----------3457999999999999999999998---7695047621203116799875860
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 22775679999987631123348655457132301588963578989999999994-99999898631000337667765
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|||+++....... ........||..|+|||++.++.++.++|||||||++|||+| |..||..... .+-..
T Consensus 154 DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~~~------- 224 (317)
T d1xkka_ 154 DFGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISS------- 224 (317)
T ss_dssp CCSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGHHH-------
T ss_pred CCCCCEECCCCCC-CCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHH-------
T ss_conf 2552223354445-32236510586446708874699983565440799999999779999999998-99999-------
Q ss_pred HCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 30258710004921128889487999999998444335999999889999999989646
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~~ 839 (911)
.+....+...+..++..+.+++.+||+.||.+|||+.+|++.|+.+.+..
T Consensus 225 ---------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 225 ---------ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp ---------HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred ---------HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCH
T ss_conf ---------99759989998556899999999847899346919999999999987586
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.90 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=207.5
Q ss_pred HCCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEE
Q ss_conf 704876630322269379999996058808999982578-8565899999999987203231754233002587057999
Q 002533 545 ATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 545 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 623 (911)
..++|...+.||+|+||+||+|.+..++..||+|+++.. .....+++.+|+.+|++++||||+++++++.+.+.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf 52699853567643211011234689998714434477886879999976079995897332479856568996699522
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DF 703 (911)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .++|+||||||+|||++.++.+||+||
T Consensus 84 Ey~~gg~L~~~l~~~------------~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp ECCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred ECCCCCCHHHHHHHC------------CCCCHHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEECCCCCEEEEEC
T ss_conf 767998689987424------------999999999999999999999998--599971445779946878998999548
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 77567999998763112334865545713230158896357898999999999499999898631000337667765302
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+|+... ........||..|+|||++.+..++.++||||+||++|||++|+.||.....................
T Consensus 150 Gla~~~~-----~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 150 GVSGQLI-----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCHHHH-----HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred CCCCCCC-----CCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 7762567-----88621113771411946875899894888998999999999888998998878999999887517754
Q ss_pred ----------------------CCCCCCCCCCCC---CCCC-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----------------------587100049211---2888-94879999999984443359999998899999
Q 002533 784 ----------------------RGTVDQIVDPRL---RGKI-APVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ----------------------~~~~~~i~d~~l---~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.....+..+... .... .......+.+++.+||+.||.+|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 57742123332211112223541347788766502687667644489999999999868994679089999609
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=366.59 Aligned_cols=277 Identities=27% Similarity=0.380 Sum_probs=217.3
Q ss_pred HHHHHHHCCCCCCCEEECCCCCEEEEEEEEEC-----CCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCE
Q ss_conf 78999870487663032226937999999605-----88089999825788-5658999999999872032317542330
Q 002533 539 LTEIKQATCDFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGF 612 (911)
Q Consensus 539 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 612 (911)
+.+++...++|...+.||+|+||+||+|+..+ .+..||||+++... .+..++|.+|++++++++|+||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred ECCCCCEEEEEEECCCCCHHHHHHHHHHCCCCC------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 025870579995269985356764321101123------------46899987144344778868799999760799958
Q 002533 613 CDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQ------------NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTI 680 (911)
Q Consensus 613 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~------------~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~i 680 (911)
|...+..++++||+++|+|.++|+......... .......+++..++.|+.|+|.||+||| ++++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCC---CCCE
T ss_conf 6059803899981589929999985275542100001110012103467889899999999999999855413---5786
Q ss_pred EEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 97332479856568996699522775679999987631123348655457132301588963578989999999994999
Q 002533 681 IHRDVKSTNILLDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP 760 (911)
Q Consensus 681 vH~DLkp~NILl~~~~~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~ 760 (911)
+||||||+|||++.++.+||+|||+++..... ..........|+..|+|||.+.+..++.++|||||||++|||++|..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGG-GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCC-CCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCC
T ss_conf 85488401168989992898331442113677-64111577776767679899726889805630252362999980689
Q ss_pred -CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf -9989863100033766776530258710004921128889487999999998444335999999889999999989
Q 002533 761 -PMINGAVRKEEVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 761 -p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~ 836 (911)
||.... ..+....+ .+. .+...+..++..+.+|+.+||+.+|++||||.+|+++|+.+.
T Consensus 241 ~p~~~~~-~~e~~~~v---------------~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMA-HEEVIYYV---------------RDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CTTTTSC-HHHHHHHH---------------HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCC-HHHHHHHH---------------HCC-CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9999989-99999999---------------739-978887325299999999974889657939999999999842
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.36 Aligned_cols=254 Identities=25% Similarity=0.313 Sum_probs=204.9
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEE
Q ss_conf 48766303222693799999960588089999825788-56589999999998720323175423300258705799952
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS-MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 625 (911)
++|...+.||+|+||+||+|++..++..||||++.... .+..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf 69985356764321101123468999871443447788687999997607999589733247985656899669952277
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGl 705 (911)
+++|+|.++|. ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~gg~L~~~l~------------~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 85 CSGGELFDRIE------------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp CTTEEGGGGSB------------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCCCHHHHHH------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHH
T ss_conf 58980899975------------3799999999999999999999999---75983575468997887899879832314
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 5679999987631123348655457132301588-963578989999999994999998986310003376677653025
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++...... .........||+.|||||++.+..+ +.++||||+||++|||++|+.||.......... ..+ ...
T Consensus 150 a~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~~---~~~- 222 (271)
T d1nvra_ 150 ATVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDW---KEK- 222 (271)
T ss_dssp CEECEETT-EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HHH---HTT-
T ss_pred HEEECCCC-CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHH--HHH---HCC-
T ss_conf 22404688-65311132557474287286189999971016173799999982997888898599999--998---638-
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 87100049211288894879999999984443359999998899999
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
..........+..+.+++.+||+.||++|||+.|++++
T Consensus 223 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 223 ---------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---------88788644699999999999767996689099999619
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.02 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=209.1
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEE
Q ss_conf 04876630322269379999996058808999982578856589999999998720323175423300258705799952
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 625 (911)
.++|...+.||+|+||+||+|++++ +..||||+++.... ..++|.+|+.++++++||||++++|+|.+.+..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETT-TEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECC-CCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEC
T ss_conf 6997996898207883999999889-98999999874757-789999999999966898601588998507816999970
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf 69985356764321101123468999871443447788687999997607999589733247985656899669952277
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGl 705 (911)
+++|+|.+++... ...+++..+++++.|+|+||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~g~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 81 MANGCLLNYLREM-----------RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 146 (258)
T ss_dssp CTTEEHHHHHHSG-----------GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred CCCCCHHHHHHCC-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCEEEEECCCCCEEECCCHH
T ss_conf 4899388864102-----------467768999999999999999875---46843466541358876998479886144
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 5679999987631123348655457132301588963578989999999994-999998986310003376677653025
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++...... ........|+..|+|||.+.++.++.++|||||||++|||+| |+.||..... .+-... ..
T Consensus 147 a~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-~~~~~~-----i~--- 215 (258)
T d1k2pa_ 147 SRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEH-----IA--- 215 (258)
T ss_dssp CCBCSSSS--CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-HHHHHH-----HH---
T ss_pred HEECCCCC--CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH-HHHHHH-----HH---
T ss_conf 20235787--22524657887757807863799885210336432467397559999889999-999999-----98---
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 87100049211288894879999999984443359999998899999999
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEF 834 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~ 834 (911)
...+...+..++..+.+++.+||+.||++|||+.+|+++|..
T Consensus 216 --------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 216 --------QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --------HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf --------079789965465999999999766897689399999987418
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.45 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=206.4
Q ss_pred CCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEECC
Q ss_conf 87663032226937999999605880899998257885658999999999872032317542330025870579995269
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFMP 627 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 627 (911)
.|+..+.||+|+||+||+|.+..++..||||++........+.+.+|+++|++++||||+++++++.+++..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCC
T ss_conf 75984799307781999999999993999999872899999999999999986799998849889800995899996279
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 98535676432110112346899987144344778868799999760799958973324798565689966995227756
Q 002533 628 RGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLSR 707 (911)
Q Consensus 628 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla~ 707 (911)
+|+|.+++... ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~g~L~~~~~~~-----------~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 93 GGAVDAVMLEL-----------ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp TEEHHHHHHHH-----------TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCCHHHHHHHC-----------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEECCHHHEEECCCCCEEEEECHHHH
T ss_conf 98188999862-----------899999999999999999999999---8898871407003148789998997161230
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 7999998763112334865545713230-----15889635789899999999949999989863100033766776530
Q 002533 708 MGPSGMSQSHVSTVVKGSFGYVDPEYIR-----RQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 708 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
.... .........||+.|+|||++. ...++.++|||||||++|||++|+.||....... .. .....
T Consensus 159 ~~~~---~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~-----~~i~~ 229 (288)
T d2jfla1 159 KNTR---TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VL-----LKIAK 229 (288)
T ss_dssp ECHH---HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HH-----HHHHH
T ss_pred CCCC---CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HH-----HHHHC
T ss_conf 3577---864100102562647999983202578888806657878999999820889999989999-99-----99970
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 2587100049211288894879999999984443359999998899999
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
... .....+..++..+.+++.+||+.||.+|||+.|++++
T Consensus 230 ~~~---------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 230 SEP---------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SCC---------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 799---------8777656699999999999766996689199999629
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.72 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=207.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECC--CCCEEEE
Q ss_conf 4876630322269379999996058808999982578--85658999999999872032317542330025--8705799
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDE--HGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 622 (911)
++|...+.||+|+||+||+|+...++..||+|++... .....+.+.+|++++++++||||+++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEEECCCCCCEEECCCCCEEE
Q ss_conf 952699853567643211011234689998714434477886879999976079--995897332479856568996699
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGA--KHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 623 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~vki 700 (911)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++.+||
T Consensus 84 mEy~~~g~L~~~i~~~~~--------~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 84 MEYCEGGDLASVITKGTK--------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp EECCTTEEHHHHHHHHHH--------HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred EECCCCCCHHHHHHHCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEE
T ss_conf 956899938999985154--------578999999999999999999999971677887885867654257478885798
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 52277567999998763112334865545713230158896357898999999999499999898631000337667765
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...... + +. ...
T Consensus 156 ~DFG~a~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~---~~--~~i 226 (269)
T d2java1 156 GDFGLARILNHD---TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-E---LA--GKI 226 (269)
T ss_dssp CCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-H---HH--HHH
T ss_pred EECCCEEECCCC---CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH-H---HH--HHH
T ss_conf 001000322457---77556677882327999983999993898875278999980188998998999-9---99--999
Q ss_pred HCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 302587100049211288894879999999984443359999998899999
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.. +.. ...+..++..+.+++.+||+.||.+|||+.|++++
T Consensus 227 ~~--~~~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 RE--GKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HH--TCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HC--CCC---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 71--899---------88974359999999999767995579189999729
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.82 Aligned_cols=247 Identities=29% Similarity=0.456 Sum_probs=206.0
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEE
Q ss_conf 48766303222693799999960588089999825788---565899999999987203231754233002587057999
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 623 (911)
.+|...+.||+|+||+||+|++..++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf 52699853567643211011234689998714434477886879999976079995897332479856568996699522
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DF 703 (911)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 86 Ey~~~g~L~~~l~~~------------~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 86 EYAPLGTVYRELQKL------------SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp ECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EECCCCCHHHHHHHC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCCEECCCCCEEECCC
T ss_conf 504798589887504------------89999999999999999999999---889465220234414668998711555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 77567999998763112334865545713230158896357898999999999499999898631000337667765302
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... + .+......
T Consensus 151 G~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~-----~~~~i~~~ 219 (263)
T d2j4za1 151 GWSVHAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-E-----TYKRISRV 219 (263)
T ss_dssp CSCSCCCCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-H-----HHHHHHTT
T ss_pred CEEEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH-H-----HHHHHHCC
T ss_conf 633544888-----523557887634999975899893144046759999983299998889999-9-----99999718
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 587100049211288894879999999984443359999998899999
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
....+..++..+.+++.+||+.||++|||+.|++++
T Consensus 220 ------------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 ------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------------999986689999999999764797689099999719
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.58 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=207.6
Q ss_pred CEEECCCCCEEEEEEEEECC---CEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEECC-CCCEEEEEEEC
Q ss_conf 30322269379999996058---808999982578-85658999999999872032317542330025-87057999526
Q 002533 552 HCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDE-HGEMILVYEFM 626 (911)
Q Consensus 552 ~~~LG~G~fG~Vy~g~~~~~---~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~ 626 (911)
.++||+|+||+||+|.+..+ ...||||+++.. .....++|.+|+++|++++||||++++|+|.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99853567643211011234689998714434477886879999976079995897332479856568996699522775
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla 706 (911)
++|+|.+++.. ....+++..+++++.|+|.||.||| +++|+||||||+|||+++++.+||+|||++
T Consensus 112 ~~g~l~~~~~~-----------~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 112 KHGDLRNFIRN-----------ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 177 (311)
T ss_dssp TTCBHHHHHHC-----------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred ECCCHHHHHCC-----------CCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHEEECCCCCEEEECCCCH
T ss_conf 06741442101-----------3454048999999999887652003---367625776687576779998899106523
Q ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 679999987-6311233486554571323015889635789899999999949999989863100033766776530258
Q 002533 707 RMGPSGMSQ-SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARG 785 (911)
Q Consensus 707 ~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 785 (911)
+........ ........|+..|+|||.+..+.++.++||||||+++|||+||+.||.......+. ..+.. .
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~---~~~i~---~-- 249 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLL---Q-- 249 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C---HHHHH---T--
T ss_pred HHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHH---C--
T ss_conf 225566555310025655564556768874379997457466199999999789999888999999---99998---0--
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7100049211288894879999999984443359999998899999999896
Q 002533 786 TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 786 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
..+...+..++..+.+++.+||+.||++||+|.||+++|+.+++
T Consensus 250 --------g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 250 --------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --------89889964475999999999768897689399999999999997
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.36 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=209.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEEC
Q ss_conf 48766303222693799999960588089999825788565899999999987203231754233002587057999526
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 626 (911)
.+|..++.||+|+||+||+|.+.++ ..||||+++... ...+.|.+|+.++++++|+|||+++|+|.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 9979846993079809999999999-999999988044-888999999999986666788689999823-9759999944
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99853567643211011234689998714434477886879999976079995897332479856568996699522775
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla 706 (911)
++|+|..++.... ...++|.+++.|+.|+|.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~g~l~~~~~~~~----------~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 94 SKGSLLDFLKGET----------GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp TTCBHHHHHSHHH----------HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CCCCHHHHHHHCC----------CCCCHHHHHHHHHHHHHHHHHHHH---HHHEECCCCCCEEEEECCCCCEEECCCCHH
T ss_conf 7994354200003----------553059999999999999999875---411433531230799989992998442555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 67999998763112334865545713230158896357898999999999499999898631000337667765302587
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRARGT 786 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 786 (911)
+...... ........|+..|+|||++..+.++.++|||||||++|||++|+.|+.......+....+.
T Consensus 161 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---------- 228 (285)
T d1fmka3 161 RLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---------- 228 (285)
T ss_dssp C----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----------
T ss_pred HHCCCCC--CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH----------
T ss_conf 4256887--3352454556654580898379989177413235899999868999998888999999998----------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 10004921128889487999999998444335999999889999999989
Q 002533 787 VDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFAL 836 (911)
Q Consensus 787 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~ 836 (911)
...+...+..++..+.+++.+||+.||++||+|.+|+++|+...
T Consensus 229 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 229 ------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ------HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ------26899998323799999999975669758919999999876662
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.64 Aligned_cols=273 Identities=27% Similarity=0.351 Sum_probs=212.7
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECC-----CEEEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCEEEECCEECC-CC
Q ss_conf 04876630322269379999996058-----808999982578-856589999999998720-32317542330025-87
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDG-----SITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDE-HG 617 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~-~~ 617 (911)
.++|...+.||+|+||.||+|.+... +..||||+++.. .....+.+.+|...+.++ +|+||+.+++++.. ..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
T ss_conf 79979844984167839999998677755578399999986001717899999999998861499849974115404797
Q ss_pred CEEEEEEECCCCCHHHHHHHHHHCCCCC----CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC
Q ss_conf 0579995269985356764321101123----468999871443447788687999997607999589733247985656
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQ----NQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD 693 (911)
Q Consensus 618 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 693 (911)
.+++|||||++|+|.++|+......... .......+++..++.++.|++.||+||| +++|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEEC
T ss_conf 579999845899299999853666665322202332146899999999999999999887---37971786773106577
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCHHHH
Q ss_conf 899669952277567999998763112334865545713230158896357898999999999499-9998986310003
Q 002533 694 ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGR-PPMINGAVRKEEV 772 (911)
Q Consensus 694 ~~~~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~-~p~~~~~~~~~~~ 772 (911)
.++.+||+|||+++....... ........||+.|+|||++.++.++.++|||||||++|||+|+. .||........-.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCCCHHHCCCCCC-CCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 998289845752001135665-2224751667210203686468899663221367899999868899998999899999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 376677653025871000492112888948799999999844433599999988999999998964
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~ 838 (911)
.. +....+...+..++..+.+++.+||+.||++|||+.+|+++|+.+++.
T Consensus 248 ~~----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 248 RR----------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH----------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----------------HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99----------------963898888865789999999997677966791999999999799867
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.62 Aligned_cols=267 Identities=31% Similarity=0.493 Sum_probs=212.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCE--EEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCEEEECCEECCCCCEEEE
Q ss_conf 487663032226937999999605880--8999982578-856589999999998720-323175423300258705799
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSI--TVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 622 (911)
++|...++||+|+||+||+|.+.+++. .||||++... ..+..++|.+|+++|+++ +||||++++|+|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHHHHHCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCE
Q ss_conf 952699853567643211011----2346899987144344778868799999760799958973324798565689966
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQ----NQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 623 ~Ey~~~gsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 698 (911)
|||+++|+|.++|+....... .........+++..+++++.|+|.||.||| +++++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663---0895455505204898688763
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCCCCHHHHHHHHH
Q ss_conf 99522775679999987631123348655457132301588963578989999999994999-99898631000337667
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRP-PMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 ki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~-p~~~~~~~~~~~~l~~~ 777 (911)
||+|||+++..... .......|+..|+|||.+.++.++.++|||||||++|||++|.. ||.... ..+ +...
T Consensus 167 kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-~~~---~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAE---LYEK 238 (309)
T ss_dssp EECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHH---HHHH
T ss_pred EECCCCCCCCCCCC----CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC-HHH---HHHH
T ss_conf 87434432244422----345530137755553875269999622153138899999836899999999-999---9999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 765302587100049211288894879999999984443359999998899999999896
Q 002533 778 ARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
+....+...+..++..+.+|+.+||+.||++||||.+|++.|+.+++
T Consensus 239 -------------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 -------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -------------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -------------98268888876678999999999767896689499999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.86 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=206.1
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEE
Q ss_conf 0487663032226937999999605880899998257885-658999999999872032317542330025870579995
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM-QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 624 (911)
.+.|...+.||+|+||+||+|.+..++..||||++..... .....+.+|+++|++++||||+++++++.+.+.+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred ECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC---CCCCEEEE
Q ss_conf 269985356764321101123468999871443447788687999997607999589733247985656---89966995
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD---ENWAAKIS 701 (911)
Q Consensus 625 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~vki~ 701 (911)
||++|+|.++|. ....+++..+..++.|++.||+||| +++|+||||||+|||+. +++.+||+
T Consensus 88 ~~~gg~L~~~l~------------~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 88 LVSGGELFDRIV------------EKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp CCCSCBHHHHHH------------TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCCCCCHHHHHH------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCEEEEEEECCCCEEECCCCCCCEEEEE
T ss_conf 268984888653------------0367887899999999999987524---1305568704630011046888249983
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 22775679999987631123348655457132301588963578989999999994999998986310003376677653
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+....
T Consensus 153 DFG~a~~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~ 222 (307)
T d1a06a_ 153 DFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQIL 222 (307)
T ss_dssp CC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHH
T ss_pred CCCEEEECCCC----CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH
T ss_conf 15435872589----70440032842259188737999807873451599999985979999989999------999986
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 02587100049211288894879999999984443359999998899999
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
... ...........+..+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 223 KAE--------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTC--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCC--------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 168--------777876666789999999999760897579189998629
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=363.68 Aligned_cols=246 Identities=27% Similarity=0.372 Sum_probs=200.8
Q ss_pred CCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEE
Q ss_conf 8766303222693799999960588089999825788---5658999999999872032317542330025870579995
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 624 (911)
.|...+.||+|+||+||+|++..++..||||++.... ....+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECC
Q ss_conf 26998535676432110112346899987144344778868799999760799958973324798565689966995227
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFG 704 (911)
||++|+|..++. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~g~l~~~~~------------~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 96 YCLGSASDLLEV------------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp CCSEEHHHHHHH------------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ECCCCCHHHHHH------------HCCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCCCEEEECCCCCEEEEECC
T ss_conf 069994578997------------3799999999999999999999998---6897666788421798799978984436
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 75679999987631123348655457132301---588963578989999999994999998986310003376677653
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR---QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVS 781 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 781 (911)
+++.... .....||+.|||||++.+ +.++.++|||||||++|||++|+.||.+..... . .....
T Consensus 161 ~a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~-----~~~i~ 227 (309)
T d1u5ra_ 161 SASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-A-----LYHIA 227 (309)
T ss_dssp TCBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-H-----HHHHH
T ss_pred CCCCCCC-------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-H-----HHHHH
T ss_conf 5334677-------873134766368899834678886721454558999999987889999979999-9-----99998
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 02587100049211288894879999999984443359999998899999
Q 002533 782 RARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 782 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
... .+. ..+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 228 ~~~-------~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 228 QNE-------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HSC-------CCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HCC-------CCC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 289-------998---8878889999999999773796579189999719
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.57 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=195.7
Q ss_pred CCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECC----CCCEEEEE
Q ss_conf 6630322269379999996058808999982578--85658999999999872032317542330025----87057999
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDE----HGEMILVY 623 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 623 (911)
...+.||+|+||+||+|.+..++..||+|++... .....+.+.+|+++|++++||||+++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEEECCCCCCEEEC-CCCCEEE
Q ss_conf 52699853567643211011234689998714434477886879999976079995--89733247985656-8996699
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHT--IIHRDVKSTNILLD-ENWAAKI 700 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~--ivH~DLkp~NILl~-~~~~vki 700 (911)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++ |+||||||+|||++ +++.+||
T Consensus 92 E~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred ECCCCCCHHHHHHCC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEECCCCHHHCEEECCCCCEEE
T ss_conf 578989489997513------------55469999999999999999999---789979968767435116679998898
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 52277567999998763112334865545713230158896357898999999999499999898631000337667765
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
+|||+++.... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||.......+ .+...
T Consensus 157 ~DFGla~~~~~-----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i 225 (270)
T d1t4ha_ 157 GDLGLATLKRA-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRV 225 (270)
T ss_dssp CCTTGGGGCCT-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHH
T ss_pred EECCCCEECCC-----CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHH
T ss_conf 00576542368-----76677553813008988478-999867110079999999878899987655999-----99999
Q ss_pred HCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 302587100049211288894879999999984443359999998899999
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
... ...+. .+..+...+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~------~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 226 TSG------VKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTT------CCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HCC------CCCCC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 738------99865----675578999999999763797589299999677
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.16 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=210.6
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECC---CEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEE
Q ss_conf 04876630322269379999996058---808999982578-85658999999999872032317542330025870579
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMIL 621 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 621 (911)
..+|...+.||+|+||.||+|.+... ...||||+++.. .....+.|.+|++++++++||||++++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEE
Q ss_conf 99526998535676432110112346899987144344778868799999760799958973324798565689966995
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKIS 701 (911)
Q Consensus 622 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~ 701 (911)
||||+++|+|.+++.. ....+++..++.++.|++.||+||| +++++||||||+||+++.++.+||+
T Consensus 85 v~E~~~~g~l~~~~~~-----------~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~ 150 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV-----------RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLG 150 (273)
T ss_dssp EEECCTTEEHHHHHHH-----------TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEECCCCCHHHHHHC-----------CCCCCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCHHHEEECCCCCEEEC
T ss_conf 9984069807765422-----------4789999999999999987752302---2674414102655320678967876
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 22775679999987631123348655457132301588963578989999999994-99999898631000337667765
Q 002533 702 DFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARV 780 (911)
Q Consensus 702 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 780 (911)
|||+++..... .........|++.|+|||++.++.++.++|||||||++|||++ |.+||...... + +.. ..
T Consensus 151 DfG~a~~~~~~--~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~---~~~--~i 222 (273)
T d1mp8a_ 151 DFGLSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-D---VIG--RI 222 (273)
T ss_dssp C---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-G---HHH--HH
T ss_pred CCHHHEECCCC--CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-H---HHH--HH
T ss_conf 50342133677--6233054005831032667516998874524442478999982699998889999-9---999--99
Q ss_pred HCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 30258710004921128889487999999998444335999999889999999989646
Q 002533 781 SRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQLQ 839 (911)
Q Consensus 781 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~~ 839 (911)
.. ..+...++.++..+.+++.+||..||++|||+.+|++.|+.+++-.
T Consensus 223 ~~-----------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 223 EN-----------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HC-----------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 81-----------8999898777999999999976879768929999999999997786
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.11 Aligned_cols=258 Identities=27% Similarity=0.382 Sum_probs=209.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECC---CEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEE
Q ss_conf 4876630322269379999996058---808999982578---8565899999999987203231754233002587057
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDG---SITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 620 (911)
.+|...+.||+|+||.||+|++... ...||||+++.. ..+..++|.+|+++|++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEE
Q ss_conf 99952699853567643211011234689998714434477886879999976079995897332479856568996699
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki 700 (911)
+|+||+++|+|.+++.... ..+++..++.++.|+|.||.||| +++|+||||||+|||++.++.+||
T Consensus 87 lv~e~~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl 152 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-----------GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKI 152 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-----------GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEE
T ss_pred EEEEEECCCCHHHHHHCCC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECHHHHCCCCCCCEEE
T ss_conf 1465423861254442126-----------89999999999999999998752---178752056688815655654332
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 522775679999987631123348655457132301588963578989999999994-9999989863100033766776
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||+++................|+..|+|||.+.+..++.++||||||+++|||+| |+.||....... ...
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~~~--- 225 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILH--- 225 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH---
T ss_pred CCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHH---
T ss_conf 5611555303588752654763257310799998379999421566148999999968999999969999----999---
Q ss_pred HHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 53025871000492112888948799999999844433599999988999999998
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFA 835 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~ 835 (911)
.+.....+.+.+..++..+.+++.+||+.||++||||.+|++.|+.+
T Consensus 226 ---------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 ---------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ---------99847999998544539999999997688966792999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.82 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=206.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEE
Q ss_conf 48766303222693799999960588089999825788---565899999999987203231754233002587057999
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 623 (911)
.+|...+.||+|+||+||+|.+..++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf 52699853567643211011234689998714434477886879999976079995897332479856568996699522
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DF 703 (911)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+||
T Consensus 88 Ey~~gg~L~~~~~~~------------~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI------------GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp CCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred ECCCCCCHHHHHHCC------------CCCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCCCCCCCCCCCEEEECCC
T ss_conf 704898777765315------------99999999999999999997621---650884767741236688853886032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 77567999998763112334865545713230158896357898999999999499999898631000337667765302
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... + ........
T Consensus 153 G~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~-----~~~~i~~~ 225 (288)
T d1uu3a_ 153 GTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-L-----IFQKIIKL 225 (288)
T ss_dssp TTCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H-----HHHHHHTT
T ss_pred CCCEECCCCCC-CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH-H-----HHHHHHCC
T ss_conf 10242256776-43335556775525844002689896662304569999980388998995999-9-----99999718
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 587100049211288894879999999984443359999998899999
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
. ..++......+.+++.+||+.||.+|||+.|++..
T Consensus 226 ~------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 226 E------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 9------------99985479999999999855797689197897377
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.16 Aligned_cols=272 Identities=26% Similarity=0.388 Sum_probs=216.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE-----CCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCEEEECCEECCCCCE
Q ss_conf 48766303222693799999960-----58808999982578-856589999999998720-323175423300258705
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID-----DGSITVAVKRLNTS-SMQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 619 (911)
++|...++||+|+||.||+|++. ..+..||||+++.. ......+|.+|+.+++++ +||||++++|+|.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 99698549820688299999980664477886999999874248779999999999987626999887899898319978
Q ss_pred EEEEEECCCCCHHHHHHHHHHCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC
Q ss_conf 7999526998535676432110112------3468999871443447788687999997607999589733247985656
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQN------QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD 693 (911)
Q Consensus 620 ~lV~Ey~~~gsL~~~L~~~~~~~~~------~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 693 (911)
++|||||++|+|.++|+........ ........+++..++.++.|||.||+||| +++++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCCC
T ss_conf 999973799879999985356654444453322233458899999999999999999887---57926662410210000
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 89966995227756799999876311233486554571323015889635789899999999949999989863100033
Q 002533 694 ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVS 773 (911)
Q Consensus 694 ~~~~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~ 773 (911)
.++.+|++|||+++...... .........|++.|+|||.+.++.++.++|||||||++|||+|++.|+.......+...
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCCCCHHEECCCCC-CCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 25752102340102336788-61586201359687677886179999740010258999999858998877899899999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7667765302587100049211288894879999999984443359999998899999999896
Q 002533 774 LVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 774 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
+++....+...+..++..+.+|+.+||+.||.+||||.+|+++|+..+.
T Consensus 259 ---------------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 ---------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ---------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf ---------------9986689889854365999999999757796579299999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.04 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=203.8
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEE
Q ss_conf 48766303222693799999960588089999825788------565899999999987203231754233002587057
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS------MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 620 (911)
+.|...+.||+|+||+||+|.+..++..||||++.... ....+.+.+|+++|++++||||+++++++.+.+.++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 67798279811789599999999999899999987566321340689999999999998679989993889999799899
Q ss_pred EEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC----
Q ss_conf 9995269985356764321101123468999871443447788687999997607999589733247985656899----
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW---- 696 (911)
Q Consensus 621 lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---- 696 (911)
+|||||++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++
T Consensus 90 iv~E~~~gg~L~~~i~~~------------~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK------------ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp EEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSC
T ss_pred EEEECCCCCCCCCHHCCC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEEECCCCCCC
T ss_conf 999867786431001035------------64215578999999999987666---254221133301279825898666
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 66995227756799999876311233486554571323015889635789899999999949999989863100033766
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 697 ~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
.+||+|||+++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.+.... +.
T Consensus 155 ~vkl~DfG~a~~~~~~----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~----- 224 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ET----- 224 (293)
T ss_dssp CEEECCCTTCEECTTS----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-----
T ss_pred CEEECCHHHHHHCCCC----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH-HH-----
T ss_conf 4696433442105777----6312247777430999981899997665221409999997088998899999-99-----
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7765302587100049211288894879999999984443359999998899999
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
+........ .........++..+.+++.+||+.||.+|||+.+++++
T Consensus 225 ~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 225 LANVSAVNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHTTCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHCCC--------CCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999981688--------88701047889999999999863896689199999619
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.64 Aligned_cols=269 Identities=24% Similarity=0.378 Sum_probs=212.8
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEEC-----CCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCE
Q ss_conf 0487663032226937999999605-----8808999982578-856589999999998720323175423300258705
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDD-----GSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 619 (911)
.++|...+.||+|+||+||+|.+.+ .+..||||+++.. ..+....|.+|++++++++||||++++|+|......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEE
Q ss_conf 79995269985356764321101123468999871443447788687999997607999589733247985656899669
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vk 699 (911)
++||||+++|+|.+++......... ......+++..+++++.|+|+||.||| +++|+||||||+|||++.++.+|
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMAN--NPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHH--CTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECEECCCCEEECCCCEEE
T ss_conf 6777604899889998750332113--444688799999999999999999876---47965432867754035996499
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHH
Q ss_conf 952277567999998763112334865545713230158896357898999999999499-9998986310003376677
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGR-PPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 700 i~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~-~p~~~~~~~~~~~~l~~~~ 778 (911)
|+|||+++....... ........|++.|+|||.+.++.++.++||||||+++|||+||+ .||.... ..+....+
T Consensus 174 l~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-~~~~~~~i--- 248 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRFV--- 248 (308)
T ss_dssp ECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-HHHHHHHH---
T ss_pred EEECCCCEECCCCCC-EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC-HHHHHHHH---
T ss_conf 942454202357763-0313402316323788887369988333444378999999968999999989-99999999---
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 65302587100049211288894879999999984443359999998899999999896
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
.+ ..+...+..++..+.+++.+||+.+|.+||||.+|+++|+..++
T Consensus 249 ------------~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 ------------ME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ------------HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------------HH-CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf ------------80-88888863353999999999757796589399999999787617
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.19 Aligned_cols=271 Identities=28% Similarity=0.416 Sum_probs=215.4
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCC-------EEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCCCEEEECCEECCCC
Q ss_conf 48766303222693799999960588-------089999825788-56589999999998720-3231754233002587
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGS-------ITVAVKRLNTSS-MQGAREFRTEIEMISEL-RHLHIVSLLGFCDEHG 617 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-------~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 617 (911)
++|...+.||+|+||.||+|+..... ..||||+++... .....++.+|...+.++ +||||++++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred CEEEEEEECCCCCHHHHHHHHHHCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC
Q ss_conf 057999526998535676432110112----3468999871443447788687999997607999589733247985656
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQN----QNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD 693 (911)
Q Consensus 618 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 693 (911)
..++||||+++|+|.++|......... ........+++..++.++.|+|.||+||| +++|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCEEEC
T ss_conf 689999736999099999860677643222334574346799999999999999998766---37978630221022454
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHH
Q ss_conf 8996699522775679999987631123348655457132301588963578989999999994-999998986310003
Q 002533 694 ENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEV 772 (911)
Q Consensus 694 ~~~~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~~~~~~~ 772 (911)
.++.+||+|||+++....... ........+++.|+|||.+.++.++.++||||||+++|||++ |..||...... +
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-~-- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-E-- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-H--
T ss_pred CCCCEEECCCHHHCCCCCCCC-CCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH-H--
T ss_conf 789767622111011355555-431466788846632667517988825554775888887401798989999999-9--
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 376677653025871000492112888948799999999844433599999988999999998964
Q 002533 773 SLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838 (911)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~ 838 (911)
+.. . +....+...+..++..+.+|+.+||+.||.+|||+.||++.|+.++++
T Consensus 246 -~~~--~-----------i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 -LFK--L-----------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -HHH--H-----------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHH--H-----------HHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -999--9-----------972888898743529999999997667976793999999999888604
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.98 Aligned_cols=251 Identities=30% Similarity=0.475 Sum_probs=205.4
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECC-CCCEEEEEEE
Q ss_conf 487663032226937999999605880899998257885658999999999872032317542330025-8705799952
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDE-HGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey 625 (911)
++|...+.||+|+||.||+|.+.+ ..||||+++... ..++|.+|++++++++||||++++|+|.+ .+.+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT--EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHEEEEEEEECCCCEEEEEEEECC--EEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 994885798207980899999999--099999988577--7999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf 69985356764321101123468999871443447788687999997607999589733247985656899669952277
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGL 705 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGl 705 (911)
+++|+|.++|..... ..++|..+++|+.|+|.||+||| +.+++||||||+|||++.++.+||+|||+
T Consensus 83 ~~~g~L~~~l~~~~~----------~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 83 MAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp CTTEEHHHHHHHHHH----------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CCCCCHHHHHHHCCC----------CCCCHHHHHHHHHHHHHHCCCCC---CCCEECCCCCHHHHEECCCCCEEECCCCC
T ss_conf 699989999874578----------88899999999999985232113---37655366656760146899776324560
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 5679999987631123348655457132301588963578989999999994-999998986310003376677653025
Q 002533 706 SRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLC-GRPPMINGAVRKEEVSLVLWARVSRAR 784 (911)
Q Consensus 706 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 784 (911)
++..... .....++..|+|||++.++.++.++||||||+++|||+| |+.|+...... .+..+
T Consensus 150 s~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~------- 212 (262)
T d1byga_ 150 TKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR------- 212 (262)
T ss_dssp ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHH-------
T ss_pred CEECCCC------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHH-------
T ss_conf 0344787------765566646778178727988858877757999999997899999999999----99999-------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 87100049211288894879999999984443359999998899999999896
Q 002533 785 GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 785 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
+....+...+..++..+.+++.+||+.||.+||||.+|+++|+.+..
T Consensus 213 ------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 213 ------VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ------HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------98089999976579999999999756697689399999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=348.78 Aligned_cols=246 Identities=17% Similarity=0.298 Sum_probs=203.8
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEE
Q ss_conf 48766303222693799999960588089999825788---565899999999987203231754233002587057999
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 623 (911)
++|...+.||+|+||.||+|++..++..||||++.... ....+.+.+|+++|+.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf 52699853567643211011234689998714434477886879999976079995897332479856568996699522
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DF 703 (911)
||+.+|+|..++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 121 e~~~~g~l~~~l~~~------------~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI------------GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp ECCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCCCCCCHHHHHHHC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHCCCCCCCCEEEEEC
T ss_conf 233466226667515------------89899999999999999899998---599861767999936077897886101
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 77567999998763112334865545713230158896357898999999999499999898631000337667765302
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++..... .....||+.|||||++.+..++.++|||||||++|||++|+.||...... . ........
T Consensus 186 G~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~-----~~~~i~~~ 253 (350)
T d1rdqe_ 186 GFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-Q-----IYEKIVSG 253 (350)
T ss_dssp TTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H-----HHHHHHHC
T ss_pred EEEEECCCC------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH-H-----HHHHHHCC
T ss_conf 033322566------64336763567889971799885331145007899997588998995999-9-----99998617
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 5871000492112888948799999999844433599999-----98899999
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 831 (911)
. ...+..++..+.+++.+||+.||.+|+ ++.+++++
T Consensus 254 ~------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 254 K------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C------------CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf 9------------8897668999999999983409986065534549999719
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.15 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=205.7
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEE
Q ss_conf 048766303222693799999960588089999825788---56589999999998720323175423300258705799
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 622 (911)
-++|...++||+|+||.||+|+...++..||+|+++... ....+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEE
Q ss_conf 95269985356764321101123468999871443447788687999997607999589733247985656899669952
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~D 702 (911)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 84 ~ey~~gg~L~~~~~~~------------~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~D 148 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp EECCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EECCCCCCHHHHHHCC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEEEE
T ss_conf 0035798605555325------------67759999999999965211343---15962246477784765899888820
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 27756799999876311233486554571323015889635789899999999949999989863100033766776530
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
||+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... + ......
T Consensus 149 FG~a~~~~~~---~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~--~~~i~~ 219 (337)
T d1o6la_ 149 FGLCKEGISD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----L--FELILM 219 (337)
T ss_dssp CTTCBCSCCT---TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----H--HHHHHH
T ss_pred CCCCCCCCCC---CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH----H--HHHHHC
T ss_conf 5652003567---862055100889966665048988833310223067889987899999969999----9--999852
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 258710004921128889487999999998444335999999-----8899999
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG 831 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~~ 831 (911)
.. ..++...+..+.+|+.+||+.||.+||+ +.+++++
T Consensus 220 ~~------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 220 EE------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CC------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC------------CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf 89------------9898668999999998666389344225652349999729
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.04 Aligned_cols=272 Identities=25% Similarity=0.294 Sum_probs=198.0
Q ss_pred CCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCC----CEEEEE
Q ss_conf 8766303222693799999960588089999825788565899999999987203231754233002587----057999
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG----EMILVY 623 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 623 (911)
+|...+.||+|+||.||+|++.+ ..||||+++.... .....+.|+..+.+++||||++++|+|.+.+ .+++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g--~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETT--EEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEEECCCEEEEEEEECC--EEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 89998898207881999999999--8999999872004-67999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEEECCCCCCEEECCCCCE
Q ss_conf 5269985356764321101123468999871443447788687999997607-----99958973324798565689966
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAG-----AKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~-----~~~~ivH~DLkp~NILl~~~~~v 698 (911)
||+++|+|.++|+. ..++|..+++++.|+|.||+|||+. .+++|+||||||+|||++.++.+
T Consensus 81 Ey~~~g~L~~~l~~-------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp ECCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred ECCCCCCHHHHHHC-------------CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCE
T ss_conf 64669898999865-------------89998999999999999999988766520468986615317313578688776
Q ss_pred EEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCHHHHCCC------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 99522775679999987-6311233486554571323015------8896357898999999999499999898631000
Q 002533 699 KISDFGLSRMGPSGMSQ-SHVSTVVKGSFGYVDPEYIRRQ------QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEE 771 (911)
Q Consensus 699 ki~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~ 771 (911)
||+|||+++........ ........||+.|+|||++.+. .++.++|||||||+||||+||..|+.........
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 88763866234677762001355250354767822105654546777675012201599999996289988766311241
Q ss_pred HH-HHHHHHHHCCCCCCCCCCCCCCCCCC-----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 33-76677653025871000492112888-----94879999999984443359999998899999999896
Q 002533 772 VS-LVLWARVSRARGTVDQIVDPRLRGKI-----APVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQ 837 (911)
Q Consensus 772 ~~-l~~~~~~~~~~~~~~~i~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~ 837 (911)
.. ...+.... ........+..++... ...++..+.+++.+||+.||++||||.||++.|+.+.+
T Consensus 228 ~~~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 228 YYDLVPSDPSV--EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTTSCSSCCH--HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHCCCCCCHH--HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 01225564309--99999875024688877655776899999999999760698589599999999998888
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=347.91 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=203.7
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEE
Q ss_conf 4876630322269379999996058808999982578---8565899999999987203231754233002587057999
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 623 (911)
.+|...+.||+|+||+||+|++..++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf 52699853567643211011234689998714434477886879999976079995897332479856568996699522
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDF 703 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DF 703 (911)
||+++|+|..++.. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 84 E~~~gg~l~~~~~~------------~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 84 DYIEGGELFSLLRK------------SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp CCCCSCBHHHHHHH------------TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred EECCCCCCCCCCCC------------CCCCCCCHHHHHHHHHHHHHHHHC---CCCEECCCCCCHHEEECCCCCEEEECC
T ss_conf 50378632234322------------221110079999999987655412---476770556810503868998898317
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 77567999998763112334865545713230158896357898999999999499999898631000337667765302
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . .......
T Consensus 149 G~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~-----~~~i~~~ 216 (316)
T d1fota_ 149 GFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-T-----YEKILNA 216 (316)
T ss_dssp SSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-H-----HHHHHHC
T ss_pred CCCEEECCC------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH-H-----HHHHHCC
T ss_conf 521671245------643457634359999838999804304653336899975989999969999-9-----9999708
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 5871000492112888948799999999844433599999-----98899999
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-----TMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 831 (911)
. ...++..+..+.+++.+||..||.+|+ ++.+++++
T Consensus 217 ~------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 E------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C------------CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 9------------8899778999999999995449976664310219999819
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=347.19 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=197.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCH---HHHHHHHH---HHHHHHHCCCCCEEEECCEECCCCCEE
Q ss_conf 487663032226937999999605880899998257885---65899999---999987203231754233002587057
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---QGAREFRT---EIEMISELRHLHIVSLLGFCDEHGEMI 620 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~---~~~~~~~~---Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 620 (911)
++|...++||+|+||.||+|++..++..||||++..... .....+.+ ++.+++.++||||+++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEE
Q ss_conf 99952699853567643211011234689998714434477886879999976079995897332479856568996699
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki 700 (911)
+||||+++|+|.++|... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 84 ivmE~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH------------GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp EEECCCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEE
T ss_pred EEEEECCCCCHHHHHHHC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCEEECCCEEEECCCCCEEE
T ss_conf 999914898389998732------------55327899999999999999999---779622044422167858896798
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 522775679999987631123348655457132301-5889635789899999999949999989863100033766776
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||+++..... ......||+.|+|||++.. ..++.++|||||||+||||+||+.||........ ..+. +
T Consensus 149 ~DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~---~ 219 (364)
T d1omwa3 149 SDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEID---R 219 (364)
T ss_dssp CCCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHH---H
T ss_pred EEECEEEECCCC-----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH---H
T ss_conf 220102333788-----643311345542168760389998441046778999999859998888998999-9999---8
Q ss_pred HHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 530258710004921128889487999999998444335999999-----8899999
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG 831 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~~ 831 (911)
.. . ......+..++..+.+++.+||+.||.+||+ +.+++++
T Consensus 220 ~~---------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 220 MT---------L--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HS---------S--SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HC---------C--CCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf 60---------4--6888788778999999999985669888088743579999749
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=347.40 Aligned_cols=260 Identities=27% Similarity=0.329 Sum_probs=209.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCC----CE
Q ss_conf 4876630322269379999996058808999982578---8565899999999987203231754233002587----05
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS---SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG----EM 619 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~ 619 (911)
++|...+.||+|+||+||+|.+..+++.||||+++.. .....+.+.+|++++++++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 20698689960899299999999999899999985566469899999999999998569998873114354326887669
Q ss_pred EEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEE
Q ss_conf 79995269985356764321101123468999871443447788687999997607999589733247985656899669
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAK 699 (911)
Q Consensus 620 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vk 699 (911)
++||||+++|+|.+++... ..+++.+++.++.|++.||+||| +++|+||||||+|||++.++..+
T Consensus 87 ~lvmE~~~g~~L~~~~~~~------------~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE------------GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEE
T ss_pred EEEEECCCCCEEHHHHCCC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9999778898710112035------------89999999999999999999998---57952763467556657543201
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 95227756799999876311233486554571323015889635789899999999949999989863100033766776
Q 002533 700 ISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 700 i~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
++|||.++................||+.|+|||++.+..++.++|||||||++|||+||+.||....... . .+ .
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~----~~-~ 225 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-V----AY-Q 225 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H----HH-H
T ss_pred EEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH-H----HH-H
T ss_conf 0034443221235443333464257624369999839999966320265289999976979989969999-9----99-9
Q ss_pred HHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHH
Q ss_conf 53025871000492112888948799999999844433599999-988999999998
Q 002533 780 VSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRP-TMGDVTWGLEFA 835 (911)
Q Consensus 780 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~Le~~ 835 (911)
....... .........+..+.+++.+||+.||.+|| ++.++++.|..+
T Consensus 226 ~~~~~~~--------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 226 HVREDPI--------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHCCCC--------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHCCCC--------CCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf 9846999--------971003478999999999986679767773999999999997
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.97 Aligned_cols=253 Identities=18% Similarity=0.257 Sum_probs=204.7
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEE
Q ss_conf 04876630322269379999996058808999982578856589999999998720323175423300258705799952
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEF 625 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 625 (911)
.++|...+.||+|+||+||+|.+..++..||+|+++... .....+.+|+++|++++||||+++++++.+.+.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC--CCCEEEEEC
Q ss_conf 699853567643211011234689998714434477886879999976079995897332479856568--996699522
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE--NWAAKISDF 703 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~vki~DF 703 (911)
|++|+|.+++.. ....+++.++..|+.|++.||+||| +++|+||||||+|||++. ...+||+||
T Consensus 83 ~~gg~L~~~i~~-----------~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 83 ISGLDIFERINT-----------SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp CCCCBHHHHHTS-----------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CCCCCHHHHHHH-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEEECCC
T ss_conf 899808899875-----------3899999999999999999999998---76997513554443443788518997644
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 77567999998763112334865545713230158896357898999999999499999898631000337667765302
Q 002533 704 GLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 704 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
|+++.... ........+++.|+|||.+.+..++.++||||+||++|||++|+.||....... .+......
T Consensus 149 G~~~~~~~----~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~ 218 (321)
T d1tkia_ 149 GQARQLKP----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNA 218 (321)
T ss_dssp TTCEECCT----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT
T ss_pred CHHHCCCC----CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHC
T ss_conf 11100346----775321223322234021048777840113027999999982899999989999------99999838
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 587100049211288894879999999984443359999998899999
Q 002533 784 RGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.... +.... ..++..+.+++.+||..||.+|||+.|++++
T Consensus 219 ~~~~----~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 219 EYTF----DEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCC----CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCC----CHHHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9998----80223----6789999999999866996689099999639
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=339.21 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=203.9
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCH---------HHHHHHHHHHHHHHHCC-CCCEEEECCEECCC
Q ss_conf 487663032226937999999605880899998257885---------65899999999987203-23175423300258
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM---------QGAREFRTEIEMISELR-HLHIVSLLGFCDEH 616 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~---------~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~ 616 (911)
.+|...+.||+|+||+||+|+...++..+|||++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CCEEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC
Q ss_conf 70579995269985356764321101123468999871443447788687999997607999589733247985656899
Q 002533 617 GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 617 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 696 (911)
+..++||||+++|+|.++|... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK------------VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDM 147 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTC
T ss_pred CCEEEEEECCCCCHHHHHHHHC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCC
T ss_conf 6059999768986689999865------------99999999999999999999998---75994323462548986899
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 6699522775679999987631123348655457132301------5889635789899999999949999989863100
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR------QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKE 770 (911)
Q Consensus 697 ~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~ 770 (911)
.+||+|||+++..... .......||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... +
T Consensus 148 ~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~ 222 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-L 222 (277)
T ss_dssp CEEECCCTTCEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred CEEECCCHHEEECCCC----CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH-H
T ss_conf 8387124031672688----7213452467888988860534456788992331856560231032288898899999-9
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0337667765302587100049211288894879999999984443359999998899999
Q 002533 771 EVSLVLWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.. ....... ..........+++.+.+++.+||+.||.+||++.||+++
T Consensus 223 ~~-----~~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 223 ML-----RMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HH-----HHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HH-----HHHHHCC--------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99-----9998189--------888985434689999999999765896689199999739
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.40 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=196.8
Q ss_pred CCCCCC-EEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCEEEECCEECC----CCCEE
Q ss_conf 487663-0322269379999996058808999982578856589999999998720-32317542330025----87057
Q 002533 547 CDFADH-CIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISEL-RHLHIVSLLGFCDE----HGEMI 620 (911)
Q Consensus 547 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~ 620 (911)
.+|.+. ++||+|+||.||+|.+..++..||||+++.. ..+.+|++++.++ +||||+++++++.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEE
T ss_conf 48798107965454869999998899989999998974-----7799999999986699997829899950346897899
Q ss_pred EEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC---CCC
Q ss_conf 99952699853567643211011234689998714434477886879999976079995897332479856568---996
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE---NWA 697 (911)
Q Consensus 621 lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~ 697 (911)
+|||||++|+|.++|... ....+++.++..|+.|++.||+||| +++|+||||||+|||++. .+.
T Consensus 86 ivmEy~~gg~L~~~i~~~----------~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR----------GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEECCCSEEHHHHHHSC----------SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCC
T ss_pred EEEECCCCCCHHHHHHHC----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 999778998499999862----------7877579999999999999999999---769864441002201135555663
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 69952277567999998763112334865545713230158896357898999999999499999898631000337667
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 698 vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
+||+|||+++...... ......|++.|+|||++.+..++.++|||||||+||||+||+.||.+.........+
T Consensus 153 ~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--- 225 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--- 225 (335)
T ss_dssp EEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred CCCCCCCEEEECCCCC----CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHH---
T ss_conf 1135455123336888----643226775637927774898888888876451677886588998898877889999---
Q ss_pred HHHHCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 76530258710004921--1288894879999999984443359999998899999
Q 002533 778 ARVSRARGTVDQIVDPR--LRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 ~~~~~~~~~~~~i~d~~--l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
...+.... +.......++..+.+|+.+||+.||++|||+.|++++
T Consensus 226 ---------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 ---------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---------HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---------99985388888985434699999999999756996579099999709
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.34 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=201.9
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC---HHHHHHHHHHHHHHH-HCCCCCEEEECCEECCCCCEEEE
Q ss_conf 48766303222693799999960588089999825788---565899999999987-20323175423300258705799
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS---MQGAREFRTEIEMIS-ELRHLHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 622 (911)
.+|...+.||+|+||+||+|++..++..||||+++... ....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEE
Q ss_conf 95269985356764321101123468999871443447788687999997607999589733247985656899669952
Q 002533 623 YEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISD 702 (911)
Q Consensus 623 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~D 702 (911)
|||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 82 mEy~~~g~L~~~i~~~------------~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC------------HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp EECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEECCCCCHHHHHHCC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCEEECCCCCEECCC
T ss_conf 7503798089986404------------78999999999999999999998---68934034765404444899630155
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 27756799999876311233486554571323015889635789899999999949999989863100033766776530
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSR 782 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 782 (911)
||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... + .+.....
T Consensus 147 FG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~-----~~~~i~~ 217 (320)
T d1xjda_ 147 FGMCKENMLG---DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-E-----LFHSIRM 217 (320)
T ss_dssp CTTCBCCCCT---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H-----HHHHHHH
T ss_pred CCHHHHCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-H-----HHHHHHC
T ss_conf 5302323566---53345457877768999982799883232011227898987388999998999-9-----9999971
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 25871000492112888948799999999844433599999988-9999
Q 002533 783 ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMG-DVTW 830 (911)
Q Consensus 783 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl~ 830 (911)
.. ...+..++..+.+|+.+||+.||.+||++. ++++
T Consensus 218 ~~------------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 DN------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC------------CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 89------------98975679999999999654489878388999980
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.57 Aligned_cols=259 Identities=23% Similarity=0.279 Sum_probs=196.2
Q ss_pred CEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHH-----HHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEEEC
Q ss_conf 303222693799999960588089999825788565-----899999999987203231754233002587057999526
Q 002533 552 HCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQG-----AREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYEFM 626 (911)
Q Consensus 552 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~-----~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 626 (911)
.++||+|+||+||+|.+..+++.||||+++...... .+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99853567643211011234689998714434477886879999976079995897332479856568996699522775
Q 002533 627 PRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFGLS 706 (911)
Q Consensus 627 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla 706 (911)
.++++..++. ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~~~~~~~------------~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 83 ETDLEVIIKD------------NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp SEEHHHHHTT------------CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred CCHHHHHHHH------------CCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEEECCCCCCCCCCCCCC
T ss_conf 4507765541------------2667789999999999999998863---163550357762588537784114657610
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC--
Q ss_conf 6799999876311233486554571323015-8896357898999999999499999898631000337667765302--
Q 002533 707 RMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA-- 783 (911)
Q Consensus 707 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~-- 783 (911)
+...... .......||+.|+|||++... .++.++|||||||++|||++|+.||..... .+...... +....
T Consensus 148 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~--~~~~~~~ 221 (299)
T d1ua2a_ 148 KSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIF--ETLGTPT 221 (299)
T ss_dssp STTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH--HHHCCCC
T ss_pred CCCCCCC---CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCH-HHHHHHHH--HHCCCCC
T ss_conf 0057875---5433020473336399972677888056436304289999859699999999-99999999--8518997
Q ss_pred CCCCC---CCCC----CCCC----CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 58710---0049----2112----88894879999999984443359999998899999
Q 002533 784 RGTVD---QIVD----PRLR----GKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~---~i~d----~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
..... .... .... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 25452100021344303478988678565689999999999763894569089999679
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.75 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=200.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEE
Q ss_conf 48766303222693799999960588089999825788--5658999999999872032317542330025870579995
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSS--MQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 624 (911)
.+|...+.||+|+||+||+|.+...++.||||+++... ....+++.+|++++++++||||+++++++.+.+.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECC
Q ss_conf 26998535676432110112346899987144344778868799999760799958973324798565689966995227
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFG 704 (911)
|+.+ ++.+++... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~-~~~~~~~~~----------~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS----------ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp CCSE-EHHHHHHHT----------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ECCC-CHHHHHHHH----------CCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCHHEEECCCCCCEECCCC
T ss_conf 2377-445554420----------2568888999999999999999865---2889921357114011346762103578
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 7567999998763112334865545713230158-896357898999999999499999898631000337667765302
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ-LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
+++..... ........|++.|+|||.+.... ++.++||||+||++|||++|+.||...... +......-......
T Consensus 148 ~a~~~~~~---~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~ 223 (298)
T d1gz8a_ 148 LARAFGVP---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPD 223 (298)
T ss_dssp HHHHHCCC---SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred CCEECCCC---CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCC
T ss_conf 61343688---641001036521541122136657774221033331342796687998988999-99999998328983
Q ss_pred CCCCCCC-CCCCCCC-----------CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 5871000-4921128-----------8894879999999984443359999998899999
Q 002533 784 RGTVDQI-VDPRLRG-----------KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~~~~i-~d~~l~~-----------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
+...... ..+.... ...+.....+.+++.+|++.||.+|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 331444222421243454322220444166789999999999763995579189999678
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.83 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=196.5
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEE-CCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHC---CCCCEEEECCEEC-----
Q ss_conf 048766303222693799999960-588089999825788--56589999999998720---3231754233002-----
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYID-DGSITVAVKRLNTSS--MQGAREFRTEIEMISEL---RHLHIVSLLGFCD----- 614 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~----- 614 (911)
.++|...+.||+|+||+||+|++. .+++.||||+++... ......+.+|+.+++.| +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC
Q ss_conf 58705799952699853567643211011234689998714434477886879999976079995897332479856568
Q 002533 615 EHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE 694 (911)
Q Consensus 615 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~ 694 (911)
.....++++||+.++.+...... ....+++..+..++.|++.||+||| +++|+||||||+|||++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~ 151 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-----------PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTS 151 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-----------CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred CCCEEEEEEEECCCCCHHHHHHC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEECC
T ss_conf 67469999974058714444430-----------3789998999999999999999997---588983579862789858
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99669952277567999998763112334865545713230158896357898999999999499999898631000337
Q 002533 695 NWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 695 ~~~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l 774 (911)
++.+||+|||+++... .........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....
T Consensus 152 ~~~~kl~dfg~~~~~~----~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~ 226 (305)
T d1blxa_ 152 SGQIKLADFGLARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGK 226 (305)
T ss_dssp TCCEEECSCCSCCCCC----GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHH
T ss_pred CCCEEECCHHHHHHHC----CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCH-HHHHHH
T ss_conf 9975421000101100----23457776548511483100179888111000328999999878799899898-999999
Q ss_pred HHHHHHHCCCC------CC-CCCC---CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 66776530258------71-0004---9211288894879999999984443359999998899999
Q 002533 775 VLWARVSRARG------TV-DQIV---DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 775 ~~~~~~~~~~~------~~-~~i~---d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
........... .. .... ...............+.+|+.+||+.||++|||+.|++++
T Consensus 227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9984079961105321111033302234564544044589999999999874896679189999669
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.25 Aligned_cols=263 Identities=24% Similarity=0.282 Sum_probs=193.2
Q ss_pred CCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEECC------CCCEEE
Q ss_conf 87663032226937999999605880899998257885658999999999872032317542330025------870579
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLLGFCDE------HGEMIL 621 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~l 621 (911)
+|...++||+|+||+||+|++..++..||||++..... ...+|+++|++++|+||+++++++.. ...+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCC-CCEEE
Q ss_conf 99526998535676432110112346899987144344778868799999760799958973324798565689-96699
Q 002533 622 VYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKI 700 (911)
Q Consensus 622 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vki 700 (911)
||||++++.+....+... ....+++..+..++.|++.||+||| +++|+||||||+|||++.+ ..+||
T Consensus 97 v~Ey~~~~~~~~l~~~~~---------~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSR---------AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp EEECCSEEHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEE
T ss_pred EEECCCCCCHHHHHHHHH---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEEECCCCCEEE
T ss_conf 984168860788886310---------3689999999999999999999998---6687645788603787358971167
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH---
Q ss_conf 522775679999987631123348655457132301-5889635789899999999949999989863100033766---
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL--- 776 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~--- 776 (911)
+|||+++..... .......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ......
T Consensus 165 ~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~ 239 (350)
T d1q5ka_ 165 CDFGSAKQLVRG----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVL 239 (350)
T ss_dssp CCCTTCEECCTT----SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHH
T ss_pred ECCCCHHHCCCC----CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH-HHHHHHHHH
T ss_conf 336605440477----653200255555682776404688821000246527785502879989879999-999999974
Q ss_pred -------HHHHHC--CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------776530--2587100049211288894879999999984443359999998899999
Q 002533 777 -------WARVSR--ARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 -------~~~~~~--~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
|..... ........................+.+|+.+||+.||++|||+.|++++
T Consensus 240 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8981776543062101103554456744443156899999999999765895579299999669
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.81 Aligned_cols=269 Identities=20% Similarity=0.309 Sum_probs=198.9
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCC----CEE
Q ss_conf 04876630322269379999996058808999982578-8565899999999987203231754233002587----057
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS-SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG----EMI 620 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 620 (911)
+.+|...+.||+|+||+||+|.+..++..||||+++.. .....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEE
Q ss_conf 99952699853567643211011234689998714434477886879999976079995897332479856568996699
Q 002533 621 LVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKI 700 (911)
Q Consensus 621 lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki 700 (911)
++++++.+|+|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 87 ~l~~~~~~g~L~~~l~~-------------~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-------------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp EEEEECCCEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEECCCCHHHHHHC-------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEE
T ss_conf 99996259865664405-------------89999999999999999999999---789867778764378879997787
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 522775679999987631123348655457132301-5889635789899999999949999989863100033766776
Q 002533 701 SDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWAR 779 (911)
Q Consensus 701 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~ 779 (911)
+|||+++................|+..|+|||++.. ..++.++||||+||++|||++|+.||....... .........
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-~~~~~~~~~ 229 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGIL 229 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHH-HHHHHHHHC
T ss_conf 5457056504777641010110265200038786047888741010046701337766979978888899-999876520
Q ss_pred HHCCCCCCCC----------CCCCCCC-C---CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 5302587100----------0492112-8---8894879999999984443359999998899999
Q 002533 780 VSRARGTVDQ----------IVDPRLR-G---KIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 780 ~~~~~~~~~~----------i~d~~l~-~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.......... ...+... . ...+.....+.+++.+|++.||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 699756642343322220244677557787778378999999999999764895679089998619
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.72 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=198.4
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCC------
Q ss_conf 04876630322269379999996058808999982578--8565899999999987203231754233002587------
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHG------ 617 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 617 (911)
..+|...+.||+|+||+||+|.+..+++.||||+++.. .....+.+.+|+++|++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CEEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCC
Q ss_conf 05799952699853567643211011234689998714434477886879999976079995897332479856568996
Q 002533 618 EMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWA 697 (911)
Q Consensus 618 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 697 (911)
.+++||||+ +++|..++. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-------------~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-------------HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-------------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCC
T ss_pred EEEEEEECC-CCCHHHHHH-------------HCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCHHHCCCCCC
T ss_conf 599998405-521899987-------------402269999999999999999987---378764566851111210012
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 699522775679999987631123348655457132301-5889635789899999999949999989863100033766
Q 002533 698 AKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 698 vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
+|++|||+++..... .+...|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .....
T Consensus 160 ~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~- 231 (346)
T d1cm8a_ 160 LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEI- 231 (346)
T ss_dssp EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH-
T ss_pred CCCCCCCCEECCCCC------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHH-HHHHH-
T ss_conf 211343102206876------3102455333588998178789965010300389999997869988897689-99999-
Q ss_pred HHHHHCCC---------C--------CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 77653025---------8--------7100049211288894879999999984443359999998899999
Q 002533 777 WARVSRAR---------G--------TVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ~~~~~~~~---------~--------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
....... . ...+.....+ ..........+.+|+.+||..||.+|||+.|++++
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 232 -MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp -HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCH-HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -85037884888865300034433115786665566-77556899999999999772995579299999639
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.37 Aligned_cols=241 Identities=22% Similarity=0.385 Sum_probs=194.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCH------HHHHHHHHHHHHHHHCC--CCCEEEECCEECCCCC
Q ss_conf 487663032226937999999605880899998257885------65899999999987203--2317542330025870
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM------QGAREFRTEIEMISELR--HLHIVSLLGFCDEHGE 618 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~ 618 (911)
++|...++||+|+||+||+|++..++..||||++..... ....++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC-CC
Q ss_conf 5799952699-853567643211011234689998714434477886879999976079995897332479856568-99
Q 002533 619 MILVYEFMPR-GNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-NW 696 (911)
Q Consensus 619 ~~lV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~ 696 (911)
.++||||+.+ +++.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++. ++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~------------~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER------------GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTT
T ss_pred EEEEEEECCCCCHHHHHHHCC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEEECCCC
T ss_conf 899998336862289998615------------89999999999999999999998---779755667611147744788
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6699522775679999987631123348655457132301588-963578989999999994999998986310003376
Q 002533 697 AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQL-TEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 697 ~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... . .
T Consensus 149 ~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~--i- 216 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E--I- 216 (273)
T ss_dssp EEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H--H-
T ss_pred EEEECCCCCCEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH----H--H-
T ss_conf 4897754653532444-----55665658774799998489978865332554034536756889988736----7--7-
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 67765302587100049211288894879999999984443359999998899999
Q 002533 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.... ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 217 -----~~~~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 217 -----IRGQ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----HHCC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----HHCC------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----6154------------47787799999999999760897589399998539
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=319.71 Aligned_cols=265 Identities=17% Similarity=0.184 Sum_probs=201.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEC-CEECCCCCEEEEEEE
Q ss_conf 4876630322269379999996058808999982578856589999999998720323175423-300258705799952
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIVSLL-GFCDEHGEMILVYEF 625 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~-g~~~~~~~~~lV~Ey 625 (911)
++|...+.||+|+||.||+|.+..++..||||++..... ..++..|+++++.++|+|++..+ ++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 889996898507880999999988998999999721005--888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC---CCCCEEEEE
Q ss_conf 69985356764321101123468999871443447788687999997607999589733247985656---899669952
Q 002533 626 MPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLD---ENWAAKISD 702 (911)
Q Consensus 626 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~vki~D 702 (911)
+ +|+|.+.+.. ....+++..++.++.|++.||+||| +++|+||||||+|||++ .+..+||+|
T Consensus 85 ~-~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~D 149 (299)
T d1ckia_ 85 L-GPSLEDLFNF-----------CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIID 149 (299)
T ss_dssp C-CCBHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred C-CCCHHHHHHH-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHCCCCCCCCCCEEEEEC
T ss_conf 3-8713332443-----------0688768999999999999999999---79944266787660643357776156504
Q ss_pred CCCCCCCCCCCCC----CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 2775679999987----631123348655457132301588963578989999999994999998986310003376677
Q 002533 703 FGLSRMGPSGMSQ----SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWA 778 (911)
Q Consensus 703 FGla~~~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~ 778 (911)
||+++........ ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~ 229 (299)
T d1ckia_ 150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229 (299)
T ss_dssp CSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred CCCCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 67513425544554100013577678735329999918998983218861778999984987665530577999999852
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 653025871000492112888948799999999844433599999988999999998964
Q 002533 779 RVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838 (911)
Q Consensus 779 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~ 838 (911)
..... ... +. ....++..+.+++.+||+.+|++||++.++.+.|+.+...
T Consensus 230 ~~~~~-~~~-----~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 230 EKKMS-TPI-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHH-SCH-----HH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCC-CCH-----HH----HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 35678-983-----57----5347889999999998439955791999999999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.32 Aligned_cols=269 Identities=22% Similarity=0.280 Sum_probs=197.7
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECC--------C
Q ss_conf 4876630322269379999996058808999982578--85658999999999872032317542330025--------8
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDE--------H 616 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------~ 616 (911)
.+|...+.||+|+||+||+|++...+..||||++... .....+++.+|+++|++++|+|++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred CCEEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC
Q ss_conf 70579995269985356764321101123468999871443447788687999997607999589733247985656899
Q 002533 617 GEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENW 696 (911)
Q Consensus 617 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 696 (911)
+..++||||+.++.+..... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~------------~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN------------VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDG 154 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC------------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTS
T ss_pred CEEEEEEECCCCCCCCHHHH------------CCCCCCCHHHHHHHHHHHHHHHHHC---CCCEEECCCCCHHEEECCCC
T ss_conf 63899985357874101222------------0344330899999999999998852---29988567672220366899
Q ss_pred CEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 669952277567999998-76311233486554571323015-8896357898999999999499999898631000337
Q 002533 697 AAKISDFGLSRMGPSGMS-QSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSL 774 (911)
Q Consensus 697 ~vki~DFGla~~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l 774 (911)
.+||+|||+++....... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~~~~~~~ 233 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLAL 233 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHH
T ss_pred CEEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCC-HHHHHHH
T ss_conf 687631350022355444321135660249787428997079998917870067864661744879989989-9999999
Q ss_pred HHHHHHHCCCCCCCCCCCCCC-------CC-CCC-------HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 667765302587100049211-------28-889-------4879999999984443359999998899999
Q 002533 775 VLWARVSRARGTVDQIVDPRL-------RG-KIA-------PVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 775 ~~~~~~~~~~~~~~~i~d~~l-------~~-~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
..................... .. ... ......+.+|+.+||+.||++|||+.|++++
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 998418998255344320344433201334455503340444599899999999873896589099999749
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=322.40 Aligned_cols=265 Identities=20% Similarity=0.270 Sum_probs=199.9
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEE
Q ss_conf 487663032226937999999605880899998257885--658999999999872032317542330025870579995
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM--QGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 624 (911)
++|...+.||+|+||+||+|++..+ ..||||++..... ...+.+.+|+.+|++++||||+++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS-CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCC-CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf 9963431872277818999996899-999999981232685899999999999986799868766012046773158997
Q ss_pred ECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECC
Q ss_conf 26998535676432110112346899987144344778868799999760799958973324798565689966995227
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFG 704 (911)
++.++.+..+.. ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 81 HLDQDLKKLLDV------------CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp CCSEEHHHHHHT------------STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred EEHHHHHHHHHH------------HCCCCCHHHHHHHHHHHHHHHHHHC---CCCEEECCCCCCEEEECCCCCEEECCCC
T ss_conf 400456789986------------0477514456899999999999860---5748826787750568689978732366
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH-------
Q ss_conf 75679999987631123348655457132301-5889635789899999999949999989863100033766-------
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRR-QQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL------- 776 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~------- 776 (911)
++...... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... +......
T Consensus 146 ~a~~~~~~---~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~ 221 (286)
T d1ob3a_ 146 LARAFGIP---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPN 221 (286)
T ss_dssp HHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred CCEECCCC---CCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHH-HHHHHHHHHHCCCC
T ss_conf 43011467---654101024311013788717888884100211175899997797998988989-99999998638997
Q ss_pred ---HHHHHCCCCCC--CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---77653025871--00049211288894879999999984443359999998899999
Q 002533 777 ---WARVSRARGTV--DQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 ---~~~~~~~~~~~--~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
|.......... .....+.............+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 110421233322143333356764666512589999999999866896689099998569
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=314.21 Aligned_cols=260 Identities=18% Similarity=0.271 Sum_probs=197.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEECC--CCCEEEEE
Q ss_conf 48766303222693799999960588089999825788565899999999987203-2317542330025--87057999
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGFCDE--HGEMILVY 623 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~ 623 (911)
++|...++||+|+||+||+|++..++..||||+++... .+++.+|+++|+.++ ||||+++++++.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 67189789831748199999988999799999988899---999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCC-CCEEEEE
Q ss_conf 526998535676432110112346899987144344778868799999760799958973324798565689-9669952
Q 002533 624 EFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDEN-WAAKISD 702 (911)
Q Consensus 624 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vki~D 702 (911)
||+.+++|..+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.+ ..+||+|
T Consensus 112 e~~~~~~L~~~~---------------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 112 EHVNNTDFKQLY---------------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp ECCCSCBGGGTT---------------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EECCCCCHHHHH---------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEECC
T ss_conf 631798589974---------------68999999999999999998876---433443456441237748998366415
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH-----
Q ss_conf 27756799999876311233486554571323015-889635789899999999949999989863100033766-----
Q 002533 703 FGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL----- 776 (911)
Q Consensus 703 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~----- 776 (911)
||+++...... ......+|..|+|||.+.+. .++.++||||+||++|||++|+.||.......+......
T Consensus 174 FG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 174 WGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp GGGCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred CCCCEECCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
T ss_conf 65426646887----44432248642476102688888845232335455587604889998876018999999998788
Q ss_pred -----HHHHHCC--CCCCCCCCCC--------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -----7765302--5871000492--------11288894879999999984443359999998899999
Q 002533 777 -----WARVSRA--RGTVDQIVDP--------RLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 777 -----~~~~~~~--~~~~~~i~d~--------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
|...... .......... .............+.+|+.+|++.||.+|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4155555422544474300000333433112115521124489999999999866995689089999649
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=317.76 Aligned_cols=266 Identities=17% Similarity=0.184 Sum_probs=206.9
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC-CCEEEECCEECCCCCEEEEEE
Q ss_conf 0487663032226937999999605880899998257885658999999999872032-317542330025870579995
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRH-LHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 624 (911)
.++|...+.||+|+||+||+|++..++..||||++.... ....+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC-----CCCEE
Q ss_conf 2699853567643211011234689998714434477886879999976079995897332479856568-----99669
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE-----NWAAK 699 (911)
Q Consensus 625 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~vk 699 (911)
|+ +++|.+++... ...+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+|
T Consensus 82 ~~-~~~l~~~~~~~-----------~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 82 LL-GPSLEDLLDLC-----------GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp CC-CCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred EC-CCCHHHHHHHH-----------CCCHHHHHHHHHHHHHHHHHHHHH---HCCCEECCCCCCCEEECCCCCCCCCCEE
T ss_conf 64-88879999752-----------031106899999999999999999---7796626677131523475434479568
Q ss_pred EEECCCCCCCCCCCCC----CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9522775679999987----631123348655457132301588963578989999999994999998986310003376
Q 002533 700 ISDFGLSRMGPSGMSQ----SHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV 775 (911)
Q Consensus 700 i~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~ 775 (911)
|+|||+++........ ........||+.|||||++.+..++.++||||||+++|||++|+.||.............
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred ECCCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 72366057714676654111024676277510267989648888869998983199999986987678853021999999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 677653025871000492112888948799999999844433599999988999999998964
Q 002533 776 LWARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWGLEFALQL 838 (911)
Q Consensus 776 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~Le~~~~~ 838 (911)
..... ....... .+ ...++..+.+++..|+..+|++||++..+.+.|+.+++.
T Consensus 227 ~i~~~-~~~~~~~-----~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 227 RIGEK-KQSTPLR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHH-HHHSCHH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHC-CCCCCHH-----HH----CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 99705-6799958-----96----579989999999998439930085999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.13 Aligned_cols=267 Identities=19% Similarity=0.254 Sum_probs=205.0
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECCCCCEEEEEE
Q ss_conf 4876630322269379999996058808999982578--85658999999999872032317542330025870579995
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDEHGEMILVYE 624 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 624 (911)
++|...+.||+|+||+||+|++..++..||||+++.. ......++.+|+.++++++|+||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECC
Q ss_conf 26998535676432110112346899987144344778868799999760799958973324798565689966995227
Q 002533 625 FMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAAKISDFG 704 (911)
Q Consensus 625 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vki~DFG 704 (911)
++.+++|..++. ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~l~~~~~------------~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 82 FCDQDLKKYFDS------------CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp CCSEEHHHHHHH------------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred ECCCCCCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHH---CCCEEEECCCCCCCCCCCCCCEEEEECC
T ss_conf 023322211212------------3565403678999999999987743---3998600146761211337826652046
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 7567999998763112334865545713230158-896357898999999999499999898631000337667765302
Q 002533 705 LSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQ-LTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLWARVSRA 783 (911)
Q Consensus 705 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 783 (911)
.++...... .......++..|+|||.+.... ++.++||||+||++|||++|+.||.......+.............
T Consensus 147 ~a~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 147 LARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_dssp TCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred HHHCCCCCC---CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 011046887---51001034431014667506988880444026541889985189999889999999999986118997
Q ss_pred CCC---CCCCC---------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 587---10004---------9211288894879999999984443359999998899999
Q 002533 784 RGT---VDQIV---------DPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 784 ~~~---~~~i~---------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
... ..... ...............+.+|+.+|++.||.+|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 355134432221133444544310433065689999999999864996689099999649
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.14 Aligned_cols=275 Identities=21% Similarity=0.290 Sum_probs=207.9
Q ss_pred CCCCCCEEECCCCCEEEEEEEEE---CCCEEEEEEECCCCC----HHHHHHHHHHHHHHHHCCC-CCEEEECCEECCCCC
Q ss_conf 48766303222693799999960---588089999825788----5658999999999872032-317542330025870
Q 002533 547 CDFADHCIIGSGGFGHVFKGYID---DGSITVAVKRLNTSS----MQGAREFRTEIEMISELRH-LHIVSLLGFCDEHGE 618 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 618 (911)
.+|...+.||+|+||+||+|... .+++.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCE
Q ss_conf 57999526998535676432110112346899987144344778868799999760799958973324798565689966
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 698 (911)
.++++||+.+|+|.+++.... .+.......++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~------------~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~v 168 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE------------RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHV 168 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred EEEEEECCCCCHHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCCCCEEECCCCCE
T ss_conf 001231234117999987304------------5437888888999999998851---4998965477320124699988
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 995227756799999876311233486554571323015--889635789899999999949999989863100033766
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ--QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVL 776 (911)
Q Consensus 699 ki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~ 776 (911)
||+|||+++..... .........|++.|++||.+.+. .++.++|||||||+||||++|+.||...........+.
T Consensus 169 kL~DFG~a~~~~~~--~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~- 245 (322)
T d1vzoa_ 169 VLTDFGLSKEFVAD--ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS- 245 (322)
T ss_dssp EESCSSEEEECCGG--GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-
T ss_pred EEEECCCHHHHCCC--CCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-
T ss_conf 87413202220344--443221222333331068760577688713251777799999976899988887777999999-
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH--HHHHHHHHHHHHCCCCCC
Q ss_conf 776530258710004921128889487999999998444335999999-----8899999--999896468642048999
Q 002533 777 WARVSRARGTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPT-----MGDVTWG--LEFALQLQEAAEKSDQGR 849 (911)
Q Consensus 777 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~~--Le~~~~~~~~~~~~~~~~ 849 (911)
..... .....+..++..+.+++.+||+.||.+||+ +.|++++ ++.+. ...........
T Consensus 246 -~~~~~------------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~--~~~l~~~~~~~ 310 (322)
T d1vzoa_ 246 -RRILK------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN--WDDLAAKKVPA 310 (322)
T ss_dssp -HHHHH------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC--HHHHHTTCSCC
T ss_pred -HHCCC------------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCC--HHHHHHCCCCC
T ss_conf -83356------------8998865479999999999744589881999745099997497234899--88997378985
Q ss_pred CCCCC
Q ss_conf 98899
Q 002533 850 PFVPR 854 (911)
Q Consensus 850 ~~~~~ 854 (911)
|++|.
T Consensus 311 p~~p~ 315 (322)
T d1vzoa_ 311 PFKPV 315 (322)
T ss_dssp SCCCC
T ss_pred CCCCC
T ss_conf 98999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.23 Aligned_cols=263 Identities=23% Similarity=0.264 Sum_probs=199.7
Q ss_pred CCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECC------CCC
Q ss_conf 4876630322269379999996058808999982578--85658999999999872032317542330025------870
Q 002533 547 CDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDE------HGE 618 (911)
Q Consensus 547 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~ 618 (911)
++|...++||+|+||+||+|.+..++..||||++... ......++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCE
Q ss_conf 57999526998535676432110112346899987144344778868799999760799958973324798565689966
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 698 (911)
+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 97 ~~iv~Ey~~~-~l~~~~~--------------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ--------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp EEEEEECCSE-EHHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred EEEEEECCCH-HHHHHHH--------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCE
T ss_conf 6999841446-7787650--------------38999999999999999998865---2211245677632113654431
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH---
Q ss_conf 99522775679999987631123348655457132301588963578989999999994999998986310003376---
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLV--- 775 (911)
Q Consensus 699 ki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~--- 775 (911)
|++|||+++.... ........+|..|+|||++.+..++.++||||+||++|||++|+.||.............
T Consensus 159 kl~df~~~~~~~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~ 234 (355)
T d2b1pa1 159 KILDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234 (355)
T ss_dssp EECCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEECHHHHHCCCC----CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHC
T ss_conf 3201023211466----655332214655558133147777877433356625789865989988897788999999720
Q ss_pred ------HH-------HHHHCCCC-----CCCCCCCCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ------67-------76530258-----7100049211288---894879999999984443359999998899999
Q 002533 776 ------LW-------ARVSRARG-----TVDQIVDPRLRGK---IAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 776 ------~~-------~~~~~~~~-----~~~~i~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
.| ........ ............. ........+.+|+.+|+..||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 58987999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.62 Aligned_cols=262 Identities=21% Similarity=0.302 Sum_probs=197.1
Q ss_pred CCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEECCEECC-----CCC
Q ss_conf 04876630322269379999996058808999982578--85658999999999872032317542330025-----870
Q 002533 546 TCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTS--SMQGAREFRTEIEMISELRHLHIVSLLGFCDE-----HGE 618 (911)
Q Consensus 546 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~ 618 (911)
.++|...+.||+|+||+||+|++..+++.||||++... +....+.+.+|+++|++++|+|++++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCE
Q ss_conf 57999526998535676432110112346899987144344778868799999760799958973324798565689966
Q 002533 619 MILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDENWAA 698 (911)
Q Consensus 619 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 698 (911)
.+++++|+.+|+|.+++. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~-------------~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-------------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-------------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred EEEEEEEECCCCHHHHCC-------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCC
T ss_conf 499999625886232002-------------245309999999999999999997---3887651667763345543220
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 995227756799999876311233486554571323015-8896357898999999999499999898631000337667
Q 002533 699 KISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQ-QLTEKSDVYSFGVVLLEVLCGRPPMINGAVRKEEVSLVLW 777 (911)
Q Consensus 699 ki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGviL~ElltG~~p~~~~~~~~~~~~l~~~ 777 (911)
|++|||++.... .......|+..|+|||.+.+. .++.++||||+||++|||++|+.||.+...... ......
T Consensus 161 kl~dfg~a~~~~------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~ 233 (348)
T d2gfsa1 161 KILDFGLARHTD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILR 233 (348)
T ss_dssp EECCC----CCT------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred CCCCCCHHCCCC------CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHH
T ss_conf 013210001257------5444434543555835533775678551243205899999768899788988999-999997
Q ss_pred HHHHCCC---------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7653025---------------87100049211288894879999999984443359999998899999
Q 002533 778 ARVSRAR---------------GTVDQIVDPRLRGKIAPVCLNKFVEIAGSCTDEEGFRRPTMGDVTWG 831 (911)
Q Consensus 778 ~~~~~~~---------------~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 831 (911)
....... ....+.....+. .........+.+|+.+|++.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3079975773200102445444303557875556-6267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-45 Score=282.09 Aligned_cols=266 Identities=18% Similarity=0.181 Sum_probs=192.6
Q ss_pred CCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEECCEECC-
Q ss_conf 8766303222693799999960588089999825788565899999999987203-----------2317542330025-
Q 002533 548 DFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-----------HLHIVSLLGFCDE- 615 (911)
Q Consensus 548 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~- 615 (911)
+|...++||+|+||+||+|++..++..||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 5799899750778189999999999799999983431-336899999999998401455555422767647899876312
Q ss_pred -CCCEEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC
Q ss_conf -8705799952699853567643211011234689998714434477886879999976079995897332479856568
Q 002533 616 -HGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNILLDE 694 (911)
Q Consensus 616 -~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~ 694 (911)
....+++++++..+......... .....+++..+..++.|++.||+|||+ ..+|+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK---------YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH---------TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHEEEEC
T ss_conf 565202343200035420000012---------234678689999999999999888764--058646567705705630
Q ss_pred CC------CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99------669952277567999998763112334865545713230158896357898999999999499999898631
Q 002533 695 NW------AAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLLEVLCGRPPMINGAVR 768 (911)
Q Consensus 695 ~~------~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ElltG~~p~~~~~~~ 768 (911)
++ .++++|||.+..... ......|+..|+|||++.+..++.++||||+||+++||++|+.||......
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred CCCCCCCCEEEEEECCCCCCCCC------CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 57656443056753144212344------542236652105713214667776432012378999998788998987554
Q ss_pred HHH---HHHHHHHHHHCC------------------CCCCCCCCCC---------CCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 000---337667765302------------------5871000492---------1128889487999999998444335
Q 002533 769 KEE---VSLVLWARVSRA------------------RGTVDQIVDP---------RLRGKIAPVCLNKFVEIAGSCTDEE 818 (911)
Q Consensus 769 ~~~---~~l~~~~~~~~~------------------~~~~~~i~d~---------~l~~~~~~~~~~~l~~li~~Cl~~d 818 (911)
... ..+......... ......+... .............+.+|+.+|+..|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred CCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 32102689999999837998788624532200013201220243235776444210001567435899999999987799
Q ss_pred CCCCCCHHHHHHH
Q ss_conf 9999998899999
Q 002533 819 GFRRPTMGDVTWG 831 (911)
Q Consensus 819 P~~RPt~~eVl~~ 831 (911)
|.+|||++|++++
T Consensus 316 P~~Rpta~e~L~H 328 (362)
T d1q8ya_ 316 PRKRADAGGLVNH 328 (362)
T ss_dssp TTTCBCHHHHHTC
T ss_pred HHHCCCHHHHHCC
T ss_conf 4579089999669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.4e-25 Score=164.23 Aligned_cols=170 Identities=18% Similarity=0.145 Sum_probs=117.5
Q ss_pred CCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCH------------------HHHHHHHHHHHHHHHCCCCCEEEECC
Q ss_conf 663032226937999999605880899998257885------------------65899999999987203231754233
Q 002533 550 ADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSM------------------QGAREFRTEIEMISELRHLHIVSLLG 611 (911)
Q Consensus 550 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~g 611 (911)
..+++||+|+||+||+|.+.++ ..||||+++.... ........|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g-~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTT-EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECCCC-CEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 2277802485659999997999-999999986044346665565630008889999997789999999816999144998
Q ss_pred EECCCCCEEEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEE
Q ss_conf 00258705799952699853567643211011234689998714434477886879999976079995897332479856
Q 002533 612 FCDEHGEMILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHAGAKHTIIHRDVKSTNIL 691 (911)
Q Consensus 612 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 691 (911)
+. ..+++|||++++.+.+ ++......++.|++.+|+||| +++|+||||||+|||
T Consensus 82 ~~----~~~lvme~~~~~~~~~-------------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NIL 135 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-------------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL 135 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-------------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred EC----CCEEEEEEECCCCCCC-------------------HHHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHEE
T ss_conf 62----8889999504565420-------------------015789999999999999982---688898368903611
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHH
Q ss_conf 56899669952277567999998763112334865545713230158896357898999999
Q 002533 692 LDENWAAKISDFGLSRMGPSGMSQSHVSTVVKGSFGYVDPEYIRRQQLTEKSDVYSFGVVLL 753 (911)
Q Consensus 692 l~~~~~vki~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGviL~ 753 (911)
++++ .++|+|||++.............. .... -.+. ..+.|+.++|+||..--++
T Consensus 136 v~~~-~~~liDFG~a~~~~~~~~~~~l~r----d~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEEGWREILER----DVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EETT-EEEECCCTTCEETTSTTHHHHHHH----HHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EECC-CEEEEECCCCCCCCCCCCHHHHHH----HHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 4289-899987788430899870999987----7999-9999-7578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.07 E-value=8e-10 Score=71.81 Aligned_cols=149 Identities=15% Similarity=0.115 Sum_probs=91.8
Q ss_pred HHHHHCCCCCCCEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEECCCCCE
Q ss_conf 99987048766303222693799999960588089999825788565899999999987203-23175423300258705
Q 002533 541 EIKQATCDFADHCIIGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELR-HLHIVSLLGFCDEHGEM 619 (911)
Q Consensus 541 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 619 (911)
+++..-..+...+..+.+....||+....+ ..+.+|+...........+.+|...+..+. +--+.+++.++..++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~--~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGEN--ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSS--CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEECC--CEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 999751352799767899877189999089--869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------
Q ss_conf 7999526998535676432110112346899987144344778868799999760-------------------------
Q 002533 620 ILVYEFMPRGNLRDHLYNSQKQNQNQNQNQNSPLTWKRRLEISIGAARGLHYLHA------------------------- 674 (911)
Q Consensus 620 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i~~~ia~gL~yLH~------------------------- 674 (911)
++||+++++.++.+..... ...-.++.++++.+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred EEEEEECCCCCCCCCCCCC-----------------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 9999860433435433440-----------------26999999899999998556842143576446565557789987
Q ss_pred -------------------------------CCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -------------------------------7999589733247985656899669952277567
Q 002533 675 -------------------------------GAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 675 -------------------------------~~~~~ivH~DLkp~NILl~~~~~vki~DFGla~~ 708 (911)
.....++|+|+.+.|||++++...-|.||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 76555543033232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.41 E-value=1.9e-06 Score=51.99 Aligned_cols=151 Identities=19% Similarity=0.200 Sum_probs=81.9
Q ss_pred EECCCCC-EEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC--CCEEEECCEECCCCCEEEEEEECCCCC
Q ss_conf 3222693-7999999605880899998257885658999999999872032--317542330025870579995269985
Q 002533 554 IIGSGGF-GHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRH--LHIVSLLGFCDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 554 ~LG~G~f-G~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gs 630 (911)
.+..|.. ..||+....++. .+.+|....... ..+..|...++.+.. ..+.++++++..++..++||+++++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~-~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRP-VLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSC-CEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred ECCCCCCCCEEEEEEECCCC-EEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 76786547758999938987-899995896677---68999999999998659998861322245661599987441355
Q ss_pred HHHHH-------HHHHHCCCCCCCC--CCCCCCH--HHHH--------------------HHHHHHHHHHHHHHH----C
Q ss_conf 35676-------4321101123468--9998714--4344--------------------778868799999760----7
Q 002533 631 LRDHL-------YNSQKQNQNQNQN--QNSPLTW--KRRL--------------------EISIGAARGLHYLHA----G 675 (911)
Q Consensus 631 L~~~L-------~~~~~~~~~~~~~--~~~~l~~--~~~l--------------------~i~~~ia~gL~yLH~----~ 675 (911)
+.+.. ......-...+.. ...+..+ ...+ .........+..+.. .
T Consensus 93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC
T ss_conf 43221268999999999999873688544887554124688999999875411011340112137999999998718765
Q ss_pred CCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 999589733247985656899669952277567
Q 002533 676 AKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 676 ~~~~ivH~DLkp~NILl~~~~~vki~DFGla~~ 708 (911)
....++|+|+.+.|||++++..+-|+||+.+..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.36 E-value=2.1e-06 Score=51.71 Aligned_cols=156 Identities=17% Similarity=0.182 Sum_probs=82.1
Q ss_pred EEECCCCCEEEEEEEEECCCEEEEEEECCCC----C---HHHHHHHHHHHHHHHHCC-C--CCEEEECCEECCCCCEEEE
Q ss_conf 0322269379999996058808999982578----8---565899999999987203-2--3175423300258705799
Q 002533 553 CIIGSGGFGHVFKGYIDDGSITVAVKRLNTS----S---MQGAREFRTEIEMISELR-H--LHIVSLLGFCDEHGEMILV 622 (911)
Q Consensus 553 ~~LG~G~fG~Vy~g~~~~~~~~vavK~l~~~----~---~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~lV 622 (911)
+.||.|....||+.....++..+.||.-... . .....+...|.+.|+.+. + ..+.+++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEEE
T ss_conf 98079852768999957998489996177130346777888778999999999986505798855289985--9887798
Q ss_pred EEECCCCCH-HHHHHHHHH-----------------CCCC------------------------------CC--CCCCCC
Q ss_conf 952699853-567643211-----------------0112------------------------------34--689998
Q 002533 623 YEFMPRGNL-RDHLYNSQK-----------------QNQN------------------------------QN--QNQNSP 652 (911)
Q Consensus 623 ~Ey~~~gsL-~~~L~~~~~-----------------~~~~------------------------------~~--~~~~~~ 652 (911)
||++++..+ ...+..... .... .. ......
T Consensus 110 mE~L~~~~~~~~~l~~~~~~~~~a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~~~~ 189 (392)
T d2pula1 110 MEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTND 189 (392)
T ss_dssp ECCCTTSEEHHHHHHHTCCCTTHHHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCTTCC
T ss_pred EECCCCCCCCHHHHCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHH
T ss_conf 71357765302220154212899999999999999873503344211101233446578887777640104788988741
Q ss_pred CCHHHHHHHH------HHHHHHHHHHH---HCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 7144344778------86879999976---079995897332479856568996699522775679999
Q 002533 653 LTWKRRLEIS------IGAARGLHYLH---AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMGPSG 712 (911)
Q Consensus 653 l~~~~~l~i~------~~ia~gL~yLH---~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla~~~~~~ 712 (911)
+... ....+ ..+...+..|. ......++|+|+.+.|||++++ .++|.||..+..++..
T Consensus 190 ~~~~-~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G~~~ 256 (392)
T d2pula1 190 FEEE-LRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEH-ETKVIDPEFAFYGPIG 256 (392)
T ss_dssp CCGG-GHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSS-CEEECCCTTCEEECTH
T ss_pred CCHH-HHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCC-CEEEECHHHCCCCCHH
T ss_conf 0654-55778765520789999999874323688600335776784667599-3089522652228789
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.92 E-value=9.2e-05 Score=42.13 Aligned_cols=168 Identities=11% Similarity=0.038 Sum_probs=86.7
Q ss_pred CCCHHHHHHHCCCCCCCEE-----ECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEE--E
Q ss_conf 6797899987048766303-----22269379999996058808999982578856589999999998720323175--4
Q 002533 536 RFSLTEIKQATCDFADHCI-----IGSGGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV--S 608 (911)
Q Consensus 536 ~~~~~el~~at~~f~~~~~-----LG~G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv--~ 608 (911)
..+..|+.....+|..+.+ |..|---+.|+....++ .+++|+..... ..+++..|++++..|...++. .
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g--~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC--CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 88999999999867999856852378885267389997897--28999807899--988999999998754302555455
Q ss_pred ECCE------ECCCCCEEEEEEECCCCCHHHHH--------------HHHHHCCCCCCCCCCCCCC--------------
Q ss_conf 2330------02587057999526998535676--------------4321101123468999871--------------
Q 002533 609 LLGF------CDEHGEMILVYEFMPRGNLRDHL--------------YNSQKQNQNQNQNQNSPLT-------------- 654 (911)
Q Consensus 609 l~g~------~~~~~~~~lV~Ey~~~gsL~~~L--------------~~~~~~~~~~~~~~~~~l~-------------- 654 (911)
.+-. .........++.+..+......- +....... ..........
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFE-IKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCC-CCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred CCEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCCCCHHHCCHHHHHHHHHHH
T ss_conf 6410489762134125502453114655333204678888899876454443202-453101110120024567777653
Q ss_pred --HHHHHHHHHHHHHHHHHHH-HCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --4434477886879999976-07999589733247985656899669952277567
Q 002533 655 --WKRRLEISIGAARGLHYLH-AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRM 708 (911)
Q Consensus 655 --~~~~l~i~~~ia~gL~yLH-~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla~~ 708 (911)
.......+..+...+.-.+ .....+++|+|+.+.||+++.+...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 114127999999987642048554545033378636564020454126742221236
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.91 E-value=3.4e-05 Score=44.66 Aligned_cols=145 Identities=13% Similarity=0.125 Sum_probs=77.5
Q ss_pred CCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCE--EEECCE-----ECCCCCEEEEEEECCCCC
Q ss_conf 6937999999605880899998257885658999999999872032317--542330-----025870579995269985
Q 002533 558 GGFGHVFKGYIDDGSITVAVKRLNTSSMQGAREFRTEIEMISELRHLHI--VSLLGF-----CDEHGEMILVYEFMPRGN 630 (911)
Q Consensus 558 G~fG~Vy~g~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~g~-----~~~~~~~~lV~Ey~~~gs 630 (911)
+.--.||++..+++ ..+++|..+.. ....+++..|...+..|....+ +..+.. ....+..+.++++++|..
T Consensus 33 s~EN~vy~v~~~dg-~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDR-RRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTC-CCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CCCCEEEEEECCCC-CEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCC
T ss_conf 61202699983899-97999984787-78899999999999999855998787520689805665347999986527768
Q ss_pred HHH----HH----------HHHHHCCCCCCCCCCCCCCHH-------------------HHHHHHHHHHHHHHHHH----
Q ss_conf 356----76----------432110112346899987144-------------------34477886879999976----
Q 002533 631 LRD----HL----------YNSQKQNQNQNQNQNSPLTWK-------------------RRLEISIGAARGLHYLH---- 673 (911)
Q Consensus 631 L~~----~L----------~~~~~~~~~~~~~~~~~l~~~-------------------~~l~i~~~ia~gL~yLH---- 673 (911)
+.. .+ |..... .....+..+++. .+-.+...+.+.++.+.
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~---~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRK---QLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTS---SCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 8999999999989999998863035---7865567789788766568999874769988989999999999999998454
Q ss_pred HCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 079995897332479856568996699522775679
Q 002533 674 AGAKHTIIHRDVKSTNILLDENWAAKISDFGLSRMG 709 (911)
Q Consensus 674 ~~~~~~ivH~DLkp~NILl~~~~~vki~DFGla~~~ 709 (911)
.....+++|+|+.+.|||++++ ..+.||+.+...
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred CCCCCEEECCCCCCCCEEEECC--CEEEECHHCCCC
T ss_conf 5687120247888042878389--358865201468
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.77 E-value=0.00016 Score=40.64 Aligned_cols=75 Identities=16% Similarity=0.166 Sum_probs=48.5
Q ss_pred CEEECCCCCEEEEEEEEECC-------CEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEE-EECCEECCCCCEEEEE
Q ss_conf 30322269379999996058-------808999982578856589999999998720323175-4233002587057999
Q 002533 552 HCIIGSGGFGHVFKGYIDDG-------SITVAVKRLNTSSMQGAREFRTEIEMISELRHLHIV-SLLGFCDEHGEMILVY 623 (911)
Q Consensus 552 ~~~LG~G~fG~Vy~g~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~ 623 (911)
...|+.|---.+|+.....+ ...|.+++..... ......+|..+++.+.-.++. ++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCC--HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 9991785334348999688775445789817999659961--165899999999999757999808998189----5699
Q ss_pred EECCCCCHH
Q ss_conf 526998535
Q 002533 624 EFMPRGNLR 632 (911)
Q Consensus 624 Ey~~~gsL~ 632 (911)
||+++..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEECCCCCC
T ss_conf 973455488
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=96.00 E-value=0.027 Score=27.61 Aligned_cols=80 Identities=15% Similarity=0.172 Sum_probs=37.5
Q ss_pred CCEEEEECCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCCCEEEEEECCEEEEECCCCCCCCCCCCCCCCCEEEEEEEEC
Q ss_conf 50685407888289996227963234446999875665420599996754996146843211223787631279999852
Q 002533 97 FTYTFPVSPGPKFLRLHFYPAPYLLGQQQGGLDNNDTISTSFFTVSANKYTLLRNFSAHLTVSAIIPPVAYFFKEFIISV 176 (911)
Q Consensus 97 ~~Y~~~~~~g~~~lR~~f~~~~~~~~~~~g~~d~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~i~~ 176 (911)
+.|.++++.|.+-++++|-.. . ...+.+.+-..+..+.. +..-+.|.|.|
T Consensus 65 ~~f~v~vPnG~Y~Vtv~~Gd~------------~-------~~~~~~eg~~~~~~~~g-----------~~~~~~~~V~V 114 (146)
T d2o14a1 65 NTFNVDLPNGLYEVKVTLGNT------------A-------RASVAAEGVFQVINMTG-----------DGAEDTFQIPV 114 (146)
T ss_dssp CCEEEECCSEEEEEEEEESSC------------S-------EEEEEETTEEEEEEEES-----------TTCEEEEEEEE
T ss_pred CEEEEECCCCEEEEEEEEECC------------C-------CCCEEEEEEEECCCCCC-----------CCEEEEEEEEE
T ss_conf 669998899718999999367------------7-------76277851780026687-----------31778999998
Q ss_pred CCCCEEEEEEECCCCCCCEEEEEEEEEECCC
Q ss_conf 8987289998139998640464247685089
Q 002533 177 SSSQMLNLTFSPSSSSSYAFINGIEVVSMPD 207 (911)
Q Consensus 177 ~~~~~~~v~~~~~~~~~~~fi~~iE~~~~~~ 207 (911)
.. +.|+|-|....+...|-||+|||.+.++
T Consensus 115 tD-G~L~l~ft~~~~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 115 TD-GQLNLLVTEGKAGTAFTLSALKIKKLSD 144 (146)
T ss_dssp CS-SEEEEEEEESSTTSCCEEEEEEEEEEES
T ss_pred EC-CEEEEEEECCCCCCCCEEEEEEEEECCC
T ss_conf 79-9487998437789863887999982266
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=95.42 E-value=0.03 Score=27.36 Aligned_cols=141 Identities=15% Similarity=0.128 Sum_probs=72.2
Q ss_pred EEEEECCCCCCC-CCC-CCCCCCCCCCCCCCEECCCCCCCCCCCCCCEEECCCCCCCCCHHHHHHHHHCCCCCCCCCCCE
Q ss_conf 888605897656-899-875533323688851026999865777873233489997447257888420038887876431
Q 002533 240 AYRLNVGGAHVS-AKD-DTGMFREWLDDTNYIYGAASGVTPHLPGARIKYTSDTPAYIAPVIVYTTSRTMGKDPNINKKY 317 (911)
Q Consensus 240 ~~R~n~G~~~~~-~~~-dd~~~R~W~~d~~~~~~~~s~~~~~~~~~~i~~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~ 317 (911)
+||+.+|...+- -|- ++ .+-.|.++..|-|....... ..... . ..+-..... ...... .-
T Consensus 2 ~~~fDfg~g~~~~Gy~~v~-~~~~ys~~~GYG~~~~~~~~------~r~~~-------~-~~~~~d~~~-~~~~~~--~~ 63 (146)
T d2o14a1 2 VYQFDFGSGSMEPGYIGVR-ASDRYDRSKGYGFQTPENMR------DVAAS-------G-AGVKSDAVE-FLAYGT--KS 63 (146)
T ss_dssp EEEEEESSSCCCTTSEEEC-TTCBCBTTTTEEESCGGGEE------EEECS-------S-SGGGGEEEE-ESSCST--TC
T ss_pred CEEECCCCCCCCCCEEEEC-CCCEECCCCCCCEECCCCCC------CCCCC-------C-CCCCCCHHH-HCCCCC--CC
T ss_conf 3587789997866627505-67410388860431577620------00244-------7-653233123-214565--88
Q ss_pred EEEEEEECCCCCCEEEEEEEEEEEEECCCCCCEEEEEEECCEECCCCCCCHHCCCCCCCCEEEEEEEEEECCCCCCCCCC
Q ss_conf 24687641899803899954554320134671799999908021455530010278883189877999622300124531
Q 002533 318 NLTWNFSVDPGFNYLVRLHFCETQLEITRENQRVFSIFINNQTAENDADVIHWSGGSGIPVFKDYVVWVPIDAIEKESKQ 397 (911)
Q Consensus 318 ~lt~~~~~~~~~~y~v~lhFae~~~~~~~~~~R~F~i~ing~~~~~~~~i~~~~~~~~~p~~~~~~v~~~~~~~~~~~~~ 397 (911)
...|.++|+.| .|.|.++|.|... .++.+.|+....++ ++. ...+.|.|.+. ++
T Consensus 64 ~~~f~v~vPnG-~Y~Vtv~~Gd~~~---------~~~~~eg~~~~~~~-----~g~---~~~~~~~V~Vt--------DG 117 (146)
T d2o14a1 64 NNTFNVDLPNG-LYEVKVTLGNTAR---------ASVAAEGVFQVINM-----TGD---GAEDTFQIPVT--------DG 117 (146)
T ss_dssp SCCEEEECCSE-EEEEEEEESSCSE---------EEEEETTEEEEEEE-----EST---TCEEEEEEEEC--------SS
T ss_pred CCEEEEECCCC-EEEEEEEEECCCC---------CCEEEEEEEECCCC-----CCC---CEEEEEEEEEE--------CC
T ss_conf 86699988997-1899999936777---------62778517800266-----873---17789999987--------99
Q ss_pred EEEEEECCCCCCCCCCCCHHCCCCCCEEEEEEC
Q ss_conf 179985367789999952000025614567407
Q 002533 398 DFWLALHPFLDLDPLPKYADAILNGLEIFKLNN 430 (911)
Q Consensus 398 ~l~~~~~p~~~~~~~~~~~~a~ln~~el~~~~~ 430 (911)
.|.+.+..-. .-..+.+|.+|+.++..
T Consensus 118 ~L~l~ft~~~------~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 118 QLNLLVTEGK------AGTAFTLSALKIKKLSD 144 (146)
T ss_dssp EEEEEEEESS------TTSCCEEEEEEEEEEES
T ss_pred EEEEEEECCC------CCCCCEEEEEEEEECCC
T ss_conf 4879984377------89863887999982266
|